Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anterograde trans-synaptic signaling (GO:0098916),0.6310051591786989,2.69634185255351,0.0,0.0,0.0,81/224,11.89%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;CHRM3;GABRA2;GRM1;GLRA1;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;GRIN2B;HCRTR1;SNCA;APBA2;SLC18A3;CAMK4;GABRB2;SLC1A1;GLRA3;GRIK2;SLC12A6;KCNN1;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1
prerank,chemical synaptic transmission (GO:0007268),0.6017568309039767,2.6299102739049984,0.0,0.0,0.0,98/284,11.92%,GRIA2;GABRB3;DLG2;GRM5;KCND2;GABRA5;GRIN1;NRXN1;CACNA1A;GABRB1;RIT2;GRIA4;DLGAP1;PTPRN2;CDH8;SYT1;MTNR1B;MBP;CACNA1B;PRKAR2B;RIMS1;SYN2;PTCHD1;PLP1;GRM7;ASIC2;NLGN1;KCNQ3;SHISA6;CHRM3;GABRA2;ERC2;GRM1;GLRA1;GRID1;GRID2;GRIN2A;GABRG3;DOC2A;GABRA3;MPZ;SNAP25;GRIA1;GRIK1;HTR2C;GABRA4;LIN7A;GRIN2B;HCRTR1;SNCA;APBA2;SLC17A6;SLC18A3;CAMK4;GABRB2;SLC1A1;GRIN2D;GLRA3;GRIK2;GRIK5;DLGAP2;UNC13A;SLC12A6;KCNN1;HSPA8;PPFIA3;SLC1A2;NRXN2;GABARAP;KCNMB4;CACNA1E;AMPH;SNPH;SLC6A2;SLC6A5;CACNB2;GRIA3;HOMER1;SYT10;GABRD;RPS6KA1;PCDHB6;GABRG2;SST;GPR176;GLRA2;HCRTR2;RPS6KA2;GAD1;CPLX1;CACNB4;HAP1;KCNQ2;CALM1;NRGN;PNOC;NPTX1;DVL1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6698238515610755,2.489713880602873,0.0,0.0,0.0,45/87,15.82%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29
prerank,cytoplasmic translation (GO:0002181),0.6617596661070899,2.486165948346587,0.0,0.0,0.0,56/91,19.67%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPL22L1;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;EIF3I;EIF2B3;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;RPS25;RPS29;RWDD1;RPS9;RPL31;RPL19;RPL3;RPS10;EIF4A1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6611246581550076,2.47102471765573,0.0,0.0,0.0,47/91,15.82%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;ARL6IP1;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;RPS25;RPS29
prerank,protein targeting to ER (GO:0045047),0.6163515953320368,2.326622829043928,0.0,0.00013134022457046555,0.001,48/99,15.82%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS8;RPS16;RPS27A;RPLP1;SGTB;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;RPL14;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28;SRPRA;SEC61G;RPS25;RPS29
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6617199160130647,2.312700297704666,0.0,0.00022515467069222667,0.002,24/57,11.89%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;DLGAP1;LRRC7;NLGN1;SHISA6;MAPK8IP2;NETO1;GRIN2A;GRIA1;GRIN2B;DLGAP2;CACNG2;SHISA8;SHISA7;GRIA3;CACNG3;RELN;OPRM1;CACNG8;NPTX1
prerank,response to copper ion (GO:0046688),0.8240879296699706,2.296970592775429,0.0,0.00019701033685569832,0.002,11/20,7.24%,MT2A;SNCA;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;ATP5F1D
prerank,glutamate receptor signaling pathway (GO:0007215),0.720087362925955,2.2947314349724337,0.0,0.0001751202994272874,0.002,17/37,10.22%,GRIA2;GRM5;GRIN1;GRIA4;GRM7;GRM1;GRID2;GRIN2A;GRM8;GRIK1;GRIN2B;GRIK2;PLCB1;GRIA3;HOMER1;GRIN3A;HOMER2
prerank,cellular response to copper ion (GO:0071280),0.8693120771359449,2.2933006376303027,0.0,0.00015760826948455866,0.002,10/16,5.22%,MT2A;SNCA;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5723978835850742,2.206034695372022,0.0,0.00028656048997192484,0.004,50/110,14.46%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;RPS28
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6975598515866421,2.1767117461620575,0.0,0.0007880413474227933,0.011,15/34,8.57%,MPP2;GABRA5;GRIN1;MAPK8IP2;GABRA2;GLRA1;GRID2;GRIN2A;GABRG3;GABRA3;GABRA4;GRIN2B;GRIN2D;AKT1;GABRG2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5568302325722617,2.16932748781672,0.0,0.0007880413474227933,0.012,32/107,7.67%,CAMK2A;NRG3;GRM5;CACNA1A;DLGAP1;LRP8;LRRC4C;SYT1;CACNA1B;RIMS1;GRM7;DGKI;TMEM108;NLGN1;MAPK8IP2;GRM1;RIMS2;GRID1;GRID2;GRM8;MCTP1;CDH2;GRIK1;RIMS3;GRIK2;GRIK5;DLGAP2;UNC13A;KCNMB4;KCTD13;HOMER1;CLSTN3
prerank,extracellular structure organization (GO:0043062),-0.508440632918931,-2.1649110072955784,0.0,0.0023883383064908495,0.002,72/204,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,response to zinc ion (GO:0010043),0.725659235738166,2.1565168260557988,0.0,0.0007880413474227933,0.013,14/25,11.74%,MT2A;GLRA1;KHK;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SLC30A3;GLRA2;SLC30A5
prerank,regulation of NMDA receptor activity (GO:2000310),0.7015933116770313,2.1555240083047775,0.0,0.000735505257594607,0.013,15/32,9.60%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;NLGN1;MAPK8IP2;GRIN2A;GRIA1;GRIN2B;GRIA3;CCL2;RELN;OPRM1
prerank,cellular response to zinc ion (GO:0071294),0.8184407446614214,2.1520071455509893,0.0,0.0007387887632088688,0.014,11/15,9.43%,MT2A;GLRA1;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;GLRA2
prerank,collagen fibril organization (GO:0030199),-0.5685248100535181,-2.135862361709366,0.0,0.004179592036358986,0.006,31/88,11.18%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;COL8A1;COL5A1;COL4A6;COL1A1;COL12A1;COL22A1;COL4A3;LOXL1;COL6A3;COL4A4;COL23A1;COL25A1;COL6A1;COL8A2;COL26A1;PLOD2;COL6A2;COL15A1;CYP1B1;COL13A1;COL18A1;LAMA3;COL5A3;COL27A1;P4HA2
prerank,peptide biosynthetic process (GO:0043043),0.5255896570521215,2.1267611473345287,0.0,0.0009734628409340388,0.02,70/153,19.34%,RPS6;RPS19;RPS20;RPL38;RPL29;PCSK1;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;CARNS1;MRPL13;RPL13;MRPS18A;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;GGT7;RPL5;FARSB;RPS4X;RPL21;GGT1;RPS7;RPL23A;EEF1A2;RPL8;MRPL36;MRPL23;RPS14;RPS3;RPS2;RPS5;EEF1A1;RPL18A;RPS28;RPS25;RPS29;HBS1L;TNIP1;MRPS5;RPS9;RPL31;MRPL18;RPL19;RPL3;RPS10
prerank,neurotransmitter secretion (GO:0007269),0.6465084541147703,2.12288282893118,0.0,0.0009631616468500807,0.021,19/44,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;RIMS2;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6647207556464385,2.120710915731678,0.0,0.0009539447889854867,0.022,11/35,9.35%,CDH12;CDH8;NLGN1;CDH7;CDH19;CDH20;PCDHGB4;CDH18;CDH10;PCDHB6;DCHS1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.8551142318907367,-2.1191713994238564,0.0,0.003582507459736274,0.007,8/13,7.78%,AKAP13;ROCK2;ASAP3;ROCK1;ALMS1;SLC9A1;FHOD1;CDC42
prerank,synapse assembly (GO:0007416),0.5923978924306207,2.110482799268648,0.0,0.0011032578863919105,0.027,23/67,9.16%,SPOCK2;DNM3;DSCAM;KIRREL3;GABRB3;ADGRL3;NRXN1;LRRTM3;NLGN1;GPM6A;GABRA2;GRID2;DNER;SHANK3;CDH2;FGF13;GABRB2;NRXN2;NRCAM;LGI2;PCDHB6;GABRG2;SHANK2
prerank,external encapsulating structure organization (GO:0045229),-0.4968230140445425,-2.1094605342200006,0.0,0.0029854228831135616,0.008,71/205,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;ADAMTSL5;ITGAV;LOXL1;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL6A1;ITGA10;COL8A2;FBLN5;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;ADAM19;ADAMTS15;MMP2;LUM;FN1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5123586857197062,2.0901843749273255,0.0,0.0015010311379481777,0.038,54/159,12.49%,CLDN5;DSCAM;BSG;KIRREL3;ADGRL3;HMCN1;CDH12;CDH8;PTPRD;LRRC4C;CADM1;IGSF11;MAG;LRFN5;IL1RAPL1;NLGN1;TENM2;PLXNB3;CDH7;CDH19;CDH20;GRID2;TENM1;PCDHGB4;PTPRT;CDH18;MPZ;CDH2;ROBO4;CNTN6;TENM4;CDH10;TGFB2;DSCAML1;CLDN14;UNC5D;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;LRRC4B;ROBO2;NTNG1;DCHS1;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;CRB1;NECTIN1;CNTN2;ITGAM
prerank,chloride transmembrane transport (GO:1902476),0.6226949561940291,2.0871485538944743,0.0,0.0015044425723526053,0.039,20/48,11.00%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2;CLCN1
prerank,positive regulation of synaptic transmission (GO:0050806),0.5777543189529841,2.071836043823209,0.0,0.0019529720349173575,0.052,26/72,10.81%,MPP2;SLC24A2;NRXN1;SYT1;RIMS1;ADCY8;NLGN1;RIMS2;GRIN2A;SHANK3;RIMS3;GRIN2B;GRIN2D;GRIK2;CACNG2;NPTN;KCTD13;SHISA7;CLSTN3;CACNG3;ADRA1A;CCL2;RELN;SHANK2;CACNG8;HAP1
prerank,signal release from synapse (GO:0099643),0.6349354734994087,2.068833675787799,0.0,0.0019044332562717504,0.052,18/43,11.92%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;PCLO;SNAP25;LIN7A;SNCA;UNC13A;HSPA8;PPFIA3;NRXN2;SNPH;SYT10;GAD1;CPLX1;DVL1
prerank,regulation of cation channel activity (GO:2001257),0.540465187276434,2.0333134916933737,0.0,0.0036880335059386728,0.098,32/89,11.22%,CAMK2A;GRIA2;DLG2;GRIN1;GRIA4;LRRC7;FGF12;NLGN1;SHISA6;MAPK8IP2;FGF14;NETO1;GRIN2A;ANK3;GRIA1;FGF13;GRIN2B;CACNG2;SHISA8;SHISA7;CACNB2;GRIA3;HOMER1;EPO;KCNAB1;CACNG3;RELN;OPRM1;CACNG8;CACNB4;CALM1;JPH3
prerank,regulation of glucose import (GO:0046324),-0.6670919582405669,-2.0330383358638535,0.0,0.015763032822839605,0.058,11/30,4.55%,PRKAG2;IGF1;PID1;RHOQ;SORBS1;APPL2;GRB10;ENPP1;OSBPL8;IRS1;CREBL2
prerank,bone development (GO:0060348),-0.6233122349712988,-2.0275077266394574,0.0,0.01512614260777538,0.065,13/39,12.29%,AKAP13;RANBP3L;SULF1;LRP6;SH3PXD2B;CYP26B1;SULF2;SKI;FGFR2;SLC10A7;GJA1;MBTPS2;GNAS
prerank,cellular zinc ion homeostasis (GO:0006882),0.6849717444121134,2.0249880775510802,0.0,0.003879588171927598,0.105,13/26,11.74%,SLC39A10;MT2A;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SLC30A1;SLC39A8;SLC30A5
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6009644048782858,1.999152998449706,0.0,0.006275144062811132,0.174,19/46,10.73%,GRM5;NRXN1;SYT1;GRM7;DGKI;NLGN1;MAPK8IP2;GRM1;GRM8;SHANK3;CDH2;GRIK1;CACNG2;UNC13A;HOMER1;CACNG3;CCL2;RELN;CACNG8
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.7460125548412523,1.999075615812772,0.0,0.006051031774853592,0.174,9/18,4.96%,GRIA2;CDH8;GRID1;GRID2;GRIK1;SLC17A6;GRIK2;GRIK5;UNC13A
prerank,extracellular matrix organization (GO:0030198),-0.45506391100249205,-1.9817168976527713,0.0,0.027636486117965542,0.138,82/276,12.79%,COL1A2;LAMA2;FBN1;COL3A1;SMOC1;COL4A5;COL5A2;ADAMTS2;ADAMTS10;TGFBR1;ITGA9;DAG1;ADAMTS12;THSD4;ADAMTSL3;COL8A1;COL5A1;COL4A6;COL1A1;GSN;COL12A1;COL22A1;DCN;NID1;ADAMTS6;COL4A3;FLRT2;ADAMTSL5;ITGAV;LOXL1;SH3PXD2B;LAMA1;COL6A3;ECM2;LAMC3;BGN;COL4A4;ELN;VTN;COL23A1;SPARC;COL25A1;COL6A1;ITGA10;COL8A2;FBLN5;COL26A1;PLOD2;HSPG2;ITGB1;VIT;MFAP5;THBS1;ADAMTS5;COL6A2;NID2;CDH1;ITGA11;ITGB5;ST7;COL15A1;RECK;ADAMTSL4;CYP1B1;ADAMTS9;COL13A1;TNC;ITGB8;COL18A1;LAMA3;LAMA4;COL5A3;COL27A1;MMP14;SH3PXD2A;P4HA2;ADAM19;ADAMTS15;MMP2;LUM;SCUBE1;FN1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.6619088594386591,-1.97439689714531,0.0,0.027764432812956125,0.157,13/27,10.72%,EGFR;DDX5;BMP4;TNRC6B;PUM2;WTIP;DDX6;EIF4ENIF1;STAT3;DHX9;PUM1;MAP2K1;LIMD1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6853929463786361,-1.969610908549876,0.0,0.027333205063173056,0.173,9/24,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,positive regulation of synapse assembly (GO:0051965),0.6628645053073579,1.9672388871641622,0.0,0.010353232874761526,0.288,10/27,8.03%,NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;SEMA4A;SEMA4D;CLSTN3;LRRC4B
prerank,actin filament bundle assembly (GO:0051017),-0.6362781106930513,-1.966767938764666,0.0,0.02627172137139934,0.185,7/33,3.47%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.665358611252074,-1.9591399015101845,0.0,0.027248768860418326,0.208,9/26,11.64%,SULF1;CCBE1;IL6ST;ARNT;SULF2;EIF2AK3;CYP1B1;HIF1A;RORA
prerank,eye morphogenesis (GO:0048592),-0.7220562533152225,-1.9551054320000252,0.0,0.026968320044125842,0.221,12/19,15.76%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;RARG;MFAP5;SKI;STAT3;NIPBL;VEGFA;FBN2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6205623416144803,1.9538849555674966,0.0,0.012871342007905623,0.346,11/33,4.69%,NRG3;CACNA1A;LRP8;LRRC4C;CACNA1B;NLGN1;GRID1;GRID2;GRIK1;GRIK2;GRIK5
prerank,embryonic limb morphogenesis (GO:0030326),-0.6177547225959018,-1.9500593772398758,0.00186219739292365,0.02700659469647345,0.236,17/34,17.05%,CACNA1C;GLI3;LRP6;AFF3;OSR1;CYP26B1;WDPCP;RARG;SKI;CREBBP;ECE1;MAP3K20;NIPBL;HDAC1;PTCH1;SALL1;TBX2
prerank,inorganic anion transmembrane transport (GO:0098661),0.5493098828748687,1.9473925244421684,0.0,0.013930537367344863,0.377,22/63,9.43%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;SLC37A4;ANO5;GABRD;SLC37A1;SLC25A14;GABRG2;ANO4;SLC12A3;GLRA2
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6927979382776116,-1.9449747945136677,0.0,0.02729529493132399,0.253,8/21,10.62%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4;CCN3;SMAD4
prerank,cell junction assembly (GO:0034329),0.5105405558578429,1.9436504609715812,0.0,0.014357128298359015,0.398,28/100,9.35%,SPOCK2;CLDN5;DNM3;DSCAM;KIRREL3;ADGRL3;NRXN1;CDH12;CDH8;ACTB;CTNND2;NLGN1;GPM6A;CDH7;CDH19;CDH20;ITGA6;DNER;CDH18;SHANK3;CDH2;CDH10;NRXN2;NRCAM;PCDHB6;VMP1;SHANK2;DCHS1
prerank,eye development (GO:0001654),-0.5684515683108227,-1.94115447857912,0.0,0.02746589052464477,0.269,15/54,6.59%,PBX1;CACNA1C;FBN1;SMOC1;COL5A2;EFEMP1;COL5A1;FOXC1;SH3PXD2B;LAMA1;SHROOM2;RBP4;PBX3;SKI;RAB3GAP1
prerank,chloride transport (GO:0006821),0.5283639902463261,1.9283712030345517,0.0,0.0186741919298371,0.492,21/74,9.43%,GABRB3;GABRA5;SLC4A1;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;CLIC5;GABRA4;GABRB2;SLC1A1;GLRA3;SLC12A6;ANO5;GABRD;GABRG2;ANO4;SLC12A3;GLRA2
prerank,dendrite self-avoidance (GO:0070593),0.7404234995823635,1.9259771054811476,0.0020408163265306124,0.018843459278080323,0.507,10/16,12.11%,DSCAM;BSG;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ROBO3;CNTN4;CNTN2
prerank,synaptic vesicle exocytosis (GO:0016079),0.5906635836004254,1.9254859020594055,0.002070393374741201,0.018462682996762587,0.51,14/40,11.21%,SYT1;RIMS1;PCLO;SYT7;RIMS2;SNAP25;RIMS3;SNCA;UNC13A;STX3;SNPH;SYT10;CPLX1;SYT2
prerank,regulation of regulated secretory pathway (GO:1903305),0.6081410697876249,1.9237936597239074,0.0,0.018431411514722,0.518,10/34,3.46%,SYT1;RIMS1;SYT6;SYT7;RIMS2;DOC2A;SYT12;SYT11;PREPL;RIMS3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8440758562446429,1.9213934933383143,0.0,0.018700008190194933,0.53,7/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,zinc ion homeostasis (GO:0055069),0.6346992955074057,1.9131240488493215,0.0,0.020966047427485368,0.583,13/28,11.74%,SLC39A10;MT2A;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SLC30A1;SLC39A8;SLC30A5
prerank,odontogenesis (GO:0042476),-0.6087412805910571,-1.9123091608102345,0.0,0.043213996233068805,0.409,11/35,6.61%,COL1A2;LRP6;ANKRD11;GLI2;FOXC1;BMP4;BCOR;EDA;OSR1;WNT6;FGFR2
prerank,neuron cell-cell adhesion (GO:0007158),0.7526758759761949,1.9122519300774656,0.0,0.02079216785892447,0.59,9/14,12.14%,NCAM2;NRXN3;NRXN1;NLGN1;ASTN1;NRXN2;ASTN2;CNTN4;RET
prerank,regulation of muscle contraction (GO:0006937),-0.6471128124022492,-1.9098909203709786,0.0,0.04179592036358986,0.419,5/26,2.75%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6
prerank,calcium-ion regulated exocytosis (GO:0017156),0.6348238280773236,1.90774744389151,0.0021598272138228943,0.021809044289925805,0.62,9/27,7.63%,SYT1;RIMS1;SYT6;SYT7;RIMS2;SYT12;SYT11;RIMS3;SYT10
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.782839120006093,-1.905271518965065,0.0,0.043122774978307,0.44,6/13,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;DAB2;BMP4
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.7331084890776688,-1.8984612131901075,0.0,0.04594408689591608,0.482,8/15,11.62%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,neuromuscular process controlling balance (GO:0050885),0.7818673818213254,1.8981763696280949,0.0020161290322580645,0.024256297084086956,0.661,2/12,0.54%,PCDH15;NRXN1
prerank,actin filament bundle organization (GO:0061572),-0.6219816794342983,-1.8965314089646936,0.0,0.04513959399267705,0.493,7/33,3.47%,CALD1;DPYSL3;PAWR;MYO1B;LIMA1;BAIAP2L1;SHROOM2
prerank,mRNA destabilization (GO:0061157),-0.5906829168697278,-1.8931125166607168,0.0,0.04543529302109973,0.512,12/38,9.95%,ROCK2;CELF1;FTO;DIS3L2;ROCK1;YTHDF3;MOV10;RC3H1;PUM1;TUT4;DHX36;UPF1
prerank,skeletal system development (GO:0001501),-0.46149222986208954,-1.8891830095169797,0.0,0.04592123198389223,0.532,40/148,13.93%,BMP6;AKAP13;COL1A2;SULF1;FBN1;IGF1;TGFBR1;SOX5;CREB3L2;COL1A1;PKD1;ANKRD11;GLI2;BMP5;WWOX;BMP7;SH3PXD2B;NPR3;PCSK5;CDH11;RBP4;EXT1;SULF2;ZBTB16;FGFR2;EIF2AK3;SLC10A7;IGF2;GJA1;TNFRSF11B;COL13A1;ITGB8;PRELP;MMP14;EVC;GNAS;SUFU;SOX6;CHD7;TRPS1
prerank,response to ethanol (GO:0045471),0.7368902800705832,1.8867485794831842,0.004366812227074236,0.028069282279630924,0.711,6/14,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;GLRA2;GRIN3A
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6765536791778667,-1.884493799138896,0.0019569471624266144,0.04740332334404664,0.555,8/20,6.42%,IGF1;LRP1;BMPR1A;IGFBP5;PDGFRB;VTN;IGFBP3;NRP1
prerank,translation (GO:0006412),0.4470877405958678,1.884208632687822,0.0,0.02835116196425724,0.721,86/208,20.34%,RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;VARS1;GARS1;RPL10A;RPS24;EEF1B2;RPL27A;RARS1;RPS17;RPL22L1;RPS6KB2;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TUFM;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;EIF4EBP2;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;RPS7;RPL23A;EEF1A2;RPL8;AIMP2;MRPL36;MRPL23;RPS14;GATB;RPS3;RPS2;IARS1;RPS5;EEF1A1;RPL18A;GATC;RPS28;RPS25;RPS29;RWDD1;HBS1L;TNIP1;MRPS5;NDUFA7;EEF2;RPS9;RPL31;MRPS28;MRPL18;RPL19;RPL3;RPS10;EEF1E1;MRPL37;MRPL2;ASMT
prerank,muscle organ development (GO:0007517),-0.5453607521870416,-1.8820752998151042,0.0,0.04672186812072725,0.563,19/54,15.24%,LAMA2;IGF1;LARGE1;FHL1;COL6A3;MEF2A;SPEG;ITGA11;MRAS;VAMP5;SMTN;CHD2;EVC;MEF2C;SRI;FKTN;SOX6;MKX;EMD
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6708962245713466,1.879789686978468,0.0,0.029372450222122298,0.739,7/20,8.01%,MRAP2;BICD1;STMN1;YWHAB;SNCA;GRK2;RNF157
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.592816675118928,-1.877209453921401,0.0,0.04900870204919222,0.598,15/35,10.58%,RBFOX2;ZMIZ1;DDX5;NR3C2;YAP1;DDX17;PPARGC1B;NR3C1;UBR5;TRIP4;AR;MED1;PMEPA1;TADA3;CALCOCO1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.637111389730038,1.8746179118798296,0.0,0.030716100519546208,0.767,9/25,7.97%,MPP2;GRIN1;MAPK8IP2;GLRA1;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,endodermal cell differentiation (GO:0035987),-0.6211104328252928,-1.8723838243307993,0.0019193857965451055,0.05121148484110186,0.62,17/31,19.87%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;CTR9;SETD2;LAMA3;MMP14;RTF1;MMP2;FN1;ITGA5;ITGA4;INHBA;CDC73
prerank,regulation of osteoblast differentiation (GO:0045667),-0.49674887367319914,-1.8711471993143065,0.0,0.05024356141062231,0.629,36/82,18.77%,BMP6;RANBP3L;IGF1;SMOC1;CRIM1;BMPR1A;WNT4;SMAD6;DDX5;BMP7;IL6ST;TMEM64;BMP4;YAP1;SKI;FGFR2;REST;NBR1;LIMD1;MEF2C;SUFU;IL6R;TRPM4;ATRAID;CCN1;ACVR1;PTCH1;RUNX2;FBN2;SUCO;TWIST2;CCN4;PRKACA;PRKD1;NPNT;BMP2
prerank,regulation of stress fiber assembly (GO:0051492),-0.5125614105642596,-1.8702287031319489,0.0,0.04891828638473222,0.632,24/74,7.95%,PHLDB2;ROCK2;LPAR1;ARHGAP6;TGFBR1;CGNL1;ASAP3;TPM1;ARHGAP28;CCN2;ROCK1;ABL1;ARHGEF10L;PPM1E;ARAP1;ALMS1;SLC9A1;WASF2;PAK2;NRP1;FHOD1;CDC42;RAPGEF3;S100A10
prerank,regulation of establishment of cell polarity (GO:2000114),-0.7090071650679457,-1.8655529656861796,0.0,0.05118456060289872,0.659,7/16,6.50%,ROCK2;GSN;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,regulation of AMPA receptor activity (GO:2000311),0.6189601899968203,1.8528439038317739,0.004166666666666667,0.0405498667249946,0.866,10/25,10.73%,NLGN1;SHISA6;MAPK8IP2;SHANK3;CACNG2;SHISA8;SHISA7;CACNG3;RELN;CACNG8
prerank,pteridine-containing compound metabolic process (GO:0042558),0.7372188857580417,1.8470072647816058,0.006369426751592357,0.04283926899287738,0.882,6/13,17.05%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5418435089637752,-1.8450599606105629,0.0019157088122605363,0.06460455119057748,0.76,20/46,15.53%,ZIC1;TCF7L2;SMAD3;XPO4;GSK3B;FLNA;KHDRBS1;UBR5;CDH1;DHX9;RAPGEF3;JUP;BAG3;PRKCD;MAVS;TPR;YWHAE;EMD;EFCAB7;ANP32B
prerank,cell-matrix adhesion (GO:0007160),-0.48245212090406486,-1.8412820216559154,0.0,0.06606451928438398,0.773,32/95,16.01%,ITGBL1;COL3A1;SORBS1;ADAMTS12;VCL;PKD1;ITGAV;ECM2;VTN;ITGA10;FBLN5;BCR;ITGB1;NID2;ITGA11;MKLN1;ITGB5;PTPRK;ACTN2;ADAMTS9;COL13A1;ITGB8;ADAM9;ZYX;FN1;CTTN;EMILIN1;MSLN;TMEM8B;WHAMM;DDR1;ITGA4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5443435218605325,-1.8383133103841844,0.0037593984962406013,0.06698542593986054,0.794,32/50,28.55%,ZIC1;GLI3;FBXL17;SMO;BTRC;DCDC2;TTC23;GPC3;IFT81;CREBBP;FGFR2;GAS1;TULP3;EVC;GLIS2;HERC4;RORA;SUFU;ARMC9;GLI1;PTCH1;WDR11;VCP;MEGF8;PDCL;DLG5;KIF7;MGRN1;GAS8;PTCH2;IFT122;KCTD6
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.6958573663412516,-1.8373934360888147,0.003937007874015748,0.06578786426061158,0.797,12/17,16.75%,PBX1;RBPJ;KAT2B;EP300;CREBBP;NOTCH3;MAML2;WWC1;MAML1;STAT1;PLXND1;HEYL
prerank,transcription by RNA polymerase II (GO:0006366),-0.41144133523855025,-1.8349479786812501,0.0,0.06624126538296679,0.803,132/305,28.25%,NOTCH2;MLLT3;MAF;SOX5;TEAD1;PRRX1;NFKB1;RBPJ;THRB;DDX5;GLIS3;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;CCNT2;NR3C2;PABPN1;TBL1X;CCNH;TBL1XR1;NR6A1;NFIX;RREB1;CCNT1;INTS4;YAP1;PCF11;WDR33;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;SCAF8;MED26;CPSF3;AR;CTR9;PHAX;TAF4;PPARGC1A;TBP;SSU72;ZBTB1;CDK13;MED1;CCNK;TEAD3;RPRD2;SETD2;SLBP;MNAT1;NR1H3;NOTCH3;MAML2;AFF4;RTF1;PARP1;RORA;ERCC3;TFCP2;TEAD2;IRF9;NABP2;COPS2;MAML1;NELFB;HDAC1;TAF5L;SNAPC3;TAF8;RXRA;TAF13;MNT;GTF2B;ICE1;PIR;PMF1;NR4A1;RNGTT;MED27;NR4A2;CSTF3;NFIC;INTS6;POLR2H;SNRPF;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;INTS14;RPAP1;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;GTF2H1;EAF2;NR2F1;TBPL1;SNAPC1;CTDP1;POLR2E;CPSF1;PPARA;NCBP2;NR2C1;TAF7;LSM11;ZBTB7B;HDAC3;TAF1C;SNAPC5;GTF2H4;GTF2E2;THRA;POLR2D;NELFA;CDK9;ESR1;NELFE
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5206659583535447,-1.833735520688789,0.0,0.06550870783517758,0.809,26/65,16.39%,FBN1;SMAD3;TGFBR1;LDLRAD4;LTBP1;SMAD6;SMURF2;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;FBN2;VASN
prerank,dermatan sulfate metabolic process (GO:0030205),-0.7434554335901218,-1.832881792341129,0.0019157088122605363,0.0643192774484133,0.812,4/13,2.90%,UST;DSE;DCN;BGN
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6068069723820868,1.830665601248875,0.001996007984031936,0.05222415679483137,0.93,8/29,6.74%,CAMK2A;SHISA6;NETO1;MCTP1;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5280940813146858,1.8283223588009225,0.0,0.05254145065367889,0.935,25/59,12.11%,DSCAM;BSG;KIRREL3;HMCN1;CADM1;IGSF11;PLXNB3;PTPRT;CDH2;ROBO4;CNTN6;DSCAML1;NPTN;TENM3;VSTM2L;PECAM1;PCDHB6;ROBO2;ROBO3;CADM3;PTPRM;CELSR2;CNTN4;NECTIN1;CNTN2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.6083717828366666,-1.8275771530664275,0.0038095238095238095,0.06758351910529511,0.835,10/26,13.64%,ROCK2;ASAP3;ROCK1;PRKN;ALMS1;SLC9A1;FHOD1;CDC42;SYNPO2;SYNPO
prerank,regulation of dendrite extension (GO:1903859),0.6609764272047753,1.8275128410887502,0.008620689655172414,0.05194768562211054,0.936,7/18,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.6573058519457842,-1.8274020031558436,0.0018796992481203006,0.06593070746076056,0.836,11/20,19.27%,CELF1;TNRC6B;WTIP;TNRC6A;MOV10;LIMD1;CNOT8;HELZ;TNRC6C;CNOT1;AJUBA
prerank,embryonic eye morphogenesis (GO:0048048),-0.7780749491412674,-1.8245114185060143,0.001838235294117647,0.06610797953479158,0.844,7/11,17.05%,FBN1;EFEMP1;LRP6;RARG;MFAP5;FBN2;TBX2
prerank,excitatory postsynaptic potential (GO:0060079),0.6515077671255584,1.8182754261209775,0.0042643923240938165,0.05692439850795236,0.957,8/19,7.97%,MPP2;GRIN1;MAPK8IP2;GRID2;GRIN2A;GRIN2B;GRIN2D;AKT1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.7526991723647221,-1.807864356177626,0.0019455252918287938,0.08090496013237752,0.898,7/12,19.21%,ROCK2;ROCK1;FLOT2;APOE;RANBP9;PICALM;ABCA7
prerank,positive regulation of dendrite extension (GO:1903861),0.6649881539889896,1.8074986365089925,0.008830022075055188,0.0635737202392042,0.968,7/17,11.21%,SYT1;RIMS1;RIMS2;CPNE9;UNC13A;RNF157;SYT2
prerank,negative regulation of axonogenesis (GO:0050771),0.6035627100219205,1.807494331878117,0.002173913043478261,0.06237421608374751,0.968,13/27,14.98%,DCC;MAG;MCF2;MAP2;FGF13;THY1;EFNB3;OMG;LINGO1;RTN4R;DIP2B;RTN4;GDI1
prerank,digestive tract development (GO:0048565),-0.5876016571377835,-1.8027867521377703,0.0038240917782026767,0.08510639672641783,0.923,18/32,21.36%,GLI3;PKD1;GLI2;CLMP;RARB;SMO;PCSK5;KIT;FGFR2;CHD8;NIPBL;GLI1;CCDC39;SALL1;MEGF8;PKDCC;ZIC3;GATA6
prerank,potassium ion transport (GO:0006813),0.46400768467983117,1.8015876174450391,0.0,0.06529068496980699,0.972,31/120,8.42%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNMB2;KCNMB3;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5230202178226866,1.7987832037682947,0.0020161290322580645,0.06661098589397393,0.974,17/54,7.97%,DPP10;KCNJ3;KCNIP4;KCNJ6;KCNN2;AKAP6;BIN1;KCNIP1;KCNMB2;KCNMB3;KCNN1;DPP6;KCNMB4;KCNJ10;KCNN3;GNG2;KCNAB1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.7490225895476759,-1.7967975001839764,0.0019455252918287938,0.09024506886668995,0.935,4/12,2.90%,UST;DSE;DCN;BGN
prerank,positive regulation of cell junction assembly (GO:1901890),0.5283510980894177,1.7954255910318602,0.006329113924050633,0.068292226054336,0.976,15/56,8.03%,CLDN5;CNTNAP2;TEK;NRXN1;PTPRD;IL1RAPL1;EPHB1;NLGN1;GRID2;PPM1F;KDR;THY1;PTPRJ;CLSTN3;LRRC4B
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6880890537182373,-1.7943858776123303,0.0019569471624266144,0.09086794114927976,0.937,7/16,8.22%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP3;IGFBP6;IGFBP4
prerank,regulation of ion transport (GO:0043269),0.4894104532596167,1.7921209903742874,0.0,0.06963796959594051,0.98,22/76,12.78%,NKAIN2;SYT1;KCNJ3;SYT6;SPTBN4;NKAIN1;SYT7;NKAIN3;KCNJ6;SYT12;SYT11;ANK3;SNCA;KCNJ11;CA2;KCNJ10;SYT10;ATP1A1;SYT2;P2RX7;KCNA2;KCNJ8
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.47580025975422613,-1.7916193996039176,0.0018796992481203006,0.09205958563201092,0.945,20/86,7.30%,BMP6;SULF1;TGFBR1;BMPR1A;FOXD1;RBPJ;RBPMS;ZNF423;BMP5;BMP7;DAB2;EP300;BMP4;NUMA1;TGFB1I1;SMAD2;THBS1;CREBBP;TWSG1;ZEB2
prerank,embryonic skeletal system development (GO:0048706),-0.5632251032276058,-1.7913065721064143,0.003745318352059925,0.09022611380076542,0.945,13/35,9.49%,SULF1;COL1A1;PDGFRA;OSR1;HOXB3;PCSK5;RBP4;SULF2;DYNC2I1;HOXC4;HOXA3;WNT9A;HOXB4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5386536796317366,-1.7906617565236453,0.0,0.08878388052389896,0.945,17/43,17.44%,IGF1;FOXP1;BMPR1A;IGFBP5;PDGFRB;BMP4;THBS1;GJA1;JUN;ID2;MMP2;IL6R;STAT1;ERN1;ADAMTS1;IL18;CCN4
prerank,actin cytoskeleton reorganization (GO:0031532),-0.504463880959733,-1.790304186994403,0.0,0.0870981246239429,0.945,25/63,19.13%,AUTS2;PARVA;PHACTR1;SIPA1L1;GSN;MCU;PTK7;KIT;FLNA;NRK;CXADR;DTNBP1;NRP1;MKLN1;ANXA1;FER;RHOA;RALA;RICTOR;CTTN;FARP2;WHAMM;EFS;PTPN1;GAB1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.723742194008544,-1.789994464433183,0.0,0.08548260855315165,0.945,4/13,1.77%,FSTL1;FBN1;LTBP1;NBL1
prerank,axon development (GO:0061564),0.4903701838271818,1.7867148551651484,0.0,0.07290741155639154,0.982,22/78,11.47%,DCC;CTNNA2;ACTB;PLP1;GRM7;SPTBN4;ADGRB1;ANK3;MAP1B;APBB1;PAX2;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CNTN4;BRSK2;SLITRK5
prerank,positive regulation of DNA replication (GO:0045740),-0.6781008488617204,-1.7841351299812616,0.009823182711198428,0.0903912936609649,0.958,10/16,26.06%,EGFR;GLI2;DHX9;BRPF3;GLI1;CTC1;PCNA;STN1;ATAD5;EGF
prerank,positive regulation of developmental growth (GO:0048639),0.5213436050921277,1.7835318931433646,0.0,0.07454336881299338,0.983,15/49,13.89%,SYT1;RIMS1;RIMS2;CPNE9;SEMA4D;SEMA7A;UNC13A;PLCB1;RNF157;SHTN1;CDKL5;NTN1;SYT2;DLL1;INSR
prerank,Golgi organization (GO:0007030),-0.45660233079014595,-1.7824914243164336,0.0,0.09047025504987337,0.959,49/112,24.10%,VTI1A;GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;ATL3;UBXN2B;HUWE1;ATP8B1;BCAS3;GOLGB1;SEC23IP;VTI1B;STX16;ARFGEF1;ARHGAP21;OBSL1;SEC22B;CDC42;USP6NL;VCPIP1;ATP8B2;ATL2;TBC1D20;COG3;COG7;STX5;SURF4;PRMT5;GOSR2;TJAP1;TMED3;PRKD1;VAMP4;SEC16B;CSNK1D;TMED5;TMED4;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;PI4K2B;PLK5;LMAN1;BAG5
prerank,negative regulation of cell differentiation (GO:0045596),-0.4250750455922844,-1.7819029238104425,0.0,0.08925829043473645,0.959,58/181,21.04%,RANBP3L;EGFR;COL5A2;SMAD3;TGFBR1;CRIM1;EFEMP1;ADAMTS12;COL5A1;LDLRAD4;ABCA1;SMAD6;BMP5;ITGAV;BMP7;TMEM64;BMP4;JAG1;ENPP1;OSR1;YAP1;SKI;ZBTB16;ADGRV1;REST;WNT9A;CTR9;NBR1;RUNX1T1;IGF2;MED1;NR1H3;LIMD1;ID2;RORA;IL17RD;HES1;SUFU;RB1;EIF2AK4;TRPM4;NELFB;TRIB2;ANKRD26;PTCH1;ANP32B;VASN;TRIO;PDCD4;TWIST2;WNT5A;HNRNPU;PTPN11;ITGB3;CDC73;SPRED2;CDK6;PPP2CA
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.553674631046989,1.7809732517983652,0.004016064257028112,0.0754943610831036,0.984,14/37,11.91%,HMCN1;PTPRD;CADM1;IL1RAPL1;NLGN1;TENM2;GRID2;TENM1;TENM4;TENM3;DCHS1;CADM3;CRB1;NECTIN1
prerank,circulatory system development (GO:0072359),-0.448656017831774,-1.7760076310505422,0.0,0.09410971519230289,0.963,35/118,12.79%,AKAP13;CACNA1C;FBN1;COL3A1;NXN;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FOXC1;ADAP2;KAT2B;SH3PXD2B;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;HSPG2;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;PDLIM2;MEF2C;PKD2;FBXW7;FN1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7629102363926804,1.7755204049557758,0.006756756756756757,0.07866202892553095,0.991,6/11,17.05%,NOS3;PRKG2;AKT1;CALM1;GCH1;HSP90AA1
prerank,gene silencing by miRNA (GO:0035195),-0.5785345118825193,-1.7748277365974028,0.0019047619047619048,0.09355076083537743,0.965,16/32,23.36%,DICER1;TNRC6B;PUM2;ZC3H7A;WTIP;TNRC6A;MOV10;PUM1;LIMD1;CNOT8;TNRC6C;CNOT1;AJUBA;RBM4;XPO5;AGO1
prerank,regulation of transmembrane transport (GO:0034762),0.5743296095605155,1.7741874539370732,0.0,0.07868974164345989,0.992,9/31,7.24%,ACTB;SLC2A1;KCNJ3;KCNJ6;SNCA;KCNJ11;OCLN;KCNJ10;TRIB3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7927054616949682,-1.7740447920935518,0.0,0.09263656635083489,0.965,5/10,9.89%,PID1;APPL2;GRB10;ENPP1;SELENOS
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.6165237089824268,-1.7738332460850255,0.003883495145631068,0.0910608259765693,0.965,9/24,9.06%,ROCK2;ERRFI1;FOXC1;ROCK1;NUMA1;HOXA7;RUNX1;SRSF6;MED1
prerank,synaptic vesicle cycle (GO:0099504),0.5907555278123858,1.7737399430279843,0.006437768240343348,0.07780344731698055,0.992,10/30,12.16%,RIMS1;PCLO;NLGN1;SYT7;SNAP25;SNCA;SLC17A6;SYT10;CPLX1;PLD2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.45859949750656936,-1.7706019519817264,0.0,0.09305989615648273,0.972,41/108,22.42%,WLS;TRABD2B;SULF1;NXN;LRP1;MDFIC;WWOX;GRB10;PTK7;RNF43;PRKN;LRRK2;BTRC;VGLL4;DCDC2;GPC3;SULF2;RSPO3;AXIN1;SKI;FGFR2;RUNX1;DACT1;RSPO2;TLE1;TCF7L1;FZD7;EMD;CSNK2A1;SALL1;FOXL1;SFRP4;DACT3;BMP2;MDFI;CDC73;TERT;FRZB;PPP2CA;SPIN1;SENP2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.46447637186300494,1.7697818053651473,0.0,0.0798753784489322,0.994,26/91,11.74%,SLC39A10;TFRC;ALAS2;MT2A;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SLC30A1;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1;SLC39A8;ATOX1;SLC30A5
prerank,Rho protein signal transduction (GO:0007266),-0.5233839189031234,-1.7696240723400802,0.0,0.09247478320044394,0.973,17/53,17.65%,COL1A2;ROCK2;ARHGAP29;ARHGAP6;ROCK1;PDPN;RHOJ;CTNNAL1;CDC42;CDC42EP5;RHOA;AGTR1;ARHGDIB;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1
prerank,positive regulation of actin nucleation (GO:0051127),-0.7534192080628757,-1.768913742938711,0.0,0.09162159882658862,0.974,7/11,15.29%,GSN;FCHSD2;WASF2;BRK1;NCKAP1;WASF1;WHAMM
prerank,cellular response to purine-containing compound (GO:0071415),0.760759690254672,1.7679211838457487,0.008368200836820083,0.08022260916764036,0.994,5/10,6.96%,RYR2;RYR3;SLC8A1;TRPM2;P2RY1
prerank,neurotransmitter transport (GO:0006836),0.48808708303964526,1.7670808071924415,0.0,0.07961605613053312,0.995,29/73,15.59%,NRXN1;PTPRN2;SYT1;RIMS1;SYN2;GABRA2;SNAP25;LIN7A;SLC17A6;SLC18A3;SLC1A1;UNC13A;HSPA8;PPFIA3;SLC1A2;NRXN2;SNPH;SLC6A2;GAD1;CPLX1;PPFIA2;DVL1;PPFIA4;CHAT;TSPOAP1;PDZD11;GLS2;GLS;SYN1
prerank,cell projection organization (GO:0030030),-0.5837870363926303,-1.766488347846035,0.005555555555555556,0.09336783565968042,0.977,9/30,13.84%,PARVA;RHOQ;GSN;RHOJ;PACSIN2;ITGB1;CDC42;NCKAP1;P2RY12
prerank,heart development (GO:0007507),-0.4303641988953925,-1.7652723898098819,0.0,0.09332431932612993,0.98,53/150,19.53%,AKAP13;TGFBR3;CACNA1C;FBN1;COL3A1;TGFBR1;PLCE1;PKD1;NTRK3;GLI2;PDLIM5;FLRT2;BMP5;FOXC1;ADAP2;KAT2B;BMP7;SH3PXD2B;BMP4;BCOR;OSR1;TGFBR2;PCSK5;MICAL2;RBP4;GPC3;MEF2A;PDLIM7;CXADR;FOXC2;ECE1;NCOA6;KDM6A;ID2;NIPBL;PDLIM2;MEF2C;PKD2;SCUBE1;FN1;CHD7;VEGFA;ACVR1;SALL1;FOXL1;CITED2;TBX2;WDR11;EEF1AKMT4-ECE2;ZDHHC16;BMP2;PTPN11;MEGF8
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.48013607269891945,-1.7651738779756165,0.0,0.09183356553892276,0.98,16/74,7.19%,PHLDB2;SMAD3;TGFBR1;DAG1;EPHA3;COL1A1;LDLRAD4;BMP5;FOXC1;DAB2;PDPN;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5785271619745214,1.7640388867623749,0.0,0.08114473516223658,0.996,8/32,16.08%,PGLYRP1;RPS19;S100A9;RPL30;CXCL14;HMGN2;DEFA6;RNASE3
prerank,negative regulation of translation (GO:0017148),-0.4656871250445409,-1.7635761142562691,0.0,0.09237476224137188,0.984,26/87,19.58%,SAMD4A;ROCK2;IGFBP5;CELF1;FTO;ROCK1;YTHDF3;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;PUM1;DHX36;LSM14A;CNOT8;TPR;EIF2AK4;YBX1;EIF2AK2;DDX3X;DAPK1;CPEB1;CNOT1;CNOT10;RBM4
prerank,DNA conformation change (GO:0071103),-0.6571852151192512,-1.7632944232940557,0.0,0.09119282216291646,0.984,6/17,17.21%,ABL1;TOP1;HMGB1;HAT1;ERCC3;TOP2B
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.68034285320654,1.7629837451588335,0.00425531914893617,0.08076264926749187,0.996,9/15,17.07%,GRM5;GRM7;GRM1;GRM8;HOMER1;HOMER2;GRM3;HOMER3;GRIK3
prerank,axonogenesis (GO:0007409),0.4135509184338604,1.7617459876541166,0.0,0.0805401098844281,0.996,71/237,12.14%,DSCAM;BSG;NRXN3;NRXN1;DCC;CTNNA2;ACTB;EPHA6;SEMA3C;EPHB1;SPTBN4;SEMA6A;DAB1;UNC5C;SPTB;ADGRB1;CXCL12;EPHA5;SEMA4A;SEMA4F;ANK3;SHANK3;MAP1B;ROBO4;APBB1;CNTN6;PAX2;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;NRCAM;RAP1GAP;VSTM2L;ZDHHC17;UNC5B;EFNA2;HSP90AB1;SHTN1;ROBO2;B4GALT6;EPHA10;PLPPR4;NTNG1;NTNG2;SPTBN5;RELN;TAOK2;TUBB3;ROBO3;FEZ1;CNTN4;BRSK2;DOK5;SPTBN1;SLITRK5;DOK2;CNTN2;RET
prerank,central nervous system neuron differentiation (GO:0021953),0.5680026261928162,1.7590247478793626,0.0041841004184100415,0.081652341326536,0.998,15/33,17.37%,SPOCK1;MDGA2;PROX1;GRID2;CEND1;MAP2;TOX;NTRK2;LHX1;SIN3A;KNDC1;CHD5;SOX4;CTNNB1;FAIM2
prerank,mesenchymal cell differentiation (GO:0048762),-0.5151833890990165,-1.7563933156994789,0.0,0.09790321167310537,0.988,16/51,6.61%,ROCK2;RANBP3L;TGFBR3;TGFBR1;LRP6;WNT4;RBPJ;FBXL17;LIMS1;DDX5;FOXC1;BMP7;ROCK1;GSK3B;DDX17;FGFR2
prerank,presynapse assembly (GO:0099054),0.6799571683937458,1.7559507516043071,0.004273504273504274,0.08343249026164981,0.998,5/16,1.68%,PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN1
prerank,carbohydrate transport (GO:0008643),0.7256628407384427,1.75378005897688,0.004123711340206186,0.08390451346309909,0.999,3/11,2.66%,AQP9;AQP11;SLC2A5
prerank,synapse organization (GO:0050808),0.44689836644854153,1.7531927953118884,0.002,0.08335966143560014,0.999,40/125,12.45%,SPOCK2;DNM3;DSCAM;KIRREL3;GRM5;ADGRL3;NRXN1;PTPRD;LRRC4C;LRFN5;CTNND2;NLGN1;GPM6A;DNER;ANK3;SHANK3;CDH2;SNCA;UNC13A;PPFIA3;NRXN2;ELFN1;NRCAM;WNT7B;ARHGAP39;RAB39B;CACNB2;PCDHB6;LRRC4B;NTNG1;SHANK2;APBB2;CACNB4;F2R;PPFIA2;DVL1;CNTN2;PPFIA4;SNCB;DCTN1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6506395356098489,1.7513681655817763,0.008213552361396304,0.08392640350052749,0.999,8/18,10.73%,NRXN1;NLGN1;SHANK3;CACNG2;CACNG3;CCL2;RELN;CACNG8
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7241614103442906,1.7503241133652463,0.006507592190889371,0.08380557049392265,1.0,6/12,4.96%,SYT1;RIMS1;SYT7;RIMS2;RIMS3;UNC13A
prerank,cellular defense response (GO:0006968),-0.5374566882018396,-1.7488956534827405,0.0018450184501845018,0.10591361797630575,0.992,12/40,19.73%,ZNF148;DCDC2;CCR9;LBP;ITGB1;LSP1;VEZF1;BECN1;TCIRG1;CX3CR1;LGALS3BP;NCF2
prerank,regulation of catecholamine secretion (GO:0050433),0.57410449137852,1.7484146250888115,0.008130081300813009,0.08444485175541092,1.0,10/29,11.73%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;GRK2;SYT10;SYT2;KCNA2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.46006615209490576,-1.7471587755740798,0.0,0.10648008283105037,0.992,35/95,16.75%,TGFBR3;SMAD3;TGFBR1;LDLRAD4;SMAD6;SMURF2;NREP;DAB2;EP300;DKK3;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;THBS1;SNX6;SKI;CREBBP;SKIL;ZEB2;PDPK1;PMEPA1;SMAD4;GIPC1;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;LATS1;VASN;CITED2
prerank,chondrocyte differentiation (GO:0002062),-0.5763405578605516,-1.746815880454063,0.001976284584980237,0.10538988362895817,0.993,15/32,15.59%,SULF1;SOX5;CREB3L2;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;EIF2AK3;RUNX1;CCN3;MEF2C;SOX6;RUNX2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.428497809259304,-1.746317014244704,0.0,0.10434931042035754,0.995,64/138,28.18%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;TBP;MED1;TEAD3;MNAT1;NR1H3;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;POLR2E;PPARA;NR2C1;TAF7;HDAC3;GTF2H4;GTF2E2;THRA;POLR2D;CDK9;ESR1
prerank,regulation of dopamine secretion (GO:0014059),0.5927576436160696,1.7438227404395836,0.008146639511201629,0.08741118374465036,1.0,9/25,11.73%,SYT1;SYT6;SYT7;SYT12;SYT11;SNCA;SYT10;SYT2;KCNA2
prerank,alanine transport (GO:0032328),0.7698981039392376,1.7429663738161116,0.002232142857142857,0.08716949673799822,1.0,3/10,9.58%,SLC6A6;SLC6A17;SLC36A1
prerank,glucose transmembrane transport (GO:1904659),0.6487843623538058,1.7413326670383646,0.008602150537634409,0.08750251518471826,1.0,4/18,2.66%,SLC2A1;RAB4B;SLC2A3;SLC2A5
prerank,cell differentiation in hindbrain (GO:0021533),0.7282324232266417,1.7403471622305848,0.0021929824561403508,0.08734453284497386,1.0,7/11,19.82%,PROX1;GRID2;CEND1;LHX1;KNDC1;FAIM2;CBLN1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.6162772815491109,-1.7399747677155062,0.002053388090349076,0.11079812926198854,0.996,11/22,15.21%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;SMAD4;PARP1;LMCD1;P2RX4
prerank,camera-type eye development (GO:0043010),-0.5936511639673823,-1.73992675986817,0.004081632653061225,0.10926647752195635,0.996,11/25,15.76%,CACNA1C;FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;CYP1B1;NES;VEGFA;FBN2
prerank,neuropeptide signaling pathway (GO:0007218),0.5000436960393814,1.739008625128712,0.0,0.08746286065840632,1.0,16/58,15.07%,GLRA1;NXPH2;HCRTR1;GPR149;GLRA3;SORCS3;SORCS1;ADCYAP1;GLRA2;HCRTR2;OPRM1;GRP;PNOC;SORL1;OPRK1;OPRL1
prerank,positive regulation of B cell proliferation (GO:0030890),0.5829072266955481,1.738950882733074,0.0021929824561403508,0.08645390196848109,1.0,9/29,14.86%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;CD40;NFATC2;CD38
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6627960548560334,1.7361040943532868,0.006550218340611353,0.08792832431906614,1.0,6/18,3.04%,GRIN1;NRXN1;RIMS1;NLGN1;RIMS2;SHANK3
prerank,inhibitory synapse assembly (GO:1904862),0.7394415335460515,1.731557487044095,0.006185567010309278,0.09069980651051865,1.0,6/11,8.57%,GABRB3;GABRA2;FGF13;GABRB2;LGI2;GABRG2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.6177200779229803,-1.729140674792563,0.004032258064516129,0.12237710928188324,0.998,6/21,8.55%,ROCK2;ERRFI1;ROCK1;BMP4;RUNX1;MAFG
prerank,sensory perception of smell (GO:0007608),0.7231828343268946,1.7288040528709923,0.01284796573875803,0.09228427732054688,1.0,3/11,7.63%,SLC24A4;ADCY3;SYT10
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.6726107351569688,-1.7272882632394024,0.0018315018315018315,0.12318186529380236,0.998,6/15,3.93%,LRP6;ANKRD11;GLI2;FOXC1;EDA;WNT6
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4984486730592159,-1.7253368146951096,0.001976284584980237,0.124504403086999,0.998,17/56,15.84%,BMP6;TGFBR1;BMPR1A;LDLRAD4;RBPMS;SMAD6;BMP5;BMP7;DAB2;BMP4;TWSG1;PMEPA1;SMAD4;BMPER;EMILIN1;ACVR1;TGFB3
prerank,BMP signaling pathway (GO:0030509),-0.4899217082082716,-1.7250763283443973,0.0,0.12312852215219718,0.998,25/62,21.85%,BMP6;TGFBR3;SMAD3;BMPR1A;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,skeletal system morphogenesis (GO:0048705),-0.5254103034750487,-1.7230899749806787,0.001890359168241966,0.12425728095903059,0.999,18/42,19.53%,TGFBR1;PDGFRA;LRP6;ANKRD11;WWOX;HOXB3;CYP26B1;SKI;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;HOXB9;FBN2;SIX1;SFRP4;MEGF8
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6997117483519587,1.721195662061942,0.012684989429175475,0.09873425021489067,1.0,6/12,8.34%,PROM1;PODXL;MYO1E;MAGI2;CD24;BASP1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5304683865034762,1.7211242281411254,0.0063025210084033615,0.09776241681303686,1.0,12/41,7.79%,KCNJ3;KCNJ6;KCNN2;ANK3;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5312757084505868,-1.7204405900864346,0.003976143141153081,0.1266290685000642,0.999,13/40,7.19%,TCF7L2;SMAD3;TGFBR1;COL1A1;FOXC1;DAB2;PDPN;JAG1;TGFBR2;TGFB1I1;SMAD2;BCL9L;MTOR
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.44148708301765693,-1.7198935782771905,0.0,0.12569793489680736,0.999,38/112,15.95%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ZMIZ1;WNT4;LIMS1;SMAD6;WWOX;TGFBR2;CLEC3B;NR3C1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;MEF2C;PDE3A;ZYX;APPL1;SOX6;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,rRNA metabolic process (GO:0016072),0.4195890287255094,1.71746797130623,0.0,0.10041258668922479,1.0,51/160,16.11%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;DIS3L;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,cellular response to BMP stimulus (GO:0071773),-0.4821045569221751,-1.71604488357031,0.0,0.1294142545177381,1.0,26/66,21.85%,BMP6;TGFBR3;SMAD3;BMPR1A;ADAMTS12;SMAD6;DDX5;BMP5;BMP7;BMP4;RGMB;SMAD2;RGMA;SMAD4;SLC33A1;SMURF1;ACVR1;ZFYVE16;RUNX2;TGFB3;PDCD4;BMP2;MEGF8;SMAD9;SMAD1;TMEM100
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.7326634728652571,-1.7159784495786055,0.007575757575757576,0.12791214398433903,1.0,5/11,10.88%,PDK1;MAP3K5;CYP1B1;PRKCD;PRODH
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4283700873601957,-1.7155792034122508,0.0,0.12683569118907967,1.0,41/128,15.95%,BMP6;COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;SMURF2;DDX5;BMP5;BMP7;BMP4;TGFBR2;RGMB;TGFB1I1;ITGB1;SMAD2;SKI;TWSG1;ITGB5;RGMA;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;SLC33A1;PARD3;SMURF1;ACVR1;PRKCZ;ZFYVE16;RUNX2;TGFB3;LRRC32
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.4194807410983471,-1.7154033163742288,0.0,0.1255499322103461,1.0,58/152,23.11%,RNF220;WLS;SULF1;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;WNT5B;TBL1XR1;RNF146;GPC3;SULF2;UBR5;RSPO3;AXIN1;LYPD6;SKI;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;RSPO2;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X;CSNK2A1;SALL1;PRDM15;USP34;SFRP4;VCP;CSNK1D;BMP2;CDC73;TERT;DKK2;PSMC1;GID8;SPIN1;PLEKHA4;PSMB6;CCAR2;PSMA3
prerank,response to cadmium ion (GO:0046686),0.5771252623080384,1.713585609141735,0.013245033112582781,0.10328654289535824,1.0,10/26,7.97%,MT2A;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;AKT1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5947840730469647,1.7134651376231986,0.006276150627615063,0.1022790108805072,1.0,7/26,3.04%,GRIN1;NRXN1;RIMS1;TMEM108;NLGN1;RIMS2;SHANK3
prerank,positive regulation of DNA binding (GO:0043388),-0.5491404314466894,-1.709769327852766,0.0075046904315197,0.13288772589468903,1.0,18/31,26.06%,IGF1;FOXC1;PRKN;NIBAN2;HMGB1;SKI;CEBPG;NGF;HES1;RB1;TXN;TRAF6;PARK7;H1-0;NME1;TWIST1;EDF1;EGF
prerank,cellular response to cadmium ion (GO:0071276),0.5840317278146986,1.7086370943394615,0.011286681715575621,0.10584867461042641,1.0,10/24,7.97%,MT2A;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;AKT1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.6320402377341505,-1.7035059030288764,0.007352941176470588,0.14060982089960888,1.0,9/17,17.10%,NSA2;LAS1L;MPHOSPH6;URB1;PRKDC;MAK16;MTREX;EXOSC10;WDR12
prerank,embryonic digit morphogenesis (GO:0042733),-0.6197513016633118,-1.7019850688514835,0.016194331983805668,0.1410399067779507,1.0,9/18,17.05%,GLI3;OSR1;WDPCP;CREBBP;ECE1;MAP3K20;HDAC1;SALL1;TBX2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5450684154080323,1.6994462538503767,0.007920792079207921,0.11434308637768334,1.0,9/32,6.13%,CAMK2A;RIMS1;RIMS2;SYT11;PREPL;MCTP1;RIMS3;SLC30A1;KCNMB4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5852061561342872,1.6964988106798033,0.0058823529411764705,0.11661317229282239,1.0,8/24,4.44%,DSCAM;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.4025040397322791,-1.6949784595860329,0.0,0.15092893192135998,1.0,86/166,31.98%,NOTCH2;TEAD1;RBPJ;THRB;NR1D2;RARB;CCN2;KAT2B;GTF2H2;NCOR1;NR3C2;TBL1X;CCNH;TBL1XR1;NR6A1;YAP1;TAF3;RARG;CDK7;NR3C1;MED17;CREBBP;MED26;AR;TAF4;PPARGC1A;CAVIN1;TAF1D;TBP;NCOA6;MED1;TEAD3;MNAT1;NR1H3;BRF1;NOTCH3;MAML2;RORA;ERCC3;TEAD2;MAML1;HDAC1;TAF8;RXRA;TAF13;GTF2B;NR4A1;MED27;NR4A2;POLR2H;TAF12;TAF9B;TAF2;GTF2F1;POLR2K;GTF2H1;NR2F1;TBPL1;GTF3C1;POLR2E;POLR3H;PPARA;NR2C1;TAF7;HDAC3;TAF1C;GTF2H4;GTF2E2;POLR1G;THRA;POLR2D;CDK9;ESR1;BRF2;TAF1A;RRN3;POLRMT;NR1H4;POLR1C;SNW1;GTF2A1;HDAC10;NR5A2;NR2C2AP;MAML3;E2F3
prerank,androgen receptor signaling pathway (GO:0030521),-0.7203466051553971,-1.6934629577398836,0.009487666034155597,0.1514789685203993,1.0,7/11,18.83%,ZMIZ1;DDX5;DDX17;AR;PMEPA1;KDM3A;RNF14
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.36001757272822704,-1.6894098449688746,0.0,0.15654596773292034,1.0,162/572,19.44%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;RBPJ;PHF21A;THRB;SMURF2;GLI2;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;ZMYM5;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;TBL1X;WWP2;FRK;NFIB;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;YAP1;EZH1;TAF3;RARG;MEF2A;HMGB1;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;CBX5;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;JDP2;FGFR2;DNMT3A;FOXC2;CHD8;RUNX1;SKIL;ZEB2;REST;GTF2IRD1;AR;CTR9;MBD2;IGF2;SP100;SP2;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BAG3;CHD3;NR1H3;JUN;HCFC1;PCGF2;SMAD4;PARP9;GLIS2;ID2;NIPBL;RTF1;WWC1;NFATC4;FNIP1;PARP1;MEF2C;ARID5B;HES1;ZNF692;TPR;SUFU;TCF3;RB1;BHLHE41;CGGBP1;KDM1B;PPM1A;SOX13;TCERG1;TRPS1;STAT1;VEGFA;USP2;MCPH1;HDAC1;CBX7;CNOT2;PRDM2;PTCH1;RXRA;MNT;SALL1;NOP53;SFPQ;CITED2;EPC1;TBX2;CNOT1;ZFP37;NR4A2;CC2D1A;NFIC;HNRNPU;TRAF6;HSBP1;ZNF436;NFATC3;BMP2;MDFI;UBE2D3;KMT5A;BPTF;ELK4;IFI27
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.3516324803233014,-1.6890997619199355,0.0,0.15533698065000426,1.0,213/807,17.31%,BMP6;FOXP2;PRDM6;FOXP1;FHL2;NR2F2;AEBP1;TCF7L2;GLI3;SMAD3;RBFOX2;FOXD1;NFKB1;PRDM5;ZNF148;KANK2;HDAC8;WNT4;RBPJ;PHF21A;THRB;MIDEAS;LIMS1;SMURF2;GLI2;ZNF423;DDX5;GLIS3;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;RARB;MDM4;WWOX;FOXC1;PER3;BMP7;ZMYM5;ZIC2;DAB2;FOXO3;EP300;BMP4;DICER1;HDAC4;BCOR;KAT6B;DKK3;NCOR1;PRKN;CUX1;OSR1;WWC2;MXI1;BTRC;TBL1X;BRD7;FOXN3;WWP2;FRK;KCNIP3;TBL1XR1;NR6A1;NFIX;RREB1;NIBAN2;VGLL4;YAP1;FLNA;RCOR1;KHDRBS1;EZH1;TAF3;RARG;MEF2A;HMGB1;RCOR3;DLG1;ZKSCAN3;NR3C1;LCOR;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;SKI;CREBBP;ZBTB16;DCAF1;STAT3;HOXA7;NSD1;TFDP2;JDP2;FGFR2;L3MBTL3;DNMT3A;NAB1;SHC1;FOXC2;CHD8;RUNX1;SKIL;WWP1;ZEB2;SCMH1;REST;BCL7A;GTF2IRD1;AR;CTR9;FOXK1;MBD2;RUNX1T1;IGF2;SP100;CBFA2T2;SP2;PTPRK;IMPACT;ZBTB1;DACT1;MED1;UBE2I;MIER1;BTAF1;CHD3;PRMT2;NR1H3;JUN;MPHOSPH8;HCFC1;PCGF2;SMAD4;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;RTF1;WWC1;FNIP1;PARP1;MEF2C;ARID5B;PCGF6;PBXIP1;HES1;ZNF692;TPR;SUFU;TCF3;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;CGGBP1;KDM1B;IRF1;PPM1A;TSHZ3;SOX13;TCERG1;KAT8;TRPS1;STAT1;HINFP;VEGFA;ZNF318;USP2;MCPH1;HDAC1;CBX7;CNOT2;CBFA2T3;PRDM2;SCML4;PHC2;PTCH1;RXRA;RUNX2;JARID2;MNT;FOXK2;KDM2A;SALL1;LOXL3;ATOH8;L3MBTL2;NOP53;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZFP37;ZMYND15;TWIST2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.6808895849257818,-1.6888887923893234,0.0039603960396039604,0.15388680919743566,1.0,3/13,3.12%,RHOQ;OPA1;LRRK2
prerank,inorganic cation transmembrane transport (GO:0098662),0.39111361349729123,1.6862155830149206,0.0,0.12692495744660737,1.0,68/268,12.78%,KCND2;SLC6A6;HCN1;SLC24A4;SLC24A2;TRPC5;CACNA1A;SCN1A;KCNH7;SLC6A17;ASIC2;SLC40A1;KCNQ3;KCNC2;KCNN2;UCP2;KCNH5;SLC39A2;ASIC4;KCNH8;RYR3;GAS6;SLC8A1;KCNJ11;KCNN1;SCN4B;ASIC1;KCNK13;KCNK10;SLC30A1;HCN2;KCNJ10;TRPM2;KCND3;KCNC3;SLC6A2;SLC6A5;KCNH1;KCNQ5;ATP1A3;KCNK9;SLC6A8;KCNN3;SLC30A3;SLC25A14;KCNAB1;LRRC55;SCN3A;KCNC1;KCNK1;SLC25A27;ATP6V1F;ATP6V1A;SLC12A3;SLC36A1;SLC39A8;KCNQ2;ATP1A4;ATP1A1;ATP5F1B;P2RX7;KCNA2;SLC30A5;SCN2A;TRPC1;TMCO1;MCOLN2;KCNJ8
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.6517142023441963,-1.6856243152512889,0.007476635514018692,0.1583335611741961,1.0,7/16,10.32%,RBFOX2;DDX5;DDX17;PPARGC1B;TRIP4;AR;TADA3
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6520940555889763,-1.6848320021195122,0.0,0.15607271628938027,1.0,9/15,16.31%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,stress fiber assembly (GO:0043149),-0.6520940555889763,-1.6848320021195122,0.0,0.15607271628938027,1.0,9/15,16.31%,PHACTR1;SORBS1;ITGB1;ITGB5;TNFAIP1;RHOA;ZYX;CUL3;ARRB1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.5057810994665112,-1.6845941494924015,0.004056795131845842,0.15471552825219484,1.0,18/45,21.07%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;KIF16B;REPS2;NCK2;HBEGF;GAB1;PTPN11;PIK3R1;AAMP;DGKD
prerank,negative regulation of secretion by cell (GO:1903531),0.5299364885634836,1.6801281367220442,0.008333333333333333,0.1332287587469209,1.0,9/38,6.03%,GRM7;IL1RAPL1;SYT11;RHBDF2;SNCA;TRH;IL12A;NOTCH1;SLC30A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.7189482437860342,-1.6796102743892862,0.005703422053231939,0.16197507131786346,1.0,9/11,25.79%,PUM2;WTIP;STAT3;DHX9;PUM1;LIMD1;AJUBA;XPO5;FXR1
prerank,cell projection assembly (GO:0030031),-0.5991300069645262,-1.6772303506375061,0.013011152416356878,0.16443080730108842,1.0,6/22,11.54%,PARVA;RHOQ;GSN;RHOJ;CDC42;NCKAP1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5143517763628432,1.6771779129865885,0.008097165991902834,0.13556773804882744,1.0,11/41,6.47%,SLC24A2;GRIN1;GRIN2A;RYR2;HTR2C;RYR3;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.3367896626502713,-1.6765973333768698,0.0,0.16370068809072696,1.0,426/1668,18.36%,ZBTB20;NFIA;BMP6;PBX1;FOXP2;PRDM6;IGF1;AUTS2;FOXP1;FHL2;NR2F2;EGFR;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;ZBTB7C;MAF;SOX5;TEAD1;BMPR1A;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;HOXB6;CDK8;ZNF148;KANK2;HIVEP2;ZKSCAN2;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;PHF21A;THRB;CCNL2;DCN;MIDEAS;SMAD6;SMURF2;GLI2;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;ZNF462;ZFHX3;ZEB1;RARB;BMP5;MDM4;BRWD1;WWOX;FOXC1;PER3;FGF1;KLF9;KAT2B;PIAS1;ZMYM5;ZIC2;DAB2;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;DICER1;HDAC4;CREB5;GTF2H2;ABL1;BCOR;KAT6B;NCOR1;PRKN;PPM1D;ARNT;TNRC6B;JAG1;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;TBL1X;BRD7;ELF1;RBBP8;WWP2;FRK;NFIB;KCNIP3;CCNH;TBL1XR1;NR6A1;SSBP3;NFIX;KIT;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;RCOR1;TNRC6A;MED15;DDX17;EZH1;GMEB1;BAZ1A;TAF3;RARG;ANXA4;MEF2A;KMT2D;CDK7;HMGB1;RCOR3;DLG1;PPARGC1B;ZKSCAN3;NR3C1;SS18;LCOR;KLF3;ZNF182;MOV10;SMAD2;SMARCC2;BCL9L;BCAS3;CBX5;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;GABPB2;PBX3;MED17;TBX15;SKI;CREBBP;ZBTB16;DCAF1;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;PHF8;JDP2;MED26;HOXC8;MED12;FGFR2;DNMT3A;FHOD1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;SKIL;CAMK2D;HIVEP3;DHX9;AKAP8L;ZEB2;HOXA3;REST;KDM5B;MYSM1;VEZF1;HDGFL2;CEBPG;HOXB5;CRTC3;ZBTB37;GTF2IRD1;ZBTB8A;AR;ZFX;RGMA;DHX36;ZNF496;PRPF6;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;SP2;SSU72;NCOA6;IMPACT;NFYC;PIAS3;ZBTB1;CDK13;NCOA1;DACT1;CHD2;MED1;UBE2I;JUP;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;MIER1;UBP1;CHD3;ZNF467;MNAT1;WASL;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;PCGF2;SMAD4;MED21;SENP1;PARP9;THAP3;MAML2;CRTC1;GLIS2;ID2;NIPBL;MAVS;BCLAF1;ZBTB24;CREBRF;VGLL3;DCAF6;ZXDC;RTF1;WWC1;NFATC4;ZBED4;FNIP1;TBX18;PARP1;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;PKD2;TPR;SUFU;TCF3;TCF7L1;PIAS4;RB1;BHLHE41;OGT;ZBTB34;PATZ1;CGGBP1;KDM1B;IRF1;MAML1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;SOX6;SIX5;TRPS1;APOE;KDM3B;ZFP3;STAT1;CC2D1B;PRKDC;HINFP;VEGFA;CRLF3;USP2;MCPH1;ACVR1;ZNF367;HDAC1;MED8;CBX7;ZSCAN18;ZBED3;NCK1;ZKSCAN1;KDM3A;MKX;CIAO1;DDX3X;CNOT2;PRDM2;ZNF18;CARF;HOXB9;MED13L;ZNF697;NCK2;PTCH1;EFCAB7;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;TGFB3;KDM2A;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;IKZF2;BRD3;KLF6;TNRC6C;ARRB1;NOP53;SFPQ;ZNF112;PTOV1;FOXL1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;STAT5A;TBX2;NR4A1;CNOT1;SMARCD2;ZFP37;NFYB;TWIST2;TLR4;CRTC2;WNT5A;PHIP;BAZ2B;MED27;NR4A2;PRKD1;CC2D1A;STAT5B;BAZ1B;LPIN2;BCL2L12;NFIC;ZFHX4;HNRNPU;TAF6L;POU6F2;SOD2;TFCP2L1;TRAF6;LPIN3
prerank,glucose import (GO:0046323),0.6794291448911796,1.6759989199194312,0.011013215859030838,0.1356649738207549,1.0,3/13,1.71%,SLC2A1;RAB4B;SLC2A3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46190729091912297,1.6758811756454122,0.0,0.1344253796414983,1.0,25/75,11.92%,DCC;CTNNA2;ACTB;SPTBN4;MAPK8IP2;ADGRB1;ANK3;MAP1B;MAP2;APBB1;PAX2;MFSD2A;DSCAML1;NRCAM;ZDHHC17;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1
prerank,negative regulation of cell development (GO:0010721),-0.5808048542846764,-1.6755766371382812,0.0038022813688212928,0.16382277239419452,1.0,6/25,7.45%,FBN1;IGF1;APPL2;PCM1;GSK3B;REST
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.6479520404648833,-1.6744485246080105,0.003861003861003861,0.16413733157363136,1.0,4/15,2.90%,UST;DSE;DCN;BGN
prerank,histone modification (GO:0016570),-0.4313259021086676,-1.6734481758282924,0.0019157088122605363,0.1642163520432648,1.0,37/109,19.99%,EYA2;EYA1;PRDM5;MIDEAS;UBE2N;EYA4;EP300;HDAC4;KAT6B;HLCS;TBL1X;TBL1XR1;RCOR1;HUWE1;BAZ2A;RCOR3;CREBBP;NSD3;UFL1;NSD1;TRRAP;ENY2;MIER1;PRMT2;PRKCD;EHMT1;KAT8;UBE2B;HDAC1;BAZ1B;ATXN7;TAF6L;MSL3;PRMT8;PARK7;CDK2;NTMT1
prerank,response to sterol (GO:0036314),-0.7045784975575187,-1.6726187531503502,0.01855287569573284,0.16403107488979152,1.0,4/11,11.64%,TGFBR1;TGFBR2;SMAD2;RORA
prerank,histone lysine demethylation (GO:0070076),-0.5702186529024164,-1.6717507021132563,0.009727626459143969,0.16392040733261948,1.0,10/25,15.84%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;KDM1B;KDM3B;KDM3A;KDM2A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3644555370431729,-1.6716574748870354,0.0,0.16244212746353204,1.0,183/476,24.96%,IGF1;MLLT3;NR2F2;EGFR;ZIC1;TCF4;GLI3;SMAD3;TGFBR1;TEAD1;CREB3L2;NFKB1;COL1A1;ZMIZ1;LRP6;WNT4;GLI2;ZNF423;NR1D2;MDFIC;ZFHX3;FOXC1;TRIM44;BMP7;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;KAT6B;TFEB;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;RREB1;NIBAN2;YAP1;RGMB;CREBL2;TGFB1I1;ZKSCAN3;SMAD2;SMARCC2;AXIN1;MED17;LBH;CREBBP;ZBTB16;FZD2;CDH1;STAT3;NSD3;TRIP4;NSD1;PHF8;MED12;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HIVEP3;REST;MAP3K5;HNRNPD;AR;ZNF496;FOXK1;PPARGC1A;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;PRMT2;NR1H3;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;PARP9;ATF7IP;GLIS2;ID2;ZXDC;RORA;MEF2C;HES1;TEAD2;TCF3;FZD7;IRF1;PPM1A;DTX3L;KAT8;GLI1;BICRA;MMS19;ING5;APOE;STAT1;NAA15;HINFP;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;KDM3A;ILF2;RXRA;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ATOH8;KLF6;ARHGEF11;AFAP1L2;CITED2;EPC1;MYBL1;SIX1;RNF20;PICALM;WNT5A;PHIP;FBXW11;NEK4;FZD1;INPP5K;BMP2;RNF14;INHBA;KARS1;SPP1;PML;ING1;MED16;NOS1;CDKN1C;NFYA;ZIC3;XRCC6;GATA6;KMT2A;NIF3L1;DVL3;FGF2;MAP3K12;SPIN1;MYRF;WAC;CAND2;MAFB;MED13;CD80;SMARCD3;MED14;HDAC2;GTF2H1;TFAP4;RNF6;CXXC1;DYRK1B;KMT2E;FOXE1;SNAI1;NAA16;ELF2;SOX11
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6027320947052177,1.671456543396303,0.013806706114398421,0.1381062361392471,1.0,7/20,4.44%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,potassium ion transmembrane transport (GO:0071805),0.41972078692117704,1.67122813599975,0.0,0.13703250990334953,1.0,34/135,10.91%,KCND2;HCN1;SLC24A4;SLC24A2;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;SLC12A6;KCNJ11;KCNN1;KCNK13;KCNK10;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;ATP1A3;KCNK9;KCNN3;KCNAB1;LRRC55;KCNC1;KCNK1;SLC12A3;KCNQ2;ATP1A4;ATP1A1
prerank,cytosolic transport (GO:0016482),-0.42638810433156893,-1.6674438684624897,0.0,0.16844741385925024,1.0,51/108,26.34%,DENND2A;VTI1A;VPS13A;ERC1;GBF1;EEA1;TMEM87A;SNX6;VTI1B;STX16;CORO7;MON2;CCDC91;KIF16B;GOSR1;VPS54;WDR91;VPS13C;STX5;BECN1;TMEM87B;DENND5A;PIK3C3;HEATR5A;DOP1B;ANKRD27;EHD3;GOSR2;LAMP1;ANKFY1;TBC1D17;HEATR5B;SNF8;CLN5;TBC1D10A;WDR81;STX8;VPS26B;BET1L;RGP1;TBC1D23;SPAG9;AP2A1;PTPN23;MYO1D;RAB9A;RAB7A;BAIAP3;RAB5A;PHETA1;TBC1D10B
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7077059728948998,-1.667399413674181,0.009708737864077669,0.16686217437463954,1.0,5/11,9.45%,MLLT3;DAB2;WNT5B;RSPO3;CSNK1E
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.4174697270686212,-1.6671425617773519,0.0,0.1657279323913555,1.0,43/132,18.04%,ZBTB20;IGF1;RNF152;DCN;FOXO3;ROCK1;ARNT;LRRK2;TFEB;PRKAA2;GSK3B;VGLL4;IRS1;TPCN1;HMGB1;MOV10;SNX9;RC3H1;UFL1;PFKFB4;TRIM8;ZSWIM8;ZC3HAV1;ABHD5;ABCD2;DACT1;NRDC;UPF1;PRKCD;HIF1A;ADAM9;CNOT8;TRIM5;DTX3L;ATF6;APOE;DAPK1;ADRA2A;PRXL2C;CNOT1;PRKD1;PRKAA1;PTPN1
prerank,positive regulation of nervous system development (GO:0051962),0.5146965640752369,1.6656609340721669,0.006,0.14311923203738908,1.0,10/42,9.60%,NRXN1;PTPRD;IL1RAPL1;EPHB1;MME;NLGN1;GRID2;CLSTN3;LRRC4B;OPRM1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.639984358027361,-1.6653515376455368,0.006036217303822937,0.16714988421417326,1.0,8/16,11.62%,ROCK2;IGF1;IL6ST;ROCK1;SLC9A1;MEF2A;CAMK2D;PARP1
prerank,regulation of microtubule depolymerization (GO:0031114),0.5804424202274614,1.6653047067573896,0.010309278350515464,0.14226464089650312,1.0,14/25,19.70%,NAV3;MAP1B;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;TRPV4;CLASP1
prerank,rRNA processing (GO:0006364),0.4036839705168355,1.665234981156906,0.0,0.14095993965939363,1.0,55/172,16.11%,TSR3;EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;TFB1M;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;ERI1;RPL21;DKC1;RPS7;RPL23A;NHP2;NOP2;RPL8;POP5;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,positive regulation of proteolysis (GO:0045862),-0.4825611654217997,-1.6643203599428869,0.0019646365422396855,0.16725064421061622,1.0,22/55,24.46%,CCBE1;CYFIP2;BTRC;CTSC;CTSH;SNX9;WDR48;ASPH;NRDC;ADAM9;RCN3;OGT;APOE;ADRA2A;ATP5IF1;FBXW11;TANK;FGFR4;TBC1D10A;PERP;HDAC2;NKD2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.4353427179964905,-1.6637844430353212,0.001893939393939394,0.1667635108263657,1.0,40/95,19.51%,GPC6;UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;CEMIP;SDC2;BGN;FMOD;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;OGN;GLCE;HS2ST1;SLC10A7;NDST1;ABCC5;PRELP;CHST15;ST3GAL3;LUM;NDST2;HEXA;PXYLP1;CHST11;SDC4;CHPF2;HS6ST1;CHSY1;XYLT2;B4GALT5;GCNT2;OMD;CHST12;B4GALT7
prerank,melanocyte differentiation (GO:0030318),-0.717800793891613,-1.6637510509683882,0.0018484288354898336,0.1652883487615938,1.0,5/11,14.79%,LRMDA;ENPP1;KIT;MEF2C;USP13
prerank,protein export from nucleus (GO:0006611),-0.5541491898907287,-1.6636718798999361,0.0072992700729927005,0.16392685649096284,1.0,14/27,23.70%,RANBP3L;PKD1;XPO4;STYX;DUSP16;NUP42;NUP214;TPR;SMURF1;RANBP3;DESI1;CHP1;XPO5;XPO1
prerank,metal ion transport (GO:0030001),0.4443085097277437,1.6628194992641656,0.00392156862745098,0.14252182407380115,1.0,32/86,19.31%,CAMK2A;TRPC5;CACNA1A;CACNA1B;RAMP2;SLC39A2;RYR2;RYR3;CACNA2D1;SLC8A1;SLC30A1;CACNA1E;TRPM2;TPT1;CACNG3;NIPA1;GRIN3A;SLC39A8;CACNG8;SLC30A5;TRPC1;NIPAL3;PSEN1;ATP2B2;SLC3A2;NIPAL4;CALCRL;FYN;MMGT1;MAGT1;ATP2C1;TRPV4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.7072270617819096,-1.6625830517511493,0.008032128514056224,0.16416060458893636,1.0,3/11,6.91%,HMGB1;TWSG1;RUNX1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5043399174715781,-1.6600506389174192,0.0078125,0.16739692594601044,1.0,20/43,18.77%,BMP6;IGF1;BMPR1A;WNT4;BMP7;IL6ST;BMP4;YAP1;MEF2C;IL6R;ATRAID;CCN1;ACVR1;RUNX2;FBN2;SUCO;CCN4;PRKD1;NPNT;BMP2
prerank,regulation of interleukin-4 production (GO:0032673),0.5950431221072038,1.6581580709686168,0.015021459227467811,0.14733371134530338,1.0,3/21,6.51%,LEF1;SLC7A5;PRKCQ
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5956055981783777,1.6580171231470402,0.006756756756756757,0.1460998920712522,1.0,11/20,17.05%,TMEM35A;CLU;PFDN6;BBS10;HSP90AB1;CCT2;HOPX;HSPD1;NDUFAF1;PTGES3;HSP90AA1
prerank,regulation of dendrite development (GO:0050773),0.5103944826738512,1.6566246792259383,0.007905138339920948,0.1464136634277115,1.0,14/37,9.89%,ADGRB3;DCC;CSMD3;LRP8;HECW1;TNIK;MFSD2A;SEMA4D;ALK;HECW2;ZDHHC15;CDKL5;LZTS1;DAB2IP
prerank,retinoid metabolic process (GO:0001523),-0.45266723588165136,-1.6564777382441174,0.0037313432835820895,0.17193922233011555,1.0,15/71,9.27%,GPC6;ALDH1A1;ALDH1A2;LRP1;RBP1;SDC2;CYP26B1;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1;CYP1B1
prerank,embryonic organ morphogenesis (GO:0048562),-0.5051251183267993,-1.654846721433697,0.0019801980198019802,0.17355258360500173,1.0,21/42,20.44%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;RARG;MFAP5;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4;ID2;NIPBL;HES1;ACVR1;HOXB9;FBN2;SIX1;MEGF8;RBPMS2
prerank,negative regulation of metabolic process (GO:0009892),-0.48043937619647803,-1.6531661734969274,0.003703703703703704,0.1750236615474055,1.0,21/54,20.37%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;CCDC3;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;FIS1;TLE3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5729366941935737,-1.6522374102640698,0.015296367112810707,0.1751825558687706,1.0,7/23,10.52%,ZBTB20;IGF1;NFKB1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,ganglioside biosynthetic process (GO:0001574),0.6480954489004639,1.6499026081556323,0.01639344262295082,0.15409856681687012,1.0,6/15,11.97%,ST6GALNAC3;ST8SIA4;B4GALNT1;B4GALT6;ST8SIA6;ST8SIA3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3806103779928013,-1.6491157541970816,0.0,0.17940095048371651,1.0,65/248,15.24%,RNF220;BICC1;WLS;MLLT3;LRRK1;EGFR;TCF7L2;GLI3;RBMS3;IGFBP2;NFKB1;COL1A1;LRP6;SMURF2;LGR4;PTK7;TNKS2;DAB2;TMEM64;STK3;DKK3;PRKN;LRRK2;CSNK1A1;BTRC;TBL1X;TBL1XR1;GSK3B;RNF146;GPC3;IGFBP6;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;CHD8;ZEB2;IGFBP4;XIAP;DACT1;JUP;WNK1;CSNK1E;LIMD1;USP47;TLE4;TLE1;LZTS2;PSMF1;CUL3;FZD7;TRPM4;PPM1A;SOX13;GLI1;UBAC2;APOE;PSMB2;UBE2B;HDAC1;ZBED3;DDX3X;LATS1;EMD
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6462647340020233,-1.6472134222668489,0.012433392539964476,0.1814226305951757,1.0,11/15,28.53%,WNT5B;GPC3;RSPO3;RNF213;DACT1;CSNK1E;SFRP4;CSNK1D;SPEF1;ZNRF3;DAAM2
prerank,nervous system development (GO:0007399),0.3623455654447484,1.6471327259868895,0.0,0.15640090338346135,1.0,104/429,14.76%,SPOCK2;PAX8;DNM3;DSCAM;KIRREL3;ST8SIA4;NELL1;ADGRL3;NAV3;SPOCK1;RBFOX3;NRXN1;TRPC5;LSAMP;MYT1L;LY6H;ERBB4;SLC2A1;MAL;MBP;LRCH4;PROX1;ASIC2;EPHB1;FGF12;NLGN1;CHRM3;GPM6A;SEMA6A;SH3GL2;PCDH1;TENM1;NRG1;ADGRB1;GPM6B;SH3GL3;DOC2A;DNER;MPZ;SEMA4F;AHI1;SHANK3;MOBP;CDH2;GRIK1;FGF13;CNTN6;ADAM22;APBA2;ADAM23;MOG;EFNB3;RBFOX1;NAB2;GJB1;DSCAML1;NRXN2;NPAS2;CYP26C1;NRCAM;NFASC;LHX1;ARHGAP26;FGF5;SRRM4;NINJ1;MTF1;PCDHB6;IL1RAPL2;ROBO2;RELN;SHANK2;ACVR1C;DCHS1;FEZ1;DPF3;HAP1;CNTN4;SMPD1;KCNQ2;PCDHA4;APC;NRGN;MBD5;SCN2A;NPTX1;DVL1;DPYSL2;DCTN1;SH3GL1;KALRN;DPYSL5;VCAN;HAPLN3;PTPRZ1;SERF1A;NHEJ1;STMN3;DCX;LGI1;PPT1;CHRM2;HPCAL4;HAPLN4
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5166637760024275,-1.646991865289835,0.007766990291262136,0.18017905165144205,1.0,9/38,12.06%,BMP6;SASH1;ANKRD17;PUM2;PLSCR1;DHX9;PUM1;DDX60;RIOK3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5858247809215826,-1.6464232303892439,0.022598870056497175,0.17814832549779472,1.0,6/20,10.52%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),-0.5858247809215826,-1.6464232303892439,0.022598870056497175,0.17814832549779472,1.0,6/20,10.52%,ZBTB20;IGF1;ARNT;PRKAA2;PFKFB4;HIF1A
prerank,mRNA metabolic process (GO:0016071),-0.43365184040756516,-1.6444917607719134,0.0,0.18041742485753828,1.0,50/90,33.43%,SON;DDX5;CELF1;DIS3L2;HNRNPR;PCF11;U2AF2;AKAP8L;CPSF3;PCBP2;PPARGC1A;PRPF3;SLBP;SF3A1;USP39;SCAF11;SF3A3;TCERG1;SRSF1;ERN1;SFPQ;PRKACA;CSTF3;SNRPF;CNOT10;RNASE4;SRSF7;SRSF11;GEMIN2;SRSF2;NUDT21;HSF1;DHX15;NONO;KIN;PRMT9;NCBP2;PCBP3;PRPF8;LSM11;LSM6;PRPF18;ZFP36L2;SF3A2;TBRG4;SF3B4;NUDT16;NUDT16L1;HNRNPA2B1;HSPA1A
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.3291078176844701,-1.644064335403838,0.0,0.17975643798649626,1.0,424/1646,18.70%,ZBTB20;NFIA;PBX1;FOXP2;IGF1;BNC2;MLLT3;FOXP1;DENND4A;NR2F2;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;TGFBR1;ZBTB7C;MAF;SOX5;RBFOX2;EFEMP1;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;TRAK1;PRDM5;COL1A1;HOXB6;ZNF148;HIVEP2;ZKSCAN2;ZMIZ1;LRP6;WNT4;RBPJ;CCNL2;MIDEAS;LIMS1;SMAD6;SMURF2;GLI2;ZNF423;DDX5;GLIS3;HOXC6;ATXN1;FOXP4;NR1D2;ZHX2;MDFIC;ZFHX3;ZEB1;MDM4;BRWD1;FOXC1;TRIM44;KLF9;BMP7;PIAS1;ZIC2;IL31RA;FOXO3;EP300;BMP4;ARID1B;HDAC4;CREB5;GTF2H2;ERC1;ABL1;BCOR;KAT6B;DKK3;NCOR1;ARNT;CUX1;OSR1;WWC2;CCNT2;CCNL1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;KDM7A;BTRC;TBL1X;BRD7;FOXN3;ELF1;RBBP8;WWP2;NFIB;SETD5;CCNH;TBL1XR1;NR6A1;NFIX;KIT;GON4L;RREB1;CCNT1;NIBAN2;VGLL4;YAP1;WTIP;RCOR1;RGMB;CREBL2;DDX17;KHDRBS1;GMEB1;BAZ1A;ANXA4;TGFB1I1;CDK16;MEF2A;KMT2D;BAZ2A;HMGB1;RCOR3;PPARGC1B;ZKSCAN3;NR3C1;LCOR;KLF3;ZNF182;SRSF10;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;PRRX2;AXIN1;HOXA5;FUS;SNX6;PBX3;MED17;LBH;TBX15;CREBBP;ZBTB16;FZD2;CDH1;ZIC5;STAT3;TEF;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;JDP2;MED26;TRRAP;HOXC8;MED12;L3MBTL3;NAB1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;CAMK2D;HIVEP3;DHX9;WWP1;ZEB2;SCMH1;HOXA3;REST;KDM5B;POFUT1;VEZF1;HDGFL2;CEBPG;HOXB5;MAP3K5;ZBTB37;HNRNPD;BCL7A;GTF2IRD1;ZBTB8A;AR;ZFX;DHX36;ZNF496;SAFB2;CTR9;FOXK1;MBD2;PPARGC1A;RUNX1T1;CDC5L;MAFG;IGF2;SETD3;SP140;SP100;CBFA2T2;SP2;PTPRK;NCOA6;MAP2K1;NFYC;PIAS3;ZBTB1;NCOA1;CHD2;MED1;UBE2I;PHF2;HNRNPK;ATF2;CCNK;TEAD3;CHD4;HOXB4;UBP1;BTAF1;CHD3;ZNF467;ZFAT;MNAT1;PRMT2;ZNF569;RFX2;GABPA;NR1H3;SSBP2;JUN;TADA3;TULP3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;SMAD4;MED21;LIMD1;PARP9;ATF7IP;GLIS2;ID2;NIPBL;USP47;CDK11B;BCLAF1;ZBTB24;CREBRF;TLE1;GPBP1L1;VGLL3;ZXDC;WWC1;NFATC4;TBX18;RAD21;RORA;MEF2C;ARID5B;NRF1;PCGF6;FBXL19;SPTY2D1;PBXIP1;TFCP2;HES1;TEAD2;EPC2;ZNF692;IRF9;SUFU;TCF3;TCF7L1;PIAS4;RB1;EHMT1;BHLHE41;OGT;ZBTB34;CCAR1;FZD7;CRABP2;PATZ1;IRF1;PPM1A;TSHZ3;HTATSF1;YBX1;SOX13;DTX3L;KAT8;GLI1;BICRA;ATF6;MMS19;SOX6;CHD7;SIX5;TRPS1;ING5;APOE;KDM3B;PHF1;ZFP3;STAT1;CC2D1B;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;KDM3A;MKX;USP13;CIAO1;ILF2;CNOT2;CBFA2T3;PRDM2;ZNF18;TAF5L;SCML4;CARF;HOXB9;PHC2;MED13L;ZNF697;RXRA;HOXC5;KLF15;RUNX2;BBX;JARID2;MNT;MAP2K7;FOXK2;TGFB3;KDM2A;SALL1;VSX1;LOXL3;PRDM15;ATOH8;L3MBTL2;PRMT5;IKZF2;BRD3;KLF6;ARRB1;SFPQ;ZNF112;DAP;FOXL1;ARHGEF11;GLRX2;AFAP1L2;HEYL;CITED2;CAMTA2;EPC1;PDCD4;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ATXN1L;RNF20;SMARCD2;ZFP37;NFYB;ZMYND15;TWIST2;PICALM;WNT5A;PHIP;BAZ2B;MED27;NR4A2;CC2D1A;STAT5B;BAZ1B;NFIC;ZFHX4;FBXW11;TAF6L;MSL3;POU6F2;SOD2;TFCP2L1;TRAF6;NEK4;RHOH;ZKSCAN7;FZD1;RRP8;HMG20A;ZNF436;NFATC3;INPP5K
prerank,response to histamine (GO:0034776),0.7008131738193996,1.6437248728393579,0.026200873362445413,0.15983627729409036,1.0,4/10,8.57%,GABRB3;GABRB1;GABRB2;GABRG2
prerank,calcium ion import across plasma membrane (GO:0098703),0.6438601675101014,1.6436932718254507,0.01939655172413793,0.1584744050195639,1.0,4/14,6.47%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,positive regulation of secretion (GO:0051047),0.7068432071542362,1.643562709890743,0.0175054704595186,0.1572635013950612,1.0,5/11,16.58%,TRH;XBP1;ACSL3;NPR1;GPLD1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.49575721368705594,-1.643554888737949,0.0057251908396946565,0.1792698289327708,1.0,8/45,2.70%,BMP6;TGFBR1;BMPR1A;RBPMS;BMP5;BMP7;DAB2;BMP4
prerank,cellular response to drug (GO:0035690),0.5729442703171055,1.643180913611673,0.014830508474576272,0.1564296943720414,1.0,5/25,3.84%,TFRC;PDE4B;ACER2;GAS6;PPM1F
prerank,protein autoubiquitination (GO:0051865),-0.4675500317870708,-1.6427269086464549,0.0036968576709796672,0.17945974034972242,1.0,25/61,20.03%,RNF220;PRKN;WWP2;RNF115;RNF146;UHRF2;RNF213;SH3RF1;RNF8;RNFT1;DDB2;TRAF2;CUL3;DTX3L;SH3RF2;UBE2B;SH3RF3;ERCC8;RNF181;BFAR;TRAF6;UBE2D3;LRSAM1;RNF11;NFX1
prerank,ethanol metabolic process (GO:0006067),-0.6889189360986565,-1.6426724947051872,0.007736943907156673,0.17813023202577585,1.0,3/12,10.52%,ALDH1A1;ALDH2;SULT1A1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4534115767217172,-1.6419059384880939,0.0019230769230769232,0.17795000964700522,1.0,16/74,7.97%,EYA2;IGF1;EYA1;TCF7L2;TGFBR1;BMP5;EYA4;ITGAV;CFLAR;BMP4;BIRC6;GSK3B;THBS1;SH3RF1;BCL2;AR
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5363430617636297,1.6412707913019886,0.010121457489878543,0.1574147154694022,1.0,11/27,13.72%,CTNNA2;IL1RAPL1;MBOAT1;HOMER1;AKT1;NTNG1;NTNG2;BRSK2;CCDC88A;EFHC2;PSEN1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5605129828265458,-1.6412442447789293,0.01509433962264151,0.17782857992196124,1.0,8/25,5.30%,SULF1;BMPR1A;FOXD1;RBPJ;ZNF423;BMP4;NUMA1;SMAD2
prerank,long-term synaptic potentiation (GO:0060291),0.5894662323591559,1.6399040616197174,0.014462809917355372,0.1578549606889693,1.0,7/21,9.16%,MPP2;SLC24A2;GRIN2A;GRIN2B;GRIN2D;NPTN;SHANK2
prerank,retrograde axonal transport (GO:0008090),0.6256031861660787,1.636644863580977,0.016736401673640166,0.16126315090622645,1.0,6/16,11.46%,DLG2;TMEM108;KIF1A;DST;HAP1;ACTR10
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5371211231496764,-1.6355614410115618,0.003738317757009346,0.18675324416723407,1.0,11/29,17.74%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;FER;PKD2;STAT1;STAT5A;STAT5B
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4477149490431859,-1.6352588862145625,0.0037735849056603774,0.1857851624952978,1.0,26/73,17.71%,ITGBL1;COL3A1;PTN;FBLN1;PLPP3;ITGAV;DAB2;ABL1;ITGA10;ITGB1;FYB1;ITGA11;NRP1;ITGB5;CDC42;ITGB8;LAMA3;ADAM9;TEC;ZYX;CUL3;FN1;ITGA5;DOCK1;ADAMTS1;PRKD1
prerank,regulation of biosynthetic process (GO:0009889),0.6818670615947884,1.6347353047354405,0.017316017316017316,0.16241734232267727,1.0,3/11,10.32%,THRSP;SNCA;MID1IP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.48111478532422997,-1.6338375698959628,0.003875968992248062,0.18697407253600692,1.0,17/46,17.44%,IGF1;FOXP1;TCF7L2;IGFBP5;PDGFRB;BMP4;ELN;IGFBP3;THBS1;OGN;ID2;APOD;IL6R;STAT1;PRKDC;IL18;CCN4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6835426320603163,-1.6336712638180912,0.011214953271028037,0.18321584792218423,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6835426320603163,-1.6336712638180912,0.011214953271028037,0.18321584792218423,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6835426320603163,-1.6336712638180912,0.011214953271028037,0.18321584792218423,1.0,9/12,24.34%,NSMCE2;ANAPC5;ANAPC7;ANAPC4;CUL3;RB1;CDC27;ANAPC11;CDC16
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4455723393670349,-1.6326304613014004,0.0,0.18391089529722685,1.0,20/73,10.80%,FSTL1;SULF1;CRIM1;BMPR1A;FOXD1;RBPJ;SMAD6;SMURF2;ZNF423;NBL1;BMP4;NUMA1;HTRA3;SMAD2;SKI;TWSG1;SKIL;XIAP;SMAD4;BMPER
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.47763273697428094,-1.6313575291458975,0.006085192697768763,0.18494694760888514,1.0,19/55,16.31%,GPC6;DCN;CEMIP;SDC2;BGN;FMOD;GPC4;SLC9A1;GNS;GPC3;HSPG2;OGN;PRELP;CEMIP2;LUM;GUSB;HEXA;SDC4;GALNS
prerank,regulation of autophagy (GO:0010506),-0.3799655830981572,-1.630430362011943,0.0,0.18531413283210021,1.0,71/216,22.60%,PRKAG2;ITPR1;RNF152;LEPR;DCN;EIF4G3;FOXO3;EP300;ROCK1;ATP6V1B2;ABL1;PRKN;LRRK2;TFEB;PRKAA2;NUPR1;GSK3B;RPTOR;TPCN1;HMGB1;ZKSCAN3;ATP6V0D1;DNM1L;SNX6;UBQLN1;STAT3;UFL1;BCL2;TRIM8;MTOR;TPCN2;PIP4K2C;FOXK1;VDAC1;PTPN22;EIF4E;USP33;RB1CC1;ABL2;PRKAB2;TRIM5;FBXW7;MTMR3;KLHL22;KAT8;ATF6;GFAP;CTSA;ERN1;USP13;FOXK2;DAPK1;DAP;RUBCN;DAPK2;PRKACA;RMC1;PRKD1;PRKAA1;GPR137B;EIF4G1;PLEKHF1;ORMDL3;PRKAG3;BMF;PRKAB1;BNIP3;DCAF12;VPS26B;TICAM1;ATP6V1G2
prerank,adherens junction organization (GO:0034332),0.48591661487044746,1.6299137600008329,0.008016032064128256,0.1675389261253866,1.0,19/48,14.24%,CDH12;CDH8;ACTB;CADM1;CADM2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;DCHS1;CADM3;TJP1;NECTIN1;SMAD7;CTNND1;JAM3
prerank,negative regulation of axon extension (GO:0030517),0.5365561364534979,1.629367518632619,0.016842105263157894,0.16686609976772726,1.0,9/30,4.44%,SEMA3C;MAG;SEMA6A;SEMA4A;SEMA4F;MAP2;SEMA6D;SEMA4D;SEMA7A
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5334412761307782,-1.6286057303770145,0.007707129094412331,0.1872422618690181,1.0,9/32,10.52%,ZBTB20;IGF1;PID1;ARNT;PRKAA2;NUPR1;PFKFB4;PPARGC1A;HIF1A
prerank,positive regulation of wound healing (GO:0090303),-0.5185784579366269,-1.6284849117929956,0.005671077504725898,0.1861529295864882,1.0,11/36,7.19%,ST3GAL4;MYLK;PLPP3;VTN;RREB1;ITGB1;THBS1;ARFGEF1;FOXC2;ANXA1;MTOR
prerank,diterpenoid metabolic process (GO:0016101),-0.46469422532399296,-1.6281535798125548,0.007707129094412331,0.1854885886176786,1.0,12/55,7.97%,GPC6;ALDH1A1;LRP1;RBP1;SDC2;GPC4;RBP4;GPC3;HSPG2;ABCA4;DHRS3;AKR1B1
prerank,RNA destabilization (GO:0050779),-0.6169361626108978,-1.6275408204399582,0.00980392156862745,0.18535876658105935,1.0,6/18,7.62%,ROCK2;CELF1;FTO;ROCK1;YTHDF3;PUM1
prerank,GTP metabolic process (GO:0046039),-0.6321071926414437,-1.6270561598020308,0.008403361344537815,0.18499530304994968,1.0,3/15,3.12%,RHOQ;OPA1;LRRK2
prerank,regulation of protein export from nucleus (GO:0046825),-0.5679220855009578,-1.62595000167081,0.012915129151291513,0.18571418041276222,1.0,13/23,19.44%,TCF7L2;XPO4;PTPN14;GSK3B;RAPGEF3;SP100;BAG3;TPR;YWHAE;EMD;ANP32B;PARK7;IFI27
prerank,neutral amino acid transport (GO:0015804),0.544240030979777,1.6256581816481448,0.01443298969072165,0.17085393113249012,1.0,7/28,9.58%,SLC7A5;SLC6A6;SLC6A17;SLC1A1;SLC7A8;SLC43A2;SLC36A1
prerank,nuclear migration (GO:0007097),-0.6752807618278593,-1.6253985014422916,0.013861386138613862,0.18542793240672012,1.0,8/13,18.27%,SYNE2;PCM1;SYNE3;CLMN;DOCK7;DYNC1H1;FBXW11;TMEM201
prerank,regulation of monocyte differentiation (GO:0045655),-0.6524993953662724,-1.625023773048012,0.014925373134328358,0.18485738492239176,1.0,4/14,6.18%,FOXP1;IL34;ACIN1;HOXA7
prerank,regulation of ossification (GO:0030278),-0.5123157111124805,-1.6249774884094117,0.006036217303822937,0.18368121009885274,1.0,19/36,24.96%,PTN;LRP6;RBPJ;SMAD6;BMP4;ENPP1;ZBTB16;NBR1;MEF2C;BMP2K;ACVR1;ECM1;WNT5A;CHSY1;BMP2;PTPN11;LRP4;TWIST1;SOX11
prerank,axon guidance (GO:0007411),0.3861769629189679,1.6241664979344657,0.0,0.17142178764888713,1.0,60/201,12.14%,DSCAM;BSG;NRXN3;NRXN1;DCC;EPHA6;SEMA3C;TMEFF1;EPHB1;SPTBN4;PLXNB3;SEMA6A;DAB1;UNC5C;SPTB;CXCL12;EPHA5;SEMA4A;SEMA4F;SHANK3;ROBO4;CNTN6;SEMA6D;SEMA4D;DOK6;SEMA7A;EFNB3;TNR;RPS6KA5;NOTCH1;DSCAML1;NCAM1;UNC5D;SLIT3;SLIT1;NPTN;ENAH;PRKCQ;LHX1;RAP1GAP;VSTM2L;UNC5B;EFNA2;PLXNA4;ROBO2;EPHA10;SPTBN5;RELN;TUBB3;ROBO3;FEZ1;NTN1;PTPRM;CHN1;CNTN4;DOK5;SPTBN1;DOK2;CNTN2;RET
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5906789018434077,-1.624099229692852,0.00984251968503937,0.1839832855966148,1.0,9/20,20.12%,IGF1;FOXC1;EP300;NIBAN2;RB1;GTF2B;TRAF6;PARK7;H1-0
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4304774643629254,-1.6235718760912514,0.0038535645472061657,0.18365998828494837,1.0,30/87,15.95%,COL1A2;TGFBR3;COL3A1;SMAD3;TGFBR1;APPL2;BMPR1A;ZMIZ1;SMAD6;FMOD;TGFBR2;ITGB1;SMAD2;SKI;TWSG1;ITGB5;PTPRK;RHOA;JUN;ADAM9;SMAD4;ARHGEF18;ZYX;APPL1;PARD3;SMURF1;ACVR1;PRKCZ;TGFB3;LRRC32
prerank,regulation of acrosome reaction (GO:0060046),0.6880747924103986,1.623284732465997,0.028824833702882482,0.17119875304994847,1.0,2/10,5.65%,GLRA1;PLCB1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7085325592187979,-1.6222944892247488,0.016728624535315983,0.18458328703621057,1.0,6/10,19.37%,GRB10;ARNT;VTN;HIF1A;ITGA5;ITGB3
prerank,calcium ion import into cytosol (GO:1902656),0.6301908168631895,1.6222561372224045,0.03325942350332594,0.17122921179854939,1.0,4/15,6.47%,SLC24A2;CACNA2D1;SLC8A1;TRPM2
prerank,endoderm formation (GO:0001706),-0.5229900073742038,-1.6190721772108,0.017013232514177693,0.18907678259719227,1.0,14/35,16.01%,COL8A1;COL12A1;ITGAV;VTN;COL6A1;ITGB5;SETD2;LAMA3;MMP14;MMP2;FN1;DUSP1;ITGA5;ITGA4
prerank,protein K63-linked ubiquitination (GO:0070534),-0.5036306006055989,-1.6156345395797174,0.0,0.19401689957993382,1.0,19/41,22.77%,RNF152;UBE2N;UBE2E2;PRKN;WWP2;RNF115;TRAF3IP2;RNF8;TRAF2;TRIM5;UBE2B;TRAF3;HECTD1;BFAR;UBE2S;TRAF6;ARIH2;TRAF5;UBE2V2
prerank,cardiac conduction system development (GO:0003161),-0.5641554637587057,-1.6151534847528473,0.013358778625954198,0.19367538135398824,1.0,11/24,21.37%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;SMAD4;TBX18;MAML1;CACNA1G;GATA6;SMAD1
prerank,central nervous system myelination (GO:0022010),0.6682309328445922,1.6146632932774891,0.0228310502283105,0.18027716856727724,1.0,5/11,8.37%,PLP1;TENM4;CLU;CNTNAP1;B4GALT6
prerank,brain morphogenesis (GO:0048854),0.6516301901843021,1.6138158881273945,0.032454361054766734,0.18008320871305672,1.0,4/12,10.52%,CTNNA2;SHANK3;PAX2;SPEF2
prerank,pharyngeal system development (GO:0060037),-0.6308442648754442,-1.6122385025193275,0.019011406844106463,0.19809158895012338,1.0,5/15,2.70%,TGFBR1;BMPR1A;BMP5;BMP7;BMP4
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.4794198774777849,-1.612061729928594,0.007936507936507936,0.19706892766609882,1.0,15/44,11.38%,ROCK2;CELF1;FTO;ROCK1;TNRC6B;YTHDF3;TNRC6A;MOV10;EIF4ENIF1;RC3H1;ZC3HAV1;PUM1;DHX36;UPF1;CNOT8
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.6023838528269079,-1.6115947961812163,0.017208413001912046,0.1965679469413146,1.0,7/17,9.06%,ATP1A2;BMP7;BMP4;NR3C1;TFPI;AR;MED1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6743852794202688,-1.6115324907638044,0.0148975791433892,0.19543802981736497,1.0,5/12,9.11%,ELF1;RC3H1;RUNX1;LYN;PTPN22
prerank,neural crest cell development (GO:0014032),0.49533439648999716,1.6115111676619973,0.009823182711198428,0.18204380555107336,1.0,11/44,6.01%,ERBB4;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;CDH2;SEMA6D;SEMA4D;SEMA7A;CYP26C1
prerank,intracellular cholesterol transport (GO:0032367),-0.6306917883009823,-1.60962320284792,0.02490421455938697,0.1976387979485931,1.0,5/15,11.63%,LRP6;ABCA1;LDLR;RELCH;NPC2
prerank,skin development (GO:0043588),-0.44697076320544404,-1.6088296836120501,0.006085192697768763,0.19777103944919638,1.0,16/65,11.74%,COL1A2;COL3A1;COL5A2;ERRFI1;COL5A1;COL1A1;PKD1;JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;COL5A3;ADAM9;UGCG
prerank,regulation of DNA repair (GO:0006282),-0.486850679685225,-1.608357773461173,0.0020325203252032522,0.19741343517645277,1.0,11/44,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;TRIP12;UBR5;DHX9;BRCC3;CEBPG;RNF8
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3952401041840307,1.6078229977440603,0.0,0.18625078019088634,1.0,54/168,14.46%,EXOSC5;RPS6;RPS19;RPS20;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPS12;RPS21;RPL15;RPL10;HELZ2;RPL10A;RPS24;PPP2R1A;RPL27A;RPS17;RPS8;RPS16;ETF1;RPS27A;RPLP1;RPL41;RPLP0;RPL30;RPL7A;RPL13;CNOT6L;RPL12;RPS15;PABPC1;RPL14;SMG8;RPL5;RPS4X;ERI1;RPL21;RPS7;RPL23A;RPL8;MAGOHB;MAGOH;RPS14;RPS3;RPS2;RPS5;RPL18A;ATM;RPS28
prerank,regulation of neurotransmitter transport (GO:0051588),0.6138338966592586,1.6075860335051815,0.026156941649899398,0.18515277720619597,1.0,5/16,10.56%,CAMK2A;RIMS1;MCTP1;KCNMB4;CPLX1
prerank,cellular response to misfolded protein (GO:0071218),-0.5857613226930612,-1.607145739986676,0.009345794392523364,0.19835149635406502,1.0,14/20,31.82%,UGGT2;KLHL15;DNAJB14;POMT2;CUL3;AUP1;DERL1;VCP;TOR1A;BAG6;DNAJC18;RNF126;UFD1;UBE2W
prerank,atrial septum development (GO:0003283),-0.6380283890598346,-1.6065597930688444,0.014388489208633094,0.19809115264425814,1.0,3/13,2.12%,NOTCH2;ANK2;MDM4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5140017635304387,-1.6055667441493184,0.011299435028248588,0.19868173572483908,1.0,15/34,22.02%,DOCK5;LIMS1;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL
prerank,calcium ion transport into cytosol (GO:0060402),0.5720774129299989,1.6046609841246748,0.017391304347826087,0.18832966433873874,1.0,10/21,11.22%,GRIN1;GRIN2A;RYR2;GRIN2B;CACNA2D1;GRIN2D;SLC8A1;TRPM2;ADRA1A;JPH3
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4824195098688752,-1.6039846921373198,0.01125703564727955,0.2001002581754128,1.0,19/46,20.37%,ALDH1A1;RBPJ;ZNF423;LGR4;NPR3;DOCK7;ADAMTS5;FOXC2;LAMA4;NRDC;NR1H3;RB1;ACOT11;LNPEP;PLCL1;TLR4;ABHD6;MAP2K6;TLE3
prerank,neuronal action potential (GO:0019228),0.5634876587046626,1.6026690491905096,0.016494845360824743,0.1898694698767441,1.0,10/22,15.67%,SCN1A;ANK3;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5945729263601245,-1.602050544802011,0.01509433962264151,0.20245536059046212,1.0,10/19,30.78%,IRS1;ABHD5;ABCD2;PRKCD;AKT2;DAGLB;TWIST1;PNPLA2;PPARA;ANGPTL3
prerank,regulation of bone mineralization (GO:0030500),-0.4636277988925319,-1.6014089464325754,0.007952286282306162,0.20240081539188814,1.0,22/55,16.44%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;BCOR;ENPP1;OSR1;ADGRV1;NBR1;KL;ATP2B1;MEF2C;TRPM4;ATRAID;CCN1;BMP2K;ACVR1;FBN2;TGFB3;ECM1
prerank,neuron development (GO:0048666),0.40091727778369946,1.600624043169487,0.0,0.1913316266880104,1.0,37/141,10.82%,CNTNAP2;GPRIN1;MYT1L;FRY;PLP1;TMEM108;NLGN1;TENM2;GPM6A;SH3GL2;PBX2;TENM1;GPM6B;EPHA5;MAP2;STMN1;NTRK2;TENM4;STX3;TGFB2;ALK;PPP1R9A;TENM3;GPRIN3;SRRM4;ADCYAP1;STMN4;RASGRF1;BICDL1;B4GALT6;CAMSAP1;RAB35;STMN2;ATP8A2;PTPRM;MICALL2;CNTN4
prerank,cellular glucan metabolic process (GO:0006073),-0.6590020649106445,-1.6004488250929214,0.013513513513513514,0.2030878877425999,1.0,5/11,14.95%,PRKAG2;PHKB;GSK3B;PHKA1;PYGM
prerank,positive regulation of glucose import (GO:0046326),-0.5707438060203532,-1.6004285784830232,0.021568627450980392,0.2019075461738791,1.0,6/21,4.55%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2
prerank,response to leucine (GO:0043201),-0.693820339761023,-1.6002296474157733,0.018148820326678767,0.19987847833049305,1.0,6/10,13.12%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,cellular response to leucine (GO:0071233),-0.693820339761023,-1.6002296474157733,0.018148820326678767,0.19987847833049305,1.0,6/10,13.12%,UBR2;RPTOR;MTOR;SESN1;UBR1;KLHL22
prerank,limb development (GO:0060173),-0.5321610505764912,-1.5998881525252302,0.00980392156862745,0.19921551285906028,1.0,15/28,25.77%,SMOC1;GLI3;KAT2B;PCSK5;MAP3K20;RSPO2;CHD7;PTCH1;SALL1;IQCE;MEGF8;LRP4;KREMEN1;ZNRF3;COMP
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.35521088710878757,-1.5988916443539354,0.0,0.19984525531242292,1.0,126/327,26.11%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ZMIZ1;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;ATF2;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;COPS2;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;PML;NFYA;PPP2CA;NIF3L1;EZH2;ZNF205;SPIN1;DRAP1;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6896614222255453,-1.5988000216912583,0.017786561264822136,0.1987736212640495,1.0,6/11,18.77%,EFNB2;FRS2;MEF2C;FZD7;SOX6;BMP2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6515117268708929,1.5986708399272513,0.024390243902439025,0.1929507299144294,1.0,5/13,13.72%,TMSB4X;HEY1;PER2;SIN3A;PSEN1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5193472869032445,-1.5981427891541236,0.011385199240986717,0.19866695028645415,1.0,10/31,9.49%,TGFBR1;PDGFRA;OSR1;TGFBR2;HOXB3;FGFR2;DYNC2I1;HOXC4;HOXA3;HOXB4
prerank,organelle disassembly (GO:1903008),-0.5178054222464331,-1.5980556031284319,0.009633911368015413,0.1976281318210072,1.0,16/33,22.89%,GBF1;UFL1;DENR;UBA5;TEX264;RB1CC1;ULK2;STX5;ATG2A;GFM2;MRRF;ATG2B;VCP;KIF9;ZFAND1;PLK5
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5683311724920428,-1.5936464983020375,0.015065913370998116,0.20462600227640315,1.0,7/22,9.06%,NOTCH2;KLF9;STXBP4;FGFR2;SRSF6;PTPRK;MED1
prerank,cellular response to glucose starvation (GO:0042149),-0.47768572361737766,-1.592518093525371,0.011857707509881422,0.205661711386489,1.0,20/41,23.65%,PRKAG2;FOXO3;PRKAA2;EIF2AK3;SESN1;IMPACT;BRSK1;SIK1;MTMR3;BECN1;PIK3C3;PIK3R4;PRKAA1;RRP8;PRKAG3;TBL2;ATG14;SIK2;SZT2;NUAK1
prerank,Golgi to endosome transport (GO:0006895),-0.6188980885331222,-1.5918673457581747,0.026465028355387523,0.20551853528905156,1.0,8/16,14.39%,VPS13A;GBF1;CORO7;MON2;KIF16B;WIPI1;VPS13C;DOP1B
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5863275144045973,-1.5915426202014806,0.02131782945736434,0.2049207684600084,1.0,10/19,13.56%,TGFBR3;TGFBR1;BMPR1A;RBPJ;VGLL4;RBP4;FGFR2;RUNX1;MEF2C;GLI1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6569548474213199,-1.5913820974210642,0.019120458891013385,0.20412286917234782,1.0,7/12,19.58%,BMP4;PTPN14;KHDRBS1;NUP214;TPR;IFI27;RBM4
prerank,anterior/posterior pattern specification (GO:0009952),-0.4637458132569001,-1.5913259058869669,0.005940594059405941,0.2030883673286052,1.0,19/53,16.75%,WLS;TGFBR1;HOXB6;HOXC6;HOXB3;PCSK5;SMAD2;HOXA5;SKI;HOXA7;HOXC4;HOXA3;HOXB5;HOXB4;HES1;BHLHE41;HOXB9;HOXC5;HEYL
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3609698562144284,1.5907339048754903,0.0,0.20374127648481333,1.0,82/306,14.46%,PAX8;ALAS2;CHEK1;RPS6;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;HOXD3;RPL10A;TBRG1;RPS24;EEF1B2;FUT9;RPL27A;RPS17;RPS6KB2;RPS8;RPA3;RPS16;RPS27A;RPLP1;XAB2;RPL41;RPLP0;RPL30;RPL7A;TUFM;ING4;MRPL13;RPL13;MRPS18A;EEF1D;RPL12;MRPS7;RPS15;PIF1;POLR2J;EIF4EBP2;SET;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;RPS7;POLR2I;RPL23A;MCM3;EEF1A2;RPL8;BCL3;MED20;MRPL36;BRIP1;MRPL23;RPS14;POLD1;RNASEH2A;RPS3;RPS2;RPS5;EEF1A1;RPL18A;ATM;RPS28;POLR3A
prerank,Golgi localization (GO:0051645),-0.679911500395028,-1.5900687368039723,0.022263450834879406,0.20434147521722262,1.0,6/11,18.62%,UVRAG;ARHGAP21;CDC42;ARCN1;TBCCD1;COPG1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.6410757022916515,-1.589416483240803,0.02355072463768116,0.2042226093118892,1.0,10/13,30.59%,SAE1;SENP6;UBA5;UBA7;DESI1;DESI2;NAE1;UBA2;ATG10;UBA1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.44499854763472096,-1.5881646684667066,0.0038461538461538464,0.20533836472772557,1.0,22/63,20.28%,IGF1;TCF7L2;TGFBR1;WWOX;ITGAV;CFLAR;BMP4;BIRC6;DEPTOR;THBS1;PAK2;SH3RF1;AR;SP100;TRAF2;STX4;LTBR;ACVR1;PHIP;BCL2L12;PARK7;PML
prerank,embryonic digestive tract development (GO:0048566),-0.5949376446359615,-1.587688439138755,0.027079303675048357,0.20498173117447552,1.0,11/18,20.84%,GLI3;PDGFRA;GLI2;RARB;PCSK5;FGFR2;ID2;NIPBL;SALL1;RBPMS2;PKDCC
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3963051461461784,-1.5864182976649512,0.0,0.2060748660397848,1.0,34/129,14.85%,RNF220;WLS;LRRK1;EGFR;NFKB1;COL1A1;SMURF2;LGR4;PTK7;TNKS2;LRRK2;TBL1X;TBL1XR1;RNF146;GPC3;UBR5;AXIN1;LYPD6;ADGRA2;FGFR2;ZEB2;XIAP;DACT1;JUP;WNK1;CSNK1E;USP47;PSMF1;TRPM4;PPM1A;PSMB2;UBE2B;ZBED3;DDX3X
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5342241712472219,1.5860811367382492,0.020491803278688523,0.20960723660330746,1.0,6/25,7.34%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;CIB2
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.6194592328708621,-1.5856975165547476,0.022222222222222223,0.20618036659851383,1.0,9/15,15.53%,TCF7L2;XPO4;GSK3B;RAPGEF3;BAG3;TPR;YWHAE;EMD;ANP32B
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.5201790091566493,-1.585333101975847,0.015444015444015444,0.2057930220988613,1.0,8/29,8.00%,SMAD3;DICER1;PUM2;ZC3H7A;SMAD2;PUS10;PUM1;TUT4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.340092309679949,-1.5850842026578014,0.0,0.20525099919584794,1.0,131/497,17.31%,SAMD4A;FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;IGFBP5;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;ENPP1;BTRC;BRD7;FOXN3;WWP2;GSK3B;NIBAN2;VGLL4;SYNCRIP;RCOR1;KHDRBS1;DDX6;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;EIF4ENIF1;ATP8B1;CBX5;EIF2AK1;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;EIF2AK3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;LARP1;BCL7A;PDS5A;DHX36;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;SELENOS;PRMT2;JUN;LSM14A;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;CNOT8;ARID5B;PCGF6;PBXIP1;HES1;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;YBX1;SOX13;KAT8;EIF2AK2;HINFP;ZNF318;HDAC1;DDX3X;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;DAPK1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;CNOT1;ZMYND15;TWIST2
prerank,cell-cell junction assembly (GO:0007043),0.44507060634830425,1.582387549011288,0.012244897959183673,0.21470916178448285,1.0,16/63,7.09%,CLDN5;CDH12;CDH8;ACTB;CTNND2;RAMP2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;GJB1;WDR1;EPB41L3;CNTNAP1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5402158537405056,-1.5823788414284055,0.025193798449612403,0.20880268786932035,1.0,7/24,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;ARAP1;WASF2;PAK2
prerank,cartilage development (GO:0051216),-0.4675373631269522,-1.5820543576300277,0.015904572564612324,0.20832595133406764,1.0,15/49,11.68%,SULF1;SOX5;CREB3L2;PKD1;BMP4;OSR1;WNT5B;NFIB;SULF2;SLC39A14;ZBTB16;RUNX1;ITGB8;CCN3;MEF2C
prerank,limb morphogenesis (GO:0035108),-0.5750468080603056,-1.5819430947565751,0.030575539568345324,0.20743530977160574,1.0,10/20,21.90%,GLI3;LRP6;PCSK5;CYP26B1;SKI;NIPBL;PTCH1;IQCE;MEGF8;FBXW4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.6353559552746783,-1.5798383487299388,0.019120458891013385,0.21012401392314284,1.0,3/13,5.68%,ERRFI1;CBLB;SNX6
prerank,cellular response to metal ion (GO:0071248),0.4033350314423457,1.5796662428269173,0.004291845493562232,0.2178760492973857,1.0,28/123,7.97%,DLG2;SYT1;MT2A;ADCY8;SYT6;NLGN1;SYT7;GLRA1;SYT12;SYT11;ANK3;RYR3;CPNE9;SNCA;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;TRPM2;CPNE8;CPNE1;KCNH1;SYT10;AKT1
prerank,regulation of protein import into nucleus (GO:0042306),-0.4967353648747531,-1.5794711698865558,0.009940357852882704,0.20964165414643252,1.0,14/36,12.63%,ZIC1;SMAD3;MDFIC;BMP4;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;SUFU;APOD
prerank,sensory perception of chemical stimulus (GO:0007606),0.6193268273633832,1.5789511980709443,0.029082774049217,0.21757418953479676,1.0,5/15,13.89%,SLC24A4;ADCY3;SYT10;GNAL;CD36
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.32380347612552707,-1.578890473807367,0.0,0.2096628635499609,1.0,290/1082,18.83%,NFIA;BMP6;PBX1;IGF1;AUTS2;MLLT3;NR2F2;EGFR;HLF;NFAT5;ZIC1;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TGFBR1;TEAD1;BMPR1A;CREB3L2;NFKB1;COL1A1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;WNT4;INO80;RBPJ;THRB;DCN;GLI2;ZNF423;GLIS3;NR1D2;ZNF462;MDFIC;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;TRIM44;KAT2B;BMP7;ZIC2;DAB2;IL31RA;FOXO3;PPP1R12A;EP300;BMP4;ARID1B;HDAC4;CREB5;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;BTRC;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;SSBP3;NFIX;RREB1;RPTOR;KMT2C;CCNT1;BCLAF3;NIBAN2;YAP1;SLC9A1;TBK1;RGMB;CREBL2;DDX17;RARG;TGFB1I1;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;ZKSCAN3;NR3C1;SS18;SMAD2;SMARCC2;BCL9L;BCAS3;SBNO2;AXIN1;HOXA5;PLSCR1;GABPB2;MED17;LBH;SKI;CREBBP;ZBTB16;FZD2;CDH1;STAT3;SCAF8;NSD3;HOXA7;TRIP4;NSD1;TFDP2;PHF8;MED12;FGFR2;EIF2AK3;FHOD1;SHC1;ELF4;ENY2;FOXC2;CHD8;RUNX1;HOXC4;HIVEP3;DHX9;MTOR;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;MAP3K5;HNRNPD;AR;RGMA;DHX36;ZNF496;PRPF6;FOXK1;PPARGC1A;CDC5L;IGF2;SETD3;SP100;NCOA6;MAP2K1;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;PRMT2;GABPA;NR1H3;SSBP2;JUN;TADA3;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;SENP1;PARP9;THAP3;ATF7IP;MAML2;CRTC1;GLIS2;ID2;MAVS;BCLAF1;CREBRF;DCAF6;ZXDC;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;WDR43;PKD2;TCF3;OGT;FZD7;KDM1B;IRF1;MAML1;PPM1A;YBX1;DTX3L;MLLT10;TCERG1;KAT8;GLI1;BICRA;ATF6;MMS19;CCN1;ING5;APOE;STAT1;PRKDC;NAA15;HINFP;VEGFA;CRLF3;ZNF318;PITHD1;BRCA2;ACVR1;HDAC1;ZBED3;NCK1;KDM3A;ILF2;DDX3X;PRDM2;NCK2;EFCAB7;RXRA;KLF15;RUNX2;MAP2K7;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;ICE1;ARHGEF11;AFAP1L2;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;RNF20;SMARCD2;NFYB;PICALM;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;FBXW11;TAF6L;TRAF6;LPIN3;NEK4;FZD1;NFATC3;INPP5K;BMP2;RNF14
prerank,keratan sulfate catabolic process (GO:0042340),-0.6788537621591616,-1.5787056310951957,0.022388059701492536,0.2089489820960712,1.0,8/11,18.91%,FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;OMD
prerank,ribosome biogenesis (GO:0042254),0.38100506252739547,1.5758594423792749,0.0,0.22107986061937276,1.0,53/187,16.11%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPF2;RPL37;RPS27;RPL7;RPL15;RPL10;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;RPL21;DKC1;RPS7;RPL23A;RPL8;POP5;MRPL36;RPS14;URB2;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;RRP1B;RRP1;NOP56;RPS25;MDN1;UTP15
prerank,Ras protein signal transduction (GO:0007265),-0.3906854899141744,-1.5733567009761569,0.001996007984031936,0.21736924938947458,1.0,47/137,22.49%,COL1A2;ROCK2;PLD1;IGF1;ARHGAP29;ARHGAP6;PLCE1;KSR1;ROCK1;PDPN;RREB1;SHOC2;RAP1B;CTNNAL1;MRAS;SHC1;RAPGEF3;BRK1;CDC42EP5;RHOA;JUN;NCKAP1;RALA;AGTR1;SETDB1;RB1;ARHGDIB;USP50;WASF1;RAPGEF2;FARP2;GNB1;ADRA2A;ARHGEF11;CDC42EP4;ARHGEF1;PRKD1;RASSF1;RHOH;PARK7;CDK2;RTKN;RAPGEF1;FGF2;CRKL;RIT1;CDC42EP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.6398633302795599,-1.573174853211865,0.02835538752362949,0.21659318789143284,1.0,7/13,19.78%,IRAK2;PIK3AP1;PIK3C3;PIK3R4;TNIP2;TRAF6;IRAK1
prerank,regulation of protein sumoylation (GO:0033233),-0.6092172651128948,-1.5730044899365152,0.015180265654648957,0.2157646538250256,1.0,12/17,29.72%,ZMIZ1;PIAS1;HDAC4;SAE1;PIAS3;PIAS4;PARK7;GNL3L;GNL3;MUL1;EGR1;UBA2
prerank,energy reserve metabolic process (GO:0006112),-0.5799754849347878,-1.5725695878900305,0.017013232514177693,0.21550252578567686,1.0,7/19,9.04%,PRKAG2;PID1;LEPR;PHKB;GSK3B;GFPT1;PHKA1
prerank,mesonephric tubule development (GO:0072164),-0.6228926148278238,-1.5723962144564718,0.030476190476190476,0.21462205106703394,1.0,10/15,18.09%,PKD1;FOXC1;BMP7;BMP4;OSR1;FGFR2;PKD2;SALL1;SIX1;NPNT
prerank,negative regulation of immune system process (GO:0002683),-0.6133638022847857,-1.572254802908993,0.03171641791044776,0.2137800429911946,1.0,4/16,15.22%,COL3A1;HOXA7;LYN;IL17D
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5061657087155282,-1.5717830817252267,0.014732965009208104,0.21363804386130275,1.0,17/37,25.95%,APPL2;STAT3;ABCD2;IL17RA;HIF1A;APOD;APPL1;IL17D;PDCD4;TLR4;CHID1;ADCY7;TICAM1;NLRC3;SIRPA;MAPK14;PPARA
prerank,protein localization to cell surface (GO:0034394),-0.5240218626710467,-1.5716918735111218,0.019891500904159132,0.21276211790433755,1.0,10/26,14.60%,ANK2;VCL;ANGPT1;FBLN5;FLNA;PIGK;PTPRK;GGA3;USP4;SMURF1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6981113150340411,-1.5705334264778044,0.020872865275142316,0.21397872170457477,1.0,6/10,18.04%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1
prerank,cell proliferation in forebrain (GO:0021846),-0.6826927607916922,-1.5698782857979126,0.03669724770642202,0.21422812087684753,1.0,4/10,14.50%,PCM1;DOCK7;NUMBL;NUMB
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5957133877857882,-1.5684275670569854,0.035856573705179286,0.21597650554594558,1.0,7/17,6.42%,IGF1;DOCK5;IGFBP5;PDGFRB;VTN;DOCK7;NRP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5166854114808682,1.5677579287903944,0.02040816326530612,0.23350402141224885,1.0,17/32,19.70%,NAV3;MAP2;STMN1;FGF13;SNCA;TUBB4A;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;FKBP4;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,negative regulation of cartilage development (GO:0061037),-0.642807433645603,-1.5662487912192764,0.025594149908592323,0.21879832596685617,1.0,4/13,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.48558978853170465,1.5659055086814488,0.006085192697768763,0.2353091463404461,1.0,14/39,15.80%,TSR3;RPS6;RPS19;RPS27;RPS24;RPS17;RPS16;MRPS7;RPS15;RPS7;RPS14;RPS5;RPS28;RPS25
prerank,supramolecular fiber organization (GO:0097435),-0.355248194562915,-1.5657847297083407,0.0,0.21867074379236412,1.0,99/333,20.00%,COL1A2;COL3A1;COL4A5;COL5A2;ADAMTS2;TGFBR1;CGNL1;COL8A1;COL5A1;COL4A6;TNXB;COL1A1;GSN;COL12A1;TPM1;COL22A1;COL4A3;PCM1;MPRIP;MYO1B;LOXL1;VIM;COL6A3;COL4A4;PRKN;FIGN;COL23A1;COL25A1;COL6A1;SHROOM2;TSPAN5;FAT1;COL8A2;FBLN5;SNCAIP;COL26A1;PLOD2;HSPG2;DLG1;RND3;SLK;COL6A2;SHROOM3;VPS4B;TMOD3;CORO7;TUBGCP6;INPPL1;CDC42;COL15A1;TUBGCP2;ARHGAP17;FIGNL2;CYP1B1;COL13A1;COL18A1;LAMA3;NCSTN;COL5A3;COL27A1;RHOA;GGA3;TPM3;CLIP4;P4HA2;RHOBTB2;LUM;MYO1F;EFEMP2;LOX;KATNA1;GFAP;EMILIN1;ZBED3;WHAMM;CARMIL1;LOXL3;DYNC1H1;MYH11;COL9A2;IAPP;TSPAN15;DPT;RHOBTB1;RHOH;MAP7D3;COL14A1;RHOC;MFAP4;TRIOBP;B4GALT7;TUBGCP4;ADAMTS14;NCKAP5L;AVIL;LMOD1;COL20A1;MARCKS;TPM2
prerank,positive regulation of telomerase activity (GO:0051973),0.5028605961926189,1.5655343753594908,0.02610441767068273,0.23426624906789933,1.0,15/33,18.94%,PRKCQ;KLF4;HSP90AB1;CCT2;DKC1;CCT4;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.4202110168582891,-1.5637873358802128,0.01195219123505976,0.22149837987900542,1.0,37/80,26.34%,DENND2A;VTI1A;ERC1;GBF1;TMEM87A;SGSM2;SNX6;VTI1B;STX16;GOSR1;VPS54;STX5;SURF4;TMEM87B;DENND5A;HEATR5A;EHD3;SNX8;GOSR2;ANKFY1;TBC1D17;HEATR5B;CLN5;TBC1D10A;VPS26B;BET1L;RGP1;LMAN1;TBC1D23;SPAG9;RAB9A;SNX12;RAB7A;RAB7B;BAIAP3;PHETA1;TBC1D10B
prerank,defense response to Gram-positive bacterium (GO:0050830),0.471348515433978,1.5633459294370895,0.01568627450980392,0.23634580918339382,1.0,11/40,16.08%,TIRAP;PGLYRP1;MBL2;IL12A;TLR2;PPP1R11;GBP4;DROSHA;DEFA6;STAB2;RNASE3
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.5488899179897441,-1.5628661639894161,0.031189083820662766,0.22229174461674714,1.0,11/24,22.07%,TGFBR1;SOX5;EFEMP1;ADAMTS12;ZBTB16;WNT9A;SOX6;TRPS1;PTPN11;PKDCC;PTHLH
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4879547421139027,-1.5622387113744973,0.016293279022403257,0.22249465365657525,1.0,15/39,14.40%,ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;ROBO1;JAG1;TSPAN5;YAP1;CREBBP;STAT3;CCN3;MAML2;MAML1;BMP2K
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3735944255949716,-1.5618392988749712,0.0,0.22208729813682718,1.0,99/193,33.24%,FBXL7;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;BTRC;TRIP12;KLHL15;RNF146;RNF217;RBBP6;RNF213;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;UBE2H;ASB2;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;UBE2K;UBE2I;ANAPC4;ANAPC16;NUB1;NTAN1;USP33;UBE2R2;PSMF1;WDR91;UBR3;CUL3;TRIM25;DTX3L;TRPC4AP;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;AREL1;RNF14;SPSB4;RNF11;ANAPC11;TTC3;ARIH2;WDR81;FBXW4;RNF144A;SIAH2;RNF6;CNOT4;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;SPSB2;UBE3C;LONP1;PSMD13;FZR1;CDC34;MIB1;KCTD6;RBX1;UBA52;RNF126;UBE2L3;UBA1;ADRM1;HERPUD1;UFD1;MAD2L1;RC3H2;BUB1B;RNF130;DDB1;ANKIB1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.5532765628354093,-1.5609917733982,0.017716535433070866,0.22279384028553956,1.0,6/25,5.45%,PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;BCAS3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5745228785983907,1.559592463002744,0.04175365344467641,0.24132801878558716,1.0,4/18,15.89%,NAV3;CD34;HOMER2;HOMER3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3384972617622453,-1.5595362106195223,0.0,0.22486093551017586,1.0,114/417,17.55%,FOXP2;FOXP1;NR2F2;TCF7L2;GLI3;RBFOX2;FOXD1;PRDM5;ZNF148;WNT4;RBPJ;MIDEAS;LIMS1;SMURF2;ZNF423;ATXN1;NR1D2;ZHX2;MDFIC;ZEB1;BMP7;ZIC2;BMP4;HDAC4;BCOR;KAT6B;DKK3;NCOR1;BTRC;BRD7;FOXN3;WWP2;NIBAN2;VGLL4;RCOR1;KHDRBS1;EIF4A2;RCOR3;ZKSCAN3;NR3C1;SMAD2;SMARCC2;ATP8B1;CBX5;SBNO2;SNX6;LBH;ZBTB16;HOXA7;TFDP2;L3MBTL3;NAB1;SHC1;CHD8;WWP1;SCMH1;REST;BCL7A;FOXK1;MBD2;RUNX1T1;CBFA2T2;PTPRK;UBE2I;BTAF1;PRMT2;JUN;MPHOSPH8;SMAD4;LIMD1;ATF7IP;GLIS2;ID2;NIPBL;USP47;BCLAF1;TLE1;ARID5B;PCGF6;PBXIP1;HES1;COPS2;PIAS4;RB1;EHMT1;BHLHE41;PATZ1;IRF1;TSHZ3;SOX13;KAT8;HINFP;ZNF318;HDAC1;CBFA2T3;SCML4;PHC2;RUNX2;JARID2;FOXK2;SALL1;LOXL3;ATOH8;L3MBTL2;SFPQ;DAP;HEYL;CITED2;EPC1;PDCD4;TBX2;ZMYND15;TWIST2;WNT5A
prerank,regulation of myoblast differentiation (GO:0045661),-0.5010371782879446,-1.5580983846818164,0.022944550669216062,0.22637003725428154,1.0,7/32,6.23%,RANBP3L;BOC;BMP4;FLOT2;RIPOR2;IGFBP3;TRIP4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.4480296163338876,1.5576604265413905,0.010351966873706004,0.24152652083321627,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.4480296163338876,1.5576604265413905,0.010351966873706004,0.24152652083321627,1.0,27/56,21.30%,NDUFC1;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;DMAC2;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;NDUFAF1;NDUFB9;BCS1L;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4799641120798928,1.5573106040766966,0.013861386138613862,0.24051993481169243,1.0,10/39,7.10%,FGF12;HECW1;FGF14;NETO1;ANK3;FGF13;WNK2;SCN4B;HECW2;GLRX
prerank,regulation of B cell proliferation (GO:0030888),0.4788303633196347,1.557068987245336,0.018292682926829267,0.239403744851749,1.0,11/44,14.86%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;TNFRSF21;CD40;ATM;NFATC2;CD38
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6061410123951001,-1.5566568018400795,0.022813688212927757,0.22800890841735094,1.0,10/16,16.36%,DDX5;DDX17;HNRNPM;DHX9;SRSF6;CDK13;SLU7;RSRC1;SRSF1;SFPQ
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.5427301940676391,-1.5546850780372494,0.030131826741996232,0.23097542718901828,1.0,11/24,26.26%,AUTS2;PLCE1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;AVIL;PIK3R1;ACTR2;TWF2
prerank,regulation of synapse assembly (GO:0051963),0.46846307311750957,1.5545539999499307,0.01020408163265306,0.24232803893620775,1.0,15/46,9.22%,NRXN1;PTPRD;LRFN5;IL1RAPL1;EPHB1;NLGN1;GRID2;SNCA;SLIT1;TLR2;CLSTN3;LRRC4B;IL1RAPL2;ROBO2;LHFPL4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.37119854495042215,-1.5539400052086527,0.0,0.23152091404549482,1.0,76/186,29.69%,BICC1;TRABD2B;MLLT3;NXN;TCF7L2;LRP1;GLI3;RBMS3;IGFBP2;LRP6;WWOX;GRB10;RNF43;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;VGLL4;IGFBP6;AXIN1;RNF213;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;MDFI;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;CXXC4;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;TSKU;RBX1;HIC1
prerank,peroxisome organization (GO:0007031),-0.522115914842574,-1.5533766285008255,0.035781544256120526,0.2314397969878941,1.0,18/25,38.00%,ABCD3;DNM1L;ABCD2;LONP2;PEX6;ABCD4;SEC16B;PEX7;FIS1;ACOT8;PEX11B;PEX10;PEX11A;PEX16;PEX19;PLAAT3;PEX12;PEX11G
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5659503921697964,1.55320935287954,0.026915113871635612,0.24303406709243086,1.0,12/21,19.70%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,positive regulation of cellular senescence (GO:2000774),0.6551844710174883,1.5530074860864644,0.05660377358490566,0.24166601320965664,1.0,5/10,19.57%,SIRT1;HMGA2;YPEL3;B2M;EEF1E1
prerank,RNA biosynthetic process (GO:0032774),-0.5068914092162741,-1.5527374094272202,0.013011152416356878,0.2315982511887388,1.0,16/31,28.50%,TAF4;TBP;NCOA6;BRF1;TTF1;TAF13;PRMT5;GTF2B;HELB;PRIM2;POLA2;TERT;TAF12;TBPL1;TAF7;BRF2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6508294253983299,-1.5523689695388885,0.037549407114624504,0.2313337999490639,1.0,7/13,18.77%,NFKB1;BMP5;DKK3;REST;ERLIN1;APOE;BMP2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.522690401747938,-1.5518286525400626,0.02414486921529175,0.23132455074849662,1.0,8/27,5.83%,PHLDB2;ARHGAP6;CGNL1;ARHGAP28;PRKN;ARAP1;WASF2;PAK2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6641665285131193,1.5517536688527769,0.04831932773109244,0.24220529095292606,1.0,4/10,9.09%,KDR;TLR2;CCL2;NAMPT
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5446666937094863,-1.5505413986294279,0.041970802919708027,0.23293260012497527,1.0,17/23,35.97%,OS9;SELENOS;SURF4;FAF2;AUP1;DERL1;SYVN1;VCP;SEC16A;LMAN1;PREB;SEL1L;DERL2;HERPUD1;UFD1;SEC13;TMEM129
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.582609049463199,-1.5492071252064936,0.032818532818532815,0.23438235188587095,1.0,8/18,22.25%,SETD7;KMT2D;SETD3;SETD2;EHMT1;ASH1L;KMT2A;PRDM9
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5338522136572781,1.549081475556899,0.045816733067729085,0.24545932627455364,1.0,11/24,18.89%,LIG3;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5423374348389157,-1.548819862907028,0.03770197486535009,0.2340996133837742,1.0,17/23,28.55%,GLI3;ENPP1;BTRC;GPC3;TULP3;GLIS2;HERC4;SUFU;PTCH1;GPR161;VCP;MEGF8;KIF7;MGRN1;PTCH2;IFT122;KCTD6
prerank,cellular response to calcium ion (GO:0071277),0.4248611856603708,1.5485616585561894,0.0136986301369863,0.24483878098751571,1.0,14/67,7.63%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR3;CPNE9;TRPM2;CPNE8;CPNE1;KCNH1;SYT10
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5582930778782986,-1.5478075944478775,0.014732965009208104,0.23425705900448796,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5582930778782986,-1.5478075944478775,0.014732965009208104,0.23425705900448796,1.0,4/21,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4496250737339321,-1.5455634129532507,0.023060796645702306,0.23751919706371385,1.0,13/51,11.09%,FSTL1;FBN1;CRIM1;BMPR1A;SMAD6;SMURF2;NBL1;HTRA3;SKI;SKIL;SMAD4;BMPER;GREM2
prerank,epithelial cell migration (GO:0010631),-0.4806677292086529,-1.5445550365651866,0.013618677042801557,0.23850008905167136,1.0,15/37,15.47%,FSTL1;KANK2;ROCK1;ABL1;KIT;DPP4;ADGRA2;NRP1;ZEB2;CYP1B1;RHOA;GIPC1;FAP;STAT1;PLXND1
prerank,spliceosomal complex assembly (GO:0000245),-0.4644740847115161,-1.5441492357428905,0.009689922480620155,0.23827309035103925,1.0,15/46,14.46%,CELF2;CELF1;LUC7L2;SRSF10;SF3B1;SRSF6;PRPF6;SF3A1;YTHDC1;USP39;SCAF11;SF3A3;DDX23;RBM5;SRSF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5508364366656849,1.5433392603088907,0.03829787234042553,0.25272588354881115,1.0,9/20,21.18%,LY6H;CHRM3;GRK2;PLCB1;CHRM2;GNAQ;LY6G6D;CDK5R1;RGS10
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3210730687660219,-1.5427082678803032,0.0,0.24015723888817944,1.0,218/834,18.36%,NFIA;BMP6;PBX1;IGF1;AUTS2;NR2F2;EGFR;HLF;NFAT5;PID1;TCF4;TCF7L2;GLI3;SMAD3;RHOQ;TEAD1;BMPR1A;NFKB1;CDK8;PKD1;ZMIZ1;LRP6;HDAC8;INO80;RBPJ;THRB;DCN;GLI2;GLIS3;NR1D2;ZNF462;ZFHX3;RARB;BMP5;WWOX;FOXC1;FGF1;KAT2B;DAB2;FOXO3;PPP1R12A;EP300;BMP4;HDAC4;ABL1;KAT6B;PRKN;ARNT;JAG1;OSR1;CCNT2;TFEB;HOXB3;MEOX2;TBL1X;ELF1;NFIB;TBL1XR1;MICAL2;SSBP3;NFIX;RREB1;KMT2C;CCNT1;BCLAF3;YAP1;SLC9A1;TBK1;DDX17;RARG;MEF2A;KMT2D;CDK7;HMGB1;PPARGC1B;NR3C1;SS18;SMAD2;BCL9L;BCAS3;SBNO2;HOXA5;PLSCR1;GABPB2;MED17;SKI;CREBBP;STAT3;HOXA7;TFDP2;MED12;FGFR2;FHOD1;ELF4;FOXC2;CHD8;RUNX1;HOXC4;DHX9;AKAP8L;ZEB2;REST;MYSM1;VEZF1;CEBPG;CRTC3;AR;RGMA;DHX36;PRPF6;PPARGC1A;CDC5L;IGF2;SETD3;GCN1;NCOA6;CDK13;NCOA1;MED1;JUP;ATF2;CCNK;HOXB4;UBP1;WASL;GABPA;NR1H3;SSBP2;JUN;HIF1A;HCFC1;CALCOCO1;SMAD4;MED21;NOTCH3;SENP1;THAP3;MAML2;CRTC1;GLIS2;MAVS;BCLAF1;CREBRF;DCAF6;WWC1;ZBED4;PARP1;RORA;MEF2C;NRF1;TFCP2;HES1;PKD2;TCF3;OGT;KDM1B;IRF1;MAML1;YBX1;MLLT10;TCERG1;KAT8;GLI1;ATF6;CCN1;STAT1;PRKDC;HINFP;VEGFA;CRLF3;ACVR1;HDAC1;ZBED3;NCK1;DDX3X;PRDM2;NCK2;PLXND1;EFCAB7;RXRA;KLF15;RUNX2;FOXK2;TGFB3;SALL1;ABHD14B;PRDM15;ATOH8;TNIP2;KLF6;ARRB1;SFPQ;PTOV1;HEYL;CITED2;CAMTA2;IL18;EPC1;MYBL1;SERPINE1;SIX1;NR4A1;SMARCD2;NFYB;TLR4;CRTC2;WNT5A;PHIP;NR4A2;PRKD1;STAT5B;LPIN2;BCL2L12;NFIC;HNRNPU;TAF6L;TRAF6;LPIN3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4677085971575261,1.5425818745043978,0.018218623481781375,0.25260029874421974,1.0,12/44,7.79%,KCNJ3;KCNJ6;KCNN2;AKAP6;WNK2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5783503689685972,-1.5421146403621648,0.020370370370370372,0.2402133019123167,1.0,8/18,15.95%,SMAD3;LTBP1;ITGAV;ITGB8;HIF1A;SMAD4;FN1;LRRC32
prerank,ceramide biosynthetic process (GO:0046513),0.4742633469317532,1.5418091305122095,0.01606425702811245,0.25227931366437,1.0,10/40,11.97%,ST6GALNAC3;ST8SIA4;SGMS1;FA2H;DEGS2;B4GALNT1;B4GALT6;SMPD1;ST8SIA6;ST8SIA3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5553709558083023,-1.5415544250760935,0.040160642570281124,0.24026375851928014,1.0,8/21,16.82%,IGF1;BMPR1A;IGFBP5;GJA1;JUN;MMP2;ERN1;ADAMTS1
prerank,response to amyloid-beta (GO:1904645),0.4610547341250133,1.5410668944728103,0.015086206896551725,0.2521129987156182,1.0,8/44,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;CACNA1B;MMP12;GRIN2A;CACNA2D1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6822043615573797,-1.5406845323938338,0.03598484848484849,0.24084452571907938,1.0,2/10,2.69%,ROCK2;ROCK1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.43925860116300486,-1.5401452476443545,0.01443298969072165,0.24091727470368332,1.0,15/61,8.31%,EYA2;EYA1;EGFR;UBE2N;EYA4;PDGFRB;HMGB1;USP7;NBN;DHX9;BRCC3;CEBPG;RNF8;DHX36;WRN
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5721019711231887,-1.5386960782150125,0.03428571428571429,0.24297294237516442,1.0,10/18,30.89%,KLF9;NR3C1;ANXA1;REST;PCK2;FAM107A;HNRNPU;ZFP36L2;UBE2L3;BCL2L11
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5825684857514779,1.538064857438695,0.03648068669527897,0.25584410732531393,1.0,3/16,9.44%,KLRC1;IL12A;CYRIB
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5445566956645179,-1.5375732249221215,0.03018867924528302,0.24411437610309847,1.0,12/21,28.16%,SAMD4A;PAN3;TUT4;CNOT8;CNOT2;PAN2;CNOT1;CNOT10;CNOT4;TNKS1BP1;PNLDC1;PARN
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6374854216875587,1.536752419121581,0.03982300884955752,0.2566487112804686,1.0,4/12,8.37%,EPHB1;SPTBN4;HSP90AB1;B4GALT6
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5819276955795751,-1.536553312252443,0.03616636528028933,0.24494516690392917,1.0,12/18,32.24%,ANKRD17;PUM2;PUM1;DDX60;NOP53;SEC14L1;GPATCH3;DHX58;BIRC3;C1QBP;UFD1;ZCCHC3
prerank,sphingolipid metabolic process (GO:0006665),0.39411024802227895,1.536316896816589,0.0019157088122605363,0.25583762344080985,1.0,35/108,18.02%,ST6GALNAC3;GAL3ST1;SGMS1;ACER2;FA2H;DEGS2;CERT1;ENPP2;ORMDL1;B4GALNT1;ORMDL2;NEU2;SPNS2;PPP2R1A;ELOVL7;SGPP2;ELOVL4;TECR;ARSA;SERINC1;GLA;SMPD1;HACD3;CPTP;HACD1;PPM1L;PPT1;SAMD8;PRKD3;GALC;KDSR;GLB1;SGPP1;HEXB;SPTLC2
prerank,positive regulation of cell division (GO:0051781),-0.48046786089400195,-1.535345843652109,0.017013232514177693,0.24658843535969957,1.0,11/38,14.98%,SVIL;FGF1;CDC14A;CSPP1;FGFR2;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,metal ion homeostasis (GO:0055065),0.4728539831766721,1.534916615094661,0.016701461377870562,0.25690147925983065,1.0,9/40,9.08%,TMTC2;GRIN1;ANK3;SNCA;SLC8A1;SLC12A6;CIB2;SLC7A8;SLC12A3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5198255052554802,-1.534760742305344,0.03187250996015936,0.24666061430764769,1.0,7/26,7.41%,IGF1;RHOQ;SORBS1;OSBPL8;IRS1;CREBL2;BRAF
prerank,ganglioside metabolic process (GO:0001573),0.5534232064179251,1.5344677003848615,0.03278688524590164,0.25612803127069345,1.0,6/20,11.97%,ST6GALNAC3;ST8SIA4;B4GALNT1;NEU2;ST8SIA6;ST8SIA3
prerank,receptor clustering (GO:0043113),0.5192795332035437,1.5333065483047978,0.0389344262295082,0.2565195451098527,1.0,7/27,5.91%,DLG2;NRXN1;LRRC7;NLGN1;MAGI2;THY1;NRXN2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5578379461971044,1.5327385667325875,0.04008016032064128,0.2561230481727423,1.0,5/19,7.55%,GRM5;RYR2;KDR;TRPM2;PTPRJ
prerank,epidermis development (GO:0008544),-0.4353857977116028,-1.5322275549117055,0.015810276679841896,0.2507011963006318,1.0,12/56,14.63%,SVEP1;CCN2;FLOT2;FGFR2;LAMA3;ATP2A2;EMP1;UGCG;CRABP2;YBX1;GLI1;HDAC1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4848645716695161,-1.5299924932996107,0.0300187617260788,0.25418038464327203,1.0,17/33,28.75%,APPL2;PKD1;INO80;STXBP4;MN1;ID2;FBXW7;APPL1;GLI1;TRIM39;CDC73;EZH2;PLK5;PHB2;TCIM;PSME1;E2F1
prerank,regulation of metal ion transport (GO:0010959),-0.5828934450296791,-1.5294132061544587,0.03910614525139665,0.254318715430469,1.0,7/16,8.15%,STIM1;ANK2;DLG1;SLC30A10;BCL2;IL16;CAMK2G
prerank,Notch signaling pathway (GO:0007219),-0.44107327554171044,-1.5292192935588265,0.015444015444015444,0.25359454444493823,1.0,22/59,16.75%,PBX1;NOTCH2;GMDS;RBPJ;ZNF423;KAT2B;EP300;JAG1;DTX4;CREBBP;POFUT1;NCSTN;NOTCH3;MAML2;WWC1;HES1;MAML1;YBX1;DTX3L;STAT1;PLXND1;HEYL
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6291220925623009,-1.5290006082060899,0.031496062992125984,0.25300788737413676,1.0,5/13,7.80%,LRRK2;NUPR1;SEC22B;CHMP4B;CHMP4A
prerank,sodium ion transport (GO:0006814),0.4157605836216852,1.5282501543149103,0.008032128514056224,0.26296223362273685,1.0,19/85,9.08%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;FGF13;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;SLC6A8;SCN3A;KCNK1;SLC12A3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.62277204981067,1.5265197837655708,0.06391752577319587,0.2647296731266992,1.0,5/13,6.74%,SHISA6;GRIK2;SHISA8;PPFIA3;SHISA7
prerank,protein stabilization (GO:0050821),-0.36655480487564635,-1.5259409961379378,0.00196078431372549,0.2584405347546064,1.0,70/168,25.25%,IGF1;PARVA;ANK2;PLPP3;MDM4;PER3;TRIM44;STK3;EP300;PRKN;TBL1X;FLOT2;CCNH;FLNA;CREBL2;COA8;CDK7;USP7;CCT6A;STXBP4;EPHA4;PPARGC1A;LAMP2;BAG3;USP33;PRKCD;HCFC1;RPL11;COG3;ATF7IP;COG7;CCT8;TELO2;PEX6;FBXW7;RASSF2;RAB21;NAA15;USP2;UBE2B;ZBED3;USP13;TRIM39;PDCL3;CCT5;TNIP2;NOP53;ZSWIM7;LAMP1;SYVN1;MORC3;PARK7;ATP1B3;SEC16A;PIK3R1;SUGT1;WDR81;DVL3;TAF9B;RABL3;WFS1;CHP1;HIP1R;USP9X;BAG5;BAG6;NAA16;IRGM;STX12;PHB2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5237270361636008,1.5252472946758822,0.029535864978902954,0.26548027668267277,1.0,3/23,4.90%,CADM1;KLRC1;IL12A
prerank,regulation of synapse maturation (GO:0090128),0.6672284625669488,1.5242950197498193,0.059063136456211814,0.2656918928614397,1.0,4/10,9.89%,ARHGEF15;NRXN1;RELN;DAB2IP
prerank,sodium ion transmembrane transport (GO:0035725),0.41530084199164347,1.5232844106178287,0.0058823529411764705,0.26618078269989787,1.0,22/84,11.75%,SLC6A6;HCN1;SLC24A4;SLC24A2;SCN1A;SLC6A17;ASIC2;ASIC4;SLC8A1;SCN4B;ASIC1;HCN2;SLC6A2;SLC6A5;ATP1A3;SLC6A8;SCN3A;KCNK1;SLC12A3;ATP1A4;ATP1A1;SCN2A
prerank,regulation of sodium ion transport (GO:0002028),0.49118845468986827,1.5232466761326038,0.0163265306122449,0.26468918198730296,1.0,9/34,5.57%,NKAIN2;SPTBN4;FGF12;NKAIN1;NKAIN3;CNKSR3;ANK3;WNK2;SCN4B
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6169264224705486,-1.5225954239054476,0.028089887640449437,0.26482513983065337,1.0,7/14,20.79%,GHR;STAT3;LYN;STAT5A;STAT5B;PTPN1;PIK3R1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5834280067805848,-1.5225449720434658,0.03377110694183865,0.2638487852906574,1.0,8/16,19.21%,LRP1;ROCK1;APOE;HDAC1;IFNGR1;HMGCR;CYP51A1;ABCA7
prerank,positive regulation of cell differentiation (GO:0045597),-0.35709775822152134,-1.5212065414645777,0.0,0.26564748420649525,1.0,75/237,18.37%,BMP6;RANBP3L;IGF1;TCF4;SMAD3;TGFBR1;SOX5;PTN;BMPR1A;NFKB1;COL1A1;WNT4;BOC;NBL1;ZEB1;MEDAG;FOXC1;CCN2;BMP7;IL6ST;CDON;DAB2;TMEM64;CTNNA1;BMP4;PDPN;ABL1;TGFBR2;RIPOR2;YAP1;CREBL2;IGFBP3;TGFB1I1;MEF2A;SMAD2;BCL9L;HOXA5;ZBTB16;MTOR;REST;CDC42;AR;DHX36;GJA1;IMPACT;HOXB4;NGF;RHOA;SMAD4;ID2;MEF2C;AGTR1;TCF3;IL6R;TRPM4;ATRAID;CCN1;SOX6;WDFY2;ACVR1;BLOC1S5;RAPGEF2;GLIPR2;RUNX2;FBN2;TGFB3;CMKLR1;SUCO;HEYL;IL18;CCN4;PRKD1;NPNT;SYAP1;GCNT2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.36542648211936096,-1.5201696310571222,0.0,0.26674872877534994,1.0,53/182,17.89%,SLC24A3;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;CELF1;BMP4;DICER1;ROBO1;SMO;PRKN;TNRC6B;PRKAA2;WWP2;FLOT2;DLG4;YAP1;TNRC6A;MOV10;RUNX1;ANXA7;REST;PARP10;MAP2K1;PTPN22;LDLR;ITGB8;PARP14;HIF1A;PARP9;ID2;MEF2C;SETDB1;RB1;FBXW7;APOBEC1;APOE;HINFP;VEGFA;EMILIN1;HDAC1;CCDC3;ATOH8;TNRC6C;CITED2;PICALM;PRKAA1;MYADM
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6381416561742442,1.518932161525622,0.04439746300211417,0.27108622351344086,1.0,5/10,14.32%,PDE4B;CACNA2D1;CACNB2;CALM1;CALM3
prerank,autophagy of nucleus (GO:0044804),-0.5766736014717823,-1.5186016028440232,0.05301645338208409,0.2690353676403278,1.0,12/16,34.10%,RB1CC1;WIPI1;ULK2;ATG2A;ATG9A;WDR45B;ATG2B;ATG5;WIPI2;ATG3;WDR45;ATG12
prerank,positive regulation of autophagy (GO:0010508),-0.4072469293001737,-1.5180952047519727,0.005813953488372093,0.26910507093056024,1.0,32/81,25.25%,RNF152;DCN;FOXO3;ROCK1;PRKN;LRRK2;TFEB;PRKAA2;GSK3B;TBK1;TPCN1;HMGB1;UFL1;TRIM8;LARP1;SESN1;PAFAH1B2;TRIM5;EIF2AK4;ATF6;DAPK1;PRKD1;PRKAA1;PARK7;PLEKHF1;ORMDL3;BNIP3;WAC;TICAM1;IRGM;TRIM68;PHB2
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.50400713783494,-1.5174596722645388,0.019801980198019802,0.2694055049794036,1.0,11/28,15.49%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,negative regulation of gene expression (GO:0010629),-0.34189610102611395,-1.515458885569373,0.0,0.272515042514637,1.0,79/302,17.89%,SLC24A3;SAMD4A;ROCK2;NOTCH2;IGF1;FOXP1;BMPR1A;RBMS3;NFKB1;ZNF148;WNT4;IGFBP5;CELF1;LGR4;DIS3L2;KAT2B;BMP4;DICER1;ROBO1;SMO;NCOR1;PRKN;PPM1D;TNRC6B;PRKAA2;WWP2;FLOT2;YAP1;SYNCRIP;TNRC6A;DDX6;MOV10;EIF4ENIF1;TWSG1;DNMT3A;EIF2AK3;RUNX1;ANXA7;PTBP3;REST;LARP1;PARP10;DHX36;MAP2K1;PTPN22;ITGB8;LSM14A;PARP14;HIF1A;MPHOSPH8;PARP9;ID2;CNOT8;ATP2B1;MEF2C;SETDB1;RB1;FBXW7;YBX1;EIF2AK2;APOE;PHF1;HINFP;VEGFA;EMILIN1;HDAC1;ERN1;DDX3X;CCDC3;JARID2;DAPK1;ATOH8;TNRC6C;CITED2;EPC1;CNOT1;PICALM;PRKAA1;MYADM
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4287080638815774,1.5154519689749375,0.01171875,0.276075624835205,1.0,13/63,14.86%,TFRC;TIRAP;SLC7A1;MIF;IL7;VAV3;FGF10;IL12A;TNFSF13B;AIF1;CD40;NFATC2;CD38
prerank,negative regulation of cellular protein localization (GO:1903828),-0.479956958688323,-1.5151319920979414,0.023952095808383235,0.27213475946762694,1.0,11/34,17.35%,ROCK2;CTNNA1;GSK3B;RIPOR2;UBXN2B;ACTN2;LEPROTL1;LEPROT;ILRUN;LATS1;PICALM
prerank,positive regulation of cell communication (GO:0010647),0.5107225419980758,1.5149884905980207,0.04242424242424243,0.2752587430177142,1.0,10/28,8.18%,SYT1;RIMS1;RIMS2;ANK3;RIMS3;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,chordate embryonic development (GO:0043009),-0.43278066771069984,-1.5149860873216499,0.02044989775051125,0.2713935989680422,1.0,19/55,15.84%,SULF1;ALDH1A2;TGFBR1;COL1A1;PKD1;BMP5;BMP7;PCSK5;RBP4;SULF2;FGFR2;IGF2;DACT1;PKD2;CHD7;HINFP;VEGFA;PTCH1;TGFB3
prerank,regulation of hemopoiesis (GO:1903706),-0.6730411012681292,-1.514555651082188,0.030534351145038167,0.2712436743996174,1.0,5/10,15.22%,PTN;CREBBP;RUNX1;MYSM1;IL17D
prerank,protein localization to synapse (GO:0035418),0.6249760493013442,1.5140372636959827,0.0465587044534413,0.27543856681731044,1.0,5/12,8.72%,NRXN1;PCLO;NLGN1;NRXN2;ZDHHC15
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5781060276541184,-1.5134493316002173,0.025408348457350273,0.2726454805113246,1.0,7/16,10.24%,PDGFRA;PDGFRB;ABL1;PLAT;NRP1;FER;PDGFC
prerank,positive regulation of cytokinesis (GO:0032467),-0.49663622223404935,-1.5132696325953097,0.019230769230769232,0.2720400323543882,1.0,9/32,14.98%,SVIL;CDC14A;CSPP1;CDC42;RHOA;GIPC1;CUL3;CDC14B;CDC25B
prerank,negative regulation of autophagy (GO:0010507),-0.4407476677428105,-1.5125993329137286,0.00984251968503937,0.27244969231294364,1.0,27/54,28.60%,LEPR;EIF4G3;SMG1;LRRK2;NUPR1;ZKSCAN3;STAT3;BCL2;MTOR;FOXK1;PTPN22;EIF4E;SNRNP70;KLHL22;CTSA;FOXK2;DAP;RUBCN;EIF4G1;NRBP2;BMF;WDR6;DAPL1;RRAGA;HGF;MET;MT3
prerank,protein K48-linked ubiquitination (GO:0070936),-0.44250676604171996,-1.5125330466331437,0.022222222222222223,0.27157053674667503,1.0,23/54,21.13%,RNF152;UBE2E2;PRKN;RNF115;RNF146;UBR5;UBE2H;RNF8;UBE2K;RNF216;UBE2R2;CUL3;DTX3L;UBE2B;FBXO38;TOPORS;UBE2E1;BFAR;SYVN1;UBE2D3;IFI27;TTC3;ARIH2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.42259385322644677,-1.511543809008244,0.019193857965451054,0.27262152504988013,1.0,25/62,24.47%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;HOXA5;CREBBP;ZBTB16;RUNX1;LYN;CTR9;MEF2C;HSPA9;HDAC1;TNRC6C;CDC73;CDK6;KMT2A;MAFB;AGO1;CNOT4;KMT2E
prerank,neuron projection morphogenesis (GO:0048812),0.37884430798346724,1.510804449327345,0.003787878787878788,0.2801509505555099,1.0,40/137,12.48%,NYAP2;CNTNAP2;DCC;CTNNA2;ACTB;EPHB1;SPTBN4;CTNND2;NLGN1;MAPK8IP2;GPM6A;ADGRB1;ANK3;SHANK3;MAP1B;MAP2;APBB1;PAX2;TNIK;DSCAML1;PAK1;NRCAM;CPNE1;EPB41L3;CNTNAP1;ZDHHC17;UBB;SHTN1;PLPPR4;NTNG1;NTNG2;TAOK2;DAB2IP;CELSR2;CNTN4;BRSK2;SLITRK5;DVL1;SRGAP2;DOCK10
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4942842220790965,-1.5107122326923954,0.03428571428571429,0.27323770773707196,1.0,13/28,18.70%,PID1;APPL2;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4433866207547254,-1.5090244273439644,0.022641509433962263,0.2755635788473912,1.0,18/50,17.27%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;ADAP2;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3;PLCL1;PIK3CD
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5485130776544881,1.5077199926822251,0.04424778761061947,0.28449188143494,1.0,6/19,11.67%,SLCO1C1;PAX8;KLF4;PDGFB;KLF2;MAPK8
prerank,regulation of neuron projection development (GO:0010975),0.37103247291594366,1.5071479221494257,0.006048387096774193,0.2840243486863824,1.0,56/163,16.55%,SPOCK1;DCC;CSMD3;CTNNA2;RIT2;LRRC4C;LRRC7;MINAR1;MAG;IL1RAPL1;PLXNB3;S100A9;ITGA6;MBOAT1;MAGI2;SHANK3;CDH2;TOX;KIF1A;MFSD2A;NTRK2;SCARF1;FUT9;PAK1;NPTN;PLPPR5;TENM3;ITM2C;NDNF;AKT1;SCARB2;STMN2;ZDHHC15;CDKL5;NTNG1;NTNG2;RTN4R;RELN;DAB2IP;CHN1;PPFIA2;BRSK2;CCDC88A;RET;EFHC2;PSEN1;CIB1;PRAG1;KNDC1;PAK3;RTN4RL1;FKBP4;CRMP1;RAP1A;STX1B;RAB29
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.33101066769012844,-1.506750032494322,0.0,0.2794400881581208,1.0,156/366,30.95%,NFIA;BNC2;DENND4A;TGFBR1;EFEMP1;ANKRD17;ZNF423;ATXN1;NR1D2;ZFHX3;FOXC1;FOXO3;EP300;ERC1;ABL1;KAT6B;WWC2;TFEB;FOXN3;GON4L;RREB1;WTIP;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;SRSF10;RBBP6;SBNO2;PRRX2;FUS;CREBBP;STAT3;NSD3;TRIP4;NSD1;TRRAP;NAB1;REST;POFUT1;HNRNPD;GTF2IRD1;CTR9;PPARGC1A;IGF2;NFYC;GEMIN5;ATF2;EIF4E;CHD3;ZFAT;SSBP2;TULP3;HIF1A;HCFC1;LIMD1;CDK11B;GPBP1L1;WWC1;RORA;MEF2C;SPTY2D1;TEAD2;SUFU;TCF3;TCF7L1;RB1;CCAR1;FZD7;CRABP2;PATZ1;YBX1;SOX13;SOX6;CHD7;PHF1;HINFP;ESCO1;BRCA2;USP13;PRDM2;TAF5L;FOXK2;VSX1;PRMT5;SFPQ;GLRX2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;TAF6L;MSL3;POU6F2;RHOH;HMG20A;BMP2;RNF14;AJUBA;NFX1;EIF2B4;PML;NFYA;PPP2CA;EZH2;ZNF205;SPIN1;DRAP1;RABL3;IRF2;NFXL1;MAFB;CCAR2;TRAPPC2;RNF6;NONO;ZNF35;CXXC1;NFKB2;MZF1;SOX11;RPS6KA4;DVL2;ACTR5;LDB1;EDF1;OGG1;ZNF219;NFIL3;JMJD1C;SOX12;OBI1;ATRX;SAP30L;APP;ESR1;MYBL2;ZBTB4;E2F1;SP3;ZFPL1;UTP4;FOXO4;HIC1;ZBTB38;CALR;MLX;MLXIPL;DDX25;UBE2L3;HDAC10;SKOR2;NR5A2
prerank,muscle contraction (GO:0006936),-0.3781807297341082,-1.5064912230278371,0.006224066390041493,0.27891481636402915,1.0,21/126,8.81%,CALD1;ROCK2;SORBS1;VCL;TPM1;MYLK;VIM;ROCK1;PABPN1;TLN1;SNTA1;MYOF;TMOD3;EDNRA;SNTB1;ITGB5;TPCN2;SSPN;ASPH;SMTN;ACTN2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5808818422144301,-1.505508128867282,0.05273069679849341,0.28004832033881,1.0,6/16,13.72%,SOX5;PTN;FOXC1;DHX36;HOXB4;SOX6
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5264711959354796,-1.5052672731807464,0.03275529865125241,0.2795558899457638,1.0,12/24,22.77%,IGF1;SORBS1;ENPP1;GSK3B;IRS1;IGF2;SELENOS;PPP1R3B;INPP5K;AKT2;PPP1R3C;PPP1R3F
prerank,receptor signaling pathway via STAT (GO:0097696),-0.5093405317898114,-1.505122913496322,0.04562043795620438,0.2787963240227478,1.0,10/25,17.74%,PKD1;PIAS1;IL31RA;GHR;STAT3;CTR9;PKD2;STAT1;STAT5A;STAT5B
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5954399340744174,-1.5048723073166272,0.03690036900369004,0.2782458355548996,1.0,9/16,25.95%,APPL2;ABCD2;APOD;PDCD4;CHID1;ADCY7;NLRC3;SIRPA;PPARA
prerank,negative regulation of ion transport (GO:0043271),0.5181473731658599,1.5033994329184832,0.03497942386831276,0.28986639989415713,1.0,5/24,4.15%,CD33;GPM6B;SYT11;SNCA;WNK2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.4407598026533642,-1.5031489353912142,0.014344262295081968,0.2809029557636018,1.0,22/51,19.91%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;SYNPO2;RHOA;SYNPO;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5786015817146812,1.500788505434044,0.05112474437627812,0.2931205639818827,1.0,6/15,13.24%,KCNJ3;KCNN2;KCND3;ATP1A1;KCNJ8;ATP1B1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5858690426583109,-1.5005623588516523,0.043560606060606064,0.28454470116708747,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5858690426583109,-1.5005623588516523,0.043560606060606064,0.28454470116708747,1.0,4/16,5.45%,PHLDB2;ARHGAP6;THBS1;BCAS3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.44362383801413013,-1.5003606860072296,0.015968063872255488,0.28393332845121505,1.0,13/53,11.13%,EYA2;EYA1;EGFR;DDX5;UBE2N;EYA4;PLA2R1;DHX9;BRCC3;CEBPG;RNF8;PRKCD;BCLAF1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5360680512980925,-1.500013687862351,0.04238921001926782,0.28370853621140574,1.0,11/21,24.88%,MED17;MED12;DHX36;MED1;JUN;BCLAF1;MED16;MED13;MED14;PAXIP1;TWIST1
prerank,ribosomal small subunit assembly (GO:0000028),0.5627722507031576,1.4994544723719099,0.04878048780487805,0.2942152370602999,1.0,8/16,16.70%,RPS19;RPS27;MRPS7;RPS15;RPS14;RPS5;RPS28;XRCC5
prerank,P-body assembly (GO:0033962),-0.6321652121528685,-1.4992563654816755,0.03977272727272727,0.28428581236953127,1.0,7/12,16.14%,DDX6;EIF4ENIF1;RC3H1;LSM14A;LIMD1;EDC3;DYNC1H1
prerank,positive regulation of signal transduction (GO:0009967),-0.34534230296937884,-1.4985960036396357,0.0,0.28454421163053345,1.0,66/238,15.98%,BMP6;WLS;SULF1;IGF1;SASH1;TGFBR1;SORBS1;ZMIZ1;RBPJ;NTRK3;LIMS1;GRB10;ITGAV;FGF1;CCBE1;TRIM44;KAT2B;AXL;IL6ST;EP300;ROBO1;PTGIS;SMO;ARNT;JAG1;LRRK2;VTN;TSPAN5;NLGN2;DLG4;YAP1;DCDC2;FLNA;TTC23;IRS1;SULF2;SLC39A14;RSPO3;SKI;CREBBP;STAT3;NRP1;FGFR2;F3;IGF2;DACT1;MN1;RSPO2;CCN3;HIF1A;EVC;MAML2;PKD2;ARMC9;MAML1;GLI1;ING5;TPD52L1;BMP2K;ERN1;PRKCZ;TRIM39;ITGA5;CSNK2A1;SALL1;LOXL3
prerank,positive regulation of binding (GO:0051099),-0.39636564268378705,-1.4985854050968976,0.0058823529411764705,0.28354644473588936,1.0,32/84,20.71%,IGF1;TCF7L2;LRP1;PKD1;FOXC1;STK3;BMP4;PRKN;LRRK2;VTN;GSK3B;MARK3;HMGB1;SKI;DHX9;CEBPG;DACT1;NGF;USP33;RPL11;PARP9;HES1;DTX3L;TXN;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;CLN5;NME1
prerank,negative regulation of ossification (GO:0030279),-0.5266569115979765,-1.498344891080496,0.04678362573099415,0.28299668843828313,1.0,8/23,17.76%,RBPJ;SMAD6;BCOR;ENPP1;MEF2C;TRPM4;ECM1;CHSY1
prerank,response to cholesterol (GO:0070723),-0.560647438660697,-1.4981047616853793,0.05555555555555555,0.28255748121719954,1.0,6/17,5.30%,TGFBR1;LRP6;SMO;TGFBR2;GRAMD1C;SMAD2
prerank,artery morphogenesis (GO:0048844),-0.4907986392994365,-1.4963936969402494,0.031446540880503145,0.2852066911480674,1.0,12/30,17.05%,LRP1;TGFBR1;BMPR1A;PDGFRB;BMP4;JAG1;NRP1;ADAMTS9;HES1;PKD2;VEGFA;TBX2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6154792676829333,-1.495978078779607,0.05451127819548872,0.28517775693673714,1.0,6/13,16.92%,IL6ST;JAK1;STAT3;TYK2;STAT1;OAS2
prerank,positive regulation of ossification (GO:0045778),-0.461882997955763,-1.4958838102556906,0.018832391713747645,0.28432618980505286,1.0,22/39,20.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ZBTB16;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;WNT5A;BMP2;PTPN11;TMEM119;PKDCC
prerank,defense response to bacterium (GO:0042742),0.38753200181250685,1.4957613376462962,0.010683760683760684,0.29959068042823106,1.0,21/105,14.42%,TIRAP;PGLYRP1;MBL2;RPS19;S100A9;S100A8;ADGRB1;ISG15;IL12A;TLR2;RPL30;EPX;NOD1;SLPI;PPP1R11;GBP4;DROSHA;DEFA6;LCN2;LPO;STAB2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.486762308792454,-1.495716838779603,0.042884990253411304,0.2837076799569553,1.0,10/30,10.62%,FSTL1;TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2;TWSG1;XIAP;SMAD4
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.6038608939629158,-1.4954218373281547,0.0509433962264151,0.28331139402347155,1.0,4/14,7.65%,TGFBR1;EFEMP1;ADAMTS12;WNT9A
prerank,RNA metabolic process (GO:0016070),-0.3743549504059653,-1.4940299281536666,0.0020876826722338203,0.2852519372107261,1.0,39/127,19.58%,RBMS1;CELF2;RBFOX2;TENT2;RBPMS;ATXN1;HNRNPH1;FTO;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;WTAP;RBMS2;RBM6;HNRNPM;DHX9;HNRNPUL1;HNRNPD;DHX36;PCBP2;HNRNPK;DUSP11;XRN2;ALKBH1;APOBEC1;RBM5;PAPOLG;DDX3X;MTREX;RNGTT;HNRNPU;POLR2H;HNRNPA3;RNASE4;SIDT2;RBM4
prerank,regulation of telomere maintenance (GO:0032204),-0.5130002121700862,-1.493951570231546,0.028513238289205704,0.2844327844832891,1.0,16/26,27.54%,SMG6;HDAC8;SMG1;USP7;NBN;YLPM1;HNRNPD;DHX36;UPF1;MRE11;TERF2;PML;ERCC1;PPP1R10;GNL3;ATRX
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4043778943671765,1.4933003011931636,0.014799154334038054,0.3029066403387712,1.0,20/75,14.16%,SLC39A10;SLC24A2;KCNJ3;KCNJ6;CACNA2D1;SLC8A1;SLC12A6;KCNJ11;HCN2;KCNJ10;TRPM2;ATP1A3;KCNK9;SLC12A3;SLC39A8;ATP1A4;ATP1A1;KCNJ8;ATP1B1;ATP2B4
prerank,organic anion transport (GO:0015711),0.40672671705584185,1.4931985178929783,0.010245901639344262,0.30145811216575213,1.0,15/76,10.66%,SLCO1C1;SLC4A1;CA4;SLCO4C1;AQP9;ABCG2;SLC35A1;SLC52A2;SLC25A42;CA2;SLCO5A1;SLC52A3;SLCO2B1;ABCC4;SLC39A8
prerank,positive regulation of protein import (GO:1904591),-0.4882061748001242,-1.4914607162069187,0.04216867469879518,0.28853697523225474,1.0,11/30,15.49%,ZIC1;SMAD3;FLNA;UBR5;CDH1;JUP;BAG3;PRKCD;MAVS;TPR;EFCAB7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6055291456220946,-1.4913599795337464,0.04780876494023904,0.2877121244682549,1.0,5/14,4.83%,LRP1;BMPR1A;TPM1;IGFBP5;IGFBP3
prerank,ceramide transport (GO:0035627),0.6205693444813348,1.491228394715146,0.06134969325153374,0.30382848493217596,1.0,7/12,20.86%,PLTP;CERT1;ABCB4;PLEKHA3;CPTP;SGPP1;PSAP
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6623454610547186,-1.4912266796566034,0.0626118067978533,0.28698355447287377,1.0,5/10,12.63%,PIAS1;HDAC4;SAE1;PIAS3;PIAS4
prerank,cellular response to interleukin-6 (GO:0071354),-0.5039682567884027,-1.490646894553647,0.040229885057471264,0.2872284589110206,1.0,13/26,14.18%,PID1;NFKB1;IL6ST;PTGIS;JAK1;YAP1;SBNO2;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.512347183859213,-1.4898913802938274,0.03621730382293763,0.28786428947874043,1.0,18/26,41.85%,ERRFI1;CBLB;SNX6;SHC1;FBXW7;NCK2;ADRA2A;HBEGF;EGF;APP;GPRC5A;ZGPAT;CBL;ADAM17;TSG101;SOCS4;BTC;CHMP6
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5813857868360397,1.4893931748866762,0.06290672451193059,0.3045101922759055,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),0.5813857868360397,1.4893931748866762,0.06290672451193059,0.3045101922759055,1.0,2/14,9.69%,ABCG2;SLCO2B1
prerank,organelle organization (GO:0006996),-0.32657010779415235,-1.4890843387472221,0.0,0.288744395327049,1.0,141/388,25.25%,ARHGAP10;MICAL3;PLCE1;TPM1;OPA1;BRWD1;DIAPH1;GBF1;PRKN;LRRK2;FBXW8;SYNE3;CSNK1A1;RAB30;NUMA1;ATL3;MICAL2;ABCD3;WDPCP;YTHDF3;ODF2;PACSIN2;WTIP;HPS3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;CXADR;GOLGB1;SEC23IP;VPS4B;VPS13D;ARFGEF1;AFG1L;RAB3GAP1;EIF2AK3;ARHGAP21;OBSL1;CDC42;CHMP4B;CHMP4A;ABCD2;PPARGC1A;MARK4;USP6NL;SEC31A;PALLD;MTX3;CHMP5;ATP8B2;ATL2;RANBP10;TBC1D20;WASL;CHMP3;GABPA;LONP2;FAM161A;HCFC1;COG3;LIMD1;RHOT1;COG7;STX4;ZMYM4;PARP1;NRF1;YME1L1;PEX6;ABCD4;PKD2;VPS13C;FGD1;SURF4;SIRT5;ZMYM3;CAPZB;APOE;TTC17;FGD4;NECTIN2;DOP1B;RANBP9;STOML2;ZFYVE16;MARK1;FAF2;AUP1;TJAP1;TMED3;MIA3;PHIP;PRKD1;ATXN7;MICAL1;SEC16B;CSNK1D;SMPD4;PARK7;TMED5;TMED4;SIPA1L3;AJUBA;TMCC1;PLEKHF1;TRIP11;PEX7;CNN2;TERT;SEC16A;KIF9;SPRYD3;STX17;PYROXD2;DES;KIFAP3;MAST2;WDR81;CUL7;PPID;COG4;PLEKHM2;SIRT4;SSBP1;TOR1A;PI4K2B;VAPA;ARMC2;LMAN1;SPTSSB;RHOT2;BAG5;KIF3A;SAR1B;SIRT3;RAB7A;CENPT;CLUH;PHB2
prerank,regulation of glycolytic process (GO:0006110),-0.4140370557467721,-1.488132325620456,0.01859504132231405,0.2899150254491341,1.0,16/68,12.87%,ZBTB20;PRKAG2;IGF1;EP300;HDAC4;NCOR1;ARNT;PRKAA2;NUPR1;RANBP2;PFKFB4;NUP42;NUP214;HIF1A;TPR;OGT
prerank,smooth muscle contraction (GO:0006939),-0.6015665559305842,-1.4879005574226278,0.04770992366412214,0.2894058822812716,1.0,8/14,16.25%,ROCK2;MYLK;ROCK1;EDNRA;TPCN2;SMTN;BDKRB2;MYH11
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.525208650728573,-1.4876976616937152,0.04725897920604915,0.2888961449147014,1.0,4/23,7.01%,ATP1A2;ANK2;DIAPH1;CAMK2D
prerank,regulation of focal adhesion assembly (GO:0051893),-0.43191678735205885,-1.4871692232823575,0.011881188118811881,0.2890291428009903,1.0,15/54,7.95%,PHLDB2;ROCK2;ARHGAP6;EPHA3;VCL;LIMS1;ROCK1;ABL1;SLC9A1;SLK;THBS1;BCAS3;MAP4K4;NRP1;S100A10
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5830053273959663,-1.4868877055325425,0.055984555984555984,0.28873647650601536,1.0,5/16,11.68%,RANBP3L;BOC;RIPOR2;IGFBP3;MEF2C
prerank,regulation of feeding behavior (GO:0060259),-0.6286604657338972,-1.4868868885409936,0.03676470588235294,0.28777479654831384,1.0,4/11,12.77%,LEPR;AGRP;STAT3;EIF2AK4
prerank,modified amino acid transport (GO:0072337),-0.5785337773002392,-1.4865562664622116,0.05304518664047151,0.28751214589921265,1.0,6/15,18.64%,SLC6A13;SLC16A12;PDPN;SLC5A6;CTNS;MGST1
prerank,urogenital system development (GO:0001655),0.6315611566210169,1.4857803579745468,0.05672268907563025,0.31066528412838673,1.0,4/11,6.59%,PAX8;AMH;PAX2;LHX1
prerank,detection of calcium ion (GO:0005513),0.6136493386016362,1.4856055910328032,0.05450733752620545,0.3093900630493424,1.0,8/13,14.32%,SYT1;RYR2;KCNMB2;KCNMB3;KCNMB4;CALM1;CALM2;CALM3
prerank,COPII-coated vesicle budding (GO:0090114),-0.40637890568674523,-1.484467062456315,0.016885553470919325,0.29095673541765105,1.0,31/68,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;SEC23B;STX5;GOSR2;MIA3;SEC16B;NAPA;CSNK1D;SEC16A;VAPA;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SCAP;SEC24A;TMED2
prerank,Wnt signaling pathway (GO:0016055),-0.3940161605446041,-1.4842798036531681,0.013358778625954198,0.2903887227683361,1.0,18/92,6.01%,WLS;NXN;TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;BTRC;WNT5B;GPC4;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5295600693497098,-1.483507473648573,0.043560606060606064,0.29110533388173865,1.0,13/21,33.67%,OPA1;PRKN;LRRK2;EIF2AK3;SELENOS;NCK1;SYVN1;PARK7;TMBIM6;BCL2L11;HERPUD1;HSPA1A;CREB3L1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4615487749439058,1.483415557346152,0.024439918533604887,0.31220196810040474,1.0,19/38,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFAF1;NDUFB9;NDUFAB1;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,myelination (GO:0042552),0.44267620791035045,1.4833749352932972,0.014767932489451477,0.31062930880990886,1.0,17/46,16.78%,GAL3ST1;MAL;MBP;PLP1;MPZ;CMTM8;NFASC;EPB41L3;CNTNAP1;B4GALT6;TPPP;TNFRSF21;SCN2A;MAL2;SCN8A;PLLP;HES5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4131213843357286,-1.483234026936165,0.009633911368015413,0.2907251941832036,1.0,24/67,22.02%,DOCK5;PLEKHA2;LIMS1;ECM2;ABL1;GSK3B;RREB1;FLNA;VIT;NRP1;CDC42;S100A10;RSU1;JUP;FN1;CARMIL1;DOCK1;MYADM;NPNT;MYOC;TRIOBP;P4HB;CDK6;CRKL
prerank,regulation of gene expression (GO:0010468),-0.3071700492722757,-1.4831948964204908,0.0,0.28986204892530665,1.0,233/903,19.00%,NFIA;BMP6;SLC24A3;ROCK2;NOTCH2;PRDM6;IGF1;BNC2;FOXP1;DENND4A;PID1;AHNAK;AFDN;SMAD3;TGFBR1;EFEMP1;ANK2;BMPR1A;RBMS3;FOXD1;SON;NFKB1;PRDM5;ZNF148;ANGPT1;GSN;WNT4;RBPJ;NTRK3;CLK1;LIMS1;ZNF423;CELF1;ATXN1;NR1D2;ZNF462;ZFHX3;HNRNPH1;FOXC1;FGF1;TRIM44;BMP7;AFF3;EP300;ROCK1;BMP4;DICER1;ROBO1;HDAC4;ERC1;ABL1;SMO;KAT6B;PRKN;TNRC6B;OSR1;WWC2;TFEB;PRKAA2;MBNL2;PABPN1;FOXN3;WWP2;FLOT2;WNT6;GSK3B;GON4L;RREB1;PUM2;YAP1;ZC3H7A;WTIP;TNRC6A;CREBL2;KMT2D;BAZ2A;PPARGC1B;NR3C1;CTSH;SRSF10;MOV10;UBR5;AFF1;SBNO2;PRRX2;HOXA5;FUS;PLSCR1;CREBBP;RC3H1;CDH1;STAT3;NSD3;TRIP4;NSD1;DTNBP1;MED26;TRRAP;ZUP1;EIF2AK3;NAB1;RUNX1;LYN;ANXA7;MTOR;PTBP3;F3;BRAF;REST;LARP1;PARP10;POFUT1;PUM1;HNRNPD;GTF2IRD1;AR;FUBP1;DHX36;CTR9;PCBP2;PPARGC1A;IGF2;GJA1;MAP2K1;NFYC;KDM6A;MED1;PTPN22;HNRNPK;ATF2;CLK2;ITGB8;NGF;CHD3;ZFAT;GABPA;SSBP2;TADA3;TULP3;PARP14;HIF1A;HCFC1;CALCOCO1;RPL11;LIMD1;PARP9;ID2;AFF4;CLK3;CDK11B;YTHDC1;TLE1;GPBP1L1;ADAM19;NFKBIZ;WWC1;RORA;MEF2C;TRIM5;SPTY2D1;TRIM11;TEAD2;SUFU;SETDB1;TCF3;TCF7L1;RB1;SNRNP70;FBXW7;YBX3;FN1;CCAR1;FZD7;CRABP2;PATZ1;ADNP2;CGGBP1;YBX1;SOX13;ATRAID;SOX6;CHD7;APOE;PHF1;HINFP;VEGFA;EMILIN1;BRCA2;HDAC1;USP13;DDX3X;PRDM2;TAF5L;TRIM39;PDCL3;CCDC3;FOXK2;EPHX2;VSX1;ATOH8;IFNGR1;PRMT5;TNRC6C;SFPQ;TRAF3;GLRX2;CITED2;MYBL1;SIX1;ATXN1L;RNF20;ZFP37;NFYB;PIK3CD;PICALM;TLR4;CCN4;WNT5A;PRKAA1;MYADM;SFRP4;TAF6L;MSL3;POU6F2;GCNT2;SEC16B;RHOH;HMG20A;MYOM1;BMP2;RNF14;PARK7;MUSK
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.6583203707964181,-1.4824635731911115,0.05628517823639775,0.29058116062305334,1.0,5/10,19.36%,SETD7;SETD3;SETD2;EHMT1;KMT5A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5435127701755997,-1.4819804781289982,0.04789272030651341,0.2906926682747136,1.0,6/19,15.90%,ENPP1;TPST1;SLC35B3;SLC26A2;SULT1A1;ABHD14B
prerank,positive regulation of bone mineralization (GO:0030501),-0.4706935848162379,-1.4819521118500332,0.028517110266159697,0.2897953869810909,1.0,19/35,20.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3;BMP2;TMEM119;PKDCC
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5104680599691352,-1.4817319110950906,0.048355899419729204,0.2893831268447165,1.0,8/24,6.61%,PARVA;BMPR1A;SMAD6;BMP4;ROBO1;TGFBR2;NRP1;FGFR2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5789247394206569,-1.4814602990582415,0.052830188679245285,0.2890043437196282,1.0,4/16,10.15%,PRKAG2;APPL2;PPARGC1A;LONP2
prerank,muscle cell migration (GO:0014812),-0.6415040045351451,-1.4806378448688453,0.05084745762711865,0.2899104804126561,1.0,7/10,20.91%,ROCK1;PLAT;CCN3;DDR1;SIX1;ITGB3;AAMP
prerank,intraciliary retrograde transport (GO:0035721),-0.6175642066076497,-1.4802922754600816,0.05380333951762523,0.28972380841046685,1.0,9/12,32.84%,IFT43;DYNC2I1;DYNC2LI1;DYNC2I2;IFT140;TTC21B;IFT122;WDR35;DYNC2H1
prerank,peptidyl-lysine modification (GO:0018205),-0.3806993640207065,-1.4785545409311478,0.015296367112810707,0.2923883111733854,1.0,30/99,15.98%,EYA1;LOXL1;KAT2B;PIAS1;EP300;HDAC4;PLOD2;SAE1;RANBP2;SENP3;SENP7;NSMCE2;P3H3;NNAT;SENP6;NUP42;PIAS3;UBE2I;NUP214;SENP1;SENP5;TPR;PIAS4;TRPM4;SIRT5;LOX;ESCO1;METTL21A;TOPORS;LOXL3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5127197331290609,-1.4779164590328295,0.039525691699604744,0.2928110369930732,1.0,6/23,5.30%,TGFBR3;SMAD3;SMURF2;NREP;DKK3;SMAD2
prerank,vesicle coating (GO:0006901),-0.4124126408390229,-1.4775748027090603,0.015384615384615385,0.290827277504269,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4124126408390229,-1.4775748027090603,0.015384615384615385,0.290827277504269,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,COPII vesicle coating (GO:0048208),-0.4124126408390229,-1.4775748027090603,0.015384615384615385,0.290827277504269,1.0,27/61,27.38%,SEC24D;TRAPPC9;CTSC;TFG;SEC23IP;SEC23A;SEC22B;SEC31A;TBC1D20;TRAPPC6B;CUL3;STX5;GOSR2;SEC16B;NAPA;CSNK1D;SEC16A;F5;NSF;TRAPPC2;LMAN1;USO1;PREB;SAR1B;MCFD2;SEC24A;TMED2
prerank,ureteric bud development (GO:0001657),-0.570195787756947,-1.4768981618944699,0.05263157894736842,0.2912796369202347,1.0,11/17,18.77%,FOXC1;BMP7;BMP4;OSR1;GPC3;FGFR2;PKD2;SALL1;SIX1;NPNT;BMP2
prerank,mitochondrion distribution (GO:0048311),-0.6148462309679806,-1.4757641466858598,0.05202312138728324,0.29276610334753894,1.0,5/12,13.35%,TRAK1;LRRK2;MEF2A;DNM1L;ARMC1
prerank,transport along microtubule (GO:0010970),-0.6000788896619189,-1.4750152347419523,0.062381852551984876,0.2934260198454203,1.0,9/13,30.16%,ARHGAP21;CDC42;SPG11;BAG3;COPG2;COPG1;CLIP3;APP;APBA1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.4953219285610708,-1.473934619002376,0.04085603112840467,0.295000702535999,1.0,18/27,31.82%,UBE2E2;PRKN;UBE2H;ANAPC5;ANAPC7;ANAPC4;CDC26;UBE2B;CDC27;UBE2S;UBE2D3;ANAPC11;ANAPC13;CDC16;ANAPC1;FZR1;UBE2L3;UBE2W
prerank,positive regulation of potassium ion transport (GO:0043268),0.4624875047531201,1.4730539486089516,0.04149377593360996,0.3307133101781226,1.0,11/38,7.79%,KCNJ3;KCNJ6;KCNN2;AKAP6;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNJ10;KCNN3;GNG2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5533002859772727,1.4728242096925614,0.04504504504504504,0.32954493659335155,1.0,6/17,16.58%,HCAR2;MFSD2A;ALK;AKT1;SORL1;GPLD1
prerank,membrane depolarization (GO:0051899),0.4793627080836538,1.4712016472535774,0.05510204081632653,0.3314265086544463,1.0,11/32,15.67%,CACNA1A;SCN1A;CACNA1B;CACNG2;CACNA1E;SCN3A;CACNB4;P2RX7;SCN2A;CACNA1I;SCN8A
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6478478125033893,-1.4708549175421775,0.0675422138836773,0.3010196330143622,1.0,1/10,1.19%,NFKB1
prerank,regulation of peptide hormone secretion (GO:0090276),0.41122445549248665,1.4708348120377595,0.029354207436399216,0.33038836594140664,1.0,11/67,6.28%,PAX8;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;HTR2C;KCNJ11;CACNA1E
prerank,positive regulation of DNA repair (GO:0045739),-0.4340759372621049,-1.4707032599945644,0.027131782945736434,0.30042412143520114,1.0,11/46,7.71%,EYA2;EYA1;EGFR;UBE2N;EYA4;SPIDR;HMGB1;DHX9;BRCC3;CEBPG;RNF8
prerank,cation transport (GO:0006812),0.3601642488322409,1.4705249114233174,0.006024096385542169,0.32928408733003395,1.0,33/167,11.75%,SLC6A6;GRIN1;SCN1A;SLC6A17;KCNJ3;SLC7A1;KCNJ6;KCNN2;FGF13;SLC1A1;KCNMB2;KCNMB3;SLC8A1;KCNN1;SCN4B;ASIC1;KCNMB4;KCNJ10;TRPM2;KCND3;KCNH1;KCNK9;SLC7A8;KCNAB1;SCN3A;KCNC1;KCNK1;SLC66A1;SLC12A3;SLC36A1;ATP1A4;KCNA2;SCN2A
prerank,RNA processing (GO:0006396),-0.3497611354046907,-1.4703163264936479,0.006060606060606061,0.30035565628480293,1.0,65/176,24.25%,RBMS1;CELF2;SON;TENT2;RBPMS;CELF1;ATXN1;HNRNPH1;RBM39;DICER1;PABPN1;HNRNPR;SYNCRIP;DDX17;RBMS2;RBM6;FUS;U2AF2;AKAP8L;SF3B1;HNRNPUL1;HNRNPD;TUT4;PRPF6;RNPC3;PPARGC1A;TSEN2;SLU7;HNRNPK;PRPF3;SF3A1;USP39;SCAF11;DUSP11;XRN2;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;APOBEC1;RBM5;SRSF1;SFPQ;RNGTT;PRKACA;CSTF3;HNRNPU;ZMAT5;SNRPF;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;NUDT21;SMU1;DHX15;NONO;PABPC4
prerank,ncRNA processing (GO:0034470),0.3498877335151023,1.4689828258843383,0.0,0.33093715972637816,1.0,62/200,18.35%,EXOSC5;IMP4;RPS6;RPS19;RPL38;RPL29;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;RPL15;RPL10;LIN28B;RPL10A;RPS24;RPL27A;RPS17;RPS16;RPLP1;RPL41;RPLP0;RPL30;RPL7A;FBL;RPL13;RPL12;NOL6;RPS15;RPL14;RPL5;INTS2;RPL21;DKC1;RPS7;RPP30;RPL23A;RPL8;POP5;DROSHA;RPS14;RPS2;DDX10;WDR75;RPL18A;PIH1D2;RPS28;INTS11;RRP1B;RRP1;NOP56;INTS10;RPS25;MDN1;UTP15;EXOSC4;RPS9;ADAR;AGO4;RPL31;NVL
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.39685213532849345,-1.468887835825591,0.009823182711198428,0.30256939413276224,1.0,15/85,7.39%,BMP6;TGFBR3;IGF1;EGFR;TCF7L2;ANGPT1;LIMS1;BMP5;FGF1;BMP4;OSR1;NUPR1;YAP1;FGFR2;SRSF6
prerank,epidermal cell differentiation (GO:0009913),-0.4491834003891081,-1.4686474670418548,0.03732809430255403,0.30217607910896194,1.0,15/41,23.38%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG;ERCC3;GLI1;HDAC1;WNT5A;GATA6;WNT16;HDAC2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3800463689361628,1.4684778890990553,0.012422360248447204,0.3302413272986605,1.0,19/107,6.24%,SLC39A10;SLC24A4;SLC24A2;MT2A;CXCL12;RYR2;HTR2C;SLC8A1;ATP2B3;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SLC30A1;NPTN
prerank,"transcription, DNA-templated (GO:0006351)",-0.34522029146710426,-1.4683480226167347,0.0020161290322580645,0.3019166378452974,1.0,87/207,28.75%,MLLT3;MAF;SOX5;NFKB1;THRB;DDX5;GLIS3;FOXO3;GTF2H2;CCNT2;CCNH;NFIX;RREB1;CCNT1;CREBL2;TAF3;MEF2A;CDK7;BAZ2A;CTR9;TAF4;TBP;NCOA6;CCNK;MNAT1;BRF1;AFF4;RTF1;PARP1;ERCC3;IRF9;COPS2;NELFB;TTF1;MMS19;TAF5L;SNAPC3;TOPORS;TAF13;MNT;PRMT5;GTF2B;PIR;PMF1;EPC1;RNGTT;NR4A2;NFIC;POLR2H;GTF3C4;TRIP11;CDC73;NFX1;MED16;TAF12;NFYA;TAF9B;TAF2;DRAP1;RPAP1;GTF2F1;POLR2K;HSF1;GTF2H1;EAF2;TBPL1;GTF3C1;CTDP1;POLR2E;POLR3H;NCBP2;TAF7;GTF3C6;ZBTB7B;TAF1C;GTF2H4;GTF2E2;THRA;NFKBIB;POLR2D;NELFA;CDK9;NELFE;BRF2;MRPL12;TAF1A;E2F1
prerank,positive regulation of organelle organization (GO:0010638),-0.47509570368811554,-1.4673914651715607,0.025590551181102362,0.3030240633956401,1.0,15/32,27.39%,UVRAG;ATL3;GSK3B;ANXA2;RAB3GAP1;STX18;ANXA1;PPARGC1A;SURF4;SORBS3;AKT2;LMAN1;IRGM;HTRA2;ADRB2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.539525579164003,-1.467091411366327,0.05575539568345324,0.3027708812096265,1.0,7/19,21.48%,MYO9A;CYTH3;CDC42;RHOA;PARD3;SIPA1L3;MSN
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.42224900751307687,-1.4662264558037477,0.02404809619238477,0.3035686548381982,1.0,26/58,26.93%,UBE2N;UVRAG;HMGB1;NBN;NSMCE2;BRCC3;RNF8;SMC5;HERC2;XRCC4;PAXX;POLM;PIAS4;PRKDC;ERCC8;KDM2A;MRE11;DCLRE1A;XRCC6;UBE2V2;SMARCAL1;ERCC1;PAXIP1;ZBTB7A;IFFO1;ABRAXAS1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.5763349608475168,-1.4651875058621917,0.06407766990291262,0.3048594792096424,1.0,9/15,30.89%,NR3C1;ANXA1;REST;FAM107A;HNRNPU;ZFP36L2;GPER1;UBE2L3;BCL2L11
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4552675390560942,-1.4649287864204406,0.04158790170132325,0.3045347154478227,1.0,17/40,15.84%,BMP6;PTN;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;KL;ATP2B1;MEF2C;ATRAID;CCN1;ACVR1;FBN2;TGFB3
prerank,mRNA splice site selection (GO:0006376),-0.48268532037451917,-1.464522284179054,0.04066543438077634,0.30448803142271025,1.0,12/30,14.46%,CELF2;CELF1;LUC7L2;PRPF39;SFSWAP;SRSF10;SRSF6;SLU7;SF3A1;YTHDC1;SF3A3;SRSF1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5411338752501159,-1.4633080057093997,0.055133079847908745,0.30634729208840633,1.0,5/18,8.85%,EGFR;DDX5;BMP4;NCOR1;MAP2K1
prerank,kidney development (GO:0001822),-0.4073153112139695,-1.4615891519906186,0.027196652719665274,0.309289810690565,1.0,16/65,5.91%,SULF1;TGFBR1;KANK2;PKD1;WNT4;GLI2;FOXC1;BMP7;BMP4;OSR1;PCSK5;ARL3;SULF2;CTSH;PYGO1;ZBTB16
prerank,negative regulation of phosphorylation (GO:0042326),-0.39138253209694385,-1.4614174741724983,0.009900990099009901,0.30880645650948946,1.0,34/85,22.57%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;BMP7;ROCK1;BMP4;HDAC4;NCOR1;PRKN;LRRK2;NUPR1;IBTK;IGFBP3;LYN;IMPACT;ANKLE2;FKBP8;PRKDC;ZBED3;CBFA2T3;MYADM;HNRNPU;INPP5K;PARK7;INHBA;CDKN1C;CDK5RAP3;ATG14;CRKL;PRKRIP1;CHP1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6469813997532435,1.4611517168639674,0.0635593220338983,0.344477549000695,1.0,7/10,17.04%,GALNT13;MGAT5B;GALNT3;GALNT2;POGLUT1;GALNT16;GALNT4
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5859737871177813,-1.4609362912159483,0.06666666666666667,0.30903113309950586,1.0,6/14,25.07%,DHX9;DHX36;YBX3;CPEB1;PKM;UNK
prerank,activin receptor signaling pathway (GO:0032924),-0.5697693814616838,-1.460868004980194,0.06296296296296296,0.308275826823756,1.0,5/15,19.36%,SMAD3;TGFBR1;SMAD2;ACVR1;INHBA
prerank,histone ubiquitination (GO:0016574),-0.5226480216242626,-1.4601974006641423,0.05858585858585859,0.308884709060408,1.0,11/21,22.39%,UBE2N;UBR2;HUWE1;RNF8;CTR9;DTX3L;UBE2B;UBE2E1;RNF20;CDC73;WAC
prerank,hemopoiesis (GO:0030097),0.3900189750153509,1.4599009148996416,0.027253668763102725,0.3455779108821352,1.0,18/87,9.01%,FLT1;KIRREL3;MECOM;KITLG;TEK;TIRAP;CSF1R;ARMC6;FST;TOX;KDR;FLT3;TAL1;TGFB2;RTKN2;MELK;CD34;TPO
prerank,regulation of secretion by cell (GO:1903530),0.4269038082655533,1.459692335622189,0.029069767441860465,0.3444095306843947,1.0,11/54,6.13%,CAMK2A;SYT1;RIMS1;RIMS2;SCG5;MCTP1;RAB3C;LGI3;RHBDF2;STXBP5L;KCNMB4
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.5207629812697602,-1.459615204574369,0.06097560975609756,0.3093284455749347,1.0,6/20,11.54%,ROCK2;RHOQ;ROCK1;DLG1;FHOD1;NCKAP1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.55226347657029,-1.4591446626047992,0.06779661016949153,0.3094053754473307,1.0,12/17,31.47%,HM13;OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3496205770239286,-1.4588525442099838,0.0040650406504065045,0.30914315833841205,1.0,70/173,24.83%,ANK2;SEC24D;VTI1A;GBF1;PROS1;CD55;ATL3;CTSC;GOLGB1;TFG;SEC23A;VTI1B;VAMP7;SEC22B;KDELR1;COPB1;COPZ2;SEC31A;BCAP29;ARCN1;DCTN5;ARFGAP1;ARFGAP3;ATL2;TBC1D20;COG3;COG7;GOSR1;CAPZA1;CNIH4;DYNC1LI1;TRAPPC6B;KDELR3;CUL3;STX5;COPB2;CAPZB;WHAMM;COPG2;DYNC1H1;GOSR2;TMED3;MIA3;VAMP4;SEC16B;NAPA;COPG1;TMED5;TMED4;TRIP11;NRBP2;SEC16A;MPPE1;STX17;COPE;COG4;ERGIC1;VAPA;BET1L;F5;ACTR1A;NSF;TRAPPC2;LMAN1;USO1;PREB;HYOU1;SAR1B;MCFD2;TEX261
prerank,neuron projection development (GO:0031175),0.3584696298808551,1.4580880904209115,0.0019157088122605363,0.34599719876322854,1.0,38/168,10.82%,NYAP2;CNTNAP2;GPRIN1;FRY;PLP1;GRM7;TMEM108;EPHB1;CTNND2;NLGN1;GPM6A;SH3GL2;GPM6B;SHANK3;MAP2;STMN1;TNIK;STX3;OMG;PAK1;PPP1R9A;GPRIN3;EPB41L3;CNTNAP1;ADCYAP1;STMN4;RASGRF1;BICDL1;UBB;SHTN1;CAMSAP1;RAB35;STMN2;TAOK2;DAB2IP;PTPRM;MICALL2;CNTN4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.48311422698434864,1.4577343574412047,0.053811659192825115,0.34512309822329124,1.0,11/28,19.66%,FGF10;THY1;IL12A;PRKCQ;CCL2;CYRIB;HSPD1;SH3KBP1;NCKAP1L;NOD2;CD47
prerank,clathrin coat assembly (GO:0048268),0.5657781387053831,1.4572714611947668,0.06493506493506493,0.3444633542966214,1.0,6/15,14.08%,NSG2;HIP1;FCHO1;CALY;SGIP1;CLTB
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4762874504591418,1.4569634459840652,0.045174537987679675,0.3434392354606415,1.0,6/31,2.79%,SYT1;SYT6;SYT7;DOC2A;SYT12;SYT11
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6271226410208806,-1.456555442893973,0.07238095238095238,0.3133353633321719,1.0,3/11,3.07%,BMPR1A;BMP4;JAG1
prerank,positive regulation of dendritic spine development (GO:0060999),0.5229249189286111,1.456443679711078,0.06041666666666667,0.34296712671080093,1.0,5/20,13.72%,LRP8;NLGN1;SHANK3;RELN;PSEN1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4078051604378634,-1.4563337519815507,0.022684310018903593,0.31293480374552923,1.0,28/67,20.91%,ROCK2;SULF1;ITGAV;AXL;ROCK1;CYFIP2;WASF2;SHB;PAK2;NRP1;CDC42;VAV2;BRK1;RHOA;ABI1;NCKAP1;VEGFA;NCK1;VEGFD;NCK2;CYBA;DOCK1;PRKD1;ITGB3;NCF2;BAIAP2;PIK3R1;AAMP
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5680937451771273,-1.4562681127155932,0.07721280602636535,0.31221812113591463,1.0,11/15,31.47%,OS9;SELENOS;FAF2;AUP1;DERL1;SYVN1;VCP;SEL1L;DERL2;HERPUD1;UFD1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5601800298439071,1.456197085218979,0.056016597510373446,0.34190283236533775,1.0,7/16,11.97%,ST6GALNAC3;ST8SIA4;B4GALNT1;ST8SIA1;B4GALT6;ST8SIA6;ST8SIA3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.40530658007996684,-1.4561125994243223,0.022857142857142857,0.31174372475980633,1.0,22/66,20.87%,SULF1;TGFBR3;NR2F2;KLF9;ROBO1;SPARC;NFIB;NUPR1;THBS1;FGFR2;PTPRK;MED1;FBXW7;APOE;STAT1;BRCA2;DUSP10;ATOH8;ATP5IF1;CDC73;CDKN1C;CDK6
prerank,regulation of actin filament-based process (GO:0032970),-0.4037069528184201,-1.4555985719623383,0.024163568773234202,0.31199820009576423,1.0,31/70,27.49%,ROCK2;LRP1;RHOQ;EPHA3;PDGFRB;ROCK1;ABL1;RND3;MTOR;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;CNN2;BAIAP2;F11R;ARHGAP35;HIP1R;ARHGAP44;TWF2;TESK1;EFNA5
prerank,keratinocyte differentiation (GO:0030216),-0.4817118375587544,-1.4553377863189005,0.057803468208092484,0.3115992240242839,1.0,8/29,11.74%,JAG1;BCR;ANXA1;CLIC4;MED1;TXNIP;ADAM9;UGCG
prerank,epithelial to mesenchymal transition (GO:0001837),-0.4299684300249256,-1.4550485242260762,0.03917910447761194,0.3113667753783013,1.0,11/47,4.59%,ROCK2;TGFBR3;TGFBR1;WNT4;RBPJ;LIMS1;DDX5;BMP7;ROCK1;GSK3B;DDX17
prerank,protein monoubiquitination (GO:0006513),-0.4577255171953468,-1.4548419502357866,0.052830188679245285,0.3109548236813758,1.0,21/36,31.82%,PRKN;HUWE1;CTR9;UBE2R2;CUL3;TRIM25;KLHL22;DTX3L;UBE2B;TOPORS;UBE2E1;RNF20;UBE2D3;CDC73;WAC;MGRN1;OBI1;RBX1;RNF126;KBTBD8;UBE2W
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.40985617299198723,-1.4547658362663307,0.029239766081871343,0.31023221768614617,1.0,11/61,6.93%,AKAP13;NOTCH2;IGF1;COL3A1;AUTS2;LPAR1;ROBO1;SHOC2;MAP4K4;SHC1;LYN
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.44369294552946514,-1.4546103831714863,0.03278688524590164,0.3096697736029612,1.0,20/44,19.91%,ROCK2;LPAR1;TGFBR1;TPM1;CCN2;ABL1;ARHGEF10L;PPM1E;NRP1;FHOD1;CDC42;RAPGEF3;S100A10;RHOA;CARMIL1;TGFB3;SORBS3;MYOC;RHOC;NF2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.40922337988012686,-1.4544742117918348,0.017408123791102514,0.30920185488890956,1.0,33/68,28.65%,GTF2H2;PABPN1;CCNH;PCF11;WDR33;CDK7;SCAF8;CPSF3;CAVIN1;TAF1D;TBP;SSU72;SLBP;MNAT1;ERCC3;TTF1;PRMT5;CSTF3;POLR2H;SNRPF;CSTF1;POLR2K;CPSF4;NUDT21;GTF2H1;POLR2E;CPSF1;NCBP2;LSM11;TAF1C;GTF2H4;POLR1G;TAF1A
prerank,protein modification by small protein conjugation (GO:0032446),-0.32228040323000146,-1.4539187406480674,0.0,0.3094382384949232,1.0,118/361,22.83%,RNF220;PDZRN3;FBXL7;EYA1;RNF152;FBXL17;SMURF2;UBE2N;RNF43;UBR2;TRIM44;PIAS1;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;SAE1;HUWE1;USP7;RANBP2;UHRF2;RNF213;DTX4;OS9;UFL1;NSMCE2;WWP1;UBE2H;ASB2;ZSWIM8;RNF8;NUP42;UBA5;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;PIAS3;VCPIP1;UBE2I;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;UBR1;UBE2R2;NUP214;HIF1A;RFWD3;RTF1;TRIM5;UBR3;TRIM11;TPR;CUL3;PIAS4;FBXW7;TRPM4;DTX3L;TRPC4AP;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;CUL2;TOPORS;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;DERL1;ASB5;KLHL18;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;FBXW5;EIPR1;AREL1;SDE2;VCP;RNF14;DCUN1D3;SPSB4;UBE2D3;CDC73;DTX2;NFX1;NUP98;PCNA;ANAPC11;CUL1;TRIM63;HIF3A;ARIH2;CUL7;CDK5RAP3;NAE1;DET1;NUP43;ARRDC4;WAC;CAND2;UBE2V2;RNF144A
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.5512472468924485,-1.4537457364865543,0.07156673114119923,0.3089231503026671,1.0,10/17,28.25%,CCNT1;CTR9;ZC3H3;CPEB1;RNF20;NUDT21;HSF1;NCBP2;CDK9;NELFE
prerank,cell-cell junction organization (GO:0045216),0.3927192590164149,1.4529112978629994,0.018255578093306288,0.3473853765813038,1.0,21/79,12.08%,CLDN5;CDH12;CDH8;CADM1;CSF1R;CADM2;CTNND2;CDH7;CDH19;CDH20;CDH18;CDH2;CDH10;OCLN;TGFB2;DCHS1;CADM3;F2R;TJP1;NECTIN1;MARVELD2
prerank,sterol metabolic process (GO:0016125),-0.41061130779559435,-1.4524195706958152,0.0326530612244898,0.3110039130425549,1.0,21/60,26.35%,PRKAG2;ABCA1;CYP7B1;CYP26B1;CYP27A1;SOAT1;INSIG2;OSBPL5;CYP1B1;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;SC5D;ARV1;LBR;GBA2;SCAP;CLN8
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.39521838313553026,-1.450982566766878,0.015296367112810707,0.3133573448371937,1.0,24/76,20.09%,UACA;EGFR;SASH1;NFAT5;LIMS1;TRIM44;BMP7;EP300;NR3C2;DLG1;PTPN22;CCN3;RHOA;RASSF2;PPM1A;EIF2AK2;DDX3X;C1QTNF3;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,canonical Wnt signaling pathway (GO:0060070),-0.40678381156279825,-1.450913015397687,0.024761904761904763,0.3125987933721836,1.0,25/68,22.10%,TCF7L2;LRP6;WNT4;PLPP3;LRRK2;CSNK1A1;WNT5B;WNT6;GSK3B;RYK;RARG;BCL9L;AXIN1;FZD2;WNT9A;CSNK1E;TCF7L1;FZD7;WNT5A;NR4A2;SFRP4;FZD1;FRZB;DVL3;WNT16
prerank,glycerolipid metabolic process (GO:0046486),0.6153653427499245,1.4476871599233663,0.06695464362850972,0.3577821377109206,1.0,6/11,18.09%,GAL3ST1;PGP;DGKB;PIP5K1A;PNPLA3;DGKG
prerank,regulation of cellular component movement (GO:0051270),-0.4277441999350226,-1.4473720536972907,0.02524271844660194,0.3193753841519581,1.0,15/49,10.56%,ROCK2;TGFBR3;EGFR;TGFBR1;DIAPH1;ROCK1;PDPN;ABL1;ARAP1;CD9;LYN;ZSWIM8;SP100;RHOA;ABL2
prerank,signal peptide processing (GO:0006465),-0.6264201348767964,-1.4473095054253293,0.07462686567164178,0.3186507699973944,1.0,8/11,27.46%,PCSK5;HM13;SEC11C;SEC11A;SPPL3;CLN5;PARL;SPCS3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.6186585362798922,-1.446821112741721,0.05945945945945946,0.3188332400731496,1.0,7/11,24.29%,UGGT2;POMT2;AUP1;DERL1;VCP;TOR1A;BAG6
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3902654952727282,-1.4462619506030288,0.025793650793650792,0.3193214913397897,1.0,29/87,20.54%,ROCK2;NOTCH2;LRP1;RHOQ;EPHA3;PDGFRA;PDGFRB;ROCK1;ABL1;RND3;MTOR;RAPGEF3;ARHGAP17;IQGAP2;SEMA3E;RHOA;PRKCD;ABL2;RHOBTB2;RICTOR;ARHGDIB;ARHGAP18;FAM107A;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4989408706542806,-1.4460490235350172,0.0595903165735568,0.3189352761377154,1.0,9/26,17.09%,FOXP1;KANK2;DAB2;NCOR1;STRN3;HDAC1;CNOT2;HEYL;CNOT1
prerank,action potential (GO:0001508),0.44092697041224727,1.4458711517248497,0.034623217922606926,0.36029702868101643,1.0,13/44,16.40%,KCND2;SCN1A;ANK3;AKAP6;KCNMB2;KCNMB3;KCNMB4;SCN3A;KCNA2;SCN2A;CACNA1I;SCN8A;GNAQ
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.44370027807519047,-1.444756852960661,0.0419047619047619,0.32099529293995965,1.0,12/43,11.49%,SMAD3;TEAD1;DDX5;FOXO3;BMP4;NFIB;NR3C1;STAT3;REST;JUN;HIF1A;NFATC4
prerank,mitotic cytokinetic process (GO:1902410),-0.5177114710991865,-1.4446322943472072,0.06728971962616823,0.3203743177897307,1.0,7/20,10.27%,VPS4B;KLHDC8B;CHMP4B;CHMP4A;CHMP5;CHMP3;RHOA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5447017937906511,1.4445330977271433,0.05668934240362812,0.3614670609071456,1.0,8/18,21.18%,CHRM3;GRK2;PLCB1;OPRM1;CHRM2;GNAQ;CDK5R1;RGS10
prerank,lipid modification (GO:0030258),0.4599374007623474,1.444345238105884,0.03938730853391685,0.36021332642764725,1.0,10/37,8.87%,DGKI;PLPPR1;MBOAT1;PLPPR5;DGKH;CYP2E1;DGKB;SGPP2;PLPPR4;PLPP4
prerank,neural crest cell migration (GO:0001755),0.45398490683598736,1.4440337701358845,0.04030710172744722,0.35926879372528486,1.0,8/36,4.44%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,barbed-end actin filament capping (GO:0051016),-0.5282841248376889,-1.4438961118211968,0.07330827067669173,0.3201642338789743,1.0,10/18,26.26%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,actin filament capping (GO:0051693),-0.5282841248376889,-1.4438961118211968,0.07330827067669173,0.3201642338789743,1.0,10/18,26.26%,ADD3;GSN;SVIL;CAPZA1;CAPZB;TRIOBP;AVIL;VILL;TWF1;TWF2
prerank,muscle cell differentiation (GO:0042692),0.45933487767819753,1.443800235038458,0.04790419161676647,0.35803715190372487,1.0,8/32,12.17%,MRTFA;SGCZ;SYNE1;TMEM204;MRTFB;NINJ1;NRAP;MEGF10
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4846498238598875,-1.4434952770791414,0.06679389312977099,0.32018335918905655,1.0,11/26,19.26%,EGFR;FOXC1;GAREM1;PDPK1;MED1;PLCG1;PTPN12;STAT5B;SYAP1;INPP5K;PTPN11
prerank,glycine transport (GO:0015816),0.6181220564962442,1.44267496325956,0.08559498956158663,0.35870242808928443,1.0,4/10,9.58%,SLC6A17;SLC6A5;SLC7A8;SLC36A1
prerank,cardiac muscle tissue development (GO:0048738),-0.4286453691179275,-1.4426122369558527,0.041015625,0.3212282659922516,1.0,14/50,13.07%,AKAP13;NOTCH2;BMPR1A;GJB6;BMP5;BMP7;BMP4;RBP4;GJA1;ADAMTS9;SMAD4;TBX18;SIK1;MAML1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6232878344672409,-1.4420882665186425,0.06367041198501873,0.32151229334824183,1.0,5/11,18.53%,LRP6;RYK;WNT5A;NR4A2;FZD1
prerank,neutrophil migration (GO:1990266),0.41321783238140986,1.4410583347886279,0.030434782608695653,0.3605674021861509,1.0,7/58,9.00%,BSG;PDE4B;S100A9;S100A8;TGFB2;PECAM1;CCL2
prerank,negative regulation of vascular permeability (GO:0043116),0.5940492919461732,1.4406994617297382,0.08225108225108226,0.35975911679636213,1.0,5/12,7.55%,CLDN5;SH3GL2;RAMP2;PDE2A;PTPRJ
prerank,T cell differentiation (GO:0030217),-0.4488624142739726,-1.4403170435589259,0.04007633587786259,0.3244695997113343,1.0,15/40,25.99%,GLI3;LEPR;KIT;ANXA1;PTPN22;PTPN2;SOX13;CHD7;PIK3CD;RHOH;RABL3;GPR89B;GPR89A;LMBR1L;FCER1G
prerank,transition metal ion transport (GO:0000041),0.459643342219213,1.4401507218543095,0.03761061946902655,0.3592560662511275,1.0,10/35,11.90%,TFRC;TRPC5;FTH1;SLC39A2;SLC30A1;MELTF;SLC39A8;ATOX1;SLC30A5;TRPC1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5334087309145888,-1.4401284509520427,0.07262569832402235,0.32398579559260143,1.0,5/17,10.83%,PRKAG2;NCOR1;PRKAA2;PANK2;PRKAB2
prerank,phosphate ion homeostasis (GO:0055062),-0.6242324068470753,-1.4398290383351222,0.06525573192239859,0.3237447000388306,1.0,3/10,20.62%,ENPP1;SFRP4;FGFR4
prerank,oligodendrocyte development (GO:0014003),0.5596945469452358,1.4396942171248481,0.087527352297593,0.3585805022887679,1.0,6/15,9.18%,PLP1;CNTNAP1;NSUN5;EIF2B3;B4GALT6;TPPP
prerank,epithelial structure maintenance (GO:0010669),-0.6130523755889221,-1.4384180043188857,0.07904411764705882,0.32610396780551265,1.0,3/11,12.98%,RBP4;CXADR;STRAP
prerank,cellular response to interleukin-4 (GO:0071353),0.6233211613625282,1.4382155546137005,0.08590308370044053,0.3602860269895305,1.0,3/10,13.69%,LEF1;TCF7;XBP1
prerank,histone H2A ubiquitination (GO:0033522),-0.5432042726677986,-1.4377438566608258,0.0599250936329588,0.326702389170421,1.0,6/17,14.56%,UBR2;BCOR;RNF8;DDB2;DTX3L;UBE2B
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5407239686612001,-1.4369776674268422,0.06642728904847396,0.32753582607725373,1.0,3/17,3.68%,BMP6;SASH1;CD55
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.45584110276891143,-1.4365478870955903,0.040160642570281124,0.32772499496613094,1.0,14/37,18.24%,IGF1;BMPR1A;TPM1;IGFBP5;GJA1;JUN;MEF2C;MMP2;EFEMP2;ERN1;TGFB3;ADAMTS1;PDCD4;SOD2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4330293494521986,-1.4364895018929473,0.03225806451612903,0.32695593213222746,1.0,22/47,27.70%,DOCK5;LIMS1;FBLN1;PDPN;ABL1;RREB1;FLNA;NRP1;CDC42;S100A10;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CRKL;KANK1;AP1AR;TESK1;EFNA5;FERMT2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5046565887599352,-1.4360637324582972,0.061224489795918366,0.3270069957794806,1.0,9/22,19.72%,TIMP3;ROCK1;SNX9;PTPN3;NRDC;ADAM9;APOE;ADRA2A;TIMP2
prerank,positive regulation of cation channel activity (GO:2001259),0.44187550337554266,1.4356149917767314,0.03958333333333333,0.3647019535811441,1.0,13/40,15.66%,TMSB4X;ANK3;SHANK3;AKAP6;ATPSCKMT;LRRC55;CCL2;RELN;HAP1;CALM1;CALM2;CALM3;NLGN3
prerank,negative regulation of signal transduction (GO:0009968),-0.3317889772800038,-1.4348788482540504,0.001968503937007874,0.32877676574128833,1.0,70/249,18.77%,TRABD2B;SULF1;EGFR;NXN;PID1;LRP1;GLI3;ADAMTS12;KANK2;DCN;IGFBP5;LGR4;BMP5;WWOX;GRB10;RNF43;DKK3;ENPP1;LRRK2;TNS2;BTRC;CYP26B1;WWP2;NIBAN2;VGLL4;IRAK3;IRS1;GPC3;IGFBP3;SULF2;THBS1;ASAH2;BCL2;LYN;PIP4K2C;DACT1;PTPN12;LEPROT;PTPN2;PRKCD;MMP14;TULP3;NOTCH3;GLIS2;TLE1;HERC4;SUFU;APOD;RB1;FBXW7;APPL1;EMILIN1;ACVR1;OTUD4;NCK1;PRKCZ;CSNK2A1;PTCH1;ARRB1;TSPAN15;CNOT1;NR4A2;LRRC14;PTPN1;CX3CR1;SFRP4;VCP;DACT3;INPP5K;BMP2
prerank,mRNA processing (GO:0006397),-0.32738525284537845,-1.434867594244979,0.0,0.32793890901552636,1.0,115/287,28.06%,SRRM2;SON;DDX5;CELF1;HNRNPH1;GTF2H2;PABPN1;CCNH;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;CDK7;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;AKAP8L;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;PPARGC1A;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;RPRD2;PRPF3;MNAT1;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;ERCC3;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;TCERG1;RBM5;SRSF1;ERN1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;RNGTT;PPWD1;PRKACA;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;GTF2H1;SMU1;DHX15;NONO;PRPF38A;POLR2E;KIN;CPSF1;PRMT9;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;GTF2H4;SUGP1;PRPF18;POLR2D;HNRNPL;ISY1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.47657661042909083,-1.4346706265397746,0.050682261208576995,0.3274743184508494,1.0,12/26,20.64%,ANK2;FHL1;WWP2;DLG1;ITGB1;CACNA1D;VAMP2;ACTN2;YWHAE;AKAP9;ATP1B3;CAB39
prerank,filopodium assembly (GO:0046847),0.5385187178780146,1.4343282046410788,0.0891304347826087,0.3659364490403473,1.0,5/16,12.15%,DNM3;FGD5;SPATA13;FGD3;SRGAP2
prerank,reticulophagy (GO:0061709),-0.591816790579589,-1.432933458817827,0.08582089552238806,0.3303826418177329,1.0,7/12,17.33%,UFL1;UBA5;TEX264;RB1CC1;ULK2;ATG2A;ATG2B
prerank,negative regulation of histone acetylation (GO:0035067),0.590395188141516,1.4323670777641686,0.09691629955947137,0.36861166486071034,1.0,4/11,12.76%,SIRT1;SNCA;SET;SIN3A
prerank,myoblast differentiation (GO:0045445),-0.5778081578184419,-1.4315813892346338,0.064,0.3325045834222762,1.0,8/14,14.36%,IGF1;TCF7L2;DDX5;JAG1;DDX17;REST;RB1;HINFP
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6213271165434848,-1.431537286295003,0.08396946564885496,0.3317370890335186,1.0,7/10,31.10%,ERRFI1;ENPP1;IMPACT;MVP;CHP1;TESK1;CAV1
prerank,dendritic spine organization (GO:0097061),0.48349681876434825,1.4314835121926557,0.07658643326039387,0.3688386887708817,1.0,4/26,3.04%,IGF1R;EPHB1;CTNND2;SHANK3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5462151397579793,-1.4313521617000804,0.0741444866920152,0.33123962971200616,1.0,5/17,3.07%,NOTCH2;BMPR1A;RBPJ;BMP4;JAG1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.41023436019569076,1.430929587982839,0.031315240083507306,0.36844099229572197,1.0,18/57,17.12%,RPS6;RPS19;RPL38;RPL35A;RPF2;RPL7;RPS24;RPS17;RPS16;RPS15;RPL14;RPL5;RPS7;MRPL36;URB2;RPS28;RPS25;NAF1
prerank,cellular response to leucine starvation (GO:1990253),-0.6373770809791081,-1.4308283661624734,0.0691588785046729,0.3316334252607203,1.0,6/10,21.41%,MTOR;GCN1;SESN1;IMPACT;EIF2AK4;LARS1
prerank,positive regulation of protein binding (GO:0032092),-0.41118015113649053,-1.4297731120842794,0.04174573055028463,0.3331578049777255,1.0,23/56,21.04%,TCF7L2;LRP1;PKD1;STK3;BMP4;ABL1;PRKN;LRRK2;VTN;GSK3B;MARK3;DACT1;PPP2CB;USP33;RPL11;DTX3L;APOE;RAPGEF2;DERL1;BMP2;SPPL3;TERT;PPP2CA
prerank,response to calcium ion (GO:0051592),0.36899957155965823,1.4293230398123389,0.010080645161290322,0.37043547178452957,1.0,34/102,19.44%,SYT1;ADCY8;SYT6;NLGN1;SYT7;SYT12;SYT11;RYR2;RYR3;CPNE9;KCNMB2;KCNMB3;KCNMB4;TRPM2;CPNE8;CPNE1;KCNH1;HOMER1;SYT10;SMPD1;CALM1;SYT2;TRPC1;CALM2;CALM3;PPP3CA;HPCA;GPLD1;KCNMA1;CPNE7;SYT4;SYT5;ALG2;PDCD6
prerank,lamellipodium organization (GO:0097581),-0.47714885067736695,-1.4291291223086358,0.05018587360594796,0.33380865137686627,1.0,11/29,16.70%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;CTTN;WASF1;WHAMM;CARMIL1;ARHGEF6
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3441349235488738,-1.4280579682673313,0.015209125475285171,0.33525533484318343,1.0,65/161,29.47%,BICC1;MLLT3;TCF7L2;GLI3;RBMS3;IGFBP2;LRP6;DAB2;TMEM64;STK3;DKK3;PRKN;CSNK1A1;GSK3B;IGFBP6;AXIN1;CHD8;IGFBP4;DACT1;LIMD1;TLE4;TLE1;LZTS2;TBX18;PSMF1;CUL3;SOX13;GLI1;UBAC2;APOE;PSMB2;HDAC1;LATS1;EMD;WNT5A;SFRP4;DACT3;INVS;BMP2;FRZB;TLE3;DKK2;PSMC1;DVL3;PSMB6;PSMA3;SIAH2;PSMA4;NKD2;LRP4;KREMEN1;DVL2;ZNRF3;LMBR1L;TPBG;PSME1;MCC;PSMD13;SDHAF2;PSMB10;PSMA5;PSMB9;RUVBL2;MAD2L2;RBX1
prerank,regulation of endothelial cell migration (GO:0010594),-0.3776479236945226,-1.4280300237209564,0.0210727969348659,0.33447731198676706,1.0,27/85,17.71%,ROCK2;FOXP1;NR2F2;SASH1;PTN;ANGPT1;DCN;FGF1;BMP4;ABL1;SPARC;RHOJ;THBS1;BCAS3;NRP1;FOXC2;SP100;GLUL;ADAMTS9;BMPER;ANXA3;APOE;VEGFA;ATOH8;PIK3CD;WNT5A;PRKD1
prerank,aminoglycan catabolic process (GO:0006026),-0.479481259615417,-1.427768706414312,0.06542056074766354,0.33426074066289346,1.0,6/28,4.72%,GPC6;SDC2;GPC4;GNS;GPC3;HSPG2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49274642693892723,1.4274472900656738,0.08281573498964803,0.37314455182192646,1.0,9/24,18.36%,PRKAR2B;PDE2A;PDE11A;PEX5L;APLNR;RNF157;PDE4D;GNAI1;PRKAR1A
prerank,epithelial cell morphogenesis (GO:0003382),-0.537607246544643,-1.4258547911821122,0.07553956834532374,0.3375244665988512,1.0,8/17,28.14%,COL22A1;COL15A1;COL18A1;RILPL2;SIPA1L3;RILPL1;DACT2;MET
prerank,cell part morphogenesis (GO:0032990),-0.572522221344217,-1.4257366800663938,0.07948243992606285,0.33692543084105175,1.0,7/13,28.80%,PID1;PACSIN2;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,hexose transmembrane transport (GO:0008645),0.5133190285475342,1.4256337883615748,0.06971677559912855,0.3757950478348783,1.0,3/21,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.46740260135303047,-1.425192920712814,0.03745318352059925,0.3373603438244479,1.0,6/32,7.19%,ZBTB20;PRKAG2;SORBS1;PRKAA2;CREBL2;MTOR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.3217855461823271,-1.4248947415264472,0.0,0.33721406917302116,1.0,141/341,29.56%,FBXL7;FBXL17;SMURF2;RNF43;SPSB1;PRKN;BIRC6;ARIH1;RAD23B;BTRC;TBL1X;WWP2;TRIP12;RNF115;TBL1XR1;KLHL15;RNF146;RNF217;UBXN2B;TGFB1I1;HUWE1;RBBP6;RNF213;VPS4B;RC3H1;UBQLN1;OS9;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;ANAPC5;RNF8;FBXO10;ANAPC7;PCBP2;UBE2K;MAEA;UBE2I;ANAPC4;ANAPC16;NUB1;TNFAIP1;NTAN1;RNF216;USP33;VPS37C;SPOPL;UBE2R2;GID4;KCTD5;PSMF1;WDR91;FBXL19;UBR3;CUL3;FBXW7;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;PSMB2;CDC26;UBE2B;SMURF1;UBR4;FBXO45;TOPORS;ERCC8;CDC27;UBE2E1;ARRB1;FEM1A;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;RNF14;SPSB4;UBE2D3;IFI27;COP1;RNF11;PML;ANAPC11;TTC3;PSMC1;ARIH2;WDR81;APPBP2;SHARPIN;KCTD17;GID8;FBXW4;PSMB6;RNF144A;RMND5A;PSMA3;SIAH2;ARMC8;USP9X;RNF6;PSMA4;CNOT4;PTPN23;BAG6;CDC16;FBXL14;UBQLN4;ANAPC1;ZNRF3;FBXO11;PCNP;SPSB2;PSME1;UBE3C;PSMD13;FZR1;CDC34;TNFAIP3;MIB1;KCTD6;PSMB10;PSMA5;SPSB3;PSMB9;KBTBD7;VPS28;RBX1;NFE2L2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3683270138880073,-1.424676878463096,0.01867219917012448,0.3369301642149283,1.0,29/104,14.60%,SMAD3;TGFBR1;CRIM1;BMPR1A;LDLRAD4;SMAD6;SMURF2;NBL1;TGFBR2;HTRA3;TGFB1I1;SMAD2;BCL9L;SNX6;SKI;SKIL;PDPK1;PMEPA1;CCN3;SMAD4;BMPER;CD109;IL17RD;STRAP;PPM1A;ASPN;EMILIN1;SMURF1;ACVR1
prerank,connective tissue development (GO:0061448),-0.4481441236215974,-1.424546846883992,0.05811623246492986,0.33639565021423123,1.0,11/35,13.72%,SULF1;SOX5;CREB3L2;PKD1;SH3PXD2B;SULF2;ZBTB16;PGRMC2;ITGB8;ARID5B;SOX6
prerank,phospholipid transport (GO:0015914),0.42329594563570827,1.424211920536347,0.024719101123595506,0.37750636863251025,1.0,18/52,14.94%,PLTP;TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;PITPNM1;PRELID3A;SCARB2;ATP11C;ATP8A2;ABCB4;PRELID2;CPTP;SCARB1;ATP11B;SCP2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.4905441129241853,-1.424119763506397,0.06015037593984962,0.3364743681314878,1.0,14/25,24.29%,NGLY1;FBXL17;UGGT2;KLHL15;POMT2;YME1L1;CUL3;CLPP;AUP1;DERL1;VCP;ZYG11B;TOR1A;BAG6
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5130386001940966,-1.424085181460664,0.0825515947467167,0.3356958760917044,1.0,8/20,18.05%,GSN;PLA2R1;THBS1;PLCG1;PIAS4;ITGA4;PDCD4;SFRP4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.49960331324624435,-1.4222194142370213,0.06333973128598848,0.33927209257304614,1.0,4/22,7.19%,ZBTB20;SORBS1;CREBL2;MTOR
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6058983779257104,-1.4217995860860535,0.09124767225325885,0.3394767433653909,1.0,3/11,3.24%,TGFBR3;TGFBR1;TGFBR2
prerank,response to cytokine (GO:0034097),-0.35130818816803894,-1.4214624636860278,0.013565891472868217,0.3393810954330148,1.0,29/141,10.53%,PTPN13;COL3A1;DPYSL3;TIMP3;ALDH1A2;NFAT5;PID1;SMAD3;AFF3;IL6ST;HDAC4;PTPN14;TBK1;IRAK3;PTPN9;PLSCR1;STAT3;ASAH2;BCL2;ANXA1;IRAK2;SP100;NUB1;SETD2;PTPN12;CXCL16;PTPN2;RHOA;ADAM9
prerank,zinc ion transmembrane transport (GO:0071577),0.5055858835015501,1.4200357449047107,0.05934065934065934,0.3857307540347962,1.0,7/22,11.74%,SLC39A10;SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.46280641345456996,-1.4200129763923466,0.06653992395437262,0.3418663904873913,1.0,8/29,14.17%,ZBTB20;SORBS1;CREBL2;MTOR;LDLR;NR1H3;APOE;SLC27A1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.49816173388883916,-1.41941261818862,0.08211678832116788,0.34238746191323144,1.0,4/22,7.81%,CACNA1C;STIM1;ADGRV1;CACNA1D
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4639600871249574,1.4189352518351979,0.06952965235173825,0.38644177170922617,1.0,9/32,9.62%,ADGRB3;PTPRD;IL1RAPL1;HECW1;TNIK;SEMA4D;HECW2;CDKL5;LZTS1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5983858923868617,-1.4179673734959022,0.09393346379647749,0.3450031157612693,1.0,4/11,8.85%,EGFR;DDX5;BMP4;MAP2K1
prerank,spindle assembly (GO:0051225),-0.3907550275627502,-1.4178312462870517,0.03413654618473896,0.3444899269841408,1.0,34/67,30.47%,INO80;NCOR1;NUMA1;FLNA;PIBF1;CEP63;SPICE1;TUBGCP6;TUBGCP2;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;MAP9;RCC1;STAG2;CSNK1D;NEK6;TUBGCP4;SMC1A;HAUS7;HAUS8;BCCIP;NEK7;HDAC3;ABRAXAS1;HAUS3;KIF11;MZT1;HAUS5;HAUS4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.47701415349475546,-1.4177890303760343,0.0708955223880597,0.34372754171283376,1.0,11/27,19.53%,DICER1;PCF11;ZC3H12C;NYNRIN;CPSF3;XRN1;KHNYN;ZC3H12B;ERN1;CSTF3;RNASE4
prerank,response to interleukin-4 (GO:0070670),0.6201792713535785,1.417530983339085,0.09777777777777778,0.38814277223256777,1.0,3/10,13.69%,LEF1;TCF7;XBP1
prerank,response to purine-containing compound (GO:0014074),0.5401589515645061,1.4171132943544473,0.07676348547717843,0.38745139799624284,1.0,6/17,13.33%,RYR2;KCNJ11;TRPM2;P2RY1;P2RX7;VGF
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.40018834823069216,-1.416312358496428,0.02676864244741874,0.3460696366647279,1.0,26/66,20.87%,EGFR;APPL2;KANK2;PKD1;INO80;ANKRD17;FHL1;UBE2E2;BRD7;RPTOR;DLG1;ANXA1;DACT1;PRMT2;ID2;PKD2;RB1;APPL1;CCND3;DDX3X;ADAMTS1;FAM107A;DCUN1D3;EIF4G1;CDC73;CDK6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4882079681744381,-1.4160152561395871,0.0625,0.3458983767567644,1.0,6/23,8.29%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K
prerank,histone H3-K36 demethylation (GO:0070544),-0.6232726856668431,-1.4143510981185956,0.08014571948998178,0.34886591296880326,1.0,4/10,15.84%,KDM7A;KDM4B;PHF8;KDM2A
prerank,regulation of water loss via skin (GO:0033561),0.5548868521419679,1.4141192356445018,0.08008213552361396,0.3910537317153305,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,establishment of skin barrier (GO:0061436),0.5548868521419679,1.4141192356445018,0.08008213552361396,0.3910537317153305,1.0,3/15,3.29%,HRNR;FA2H;STMN1
prerank,regulation of cellular localization (GO:0060341),-0.4306875387345045,-1.4131626299873354,0.048638132295719845,0.3507842902970249,1.0,16/46,11.62%,ADCY5;GSN;PARD6G;PRKN;LRRK2;NUMA1;CDK16;STXBP4;LYN;CAMK2D;CSNK1E;BRSK1;FER;GOSR1;WWC1;PARP1
prerank,negative regulation of proteolysis (GO:0045861),-0.45405505916246064,-1.413086312592266,0.07692307692307693,0.35011131215671243,1.0,8/34,8.09%,TIMP3;DNAJC1;ROCK1;LRRK2;PLAT;GAS1;PTPN3;EPHA4
prerank,polarized epithelial cell differentiation (GO:0030859),-0.5826499619438932,-1.412622291064759,0.055970149253731345,0.3503530765495067,1.0,6/13,21.64%,MYO9A;RAB10;CDC42;RHOA;MSN;SCRIB
prerank,phosphorylation (GO:0016310),-0.31124563207664946,-1.4122811872379721,0.0,0.3502886591133139,1.0,130/384,22.26%,PRKAG2;ROCK2;GRK5;TGFBR1;BMPR1A;EPHA7;CDK8;TLK1;PI4KA;PDK1;STK3;FAM20A;ROCK1;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;GK5;TOP1;GSK3B;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;DGKA;PAK2;STAT3;MAP4K4;NADK;TAOK3;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;PANK2;BRSK1;FER;PRKCD;DMPK;LIMD1;FAM20C;CLK3;CDK11B;MKNK2;TEC;SIK1;COPS2;EIF2AK4;MAML1;GMFB;PGK1;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;PRKACA;PXK;PRKD1;MORC3;PRKAA1;NEK4;CSNK1D;MAP3K1;BMP2;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;SHPK;GNPTG;NRBP2;BCKDK;PRKAG3;CDK6;DGKD;MAST2;PPP4R1;PRKAB1;MKNK1;MAP3K12;PRKCA;SIK2;SPHK1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.618314460316282,-1.4110029958566341,0.062146892655367235,0.3523947241644431,1.0,5/10,25.99%,ABCA1;APOE;PRKACA;ABCA7;ZDHHC8
prerank,positive regulation of locomotion (GO:0040017),0.465560037753713,1.4108766159759882,0.07462686567164178,0.3972264929800613,1.0,7/27,10.49%,SPOCK2;CSF1R;PPM1F;STX3;NTN1;PDGFB;AIF1
prerank,aminoglycan metabolic process (GO:0006022),0.6093179949617752,1.4108433903217785,0.1095890410958904,0.3956301479887601,1.0,3/10,5.44%,B3GAT1;CHST9;B3GAT2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5689361559663577,-1.409887824139497,0.08178438661710037,0.35408117693975366,1.0,4/14,16.18%,IRAK3;PIBF1;THBS1;CMKLR1
prerank,regulation of histone modification (GO:0031056),-0.5761255564246339,-1.4095623732897884,0.08941605839416059,0.35400544606519996,1.0,5/13,8.57%,UBE2N;SETD5;MTHFR;AKAP8L;IGF2
prerank,regulation of gastrulation (GO:0010470),-0.5576725698745126,-1.4088314927819112,0.0856610800744879,0.3549931437250367,1.0,3/14,3.11%,PHLDB2;DAG1;OSR1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4395082957171562,-1.4084737246853603,0.05380333951762523,0.3550350190395308,1.0,10/40,10.56%,EGFR;LPAR1;ARHGAP6;PDGFRA;NTRK3;PDGFRB;KIT;EDNRA;PLCG1;ABL2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.600480377868486,-1.4081323918937265,0.08411214953271028,0.35496323516932465,1.0,5/11,10.17%,VCL;KIT;ITGB5;JUP;CCN3
prerank,sensory perception of taste (GO:0050909),0.6183536439051285,1.4075825714884778,0.09761388286334056,0.4017913599094012,1.0,3/10,13.89%,ASIC2;ASIC1;CD36
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.38555915167488986,-1.4075154980568927,0.0260707635009311,0.35574638649347995,1.0,36/76,31.10%,ANGPT1;PIAS1;HDAC4;LRRK2;SAE1;HUWE1;AXIN1;UBQLN1;WDR48;XIAP;PIAS3;CUL3;PIAS4;FBXW7;FANCI;SPRTN;DERL1;FAM107A;TRAF6;TANK;DCUN1D3;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;PAXIP1;FBXO4;HDAC3;GNL3;MUL1;DCUN1D5;BIRC3;UBA2;UBE2L3;CAV1
prerank,regulation of vasculogenesis (GO:2001212),0.5488362910208806,1.4069381626594308,0.08817635270541083,0.4017752654578848,1.0,4/14,9.06%,HEY1;KDR;CD34;RIN2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.36692700472298123,-1.4064366470371998,0.025793650793650792,0.35733324012302514,1.0,43/100,24.46%,FHIT;ARAF;PIAS1;DAB2;PRKN;LRRK2;ARIH1;RAD23B;CSNK1A1;GSK3B;RNF217;USP7;UFL1;RNF19A;NUB1;CSNK1E;RPL11;GIPC1;OGT;TRIB2;SH3RF2;CBFA2T3;TRIM39;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;PARK7;COP1;ZYG11B;DESI1;ARIH2;DET1;WAC;RNF144A;CCAR2;XPO1;EIF3H;BAG5;BAG6;NKD2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4568756933318736,1.4063523294215527,0.079002079002079,0.401495526157453,1.0,10/30,21.02%,MIF;CXCL12;SIRT1;CLU;TPT1;RPS3;THOC1;MDM2;THOC5;RTEL1
prerank,postsynaptic membrane organization (GO:0001941),0.5313039187754484,1.4063458260999777,0.09554140127388536,0.39983904565986833,1.0,6/17,9.22%,NRXN1;NLGN1;SHANK3;NRXN2;SHISA7;LHFPL4
prerank,regulation of RNA metabolic process (GO:0051252),-0.4055930521340063,-1.4053641830272336,0.030245746691871456,0.358906975720576,1.0,14/59,12.68%,AHNAK;SON;CLK1;CELF1;HNRNPH1;MBNL2;FUS;RC3H1;PTBP3;PCBP2;MED1;CLK2;CLK3;SNRNP70
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4791053987674931,-1.405145749483011,0.0779896013864818,0.35858792314630844,1.0,13/26,31.73%,IRAK3;TRAFD1;MAPKBP1;PCBP2;ILRUN;CARD16;NLRC3;DHX58;CACTIN;MUL1;TNFAIP3;C1QBP;TYRO3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.41761977051558524,-1.404508334291929,0.04770992366412214,0.35927391907441275,1.0,16/50,20.09%,EGFR;SASH1;NFAT5;LIMS1;TRIM44;EP300;NR3C2;RHOA;EIF2AK2;DDX3X;PDCD4;TLR4;TRAF6;IFI35;IRAK1;TRIP6
prerank,monocyte chemotaxis (GO:0002548),0.4510187453080544,1.4041496453800424,0.05307855626326964,0.40353602774044367,1.0,8/32,20.52%,FLT1;RPS19;CCL2;PDGFB;CCL25;PTPRO;CCL13;CCL19
prerank,regulation of cation transmembrane transport (GO:1904062),0.4679497683719555,1.4035128833790642,0.0649895178197065,0.40333388963548417,1.0,8/29,7.97%,DPP10;KCNIP4;FGF12;KCNN2;KCNIP1;DPP6;HOMER1;KCNAB1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.4520430340075482,-1.4025603817809564,0.0694980694980695,0.36292394657098836,1.0,15/34,26.26%,AUTS2;PLCE1;WASF2;CDC42;BRK1;FER;NCKAP1;ARPC2;CAPZB;AVIL;PIK3R1;SLIT2;ACTR2;TWF1;TWF2
prerank,DNA methylation (GO:0006306),-0.4830089114751942,-1.4023604811143762,0.06883365200764818,0.3625279920295275,1.0,6/23,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;N6AMT1;EHMT1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47446132216453024,-1.4018364488461499,0.06666666666666667,0.3629828848093319,1.0,4/26,6.72%,EYA2;EYA1;EYA4;BCL2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5994931087334141,-1.4014516184813448,0.08442776735459662,0.363063525374963,1.0,4/11,10.05%,LRRK2;USP7;MAP2K1;CHMP3
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.47407953774038647,-1.4011360254491587,0.07393715341959335,0.3629858621752433,1.0,14/26,29.50%,KMT5B;SETD5;KMT2D;CTR9;SETD3;SETD2;OGT;KMT5C;EEF2KMT;KMT2A;PRDM9;TET2;ANTKMT;TET3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.594170806078545,-1.4009046624080144,0.07692307692307693,0.3627178231765084,1.0,4/11,17.55%,TGFBR2;FGFR2;STAT1;WNT5A
prerank,aorta development (GO:0035904),-0.554297112569437,-1.399755467178288,0.08092485549132948,0.3644753182112139,1.0,9/14,17.05%,LRP1;PDGFRB;ROBO1;JAG1;ADAMTS9;PKD2;EFEMP2;HECTD1;TBX2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.45794770585946043,-1.3992592902072187,0.06986027944111776,0.36482142785830496,1.0,5/30,8.57%,IGF1;IGFBP2;HMGB1;RC3H1;IGF2
prerank,defense response to fungus (GO:0050832),0.5152388692774685,1.3980592150406757,0.09267241379310345,0.41511942682387687,1.0,3/17,11.60%,S100A9;S100A8;BCL10
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.46132839142726634,-1.3978762640428664,0.06641366223908918,0.3671919159325247,1.0,12/27,18.70%,PID1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;PTPN2;PRKCD;NCK1;PRKCZ;PTPN1;INPP5K
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4338467790074933,-1.397864216128679,0.04914933837429111,0.366366166159559,1.0,9/40,7.19%,ZBTB20;SORBS1;WNT4;VIM;SLC5A3;BMP4;CREBL2;RUNX1;MTOR
prerank,anterior/posterior axis specification (GO:0009948),-0.551522018971812,-1.3978395839708362,0.07195571955719557,0.3655797200445753,1.0,2/15,5.85%,WLS;SKI
prerank,regulation of response to stress (GO:0080134),0.6074425187686348,1.3977110893102653,0.08686440677966102,0.4142190777555858,1.0,5/10,19.33%,ADCY8;MLC1;OPRM1;STOX1;SLC38A2
prerank,aorta morphogenesis (GO:0035909),-0.527758340792356,-1.3966073540384345,0.09607843137254903,0.36757780687146435,1.0,6/17,3.07%,LRP1;BMPR1A;RBPJ;MYLK;PDGFRB;JAG1
prerank,neuron migration (GO:0001764),0.4156405248429417,1.39624579639835,0.05040322580645161,0.4161887592886942,1.0,13/48,9.85%,ADGRL3;SPOCK1;GPM6A;DNER;MAP1B;FGF13;NTRK2;ASTN1;NRCAM;NDNF;CDKL5;RELN;ASTN2
prerank,regulation of interferon-alpha production (GO:0032647),-0.48601385072783315,-1.395947211525565,0.05805243445692884,0.3681849276311497,1.0,9/23,17.43%,TBK1;PTPRS;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,regulation of cellular catabolic process (GO:0031329),-0.3941073925180389,-1.3953564858460399,0.0412573673870334,0.3687567205013843,1.0,20/62,17.69%,ITPR1;EP300;ROCK1;ABL1;PRKN;LRRK2;NUPR1;RPTOR;TPCN2;PIP4K2C;USP33;LONP2;ABL2;WDR91;MTMR3;KAT8;USP13;DAPK1;DAPK2;RMC1
prerank,base conversion or substitution editing (GO:0016553),0.5707000061843033,1.3944013203536842,0.1004566210045662,0.4192283865685916,1.0,1/11,0.14%,ADARB2
prerank,protein polyubiquitination (GO:0000209),-0.31742203738425695,-1.3943808825039716,0.0,0.37021951617168813,1.0,120/297,29.47%,FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;TNKS2;UBE2E2;UBR2;SPSB1;PRKN;FBXW8;ARIH1;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;RBBP6;RNF213;RC3H1;BCL2;RNF19A;UBE4B;WWP1;UBE2H;TRAF3IP2;FBXL4;ANAPC5;RNF8;FBXL12;FBXO10;ANAPC7;UBE2K;DDB2;ANAPC4;RNF216;TRAF2;UBE2R2;TRIM5;PSMF1;FBXL19;FBXL18;NPEPPS;CUL3;FBXW7;FBXO30;DTX3L;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;TRAF3;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;AREL1;TRAF6;RNF14;UBE2D3;TPP2;LRSAM1;IFI27;ANAPC11;CUL1;TTC3;PSMC1;ARIH2;SHARPIN;FBXW4;TRAF5;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;ANKRD39;SIAH2;ANAPC13;RNF6;PSMA4;CDC16;FBXL14;TRIM68;FBXO4;ANAPC1;FBXW9;FBXO11;PSME1;UBE3C;PSMD13;SHPRH;FZR1;CDC34;MUL1;TNFAIP3;PSMB10;PSMA5;FBXL3;PSMB9;KBTBD7;RBX1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5978985316005795,1.3920876074403867,0.10020449897750511,0.4234844868427711,1.0,5/10,17.12%,TSR3;RPUSD1;DKC1;NHP2;NAF1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.44492635531122154,-1.3920544197326123,0.05697445972495088,0.37485023755177194,1.0,12/35,10.56%,NOTCH2;PDGFRA;NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42;RAPGEF3;IQGAP2;SEMA3E;ABL2
prerank,V(D)J recombination (GO:0033151),-0.5997046573844421,-1.3914288130112413,0.09208103130755065,0.37544354701064614,1.0,5/11,14.31%,HMGB1;DCAF1;XRCC4;TCF3;PRKDC
prerank,skeletal muscle organ development (GO:0060538),-0.4658975619642568,-1.3912904928813512,0.09003831417624521,0.37492608099642394,1.0,5/26,6.08%,LARGE1;SVIL;CFLAR;DISP1;IGSF8
prerank,positive regulation of gene expression (GO:0010628),-0.30207658438730745,-1.3910329732901259,0.0,0.3746953944479824,1.0,80/442,11.32%,BMP6;SLC24A3;SAMD4A;ROCK2;PLD1;IGF1;EGFR;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;DDX5;CELF1;FGF1;VIM;KAT2B;BMP7;EP300;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;ZCCHC4;WNT6;GSK3B;PLA2R1;YTHDF3;YAP1;TNRC6A;CTSH;MOV10;UBR5;THBS1;HOXA5;PLSCR1;STAT3;DTNBP1;MED26;U2AF2;EIF2AK3;MTOR;SF3B1;F3;BRAF;HNRNPD;AR;FUBP1;DHX36;PPARGC1A;TAF1D;GJA1;TBP;MAP2K1;MED1;PTPN22;PHF2;ATF2;PLXNB2;ITGB8;NGF;GABPA;TADA3;HIF1A;HCFC1;CALCOCO1;RPL11;ID2;TLE1;ADAM19
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3592051911979679,-1.3908498104512026,0.026859504132231406,0.3742515416233912,1.0,51/107,31.66%,ITPR1;CREB3L2;PRKN;GSK3B;THBS1;UBQLN1;OS9;UFL1;EIF2AK3;BCL2;MAP3K5;UBA5;AIFM1;SELENOS;ERLEC1;TRAF2;JUN;TMEM259;ATP2A2;RCN3;MBTPS2;ERP44;ATF6;ERN1;NCK1;MBTPS1;DERL1;SYVN1;VCP;TMTC3;SEC16A;P4HB;ATP2A3;PIK3R1;CDK5RAP3;WFS1;EIF2B5;BAG6;HYOU1;QRICH1;ATF6B;SEL1L;PPP1R15B;USP19;CCDC47;BAK1;UFM1;ATG10;BCL2L11;HERPUD1;CEBPB
prerank,negative chemotaxis (GO:0050919),0.45797998544281404,1.3907001123951017,0.07547169811320754,0.42546288795635046,1.0,10/33,6.18%,SEMA3C;SEMA6A;UNC5C;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;SLIT3;SLIT1
prerank,sensory perception of pain (GO:0019233),0.49649781997662173,1.390325640735156,0.07692307692307693,0.4246466822214785,1.0,8/21,15.07%,MME;CCL2;OPRM1;RETREG1;P2RX7;KCNA2;OPRK1;OPRL1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5922682320541598,1.38876433793493,0.11086474501108648,0.4269671063644488,1.0,5/10,17.05%,NAB2;CLU;HSP90AB1;SORL1;HSP90AA1
prerank,regulation of membrane depolarization (GO:0003254),-0.5208047978219005,-1.3887433736418977,0.09292929292929293,0.37852223486585623,1.0,4/18,7.01%,FHL1;LRRK2;PTPN3;CAMK2D
prerank,lipid translocation (GO:0034204),0.49059673159117845,1.388735240401453,0.0945054945054945,0.425369649225407,1.0,8/21,11.06%,TMEM30A;ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,sensory perception (GO:0007600),0.41340060174810994,1.3881642059637378,0.05856832971800434,0.42520459560227003,1.0,15/45,19.10%,PCDH15;MME;GNAL;CCL2;OPRM1;RETREG1;TTC8;P2RX7;PNOC;KCNA2;OPRK1;OPRL1;NTSR2;TMEM150C;ADORA2A
prerank,positive regulation of sodium ion transport (GO:0010765),0.5742218565752816,1.3880927092576685,0.12943632567849686,0.42370771751490116,1.0,3/12,5.57%,CNKSR3;ANK3;SCN4B
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4781651571954691,-1.3880651088220488,0.08712121212121213,0.37928998063114105,1.0,13/25,28.85%,RNF8;CDK13;WDR43;NELFB;TCERG1;HNRNPU;CDC73;EAF2;RECQL5;LDB1;NELFA;NELFE;ZMYND11
prerank,cyclooxygenase pathway (GO:0019371),-0.6089878833142458,-1.3878845099796644,0.09774436090225563,0.3788893932546619,1.0,4/10,10.32%,PTGDS;PTGIS;PTGS1;PTGES
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.39432876022852537,-1.3875310313052442,0.04048582995951417,0.3789496779632148,1.0,29/62,28.25%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,response to amino acid (GO:0043200),0.44986566483256807,1.3865904546854286,0.09188034188034189,0.4257905296074967,1.0,6/31,9.43%,GRIN1;IPO5;GLRA1;GLRA3;MEAK7;GLRA2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.31458957453019115,-1.3865716974767404,0.002044989775051125,0.3804607035288882,1.0,76/259,20.60%,PARVA;VCL;GSN;PKD1;MYLK;PCM1;ASAP1;GBF1;BBS9;CDC14A;KIT;WDPCP;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;ITGB1;IFT43;ATP6V0D1;PDE6D;ARL13B;RAP1B;IFT81;CFAP44;MAP4K4;NRP1;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;ACTN2;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;EMP1;ARFIP2;RAB11A;CC2D2A;POC1B;ARMC9;FGD1;SNX10;P2RY12;EMP3;RILPL2;FGD4;CDC14B;DZIP1L;RAPGEF2;EHD3;WHAMM;CARMIL1;CCDC57;ARHGEF6;FXYD5;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;INPP5K;EHD4;RILPL1;AVIL;CEP89;GALNT11;SPEF1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4996831738048236,-1.3853166819320988,0.07985480943738657,0.38261232509326465,1.0,5/21,6.01%,LRP6;CSNK1A1;GSK3B;AXIN1;FZD2
prerank,positive regulation of cell cycle process (GO:0090068),-0.3660416102928675,-1.3851401858246106,0.027944111776447105,0.3822158492234159,1.0,23/91,17.59%,IGF1;INO80;SVIL;PDGFRB;CDC14A;NUMA1;CSPP1;UBXN2B;PLSCR1;CDC42;IGF2;MAP3K20;RHOA;GIPC1;RAD21;DYNC1LI1;TPR;CUL3;CDC14B;CDC25B;DYNC1H1;CEP295;PHIP
prerank,regulation of chromatin organization (GO:1902275),-0.5525541963108636,-1.384224759243738,0.09665427509293681,0.3835255728316347,1.0,4/14,8.57%,MLLT3;TLK1;SETD5;IGF2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.47287583642200315,1.3840560386812604,0.08108108108108109,0.43028911784219626,1.0,5/24,8.10%,MIF;CXCL12;SIRT1;CLU;TPT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5111386090379533,-1.3840054602751994,0.1157684630738523,0.38320231990748294,1.0,6/18,6.50%,ROCK2;ROCK1;RIPOR2;BCAS3;RAP1B;ARFGEF1
prerank,neutrophil chemotaxis (GO:0030593),0.407219342357332,1.3838517280155382,0.04666666666666667,0.4290515742335505,1.0,13/53,20.52%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5537593458369491,-1.3836241836501,0.08348134991119005,0.38323402167968296,1.0,7/15,22.55%,STAT3;IL17RA;HIF1A;APPL1;IL17D;TLR4;TICAM1
prerank,histone deacetylation (GO:0016575),-0.4148667199014759,-1.3835831144030935,0.06432748538011696,0.3824816662319312,1.0,11/43,9.54%,PRDM5;HDAC8;MIDEAS;HDAC4;TBL1X;TBL1XR1;RCOR1;BAZ2A;RCOR3;REST;MIER1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4380199420087782,-1.3834429690914611,0.06641366223908918,0.3820141906519654,1.0,16/35,25.75%,FOXO3;ARNT;HOXA5;STAT3;LYN;MED1;HIF1A;HSPA9;STAT1;PRKDC;STAT5B;INHBA;CDK6;MAFB;LDB1;MAPK14
prerank,lipid droplet formation (GO:0140042),-0.6026514256913114,-1.3831530759762167,0.10076045627376426,0.38187396146702274,1.0,7/10,31.17%,ZFYVE1;AUP1;SQLE;CDS2;BSCL2;PLA2G4C;FITM2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4375444334294435,-1.3830791595435123,0.07894736842105263,0.38125148227309363,1.0,15/36,19.97%,ERRFI1;EPHA7;ENPP1;NBN;IMPACT;PDGFC;PPP2R5E;RASSF2;MOB1B;VEGFA;PPP2R5D;DDX3X;MRE11;PPP2R5C;MVP
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4804254260029763,1.3828853956363494,0.09322033898305085,0.4298750218647613,1.0,9/24,19.31%,STMN1;FGF13;STMN4;STMN2;TPPP;STMN3;TPPP3;KIF18A;TRPV4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5915301336142587,-1.3828657178989234,0.11151736745886655,0.3809529118283842,1.0,7/11,29.15%,PARP10;PARP14;PARP9;PARP4;PARP6;PARP12;PARP3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5334696297626617,1.382556613816017,0.08847736625514403,0.4290671327049204,1.0,2/16,6.05%,CLDN5;CLDN14
prerank,regulation of protein processing (GO:0070613),-0.49172708820534206,-1.3824813029518195,0.09461966604823747,0.38095805335730937,1.0,4/21,6.91%,CCBE1;LRRK2;GAS1;RUNX1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4798457621152324,-1.382305729771671,0.0925553319919517,0.38051955044257124,1.0,16/24,35.68%,SEC24D;SEC23A;SEC31A;MFSD6;TAP2;SAR1B;TAPBPL;TAP1;FCER1G;SEC24A;ERAP1;CALR;SEC24C;IDE;SEC13;TAPBP
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.48818285103840714,-1.3822826291719548,0.08382066276803118,0.37976637985537687,1.0,6/21,5.26%,ROCK2;EPHA3;VCL;ROCK1;SLC9A1;SLK
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.37723665644663973,1.3820490405242793,0.03347280334728033,0.428539318833063,1.0,15/75,8.01%,CAMK2A;MRAP2;RGS12;GIT1;METAP2;GNG4;YWHAB;RGS20;PLCB1;RGS5;KCTD8;RGS11;GUCA1B;ADCYAP1;RNF157
prerank,dicarboxylic acid transport (GO:0006835),-0.4537096272454987,-1.3816665019427266,0.0823293172690763,0.38037240852428567,1.0,7/28,10.69%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6;GIPC1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5709463393802222,-1.381544259459693,0.09941520467836257,0.37985854490102106,1.0,5/12,13.59%,RESF1;MPHOSPH8;ATF7IP;SETDB1;APOBEC1
prerank,response to molecule of bacterial origin (GO:0002237),0.3836406653322043,1.381417635035988,0.0457516339869281,0.42847020430681,1.0,19/69,15.14%,TIRAP;S100A9;S100A8;SNCA;NOS3;IL12A;CD24;HNRNPA0;IFNAR1;TRIM6;CYRIB;SLPI;GGT7;F2R;GGT1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,cellular component maintenance (GO:0043954),0.5546280578746094,1.3814041746359802,0.1160337552742616,0.4268647878005351,1.0,1/12,0.11%,IGF1R
prerank,histone lysine methylation (GO:0034968),-0.43969081770126883,-1.3812867160456752,0.09021113243761997,0.37961282114752953,1.0,17/33,33.03%,PRDM5;KMT2D;SMYD3;SETD3;KDM6A;N6AMT1;SETDB1;KMT2A;EZH2;PRDM9;PAXIP1;CXXC1;SMYD1;WDR5;SETDB2;WDR5B;DPY30
prerank,regulation of RNA splicing (GO:0043484),-0.38792939330047427,-1.3812381216081622,0.049523809523809526,0.37894967796321477,1.0,19/69,14.72%,AHNAK;SON;CLK1;CELF1;HNRNPH1;RBM39;MBNL2;KHDRBS1;SRSF10;FUS;U2AF2;PTBP3;HNRNPK;CLK2;CLK3;YTHDC1;SNRNP70;CWC22;ERN1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5589536283967735,-1.3806984264279734,0.10566037735849057,0.37944788499445503,1.0,4/12,8.57%,IGF1;SORBS1;IRS1;IGF2
prerank,regulation of type I interferon production (GO:0032479),-0.3655173956436304,-1.3806482958055517,0.030852994555353903,0.3787701291259892,1.0,46/84,34.85%,NFKB1;EP300;TAX1BP1;TBK1;DTX4;CREBBP;DHX9;DHX36;PCBP2;PTPN22;RNF216;MAVS;TRIM25;IRF1;ILRUN;PRKDC;NLRP4;MRE11;TRAF3;IKBKE;UBA7;POLR2H;IRAK1;XRCC6;NLRX1;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;GPATCH3;DHX58;TNFAIP3;POLR3E;CGAS;POLR1C;IFIH1;DHX33;UFD1;POLA1;IRF5;OTUD5;MYD88;ZBP1;IRF8
prerank,positive regulation of macroautophagy (GO:0016239),-0.40801316229303564,-1.379975554182607,0.049800796812749,0.3795226763254939,1.0,12/48,11.15%,DCN;PRKAA2;UVRAG;TBK1;VPS13D;RAB3GAP1;LARP1;PIP4K2C;VDAC1;SESN1;BAG3;PAFAH1B2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4877061403140178,-1.3796002614648182,0.07984790874524715,0.37884700802896815,1.0,8/23,10.69%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4877061403140178,-1.3796002614648182,0.07984790874524715,0.37884700802896815,1.0,8/23,10.69%,DAB2;EP300;TGFB1I1;THBS1;CREBBP;ZEB2;SMAD4;GIPC1
prerank,stress granule assembly (GO:0034063),-0.5020163248725008,-1.3794255079709326,0.10654205607476636,0.3784357317453623,1.0,9/20,16.14%,PRRC2C;YTHDF3;DDX6;ATXN2L;UBAP2L;CSDE1;LSM14A;DDX3X;DYNC1H1
prerank,regulation of organelle assembly (GO:1902115),-0.3850195265595922,-1.379365786667292,0.04356435643564356,0.37778483928039996,1.0,36/72,32.00%,GSN;ALMS1;TBC1D16;DCDC2;SPICE1;STX18;TBC1D19;TBC1D24;SENP6;ATXN2L;USP6NL;TBC1D2B;TBC1D20;IFT88;MTMR3;TBC1D22B;DYNC2LI1;CEP295;CEP76;NPRL3;ATG5;TBC1D17;RABGAP1;KIF9;TBC1D10A;MSN;RAB5A;IFT140;TBC1D10B;ATG3;TBC1D9B;RABEP2;STIL;RDX;CEP295NL;NPRL2
prerank,wound healing (GO:0042060),-0.3916520027816469,-1.378988685403795,0.04,0.3778491691357141,1.0,12/62,5.64%,IGF1;COL3A1;SMAD3;TGFBR1;PDGFRA;TPM1;DCBLD2;CFLAR;FGF1;ANXA6;MYOF;FUT10
prerank,regulation of defense response to virus by host (GO:0050691),-0.4560590238382586,-1.378714281598563,0.09251968503937008,0.3776979283266892,1.0,11/30,17.54%,TRIM44;DHX9;TRAF3IP2;PTPN22;RNF216;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5837356431653766,-1.3771128181219365,0.09811320754716982,0.3807176145826987,1.0,5/11,20.38%,PRKN;UBQLN1;REST;PARK7;P4HB
prerank,nuclear export (GO:0051168),-0.3666383221909461,-1.3766416578240501,0.037848605577689244,0.3809673833940289,1.0,27/80,23.70%,RANBP3L;PKD1;ATXN1;XPO4;CASC3;U2AF2;SRSF6;NUP42;PHAX;SLU7;EIF4E;NUP214;TPR;SRSF1;SMURF1;NXF1;RANBP3;SRSF7;SRSF11;SRRM1;UPF3B;DESI1;SRSF2;CHP1;WASHC4;XPO5;XPO1
prerank,cellular protein modification process (GO:0006464),-0.28382766636426027,-1.37601698034473,0.0,0.3816912913108741,1.0,287/982,21.50%,UST;PTPN13;FSTL1;PRKAG2;CP;ROCK2;FBN1;COL3A1;FBXL7;GRK5;TGFBR1;LARGE1;BMPR1A;ST3GAL4;CDK8;NGLY1;TLK1;LTBP1;IGFBP5;PDK1;SDC2;ARAF;B3GALT1;TNKS2;UBE2E2;LOXL1;PPP1R12A;STK3;FAM20A;ROCK1;BMP4;SPSB1;ABL1;PPM1D;BIRC6;LRRK2;JAK1;PTPN14;PRKAA2;PPM1E;TGFBR2;FBXW8;HLCS;CSNK1A1;KLHL13;BTRC;WWP2;FRK;GSK3B;CCNT1;STK17B;RYK;TBK1;PLOD2;IRAK3;NRK;GPC3;ASB3;PLAT;IGFBP3;MARK3;PTPN9;CDK16;BCR;CDK7;PTPRS;PIGK;THBS1;STT3A;FUT10;PAK2;ZBTB16;PTPN21;UFL1;MAP4K4;DUSP16;TAOK3;EIF2AK3;WDTC1;ITIH2;LYN;PTPN3;CAMK2D;ANXA1;MTOR;OBSL1;ASB2;MERTK;ZC3HAV1;BRAF;FBXL4;GRK4;PARP10;OGA;MAP3K5;PDPK1;FBXL12;DCLK1;FBXO10;IGFBP4;ASB13;SETD3;PTPRK;MARK4;MAP2K1;KTN1;DDB2;DAPP1;CDK13;GRK3;WNK4;PTPN22;UBE2I;PPP4R2;PPP2CB;PMM2;CLK2;PPM1H;TNC;MAP3K20;WNK1;NUB1;CSNK1E;HIPK1;PTPN12;BRSK1;FER;EGLN3;MAN2A1;ST3GAL3;DCAF10;PRKCD;PARP14;HIF1A;ABL2;GGCX;WIPI1;DMPK;COG3;FAM20C;PARP9;DNAJC3;COG7;CLK3;CDK11B;YES1;DCAF6;DUSP11;SERPIND1;LGALS1;PARP1;PPP2R5E;UGCG;PSMF1;PPM1M;FBXL19;FBXL18;RAB11A;LRRC41;MKNK2;TEC;SIK1;CUL3;COPS2;FBXW7;FBXO30;EIF2AK4;WSB2;FN1;MTMR3;MAML1;DCAF8;PPM1A;KLHL22;MXRA8;GMFB;SIRT5;TBCK;PARP4;CCN1;TRIB2;COPS8;MAPK6;LOX;TYK2;IGFBP7;EIF2AK2;APOE;PIK3C3;PSMB2;PRKDC;BMP2K;PPP2R5D;DUSP1;ACVR1;CDC14B;ERN1;MSLN;LATS1;CDC25B;PRKCZ;MBTPS1;PPP1CB;CUL2;CSNK2A1;PIK3R4;ERCC8;GRK6;MARK1;KLHL11;DAPK1;UBE2E1;DUSP10;DCAF4;MANBA;SIK3;FEM1A;UBL5;WDR45B;IKBKE;ASB5;DAPK2;PIK3CD;PIGS;FBXO22;UBE2S;PRKACA;MIA3;MAN2A2;PXK;UBA7;PRKD1;MORC3;PRKAA1;RPN1;PPP2R5C;PTPN1;RABGGTB;FBXW11;ATG5;FBXW5;B4GALT5;GCNT2;NEK4;RCN1;CSNK1D;MAP3K1;BMP2;DCUN1D3;PARK7;CHM;SPSB4;CDK10;ABCA7;UBE2D3;TRIOBP;GPAA1;CDK2;NEK6;B4GALT7;FASTK;IRAK1;TAOK1;COP1;NRBP2;SPP1;PPP2R1B;P4HB;PIGH;WIPI2;CUL1;BCKDK;PRKAG3;CDK6;PSMC1;HIF3A;PPP2CA;CHML;MAST2;PPP4R1;PTPRA;PARP6;CUL7;AKT2;NAE1;PRKAB1;MKNK1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5947822982439647,-1.375817665820806,0.11433756805807622,0.3813347060295026,1.0,4/11,19.24%,OPA1;MEF2A;PARP1;MGME1
prerank,response to amino acid starvation (GO:1990928),-0.37539231068837287,-1.3758103285969119,0.044,0.38055594283393557,1.0,21/72,17.78%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;LARP1;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,negative regulation of lipid storage (GO:0010888),-0.49267994604861237,-1.375669390065606,0.10964083175803403,0.3801067611179122,1.0,6/19,10.23%,ABCA1;ITGAV;OSBPL8;ABHD5;PTPN2;NR1H3
prerank,phospholipid homeostasis (GO:0055091),-0.5822021470821879,-1.3753687566059667,0.11317254174397032,0.38004680031199534,1.0,3/11,11.11%,ABCA1;TLCD2;RCN3
prerank,actin crosslink formation (GO:0051764),-0.571066175043267,-1.3749762200280098,0.10810810810810811,0.380186525326748,1.0,7/12,27.00%,DPYSL3;BAIAP2L1;FLNA;GAS2;BAIAP2;GAS2L3;GAS2L1
prerank,regulation of cartilage development (GO:0061035),-0.5140460100301771,-1.3749565532399717,0.0851063829787234,0.379458305565523,1.0,8/18,22.07%,SOX5;BMP4;ZBTB16;SOX6;TRPS1;BMP2;TAPT1;PTHLH
prerank,regulation of neuron migration (GO:2001222),0.4674002636826238,1.374877651164826,0.09330628803245436,0.4417001830218781,1.0,11/26,14.03%,CAMK2A;CTNNA2;SEMA6A;SHTN1;NEXMIF;NTNG1;NTNG2;ARHGEF2;DAB2IP;SRGAP2;ADGRG1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4727013006242919,-1.3740667024235016,0.08858267716535433,0.38060402318304276,1.0,9/24,19.37%,GRB10;ARNT;VTN;NIBAN2;HIF1A;EMILIN1;ITGA5;PTPN1;ITGB3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5177538176285467,1.373650391150728,0.1,0.44302605864333505,1.0,4/16,13.23%,CXCL12;CLU;TPT1;RPS3
prerank,heart trabecula morphogenesis (GO:0061384),-0.5093162864581016,-1.3734857766557294,0.08664259927797834,0.3811895608148623,1.0,7/18,4.49%,TGFBR3;TGFBR1;BMPR1A;RBPJ;BMP5;BMP7;RBP4
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5124165075210761,-1.3732670527217832,0.08450704225352113,0.3809155392482098,1.0,4/18,8.57%,IGF1;IGFBP2;HMGB1;IGF2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4493205839771416,1.3730201298591247,0.08227848101265822,0.44294192235879115,1.0,6/30,4.46%,FLT1;CSF1R;ARMC6;FST;KDR;FLT3
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.389148646237625,-1.3730146040646256,0.05202312138728324,0.38074743057282845,1.0,25/57,31.80%,DCN;MCU;PRKN;GSK3B;DNM1L;DDHD1;FAM162A;PPARGC1A;RALA;PARK7;FIS1;BMF;BNIP3;ZNF205;HIP1R;HTRA2;PDCD5;CHCHD10;MUL1;PLAUR;GPER1;BAK1;PPIF;BCL2L11;HTT
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5036082773195993,-1.3726652180213075,0.08846153846153847,0.3807648475043665,1.0,3/19,6.13%,IGF1;NUPR1;DAGLA
prerank,stem cell differentiation (GO:0048863),-0.43094573501686967,-1.3725760253818589,0.05736137667304015,0.3801754003664443,1.0,12/39,13.09%,MLLT3;LRP6;FBXL17;OSR1;KIT;UFL1;FGFR2;PUM1;HOXB4;SETD2;MEF2C;NELFB
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5927196997563308,-1.3720884231766006,0.0914179104477612,0.38053059966845787,1.0,8/11,32.97%,WIPI1;UGCG;APOE;PIK3C3;WDR45B;WIPI2;ATG10;WDR45
prerank,cellular response to organonitrogen compound (GO:0071417),0.36072783472597536,1.3719602310469021,0.034,0.44380109694104786,1.0,17/99,9.43%,GABRB3;HCN1;GABRB1;ACTB;IPO5;AQP9;GLRA1;AKAP6;PDE2A;RYR3;GABRB2;HCN2;TRPM2;P2RY1;CIB2;GABRG2;GLRA2
prerank,glucan biosynthetic process (GO:0009250),0.5504279855245323,1.3718412257905876,0.12815126050420167,0.4407777936584824,1.0,4/12,16.81%,PGM2L1;GYS1;PER2;GBE1
prerank,glycogen biosynthetic process (GO:0005978),0.5504279855245323,1.3718412257905876,0.12815126050420167,0.4407777936584824,1.0,4/12,16.81%,PGM2L1;GYS1;PER2;GBE1
prerank,central nervous system development (GO:0007417),0.3178255773517233,1.3708264881838568,0.016885553470919325,0.4417559842862535,1.0,58/250,14.97%,PAX8;ADGRL3;CNTNAP2;SPOCK1;GRIN1;SLC6A17;SLC2A1;MAL;MBP;PROX1;ASIC2;SH3GL2;PBX2;GRIN2A;SH3GL3;DNER;AHI1;CDH2;GRIK1;CNTN6;GRIN2B;MFSD2A;ADAM22;ADAM23;GRIN2D;MOG;AATK;PITPNM1;DSCAML1;NPAS2;CYP26C1;NRCAM;MTF1;IL1RAPL2;ROBO2;UBE3A;RELN;TPPP;ADGRL2;PHGDH;FOXJ1;HAP1;CNTN4;NPTX1;ITGAM;SH3GL1;VCAN;HAPLN3;DLL1;PTPRZ1;ADGRG1;NHEJ1;LSR;DCX;PPT1;HPCAL4;HAPLN4;ELP3
prerank,MAPK cascade (GO:0000165),0.3112486099633933,1.3708019313611817,0.005454545454545455,0.4401606410790881,1.0,56/295,11.67%,CAMK2A;DLG2;GRIN1;KITLG;TEK;RIT2;ERBB4;MBP;LRRC7;RASGRP3;SPTBN4;NRG2;NRG1;SPTB;SHANK3;DUSP6;RASAL3;FGF13;YWHAB;IL2RG;GRIN2B;TNIK;KDR;FGF10;PSMA1;FRS3;FLT3;LYPLA1;PEBP1;RASGEF1A;PAK1;NCAM1;PRKG2;PRKCQ;FGF5;IL5;RPS27A;UBC;RASGRF1;UBB;PSMD12;GOLGA7;PSMA6;WDR83;PSMB3;SPTBN5;CCL2;TAOK2;DAB2IP;PDGFB;SHC2;SCG2;MEN1;CALM1;SPTBN1;MAPK8
prerank,response to axon injury (GO:0048678),-0.5115307094766228,-1.3696522329867469,0.09980806142034548,0.3854603977730819,1.0,5/18,15.21%,DPYSL3;NREP;APOD;P2RY12;P2RX4
prerank,regulation of telomerase activity (GO:0051972),0.4099490708667368,1.368713055548209,0.07283464566929133,0.443676034614004,1.0,19/45,18.94%,PRKCQ;KLF4;TERF1;HSP90AB1;PIF1;MEN1;CCT2;DKC1;CCT4;ATM;PARM1;PTGES3;XRCC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;TCP1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5712372601475709,-1.3685371607142847,0.09611829944547134,0.3874825593673139,1.0,6/12,25.95%,IRS1;ABCD2;PPARGC1A;AKT2;TWIST1;PPARA
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.43514535460704495,-1.3682772217988344,0.07869481765834933,0.38732491269659464,1.0,15/34,26.06%,IGF1;PDGFRB;NSMCE2;ANAPC5;ANAPC7;IGF2;ANAPC4;CUL3;RB1;CDC27;PHIP;ANAPC11;CDC16;EDN3;EGF
prerank,peptide catabolic process (GO:0043171),-0.4784042965573804,-1.3679189778820142,0.09652509652509653,0.3873673290702634,1.0,8/23,18.02%,CPQ;XPNPEP1;CTSH;ECE1;ANPEP;NPEPPS;LNPEP;CHAC2
prerank,negative regulation of type I interferon production (GO:0032480),-0.4275256539295569,-1.367911781270094,0.0575139146567718,0.3866134623282195,1.0,24/40,37.83%,TAX1BP1;TBK1;PTPRS;PCBP2;RNF216;MAVS;TRIM25;ILRUN;IKBKE;UBA7;NLRX1;NLRC3;SIRPA;GPATCH3;DHX58;CACTIN;TNFAIP3;IFIH1;UFD1;PYCARD;OTUD5;PIN1;TRAF3IP1;NLRC5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4473788413258028,1.3676504610746711,0.09544468546637744,0.4448071760462272,1.0,8/32,11.90%,GRIN1;AKAP6;SNCA;THY1;APLNR;F2R;P2RX7;TRPC1
prerank,organelle assembly (GO:0070925),-0.3000820453864732,-1.3667771070912778,0.004291845493562232,0.38874872531022,1.0,109/384,20.57%,PARVA;GSN;PKD1;INO80;PCM1;ASAP1;SH3PXD2B;GBF1;NCOR1;BBS9;CDC14A;WDPCP;PRRC2C;YTHDF3;DCDC2;FLNA;NUDCD3;CYS1;ARL3;UBXN2B;DDX6;PIBF1;IFT43;CEP63;ATP6V0D1;EIF4ENIF1;PDE6D;ARL13B;IFT81;CFAP44;VPS4B;RC3H1;UBQLN1;TMOD3;CEP162;DYNC2I1;ABLIM3;ZFYVE1;PCNT;TUBGCP6;CHMP4B;CHMP4A;EHD2;ATXN2L;TUBGCP2;UBAP2L;CHMP5;RB1CC1;CHMP3;CSDE1;RFX2;RAB3IP;IFT88;VPS37C;LSM14A;FAM161A;RPGR;WIPI1;RP2;LIMD1;EXOC2;ATP2A2;IFT80;ULK2;RAB11A;CC2D2A;POC1B;ARMC9;BECN1;SNX10;MAPRE1;SYNPO;ATG2A;RILPL2;PIK3C3;CDC14B;EDC3;RCC1;DDX3X;DZIP1L;EHD3;FARP2;ATG9A;CCDC57;DYNC1H1;WDR45B;AUP1;ATG2B;CCDC66;TCTN1;WDR11;AMBRA1;PTPDC1;CPLANE1;ATG5;SQLE;DYNC2I2;CSNK1D;EHD4;HPS1;NEK6;TUBGCP4;RILPL1;AVIL;LMOD1;CEP89;SNF8;GALNT11;WIPI2
prerank,negative regulation of chemotaxis (GO:0050922),0.45039555091757716,1.3665694582717351,0.08130081300813008,0.44595607515956204,1.0,10/31,10.49%,SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;NOTCH1;ROBO2;AIF1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5666253402540508,-1.3664753178179045,0.11654135338345864,0.3886877293515468,1.0,6/13,21.57%,HMGB1;PDPK1;IGF2;PLCG1;ITGA4;FGF2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3440346025226205,-1.3663712884442292,0.03468208092485549,0.38811689266058386,1.0,21/122,9.33%,SAMD4A;PLD1;IGF1;EGFR;SORBS1;NFKB1;GLI2;PDGFRB;VIM;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;SLC6A9;BRPF3;HNRNPD;AR;IGF2;PLXNB2
prerank,renal system development (GO:0072001),-0.3923699869672158,-1.3663009896872087,0.046875,0.3875055114051259,1.0,20/52,17.02%,SULF1;TGFBR1;PKD1;WNT4;GLI2;FOXC1;BMP4;PCSK5;RBP4;ARL3;SULF2;PYGO1;IFT88;TBX18;AGTR1;STAT1;VEGFA;GREB1L;SALL1;SIX1
prerank,negative regulation of neuron projection development (GO:0010977),0.39206997393992343,1.3658783777070584,0.05858585858585859,0.44612088718990944,1.0,22/56,16.55%,SPOCK1;DCC;MINAR1;MAG;NLGN1;MCF2;THY1;EFNB3;OMG;LINGO1;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4;GDI1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.4074595592181546,-1.3657820714152276,0.06153846153846154,0.38790317683652076,1.0,19/47,21.76%,MEDAG;BMP7;TMEM64;RREB1;CREBL2;ZBTB16;ID2;NAPEPLD;TRPM4;SOX13;WDFY2;CMKLR1;SIX1;HNRNPU;SYAP1;BMP2;METRNL;FRZB;CCDC71L
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5669931616166612,-1.3657650032713597,0.12454873646209386,0.387176176574461,1.0,8/12,35.41%,TNKS2;PARP10;PARP1;PARP6;PARP12;PARP3;PARP2;TIPARP
prerank,activation of protein kinase activity (GO:0032147),-0.3511662058645886,-1.3654788274744143,0.02594810379241517,0.3871070750371005,1.0,40/106,19.83%,IGF1;ADCY9;ADCY5;ANGPT1;NTRK3;FGF1;STK3;GHR;ABL1;TGFBR2;OSBPL8;NRK;MAPKAP1;PIBF1;AXIN1;PAK2;MAP4K4;TAOK3;ADCY1;MTOR;ADCY6;PDPK1;PRRC1;TRAF2;PRKCD;RICTOR;CARD14;COPS8;TXN;VEGFA;ADRA2A;IL18;PRKACA;WNT5A;TRAF6;PARK7;ITGB3;IRAK1;TAOK1;ADCY7
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5542491860132488,-1.3654007979262817,0.11776447105788423,0.38653320275721076,1.0,7/13,10.58%,BMP7;BMP4;NR3C2;NR3C1;AR;MED1;CALCOCO1
prerank,regulation of autophagosome assembly (GO:2000785),-0.4371199425086584,-1.365394926209796,0.07858546168958742,0.3857920081213567,1.0,12/33,19.39%,LRRK2;NUPR1;RAB3GAP1;SEC22B;CHMP4B;CHMP4A;PIP4K2C;IFT88;MTMR3;NPRL3;FEZ2;LRSAM1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3696805756970699,-1.3648459126330639,0.0499001996007984,0.3863748399685649,1.0,29/76,22.83%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;AXIN1;RNF19A;NUB1;CSNK1E;FBXW7;TRIB2;SH3RF2;SMURF1;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;CDK5RAP3;DET1;RNF144A
prerank,cilium organization (GO:0044782),-0.32073391617026253,-1.3643953027852447,0.008658008658008658,0.38662692654043174,1.0,61/209,21.17%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;ARL3;PIBF1;IFT43;ATP6V0D1;PDE6D;ARL13B;IFT81;CFAP44;CEP162;DYNC2I1;ABLIM3;PCNT;EHD2;MARK4;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;PKD2;CC2D2A;POC1B;ARMC9;SNX10;RILPL2;TTC17;CDC14B;DZIP1L;EHD3;CCDC57;CCDC66;TCTN1;WDR11;PTPDC1;CPLANE1;DYNC2I2;EHD4;RILPL1;AVIL;CEP89;GALNT11;KIFAP3;TRAPPC14
prerank,regulation of transferase activity (GO:0051338),-0.5205445068440421,-1.3643168438993583,0.10654205607476636,0.38605615517909686,1.0,11/17,30.55%,SMG6;NABP2;PARP4;FEM1A;PPP1R3F;SPTSSB;BAG5;LDB1;LDB2;JMJD8;PINX1
prerank,gene expression (GO:0010467),0.30864406683694157,1.3641217370487915,0.003875968992248062,0.44902826061215706,1.0,90/348,14.48%,PAX8;ADARB2;BICD1;RPS6;LMF2;RPS19;RPS20;RPL38;RPL29;PTMA;RPL23;RPL17;RPL35A;RPL37;RPS27;RPL7;MRPS12;RPS12;RPS21;RPL15;RPL10;NUP210;HOXD3;RPL10A;NXT1;RPS24;RPL27A;RPS17;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;XAB2;DHX38;RPL41;RPLP0;RPL30;RPL7A;RBM15B;GLE1;MRPL13;RPL13;MRPS18A;TSPAN17;RPL12;MRPS7;RPS15;ALYREF;NUP62;POLR2J;EIF4EBP2;POLR2B;RPL14;MRPS14;RPL5;FARSB;RPS4X;RPL21;THAP1;DKC1;RPS7;POLR2I;TSPAN14;RPL23A;EEF1A2;RPL8;BCL3;MAGOHB;MAGOH;MED20;HSPD1;DROSHA;MRPL36;NUP205;MRPL23;SORL1;TASP1;RPS14;GALNT2;RPS3;CPSF2;RPS2;DDX20;RPS5;EEF1A1;RPL18A;RPS28;POLR3A;THOC1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5547308580375838,-1.3640671229146444,0.10150375939849623,0.38581712431351595,1.0,7/12,21.69%,INSIG2;OS9;KDELR1;KDELR3;GPAA1;RER1;TAPT1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5493356003259304,-1.3639088791148133,0.12109375,0.3854390854646077,1.0,10/14,33.67%,OPA1;PRKN;LRRK2;SELENOS;SYVN1;PARK7;TMBIM6;HERPUD1;HSPA1A;CREB3L1
prerank,regulation of coagulation (GO:0050818),0.5726482580664131,1.3637705058739353,0.12747252747252746,0.4483410801904747,1.0,3/11,11.25%,HS3ST5;F2R;PROC
prerank,protein ubiquitination (GO:0016567),-0.29627663442977026,-1.3632313838941423,0.0,0.38628229557086213,1.0,148/471,24.04%,RNF220;PDZRN3;FBXL7;SASH1;RNF152;FBXL17;PELI2;SMURF2;UBE2N;RNF43;TNKS2;UBE2E2;UBR2;TRIM44;SPSB1;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;USP7;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;SH3RF1;OS9;BCL2;RNF19A;UBE4B;WWP1;UBE2H;ASB2;ZSWIM8;FBXL4;RNF8;FBXL12;FBXO10;ANAPC7;CTR9;UBE2K;HLTF;RNFT1;DDB2;VCPIP1;ANAPC16;NUB1;TNFAIP1;LZTR1;SELENOS;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;HIF1A;RFWD3;RTF1;TRIM5;PSMF1;FBXL19;UBR3;FBXL18;TRIM11;NPEPPS;CUL3;FBXW7;FBXO30;TRIM25;KLHL22;DTX3L;NHLRC3;TRPC4AP;SH3RF2;PSMB2;PRKDC;UBE2B;SMURF1;TRIM39;FBXO45;SH3RF3;CUL2;TOPORS;ERCC8;LNPEP;CDC27;UBE2E1;MSL2;ARRB1;RNF181;RNF20;BFAR;DERL1;ASB5;KLHL18;FBXO22;UBE2S;MYLIP;SYVN1;FBXW11;FBXW5;HERC6;EIPR1;AREL1;SDE2;TRAF6;VCP;RNF14;SPSB4;UBE2D3;TPP2;LRSAM1;CDC73;DTX2;RNF11;NFX1;PCNA;ANAPC11;CUL1;TRIM63;PSMC1;HIF3A;ARIH2;CUL7;FBXW4;DET1;ARRDC4;WAC;CAND2;PSMB6;UBE2V2;RNF144A;RMND5A;PSMA3;SIAH2;USP9X;RNF6;PSMA4;CNOT4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.372619824740542,-1.3629876868192066,0.040697674418604654,0.38609300887731063,1.0,24/77,18.94%,IGF1;TCF7L2;TGFBR1;OPA1;ITGAV;CFLAR;BMP4;PRKN;BIRC6;THBS1;SH3RF1;ASAH2;BCL2;AR;ACAA2;RB1;ACVR1;DDX3X;CSNK2A1;PHIP;NR4A2;CX3CR1;TMEM14A;PARK7
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.5051350217700625,-1.362382400023904,0.09923664122137404,0.38678327302350113,1.0,11/19,39.28%,PRKN;DNM1L;VDAC1;FBXW7;PARK7;HTRA2;USP36;HTT;SREBF1;FZD5;HAX1
prerank,maintenance of blood-brain barrier (GO:0035633),0.4559172077134478,1.362381869982518,0.09375,0.4504113136084987,1.0,9/30,7.13%,CLDN5;ACTB;MBP;MFSD2A;JAM2;SLC1A1;OCLN;ESAM;PECAM1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.517793411424487,-1.3617450448140889,0.11380597014925373,0.38750326166553084,1.0,10/16,30.13%,AUTS2;BCOR;CTR9;SMAD4;PIH1D1;KMT2A;PAXIP1;KDM1A;WDR5;SNW1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.46417798579275715,-1.3614856089610574,0.08067542213883677,0.3873334999552776,1.0,7/25,10.05%,VPS4B;CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT;CHMP3
prerank,female gonad development (GO:0008585),-0.5039097804670463,-1.3614570539489326,0.0918918918918919,0.38664799622396934,1.0,12/19,38.28%,NR2F2;KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;COL9A3;LHCGR
prerank,intestinal lipid absorption (GO:0098856),-0.5803427228613414,-1.3606250620170042,0.11338289962825279,0.3879163006803582,1.0,3/11,11.74%,LIMA1;LDLR;UGCG
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5624999678764535,-1.3603049414352189,0.10163339382940109,0.38785006562012797,1.0,3/12,2.75%,ANK2;DIAPH1;ANXA6
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5829177966507856,-1.360156361344927,0.09883720930232558,0.3874379820531423,1.0,3/10,14.18%,TGFBR2;FGFR2;STAT1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.30248292932969717,-1.3599884083228655,0.0019880715705765406,0.38705492951484033,1.0,68/348,11.68%,BMP6;SLC24A3;ROCK2;IGF1;PID1;AFDN;SMAD3;TGFBR1;ANK2;RBMS3;FOXD1;ANGPT1;GSN;RBPJ;NTRK3;LIMS1;CELF1;FGF1;BMP7;ROCK1;BMP4;ROBO1;SMO;PRKN;TNRC6B;OSR1;WNT6;GSK3B;YAP1;TNRC6A;RESF1;CTSH;MOV10;UBR5;HOXA5;PLSCR1;ANXA2;STAT3;DTNBP1;MED26;EIF2AK3;MTOR;F3;BRAF;ECE1;AR;FUBP1;DHX36;PPARGC1A;GJA1;MAP2K1;MED1;PTPN22;ATF2;ITGB8;NGF;GABPA;TADA3;HIF1A;MPHOSPH8;HCFC1;CALCOCO1;RPL11;ATF7IP;ID2;TLE1;ADAM19;MEF2C
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3539953638792838,-1.3598540539907573,0.022587268993839837,0.3866071259242104,1.0,37/102,21.34%,RHOQ;SORBS1;NFKB1;ADCY9;ADCY5;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;SLC30A10;RAB10;ADCY1;RAB12;ADCY6;PDPK1;VAMP2;SELENOS;FER;PRKCD;DENND4C;PARP1;PCK2;PRKDC;CPEB1;NR4A1;PRKACA;NR4A2;LPIN2;SYAP1;LPIN3;INPP5K;ADCY7;PKM;PIK3R1;USF1;AKT2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5048165736781693,-1.3592695720790726,0.09496124031007752,0.38727543745403525,1.0,9/18,14.18%,IL6ST;JAK1;YAP1;STAT3;CTR9;FER;SMAD4;IL6R;STAT1
prerank,ceramide metabolic process (GO:0006672),0.40515880108654617,1.3591821489517535,0.05473684210526316,0.4568164739340079,1.0,8/49,5.78%,ST6GALNAC3;SGMS1;ACER2;FA2H;DEGS2;ORMDL1;ORMDL2;PPP2R1A
prerank,hippo signaling (GO:0035329),-0.47165731718054704,-1.3586023079183058,0.10240963855421686,0.38804583499907846,1.0,10/26,14.89%,TEAD1;STK3;YAP1;AMOTL2;TEAD3;WWC1;TEAD2;MOB1B;YWHAE;LATS1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.4484172447519381,-1.3585040216150903,0.10396975425330812,0.3875169713623855,1.0,4/30,2.75%,AKAP13;COL3A1;LPAR1;ROBO1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.48966281333448836,-1.357829709600853,0.09090909090909091,0.3883202424889344,1.0,8/19,17.43%,TBK1;DHX9;DHX36;SETD2;MAVS;STAT1;DDX3X;TLR4
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5747680620309629,1.3578203210507007,0.11231101511879049,0.45860604802679567,1.0,3/10,14.32%,GPR35;CALM1;CALM3
prerank,melanosome organization (GO:0032438),-0.46354561899143404,-1.3576570673925934,0.07692307692307693,0.3880031990246569,1.0,6/26,19.02%,KIF13A;SHROOM2;DTNBP1;AP3B1;BLOC1S5;HPS1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4978828775880548,-1.3568704505404947,0.09193245778611632,0.38920207538789586,1.0,9/18,20.74%,HDAC4;FRS2;CCN3;BHLHE41;FZD7;SOX6;HDAC1;BMP2;TMEM119
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5964697485943371,-1.3566837419110587,0.10392156862745099,0.3889138554198858,1.0,3/10,8.85%,LYN;NBR1;MAP2K1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.538026161561438,-1.356569481775418,0.11516314779270634,0.3884782932217851,1.0,4/13,8.57%,IGF1;SORBS1;IRS1;IGF2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.37992594477660463,1.3564243538606053,0.03792415169660679,0.46034607485900253,1.0,31/69,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;COA6;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,response to reactive oxygen species (GO:0000302),-0.3914585316142333,-1.356140367187281,0.05956678700361011,0.3886975700236668,1.0,17/54,18.24%,EGFR;PDGFRA;TPM1;COA8;PTPRK;FER;JUN;HIF1A;ADAM9;PKD2;APOD;APTX;ERCC6L2;APOE;TXNRD2;GLRX2;SOD2
prerank,endomembrane system organization (GO:0010256),-0.32005858018355887,-1.3552116579153186,0.01383399209486166,0.3900788266321724,1.0,60/178,24.59%,GBF1;LRRK2;FBXW8;CSNK1A1;RAB30;A4GALT;ATL3;UBXN2B;HUWE1;DNM1L;ATP8B1;BCAS3;MYOF;GOLGB1;SEC23IP;ARFGEF1;RAB22A;EIF2AK3;ARHGAP21;OBSL1;CDC42;TLCD2;USP6NL;SEC31A;ATP8B2;ATL2;TBC1D20;DMPK;COG3;COG7;SNX10;SURF4;USP50;DOP1B;TJAP1;TMED3;MIA3;PRKD1;SEC16B;CSNK1D;SMPD4;TMED5;TMED4;TMCC1;PLEKHF1;TRIP11;SEC16A;STX17;CUL7;COG4;PLEKHM2;ALS2;TOR1A;PI4K2B;VAPA;WASHC4;LMAN1;SPTSSB;BAG5;ARFGEF2
prerank,negative regulation of transposition (GO:0010529),-0.5166896064499342,-1.355195896733896,0.11720226843100189,0.3893751771999754,1.0,4/16,16.94%,UBR2;MOV10;TUT4;MYBL1
prerank,cellular response to lipid (GO:0071396),-0.32653776796068384,-1.3551172318211255,0.01050420168067227,0.3888348688479616,1.0,38/191,13.00%,ATP1A2;ROCK2;EGFR;PID1;NFKB1;EPHA3;ADCY5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;IRS1;LBP;HMGB1;NR3C1;LCOR;SBNO2;TFPI;ADCY1;LYN;WNT9A;ADCY6;AR;CTR9;MED1;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;ABL2;RORA;MEF2C;FZD7;ADNP2
prerank,histone H3-K9 demethylation (GO:0033169),-0.5782209779518933,-1.3549688911949227,0.12098298676748583,0.38846589906376633,1.0,7/11,27.07%,KDM7A;KDM4B;PHF8;KDM3B;KDM3A;KDM1A;JMJD1C
prerank,histone H2B ubiquitination (GO:0033523),-0.5869994752547749,-1.354242802015814,0.11259541984732824,0.38945036090851254,1.0,7/10,22.39%,RNF8;CTR9;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3973732069500998,1.3537562583933844,0.07760532150776053,0.4654144053545181,1.0,7/48,12.68%,SLC7A5;PDE4B;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5272023788987035,-1.3533951268264837,0.11787072243346007,0.3907774277053346,1.0,5/15,10.96%,TGFBR1;PDGFRA;TGFBR2;FGFR2;NIPBL
prerank,positive regulation of response to wounding (GO:1903036),-0.47051417438990106,-1.3530753297704348,0.09441233140655106,0.39078354717261776,1.0,6/24,7.02%,PTN;MYLK;VTN;ITGB1;ARFGEF1;ANXA1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5302710873030871,-1.3527606310990639,0.125,0.39082502676493314,1.0,4/15,12.21%,LARGE1;OGA;RENBP;MGAT3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4188199512786293,1.3524021060687754,0.07851239669421488,0.46732814994496186,1.0,8/41,10.22%,GRM5;LRP8;CSF1R;DOCK3;GAS6;NTRK2;RELN;PDGFB
prerank,regulation of secretion (GO:0051046),0.5441322371583786,1.3521851031261647,0.13097713097713098,0.46624941380656315,1.0,6/13,16.58%,NRG1;FGF10;MYO6;OPRK1;ACSL3;GPLD1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.38050519296797897,-1.3517379919851273,0.055776892430278883,0.39250419684250454,1.0,15/64,10.27%,ROCK2;PLEKHA2;EPHA3;VCL;ROCK1;JAG1;GSK3B;SLC9A1;SLK;THBS1;HOXA7;MAP4K4;JUP;SEMA3E;RHOA
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3265481605225596,-1.3515386484732546,0.017241379310344827,0.392220672181631,1.0,50/166,23.06%,SAMD4A;PLD1;IGF1;EGFR;SMAD3;SORBS1;GLI2;PDGFRB;VIM;ARNT;ZCCHC4;YTHDF3;IRS1;THBS1;DHX9;MTOR;ZEB2;SLC6A9;BRPF3;HNRNPD;PPARGC1A;IGF2;LDLR;PLXNB2;PTPN2;NR1H3;HIF1A;GIPC1;PKD2;APPL1;GLI1;SLC27A1;PRKDC;CTC1;DDX3X;P2RX4;UPF3A;TLR4;PARK7;PCNA;UPF3B;FGFR4;ASS1;STN1;AKT2;FGF2;ZNF205;PYM1;CHP1;PTH1R
prerank,bone morphogenesis (GO:0060349),-0.5349653243426268,-1.3513607525292337,0.11049723756906077,0.39196238308246556,1.0,4/14,6.61%,LRP6;CYP26B1;SKI;FGFR2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6063495433787419,-1.3513115709778116,0.13099630996309963,0.3913318657151872,1.0,4/10,18.53%,LRP6;RYK;WNT5A;FZD1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.43976925713461307,-1.3512486407519526,0.096045197740113,0.390771587391001,1.0,11/32,20.79%,AUTS2;PLCE1;RREB1;WASF2;CDC42;BRK1;NCKAP1;ARPC2;CARMIL1;AVIL;PIK3R1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.6019318478755156,-1.3512117673698216,0.11940298507462686,0.3901302506946994,1.0,5/10,16.75%,IMPACT;BAG3;JUN;NCK1;CITED2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4093967939289556,-1.3509233570137558,0.09375,0.3900435894447666,1.0,16/43,19.26%,PID1;SORBS1;GRB10;ENPP1;TNS2;IRS1;PIP4K2C;IGF2;PTPN2;PRKCD;OGT;NCK1;PRKCZ;PTPN1;INPP5K;PTPN11
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5603139425624228,-1.3506509256990746,0.10820895522388059,0.38999646901099844,1.0,4/13,15.90%,ENPP1;TPST1;SULT1A1;ABHD14B
prerank,negative regulation of macroautophagy (GO:0016242),-0.4661899764112919,-1.350476117635314,0.08627450980392157,0.38969284999942455,1.0,7/26,7.80%,SMG1;LRRK2;NUPR1;MTOR;SEC22B;CHMP4B;CHMP4A
prerank,positive regulation of chemokine production (GO:0032722),0.41189749671758313,1.3504676209952489,0.06762295081967214,0.4690628160142124,1.0,8/44,10.49%,TIRAP;MBP;IL17F;CSF1R;IL7;TLR2;ADCYAP1;AIF1
prerank,DNA geometric change (GO:0032392),-0.46857020714742353,-1.3504406194072607,0.09923664122137404,0.3890581389107171,1.0,10/24,16.79%,HMGB1;NBN;ANXA1;DHX9;DHX36;WRN;MCM9;ASCC3;MRE11;ZRANB3
prerank,granulocyte chemotaxis (GO:0071621),0.3945537606175081,1.3503623392500823,0.05908096280087528,0.46768866572804363,1.0,14/55,20.52%,BSG;PDE4B;S100A9;S100A8;TGFB2;CCL2;SCG2;EDN1;CCL25;PPIA;NCKAP1L;CKLF;CCL13;CCL19
prerank,calcium ion homeostasis (GO:0055074),0.35450250469948774,1.349091202899507,0.049800796812749,0.4693878421559689,1.0,14/95,8.10%,TMTC2;SLC24A4;SLC24A2;GRIN1;CXCL12;RYR2;HTR2C;SNCA;SLC8A1;ATP2B3;SLC30A1;NPTN;CIB2;TPT1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3564410759613995,-1.3487122066109798,0.04061895551257253,0.3922878177553323,1.0,29/92,17.71%,ROCK2;FOXP1;DOCK5;SASH1;ANGPT1;FGF1;BMP4;ABL1;SPARC;RREB1;CTSH;THBS1;BCAS3;MAP4K4;NRP1;FOXC2;MTOR;PLCG1;HIF1A;ADAM9;RAB11A;ANXA3;VEGFA;GLIPR2;ATOH8;DOCK1;PIK3CD;WNT5A;PRKD1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3854894017952568,-1.3483728171316005,0.06844106463878327,0.39244249138493886,1.0,26/56,25.25%,EGFR;ANKRD17;UBE2E2;RPTOR;VPS4B;RAD51B;NSMCE2;ANXA1;ANAPC5;ANAPC7;ANAPC4;RAB11A;CUL3;RB1;CCND3;DDX3X;CDC25B;CDC27;ADAMTS1;KLHL18;EIF4G1;ANAPC11;RAD51C;CDC16;KMT2E;PHB2
prerank,angiogenesis involved in wound healing (GO:0060055),0.5829308395052739,1.3479405572413967,0.12658227848101267,0.4709456329328986,1.0,4/11,8.98%,KDR;NDNF;CD34;ADIPOR2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.540569395961638,-1.34770116184352,0.12043795620437957,0.3933329739367832,1.0,6/14,26.18%,MOXD1;DAGLA;NOS1;SLC5A7;DAGLB;SLC22A2
prerank,smooth muscle cell differentiation (GO:0051145),0.5604888169559783,1.3475256282169448,0.15824175824175823,0.4703590902307294,1.0,5/12,7.29%,MRTFA;HEY1;TMEM204;MRTFB;APLNR
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.47721408369951634,1.347154182493509,0.10675381263616558,0.46972463190287733,1.0,5/22,10.30%,SLA2;THY1;PTPRJ;GPS2;LPXN
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5044521661276319,-1.3471415904368031,0.13549618320610687,0.39387535535212403,1.0,7/18,18.77%,SMAD3;PDPN;RUNX1;RB1;EFEMP2;EMILIN1;BMP2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5833131674041645,1.3462774637832835,0.13118279569892474,0.47033525222462064,1.0,3/10,6.24%,NETO1;SHANK3;NPTN
prerank,water transport (GO:0006833),0.5576982700167651,1.3459118811500577,0.11790393013100436,0.469634599688592,1.0,4/12,15.99%,AQP9;AQP11;AQP4;CFTR
prerank,regulation of histone methylation (GO:0031060),-0.5492482554541985,-1.3458598931781645,0.10056925996204934,0.3961693819874006,1.0,8/13,35.50%,NSD1;MTHFR;CTR9;JARID2;PIH1D1;NNMT;AASS;TTLL12
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4591522917903237,1.3458402195408887,0.09071274298056156,0.4682184224331737,1.0,3/23,3.78%,CD33;GIT1;GAS6
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.536643718649254,-1.3455470775069278,0.14694656488549618,0.39619998116911914,1.0,10/14,37.28%,FUS;WDR48;PARP1;MMS19;ARID2;ACTR2;FANCB;TIMELESS;ERCC6;MRNIP
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3309045268064789,-1.344815168548584,0.02982107355864811,0.3972016708859485,1.0,43/140,18.97%,AKAP13;ARHGAP29;ARHGAP10;ARHGAP6;RHOQ;CGNL1;PLCE1;ARHGAP28;ITGAV;ARHGAP20;TIAM2;ARHGEF17;ARAP1;RHOJ;MYO9A;ARHGAP24;BCR;INPP5B;GMIP;ARHGAP21;PLEKHG2;CDC42;VAV2;ARHGAP17;TRIP10;RHOA;ARHGEF12;RHOT1;ARHGEF18;ARHGAP32;SOS2;FGD1;ARHGDIB;FGD4;NGEF;ARHGAP18;ARHGEF11;TRIO;ARHGEF6;ARHGEF1;ARHGAP15;RHOH;RHOC
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.46826802414314966,-1.3447545365686664,0.11354581673306773,0.39663750601262954,1.0,9/24,17.54%,TRIM44;TRAF3IP2;PTPN22;PARP9;MAVS;EIF2AK4;DTX3L;STAT1;ZDHHC1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3430531060043483,1.3442010998141922,0.035940803382663845,0.4709167768350872,1.0,20/110,11.18%,ADGRL4;ADGRL3;ADGRB3;ADCY8;ADCY3;RAMP2;ADGRB1;ADRB1;S1PR5;GPR101;LGR5;ADCYAP1;GPR26;GNG2;GNAL;ADRA1D;ADRA1A;ADGRL2;ADCY4;CNR1
prerank,respiratory tube development (GO:0030323),-0.4432964275331712,-1.3440727638326155,0.11377245508982035,0.39761133031807633,1.0,10/28,15.98%,GLI2;FGF1;BMP4;PDPN;PCSK5;RBP4;FGFR2;CCDC39;VEGFA;LOXL3
prerank,positive regulation of signaling (GO:0023056),0.42815236360095166,1.34391232957858,0.08902691511387163,0.46996042608164434,1.0,10/37,8.18%,SYT1;RIMS1;RIMS2;RIMS3;SNCA;GRIK2;KCTD13;HOMER1;CLSTN3;NMB
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.40262635546591263,-1.3438431615444044,0.07254901960784314,0.3974045670856618,1.0,20/48,22.02%,DOCK5;LIMS1;ABL1;CUX1;FBXW8;RREB1;FLNA;NRP1;OBSL1;CDC42;S100A10;PRKDC;CARMIL1;DOCK1;MYADM;MYOC;TRIOBP;P4HB;CUL7;CRKL
prerank,ribosome assembly (GO:0042255),0.40389008694406126,1.3437670194186964,0.07142857142857142,0.4686808903478405,1.0,15/47,17.50%,RPS19;RPF2;RPS27;RPL10;RPLP0;MRPS7;RPS15;RPL5;RPL23A;NOP2;RPS14;RPS5;RPS28;MDN1;PPAN
prerank,positive regulation of B cell activation (GO:0050871),0.39866813350486835,1.3423224486076393,0.06666666666666667,0.47073315972475377,1.0,15/50,18.99%,TFRC;TIRAP;MIF;IL7;VAV3;TNFSF13B;SHLD3;CD40;XBP1;NFATC2;SH3KBP1;CD38;BTK;NCKAP1L;NOD2
prerank,negative regulation of protein processing (GO:0010955),-0.5615511000252509,-1.3414676811232016,0.11259541984732824,0.40230515737392564,1.0,5/12,24.68%,LRRK2;THBS1;GAS1;SERPINE1;SNX12
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5064240212504676,1.3414204835312096,0.12101910828025478,0.4715655396789092,1.0,4/17,10.78%,ANK3;AKAP6;KCNAB1;RNF207
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5792518096838226,-1.3412706878808713,0.14028776978417265,0.4020440311131082,1.0,4/10,12.87%,USP7;SELENOS;ZNF692;OGT
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5361679593345585,1.340087424424112,0.13211382113821138,0.4732599558643741,1.0,4/13,9.08%,ADCY8;SHANK3;SHISA7;RELN
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5066512878278373,-1.3400656297222817,0.12962962962962962,0.4042739827180665,1.0,7/18,20.00%,LBP;THBS1;NECTIN2;TNIP2;TLR4;WNT5A;KARS1
prerank,selective autophagy (GO:0061912),-0.3868773686949913,-1.3400230420863735,0.08414872798434442,0.40365458165127793,1.0,22/56,18.94%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;UFL1;PCNT;UBA5;NBR1;TEX264;RB1CC1;IFT88;ULK2;DYNC1LI1;BECN1;ATG2A;DYNC1H1;AUP1;ATG2B;AMBRA1;ATG5;PARK7
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5807889248505724,-1.3399884788448244,0.16029143897996356,0.40304160030208236,1.0,9/10,39.67%,MLLT3;UFL1;HOXB4;LMBR1L;BATF;SP7;TP53;SFRP1;ACE
prerank,actin filament organization (GO:0007015),-0.3321529223407106,-1.33975663647748,0.02404809619238477,0.40288440045579516,1.0,44/151,20.82%,DPYSL3;CGNL1;GSN;TPM1;SVIL;MCU;MPRIP;MYO1B;BAIAP2L1;SHROOM2;FAT1;FLNA;DLG1;RND3;SHROOM3;TMOD3;FHOD1;CORO7;INPPL1;CDC42;ARHGAP17;WASL;RHOA;TPM3;ABI1;RHOBTB2;MYO1F;ZBED3;WHAMM;CARMIL1;EFS;RHOBTB1;RHOH;RHOC;TRIOBP;AVIL;LMOD1;VILL;MARCKS;TPM2;GAS2;BAIAP2;ARHGAP12;PLS1
prerank,regulation of telomere capping (GO:1904353),-0.4664722599964871,-1.3395537020766974,0.10474308300395258,0.4026034941185928,1.0,8/23,19.61%,SMG6;TNKS2;USP7;NBN;HNRNPD;NABP2;MAP2K7;TERF2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5162442476880267,-1.3394028785252674,0.12455516014234876,0.40224368528993115,1.0,12/16,41.54%,PDS5A;NIPBL;RAD21;PDS5B;RB1;SMC1A;BOD1;POGZ;MAU2;REC8;SGO1;DSCC1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3271428779068578,-1.339059401810039,0.022540983606557378,0.40231327914126835,1.0,48/151,19.26%,BMP6;EGFR;SMAD3;TGFBR1;SOX5;APPL2;BMPR1A;ADAMTS12;WNT4;NTRK3;LIMS1;WWOX;FOXC1;BMP7;BMP4;TGFBR2;CLEC3B;NR3C1;GAREM1;NRP1;SHC1;GAS1;ANXA1;PDPK1;MED1;PLCG1;PTPN12;SMAD4;MEF2C;PDE3A;APPL1;CPNE3;SOX6;VEGFA;ACVR1;ERN1;ACAP2;RAPGEF2;EMD;RUNX2;NR4A1;WNT5A;PRKD1;STAT5B;SYAP1;INPP5K;BMP2;PTPN11
prerank,negative regulation of locomotion (GO:0040013),0.544605993752287,1.3389917981513448,0.12978723404255318,0.4746626901196453,1.0,2/12,0.66%,SPOCK3;FRMD5
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5252748830171444,-1.3389390450402883,0.13733075435203096,0.4018986760415488,1.0,10/15,21.57%,FGF1;JAK1;PDPK1;BMPER;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,camera-type eye morphogenesis (GO:0048593),-0.5902584399150097,-1.338360413385105,0.1189083820662768,0.40250611103812206,1.0,5/10,17.05%,LRP6;SHROOM2;SKI;VEGFA;TBX2
prerank,regulation of DNA replication (GO:0006275),-0.3916985175208436,-1.3378789315412036,0.07632093933463796,0.40298615963751366,1.0,21/49,29.76%,EGFR;ANKRD17;GLI2;RBBP6;DHX9;BRPF3;PDS5A;GLI1;ESCO1;CTC1;S100A11;CDAN1;PCNA;PPP2CA;STN1;ATR;ATAD5;EGF;OBI1;WAPL;ZBTB38
prerank,regulation of nervous system process (GO:0031644),0.4946900432978613,1.3377440930301283,0.11904761904761904,0.47635122759364823,1.0,5/18,4.75%,DLGAP1;TMEM108;HTR2C;NOS3;DLGAP2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.35936386246515367,-1.3376343727462223,0.06109979633401222,0.4028789104546004,1.0,31/80,25.13%,PLPP3;GBF1;UVRAG;STX18;SEC22B;KDELR1;COPB1;COPZ2;ARCN1;ARFGAP1;ARFGAP3;COG3;COG7;KDELR3;RINT1;COPB2;KIF1C;SURF4;COPG2;TMED3;NAPA;COPG1;RER1;KIFAP3;COPE;COG4;ERGIC1;NSF;KIF3A;ATP9A;KIF23
prerank,neurotransmitter uptake (GO:0001504),-0.5538311066910315,-1.3374121514236241,0.1431064572425829,0.4026992197699488,1.0,2/12,0.95%,ATP1A2;SLC1A3
prerank,cellular response to starvation (GO:0009267),-0.3264010083932632,-1.3359332797375318,0.022,0.4052677815567981,1.0,51/147,23.65%,PRKAG2;RNF152;FOXO3;ATP6V1B2;LRRK2;TFEB;PRKAA2;RPTOR;ATP6V0D1;EIF2AK3;ZFYVE1;MTOR;MAP3K5;WRN;LAMP2;GCN1;SESN1;IMPACT;ATF2;BRSK1;USP33;WIPI1;FNIP1;WDR59;SIK1;CASTOR2;EIF2AK4;MTMR3;BECN1;EIF2AK2;PIK3C3;PIK3R4;DAP;WDR45B;TCIRG1;PRKD1;NPRL3;PRKAA1;ATG5;RRP8;WIPI2;PRKAG3;LARS1;TBL2;ATG14;SIK2;ATP6V1G2;SZT2;MAP1LC3A;DAPL1;NUAK1
prerank,oligosaccharide metabolic process (GO:0009311),0.3967999898722759,1.335795345867777,0.08108108108108109,0.4797963475738763,1.0,11/46,12.69%,ST6GALNAC3;ST8SIA4;ST3GAL6;NEU2;ST8SIA1;FUT9;B3GALT5;GLA;ST8SIA6;ST8SIA3;ST6GAL2
prerank,response to ATP (GO:0033198),0.4987901290518515,1.3355064376268855,0.12236286919831224,0.4789642003463884,1.0,5/18,11.50%,RYR3;KCNJ11;P2RY1;CIB2;P2RX7
prerank,response to metal ion (GO:0010038),0.37349904351509045,1.334687349510987,0.0507399577167019,0.4795335975405104,1.0,18/67,14.53%,MT2A;AQP9;KHK;SNCA;MT1X;MT1A;ATP5F1D;HOMER1;MTF1;SLC30A3;CALM1;SLC30A5;TRPC1;SNCB;CALM2;NDRG1;CALM3;PPP3CA
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3645477882417939,-1.3344775922817418,0.05870841487279843,0.4079663298188102,1.0,18/72,16.31%,AKAP13;COL3A1;LPAR1;KANK2;ABCA1;ROBO1;ABL1;RIPOR2;BCR;NRP1;TNFAIP1;ABL2;ARHGEF18;CUL3;ARHGDIB;APOE;GPR4;ARRB1
prerank,regulation of stem cell proliferation (GO:0072091),-0.499467261741018,-1.3344324457880714,0.11673151750972763,0.4073731114021892,1.0,8/17,25.24%,FBLN1;YAP1;GJA1;EIF2AK2;HNRNPU;TERT;SOX11;KDM1A
prerank,negative regulation of viral transcription (GO:0032897),0.5241738748246814,1.3344217162517198,0.1145374449339207,0.47864539107919485,1.0,4/13,10.91%,TRIM13;TRIM62;IFITM3;MID2
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.5189966083163772,-1.3342564489142088,0.12375249500998003,0.4071497001587705,1.0,8/15,25.70%,STXBP4;CUL3;GLI1;KLHL18;CDC73;EZH2;PHB2;ATAD5
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4269581388275426,-1.3341397138512219,0.08506616257088846,0.4067125639249361,1.0,11/31,17.31%,RANBP3L;CRIM1;SMAD6;TMEM64;SKI;NBR1;LIMD1;SUFU;TRPM4;PTCH1;TWIST2
prerank,aerobic electron transport chain (GO:0019646),0.37418711116163317,1.3335897868228885,0.05040322580645161,0.47912913923305833,1.0,30/68,21.30%,NDUFC1;SDHC;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;COX7C;NDUFAF1;UQCRH;NDUFB9;UQCC3;NDUFAB1;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;UQCRC2;NDUFA6;COX5B;NDUFB7
prerank,tRNA methylation (GO:0030488),-0.42707779046294436,-1.3334348990089937,0.08785046728971962,0.407779941060648,1.0,20/34,33.29%,NSUN6;METTL2A;METTL2B;METTL1;NSUN2;THUMPD3;TRMT1L;FTSJ1;DALRD3;LCMT2;WDR6;GTPBP3;TRMT1;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;ALKBH8;TRMT12
prerank,carnitine metabolic process (GO:0009437),-0.549600951149397,-1.333334212069731,0.11602209944751381,0.4072938960004589,1.0,6/12,18.84%,ACADM;CPT1C;TMLHE;CPT2;BBOX1;CPT1A
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.4271970045395496,-1.3329152364828327,0.1036468330134357,0.4075522862041791,1.0,15/33,26.61%,PABPN1;PCF11;WDR33;SCAF8;CPSF3;SSU72;SLBP;CSTF3;SNRPF;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.3089832332430263,-1.3327625357508084,0.0099601593625498,0.407174811540123,1.0,94/241,28.06%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SF3A3;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;DDX23;YBX1;CWC22;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.49429121328254383,-1.3325669340402508,0.12754158964879853,0.40689473567663326,1.0,4/17,2.69%,ROCK2;VCL;PPP1R12A;ROCK1
prerank,cellular response to amyloid-beta (GO:1904646),0.420133591205095,1.3316283654915317,0.08855291576673865,0.4825603487720009,1.0,6/35,3.72%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;CACNA2D1
prerank,protein-containing complex assembly (GO:0065003),-0.304776751640757,-1.3311446779078013,0.015968063872255488,0.4095224496010895,1.0,93/259,24.49%,FBXL7;AFDN;TCF7L2;TEAD1;SEC24D;OPA1;MCU;MDM4;SH3PXD2B;EP300;LRRK2;CSNK1A1;TRAPPC9;DLG4;GSK3B;YAP1;SLC9A1;KMT2D;CTSC;BCL9L;DNM1L;SNX9;AXIN1;TFG;SEC23IP;DNAJB14;PYGO1;CREBBP;SEC23A;TRRAP;DHX9;SEC22B;TUBGCP2;PPARGC1A;VAMP2;SEC31A;GEMIN5;TBC1D20;MNAT1;WASL;TRAF2;TLE4;TLE1;CAPZA1;WIPF1;HES1;TEAD2;TRAPPC6B;CUL3;TCF7L1;GSDMD;FN1;CDC123;STX5;PARD3;HDAC1;RANBP9;WASF1;REPS2;FARP2;STOML2;GOSR2;PPIH;PICALM;SEC16B;NAPA;CSNK1D;GPAA1;TUBGCP4;CDC73;TERT;PML;SEC16A;TLE3;CUL1;FANCC;KIFAP3;CLDN1;KMT2A;PPID;DET1;CAND2;LAMC1;F5;NSF;TRAPPC2;LMAN1;HSF1;USO1;PREB;TFAP4;SAR1B;MCFD2
prerank,macroautophagy (GO:0016236),-0.3363680536472645,-1.330723801626406,0.04462474645030426,0.40981195402041193,1.0,39/118,22.01%,PRKAG2;PRKN;PRKAA2;UVRAG;VPS4B;UBQLN1;VTI1B;VAMP7;ZFYVE1;CHMP4B;CHMP4A;LIX1L;NBR1;LAMP2;VDAC1;RB1CC1;CHMP3;VPS39;VPS37C;WIPI1;PRKAB2;MTMR3;BECN1;ILRUN;PIK3C3;CSNK2A1;PIK3R4;TCIRG1;AMBRA1;PRKAA1;ATG5;VCP;SNF8;TOMM7;WIPI2;STX17;PRKAG3;PRKAB1;ATG14
prerank,nucleotide metabolic process (GO:0009117),-0.46788049038082336,-1.3305571978921957,0.11560693641618497,0.4094820266996573,1.0,8/23,14.93%,FHIT;NMNAT2;NUDT5;ENPP3;ME1;CTPS2;NMNAT3;NMNAT1
prerank,histone methylation (GO:0016571),-0.4517373380148749,-1.33024114188939,0.08637236084452975,0.40950862906675883,1.0,11/26,21.59%,CREBBP;NSD3;NSD1;SMYD3;PRMT2;N6AMT1;EHMT1;PRMT5;PRMT8;NTMT1;EZH2
prerank,endothelial cell migration (GO:0043542),-0.41753230818899595,-1.3300528592338412,0.1015625,0.4092796821672337,1.0,14/37,17.06%,FSTL1;ABL1;DPP4;ADGRA2;NRP1;CYP1B1;CCN3;RHOA;GIPC1;FAP;STAT1;VEGFA;PLXND1;NR4A1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.3765449368139285,-1.329779453426797,0.06626506024096386,0.4092923692050564,1.0,29/64,28.25%,MLLT3;GTF2H2;CCNT2;CCNH;CCNT1;CDK7;CTR9;CDK13;CCNK;SETD2;MNAT1;AFF4;RTF1;ERCC3;NELFB;POLR2H;CDC73;GTF2F1;POLR2K;GTF2H1;EAF2;CTDP1;POLR2E;NCBP2;GTF2H4;POLR2D;NELFA;CDK9;NELFE
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.344305840703574,-1.3295735528424915,0.045275590551181105,0.40906860418703256,1.0,30/101,23.38%,SAMD4A;PLD1;VIM;CYFIP2;BTRC;ZCCHC4;YTHDF3;VGLL4;THBS1;MTOR;HNRNPD;ASPH;DACT1;PLXNB2;NR1H3;AGTR1;OGT;PRKDC;DDX3X;UPF3A;FBXW11;EIF4G1;INHBA;UPF3B;FGFR4;TBC1D10A;MSN;PYM1;PERP;HDAC2
prerank,relaxation of muscle (GO:0090075),-0.5488011637435112,-1.3291953072345892,0.10305343511450382,0.4092490306566525,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.48929435065355564,1.3288881699609358,0.1111111111111111,0.4883203796544699,1.0,5/18,3.46%,RIMS1;NLGN1;RIMS2;PREPL;RIMS3
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3585110934552473,-1.3278565759934091,0.068,0.41174469097668215,1.0,23/76,16.43%,EGFR;ZMIZ1;RBPJ;KAT2B;IL6ST;EP300;JAG1;WWP2;TSPAN5;NIBAN2;YAP1;CREBBP;STAT3;POFUT1;CCN3;MMP14;NOTCH3;MAML2;FBXW7;MAML1;BMP2K;ARRB1;TSPAN15
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.435514459466078,-1.3276905647087112,0.10097087378640776,0.41145962640956457,1.0,14/32,19.91%,PHLDB2;ARHGAP6;JAG1;THBS1;BCAS3;HOXA7;MAP4K4;SEMA3E;APOD;RASA1;SERPINE1;FAM107A;MYOC;NF2
prerank,cellular response to amino acid starvation (GO:0034198),-0.36319383006264505,-1.326907834794809,0.06387225548902195,0.4126125370405276,1.0,20/71,17.78%,RNF152;ATP6V1B2;TFEB;RPTOR;ATP6V0D1;EIF2AK3;MTOR;MAP3K5;GCN1;SESN1;IMPACT;ATF2;WDR59;CASTOR2;EIF2AK4;EIF2AK2;DAP;TCIRG1;PRKD1;NPRL3
prerank,positive regulation of lipid localization (GO:1905954),-0.5736776003424514,-1.3264191540348103,0.1340782122905028,0.4130703232098603,1.0,2/11,1.19%,LRP1;NFKB1
prerank,negative regulation of growth (GO:0045926),0.3345131042652896,1.326328294263243,0.045174537987679675,0.4933446864057861,1.0,37/121,17.98%,MT2A;MINAR1;SIRT1;GNG4;APBB1;MT1M;MT1X;MT1E;MT1B;MT1H;MT1F;MT1A;MT1G;SCGB3A1;NOTCH1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;ING4;TMPRSS4;APBB2;SOX17;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2;PNPT1;CDKN2AIP;RERG
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5462572954444067,1.3248486118350744,0.15644820295983086,0.49573685477241336,1.0,3/11,10.78%,AKAP6;LRRC55;RNF207
prerank,regulation of chromosome segregation (GO:0051983),-0.5165786492808434,-1.3246388871548191,0.1254681647940075,0.41658900954884154,1.0,6/16,15.45%,NUMA1;PUM2;SMC6;PUM1;SMC5;CSNK2A1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5540988722906243,1.3245793275644955,0.14343434343434344,0.4949001673640051,1.0,3/12,4.60%,SMS;DDC;TRH
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5275231612726443,1.3245407920454058,0.13026052104208416,0.4933977717591362,1.0,6/13,16.47%,ELOVL7;ELOVL4;TECR;HACD3;HACD1;TECRL
prerank,positive regulation of interleukin-4 production (GO:0032753),0.49383598789234817,1.324387252317329,0.1271186440677966,0.49226231705843565,1.0,2/17,6.51%,SLC7A5;PRKCQ
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4270678878365597,1.324249320163644,0.0876068376068376,0.4910533161599269,1.0,5/29,10.49%,CXCL12;GAS6;JAM2;IL12A;AIF1
prerank,endochondral bone morphogenesis (GO:0060350),-0.5663373031538974,-1.3241180540036275,0.14312267657992564,0.4171484466522571,1.0,5/11,11.68%,FOXC1;BMP4;INPPL1;COL13A1;MEF2C
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4719982005249436,1.3228923597436328,0.11226611226611227,0.4931099494638531,1.0,7/22,8.72%,TMEM108;SH3GL2;MAGI2;NTRK2;AKT1;RAB35;STMN2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5504739473234437,-1.322614220984543,0.14156079854809436,0.42005049485752544,1.0,6/12,21.90%,LRP6;CYP26B1;SKI;PTCH1;MEGF8;FBXW4
prerank,protein heterooligomerization (GO:0051291),0.49504560807962394,1.3225028320116,0.13263157894736843,0.4925810552272818,1.0,5/17,13.62%,GRIN1;KCNC2;GRIN2B;FARSB;MAT2A
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.33141214880483705,1.3222889490754928,0.03415559772296015,0.49161021314509745,1.0,19/138,5.87%,FLT1;PTPRG;IGF1R;TEK;MPZL1;PTPRD;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;PTPRT;AHI1;KDR;NTRK2;FLT3;SRMS;ALK
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.4408263060360713,-1.3220974999332353,0.10714285714285714,0.4205565215442075,1.0,18/30,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;POLR1C
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.3470691163419763,-1.3218969608758588,0.05731225296442688,0.42031575041751107,1.0,29/101,19.92%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;LYN;CTR9;PTPN22;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;IL18;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,regulation of ion transmembrane transport (GO:0034765),0.42495374757996474,1.321489266157606,0.09010989010989011,0.49209690824128155,1.0,8/33,12.78%,KCNJ3;CHRM3;KCNJ6;AKAP6;KCNJ11;KCNJ10;P2RX7;KCNJ8
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3941221188493822,1.3211186989904897,0.08669354838709678,0.4916259337235769,1.0,9/47,13.01%,SPOCK2;SPOCK1;SPOCK3;BIN1;TIMP1;AKT1;SERPINB8;TIMP4;SORL1
prerank,positive regulation of reproductive process (GO:2000243),0.43332125588939296,1.3210513351539384,0.11464968152866242,0.49023606162031924,1.0,6/31,9.31%,GLRA1;PGAM4;PLCB1;TACR1;CFAP69;TACR3
prerank,aortic valve morphogenesis (GO:0003180),-0.4332205593095606,-1.321002409346539,0.11302681992337164,0.42170040467081704,1.0,7/30,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,activation of phospholipase C activity (GO:0007202),-0.44306919293284736,-1.3209451992145864,0.10536044362292052,0.421129792051066,1.0,5/29,9.48%,EGFR;LPAR1;ARHGAP6;EDNRA;PLCG1
prerank,lung development (GO:0030324),-0.4253445109501087,-1.3207803497546988,0.11336032388663968,0.42078052711550334,1.0,12/33,15.98%,ERRFI1;PKD1;GLI2;FGF1;BMP4;PDPN;RBP4;FGFR2;RCN3;CCDC39;VEGFA;LOXL3
prerank,protein sumoylation (GO:0016925),-0.3898662045268642,-1.3202271457668584,0.07307692307692308,0.4214331502635217,1.0,13/49,15.42%,EYA1;PIAS1;SAE1;RANBP2;NSMCE2;NUP42;PIAS3;UBE2I;NUP214;TPR;PIAS4;TRPM4;TOPORS
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3514775060753113,-1.3197923722090084,0.07707910750507099,0.4217624156256077,1.0,13/79,6.97%,SULF1;CRIM1;BMPR1A;ADAMTS12;SMAD6;SMURF2;NBL1;HTRA3;NIBAN2;SULF2;THBS1;SKI;SKIL
prerank,regulation of steroid metabolic process (GO:0019218),-0.46381814810323185,-1.3189014197089317,0.12840466926070038,0.42324935331147845,1.0,13/23,41.25%,PANK2;RORA;APOE;EPHX2;ARV1;ACADVL;NR1H4;ASAH1;STAR;ACADL;ABCG1;RORC;FMO5
prerank,sulfur compound catabolic process (GO:0044273),-0.4118114008341941,-1.3186098961318837,0.10039370078740158,0.42331725207348675,1.0,14/38,24.80%,DCN;BGN;FMOD;GNS;OGN;PRELP;LUM;HEXA;GALNS;CHAC2;OMD;TXN2;CSPG4;GGT5
prerank,microtubule anchoring at centrosome (GO:0034454),-0.5820445130650038,-1.317544747094214,0.15019762845849802,0.42506343161982013,1.0,3/10,4.74%,PCM1;NIN;NINL
prerank,myoblast fusion (GO:0007520),0.5475812198974102,1.3172039487506235,0.14692982456140352,0.49914390724816643,1.0,4/12,6.91%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3376558446450174,1.3168509011973784,0.03288201160541586,0.4985518958178195,1.0,26/124,10.82%,CNTNAP2;GPRIN1;FRY;PLP1;CSF1R;TMEM108;NLGN1;GPM6A;SH3GL2;GPM6B;MAP2;STMN1;STX3;PPP1R9A;GPRIN3;ADCYAP1;STMN4;RASGRF1;BICDL1;CAMSAP1;RAB35;STMN2;IQCG;PTPRM;MICALL2;CNTN4
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.48520336830490746,-1.3160098912709237,0.11685823754789272,0.42803525057320063,1.0,7/18,24.99%,PTN;CAMK1D;LYN;IL6R;SLC8B1;EDN3;SLIT2
prerank,phospholipid translocation (GO:0045332),0.4354477368240466,1.3157112283435735,0.12663755458515283,0.5001435751643328,1.0,10/28,11.50%,TMEM30A;ATP8A1;ATP11A;ATP10A;MFSD2A;ATP10B;ATP11C;ATP8A2;ABCB4;P2RX7
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.37762056101715585,1.3146116442662557,0.07952286282306163,0.5015271343001807,1.0,12/53,20.08%,MTNR1B;CHRM3;HTR2C;MTNR1A;CCL2;OPRM1;CNR1;CHRM2;CALCRL;HTR1B;HTR4;AGT
prerank,response to interleukin-6 (GO:0070741),-0.5750584498127272,-1.314150887326083,0.1475095785440613,0.43188661670631906,1.0,4/10,5.53%,PID1;NFKB1;PTGIS;SBNO2
prerank,arachidonic acid secretion (GO:0050482),-0.5667519721102506,-1.3136498007346127,0.16030534351145037,0.4317106555979859,1.0,3/10,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5667519721102506,-1.3136498007346127,0.16030534351145037,0.4317106555979859,1.0,3/10,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,negative regulation of developmental process (GO:0051093),0.36668686050778676,1.3134235900846682,0.07676348547717843,0.5033193248667952,1.0,17/69,13.73%,TFRC;ARHGEF15;DCC;OMA1;MIF;HEY1;SPRY3;GAS6;THY1;NOS3;NOTCH1;FOXJ1;GRIN3A;WDR77;HOPX;VAT1;DLL1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.48491113437231037,-1.3132469408628147,0.12572533849129594,0.4319430411144566,1.0,6/20,10.95%,ATP1A2;CACNA1C;ANK2;SLC9A1;CAMK2D;ATP2A2
prerank,regulation of interleukin-2 production (GO:0032663),0.40131580701563746,1.3124028381325428,0.08641975308641975,0.5045945494414431,1.0,8/43,13.23%,NAV3;PDE4B;IL17F;CD34;HOMER2;SPTBN1;PDE4D;RPS3
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.472422929036984,-1.3123665527459918,0.1222879684418146,0.4334581600281019,1.0,6/20,15.61%,WNT4;EP300;NCOR1;CLK2;SIK1;C1QTNF3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.46907338419179023,-1.3121038297001086,0.13333333333333333,0.43339422765885327,1.0,8/22,26.85%,ROCK2;ROCK1;GSK3B;BOD1L1;PTPA;CRY2;MASTL;BOD1
prerank,potassium ion import across plasma membrane (GO:1990573),0.3989047764769738,1.3116151617752627,0.09523809523809523,0.5050350892511049,1.0,13/41,13.24%,KCNJ3;KCNJ6;SLC12A6;KCNJ11;HCN2;KCNJ10;ATP1A3;KCNK9;SLC12A3;ATP1A4;ATP1A1;KCNJ8;ATP1B1
prerank,cellular response to oxidative stress (GO:0034599),-0.33416723063517,-1.3115028987681372,0.049429657794676805,0.43417242081051277,1.0,51/118,30.10%,EGFR;PDGFRA;TPM1;FOXO3;ABL1;ARNT;LRRK2;PRKAA2;PLA2R1;NOX4;PPARGC1A;PTPRK;SELENOS;FER;JUN;PRKCD;HIF1A;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;ERCC6L2;TXNRD2;GPX8;CYBA;DAPK1;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;WNT16;ZFAND1;GPX7;NUDT2;CCS;GSR;MAPK9;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3817700220500373,-1.3114496764655417,0.08484848484848485,0.43358774750555723,1.0,24/52,34.78%,ME2;MTHFR;MTHFD2L;ADHFE1;D2HGDH;ME1;MDH1;DLST;ALDH1L1;ALDH18A1;SDHA;NIT2;ASS1;ACOT8;DGLUCY;ME3;GCLC;GOT1;SLC25A32;MDH2;IDH2;SLC19A1;GOT2;SDHAF3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5280416770817287,1.3111751062114458,0.15604395604395604,0.504757404157526,1.0,6/13,18.99%,KDR;TLR2;CCL2;NAMPT;EDN1;NOD2
prerank,phospholipid biosynthetic process (GO:0008654),0.41264879800745846,1.310624719928606,0.10216110019646366,0.5047079492072036,1.0,15/36,19.22%,SGMS1;MBOAT1;CPNE1;MVD;GPAM;CRLS1;FADS1;DHDDS;FAR1;IDI1;PIP5K1A;SAMD8;CPNE7;FDPS;PCYT2
prerank,generation of neurons (GO:0048699),0.31102427840050895,1.3104904379284097,0.029197080291970802,0.5035560184380813,1.0,43/190,17.00%,ADGRL3;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;GPM6A;HEY1;DNER;MAP1B;FGF13;NTRK2;ASTN1;NEUROD6;FUT9;TGFB2;TAFA1;SNPH;NRCAM;LHX1;WNT7B;ITM2C;NDNF;CDKL5;RELN;RNF112;ASTN2;BRSK2;FZD4;PER2;HES6;BHLHE40;POMGNT2;CIT;DLL1;ATP2B2;DCX;ELP3;ACSL3;LMX1B;DDIT4;HES5;CTNNB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5589377403574929,1.3104461654762816,0.15432098765432098,0.502116473005753,1.0,4/11,22.08%,KLRC1;SMAD7;HFE;CEACAM1
prerank,protein secretion (GO:0009306),-0.3769146461316304,-1.3104173757352777,0.09357798165137615,0.43541452269658454,1.0,17/56,18.94%,WLS;ABCA1;STEAP3;TANGO6;PCSK5;CYB5R4;RAB10;ANXA1;RAB12;CAMK2G;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;PARK7
prerank,regulation of mast cell degranulation (GO:0043304),-0.5242591733238796,-1.3102568915187587,0.1596958174904943,0.43511093961920594,1.0,11/14,42.26%,GAB2;LYN;FER;CD84;CD300A;SYK;SPHK2;FES;FGR;STXBP2;UNC13D
prerank,protein deacetylation (GO:0006476),-0.4042215616721693,-1.3101970515574954,0.09864603481624758,0.4345564241860778,1.0,9/41,5.05%,PRDM5;MIDEAS;HDAC4;TBL1X;TBL1XR1;FLNA;RCOR1;BAZ2A;RCOR3
prerank,sodium-independent organic anion transport (GO:0043252),0.568767134548009,1.310178692191096,0.163135593220339,0.5013184731732178,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,negative regulation of hippo signaling (GO:0035331),-0.5575179949313144,-1.3101255917108279,0.15939278937381404,0.434015211077364,1.0,9/12,25.75%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;DLG5;MAPK14
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.4051893830623742,-1.309570753896238,0.11154598825831702,0.4346507365194639,1.0,8/41,6.61%,TGFBR3;BMPR1A;TPM1;RBPJ;BMP4;JAG1;TGFBR2;FGFR2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5038396154213661,-1.3089763591439376,0.13721804511278196,0.4354373236304346,1.0,5/16,19.78%,NFAT5;ST3GAL4;RHOA;TRAF6;IRAK1
prerank,transcription by RNA polymerase I (GO:0006360),-0.4232572136009953,-1.3086682255797992,0.10467289719626169,0.435504892170703,1.0,19/34,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;TTF1;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,regulation of RNA export from nucleus (GO:0046831),-0.5588630432699583,-1.3082868483775782,0.15134099616858238,0.4357916209594422,1.0,6/11,16.82%,KHDRBS1;DHX9;AKAP8L;SETD2;TPR;NSUN2
prerank,catecholamine biosynthetic process (GO:0042423),0.5534800699595748,1.30802620993882,0.1598173515981735,0.5053987713401976,1.0,3/11,5.82%,DDC;SNCA;TGFB2
prerank,DNA alkylation (GO:0006305),-0.47888056158429826,-1.3080129064897545,0.14910536779324055,0.43505597888562736,1.0,5/19,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),-0.47888056158429826,-1.3080129064897545,0.14910536779324055,0.43505597888562736,1.0,5/19,12.83%,PPM1D;BAZ2A;DNMT3A;ATF7IP;EHMT1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4084629061122346,-1.3079384367771205,0.10940499040307101,0.43456555909446415,1.0,20/38,32.52%,PRKN;LRRK2;SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;ATP5IF1;UBE2D3;TOMM7;ARIH2;PARL;LMAN1;HTRA2;USP36;UBE2L3;RNF31;SREBF1
prerank,homocysteine metabolic process (GO:0050667),-0.5554301499791146,-1.3077229229426024,0.16847826086956522,0.4344159918715761,1.0,3/11,7.13%,MMUT;NOX4;MTHFR
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.40575589484671276,-1.3075158844322394,0.08946322067594434,0.4342612212049257,1.0,16/37,27.86%,PRKAG2;CEMIP;BMP7;RPTOR;AXIN1;UBE2K;PARD3;INPP5K;EIF4G1;SPRED2;CAB39;SPHK1;IRGM;EGF;TNKS1BP1;APP
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3162988086889993,-1.3070844848157412,0.021526418786692758,0.4346624557161036,1.0,45/158,22.70%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;TRIM8;TRAF3IP2;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;LGALS1;TRIM5;TRIM25;PPM1A;LTBR;MAP3K14;TNIP2;ECM1;IKBKE;PRKD1;CC2D1A;TRAF6;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;TICAM1;VAPA
prerank,regulation of microtubule polymerization (GO:0031113),0.4029969778657167,1.306333112785899,0.09611451942740286,0.5082415703358913,1.0,12/40,13.23%,NAV3;MAP2;STMN1;SNCA;OCLN;PAK1;MAPRE3;TUBB4A;CAMSAP1;STMN2;DCTN1;RPS3
prerank,activation of protein kinase B activity (GO:0032148),-0.43112231493930453,-1.3061213341480662,0.10961538461538461,0.4362980951662285,1.0,13/29,18.94%,IGF1;NTRK3;FGF1;OSBPL8;MAPKAP1;MTOR;PDPK1;RICTOR;TXN;ADRA2A;IL18;WNT5A;PARK7
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5313048380203105,-1.3056484945541336,0.1519230769230769,0.43674382345500995,1.0,4/13,12.21%,LARGE1;OGA;RENBP;MGAT3
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3642920994982673,1.3056193092526425,0.081799591002045,0.5086440091581547,1.0,19/72,11.24%,NAV3;KANK3;SHANK3;MAP2;STMN1;FGF13;SNCA;PFDN5;HSPA8;CLU;PFDN6;TUBB4A;CAMSAP1;STMN2;CYRIB;ARHGEF2;MID1IP1;CORO1A;APC
prerank,regulation of lamellipodium organization (GO:1902743),-0.5238678872722263,-1.3053432383002284,0.13714285714285715,0.43676313649149073,1.0,7/14,26.26%,PDPN;CDC42;FER;CAPZB;CARMIL1;TWF1;TWF2
prerank,cellular response to nitrogen compound (GO:1901699),-0.4700537422063653,-1.304754784640763,0.13545816733067728,0.4375240504547938,1.0,9/20,29.42%,ROCK2;SPIDR;DDI2;RIOK3;HSF1;PDE12;ATRX;TIMELESS;NR1H4
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.43705162171482287,-1.3042351480241,0.11507936507936507,0.43810073170884817,1.0,16/30,25.26%,FOXP1;DDX5;DAB2;EP300;NCOR1;AR;SAFB2;PRMT2;HDAC1;HEYL;RNF14;PARK7;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.4032208011365218,-1.3041976785313378,0.10567514677103718,0.437502025154763,1.0,6/39,7.79%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT
prerank,regulation of lipid metabolic process (GO:0019216),-0.3416510701886811,-1.304025575751983,0.06601941747572816,0.43725652863810877,1.0,37/88,26.86%,PRKAG2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;PANK2;ID2;NPC2;RORA;TGS1;MBOAT7;LACTB;C1QTNF2;CCDC3;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;SC5D;FDFT1;SMARCD3;MVK;PPARA;EDF1;ZFP69;BBS4;HDAC3
prerank,cellular iron ion homeostasis (GO:0006879),0.37644099067870845,1.3038873775727866,0.0784313725490196,0.5117337601313684,1.0,12/55,10.63%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5534318522975201,-1.303036684662879,0.14258188824662812,0.4388720909321091,1.0,5/11,12.51%,RESF1;MPHOSPH8;ATF7IP;TPR;SETDB1
prerank,mammary gland epithelium development (GO:0061180),0.5186519637970975,1.3030043943194243,0.15670103092783505,0.512756157326816,1.0,5/14,7.97%,ERBB4;CSF1R;IRF6;WNT7B;AKT1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5648992060660287,-1.3025230436924908,0.15162454873646208,0.4393182509712478,1.0,3/10,2.52%,LRP6;BMP5;BMP7
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.41634538130829357,1.3020180367282346,0.1329243353783231,0.5138827007988648,1.0,8/34,9.89%,FLT1;SEMA6A;RAMP2;KDR;MT1G;NOTCH1;HSPB1;DAB2IP
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5360162290856089,-1.3018396795227194,0.16573556797020483,0.44027826231158684,1.0,9/13,27.55%,BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL;ZBTB7B;PIM1
prerank,regulation of embryonic development (GO:0045995),-0.41126721412974715,-1.3016222950360177,0.12737642585551331,0.4401284060966928,1.0,9/34,14.74%,PHLDB2;DAG1;TRIP12;WDPCP;NIBAN2;DHX36;NIPBL;EHMT1;ZBED3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.32437630590080524,-1.3013179388103349,0.03231939163498099,0.44020153126505845,1.0,48/136,25.25%,TCF7L2;PKD1;BMP7;PTGIS;HDAC4;TAX1BP1;BTRC;WWP2;NUPR1;FLNA;IRAK3;TAF3;ANXA4;USP7;UFL1;IRAK2;PARP10;CEBPG;SP100;CYP1B1;PRMT2;GLIS2;ID2;HES1;PKD2;SUFU;SIK1;RB1;EIF2AK4;PTCH1;CMKLR1;ARRB1;DAP;TRAF3;HEYL;LRRC14;SFRP4;MDFI;IRAK1;CDK5RAP3;WFS1;CHP1;COMMD7;HDAC2;NLRC3;PAXIP1;KDM1A;PHB2
prerank,sulfur compound biosynthetic process (GO:0044272),-0.3346968984690787,-1.3003302433798265,0.061601642710472276,0.44183888385071957,1.0,29/104,19.07%,UST;DSE;ST3GAL4;ANGPT1;DCN;B4GALT1;BGN;FMOD;SLC35B3;OGN;GLCE;SLC26A2;SLC10A7;PRELP;CHST15;ST3GAL3;TPK1;AKR1A1;LUM;GGTA1;CHST11;CHPF2;CHSY1;CHAC2;B4GALT5;GSTT1;MGST1;OMD;CHST12
prerank,protein phosphorylation (GO:0006468),-0.28005961406041957,-1.300322238376643,0.003976143141153081,0.44117895399799734,1.0,154/478,22.14%,PRKAG2;ROCK2;TGFBR3;GRK5;EGFR;TGFBR1;EFEMP1;BMPR1A;EPHA3;PDGFRA;CDK8;PKD1;TLK1;PDK1;PDGFRB;STK3;FAM20A;ROCK1;BMP4;SMG1;ERC1;MAP3K3;CAMK1D;ABL1;BIRC6;LRRK2;JAK1;PRKAA2;TGFBR2;CSNK1A1;FRK;CCNH;TOP1;GSK3B;KIT;CCNT1;STK17B;RYK;TBK1;IRAK3;NRK;IGFBP3;MARK3;CDK16;BCR;CDK7;SLK;SMAD2;EIF2AK1;PAK2;MAP4K4;TAOK3;EEF2K;FGFR2;EIF2AK3;LYN;CAMK2D;MTOR;MERTK;BRAF;GRK4;MAP3K5;PDPK1;EPHA4;DCLK1;MARK4;MAP2K1;CDK13;GRK3;WNK4;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;FER;PRKCD;ABL2;DMPK;FAM20C;CLK3;CDK11B;ULK2;ABI1;MKNK2;TEC;SIK1;COPS2;EIF2AK4;RICTOR;MAML1;GMFB;STK33;TBCK;TRIB2;COPS8;MAPK6;TYK2;EIF2AK2;EPHA8;PRKDC;BMP2K;ACVR1;ERN1;LATS1;CDC25B;PRKCZ;DDR1;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;IKBKE;DAPK2;PIK3CD;TLR4;PRKACA;PXK;PRKD1;MORC3;BAZ1B;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;BMP2;MUSK;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;MAP2K6;NRBP2;FGFR4;CAB39;BCKDK;PRKAG3;PKDCC;CDK6;MAST2;PPP4R1;AKT2;PRKAB1;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,ERAD pathway (GO:0036503),-0.34988345967510726,-1.3003024698776744,0.08301158301158301,0.44052106411390796,1.0,36/83,29.11%,PRKN;UGGT2;ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;ERLEC1;RNF103-CHMP3;MAN1B1;RCN3;RHBDD2;ERLIN1;POMT2;TRIM25;USP13;FAF2;AUP1;DERL1;SYVN1;GET4;VCP;UBXN4;TOR1A;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2;CCDC47
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32851678007757446,-1.3000031833804984,0.03937007874015748,0.4405046749643007,1.0,19/113,7.39%,BMP6;NOTCH2;IGF1;EGFR;TCF7L2;TGFBR1;PTN;BMP5;FGF1;BMP4;ARNT;OSR1;RREB1;YAP1;STXBP4;NRP1;FGFR2;F3;SRSF6
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.48941979398767294,-1.299671728379994,0.13424124513618677,0.44064657753345815,1.0,10/16,22.70%,ANK2;GBF1;LRRK2;BCAP29;UBAC2;MIA3;SEC16B;SEC16A;TAPT1;VAPA
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.44096826767177605,-1.2990336730412295,0.13358778625954199,0.4414586153884559,1.0,11/29,17.09%,KANK2;YAP1;KMT2D;STRN3;AXIN1;UFL1;RUNX1;UBA5;CNOT2;LATS1;CNOT1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4755910779317633,1.2983232460247134,0.13709677419354838,0.5220832386716615,1.0,5/19,9.08%,LRP8;PTPRD;IL1RAPL1;CDKL5;RELN
prerank,regulation of mitochondrial fission (GO:0090140),-0.44689046806499955,-1.2981000715402276,0.13813229571984437,0.44295420959921994,1.0,6/24,6.92%,DCN;MCU;PRKN;LRRK2;DNM1L;DDHD1
prerank,regulation of dendritic spine development (GO:0060998),0.473856370511017,1.297809521164246,0.15578947368421053,0.5221053704669173,1.0,6/19,13.72%,NLGN1;SHANK3;KIF1A;GRIN3A;PPFIA2;PSEN1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3457431295352472,-1.2977536812032235,0.06126482213438735,0.44316313265094515,1.0,28/88,16.31%,MYO1B;VPS13A;DNAJC6;GBF1;CCDC93;ARL3;GOLGB1;RAB10;OSBPL5;DTNBP1;VAMP7;CORO7;AP4E1;PUM1;MON2;VAMP2;ACBD3;KIF16B;RP2;EXOC2;STX4;SCAMP2;ARF1;AP4S1;VPS13C;DOP1B;TXNDC5;ARRB1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5424076848242951,-1.2977127488567497,0.13568773234200743,0.44258322759983376,1.0,3/12,11.51%,FOXP1;LYN;FNIP1
prerank,regulation of translation (GO:0006417),-0.3116712611792674,-1.2974180426971527,0.032719836400818,0.4426094843221574,1.0,46/173,20.56%,SAMD4A;PLD1;IGFBP5;EIF4G3;VIM;FOXO3;ZCCHC4;YTHDF3;SYNCRIP;EIF4A2;DDX6;EIF4ENIF1;THBS1;EIF2AK3;DHX9;MTOR;LARP1;HNRNPD;DHX36;IMPACT;GEMIN5;PLXNB2;EIF4E;UPF1;CSDE1;LSM14A;NSUN3;CNOT8;ALKBH1;EIF2AK4;YBX1;EIF2AK2;PRKDC;DDX3X;DAPK1;CNOT1;UPF3A;SHFL;PAIP1;MIF4GD;EIF4G1;CNOT10;MTG2;RBM4;EIF2B4;UPF3B
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5067353438678059,-1.2973738091532918,0.16370808678500987,0.4420522499872548,1.0,3/16,1.01%,ATP1A2;CACNA1C;ANK2
prerank,embryonic organ development (GO:0048568),-0.3736360354774702,-1.2973384257463274,0.09979633401221996,0.44148579225867896,1.0,18/61,12.15%,PBX1;GLI3;TEAD1;BMPR1A;RBPJ;GLI2;RARB;TGFBR2;PCSK5;KIT;RBP4;PBX3;FGFR2;COL13A1;TEAD3;NES;ERCC3;TEAD2
prerank,heart contraction (GO:0060047),0.398467465311012,1.2972970068051404,0.09603340292275574,0.5219018849338825,1.0,9/41,10.10%,SGCZ;RYR2;GPX1;MYH6;GRK2;SLC8A1;SCN4B;TCAP;SGCG
prerank,protein localization to organelle (GO:0033365),-0.3213419691405572,-1.2970259411411376,0.042682926829268296,0.4415426812056999,1.0,38/133,19.21%,ANK2;COL1A1;ZNF423;TRAM2;BMP7;BMP4;GBF1;BBS9;LRRK2;LMNA;PACSIN2;CNTLN;ARL3;DHX9;OBSL1;DCP1A;LAMP2;VAMP2;TULP3;RPL11;COG3;COG7;RAB11A;STX5;SNX10;YBX1;UBAC2;DDX3X;YWHAE;EMD;TOPORS;SIX1;AUP1;LAMP1;GBP2;GET4;CSNK1D;ABCA7
prerank,relaxation of cardiac muscle (GO:0055119),-0.5410479810177795,-1.2969040645530037,0.14587332053742802,0.4411456855536244,1.0,4/13,7.68%,ATP1A2;GSN;CAMK2D;KCNJ2
prerank,fatty acid elongation (GO:0030497),0.52137412281226,1.296146933903047,0.15605749486652978,0.5234773249436105,1.0,5/13,13.75%,ELOVL7;ELOVL4;TECR;HACD3;HACD1
prerank,keratan sulfate metabolic process (GO:0042339),-0.4187134551027846,-1.2958036519761331,0.11829944547134935,0.4429860172557356,1.0,12/31,18.91%,ST3GAL4;B4GALT1;FMOD;GNS;OGN;PRELP;ST3GAL3;LUM;HEXA;GALNS;B4GALT5;OMD
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3717116513411148,1.2956651722568253,0.10020876826722339,0.5232871863490546,1.0,15/57,16.23%,RGS1;ADCY8;ADCY3;GRM7;CHRM3;GRM8;PDE2A;MTNR1A;GNAL;OPRM1;ADCY4;OPRK1;CHRM2;OPRL1;GNAI1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4864349296821938,-1.2954327236516712,0.16292134831460675,0.44323940274066387,1.0,8/17,14.80%,FCHSD2;WASF2;BRK1;NCKAP1;ARFIP2;ARF1;GMFB;WASF1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.562332222840207,-1.2954011687892035,0.16728624535315986,0.44265014133242697,1.0,7/11,29.50%,KMT2D;CTR9;OGT;KMT2A;PRDM9;TET2;TET3
prerank,motor neuron axon guidance (GO:0008045),0.5024343105401294,1.2953202814473355,0.16263736263736264,0.5226603589275362,1.0,5/15,10.69%,TMEFF1;SLIT1;LHX1;NTN1;CHN1
prerank,phospholipid catabolic process (GO:0009395),0.45211605660618104,1.2953198527319651,0.1206140350877193,0.5211388652902763,1.0,8/24,19.73%,GPCPD1;ENPP2;SMPDL3A;SMPD1;PNPLA6;PLA2G4E;PLBD2;PRDX6
prerank,mitochondrion morphogenesis (GO:0070584),-0.5499520020415238,-1.2942220449567479,0.15722120658135283,0.444806363013167,1.0,6/11,28.80%,PID1;DNM1L;WASF1;FIS1;MYH14;SUPV3L1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.34163418444891713,1.29370207011516,0.04809619238476954,0.5238917204209693,1.0,36/87,21.30%,OMA1;NDUFC1;CHCHD4;NDUFAF5;NDUFA1;NDUFA2;TIMM21;NDUFC2;COA5;DMAC2;FASTKD3;COX16;NDUFA13;NDUFA3;TMEM126A;DMAC1;NDUFB2;ECSIT;COX17;NDUFAF1;NDUFB9;BCS1L;UQCC3;NDUFAF6;NDUFAB1;NDUFA7;NDUFA12;COA3;OXA1L;NDUFB4;NDUFB8;NDUFA10;NDUFS3;SCO1;NDUFA6;NDUFB7
prerank,retina homeostasis (GO:0001895),0.4553136691730454,1.2933474230620616,0.15856236786469344,0.5233439692680235,1.0,3/23,8.43%,POTEF;ACTB;HSPB1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5314310675551277,1.2933453240880326,0.1511111111111111,0.5218359695958468,1.0,5/12,8.72%,MAP2;STMN1;SNCA;TUBB4A;STMN2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5159603552166533,-1.2931848785659,0.13479052823315119,0.4464481531032936,1.0,11/14,35.29%,SEC24D;SEC23A;SEC31A;TBC1D20;SEC23B;MIA3;SCAP;SEC24A;SEC24C;SEC13;SEC31B
prerank,intracellular lipid transport (GO:0032365),-0.4621719464698488,-1.2928354277583747,0.15355086372360843,0.4465850928109098,1.0,9/21,14.23%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;NPC2;ABCD4;PLEKHA8
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4540270472455632,-1.2925773031911123,0.13584905660377358,0.4465653910211613,1.0,9/22,12.26%,PDGFRA;NTRK3;PDGFRB;KIT;FGFR2;PDPK1;PLCG1;ABL2;AGTR1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5330409543799778,1.2924870736092426,0.15657620041753653,0.5227280377570434,1.0,2/12,0.98%,DSCAM;PROM1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4511542923927183,1.2923566990312616,0.13859275053304904,0.5215588252292103,1.0,6/24,10.54%,TEK;RAMP2;GAS6;KDR;NDNF;SCG2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.31482695540822964,-1.2920466614226465,0.043933054393305436,0.4472342783581779,1.0,36/150,15.41%,PTPN13;PRKAG2;PID1;ERRFI1;LDLRAD4;LRP6;NTRK3;SMAD6;FBLN1;PLPP3;PRKN;ENPP1;LRRK2;PPM1E;IBTK;DEPTOR;IGFBP3;PAK2;DTNBP1;LYN;PDPK1;IMPACT;PMEPA1;PRKCD;DNAJC3;RB1;RASSF2;FKBP8;TRIB2;PARD3;PRKDC;EMILIN1;ZBED3;NCK1;PRKCZ;NCK2
prerank,mesenchymal to epithelial transition (GO:0060231),0.557678037794884,1.29187857916193,0.17124735729386892,0.5214101542201409,1.0,3/10,8.34%,PAX8;PAX2;BASP1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.29211660311858695,-1.2916018551396014,0.009505703422053232,0.44763439661197496,1.0,131/314,30.21%,FBXL7;FBXL17;SMURF2;UBR2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;ECPAS;KLHL15;UBXN2B;HUWE1;DNAJB14;UBQLN1;OS9;UBE4B;WWP1;ZSWIM8;FBXL4;ANAPC5;FBXL12;ANAPC7;PCBP2;UBE2K;JKAMP;EDEM1;MAEA;ANAPC4;ANAPC16;TNFAIP1;RNF216;FAM8A1;SELENOS;RNF103-CHMP3;UBR1;SPOPL;MAN1B1;GID4;RHBDD2;KCTD5;ERLIN1;PSMF1;FBXL19;UBR3;FBXL18;AMN1;CUL3;RB1;FBXW7;TRIM25;KLHL22;NHLRC3;PSMB2;CDC26;UBE2B;SMURF1;FBXO38;FBXO45;CUL2;TOPORS;ERCC8;FAF2;CDC27;UBE2E1;ARRB1;FEM1A;AUP1;BFAR;DERL1;UBE2S;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;CDK2;COP1;PML;ANAPC11;CUL1;PSMC1;UBXN4;APPBP2;SHARPIN;KCTD17;GID8;ECRG4;FBXW4;DCAF12;WFS1;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;DNAJC18;CDC16;FBXL14;FBXO4;ANAPC1;PCNP;TMUB2;SPSB2;PSME1;SEL1L;PSMD13;FZR1;USP19;CDC34;DERL2;PSMB10;PSMA5;SPSB3;FBXL3;PSMB9;LTN1;KBTBD7;RBX1;NFE2L2;FBXL8;UBA52;ZFAND2B
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4821984813986443,-1.2906089039339261,0.1411764705882353,0.44937943872188896,1.0,6/18,12.22%,DCN;MCU;PRKN;DNM1L;DDHD1;RALA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.40022289872237976,-1.290306803371816,0.11428571428571428,0.4494003029860704,1.0,21/37,33.44%,PCM1;IFT43;IFT81;DYNC2I1;IFT88;IFT80;DYNC2LI1;DYNLRB1;DYNC2I2;TRIP11;KIFAP3;IFT27;KIF3A;SSX2IP;IFT140;TTC21B;IFT122;WDR35;DYNC2H1;IFT52;IFT74
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4839270815907535,1.2902363567600164,0.15051546391752577,0.5244640321769382,1.0,2/16,4.90%,CADM1;IL12A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4363584504511062,-1.290029249021317,0.138996138996139,0.4494264519949255,1.0,7/25,13.20%,CCNT2;SETD5;CCNT1;SCAF8;CCNK;WDR43;HTATSF1
prerank,autophagosome assembly (GO:0000045),-0.3676823228309214,-1.2895593135508632,0.09906542056074766,0.449904563249543,1.0,24/52,26.44%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;SMURF1;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;STX17;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;MFN2;ATG3
prerank,regulation of cell communication (GO:0010646),-0.4107115755564203,-1.2895536375056886,0.123046875,0.4492457246359566,1.0,16/35,19.19%,GRK5;ANK2;CXADR;CAMK2D;ANXA1;GRK4;GRK3;TBX18;UGCG;CDC42SE2;SRI;IGFBP7;GRK6;GLRX2;PTPN1;MGLL
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5679134839591656,-1.2885739700286403,0.1791044776119403,0.45096121267187433,1.0,3/10,13.02%,GLI3;BMP4;IRF1
prerank,positive regulation of type I interferon production (GO:0032481),-0.35083248432038683,-1.2884134751460843,0.07462686567164178,0.4506854624335192,1.0,34/73,31.05%,NFKB1;EP300;TBK1;CREBBP;DHX9;DHX36;PTPN22;SETD2;MAVS;RIOK3;IRF1;STAT1;PRKDC;DDX3X;MRE11;OAS2;TLR4;POLR2H;PTPN11;IRAK1;XRCC6;POLR2K;DDX41;POLR3D;NFKB2;POLR2E;POLR3H;DHX58;POLR3E;CGAS;POLR1C;TLR3;IFIH1;DHX33
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43540413734073335,1.2880899871901246,0.14225053078556263,0.5288543237422322,1.0,11/28,17.02%,MAP1B;MAP2;STMN1;MAPRE3;STMN4;CAMSAP1;STMN2;STMN3;FKBP4;CAMSAP3;CLASP2
prerank,electron transport chain (GO:0022900),0.5117807955294525,1.2873807820259506,0.1479028697571744,0.5292749862243173,1.0,6/15,13.39%,CYB561;NDOR1;ENOX2;ETFA;ETFB;ETFDH
prerank,regulation of cytokinesis (GO:0032465),-0.34903487574867553,-1.2873496743657666,0.09505703422053231,0.45272987109943286,1.0,19/78,15.52%,SVIL;KIF13A;BIRC6;CDC14A;KLHL13;UVRAG;CSPP1;CDC42;SETD2;RHOA;GIPC1;RAB11A;CUL3;BECN1;PIK3C3;CDC14B;MAP9;CDC25B;PIK3R4
prerank,platelet degranulation (GO:0002576),-0.3304724617493477,-1.2869884505343532,0.045098039215686274,0.45289571745799145,1.0,36/118,19.37%,IGF1;TIMP3;VCL;PHACTR2;SERPING1;SPARC;PROS1;TLN1;FLNA;NHLRC2;CLEC3B;ANXA5;THBS1;CD9;VTI1B;STXBP1;LYN;ISLR;BRPF3;LAMP2;IGF2;ACTN2;TEX264;GTPBP2;CD109;FN1;VEGFA;VEGFD;TGFB3;ECM1;SERPINE1;SYTL4;TMX3;CHID1;LGALS3BP;ITGB3
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.2888130908332291,-1.2864574478199684,0.01646090534979424,0.45348088518398777,1.0,154/336,33.66%,FOXP1;INO80;SETD7;RNF169;UBE2E2;ABL1;KMT5B;RBBP8;UVRAG;TRIP12;YAP1;SPIDR;CEP63;SMC6;CBX1;UBR5;CBX5;RBBP6;NBN;STXBP4;WDR48;RAD51B;UFL1;TAOK3;TRRAP;BCL2;LYN;RNF8;PDS5A;WRN;NCOA6;XIAP;DDB2;VCPIP1;ZBTB1;ATF2;CCNK;CSNK1E;SMC5;BRSK1;HERC2;UPF1;MNAT1;SUSD6;MCM9;NIPBL;USP47;RFWD3;PARP1;RAD51D;PDS5B;ERCC3;PAXX;ALKBH1;WDR76;NABP2;CASP2;KMT5C;APTX;SLF1;STK33;DTX3L;PARP4;MMS19;PHF1;PRKDC;HINFP;UBE2B;MSH3;FBXO45;TOPORS;ERCC8;MTREX;BOD1L1;NOP53;MRE11;SPRTN;HELB;ZRANB3;IKBKE;UBA7;BAZ1B;VCP;NEK4;TANK;ZDHHC16;PARK7;MSH6;TAOK1;MAP2K6;PML;SMC1A;FANCC;RPAIN;ATR;SIRT4;WAC;MACROD1;PLK5;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;AATF;BRAT1;USP28;MASTL;POLE2;UBQLN4;RECQL5;BCL2L2;KIN;MAPK14;OGG1;HTRA2;ENDOV;RAD54L;GTF2H4;SHPRH;POLH;TIMELESS;CGAS;ZBTB4;DCUN1D5;IGHMBP2;E2F1;NUDT1;PARP3;BAK1;MGMT;SAMHD1;HIC1;ZBTB38;GNL1;BATF;UBA1;FANCG;BCL2L11;PARP2;FAAP20;TNFRSF1B;BCL6;RAD9A;PNKP;RMI2;RAD51;PSME4;POLA1;ALKBH8;DDB1;TIGAR;BRCA1;PCLAF
prerank,regulation of fat cell differentiation (GO:0045598),-0.35390220988161475,-1.2864461672283216,0.07755102040816327,0.4528525444839004,1.0,21/74,18.77%,SMAD3;MEDAG;FTO;TMEM64;ENPP1;YAP1;CREBL2;ZBTB16;RUNX1T1;ID2;RORA;TRPM4;TRIB2;WDFY2;ANKRD26;TAF8;CMKLR1;TRIO;WNT5A;SYAP1;BMP2
prerank,actin filament depolymerization (GO:0030042),-0.5481472219183847,-1.2863853773019667,0.16135084427767354,0.45234740607096163,1.0,3/11,3.91%,MICAL3;GSN;MICAL2
prerank,microtubule depolymerization (GO:0007019),0.4726406390407882,1.286082273662889,0.1673228346456693,0.5314122223963496,1.0,6/17,18.21%,STMN1;STMN4;STMN2;KIF19;STMN3;KIF18A
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4760349906482656,1.2856919005179288,0.15463917525773196,0.5309395186678552,1.0,2/17,4.90%,CADM1;IL12A
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5205499661027068,-1.2855394786363403,0.16506717850287908,0.45371227685784515,1.0,4/13,9.15%,DDO;ASPA;GLUD1;GLUL
prerank,regulation of MAPK cascade (GO:0043408),-0.313647295504481,-1.2848247647638902,0.04426559356136821,0.4547645139992881,1.0,30/157,8.85%,ROCK2;TGFBR3;IGF1;ROR1;EGFR;LPAR1;DAG1;EPHA7;NTRK3;PELI2;KSR1;STK3;ROCK1;ADRA1B;GSDME;KIT;STYX;RYK;NRK;HMGB1;LBH;PAK2;MAP4K4;TAOK3;FGFR2;SHC1;LYN;NBR1;IGF2;MAP2K1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5590184441811353,1.284706350390405,0.2013888888888889,0.5321010566233404,1.0,5/10,12.59%,PDE2A;PDE11A;APLNR;RNF157;PDE4D
prerank,regulation of cellular metabolic process (GO:0031323),-0.39005488422084483,-1.2843302786617294,0.10311284046692606,0.4552235847493431,1.0,10/45,12.82%,PID1;PRKN;TBC1D16;MKLN1;CYP1B1;PANK2;KIF16B;NPC2;ARF1;MBOAT7
prerank,negative regulation of blood coagulation (GO:0030195),-0.3996916969882793,-1.2842189835999231,0.12218045112781954,0.45482108981140856,1.0,6/38,7.34%,PDGFRA;SERPING1;VTN;PLAT;TFPI;F3
prerank,sulfation (GO:0051923),-0.5434107351892898,-1.2838240233727636,0.17177914110429449,0.4552211221120932,1.0,2/11,10.52%,UST;SULT1A1
prerank,positive regulation of protein secretion (GO:0050714),-0.3503005147886169,-1.2837541921788982,0.08918406072106262,0.4547152071790031,1.0,12/69,10.53%,BMP6;WLS;IGF1;TCF7L2;MCU;NLGN2;RBP4;DNM1L;GLUD1;NNAT;UNC13B;ADAM9
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4143388835395733,-1.2831687597734167,0.1256931608133087,0.45543278871157533,1.0,11/31,12.58%,BOC;CDON;CTNNA1;ABL1;MEF2A;FGFR2;CDC42;IGF2;ID2;MEF2C;TCF3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4324466999582828,-1.2831261133078005,0.12475247524752475,0.4548619854749093,1.0,4/26,4.33%,IGF1;FHL2;GSK3B;SLC9A1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.29473530959664535,-1.2828131289086369,0.019417475728155338,0.45500274734020657,1.0,102/264,28.06%,SRRM2;DDX5;HNRNPH1;PABPN1;HNRNPR;SYNCRIP;PCF11;WDR33;DDX17;CASC3;IK;SRSF10;RBM6;DDX46;FUS;HNRNPM;U2AF2;DHX9;SF3B1;CPSF3;SRSF6;HNRNPUL1;HNRNPD;RBM10;PRPF6;PCBP2;RNPC3;DDX42;CDC5L;CDK13;PRCC;SLU7;GEMIN5;HNRNPK;PRPF3;SF3A1;SF3B6;YTHDC1;USP39;SCAF11;SF3A3;TGS1;RSRC1;ZCRB1;SNRNP70;CCAR1;DNAJC8;STRAP;DDX23;YBX1;CWC22;COIL;RBM5;SRSF1;CWF19L1;EFTUD2;GEMIN7;SNU13;MTREX;PRMT5;SFPQ;PPIH;UBL5;PRPF40B;PPWD1;WBP11;CSTF3;HNRNPU;ZMAT5;POLR2H;SNRPF;HNRNPA3;RBM4;SRSF7;SRSF11;GEMIN2;SRRM1;UPF3B;SRSF2;CSTF1;GTF2F1;POLR2K;CPSF4;NUDT21;DDX41;SMU1;DHX15;NONO;PRPF38A;POLR2E;CPSF1;NCBP2;PRPF8;CRNKL1;LSM6;RBM22;RBM19;CACTIN;SUGP1;POLR2D;HNRNPL;ISY1
prerank,sprouting angiogenesis (GO:0002040),-0.3730378006442814,-1.2821131818895741,0.12266112266112267,0.4560755577987047,1.0,18/51,17.48%,PARVA;ANGPT1;EFNB2;CCBE1;BMP4;ROBO1;THBS1;RSPO3;RNF213;ADGRA2;NRP1;RECK;SEMA3E;BMPER;VEGFA;VEGFD;NR4A1;MIA3
prerank,ion transport (GO:0006811),0.32791438219336694,1.2817164467144466,0.06365503080082136,0.5388210577010445,1.0,20/111,10.90%,SLC24A4;SLC24A2;GRIN1;SLC4A1;GABRB1;GLRA1;KCNN2;AQP11;SLC17A6;SLC1A1;SLC8A1;SLC12A6;SLC15A3;KCNN1;SLC1A2;KCNN3;SLC12A3;SLC36A1;VDAC2;ATP1A4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.485951804273426,-1.2812328180332337,0.16292134831460675,0.45763157972263036,1.0,6/17,7.78%,NTRK3;ABL1;BAIAP2L1;BCAS3;NRP1;CDC42
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.480653945900571,-1.280944922971367,0.14471243042671614,0.45765539097315977,1.0,8/18,31.90%,KAT2B;NCOR1;PTBP3;TERT;TMBIM6;ESR1;ZC3H10;NUDT16
prerank,DNA recombination (GO:0006310),-0.3964210699455311,-1.279268952319972,0.1280148423005566,0.46096827561037224,1.0,23/37,39.79%,HMGB1;RAD51B;WRN;RAD21;RAD51D;MSH3;DMC1;MRE11;RPAIN;RAD51C;ERCC1;RECQL5;RAD54L;IGHMBP2;SUPV3L1;HDAC10;RAD51;LIG4;GEN1;MSH2;RAD52;XRCC3;EXO1
prerank,response to steroid hormone (GO:0048545),-0.4126203264100151,-1.2786477505602538,0.12075471698113208,0.46181433343401707,1.0,8/31,10.23%,ATP1A2;YAP1;NR3C1;THBS1;TFPI;AR;MED1;NR1H3
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.47056577171745817,-1.2785676224603704,0.16071428571428573,0.46130031693841406,1.0,14/20,42.18%,MBTPS2;APOE;MBTPS1;EPHX2;LPCAT3;ARV1;ACADVL;NR1H4;SREBF1;RAN;ACADL;FMO5;LDLRAP1;KPNB1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5614196813975344,-1.277911754319336,0.1881918819188192,0.4623324674957016,1.0,3/10,12.95%,HMGB1;ZBTB1;TRPM4
prerank,visual system development (GO:0150063),-0.4046432274698049,-1.277904769179752,0.12452107279693486,0.46169050159267944,1.0,6/37,5.76%,PBX1;SMOC1;FOXC1;SH3PXD2B;RBP4;PBX3
prerank,stem cell development (GO:0048864),0.4954817072415785,1.277559772805368,0.15212981744421908,0.5485893551416102,1.0,3/16,6.01%,NRG1;CDH2;CYP26C1
prerank,vascular process in circulatory system (GO:0003018),-0.5035524310149764,-1.2772912649625319,0.15819209039548024,0.46186288388028846,1.0,4/13,12.26%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.5035524310149764,-1.2772912649625319,0.15819209039548024,0.46186288388028846,1.0,4/13,12.26%,ROCK2;ROCK1;ADCY6;AGTR1
prerank,regulation of cell motility (GO:2000145),0.32555945771994227,1.2767722204917122,0.06748466257668712,0.549123940253589,1.0,23/121,9.96%,SPOCK2;SPOCK3;FRMD5;ERBB4;CSF1R;PLXNB3;TMSB4X;NRG2;NRG1;TMSB10;ROBO4;FGF10;ENPP2;MEAK7;PKN1;FGF5;AKT1;PLXNA4;SGK3;SST;SPATA13;CYRIB;NTN1
prerank,positive regulation of cell aging (GO:0090343),0.5334742060859317,1.2765115791951716,0.17954070981210857,0.5482923893015746,1.0,3/11,4.97%,SIRT1;HMGA2;YPEL3
prerank,gas transport (GO:0015669),0.5465684319231834,1.276398754646006,0.19438444924406048,0.5471743205792737,1.0,2/10,9.13%,CA2;MB
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4914407478550331,-1.2759455149273016,0.1586998087954111,0.46462917921294944,1.0,7/16,16.99%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1
prerank,midbody abscission (GO:0061952),-0.48103994057638033,-1.2757810700642067,0.1524163568773234,0.4643509692835502,1.0,5/17,10.05%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3
prerank,protein kinase B signaling (GO:0043491),0.44283623676968886,1.275670998549582,0.15723270440251572,0.5476494435384712,1.0,6/23,11.13%,PAX2;GAS6;KDR;AKT1;CCL2;PIK3R3
prerank,histone H3-K4 methylation (GO:0051568),-0.43762858129380877,-1.2753869094170855,0.14232209737827714,0.4646612683095411,1.0,14/26,33.03%,KMT2C;KMT2D;CTR9;KDM6A;OGT;KMT2A;PRDM9;PAXIP1;CXXC1;TET2;TET3;WDR5;WDR5B;DPY30
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.436414171420071,-1.274681618674185,0.11588785046728972,0.4657021544264771,1.0,8/27,18.15%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;KAT8;TAF6L;MSL3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5068630671074119,-1.2744499578039743,0.19130434782608696,0.46559177437011623,1.0,4/14,10.34%,ANKRD17;PUM2;PUM1;DDX60
prerank,osteoclast differentiation (GO:0030316),-0.4526614575416257,-1.2739833474499191,0.16116504854368932,0.4660448672100482,1.0,7/22,15.24%,FOXP1;GAB2;SBNO2;ANXA2;SNX10;GLO1;FARP2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3838922189262393,-1.2730547158260428,0.12981744421906694,0.4677027008321517,1.0,8/43,10.03%,EGFR;ERRFI1;CBLB;RNF115;SNX6;PTPN3;CDC42;PTPN2
prerank,response to UV (GO:0009411),-0.33266742140114985,-1.27275197018072,0.10153256704980843,0.4677726336119295,1.0,35/95,24.05%,EGFR;INO80;SCARA3;EP300;GTF2H2;CREBBP;UBE4B;DHX36;WRN;PTPRK;DDB2;ZBTB1;BRSK1;PRKCD;USP47;PARP1;ERCC3;EIF2AK4;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;SDE2;DCUN1D3;MFAP4;MSH6;PCNA;USF1;BMF;ATR;CCAR2;PRIMPOL;USP28
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4997854386506778,-1.2727307511983188,0.1751412429378531,0.4671616752540587,1.0,6/14,16.11%,PIAS1;JAK1;PTPN2;PARP9;STAT1;IFNGR1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5400265323461305,-1.2723183993864489,0.1780821917808219,0.46756445052424317,1.0,6/11,24.20%,DAB2;PRKN;RAB21;EIPR1;MSN;PTPN23
prerank,primary alcohol metabolic process (GO:0034308),-0.4435177326380163,-1.2716720507158061,0.1523046092184369,0.46846632690581486,1.0,5/25,11.18%,IGF1;RBP4;DHRS3;CYP1B1;NAPEPLD
prerank,negative regulation of organelle assembly (GO:1902116),-0.40408042375069236,-1.2710599167290162,0.13575525812619502,0.46925465551713663,1.0,13/35,22.38%,KAT2B;LRRK2;NUPR1;YAP1;SEC22B;CHMP4B;CHMP4A;SMAD4;ODF2L;FEZ2;CDK10;TBC1D7;TCHP
prerank,regulation of protein localization to membrane (GO:1905475),-0.42757933386183594,-1.2707764213711419,0.14258188824662812,0.4692916815974175,1.0,10/28,12.97%,GPC6;GSN;SLC5A3;PRKN;GPC4;GPC3;VTI1B;AR;MMP14;APPL1
prerank,synaptic vesicle endocytosis (GO:0048488),0.40533047639837744,1.2702439315199856,0.13771186440677965,0.5611659850276107,1.0,14/33,18.87%,DNM3;SYT1;NLGN1;SNCA;SNAP91;AMPH;SYT2;SNCB;NLGN3;PACSIN1;DNM1;GAK;SYNJ1;SYT5
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5328753265977202,-1.2701006105439778,0.19144981412639406,0.4702762238566634,1.0,7/12,28.25%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,positive regulation of lyase activity (GO:0051349),-0.5048407305647996,-1.2697830509160601,0.18631178707224336,0.470378707364195,1.0,7/14,22.09%,CACNA1C;STIM1;CACNA1D;PARK7;NOS1;FXN;ORAI1
prerank,digestive tract morphogenesis (GO:0048546),-0.5043394342573403,-1.269204186001098,0.19642857142857142,0.4710997309553201,1.0,8/14,25.77%,PDGFRA;FGFR2;ID2;NIPBL;GLI1;RBPMS2;SOX11;EPHB3
prerank,fluid transport (GO:0042044),0.5150592020292265,1.2687550350847319,0.16198704103671707,0.5639532151775509,1.0,3/12,12.22%,AQP9;AQP11;AQP4
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4624485372838252,-1.268639906100658,0.1509090909090909,0.4718738531966197,1.0,8/20,18.77%,WNT4;BMP5;WDTC1;ERLIN1;SIK1;FBXW7;SLC27A1;BMP2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3438434807274769,-1.268553719064386,0.09664694280078895,0.4714266264218509,1.0,15/85,7.81%,EYA1;ROR1;PIEZO2;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,lamellipodium assembly (GO:0030032),-0.4360541981931143,-1.2682598665905214,0.15808823529411764,0.47147197196752416,1.0,9/26,16.70%,VCL;KIT;ITGB1;ABLIM3;ARFIP2;P2RY12;WHAMM;CARMIL1;ARHGEF6
prerank,catecholamine metabolic process (GO:0006584),-0.4987732887570696,-1.2676329361104552,0.17509727626459143,0.47237705952035136,1.0,3/14,8.28%,PRKN;SNCAIP;COMT
prerank,cellular response to ATP (GO:0071318),0.5056514556390096,1.267606269402281,0.16317991631799164,0.5655993575226567,1.0,4/14,11.50%,RYR3;P2RY1;CIB2;P2RX7
prerank,mitochondrion localization (GO:0051646),-0.4559691501301503,-1.267589264688855,0.1684981684981685,0.4718097550346141,1.0,6/19,15.67%,TRAK1;LRRK2;MEF2A;NECTIN2;ZBED3;MARK1
prerank,photoperiodism (GO:0009648),-0.412009905277554,-1.2675280011469352,0.15885947046843177,0.4713203205350167,1.0,10/28,20.28%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.48063289857545716,1.267288917699475,0.16379310344827586,0.5649824657543389,1.0,3/17,7.55%,SLA2;THY1;PTPRJ
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4973824791549832,1.2672537659888448,0.1683991683991684,0.5635313819078493,1.0,4/13,13.01%,TMEM30A;SAR1A;BRSK2;SORL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5067642986600518,1.2670996533911034,0.17255717255717257,0.5624167353742989,1.0,6/13,14.32%,ANK3;SLC8A1;CALM1;PDE4D;CALM2;CALM3
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.49176755386583915,-1.266965071402933,0.19144981412639406,0.4719982562890727,1.0,6/15,20.62%,LRP1;PDPN;DPP4;FAP;DDR1;FGFR4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.41840500983409273,-1.2667978527350174,0.1489795918367347,0.47176628243559415,1.0,10/27,20.28%,FBXL17;PER3;FBXL12;CRTC1;ID2;SIK1;USP2;PPP1CB;RBM4;PML
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3254917379850142,-1.2667848918978537,0.09161793372319688,0.4711368938957737,1.0,33/108,20.60%,PHLDB2;ROCK2;LRP1;RHOQ;EPHA3;DIAPH1;PDGFRB;ROCK1;ABL1;PRKAA2;GSK3B;RND3;PAK2;MTOR;CLIC4;ARHGAP17;IQGAP2;RHOA;PRKCD;RHOBTB2;RICTOR;PLXNB1;SORBS3;ARHGAP18;FAM107A;PRKAA1;RHOBTB1;RHOH;RHOC;CDK10;TAOK1;BAIAP2;SPEF1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3363648955224235,-1.2667660283222062,0.08130081300813008,0.4705240886424987,1.0,19/86,15.36%,BMP6;IGF1;EGFR;EPHA7;ANGPT1;GHR;ABL1;VTN;PAK2;NRP1;IGF2;PRKCD;TEC;IL6R;VEGFA;ACVR1;PRKCZ;PDCL3;ITGA5
prerank,negative regulation of protein depolymerization (GO:1901880),0.4485672729761636,1.2667102966159693,0.15625,0.5620083899648637,1.0,12/24,19.70%,NAV3;FGF13;CAMSAP1;STMN2;ARHGEF2;MID1IP1;APC;CIB1;CAMSAP3;CLASP2;TTBK2;CLASP1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5014861296562523,1.2664315510313306,0.1565217391304348,0.5612712377314943,1.0,3/14,6.83%,TIRAP;HNRNPC;HNRNPA0
prerank,cellular response to heat (GO:0034605),-0.4003073022003269,-1.2662774426191719,0.133086876155268,0.4711137315591856,1.0,16/35,27.98%,FGF1;THBS1;DHX36;SLU7;BAG3;TPR;YWHAE;PRKACA;ANO1;VCP;HSBP1;ZFAND1;HSF1;HTRA2;TCIM;POLR2D
prerank,response to peptide hormone (GO:0043434),-0.381535136670081,-1.2660107410922574,0.14084507042253522,0.47113427303826516,1.0,13/43,17.74%,ROCK2;TGFBR3;IGFBP5;ROCK1;IRS1;STAT3;ANXA1;OGT;SLC27A1;STAT1;ZBED3;STAT5A;STAT5B
prerank,ovarian follicle development (GO:0001541),-0.525751309874278,-1.2654061498421512,0.18878504672897195,0.4719727720900518,1.0,10/13,38.28%,KIT;VEGFA;INHBA;EIF2B4;EIF2B5;INHBB;INHA;CEBPB;ANG;LHCGR
prerank,intracellular protein transport (GO:0006886),-0.28458138721851695,-1.2649052535470278,0.017786561264822136,0.47251042528470333,1.0,109/304,26.39%,WLS;RANBP3L;APPL2;TRAK1;PKD1;TLK1;KIF13A;KIF13B;XPO4;TBC1D16;SGSM2;EIF4ENIF1;SNX9;FUT10;SNX6;SEC23IP;STAT3;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;AP4E1;NUP42;LAMP2;COPZ2;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;BAG3;TBC1D2B;HERC2;TBC1D8B;GGA3;NUP214;RPGR;RPL11;GIPC1;IPO13;COG7;STX4;ARFIP2;ARF1;TPR;AP4S1;APPL1;STX5;COPB2;SURF4;TBCK;RAB21;CTTN;GRTP1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;SNX8;FAM53C;TMED3;WDR11;NAPA;TBC1D17;RANBP3;TMED5;TMED4;RABGAP1;SNF8;SEC16A;DESI1;STX17;RPAIN;TBC1D10A;RAB24;AKT2;GGA2;STX8;IFT27;IPO9;RABL3;VPS26B;CHP1;TNPO3;ARL5A;XPO5;NSF;LMAN1;USO1;XPO1;AP2A1;PREB;SAR1B;PPP1R10;SYK;RAB7A;STX12;PHB2;RAB5A;CLIP3;STX1A;VPS45;TBC1D10B;NUP93
prerank,positive regulation of macrophage activation (GO:0043032),-0.47921024862044403,-1.264779531251518,0.1687612208258528,0.47217022415373694,1.0,6/17,20.00%,LBP;THBS1;TNIP2;TLR4;WNT5A;KARS1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5368228232558779,-1.2643695519109615,0.19854280510018216,0.47247875095009517,1.0,2/11,11.85%,PTGIS;FAP
prerank,bile acid and bile salt transport (GO:0015721),0.4409740387068286,1.264305280135576,0.15913978494623657,0.5659649061946116,1.0,4/24,10.50%,SLCO1C1;NCOA2;SLCO2B1;ABCC4
prerank,respiratory system development (GO:0060541),-0.40930567018299036,-1.2642004106144515,0.15169660678642716,0.4722849152517353,1.0,14/32,21.57%,GLI2;FGF1;BMP4;PDPN;DISP1;RBP4;FGFR2;CHD7;CCDC39;VEGFA;LOXL3;SMCHD1;ZIC3;FGF2
prerank,negative regulation of RNA splicing (GO:0033119),-0.4702414320202547,-1.2641992792777599,0.14559386973180077,0.4716413486587046,1.0,5/19,7.39%,SFSWAP;SRSF10;U2AF2;PTBP3;SRSF6
prerank,central nervous system neuron development (GO:0021954),0.4887152287195428,1.2640416709058324,0.17813765182186234,0.5652040705581631,1.0,4/15,8.37%,MAP2;NTRK2;HSP90AB1;B4GALT6
prerank,primary miRNA processing (GO:0031053),-0.5726896598068056,-1.2633536144746715,0.18518518518518517,0.4730441250677326,1.0,3/10,6.96%,SMAD3;SMAD2;PUS10
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.41375892893329924,-1.262818888753235,0.14579439252336449,0.4737353631464067,1.0,18/32,29.73%,GTF2H2;CCNH;CDK7;CAVIN1;TAF1D;TBP;MNAT1;ERCC3;POLR2H;POLR2K;GTF2H1;POLR2E;TAF1C;GTF2H4;POLR1G;TAF1A;RRN3;POLR1C
prerank,cellular response to peptide (GO:1901653),0.35929867721284037,1.262804838898338,0.11538461538461539,0.5671525103838968,1.0,14/56,13.89%,IGF1R;GRM5;GRIN1;CACNA1A;GRIN2A;RPL23;CACNA2D1;ATP1A3;DDX11;ARHGEF2;NOD1;XBP1;PSEN1;CD36
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3376715853930068,-1.2625929629101669,0.09650924024640657,0.47362535809643574,1.0,33/85,24.46%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;NUPR1;GSK3B;RNF217;RNF19A;RNFT1;NUB1;CSNK1E;TMEM259;FBXW7;TRIB2;SH3RF2;USP13;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;TMTC3;ARIH2;DET1;RNF144A;BAG6;NKD2
prerank,regulation of exosomal secretion (GO:1903541),-0.4727775200149765,-1.2620609456386203,0.1791907514450867,0.4742344249825893,1.0,8/19,25.11%,PRKN;VPS4B;CHMP3;SDC4;SNF8;RAB7A;SDC1;ATP9A
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4001923851562516,-1.2617381152666791,0.129979035639413,0.4743719488725238,1.0,5/37,3.78%,NFKB1;ITGAV;NCOR1;PRKN;DLG4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.53785244422778,-1.261497870132745,0.18490566037735848,0.47429874506909536,1.0,6/10,26.22%,DHX36;CPEB1;CDC73;NUDT21;HSF1;NCBP2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4811801606735648,-1.2614124976606975,0.17005545286506468,0.4738783153382774,1.0,11/17,30.48%,PID1;HDAC4;NCOR1;NUPR1;PARP1;CBFA2T3;FIS1;PPARA;PDE12;MLXIPL;PPIF
prerank,regulation of potassium ion transport (GO:0043266),0.4113668059325841,1.2613711736221511,0.14375,0.5695003688202165,1.0,7/31,7.97%,DPP10;KCNIP4;KCNN2;ANK3;KCNIP1;DPP6;KCNAB1
prerank,hepaticobiliary system development (GO:0061008),-0.44727344283760434,-1.2611929616379896,0.173828125,0.4737220618661631,1.0,7/20,12.34%,TGFBR3;WNT4;CEBPG;PHF2;NIPBL;ARID5B;PKD2
prerank,iron ion homeostasis (GO:0055072),0.3617550609753534,1.2609462375754197,0.1072961373390558,0.5691870943940145,1.0,12/58,10.63%,TFRC;ALAS2;TMPRSS6;SLC40A1;ABCG2;FTH1;SLC22A17;FTL;ISCU;FBXL5;ATP6V1A;ATP6AP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5037273215900872,-1.2607355159713223,0.18450184501845018,0.47413350076771477,1.0,4/14,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.37861229566207444,-1.2600447402571477,0.12927756653992395,0.47507493015817204,1.0,17/44,22.49%,GSN;FCHSD2;BAIAP2L1;SNX9;VASP;CDC42EP5;FER;NCKAP1;CTTN;NCK1;WHAMM;CARMIL1;NCK2;CDC42EP4;LMOD1;BAIAP2;CDC42EP1
prerank,dopamine metabolic process (GO:0042417),-0.47204737973807304,-1.2596350635203386,0.17790262172284643,0.47541111554964144,1.0,4/18,8.28%,MOXD1;PRKN;SNCAIP;COMT
prerank,regulation of macrophage differentiation (GO:0045649),-0.49169384850060077,-1.2596274268991485,0.19746376811594202,0.4747817525111601,1.0,6/15,23.41%,IL34;PTPN2;ID2;INHBA;PRKCA;HSF1
prerank,regulation of cilium assembly (GO:1902017),-0.35891475010333196,-1.2595402723890607,0.11670020120724346,0.4743720750175356,1.0,30/62,28.24%,TBC1D16;YAP1;DCDC2;TBC1D19;TBC1D24;MARK4;USP6NL;TBC1D2B;TBC1D20;IFT88;ODF2L;TBC1D22B;DYNC2LI1;ATG5;TBC1D17;CDK10;RABGAP1;TBC1D7;TBC1D10A;KCTD17;TAPT1;TCHP;ARHGAP35;IFT140;TBC1D10B;BBS4;ATG3;TESK1;TBC1D9B;RABEP2
prerank,liver development (GO:0001889),-0.401896623951347,-1.258326895325559,0.15674603174603174,0.4767216104006255,1.0,12/32,21.31%,TGFBR3;WNT4;ANXA1;CEBPG;PHF2;ARID5B;PKD2;PCK2;CCDC39;CITED2;ZIC3;CDK5RAP3
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.38681211357404105,-1.2582058794776465,0.12293577981651377,0.47633920806343505,1.0,23/39,33.80%,ABCA1;STEAP3;TANGO6;RAB10;RAB12;ARFGAP3;RCN3;MON1A;COPG2;MIA3;COPG1;RAB3D;PREB;RAB8A;TVP23B;AFM;SEL1L;PPY;RAB8B;MIA2;LTBP2;TVP23A;RAB15
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44453764127282025,-1.257218981263581,0.16377649325626203,0.47811467648922434,1.0,8/20,25.48%,HOXA5;ZBTB16;CTR9;HSPA9;CDC73;CDK6;MAFB;LDB1
prerank,regulation of macroautophagy (GO:0016241),-0.3217025480738894,-1.2569653436807708,0.09381237524950099,0.4781635045647378,1.0,17/105,11.15%,PRKAG2;DCN;SMG1;ATP6V1B2;LRRK2;PRKAA2;RPTOR;TBK1;ATP6V0D1;SNX6;UBQLN1;MTOR;LARP1;SESN1;RB1CC1;PRKAB2;PAFAH1B2
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4252460790480855,-1.2567845532033357,0.15648854961832062,0.47795266966941113,1.0,14/28,29.54%,PDK1;PRKN;FOXK1;PANK2;RORA;APOE;FOXK2;EPHX2;BCKDK;ARV1;PPARA;ACADVL;NR1H4;PDK3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.41484851853358734,-1.2566736619342893,0.14885496183206107,0.4775674846581506,1.0,14/29,20.37%,TCF7L2;EP300;KMT2D;BCL9L;PYGO1;CREBBP;TRRAP;TLE4;TLE1;TCF7L1;HDAC1;CDC73;TERT;TLE3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5348552136084262,1.2566515799754918,0.1905781584582441,0.5797588671335594,1.0,3/11,7.41%,ITM2A;NECAB2;ITM2C
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5537407227530802,1.2561037223426765,0.19829424307036247,0.5797867503837885,1.0,4/10,19.95%,ANK3;KCNAB1;KCNRG;SUMO1
prerank,neuron differentiation (GO:0030182),0.3064067637067338,1.2560945657648022,0.04554079696394687,0.5782822992197962,1.0,36/165,17.00%,PHOX2A;SPOCK1;MYT1L;PTPRD;IRX2;IL1RAPL1;TENM2;PBX2;TENM1;EPHA5;NTRK2;TENM4;NEUROD6;FUT9;TGFB2;ALK;SNPH;LHX1;WNT7B;TENM3;ITM2C;RNF112;ERCC2;ATP8A2;BRSK2;FZD4;RORB;XBP1;ATP2B2;PPT1;ACSL3;SOX4;LMX1B;PBX4;DDIT4;CTNNB1
prerank,negative regulation of cell migration (GO:0030336),-0.3117195738967432,-1.2555481495910772,0.07878787878787878,0.4796875857169574,1.0,25/137,9.27%,PHLDB2;SULF1;COL3A1;DPYSL3;AFDN;LRP1;DAG1;BMPR1A;VCL;LDLRAD4;TPM1;IGFBP5;FOXO3;ROBO1;JAG1;PODN;IGFBP3;CDH1;HOXA7;CLIC4;EPHA4;RECK;GJA1;PTPRK;CYP1B1
prerank,nucleic acid metabolic process (GO:0090304),-0.3497196339277703,-1.2554845116352154,0.11218568665377177,0.4792186539035803,1.0,33/69,33.61%,RBFOX2;HNRNPH1;ENPP1;HNRNPR;WTAP;HNRNPM;HNRNPD;PCBP2;WRN;HNRNPK;DUSP11;XRN2;MMS19;HNRNPU;POLR2H;HNRNPA3;GTF2F1;POLR2K;DNASE2;POLR2E;RECQL5;NCBP2;PDE12;DNASE1L1;POLR2D;HNRNPL;KPNA2;LSM1;WDR74;PCBP1;RBMX;HNRNPA2B1;RAN
prerank,positive regulation of neuron migration (GO:2001224),0.5222054394111667,1.2554117179380486,0.18480492813141683,0.5787246400013892,1.0,4/11,9.89%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.4801021945080465,-1.2552746864697373,0.1724770642201835,0.47908514325062956,1.0,5/16,9.94%,CHMP4B;CHMP4A;LEPROTL1;CHMP5;LEPROT
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4364187885955674,-1.255267866904719,0.15473887814313347,0.4784695735639916,1.0,4/25,7.56%,ERRFI1;CBLB;SNX6;SLC6A9
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.512873357818584,-1.2545494254076959,0.2026266416510319,0.4795536903576606,1.0,7/13,28.25%,RNF8;NELFB;TCERG1;HNRNPU;RECQL5;NELFA;NELFE
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5320438805594476,1.2543373537159803,0.20697167755991286,0.5802874495060565,1.0,3/10,11.89%,DLGAP1;DLGAP2;NPTX1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.46551703084035445,-1.2534986613289212,0.2,0.48142211649595607,1.0,8/18,31.48%,VGLL4;CTSC;DACT1;APOE;ATP5IF1;MSN;CD81;RDX
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4739260002821756,-1.253380721210286,0.17958412098298676,0.4810658444954659,1.0,5/17,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5284129960979682,-1.253255730459471,0.17068645640074212,0.4807309647782342,1.0,5/12,16.75%,FOXP1;DAB2;NCOR1;HDAC1;HEYL
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5433860721198741,1.2532400001311998,0.2062780269058296,0.5818752143858539,1.0,3/10,10.18%,SIRT1;SNCA;SET
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5132741265099494,-1.2530895329822243,0.17984189723320157,0.4805038130371278,1.0,5/13,17.09%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.47798549388094813,-1.2529735312509394,0.1657559198542805,0.48019565933480385,1.0,5/17,7.81%,ATP1A2;CACNA1C;ANK2;KCNJ2;CACNA1D
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3504105955661915,-1.252357836942032,0.09381237524950099,0.4811294981216858,1.0,23/66,21.31%,ZIC1;SMAD3;YAP1;FLNA;UBR5;CCT6A;CDH1;EIF2AK3;JUP;BAG3;PRKCD;PARP9;MAVS;CCT8;TPR;DTX3L;CCT5;EFCAB7;PARK7;ORMDL3;TERT;PIK3R1;CDK5RAP3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4742524528014829,1.2520096247061974,0.2,0.5838021273407362,1.0,4/16,10.84%,MRAP2;NECAB2;GRP;PDE6H
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4840561769063372,1.2516706668132533,0.19742489270386265,0.583280562027128,1.0,1/15,0.37%,PLTP
prerank,Golgi ribbon formation (GO:0090161),-0.5098455160860632,-1.251572480109675,0.1873873873873874,0.4823864293152537,1.0,6/13,19.84%,VTI1A;STX16;PRMT5;VAMP4;TMED5;TRIP11
prerank,brain development (GO:0007420),0.3133634817933858,1.2514806019112614,0.07630522088353414,0.5823172896628246,1.0,26/136,10.82%,ADGRL3;CNTNAP2;GRIN1;CTNNA2;SLC6A17;PROX1;PBX2;GRIN2A;SHANK3;CDH2;PAX2;GRIN2B;MFSD2A;GRIN2D;AATK;PITPNM1;DSCAML1;ROBO2;UBE3A;RELN;ADGRL2;PHGDH;FOXJ1;SPEF2;HAP1;CNTN4
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.3059667561966932,-1.2514347119264306,0.059813084112149535,0.48207702148312453,1.0,39/170,15.50%,ROCK2;PRDM6;IGF1;FOXP1;PRDM5;ZNF462;TRIM44;AFF3;TFEB;TBC1D16;AFF1;CDH1;ZUP1;MKLN1;REST;HNRNPD;FUBP1;PCBP2;KDM6A;LDLR;HNRNPK;KIF16B;HIF1A;AFF4;NFKBIZ;TRIM5;TRIM11;ARF1;YBX3;ADNP2;CGGBP1;MTMR3;YBX1;ATRAID;APOE;HINFP;PRDM2;TRIM39;RASA1
prerank,retinoic acid metabolic process (GO:0042573),-0.49917087009255756,-1.2512965868971098,0.1863468634686347,0.4817590565277859,1.0,2/14,3.51%,ALDH1A2;CYP26B1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4745197856100445,-1.2506308105410442,0.19076305220883535,0.48277172109937816,1.0,7/16,13.56%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5015009411404752,-1.2506015837257525,0.18882466281310212,0.48220456991949606,1.0,10/14,33.55%,AUTS2;CTR9;SMAD4;KMT2A;PRDM9;PAXIP1;KMT2E;WDR5;SNW1;BRCA1
prerank,pyroptosis (GO:0070269),-0.4920771023616581,-1.2503323005498068,0.19195612431444242,0.48219088794763726,1.0,9/15,41.55%,GSDME;DHX9;GSDMD;APIP;ZBP1;CASP1;CASP4;TREM2;NLRC4
prerank,homotypic cell-cell adhesion (GO:0034109),-0.39376322591701557,-1.250300358015802,0.14971209213051823,0.4816725536859721,1.0,11/39,15.57%,VCL;PDGFRA;PLPP3;MEGF11;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,polyol metabolic process (GO:0019751),-0.37541527999527746,-1.2501721976963946,0.138996138996139,0.48136803480420054,1.0,11/46,10.26%,PLCE1;SLC5A3;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4586943790317216,-1.2501588737150306,0.16261682242990655,0.4807746694971457,1.0,7/19,16.50%,WNT4;VIM;BMP4;RUNX1;EMILIN1;TGFB3;SUCO
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3332785045134486,-1.249937265115298,0.10136452241715399,0.48071341137943957,1.0,23/84,18.42%,SMURF2;PRKN;WWP2;GSK3B;VGLL4;GPC3;HUWE1;SNX9;AXIN1;WWP1;SEC22B;DACT1;NRDC;ADAM9;STX5;APOE;SMURF1;CSNK2A1;ADRA2A;ASB5;WNT5A;AREL1;VCP
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4439131744770871,-1.2496278045671616,0.14575645756457564,0.4808052519194395,1.0,6/22,13.54%,CCNT2;CCNT1;SCAF8;CDK13;CCNK;TCERG1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.34975626675711813,-1.2495980089969858,0.11354581673306773,0.48023497069222715,1.0,30/63,28.60%,TIMP3;LEPR;EIF4G3;ROCK1;NUPR1;ZKSCAN3;STAT3;BCL2;PTPN3;MTOR;FOXK1;PTPN22;EIF4E;KLHL22;ATRAID;FOXK2;DAP;RUBCN;EIF4G1;TIMP2;CDK5RAP3;BMF;RGP1;WDR6;DAPL1;RRAGA;HGF;RIC1;MET;MT3
prerank,positive regulation of neuron projection development (GO:0010976),0.33846959097579354,1.2494518963020569,0.10485436893203884,0.586782975178644,1.0,21/85,9.89%,RIT2;LRP8;LRRC7;PLXNB3;S100A9;ITGA6;MAGI2;TOX;NTRK2;SCARF1;FUT9;ALK;NPTN;PLPPR5;TENM3;NDNF;SCARB2;STMN2;ZDHHC15;RELN;DAB2IP
prerank,protein localization to centrosome (GO:0071539),-0.46900889853081246,-1.2494110990366936,0.18007662835249041,0.4801145524147553,1.0,7/17,13.28%,PCM1;NUDCD3;PIBF1;GOLGB1;CCDC14;SNX10;C2CD3
prerank,nucleoside catabolic process (GO:0009164),-0.5372870414253552,-1.2492807607147116,0.20840950639853748,0.47982516793844066,1.0,5/11,14.78%,DERA;UPP2;NT5M;UPB1;DPYD
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2733333191078702,-1.2491880203343402,0.016359918200409,0.47944892519599674,1.0,122/420,20.84%,AKAP13;PTPN13;PRKAG2;ARHGAP29;EGFR;ARHGAP10;ARHGAP6;RHOQ;NTRK3;ZFAND6;ARHGAP28;ARAF;MDM4;ITGAV;FGF1;ARHGAP20;STK3;EP300;TIAM2;LRRK2;WWC2;PRKAA2;ARHGEF17;ARAP1;BRD7;RHOJ;RBBP8;MYO9A;AKAP12;NRK;MAPKAP1;TAF3;ARHGAP24;BCR;INPP5B;USP7;DLG1;LBH;PAK2;NBN;UFL1;MAP4K4;TAOK3;TMBIM4;TMEM127;GMIP;LYN;ARHGAP21;MTOR;PLEKHG2;CDC42;VAV2;PDPK1;PIP4K2C;TTI1;WRN;TAF4;TBP;ARHGAP17;XIAP;PTPN22;CHD4;HIPK1;CHD3;TRIP10;TRAF2;RHOA;RPL11;ARHGEF12;RHOT1;PRKAB2;ARHGEF18;RCN3;WWC1;ARHGAP32;SOS2;TELO2;CASTOR2;RASSF2;EHMT1;RICTOR;FGD1;TBCK;ARHGDIB;ING5;FGD4;VEGFA;USP2;HDAC1;CSNK2A1;TAF13;NGEF;PRMT5;CMKLR1;ARHGAP18;NOP53;MRE11;ARHGEF11;TRAF3;TRIO;ARHGEF6;TTC5;DAPK2;WNT5A;ARHGEF1;PRKAA1;PPP2R5C;ARHGAP15;TRAF6;RHOH;MYOC;RHOC;KMT5A;CDK2;TAOK1;NF2;MAP2K6;PML;GPAT3;TAF12;ARHGAP12;PRKAG3
prerank,fat cell differentiation (GO:0045444),-0.3590384701665028,-1.2490778307922945,0.1381957773512476,0.4790982084071991,1.0,24/57,28.24%,PID1;TCF7L2;SMAD6;EP300;BBS9;WNT5B;OSBPL8;OSBPL11;PPARGC1A;MED1;FAM120B;C1QTNF3;NR4A1;NR4A2;METRNL;AKT2;SENP2;MAFB;ZBTB7A;BSCL2;CLIP3;BBS4;ERAP1;BBS2
prerank,post-translational protein modification (GO:0043687),-0.27967479765440023,-1.2489708649610731,0.031496062992125984,0.4787729192692738,1.0,122/332,29.48%,FSTL1;CP;FBN1;FBXL7;LTBP1;IGFBP5;SDC2;BMP4;SPSB1;FBXW8;KLHL13;BTRC;GPC3;ASB3;IGFBP3;STT3A;ZBTB16;WDTC1;ITIH2;OBSL1;ASB2;FBXL4;FBXL12;FBXO10;IGFBP4;ASB13;KTN1;DDB2;TNC;NUB1;DCAF10;HIF1A;FAM20C;DNAJC3;DCAF6;SERPIND1;LGALS1;PSMF1;FBXL19;FBXL18;RAB11A;LRRC41;CUL3;COPS2;FBXW7;FBXO30;WSB2;FN1;DCAF8;KLHL22;MXRA8;CCN1;COPS8;IGFBP7;APOE;PSMB2;ESCO1;MSLN;MBTPS1;CUL2;ERCC8;KLHL11;DCAF4;FEM1A;ASB5;FBXO22;MIA3;RABGGTB;FBXW11;ATG5;FBXW5;RCN1;DCUN1D3;CHM;SPSB4;COP1;SPP1;P4HB;CUL1;PSMC1;HIF3A;CHML;CUL7;NAE1;FBXW4;SUMF1;WFS1;BTBD1;LAMB2;LAMC1;PSMB6;F5;PSMA3;CALU;PSMA4;RAB8A;FBXL14;KCTD7;FBXO4;PNPLA2;RAB5A;FBXW9;FBXO11;CCDC8;EVA1A;SPSB2;PSME1;PSMD13;MGAT4A;APP;GPS1;KCTD6;PSMB10;PSMA5;SPSB3;ASB6;FBXL3;PSMB9;ICMT;KBTBD7;RBX1;PENK
prerank,positive regulation of protein acetylation (GO:1901985),-0.5199577373543836,-1.2488921935824537,0.19029850746268656,0.4783489501099573,1.0,7/12,19.80%,PRKAA2;RAPGEF3;FAM161A;DDX3X;CEP295;PRKAA1;TAOK1
prerank,chromatin organization (GO:0006325),-0.3115607379039202,-1.2483029090826556,0.07474747474747474,0.47922726761866963,1.0,52/132,29.13%,HDAC8;INO80;SETD7;BRWD1;KAT2B;HDAC4;SETD5;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;KDM5B;MYSM1;ZBTB1;KDM6A;SETD2;HCFC1;MCM3AP;SETDB1;TCF7L1;RB1;EHMT1;PHF1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;HMG20A;BPTF;CDAN1;PBRM1;PIH1D1;EZH2;HMGN3;SMARCD3;HDAC2;SNAI1;FAM50A;INO80C;ZBTB7A;HDAC3;MPND;ATRX;SAFB;ESR1;SUPV3L1;RUVBL2
prerank,regulation of exocytosis (GO:0017157),0.384443730268564,1.2480428365536855,0.12608695652173912,0.5893157413485488,1.0,11/46,10.81%,SYT1;IL1RAPL1;CADPS;RIMS2;RAB3C;LGI3;SNCA;STXBP5L;CPLX1;ATP6AP1;HAP1
prerank,response to glucocorticoid (GO:0051384),-0.4284271608946184,-1.2480249881422028,0.19223300970873786,0.4792451251540554,1.0,11/26,30.89%,NR3C1;ANXA1;REST;ADAM9;FAM107A;HNRNPU;SLIT2;ZFP36L2;GOT1;UBE2L3;BCL2L11
prerank,regulation of gluconeogenesis (GO:0006111),-0.4160974827955818,-1.2479476343800062,0.14933837429111532,0.47880082564154325,1.0,10/27,15.61%,EP300;USP7;PPARGC1A;CLK2;SELENOS;PTPN2;ZNF692;SIK1;OGT;C1QTNF3
prerank,aortic valve development (GO:0003176),-0.39938107822907404,-1.2478728573301487,0.15163147792706333,0.47836832177073735,1.0,7/34,3.07%,ROCK2;SMAD6;ROCK1;BMP4;ROBO1;ELN;JAG1
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2783999551341,-1.2477070903033045,0.021696252465483234,0.4781590200707791,1.0,102/351,20.87%,TGFBR3;ALDH1A2;ZBTB7C;APPL2;KANK2;SMAD6;IGFBP5;CELF1;COL4A3;FBLN1;BMP5;MDM4;DIS3L2;KAT2B;BMP4;PDPN;PPM1D;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;VGLL4;RBP4;RARG;IGFBP3;TGFB1I1;IGFBP6;OGN;SKI;SPEG;TMEM127;NOX4;LYN;TES;REST;PARP10;WNT9A;P3H3;AR;PTPRK;MAP2K1;CYP1B1;BTG3;MN1;COL18A1;NGF;PTPN2;CCN3;ABI1;ROR2;PDS5B;FAP;HES1;PKD2;APOD;IRF1;ATRAID;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;CD164;RBM5;CBFA2T3;RAPGEF2;EMD;NCK2;MNT;TGFB3;PLXNB1;DUSP10;ADAMTS1;WNT5A;ARID2;MORC3;S100A11;PPP2R5C;SFRP4;SOD2;FGFBP1;IFI35;BMP2;CDK10;INHBA;B4GALT7;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;CDKN1C;NME1;ZBTB49;CDK6
prerank,mitochondrial protein processing (GO:0034982),0.5335405914891134,1.2469031010457925,0.1910828025477707,0.5910228443355154,1.0,3/11,7.90%,OMA1;PMPCA;ATP23
prerank,regulation of fibrinolysis (GO:0051917),-0.5077075862788879,-1.2468246220242911,0.20646319569120286,0.4796078063473994,1.0,4/13,21.29%,THBS1;FAP;SERPINE1;USF1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5339147137241974,-1.2467063397382556,0.21212121212121213,0.4792927631572878,1.0,3/10,6.72%,DCN;LRRK2;BCL2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5252236945252141,-1.2466280567487358,0.18401486988847585,0.47885728412215167,1.0,3/12,17.43%,RBP4;STRAP;TLR4
prerank,receptor internalization (GO:0031623),0.3719611127791949,1.2465776310514904,0.145610278372591,0.5905056496688131,1.0,6/44,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3628024003789957,-1.246538944026475,0.12966601178781925,0.47847134167887123,1.0,23/52,28.16%,SAMD4A;PAN3;DDX6;RC3H1;TUT4;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9;CNOT2;PAN2;CNOT1;CNOT10;EXOSC3;CNOT4;TNKS1BP1;LSM6;PNLDC1;PDE12;DIS3;POLR2D;PARN
prerank,regulated exocytosis (GO:0045055),0.3031013285468675,1.2462779750505153,0.07414829659318638,0.5898367623395574,1.0,35/173,12.38%,SYT1;PCYOX1L;RIMS1;PCLO;SYT6;STEAP2;SYT7;TMSB4X;RIMS2;SYT12;SYT11;SNAP25;RIMS3;GAS6;SNCA;PCDH7;FERMT3;TGFB2;WDR1;CLU;PECAM1;SYT10;ITIH3;TIMP1;SELENOP;CYRIB;SCG3;PDGFB;ABCC4;CPLX1;CALM1;SYT2;ITGA2B;TUBA4A;VWF
prerank,negative regulation of inclusion body assembly (GO:0090084),0.537574185955121,1.2457969250936878,0.20512820512820512,0.5897709547365115,1.0,4/10,16.45%,SACS;DNAJA4;SORL1;DNAJB2
prerank,diol metabolic process (GO:0034311),0.4551413595962284,1.2457235364207866,0.1879049676025918,0.5884527009278347,1.0,9/19,17.88%,DEGS2;NOS3;PRKG2;SGPP2;AKT1;CALM1;GCH1;HSP90AA1;SGPP1
prerank,lymphocyte differentiation (GO:0030098),-0.3441716557469784,-1.2455067942726241,0.10018552875695733,0.4802751825505095,1.0,24/68,26.70%,PBX1;LEPR;AXL;HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN22;PTPN2;TCF3;CHD7;ITGA4;KLF6;PIK3CD;BLNK;RHOH;RABL3;VCAM1;GPR89B;GPR89A;ZBTB7A;LMBR1L;NFIL3
prerank,modulation by host of viral genome replication (GO:0044827),-0.5040602860057091,-1.245399476429655,0.2131782945736434,0.47994428213646834,1.0,6/13,22.70%,PRKN;CCNK;TBC1D20;EIF2AK4;IFI27;VAPA
prerank,mitotic sister chromatid segregation (GO:0000070),-0.32136333510214543,-1.2453645142642118,0.09426987060998152,0.47943780597734936,1.0,25/98,15.45%,INO80;EML4;DIS3L2;PIBF1;VPS4B;PHF8;SMC4;AKAP8L;CHMP4B;CHMP4A;PDS5A;CHMP5;CHMP3;NIPBL;RAD21;PDS5B;RAB11A;CUL3;RB1;KLHL22;BECN1;NUDC;MCPH1;ZWINT;CSNK2A1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.42695489954546156,-1.2453040414831362,0.16122840690978887,0.4790033839197697,1.0,10/25,15.44%,CACNA1C;ANK2;DLG1;CXADR;CAMK2D;JUP;ATP2A2;TBX18;TRPM4;AKAP9
prerank,regulation of monooxygenase activity (GO:0032768),0.4346711012326654,1.245284627585176,0.1694560669456067,0.5881327920054736,1.0,9/23,18.05%,NOSTRIN;SNCA;NOS3;LYPLA1;AKT1;CALM1;HSP90AA1;NOSIP;DDAH1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.44050747334188795,1.2450094378158632,0.18101545253863136,0.587382298716145,1.0,5/23,11.41%,KIF1A;HOOK1;MAP6D1;MYO10;CCDC88A
prerank,response to insulin (GO:0032868),-0.3311726545417895,-1.2449455879998932,0.09980430528375733,0.479278436062812,1.0,29/80,21.34%,RHOQ;SORBS1;KAT2B;ENPP1;IRS1;SLC39A14;INSIG2;RAB10;RAB12;PDPK1;VAMP2;SELENOS;FER;DENND4C;PARP1;OGT;PCK2;SLC27A1;PRKDC;ZBED3;CPEB1;LPIN2;SYAP1;LPIN3;INPP5K;PKM;PIK3R1;USF1;AKT2
prerank,visual perception (GO:0007601),-0.3307997068738201,-1.244909132938588,0.10159362549800798,0.47875067508369185,1.0,20/84,18.22%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,activation of GTPase activity (GO:0090630),-0.3324629811447714,-1.2446820483456096,0.11290322580645161,0.4787238109010402,1.0,28/89,21.64%,ARHGAP29;ARHGAP42;SIPA1L1;NTRK3;TIAM2;TBC1D16;DOCK7;ARHGAP24;BCR;SGSM2;BCAS3;GMIP;USP6NL;TBC1D2B;TBC1D8B;TBCK;GRTP1;TBC1D22B;TBC1D9;NGEF;TBC1D17;SIPA1L3;RALGAPB;RABGAP1;TBC1D7;TBC1D10A;RALGAPA2;SCRIB
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4176362445001341,-1.2437316898511308,0.1650853889943074,0.48047852871534485,1.0,15/30,31.38%,SAE1;HUWE1;ABLIM3;LEPROT;NPEPPS;FBXW7;UBL5;UBE2D3;TOMM7;ARIH2;HTRA2;PDCD5;USP36;UBE2L3;RNF31
prerank,mRNA polyadenylation (GO:0006378),-0.4161946756531428,-1.243377769419589,0.17293233082706766,0.48014716896429527,1.0,10/26,21.31%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,RNA polyadenylation (GO:0043631),-0.4161946756531428,-1.243377769419589,0.17293233082706766,0.48014716896429527,1.0,10/26,21.31%,TENT2;PCF11;WDR33;SCAF8;CPSF3;SSU72;PAPOLG;CSTF3;CDC73;AHCYL1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5038057193377337,1.2430629670687952,0.19879518072289157,0.591446085780623,1.0,3/12,6.59%,PAX8;PAX2;LHX1
prerank,negative regulation of translational initiation (GO:0045947),-0.4997946437565072,-1.2426338420859029,0.20411985018726592,0.48136809296178906,1.0,6/13,24.31%,EIF2AK1;LARP1;TPR;EIF2AK4;RBM4;EIF4EBP1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4525847102290453,-1.241840747192584,0.19850187265917604,0.48206315673505334,1.0,8/20,24.26%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4525847102290453,-1.241840747192584,0.19850187265917604,0.48206315673505334,1.0,8/20,24.26%,ACADSB;IVD;HIBCH;MCCC2;ALDH6A1;BCKDK;HIBADH;AUH
prerank,dendritic spine morphogenesis (GO:0060997),0.4785558108984196,1.241765909558233,0.19148936170212766,0.5936431476222579,1.0,3/15,3.04%,EPHB1;CTNND2;SHANK3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.341134032809283,1.2416064262330724,0.11614173228346457,0.5925971180550111,1.0,19/76,15.07%,GRM5;GRM1;HTR2C;TACR1;GPR35;P2RY1;HOMER1;GPR17;ADRA1D;ADRA1A;TRHR;OPRM1;F2RL2;F2R;GRPR;OPRK1;CCKBR;CHRM2;OPRL1
prerank,regulation of actin nucleation (GO:0051125),-0.5035369555416445,-1.2415569013597838,0.19659735349716445,0.4821588080513469,1.0,4/12,15.29%,GSN;ARFIP2;ARF1;WHAMM
prerank,actomyosin structure organization (GO:0031032),-0.3366387960446148,-1.2412126697680952,0.10505836575875487,0.4824190880658715,1.0,16/75,12.57%,ROCK2;PHACTR1;SORBS1;FRMD6;TPM1;EPB41L5;EPB41L2;ROCK1;ITGB1;TMOD3;ITGB5;ACTN2;TNFAIP1;RHOA;ZYX;CUL3
prerank,establishment of spindle orientation (GO:0051294),-0.403976088701564,-1.2409663376457414,0.15182186234817813,0.48238054999364904,1.0,6/28,8.60%,NUMA1;MAP4;UBXN2B;ITGB1;NDEL1;GJA1
prerank,cilium assembly (GO:0060271),-0.27759774049220415,-1.2406536515789313,0.03640256959314775,0.4825791634607115,1.0,82/296,21.17%,PARVA;GSN;PKD1;PCM1;ASAP1;GBF1;BBS9;CDC14A;ALMS1;WDPCP;ODF2;DCDC2;FLNA;NUDCD3;CYS1;NINL;ARL3;PIBF1;IFT43;CEP63;ATP6V0D1;PDE6D;ARL13B;CEP135;IFT81;CFAP44;CEP162;DYNC2I1;ABLIM3;PCNT;SPATA6;EHD2;MARK4;CSNK1E;RFX2;RAB3IP;IFT88;FAM161A;RPGR;RP2;EXOC2;IFT80;RAB11A;CC2D2A;POC1B;ARMC9;SNX10;C2CD3;MAPRE1;TOGARAM1;CCDC39;RILPL2;CDC14B;YWHAE;DZIP1L;DYNC2LI1;EHD3;AKAP9;CCDC57;DYNC1H1;CEP76;CCDC66;TCTN1;PRKACA;WDR11;CFAP74;PTPDC1;CPLANE1;DYNLRB1;DYNC2I2;CEP57;CSNK1D;EHD4;GORAB;RILPL1;AVIL;TRIP11;CEP89;GALNT11;NPHP1;KIFAP3;TRAPPC14
prerank,response to estradiol (GO:0032355),-0.4103237403683518,-1.2405259547049834,0.1806083650190114,0.48228452345198125,1.0,5/31,7.02%,EGFR;LCOR;STRN3;STAT3;ANXA1
prerank,negative regulation of neurogenesis (GO:0050768),0.3949517748049831,1.240480167431128,0.14799154334038056,0.5943105361745514,1.0,12/34,14.98%,MAG;MCF2;THY1;EFNB3;OMG;NOTCH1;LINGO1;RTN4R;SORL1;B2M;RTN4;GDI1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4073111031614769,1.2403419194848555,0.16736401673640167,0.5931906805570093,1.0,10/30,14.52%,DACH1;HNRNPC;TERF1;ACVRL1;TEN1;PIF1;MEN1;BMPR2;TINF2;CDKN1A
prerank,mesenchyme development (GO:0060485),-0.4814233366039607,-1.2399174378017832,0.19066147859922178,0.4831212308222733,1.0,5/15,12.34%,TGFBR1;BMP7;BMP4;FGFR2;PKD2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.34985357233547243,-1.2393401448052512,0.11585365853658537,0.48389534937918655,1.0,14/60,10.77%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;DHX36;MED1;ATF7IP
prerank,regulation of presynapse assembly (GO:1905606),0.456383238342442,1.2385966284002583,0.18633540372670807,0.5954630025059842,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),0.456383238342442,1.2385966284002583,0.18633540372670807,0.5954630025059842,1.0,6/18,8.22%,PTPRD;LRFN5;IL1RAPL1;SNCA;LRRC4B;IL1RAPL2
prerank,response to chemokine (GO:1990868),-0.508862125224083,-1.2381782588880523,0.1871559633027523,0.4860312682196036,1.0,6/13,14.51%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA;DUSP1
prerank,regulation of actin filament polymerization (GO:0030833),-0.3397775339116562,-1.2378378246808341,0.1233140655105973,0.4862580223832917,1.0,35/69,30.41%,ARHGAP28;FCHSD2;BAIAP2L1;SNX9;ARFGEF1;PLEKHG2;VASP;CDC42EP5;FER;PRKCD;NCKAP1;CTTN;NCK1;LATS1;CARMIL1;NCK2;RASA1;ARHGAP18;CDC42EP4;MYADM;LMOD1;BAIAP2;CDC42EP1;HIP1R;GBA2;SLIT2;ABITRAM;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4;ARF6
prerank,thyroid hormone generation (GO:0006590),-0.5372585942107033,-1.2375994411983213,0.20433996383363473,0.48622979530087296,1.0,2/10,11.33%,CPQ;SLC5A5
prerank,positive regulation of cartilage development (GO:0061036),-0.47244456830473547,-1.2375655802922474,0.21739130434782608,0.4857125130230471,1.0,7/17,21.69%,SOX5;BMP4;ZBTB16;SOX6;BMP2;PKDCC;TAPT1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3642871995247057,-1.237564889858918,0.1350844277673546,0.4851172816423717,1.0,13/47,15.61%,ROCK2;NFKB1;WNT4;EP300;PTGIS;WDTC1;CLK2;ERLIN1;SIK1;FBXW7;SLC27A1;RAPGEF2;C1QTNF3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.47235008167894843,-1.2375471782798746,0.1937984496124031,0.48456160714604685,1.0,10/16,39.25%,COA8;SLC30A10;ABCD2;EMILIN1;PARK7;PPARA;GPER1;CIITA;SLC18A2;TRAP1
prerank,neuron projection regeneration (GO:0031102),-0.53799024921158,-1.2374501428639897,0.20696324951644102,0.4841741270522497,1.0,2/10,1.86%,PTN;NREP
prerank,sensory perception of sound (GO:0007605),-0.3358725197116456,-1.2370537191057784,0.1016260162601626,0.48457396392862845,1.0,15/88,7.81%,EYA1;ROR1;COL1A1;CEMIP;COL4A3;CDC14A;TBL1X;GSDME;KIT;RIPOR2;DCDC2;EML2;ADGRV1;ATP6V0A4;CACNA1D
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5343084434594768,-1.2370203615612192,0.23756906077348067,0.4840735466825721,1.0,8/10,36.86%,RIOK3;SEC14L1;GPATCH3;DHX58;C1QBP;UFD1;TKFC;TSPAN6
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5099557891771763,-1.236833506542265,0.21722846441947566,0.4839170007252882,1.0,2/12,0.78%,NOTCH2;DOCK11
prerank,positive regulation of kinase activity (GO:0033674),0.31990191656429645,1.2367847329564021,0.09274193548387097,0.5991773879960781,1.0,19/107,9.08%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;MMD2;EPHB1;TIE1;EPHA5;GAS6;KDR;NTRK2;FLT3;ALK;MAPRE3;ADCYAP1;EPHA10;RELN
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43441745573675317,1.2366653152307248,0.1716101694915254,0.5980329839358416,1.0,8/23,15.73%,FAR2;ELOVL7;DGAT2;TECR;ACOT7;HACD1;FAR1;ACSL3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.45824065371096956,-1.2364350798954655,0.2007168458781362,0.4843040379217545,1.0,11/19,35.44%,DDO;ASPA;DLST;ALDH7A1;PIPOX;PHYKPL;GOT1;GCDH;HYKK;GOT2;AASS
prerank,regulation of spindle assembly (GO:0090169),-0.4316996264613391,-1.2363517135082283,0.16929133858267717,0.48390177699952175,1.0,10/25,20.16%,NUMA1;VPS4B;CHMP4B;SENP6;CHMP5;CHMP3;TPR;DYNC1H1;HNRNPU;EML3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.49367525919504607,-1.2362577195704674,0.20637898686679174,0.48353681382750263,1.0,6/14,19.13%,FOXC1;NRP1;VEGFA;VEGFD;PIK3CD;GAB1
prerank,mitotic recombination (GO:0006312),-0.48980257268981464,-1.2358349802528639,0.19114688128772636,0.4839272551342583,1.0,6/15,15.93%,SMC6;NSMCE2;SMC5;RAD51D;MSH3;DMC1
prerank,mitotic spindle assembly (GO:0090307),-0.3758640027464382,-1.235380268030887,0.16367265469061876,0.48435297962817125,1.0,24/42,36.82%,FLNA;PIBF1;SPICE1;STAG1;RHOA;LSM14A;RAB11A;ABRAXAS2;TOGARAM1;MAP9;STAG2;SMC1A;BCCIP;KIF23;ABRAXAS1;KIF11;RACGAP1;MZT1;KIF2A;PRC1;SMC3;MISP;TPX2;KIFC1
prerank,carbohydrate derivative transport (GO:1901264),0.45706607013854544,1.2352437605387447,0.21414141414141413,0.6005502363956648,1.0,7/18,18.89%,PLTP;MFSD2A;SLC15A3;CPTP;SCARB1;SLC15A2;VLDLR
prerank,serine family amino acid biosynthetic process (GO:0009070),0.508999854922969,1.2350157266405914,0.23044397463002114,0.5997053317015056,1.0,7/12,20.32%,SEPHS2;PHGDH;MTHFD1;GGT1;SEPHS1;SERINC3;SRR
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.461652077253367,-1.2340733900686172,0.1958568738229755,0.4869329664495929,1.0,12/18,35.09%,ABL1;POR;ABL2;AGTR1;RFK;PARK7;FXN;SIRT3;EDN3;GDNF;ATP7A;PDP2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4581225868773868,-1.2338927298629427,0.2014260249554367,0.4867554909559189,1.0,9/18,33.43%,GSK3B;ACAA2;TMEM14A;ZNF205;HIP1R;CHCHD10;MUL1;BAK1;HSPA1A
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5181292557612209,-1.2338821269226279,0.21124031007751937,0.48560859772059656,1.0,2/12,4.00%,FHL2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5181292557612209,-1.2338821269226279,0.21124031007751937,0.48560859772059656,1.0,2/12,4.00%,FHL2;GSK3B
prerank,ephrin receptor signaling pathway (GO:0048013),0.3308918718964708,1.233794038160014,0.11416490486257928,0.6014979161865769,1.0,23/82,14.65%,GRIN1;ANKS1B;ACTB;EPHA6;EPHB1;GIT1;EPHA5;AP2M1;VAV3;GRIN2B;EFNB3;PSENEN;PAK1;EFNA2;EPHA10;AP2B1;CHN1;KALRN;EPHA1;HRAS;PSEN1;PAK3;ARHGEF7
prerank,regulation of signal transduction (GO:0009966),-0.2966331780406432,-1.233138590166588,0.06391752577319587,0.48680759287518094,1.0,55/190,18.48%,SULF1;GRK5;ZIC1;PLCE1;IGFBP2;FBXL17;IGFBP5;MDFIC;LRRK2;ELF1;CD55;DCDC2;IGFBP3;IGFBP6;RSPO3;AXIN1;PLSCR1;IFT81;CREBBP;DTNBP1;FGFR2;GAS1;RUNX1;IRAK2;GRK4;DHRS3;POFUT1;IGFBP4;SP100;GRK3;USP33;PTPN2;TULP3;RORA;TRIM5;UGCG;TCF7L1;CDC42SE2;CASTOR2;OGT;GLI1;IGFBP7;ACVR1;NCK1;NCK2;PTCH1;GRK6;TSPAN15;FOXL1;GLRX2;RIC8B;WDR11;PRKD1;PTPN1;SLC8A3
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4995282106684145,-1.232709963916855,0.21511627906976744,0.48726129974858007,1.0,2/13,4.33%,ATP1A2;SLC9A1
prerank,negative regulation of wound healing (GO:0061045),-0.41073182866984925,-1.2316147751822342,0.18147448015122875,0.4893018291256969,1.0,7/28,17.01%,PHLDB2;VTN;TFPI;SLC12A2;CD109;APOE;SERPINE1
prerank,RNA stabilization (GO:0043489),-0.3958325613419923,-1.2308323487851847,0.18388429752066116,0.49059827416065543,1.0,11/33,18.07%,TENT2;EIF4ENIF1;FUS;LARP1;DHX36;PHAX;YBX1;NSUN2;TENT5A;HNRNPU;PAIP1
prerank,negative regulation of bone mineralization (GO:0030502),-0.5034938168816836,-1.2306514071827797,0.22030651340996169,0.49044082715101106,1.0,7/13,34.17%,BCOR;ENPP1;TRPM4;ECM1;RFLNA;GREM1;SRGN
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42960253702468937,-1.230528126713176,0.18972332015810275,0.49016920911230155,1.0,8/23,15.61%,EP300;HDAC4;NCOR1;NUPR1;CLK2;SIK1;CBFA2T3;C1QTNF3
prerank,erythrocyte development (GO:0048821),0.5282825723160137,1.2303922565176864,0.1987704918032787,0.6099031415020423,1.0,1/10,0.29%,ALAS2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3226622162261938,-1.2300750817100383,0.1075050709939148,0.4906948311387837,1.0,19/85,13.81%,AKAP13;NOTCH2;IGF1;DENND4A;PLCE1;KANK2;SHOC2;MAPKAP1;BCR;SHC1;LYN;ARHGAP17;ARFGAP1;LZTR1;NGF;ARHGEF18;DENND4C;OGT;ARHGDIB
prerank,hyaluronan catabolic process (GO:0030214),-0.4539970838602443,-1.2291747571808018,0.22796934865900384,0.49237336875350685,1.0,7/18,22.57%,CEMIP;SLC9A1;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,response to fatty acid (GO:0070542),-0.46879406497480547,-1.2288932939977437,0.1961904761904762,0.4923957475215301,1.0,3/17,4.52%,PID1;FOXO3;IRS1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.47814132683160937,-1.2288567687327523,0.2029520295202952,0.4918979395372019,1.0,5/15,13.44%,EGFR;RBPJ;PTPN12;FER;RHBDF1
prerank,regulation of axonogenesis (GO:0050770),0.3604519759053063,1.2282690703845254,0.14777327935222673,0.6147207757032901,1.0,16/51,11.20%,LRRC4C;MAG;PLXNB3;MCF2;CDH2;NTRK2;THY1;EFNB3;OMG;PAK1;LINGO1;PLXNA4;ROBO2;RTN4R;CHN1;BRSK2
prerank,vasculature development (GO:0001944),-0.47364933753059324,-1.22757157646975,0.203125,0.4943874527679839,1.0,3/16,2.43%,ERRFI1;PDGFRA;PDGFRB
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3603744320902168,-1.2275236199041932,0.1519230769230769,0.4939112050421963,1.0,13/49,14.36%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,mRNA catabolic process (GO:0006402),-0.36744272089910734,-1.2274963765360456,0.16412213740458015,0.4934034312818391,1.0,21/44,33.70%,DDX5;DIS3L2;RC3H1;TUT4;UPF1;XRN1;XRN2;EXOSC9;ERN1;EXOSC10;CNOT10;AGO1;LSM6;PDE12;ZFP36L2;SUPV3L1;THRAP3;NUDT16;NUDT16L1;HSPA1A;MRTO4
prerank,regulation of heart contraction (GO:0008016),-0.32305229796083845,-1.2274268064603993,0.10647181628392484,0.4929890500897498,1.0,26/90,21.31%,ATP1A2;ITPR1;CELF2;STIM1;ANK2;ITPR2;TPM1;TMEM65;ASB3;CAMK2D;ASPH;DMPK;ATP2A2;ATP2B1;SRI;P2RX4;TBX2;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;DES;S100A1;AHCYL1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5313344850735795,-1.227317456661133,0.23243243243243245,0.49265639654193005,1.0,5/11,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,spinal cord development (GO:0021510),-0.5069724061987995,-1.227141804593081,0.20650095602294455,0.49250846727967607,1.0,5/12,15.98%,PKD1;GLI2;VIT;PKD2;LOXL3
prerank,cellular response to dsRNA (GO:0071359),-0.48621974067652346,-1.227100633346335,0.216796875,0.4920372612392343,1.0,11/15,38.69%,DHX9;MAVS;RIOK3;PDE12;MUL1;CGAS;IFIH1;CAV1;ZCCHC3;NPM1;FLOT1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.49779943652075886,-1.2270959187240154,0.22444889779559118,0.49146553774376567,1.0,7/13,17.05%,TGFBR3;BMPR1A;RBPJ;FGFR2;MEF2C;GLI1;TBX2
prerank,negative regulation of protein modification process (GO:0031400),-0.33689966843110075,-1.227020766700474,0.12525252525252525,0.4910460215049536,1.0,13/79,4.83%,PTPN13;PID1;LRP6;NTRK3;FBLN1;PLPP3;PRKN;LRRK2;PRKAA2;IBTK;GSK3B;SNTA1;IGFBP3
prerank,calcium ion transmembrane transport (GO:0070588),0.3281179327644411,1.226745938467037,0.13250517598343686,0.6176675825977961,1.0,15/86,6.47%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;GRIN2A;RYR3;GRIN2B;CACNA2D1;GAS6;GRIN2D;SLC8A1;ATP2B3;SLC25A23;TRPM2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3615290256017574,-1.226585564949012,0.15109343936381708,0.4914977736260276,1.0,16/49,16.40%,LDLRAD4;SMAD6;EP300;GSK3B;HMGB1;CDC42;IMPACT;DACT1;PMEPA1;RIOK3;PPM1A;ANKRD27;DDX3X;PRKCZ;NOP53;IAPP
prerank,T cell activation (GO:0042110),-0.3410632864209403,-1.2263975913541447,0.1245136186770428,0.49137880488572755,1.0,19/69,23.39%,LEPR;KIF13B;KIT;CXADR;DPP4;PTPN22;PTPN2;EIF2AK4;CHD7;NCK1;NCK2;CTPS1;PIK3CD;RHOH;MSN;SCRIB;GPR89B;GPR89A;NLRC3
prerank,regulation of interleukin-17 production (GO:0032660),0.4004507858543161,1.2262353264865058,0.18859649122807018,0.6175655988781106,1.0,3/31,6.51%,SLC7A5;IL12A;PRKCQ
prerank,regulation of cell size (GO:0008361),-0.42531389938809416,-1.2261012356300423,0.2045028142589118,0.49153126271490616,1.0,6/23,10.27%,RPTOR;DEPTOR;RARG;MTOR;VAV2;RHOA
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5288349165038635,1.2255334502010253,0.22085889570552147,0.6179034131893584,1.0,3/10,8.89%,PODXL;FERMT3;SKAP1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4404951705727751,1.2250334858032517,0.19078947368421054,0.6178513251084063,1.0,6/20,15.73%,FAR2;DGAT2;SCD;FAR1;PPT1;ACSL3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.400539944318447,-1.2248588613211961,0.18613861386138614,0.49402258665783544,1.0,5/31,1.51%,TGFBR3;TGFBR1;BMPR1A;TPM1;RBPJ
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4956983562210551,-1.2246130288915267,0.22113502935420742,0.49412813375792836,1.0,3/13,6.91%,GLI3;TGFBR2;RUNX1
prerank,regulation of microtubule-based process (GO:0032886),-0.3826776352367193,-1.224192731390228,0.16346153846153846,0.4945848243085072,1.0,6/36,4.00%,PHLDB2;EPHA3;DIAPH1;ROCK1;PRKAA2;GSK3B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5206871326829761,-1.2241562282305365,0.21132075471698114,0.4940867879930268,1.0,5/11,25.95%,COA8;SLC30A10;ABCD2;PARK7;PPARA
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5378704840539498,-1.2232508803549156,0.23132969034608378,0.49559416548753243,1.0,3/10,10.27%,MYO9A;CDC42;RHOA
prerank,regulation of leukocyte migration (GO:0002685),-0.4704153608767391,-1.2232072380731427,0.19736842105263158,0.49511145930305395,1.0,5/16,18.46%,HOXA7;ANXA1;VEGFA;MIA3;RHOH
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.41093006196764814,-1.2229592196294166,0.1875,0.49516495658090354,1.0,13/29,23.13%,VTI1A;VTI1B;COPB1;COPZ2;COG3;GOSR1;COPB2;COPG2;GOSR2;NAPA;COPG1;COPE;NSF
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5089656973969184,1.2228682424195305,0.23232323232323232,0.6228326012930182,1.0,4/11,13.24%,KCNJ3;KCND3;ATP1A1;ATP1B1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4361702152390592,1.2224832036185878,0.1960352422907489,0.6225411881337045,1.0,2/19,1.77%,CD33;GIT1
prerank,protein localization to membrane (GO:0072657),0.2954839337897249,1.2223372805697097,0.07364341085271318,0.6214116263871088,1.0,27/187,7.36%,BSG;DLG2;DPP10;EFR3B;NRXN1;LRRC7;MRAP2;KCNIP4;SPTBN4;NLGN1;RAMP2;MAGI2;ANK3;SHANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;THY1;NRXN2;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,protein localization to cilium (GO:0061512),-0.3964062754911538,-1.221641832911641,0.17391304347826086,0.4978196137105714,1.0,17/32,33.88%,ZNF423;BBS9;ARL3;TULP3;SNX10;TCTN1;CSNK1D;INVS;IFT140;TTC21B;BBS4;RABEP1;IFT122;EHD1;TULP1;WDR35;TMEM107
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5308987462697207,-1.220996673704102,0.23076923076923078,0.49884157325751927,1.0,3/10,6.91%,HMGB1;SH3RF1;RUNX1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2628342278488024,-1.2208435112005902,0.0189873417721519,0.4986378270566726,1.0,138/509,22.26%,WLS;AKAP13;ROCK2;IGF1;ROR1;EGFR;LPAR1;SASH1;NFAT5;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;NTRK3;DCN;LIMS1;PELI2;ANKRD17;UBE2N;ITGAV;CFLAR;KSR1;FGF1;PDGFRB;TRIM44;AXL;EP300;ROCK1;MAP3K3;PRKN;NR3C2;NUPR1;ADRA1B;GSDME;KIT;RPTOR;OSBPL8;PUM2;FLNA;RYK;TBK1;IRS1;HMGB1;ITGB1;DNM1L;THBS1;TFG;ALPK1;ADGRV1;FGFR2;SHC1;BCL2;LYN;TRIM8;TRAF3IP2;F3;PUM1;PDPK1;DHX36;IGF2;GJA1;MIER1;FRS2;TRAF2;PDGFC;RHOA;DDX60;ZDHHC13;KL;MAVS;BCLAF1;WWC1;FNIP1;LGALS1;ROR2;TRIM5;WDR59;TRIM25;FN1;RICTOR;PPM1A;PIK3AP1;BECN1;LTBR;P2RY12;EIF2AK2;EPHA8;TXN;VEGFA;DDX3X;RAPGEF2;P2RX4;MAP3K14;PLXNB1;TNIP2;IAPP;ECM1;ADRA2A;IL18;PDCD4;IKBKE;PIK3CD;TLR4;WNT5A;PRKD1;CC2D1A;CX3CR1;TRAF6;GCNT2;IFI35;BMP2;PARK7;MYOC;RHOC;TMED4;HBEGF;NRG4;GAB1;PTPN11;NEK6;IRAK1;CARD16;FIS1;TRIP6;FGFR4;PIK3R1;SHARPIN;CDK5RAP3;AKT2;LARS1;BMF;FGF2;CXXC5;DLG5;WNT16;TRAF5;SPHK1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.36166414361280613,-1.2206789206786601,0.1610337972166998,0.4984872584635207,1.0,9/52,5.12%,EGFR;LRP1;SORBS1;EPHA3;EPB41L2;NUMA1;PTPN9;DLG1;ITGB1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3929252560238692,1.2205068013065126,0.17682926829268292,0.6253469753287813,1.0,8/35,4.44%,SEMA3C;PLXNB3;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,early endosome to Golgi transport (GO:0034498),-0.514288601385924,-1.220097934196107,0.2320754716981132,0.49926383639091115,1.0,5/11,23.33%,STX5;SURF4;EHD3;SNX8;LMAN1
prerank,cellular protein metabolic process (GO:0044267),0.27214361196135045,1.2198690967316315,0.04222648752399232,0.6257181221173893,1.0,87/396,14.11%,ST8SIA4;RPS6;CHRM3;RPS19;OMA1;TMEM132A;RPS20;RPL38;RPL29;ST3GAL6;CDH2;RPL23;RPL17;LCMT1;RPL35A;RPL37;QPCT;PHEX;GAS6;RPS27;SLC35A1;RPL7;PDIA6;MRPS12;RPS12;RPS21;RPL15;RPL10;RPL10A;PSENEN;RPS24;RPL27A;RPS17;AMELX;RPS6KB2;RPS8;RPS16;RPS27A;RPLP1;RPL41;RPLP0;MELTF;RPL30;RPL7A;TIMP1;ATP23;MSRB2;MRPL13;RPL13;MRPS18A;FBXL2;RPL12;MRPS7;RPS15;FDX2;DAB2IP;SCG3;EIF4EBP2;RPL14;MRPS14;VWA1;SCG2;MEN1;RPL5;FARSB;PROC;RPS4X;RPL21;RPS7;CSNK1G3;RPL23A;SERP1;EEF1A2;RABGGTA;SPARCL1;RPL8;MRPL36;MRPL23;RPS14;VCAN;RPS3;VGF;RPS2;PSEN1;RPS5;EEF1A1;RPL18A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.44860259921498497,-1.2198677358247054,0.21384928716904278,0.49924849804673954,1.0,10/20,21.37%,RBPJ;EP300;HIF1A;SMAD4;VEGFA;CARF;RUNX2;BMP2;SMAD9;SMAD1
prerank,early endosome to late endosome transport (GO:0045022),-0.44144366961194287,-1.2197167119214485,0.2198443579766537,0.4990493705582471,1.0,12/20,25.62%,EEA1;KIF16B;WDR91;BECN1;PIK3C3;ANKRD27;SNF8;WDR81;STX8;PTPN23;RAB7A;RAB5A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.41541085033308006,-1.2196057263544817,0.20801526717557253,0.49871955195463163,1.0,14/25,31.44%,SRSF10;SF3B1;PRPF6;SLU7;PRPF3;SCAF11;SF3A3;DDX23;GEMIN2;SRRM1;PRPF8;MPHOSPH10;LSM1;SF3B4
prerank,negative regulation of reproductive process (GO:2000242),-0.46504877234103353,-1.219404590333298,0.21663442940038685,0.49867593733707755,1.0,5/17,14.51%,SULF1;IGF1;GJA1;ARHGDIB;DUSP1
prerank,ribosomal large subunit assembly (GO:0000027),0.4160107775429522,1.2191239184880645,0.1629327902240326,0.6263394304579927,1.0,9/24,19.14%,RPF2;RPL10;RPLP0;RPL5;RPL23A;NOP2;MDN1;PPAN;RPL3
prerank,regulation of trophoblast cell migration (GO:1901163),-0.49582329589655716,-1.2190417897732162,0.22641509433962265,0.4989423288195411,1.0,5/14,14.36%,SMURF2;YTHDF3;GJA1;ARHGDIB;VEGFA
prerank,negative regulation of developmental growth (GO:0048640),0.40121783848387416,1.2185806372245773,0.19700214132762311,0.6264116103427534,1.0,9/30,16.15%,DCC;MAG;MAP2;FGF13;RTN4R;DIP2B;CDKN1A;RTN4;CDKN1B
prerank,regulation of mitotic cell cycle (GO:0007346),-0.29478846843559053,-1.2174516894903111,0.084,0.5021550077942705,1.0,68/171,29.12%,SMAD3;FOXC1;GBF1;BTRC;ASAH2;GAS1;PTPN3;OBSL1;ANAPC5;ANAPC7;MAEA;CDK13;ANAPC4;ANAPC16;BTG3;EIF4E;CDK11B;PSMF1;ERCC3;SIK1;RB1;TTL;PSMB2;CDC26;USP2;RCC1;CDC25B;TMEM8B;CDC27;UBE2E1;CCDC57;PRMT5;AFAP1L2;TTC28;RNF20;UBE2S;HNRNPU;CDK10;NEK6;CDKN1C;ANAPC11;CUL1;PSMC1;CUL7;CDK5RAP3;SCRIB;PRKCA;SPHK1;PSMB6;ANGEL2;PSMA3;HSF1;BORA;TFAP4;PSMA4;EIF4EBP1;CDC16;ANAPC1;NEK7;CCDC8;PSME1;PSMD13;APP;FZR1;CDK9;PSMB10;PSMA5;PSMB9
prerank,negative regulation by host of viral process (GO:0044793),-0.5343628994187029,-1.2169547986127638,0.23856858846918488,0.5028029294017511,1.0,4/10,22.70%,PRKN;CCNK;EIF2AK4;VAPA
prerank,pulmonary valve development (GO:0003177),-0.44845253604942203,-1.2165081368711972,0.1958568738229755,0.5033326898353916,1.0,5/18,3.07%,NOTCH2;SMAD6;BMP4;ROBO1;JAG1
prerank,ameboidal-type cell migration (GO:0001667),0.3548635830761989,1.2160405033660648,0.15674603174603174,0.6323805581102149,1.0,10/51,7.97%,ERBB4;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A;PKN1;AKT1
prerank,negative regulation of mRNA processing (GO:0050686),-0.4738999274606608,-1.215779923911507,0.20917431192660552,0.5045426368916449,1.0,4/15,7.39%,SFSWAP;SRSF10;U2AF2;SRSF6
prerank,regulation of proteolysis (GO:0030162),-0.36047947084405485,-1.2156694801551267,0.14705882352941177,0.5042351860378044,1.0,21/48,32.60%,DNAJC1;CYFIP2;BTRC;PLAT;ASPH;SPOPL;OGT;TRAF3;FBXW11;FGFR4;TBC1D10A;PARL;PERP;HDAC2;BAG6;CLN8;PLAUR;BAK1;CAV1;CLN6;LTBP4
prerank,substantia nigra development (GO:0021762),0.37615316234811674,1.2155872712943065,0.17316017316017315,0.6322122834624876,1.0,11/37,14.32%,ACTB;MBP;PLP1;HSPA5;DYNLL1;BASP1;CALM1;COX6B1;CALM2;INA;CALM3
prerank,positive regulation of axon extension (GO:0045773),0.4387646488275104,1.214841155216195,0.21836734693877552,0.6328947690044696,1.0,5/22,9.96%,DSCAM;SEMA7A;SHTN1;CDKL5;NTN1
prerank,secretory granule organization (GO:0033363),-0.5377253050354307,-1.2145460148285123,0.24253731343283583,0.5063755971734983,1.0,2/10,6.34%,ABCA1;DTNBP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5099866601997407,1.2142298032077925,0.2191780821917808,0.6331434909336461,1.0,1/10,1.24%,KLRC1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.4498310932765223,-1.2140121526535885,0.20076481835564053,0.5071365861233385,1.0,8/18,22.73%,PTN;REST;WDR43;CNOT2;TAF5L;CNOT1;TAF6L;ZC3H13
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.32302575733535,-1.213392148008019,0.11752577319587629,0.5080814436753976,1.0,20/88,17.09%,SAMD4A;NFKB1;IGFBP5;DNAJC1;SYNCRIP;PLAT;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;LSM14A;CNOT8;YBX1;ATRAID;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.282712664358197,-1.2130142571838545,0.0631163708086785,0.5083466302408506,1.0,61/208,23.39%,WLS;AKAP13;ROR1;LPAR1;PELI2;ANKRD17;ZFAND6;UBE2N;CFLAR;MAP3K3;PRKN;FLNA;TBK1;TFG;ALPK1;UFL1;MAPKBP1;TRIM8;TRAF3IP2;PDPK1;DHX36;GJA1;MIER1;TRAF2;RHOA;ZDHHC13;MAVS;TLE1;LGALS1;RORA;TRIM5;RIOK3;TRIM25;PPM1A;LTBR;STAT1;TRIM39;MAP3K14;TNIP2;ECM1;TRAF3;IKBKE;WNT5A;PRKD1;CC2D1A;TRAF6;RHOH;TANK;RHOC;TMED4;NEK6;IRAK1;CARD16;SHARPIN;CXXC5;TRAF5;NLRX1;TICAM1;VAPA;GPR89A;NLRC3
prerank,hemidesmosome assembly (GO:0031581),0.5020112926418232,1.2128459670442462,0.2151029748283753,0.6357439537488281,1.0,2/11,4.92%,ITGA6;DST
prerank,regulation of DNA metabolic process (GO:0051052),-0.3698526620961504,-1.2121072004143771,0.17928286852589642,0.5099728644461148,1.0,10/44,13.02%,SMG6;HDAC8;UBE2N;SMG1;NBN;YLPM1;HNRNPD;UPF1;MPHOSPH8;KDM1B
prerank,myelination in peripheral nervous system (GO:0022011),-0.502467250219079,-1.2120505386107008,0.24,0.5095606823396869,1.0,7/13,23.63%,DICER1;SKI;PARD3;LGI4;MYOC;ADGRG6;PRX
prerank,regulation of interleukin-1 production (GO:0032652),-0.4701802023295784,-1.2118816672641588,0.22043010752688172,0.5094238660275349,1.0,3/15,7.02%,FOXP1;HMGB1;ANXA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5223443675507017,-1.2113066998410278,0.24427480916030533,0.5102318399009318,1.0,3/10,7.01%,ATP1A2;OSR1;CAMK2D
prerank,neuron remodeling (GO:0016322),0.5242072474005497,1.2105210813317127,0.21935483870967742,0.6412029763530128,1.0,2/10,5.01%,ADGRB3;SCARF1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.40371330889988755,1.209865114007341,0.19166666666666668,0.641619919613088,1.0,11/28,21.51%,NAV3;GIT1;OCLN;PAK1;DCTN1;RPS3;MECP2;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,regulation of cellular protein localization (GO:1903827),-0.3608814326270531,-1.2098282954385422,0.17481203007518797,0.513424962390808,1.0,18/45,22.47%,GPC6;GBF1;PRKAA2;GPC4;GPC3;SPIDR;NDEL1;VCPIP1;CSNK1E;SETD2;PARP1;CCDC66;PRKAA1;PTPN1;VCP;DVL3;TOR1A;GPC1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5194178589885604,-1.2094686111375892,0.23754789272030652,0.5137960169503252,1.0,2/11,5.41%,BMPR1A;THBS1
prerank,calcium ion transport (GO:0006816),0.30981655591468404,1.2094185131492226,0.13496932515337423,0.6414489688677377,1.0,27/113,14.44%,CAMK2A;SLC24A4;SLC24A2;TRPC5;CACNA1A;CACNA1B;RAMP2;RYR2;RYR3;CACNA2D1;GAS6;SLC8A1;CACNA1E;TRPM2;CACNB2;TPT1;CACNG3;GRIN3A;CACNG8;P2RX7;TRPC1;TMCO1;MCOLN2;PSEN1;ATP2B2;ATP2B4;CACNA1I
prerank,response to iron ion (GO:0010039),-0.5036524233769698,-1.2091464964808085,0.23497267759562843,0.5139795998764707,1.0,4/12,14.13%,BMP6;BCL2;HIF1A;ACO1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.49294343395667917,-1.2088968191114564,0.21875,0.5140128208774325,1.0,6/12,17.48%,NBL1;BMP5;WASL;CCN3;DUSP1;MIA3
prerank,actin polymerization or depolymerization (GO:0008154),-0.35956213896914535,-1.2083845186621673,0.1792452830188679,0.514692302423482,1.0,16/50,19.90%,ARHGAP6;MICAL3;GAS7;GSN;SVIL;DIAPH1;MICAL2;CORO7;WASL;ABI1;TTC17;WASF1;FAM107A;MICAL1;AVIL;VILL
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.47361503882680733,-1.2082242314070857,0.2144177449168207,0.5144806884794253,1.0,5/15,16.48%,SNX9;NRDC;ADAM9;APOE;ADRA2A
prerank,hyaluronan metabolic process (GO:0030212),-0.4197769514379486,-1.2082222212405973,0.21706864564007422,0.5139033577576971,1.0,8/23,22.57%,CEMIP;SLC9A1;ABCC5;CEMIP2;GUSB;HEXA;FGF2;CHP1
prerank,regulation of insulin secretion (GO:0050796),-0.31675450746631184,-1.207376727193133,0.13609467455621302,0.5153418153839476,1.0,18/101,7.83%,ITPR1;CACNA1C;TCF7L2;ITPR2;ADCY5;MCU;PRKN;NLGN2;RBP4;IRS1;CDK16;DPP4;STXBP4;GLUD1;REST;NNAT;CACNA1D;RAPGEF3
prerank,positive regulation of calcium ion transport (GO:0051928),0.38056054218247504,1.2070263271855635,0.16560509554140126,0.6472020798499427,1.0,8/36,11.50%,CAMK2A;GRIN1;CXCL12;CACNB2;CCL2;PDGFB;F2R;P2RX7
prerank,aggrephagy (GO:0035973),-0.4113453091931653,-1.2067101229494082,0.19797979797979798,0.5163861446200441,1.0,12/27,21.16%,UBE2N;VIM;PRKN;ARL13B;UBQLN1;PCNT;IFT88;DYNC1LI1;DYNC1H1;ATG5;PARK7;WDR81
prerank,cell cycle G2/M phase transition (GO:0044839),-0.30161885323764104,-1.2066011734276212,0.10062893081761007,0.5160434275363411,1.0,38/129,19.49%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHLDA1;PCNT;AKAP8L;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2
prerank,recombinational repair (GO:0000725),-0.32320933621582026,-1.2064708723100441,0.12987012987012986,0.5157617913124176,1.0,19/77,17.04%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;RFWD3;PARP1;RAD51D;NABP2;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,telomere maintenance via recombination (GO:0000722),-0.513039700855472,-1.2061326242646746,0.2144212523719165,0.5160216434409144,1.0,4/11,11.74%,SMC6;NSMCE2;SMC5;RAD51D
prerank,regulation of peptidase activity (GO:0052547),-0.45238439819989584,-1.2058049619590954,0.20186915887850468,0.516284925360232,1.0,9/19,34.03%,CTSH;NRDC;RCN3;HDAC1;ECM1;PSMA3;CAV1;PSMB8;FURIN
prerank,cellular response to alkaloid (GO:0071312),0.4532625999492478,1.2054542964777009,0.23481781376518218,0.6504792257501935,1.0,3/17,4.70%,RYR2;RYR3;SLC8A1
prerank,positive regulation of cell growth (GO:0030307),0.31733225438228163,1.205126378301423,0.14314928425357873,0.6499076417973255,1.0,21/96,11.21%,SYT1;RIMS1;S100A9;S100A8;RIMS2;AKAP6;MFSD2A;CPNE9;SEMA4D;SEMA7A;UNC13A;TGFB2;RPS6KA1;AKT1;RNF157;SHTN1;H3-3A;CDKL5;NTN1;CEP43;SYT2
prerank,positive regulation of developmental process (GO:0051094),-0.2910913752379156,-1.2051096959396828,0.076,0.5174145263137973,1.0,28/164,8.60%,PHLDB2;SOX5;PTN;DAG1;BMPR1A;FOXD1;DCN;SMURF2;MCU;BMP5;CCN2;BMP7;BMP4;PRKN;KMT5B;NUMA1;DLG4;LMNA;RREB1;NIBAN2;ADGRL1;DNM1L;ZBTB16;DDHD1;REST;RAPGEF3;AR;GJA1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3279814384800784,-1.204681175234453,0.13799621928166353,0.5179078260945149,1.0,17/80,17.35%,SAMD4A;ROCK2;PLD1;VIM;ZCCHC4;YTHDF3;THBS1;MTOR;HNRNPD;EPHA4;PLXNB2;PRKCD;PRKDC;DDX3X;IFNGR1;UPF3A;PICALM
prerank,regulation of cell-cell adhesion (GO:0022407),0.38090387387004854,1.2044955183089803,0.18712273641851107,0.6502755549425727,1.0,10/39,12.17%,PTPRG;PTPRR;PODXL;MAGI1;FERMT3;FUT9;TENM3;CELSR2;SMAD7;MEGF10
prerank,DNA repair (GO:0006281),-0.2732914652756075,-1.2039233424078082,0.04921259842519685,0.519123723253191,1.0,127/284,33.55%,EYA1;INO80;UBE2N;FTO;GTF2H2;ABL1;KMT5B;RAD23B;RBBP8;UVRAG;WDR33;HUWE1;KDM4B;NBN;WDR48;RAD51B;TDP2;MLH1;TRRAP;APEX2;BRCC3;RNF8;PDS5A;WRN;TEX264;DDB2;VCPIP1;ZBTB1;CSNK1E;SETD2;HERC2;UPF1;MNAT1;PARP9;USP47;ASCC3;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;PIAS4;FANCE;KMT5C;APTX;DTX3L;PARP4;MMS19;ERCC6L2;PRKDC;FANCM;HINFP;UBE2B;BRCA2;MSH3;FANCI;ERCC8;NOP53;MRE11;SPRTN;ZRANB3;BAZ1B;VCP;DCLRE1A;PARK7;MGME1;MSH6;PCNA;POLN;SMC1A;FANCC;RPAIN;FAAP100;ATR;UBE2V2;SMARCAL1;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;EYA3;POLE2;ACTR5;RECQL5;SLC30A9;OGG1;TNKS1BP1;ENDOV;ABRAXAS1;RAD54L;GTF2H4;FANCB;MPG;POLH;TIMELESS;IGHMBP2;NUDT1;KPNA2;PARP3;MGMT;MAD2L2;UBA52;FANCD2;FANCG;MDC1;PARP2;POLD2;FAAP20;NEIL3;NSD2;RPA2;EME2;RAD9A;PNKP;EXO5;RMI2;RAD51;PSME4;POLA1;DDB1;LIG4;BRCA1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5351185919066398,-1.2038100414534447,0.23846153846153847,0.5188152423332976,1.0,4/10,16.48%,ATP1A2;VDAC1;YWHAE;ADRA2A
prerank,response to nutrient levels (GO:0031667),-0.45916590414281144,-1.2037405535008223,0.2265625,0.5183957444345259,1.0,7/17,22.37%,PRKAA2;RPTOR;MTOR;FAM107A;PRKAA1;EIF4G1;KCNB1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3406683013173519,-1.2035286340197833,0.15495867768595042,0.5183398140270037,1.0,18/59,17.61%,TCF7L2;NFKB1;CDK8;PPM1D;TNRC6B;TNRC6A;MED15;MOV10;MED17;MED26;MED12;MED1;JUN;BCLAF1;MED8;RUNX2;TNRC6C;MED27
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.5170218045986753,-1.2034717346779324,0.23119266055045873,0.5179177960356143,1.0,7/12,33.61%,CLCN2;MBTPS2;MBTPS1;H6PD;LPCAT3;SREBF1;RAN
prerank,transport across blood-brain barrier (GO:0150104),0.32461569428087234,1.2032831628830747,0.1288981288981289,0.6525037336289619,1.0,24/83,14.16%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1;SLC1A2;SLC7A8;SLCO2B1;ABCC4;ATP1A4;FABP5;KCNJ8;SLC16A1;SLC27A4;INSR;CD36;ATP2B4
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.41930288623812173,-1.202912730205574,0.2092130518234165,0.5186736540087805,1.0,5/23,5.70%,MCU;CAMK1D;RIPOR2;DNM1L;DPP4
prerank,negative regulation of protein metabolic process (GO:0051248),-0.358994900816514,-1.2019872125029627,0.18110236220472442,0.5203995878605896,1.0,9/48,5.51%,EGFR;NFKB1;MDM4;ITGAV;ROCK1;FLOT2;FLNA;IRAK3;EIF2AK1
prerank,dendritic cell differentiation (GO:0097028),0.42674656792832816,1.2017722313925667,0.225531914893617,0.6557125667305027,1.0,5/22,7.12%,GAS6;CAMK4;FLT3;TRPM2;BATF2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2655405654956301,-1.2013305060459256,0.04056795131845842,0.5213705494568649,1.0,115/390,20.91%,ROCK2;SULF1;IGF1;ROR1;EGFR;RHOQ;SORBS1;RBFOX2;EPHA7;COL4A6;SIPA1L1;EPHA3;COL1A1;PDGFRA;ANGPT1;NTRK3;EFNB2;SDC2;FLRT2;HNRNPH1;FOXC1;GRB10;ITGAV;FGF1;PDGFRB;AXL;IL31RA;ROCK1;GHR;ATP6V1B2;CYFIP2;FRK;GSK3B;KIT;SHOC2;RYK;WASF2;IRS1;PLAT;SULF2;ATP6V0D1;SLC39A14;SHB;PAK2;STAT3;NRP1;HNRNPM;FGFR2;EIF2AK3;SHC1;FOXC2;LYN;ATP6V0A4;MERTK;CDC42;VAV2;BRK1;EPHA4;IGF2;FRS2;NGF;NCSTN;WASL;FER;PTPN2;PDGFC;RHOA;KIF16B;KL;YES1;ABI1;NFATC4;NCKAP1;ROR2;ANGPT2;MMP2;ARPC2;FLRT1;APPL1;EPHA8;VEGFA;NCK1;RAPGEF2;VEGFD;DDR1;NCK2;CYBA;RASA1;BDKRB2;FIBP;NGEF;EFS;DOCK1;STYK1;ZFYVE27;TCIRG1;PHIP;PRKD1;BLNK;FGFBP1;CEP57;POLR2H;MUSK;GAB1;PTPN11;ITGB3;NCF2;MVP;RAPGEF1;SPRED2;GFRA2;BAIAP2;FGFR4;PIK3R1;AAMP
prerank,response to acidic pH (GO:0010447),-0.4948177088717334,-1.1996106671565165,0.2391713747645951,0.5249549103896815,1.0,8/13,41.30%,SLC9A1;IMPACT;GPR4;CHP1;PKD2L1;PKD1L3;LGMN;RAB11FIP5
prerank,natural killer cell activation (GO:0030101),-0.42592329394666417,-1.1992382284358132,0.22727272727272727,0.5253196288464042,1.0,3/23,6.72%,PBX1;AXL;ELF4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4080954179813707,-1.1990700262879923,0.19553072625698323,0.5251655416583819,1.0,12/26,30.83%,FBN1;HOXA7;PTPN2;TLR4;GPR137B;INHBA;TCTA;CDK6;MAFB;INHA;TLR3;FSTL3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.41153415787399605,-1.1988745888923276,0.22242647058823528,0.5250763083434414,1.0,6/26,11.70%,PRKAG2;PRKAA2;WDTC1;NR1H3;PRKAB2;ERLIN1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.455312634228468,-1.1985164525323762,0.22796934865900384,0.5254015483213447,1.0,4/16,9.95%,MOV10;RC3H1;DHX36;UPF1
prerank,regulation of kinase activity (GO:0043549),0.31905103500212084,1.1982693450681206,0.14107883817427386,0.6646490306086266,1.0,13/89,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,regulation of cell migration (GO:0030334),0.2680482994848183,1.1978509610081456,0.06203007518796992,0.6643770944989333,1.0,78/382,13.90%,FLT1;CAMK2A;CLDN5;IGF1R;PRR5L;LEF1;NAV3;LIMCH1;CTNNA2;FRMD5;SRGAP1;ERBB4;PTP4A1;SEMA3C;CSF1R;PODXL;PLXNB3;TMSB4X;SEMA6A;MIF;ITGA6;DACH1;TMSB10;CXCL12;MAGI2;SEMA4A;PTPRT;MCTP1;SEMA4F;ROBO4;PPM1F;SEMA6D;KDR;FGF10;SEMA4D;SEMA7A;THY1;FERMT3;ENPP2;MEAK7;HSPA5;NOTCH1;PAK1;FGF5;PECAM1;PTPRJ;ACVRL1;AKT1;GPNMB;PLXNA4;SGK3;SST;NTNG1;NTNG2;SPATA13;CYRIB;PDGFB;AIF1;F2R;CEP43;PIK3R3;TMEFF2;APC;TJP1;SMAD7;RET;SRGAP3;SRGAP2;DOCK10;EPHA1;BCAR1;SORL1;ACTN4;RFFL;HRAS;XBP1;INSR;CIB1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4030274788770415,-1.1978354051751154,0.22753346080305928,0.526514303163925,1.0,4/26,5.66%,LARGE1;ST3GAL4;GK5;RRM2B
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4167973510258475,-1.1976236274564118,0.21575984990619138,0.5264868710113966,1.0,10/24,12.22%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;RALA
prerank,prostanoid biosynthetic process (GO:0046457),-0.4622458754663762,-1.1969594819410048,0.24053030303030304,0.5275959915703597,1.0,6/15,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5192768849884217,-1.1966341047070432,0.24955436720142601,0.5277991966064531,1.0,6/10,27.07%,EMC2;EMC7;EMC9;EMC4;EMC10;EMC3
prerank,mRNA 3'-end processing (GO:0031124),-0.32265699226662625,-1.1959194159690554,0.14777327935222673,0.528950228834256,1.0,31/78,27.98%,TENT2;PABPN1;PCF11;WDR33;CASC3;SCAF8;U2AF2;CPSF3;SRSF6;SSU72;SLU7;RPRD2;SLBP;SRSF1;PAPOLG;CSTF3;SRSF7;CDC73;SRSF11;SRRM1;UPF3B;SRSF2;AHCYL1;CSTF1;CPSF4;NUDT21;CPSF1;NCBP2;LSM11;APP;POLR2D
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.38474592363488463,1.1958596367922,0.19198312236286919,0.6687366084080131,1.0,7/31,11.12%,LRP8;NLGN1;SHANK3;KIF1A;ZDHHC15;RELN;PPFIA2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3254832949433485,-1.1957448917964795,0.140625,0.5288301009830031,1.0,20/80,13.84%,DPYSL3;AUTS2;DOCK11;RHOQ;PLCE1;ARAP1;RIPOR2;WASF2;BCAS3;NRP1;CDC42;BRK1;NDEL1;MARK4;CDC42EP5;WASL;NCKAP1;RALA;ARPC2;P2RY12
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3393373990422068,-1.1954834576743307,0.166015625,0.5289060011412469,1.0,14/59,14.02%,EGFR;PDGFRA;TPM1;ABL1;ANXA1;MAP3K5;PTPRK;IMPACT;CYP1B1;FER;JUN;PRKCD;PKD2;ERCC6L2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.46952292139605256,-1.1951475472968762,0.23883495145631067,0.5291916277551193,1.0,5/14,19.61%,ANK2;ACTN2;AKAP9;LRRC38;ATP1B3
prerank,mononuclear cell differentiation (GO:1903131),0.4150034976379872,1.194550350961914,0.23636363636363636,0.671182967751863,1.0,6/24,6.47%,CSF1R;PPARG;GAS6;FLT3;MT1G;TRPM2
prerank,embryonic hemopoiesis (GO:0035162),0.4951563243341155,1.1943413230429272,0.2291220556745182,0.6702851964458612,1.0,4/12,9.01%,KITLG;KDR;TAL1;TPO
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.4125648493021987,-1.19412798564655,0.24187725631768953,0.5311461241631389,1.0,9/25,19.36%,FOXO3;ARNT;STAT3;MED1;HIF1A;STAT1;PRKDC;STAT5B;INHBA
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.45612201425325927,-1.1938651529218773,0.2164750957854406,0.5312478718134486,1.0,6/17,16.50%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,somite development (GO:0061053),-0.509361006838186,-1.193195538503081,0.27692307692307694,0.5323096711601104,1.0,4/11,15.98%,SMO;MEOX2;PTCH1;LOXL3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.3179494050239349,-1.1931410200245878,0.16205533596837945,0.5318608746863761,1.0,23/84,20.17%,SAMD4A;IGF1;IGFBP5;ROCK1;SYNCRIP;DDX6;EIF4ENIF1;EIF2AK3;LARP1;DHX36;GGA3;LSM14A;CNOT8;YBX1;EIF2AK2;APOE;DDX3X;DAPK1;CNOT1;ABCA7;CNOT10;RBM4;ORMDL3
prerank,response to UV-B (GO:0010224),0.4919851850634107,1.1925956138576155,0.24892703862660945,0.6741720776676166,1.0,2/12,4.90%,MME;IL12A
prerank,apical protein localization (GO:0045176),0.5189048421883002,1.1923412539806875,0.2809734513274336,0.6734011223655204,1.0,5/10,14.24%,ACTB;MAL;INSC;VANGL2;JAM3
prerank,membrane assembly (GO:0071709),0.38541821353446293,1.1920879328750122,0.18219461697722567,0.6726839417065497,1.0,6/34,5.91%,NRXN1;PTPRD;IL1RAPL1;NLGN1;ANK3;NRXN2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.29642468419759876,-1.1920825855965227,0.12396694214876033,0.5338675177349448,1.0,42/128,22.93%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHLDA1;PCNT;FBXL12;CSNK1E;BRSK1;MNAT1;NES;MAPRE1;TPD52L1;YWHAE;LATS1;CDC25B;PPP1CB;AKAP9;CCDC57;DYNC1H1;CEP76;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;CDK2;CUL1;TAF2;HAUS7;HAUS8;ACTR1A
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49956382110938696,-1.1918210684630024,0.24750499001996007,0.534007318561752,1.0,4/12,9.06%,THRB;KLF9;CTSH;MED1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4479527121821514,-1.1918131516600279,0.2326454033771107,0.5334455817041468,1.0,7/18,24.68%,DAB2;MAP2K1;CHMP3;RAB21;MSN;PTPN23;SNX12
prerank,positive regulation of nervous system process (GO:0031646),0.44770379268018645,1.1916572798566964,0.23736263736263735,0.6724912028508017,1.0,5/18,9.18%,RIMS1;RIMS2;TENM4;ATPSCKMT;TPPP
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.35243735257980885,1.1915960538031725,0.18333333333333332,0.6711271042531083,1.0,7/46,4.15%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2
prerank,negative regulation of cellular process (GO:0048523),-0.25674446373235355,-1.1912963258455722,0.023529411764705882,0.5341593581136577,1.0,152/521,22.10%,PLXNA2;TGFBR3;ALDH1A2;SMAD3;ZBTB7C;APPL2;KANK2;ANGPT1;DCBLD2;SMAD6;CELF1;COL4A3;FBLN1;BMP5;MDM4;CCN2;FHL1;DIS3L2;UBR2;KAT2B;BMP7;BMP4;ANXA6;PDPN;PRKN;PPM1D;ENPP1;PTPN14;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;CLMN;NIBAN2;RIPOR2;VGLL4;RARG;IGFBP3;TGFB1I1;IGFBP6;PLSCR1;SKI;VPS4B;SPEG;CD9;TMEM127;EIF2AK3;BCL2;NOX4;LYN;TES;SRSF6;REST;WNT9A;P3H3;CHMP4B;AR;GJA1;SP100;PTPRK;IMPACT;MAP2K1;TXNIP;CYP1B1;PLXNB2;BTG3;COL18A1;NGF;PTPN2;CCN3;NR1H3;SMAD4;ABI1;ROR2;PDS5B;PKD2;RB1;VPS13C;ADNP2;IRF1;BECN1;CCN5;FKTN;CCN1;COPS8;ARHGDIB;IGFBP7;EIF2AK2;ING5;CD164;RBM5;EMILIN1;CRLF3;DUSP1;NCK1;DDX3X;CBFA2T3;RAPGEF2;NCK2;PLXND1;RASA1;ANP32B;MNT;TGFB3;PLXNB1;ADAMTS1;PDCD4;MYBL1;NR4A1;CCN4;MIA3;OSGIN2;ARID2;PRKD1;S100A11;PPP2R5C;SFRP4;ATG5;SOD2;NDRG3;FGFBP1;DACT3;NME6;IFI35;BMP2;DCUN1D3;PARK7;CDK10;INHBA;PBRM1;CDC73;NF2;IFIT3;PML;ING1;FRZB;NOS1;SPEF1;NME1;ZBTB49;CDK6;PPP2CA;BNIP3;FGF2;TGFBI;DLG5;LPCAT3;PTHLH;WNT16
prerank,cellular response to organic substance (GO:0071310),-0.3086386562693945,-1.1912701233830076,0.1402805611222445,0.5336412742465612,1.0,24/116,10.27%,PTPN13;DPYSL3;NFAT5;PID1;SMAD3;TGFBR1;BMPR1A;IGFBP5;GHR;LRRK2;PTPN14;TGFBR2;TBK1;CLEC3B;PTPN9;STAT3;ASAH2;SHC1;RAMP1;NCOA1;CYP1B1;PTPN12;PTPN2;RHOA
prerank,double-strand break repair (GO:0006302),-0.2886782628473625,-1.1912496664208427,0.123046875,0.533103675758819,1.0,69/158,33.55%,EYA1;INO80;UBE2N;RBBP8;SPIDR;HMGB1;KDM4B;SMC6;NBN;RAD51B;TDP2;NSMCE2;BRCC3;RNF8;WRN;SMC5;HERC2;PARP9;MCM9;RFWD3;XRCC4;PARP1;RAD21;RAD51D;PAXX;POLM;NABP2;PIAS4;APTX;DTX3L;PRKDC;BRCA2;KDM2A;SFPQ;MRE11;ZSWIM7;BAZ1B;VCP;DCLRE1A;POLN;XRCC6;UBE2V2;SMARCAL1;RAD51C;ERCC1;PAXIP1;EYA3;ACTR5;RECQL5;IFFO1;TNKS1BP1;ABRAXAS1;SFR1;HELQ;KPNA2;PARP3;MAD2L2;SAMHD1;MDC1;ZFYVE26;PARP2;RNF138;NSD2;RPA2;EME2;RAD51;POLA1;LIG4;BRCA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45479998198556204,1.1906703939036622,0.2511013215859031,0.6725130595714309,1.0,4/15,5.70%,IGF1R;KDR;AATK;SRMS
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5135071183782633,1.190358103054397,0.24520255863539445,0.6719324381956305,1.0,4/11,16.97%,EXOSC5;FBL;DKC1;EXOSC4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.46651816116598344,-1.1896831569713437,0.2555147058823529,0.5364640674388684,1.0,2/14,3.11%,ZEB1;OSR1
prerank,regulation of complement activation (GO:0030449),-0.3659480950701106,-1.1895912092432082,0.19195612431444242,0.5360790041905366,1.0,5/40,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.424159757462979,-1.189539766704659,0.2182468694096601,0.5356163583890816,1.0,5/20,10.52%,TGFBR1;ZMIZ1;PRKN;UBQLN1;HIF1A
prerank,chromatin remodeling (GO:0006338),-0.30941573510422243,-1.1893544200655395,0.1470019342359768,0.535475720738072,1.0,40/100,28.18%,INO80;KAT2B;ARID1B;HDAC4;TOP1;EZH1;BAZ1A;BAZ2A;KDM4B;SMARCC2;NUDT5;CHD8;KDM5B;MYSM1;MBD2;ZBTB1;KDM6A;CHD4;CHD3;HCFC1;RB1;HDAC1;JARID2;SMARCD2;BAZ2B;BAZ1B;TAF6L;BPTF;PBRM1;PIH1D1;SMARCD3;HDAC2;MBD3;INO80C;ZBTB7A;ACTR5;MPND;CECR2;ATRX;ESR1
prerank,response to thyroid hormone (GO:0097066),-0.4863052679759593,-1.1893477197309776,0.250996015936255,0.5349133855831788,1.0,4/13,9.06%,THRB;KLF9;CTSH;MED1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4749787238061114,-1.188828167796709,0.27169811320754716,0.5355361759303333,1.0,8/13,31.31%,UBQLN1;RNFT1;TMEM259;USP13;BAG6;NFE2L2;CAV1;HERPUD1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3212126392915781,-1.188799014564463,0.17870722433460076,0.5350325779962478,1.0,13/78,7.97%,EGFR;PID1;LRP1;RHOQ;SORBS1;EPHA3;DAB2;PTPN9;DLG1;ITGB1;VTI1B;PDPK1;AR
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.49330166017273436,1.1885056131734024,0.23214285714285715,0.6761448006924555,1.0,3/11,7.36%,CACNA2D1;BIN1;CACNB2
prerank,regulation of interleukin-13 production (GO:0032656),0.47110959091762483,1.1884734053850508,0.25158562367864695,0.6746962093513419,1.0,2/13,11.20%,LEF1;TNFRSF21
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4354206160723075,-1.1884427266939162,0.25147347740667975,0.5353176475078446,1.0,4/19,11.49%,NFAT5;PLCE1;INPP5A;NFATC4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.45012762807640555,1.1881324024417754,0.22244897959183674,0.674282454886646,1.0,5/18,9.08%,LRP8;ADCY8;EPHA5;RPS6KA5;RELN
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5037787978656447,-1.1881318221014305,0.23668639053254437,0.5355369707458171,1.0,4/12,4.53%,DOCK5;TPM1;IGFBP5;DOCK7
prerank,fatty acid beta-oxidation (GO:0006635),-0.3447716443374141,-1.187984799089258,0.17348927875243664,0.5353386316338034,1.0,21/51,24.26%,ABCD3;IVD;ACADM;ACAD10;ABCD2;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1;DECR2;AMACR;MECR;ACOT8;ACOX3;AUH
prerank,cellular protein localization (GO:0034613),-0.2707994932152352,-1.1877794359402831,0.06736842105263158,0.5352554172838132,1.0,103/285,27.92%,WLS;EGFR;ANK2;VCL;ANGPT1;TLK1;KIF13A;SH3PXD2B;LRRK2;TBC1D16;FBLN5;CNTLN;FLNA;SGSM2;PIGK;SNX9;SNX6;SEC23IP;STX16;RAB22A;STXBP1;VPS26C;SIL1;AP3B1;GJA1;COPZ2;PTPRK;USP6NL;SEC31A;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;GGA3;RPGR;WIPI1;COG3;TM9SF2;COG7;NIPBL;STX4;ARFIP2;ARF1;STX5;USP4;COPB2;TBCK;RAB21;CTTN;GRTP1;TM9SF1;TBC1D22B;CTSA;DNAJC27;SMURF1;FAM91A1;TBC1D9;COX18;ATG9A;SNX8;WDR45B;TMED3;WNT5A;WDR11;NAPA;TBC1D17;TMED5;TMED4;RABGAP1;WIPI2;STX17;TBC1D10A;NPHP1;RAB24;GGA2;STX8;IFT27;RABL3;VPS26B;ARL5A;NSF;USO1;AP2A1;SAR1B;STX12;PRRT1;RAB5A;CD63;STX1A;VPS45;RRAGA;TBC1D10B;BBS4;MFN2;GAS8;STX7;TMED2;TBC1D9B;FERMT2;ARL4C;RIC1
prerank,regulation of defense response to virus (GO:0050688),-0.47950355408054623,-1.1876772064588756,0.24511545293072823,0.5349304910890291,1.0,5/14,16.57%,DHX9;PCBP2;RNF216;ILRUN;TRAF3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.32678575614595357,-1.1874243054683062,0.17735849056603772,0.5350004981103214,1.0,30/67,28.24%,PLD1;TBC1D16;DCDC2;ATP8B1;TBC1D19;TBC1D24;CDC42;USP6NL;TBC1D2B;TBC1D20;FER;IFT88;CAPZB;TBC1D22B;DYNC2LI1;P2RX4;ATG5;TBC1D17;RABGAP1;TBC1D10A;ABITRAM;RAB5A;IFT140;FXR1;TWF1;TWF2;TBC1D10B;ATG3;TBC1D9B;RABEP2
prerank,proteoglycan metabolic process (GO:0006029),-0.4045024187151797,-1.1871657555742052,0.21804511278195488,0.5350411371480315,1.0,4/26,4.87%,SULF1;IGF1;ADAMTS12;SULF2
prerank,DNA double-strand break processing (GO:0000729),-0.44068609585533425,-1.1870818908393201,0.2337917485265226,0.5346743271142568,1.0,3/18,5.93%,UBE2N;RBBP8;NBN
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.44350646934314053,-1.1868565669189561,0.26045627376425856,0.534655644435107,1.0,7/18,14.89%,MDFIC;CTNNA1;GSK3B;SUFU;APOD;ILRUN;LATS1
prerank,purine nucleotide catabolic process (GO:0006195),0.47192508596372124,1.1866485332589407,0.2558139534883721,0.6773030270715286,1.0,3/13,12.86%,GPX1;NT5C;HINT1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2919044607448622,1.186591669097119,0.10330578512396695,0.6759776461691966,1.0,32/149,14.07%,CAMK2A;TFRC;TIRAP;PRKCH;S100A9;S100A8;TRIM13;TRAF1;RPS6KA5;ALK;CLU;PRKCQ;RTKN2;TRIM37;RPS27A;UBC;TRIM62;TLR2;UBB;TRIM6;PSMA6;ARHGEF2;NOD1;TERF2IP;MID2;BCL10;CD40;RPS3;NFKBIA;CD36;CIB1;TAB2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.431216451134994,-1.1862302450577356,0.23595505617977527,0.5357374605465497,1.0,4/20,2.70%,TGFBR3;TGFBR1;RBPJ;BMP4
prerank,positive regulation of cyclase activity (GO:0031281),-0.4734473758639052,-1.1859653927371625,0.2701252236135957,0.5358049769177178,1.0,3/14,7.81%,CACNA1C;STIM1;CACNA1D
prerank,regulation of axon extension (GO:0030516),0.3756930395091313,1.185135329920938,0.21473684210526317,0.6789757228981892,1.0,12/37,15.90%,MAG;MAP2;SEMA7A;NRCAM;SHTN1;CDKL5;RTN4R;NTN1;DIP2B;SIN3A;RTN4;MACF1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.31918840497554424,-1.1849105822114288,0.15748031496062992,0.5378563139638626,1.0,25/84,17.71%,ROCK2;FOXP1;SASH1;ANGPT1;PLPP3;FGF1;BMP4;ABL1;SPARC;HMGB1;THBS1;BCAS3;NRP1;FOXC2;PDPK1;PLCG1;HIF1A;ANXA3;VEGFA;P2RX4;ATOH8;STAT5A;PIK3CD;WNT5A;PRKD1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5108445273051866,1.1848027080553187,0.2605932203389831,0.6770131361191589,1.0,2/10,6.77%,MBP;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5108445273051866,1.1848027080553187,0.2605932203389831,0.6770131361191589,1.0,2/10,6.77%,MBP;KLF4
prerank,antibacterial humoral response (GO:0019731),0.45145609302688533,1.1845696980873357,0.2510548523206751,0.6761952666266272,1.0,4/16,21.93%,SLPI;DEFA6;RNASE3;RNASE7
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.47272379719376295,-1.1844929089631753,0.2617702448210923,0.5383001483686606,1.0,2/13,2.90%,DCN;BGN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3883161715787514,-1.1844563023573638,0.22348484848484848,0.5378111647448863,1.0,12/31,20.87%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4894208599911466,-1.1843419622575415,0.27355072463768115,0.5375386166616738,1.0,5/13,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,B cell activation involved in immune response (GO:0002312),-0.49234093775931254,-1.1842909659468788,0.25475285171102663,0.5370854413267216,1.0,8/13,37.27%,RNF8;MSH6;EXOSC3;BATF;GPR183;LIG4;FCGR2B;MSH2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4160943510377264,1.1833909825797473,0.2263779527559055,0.6781730750625695,1.0,8/22,15.62%,RPS20;RPL23;RPL37;UBB;RPS15;RPS7;ATM;CHD5
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.456204009974831,1.183154522380571,0.22044088176352705,0.6774065910306479,1.0,4/15,12.04%,FST;MAGI2;CSNK2B;SMAD7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.45837206387176366,-1.1831295803121475,0.2346368715083799,0.5395721331822514,1.0,6/16,16.50%,WNT4;VIM;BMP4;RUNX1;TGFB3;SUCO
prerank,intracellular sterol transport (GO:0032366),-0.4767771015480268,-1.1831237927022153,0.26022304832713755,0.5390210838297907,1.0,3/13,11.63%,ABCA1;RELCH;NPC2
prerank,L-amino acid transport (GO:0015807),0.3945978161158984,1.1829941388806788,0.23284823284823286,0.6763940740625394,1.0,6/28,9.58%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC7A8;SLC36A1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3181473481941319,-1.182396230581426,0.15779092702169625,0.5402348495279268,1.0,26/78,22.83%,PIAS1;DAB2;PRKN;LRRK2;ARIH1;CSNK1A1;GSK3B;RNF217;UBQLN1;RNF19A;NUB1;CSNK1E;TRIB2;SH3RF2;CBFA2T3;NOP53;HECTD1;FBXO22;VCP;CSNK1D;RNF14;COP1;ZYG11B;ARIH2;DET1;RNF144A
prerank,regulation of protein catabolic process (GO:0042176),-0.31137884887842077,-1.1821800125572381,0.148,0.5401641844021736,1.0,27/99,19.02%,EGFR;SMURF2;MDM4;PRKN;WWP2;GSK3B;FLNA;IRAK3;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;WDR91;STX5;GFAP;CTSA;SMURF1;CSNK2A1;CENATAC;ASB5;WNT5A;HMGCR;AREL1;VCP;CYP51A1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.46009774116884083,1.1818703830998647,0.23880597014925373,0.6781441426743059,1.0,5/16,13.89%,IGF1R;ETF1;GLE1;OGFOD1;INSR
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.37170200828351124,1.1818663787766517,0.20086393088552915,0.6766636874008278,1.0,7/38,10.22%,GRM5;LRP8;CSF1R;GAS6;THY1;RELN;PDGFB
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.45719071957718693,-1.1816465912951875,0.23978685612788633,0.5409486124230851,1.0,8/16,18.78%,FTO;BMP7;RREB1;NAPEPLD;SOX13;SIX1;HNRNPU;METRNL
prerank,heart process (GO:0003015),0.4646791635838916,1.1813871614215443,0.2449438202247191,0.6766745871347141,1.0,3/14,10.10%,SGCZ;GPX1;SGCG
prerank,negative regulation of cell motility (GO:2000146),0.30761281175180627,1.1813667110656576,0.15019762845849802,0.6752638745916203,1.0,13/108,4.49%,CLDN5;NAV3;LIMCH1;SPOCK3;FRMD5;SRGAP1;PLXNB3;MIF;DACH1;MAGI2;PTPRT;MCTP1;THY1
prerank,modulation by symbiont of host process (GO:0044003),0.5306613936414502,1.1812359591925081,0.2422907488986784,0.6741899303205673,1.0,6/10,19.23%,RPS27A;UBC;TLR2;UBB;B2M;HGS
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.38028926262196805,-1.1809792184183576,0.21428571428571427,0.5419677306156424,1.0,15/33,21.57%,FGF1;JAK1;RHOJ;THBS1;PDPK1;GLUL;ADAMTS9;BMPER;CEMIP2;VEGFA;ITGA5;PKM;S100A1;SMAD1;FGF2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5210708352933482,-1.1806730211009406,0.2596685082872928,0.5421665360134705,1.0,4/10,21.93%,GFPT1;PFKP;PFKM;PFKL
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38643397633794907,1.1802110305872218,0.22269807280513917,0.6758813540855878,1.0,11/32,16.35%,AKAP6;SNCA;THY1;APLNR;HAP1;F2R;CALM1;TRPC1;CALM2;CALM3;NPSR1
prerank,regulation of leukocyte activation (GO:0002694),0.46789441518956426,1.1800241922830514,0.24748490945674045,0.6749574140676224,1.0,2/14,2.15%,CD33;MIF
prerank,histone H4 deacetylation (GO:0070933),-0.5165849657877563,-1.1798408470559794,0.28433268858800775,0.5437400298084575,1.0,5/10,14.63%,HDAC8;HDAC4;RCOR1;REST;HDAC1
prerank,regulation of cardiac conduction (GO:1903779),-0.3419134679826762,-1.1795090120397647,0.19238476953907815,0.5440288128757552,1.0,17/54,21.31%,ATP1A2;ITPR1;STIM1;ANK2;ITPR2;TMEM65;ASPH;DMPK;ATP2A2;ATP2B1;NPR2;PRKACA;SLC8A3;ATP1B3;NOS1;ATP2A3;AHCYL1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.27808696988350506,-1.179469264380043,0.11741682974559686,0.543558652689183,1.0,53/199,21.14%,ROCK2;ALDH1A1;EGFR;LDLRAD4;RBPJ;SMAD6;ZNF423;LGR4;BMP5;ROCK1;BMP4;ROBO1;NPR3;WWC2;NFIB;GSK3B;DOCK7;ADAMTS5;HOXA7;TWSG1;FOXC2;SRSF6;GJA1;LAMA4;NRDC;NR1H3;ATP2B1;WWC1;TBX18;MEF2C;IL17RD;RB1;ACOT11;ARHGDIB;BRCA2;IL17D;PTCH1;LNPEP;DUSP10;IFNGR1;VASN;PLCL1;TLR4;HMGCR;CHSY1;BMP2;ABHD6;CYP51A1;MAP2K6;SPRED2;TLE3;PPP2CA;SFMBT1
prerank,neutrophil activation involved in immune response (GO:0002283),0.2594852556400349,1.1788185962019138,0.05588822355289421,0.6771658020768688,1.0,91/428,17.91%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;DNASE1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,positive regulation of cell migration (GO:0030335),-0.27210641314388057,-1.1785946826133786,0.08979591836734693,0.5451009006704974,1.0,72/253,19.13%,SYNE2;ROCK2;IGF1;EGFR;DOCK5;TGFBR1;COL1A1;PDGFRA;NTRK3;SMURF2;MYLK;CEMIP;SEMA3D;FGF1;PDGFRB;DAB2;PDPN;SMO;VTN;WNT5B;KIT;RREB1;ITGB1;CTSH;THBS1;STAT3;MAP4K4;NRP1;MTOR;F3;PLCG1;SEMA3E;CXCL16;FER;PDGFC;MMP14;HIF1A;ADAM9;NIPBL;STX4;ROR2;RAB11A;FN1;CCAR1;MAPRE1;CPNE3;CCN1;SH3RF2;SEMA3B;VEGFA;SEMA4B;NUMB;ACVR1;RAPGEF2;GLIPR2;CARMIL1;DOCK1;ADRA2A;PIK3CD;TWIST2;CCN4;MIA3;FAM107A;S100A11;MYADM;SOD2;GCNT2;BMP2;MYOC;RHOC;HBEGF;GAB1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4522568829971653,1.1784336735044738,0.25277161862527714,0.6769122321514235,1.0,4/16,5.82%,PROX1;MYH6;NOTCH1;TGFB2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.39844340265479655,1.1783490528727134,0.21442885771543085,0.6757378292084573,1.0,11/26,21.51%,NAV3;OCLN;PAK1;STMN2;DCTN1;RPS3;TRPV4;CLASP1;RAC1;CDK5R1;CDK5RAP2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5033658951906411,-1.178209114336388,0.24524714828897337,0.5454519829843142,1.0,4/11,14.18%,IL6ST;JAK1;STAT3;STAT1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.381690420335998,-1.1780392910343198,0.22465208747514911,0.5453579356500129,1.0,19/33,30.05%,DDX5;EP300;AXIN1;UFL1;RUNX1;AR;UBA5;SAFB2;PRMT2;LATS1;RNF14;PARK7;RNF6;TRIM68;KDM1A;ESR1;KCTD6;UFM1;CALR
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4779149474522052,-1.1777609518133372,0.2480916030534351,0.5454488512425052,1.0,7/13,19.15%,PKD1;FLNA;PKD2;SUFU;LATS1;GET4;MDFI
prerank,mitochondrial membrane organization (GO:0007006),-0.38313866613951686,-1.1770855468963195,0.24084778420038536,0.5465058146652323,1.0,12/32,30.48%,OPA1;BCL2;MICOS10;MTX3;RCC1L;HSPA9;BNIP3;APOO;MFN2;SAMM50;BAK1;PPIF
prerank,negative regulation of DNA binding (GO:0043392),0.39571375470410414,1.1768557792636216,0.21792260692464357,0.6787910830260077,1.0,7/28,13.27%,LEF1;HEY1;HMGA2;CPNE1;PER2;SIN3A;NFKBIA
prerank,neuron maturation (GO:0042551),0.43616018822317926,1.176425695299649,0.22826086956521738,0.6786014725039384,1.0,4/18,8.37%,ADGRB3;SCARF1;SRRM4;B4GALT6
prerank,lipid droplet organization (GO:0034389),-0.4206835519311929,-1.1764126646101358,0.25443786982248523,0.5476707232981082,1.0,10/22,31.17%,RAB3GAP1;ZFYVE1;FAF2;AUP1;SQLE;CDS2;PPID;BSCL2;PLA2G4C;FITM2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.45437644106477004,-1.1759991052244756,0.2704626334519573,0.5481471291387303,1.0,10/17,33.61%,FGF1;MBTPS2;ERLIN1;APOE;MBTPS1;PRKAA1;LPCAT3;SCAP;SREBF1;RAN
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3562320196694939,1.1757544313136765,0.22698072805139186,0.6792310229132614,1.0,11/42,21.32%,CXCL12;GPR35;CCL2;THPO;GPR75;STK39;CIB1;CCL25;CCL13;CCL19;RBM15
prerank,vascular transport (GO:0010232),0.31840937799499663,1.1755979003808616,0.17708333333333334,0.6782028338171899,1.0,12/81,4.33%,SLCO1C1;TFRC;SLC7A5;SLC6A6;SLC6A17;SLC2A1;ATP8A1;SLC2A3;SLC7A1;ABCG2;MFSD2A;SLC1A1
prerank,positive regulation of protein processing (GO:0010954),-0.4359057875557417,-1.1755734112383769,0.2533081285444234,0.5486423083969023,1.0,3/19,4.69%,GSN;CCBE1;CLEC3B
prerank,gland development (GO:0048732),-0.33234767669526183,-1.1754069118743653,0.15737051792828685,0.5484863332105737,1.0,17/59,17.02%,TGFBR3;TGFBR1;WNT4;GLI2;DKK3;FGFR2;ANXA1;CEBPG;ZBTB1;PHF2;ARID5B;HES1;PKD2;TGFB3;SALL1;CITED2;SIX1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.44950806728797155,-1.1751908444308716,0.25,0.5484354316345633,1.0,3/15,2.99%,IGF1;OPA1;PRKN
prerank,secondary palate development (GO:0062009),-0.4688417556920499,-1.1751315229257429,0.2707509881422925,0.5480140732420842,1.0,8/14,17.55%,TGFBR3;TGFBR2;SMAD2;SMAD4;CHD7;TGFB3;LRRC32;WNT5A
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3185284256766618,-1.1750294584975005,0.16731517509727625,0.5476858203112716,1.0,41/80,35.65%,ANGPT1;UBE2N;LRRK2;HUWE1;AXIN1;UBQLN1;XIAP;CUL3;FBXW7;FANCM;FANCI;TOPORS;SPRTN;DERL1;FAM107A;TRAF6;DCUN1D3;SPSB4;TBC1D7;CDK5RAP3;SPHK1;ARRDC4;SENP2;WFS1;MAGEC2;PAXIP1;KDM1A;FBXO4;HDAC3;DCUN1D5;BIRC3;RBX1;PEF1;UBE2L3;CAV1;DCUN1D4;BRCA1;PSMD10;CENPX;RIPK2;PIN1
prerank,mesenchymal cell development (GO:0014031),0.4409493489237884,1.1741470199712754,0.27370689655172414,0.6812231811214927,1.0,4/18,6.01%,NRG1;CDH2;NOTCH1;CYP26C1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3598118578676839,-1.1740450994775034,0.20309477756286268,0.5495217529614537,1.0,17/41,28.64%,ACSL1;DAGLA;PTGS1;CYP1B1;PLA2G4A;PNPLA8;EPHX1;ACOX1;DECR2;MGLL;ELOVL1;ACOT8;DAGLB;GSTM2;ALOX12;ELOVL5;PLA2G4C
prerank,carboxylic acid transport (GO:0046942),0.34270250648857725,1.174000959736693,0.18236472945891782,0.6802453220899786,1.0,10/55,10.56%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;AQP9;SLC1A1;SLC7A8;SLC66A1;SLC36A1;SLC16A4
prerank,regulation of protein secretion (GO:0050708),0.3005778940831115,1.1732188185204206,0.1443089430894309,0.6810814303014081,1.0,16/119,6.28%,CD33;CACNA1A;SLC2A1;MTNR1B;SYT7;KCNC2;SNAP25;HADH;APBB1;RHBDF2;IL12A;KCNJ11;STXBP5L;APBB3;TGFB2;CACNA1E
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.45661431467348257,-1.1731995400677815,0.2580071174377224,0.5511133597952572,1.0,4/16,11.70%,APPL2;NCOR1;WDTC1;ERLIN1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5099653913806046,-1.1731825131632065,0.27634194831013914,0.5505806382422206,1.0,5/11,24.08%,PRKN;REST;HIF1A;PARK7;NONO
prerank,covalent chromatin modification (GO:0016569),-0.4720901283392157,-1.1725458096973034,0.27339449541284405,0.5516008169561256,1.0,6/14,18.94%,HLCS;SETD5;UFL1;MBD2;HDAC1;PARK7
prerank,cytoskeleton organization (GO:0007010),-0.30257918331689193,-1.17249625558004,0.1337099811676083,0.5511543349795976,1.0,40/114,21.25%,ARHGAP10;MICAL3;PLCE1;TPM1;BRWD1;DIAPH1;SYNE3;MICAL2;WDPCP;PACSIN2;WTIP;RND3;LRCH3;OBSL1;PALLD;RANBP10;RHOA;LIMD1;ZMYM4;RHOBTB2;FGD1;ZMYM3;CAPZB;APOE;FGD4;NECTIN2;RANBP9;MARK1;PHIP;MICAL1;RHOBTB1;RHOH;RHOC;SIPA1L3;AJUBA;CNN2;SPRYD3;DES;MAST2;PPP2R3C
prerank,regulation of immune effector process (GO:0002697),-0.35817039812538237,-1.1722189736285782,0.21626617375231053,0.5512477931878539,1.0,5/41,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,regulation of plasminogen activation (GO:0010755),-0.4946463520126564,-1.172164869666285,0.2665406427221172,0.5508514265015623,1.0,4/12,17.01%,CLEC3B;THBS1;RUNX1;SERPINE1
prerank,replicative senescence (GO:0090399),0.47729128917209196,1.1716312874606427,0.2731006160164271,0.6842381420291842,1.0,2/12,1.59%,CHEK1;MME
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4926646872290458,-1.1716240765236527,0.26019417475728157,0.5516122253828387,1.0,3/13,7.27%,IGF1;SOAT1;RAMP1
prerank,regulation of chromosome organization (GO:0033044),-0.4166133181731872,-1.1713468283104185,0.23032629558541268,0.5517366122981935,1.0,7/22,12.66%,SMG6;HDAC8;SMG1;YLPM1;HNRNPD;UPF1;RB1
prerank,smooth muscle tissue development (GO:0048745),-0.5056285246992452,-1.171324241308058,0.2712871287128713,0.5512350545462711,1.0,5/10,15.46%,MYLK;BMP4;SMO;EFEMP2;PTCH1
prerank,regulation of DNA binding (GO:0051101),-0.34799875092716054,-1.1710350016102802,0.20857699805068225,0.5513693006777477,1.0,14/44,14.00%,IGF1;FOXC1;SMO;PRKN;HMGB1;SKI;CEBPG;SP100;NGF;JUN;HJURP;HES1;ILRUN;TXN
prerank,regulation of cholesterol efflux (GO:0010874),0.38195665101675985,1.170576782584319,0.23541247484909456,0.6860747821904415,1.0,5/30,8.56%,PLTP;SIRT1;NAXE;PPARG;GPS2
prerank,neutrophil activation (GO:0042119),0.4677302263684474,1.1701542000249494,0.27479338842975204,0.6859277791409556,1.0,2/12,6.97%,DNASE1;PREX1
prerank,regulation of defense response (GO:0031347),-0.3224535649716146,-1.1698829727255906,0.18908382066276802,0.5537968559333998,1.0,46/76,37.78%,FOXP1;APPL2;ADAMTS12;CELF1;NR1D2;SBNO2;UFL1;ANXA1;CASP12;XIAP;PTPN22;PTGES;AGTR1;APPL1;IRF1;PIK3AP1;APOE;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;DAGLB;USP18;IL1RL2;DHX58;ERAP1;GRN;BIRC3;SAMHD1;BCL6B;ACE2;BCL6;TKFC;HCK;MYD88;ZBP1;LACC1;FGR;CASP1;FCGR2B;CASP4;SETD6;LRRC19;CCR2
prerank,peptidyl-proline modification (GO:0018208),-0.40031289507272233,-1.1697732241667047,0.2333965844402277,0.553508324808095,1.0,11/25,30.48%,FKBP5;FKBP10;FKBP7;PPIH;PPWD1;NKTR;NTMT1;PPID;PPIC;PPIL1;PPIF
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3495732795043324,-1.1696162555213223,0.20355731225296442,0.5533573755879347,1.0,18/49,19.51%,GPC6;SDC2;B3GALT1;HS3ST3A1;GPC4;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42801402251095105,-1.169195745973105,0.24767225325884543,0.5537832280060961,1.0,4/19,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,response to muscle stretch (GO:0035994),0.4604492844044452,1.1691827385211397,0.2683982683982684,0.6875048203115665,1.0,4/15,9.53%,RYR2;CDH2;SLC8A1;TCAP
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.32164419817505924,-1.1689823358090548,0.18236472945891782,0.5537811235692098,1.0,27/69,29.30%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3195073115670659,1.1688360599832752,0.18958333333333333,0.6870993635076305,1.0,12/72,7.75%,FLT1;IGF1R;TEK;SIRT1;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO
prerank,epithelial cell differentiation (GO:0030855),-0.3091089125535333,-1.1685136432005954,0.17729083665338646,0.5544111594926688,1.0,29/88,21.64%,FSTL1;MAF;DAB2;BMP4;JAG1;ANXA4;RAB10;FGFR2;ANXA7;ANXA1;CNN3;VDAC1;SCUBE1;FZD7;PGK1;PCK2;GLI1;VEGFA;HDAC1;LATS1;BDH2;SIX1;TAGLN;CPT1A;PCNA;PIH1D1;AKT2;GATA6;SCRIB
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2861269059253243,1.1682670629916356,0.13333333333333333,0.6874819959010345,1.0,31/152,16.95%,ADGRL4;ADGRL3;ADGRB3;RGS1;ADCY8;ADCY3;RAMP2;ADGRB1;GRM8;S1PR5;PDE2A;LGR5;MTNR1A;ADCYAP1;GPR26;GNAL;ADRA1D;ADGRL2;ADCY4;CNR1;PTGER2;OPRK1;ADGRG1;CHRM2;OPRL1;GNAI1;GNAQ;CALCRL;ADCYAP1R1;ADGRE1;PTGER4
prerank,protein localization to cell-cell junction (GO:0150105),-0.4620719206987777,-1.1677810552981032,0.2822429906542056,0.5556484766915463,1.0,5/15,10.94%,CGNL1;MPP7;JAK1;PAK2;ARHGEF18
prerank,fatty acid catabolic process (GO:0009062),-0.32449826509255103,-1.1672619980000796,0.21414141414141413,0.5563561711082359,1.0,24/67,24.49%,PCCA;ABCD3;ACADM;MMUT;ACAD10;ABCD2;ACAD11;CPT2;ABHD3;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;LPIN2;ECI1;LPIN3;MECR;MCEE;ACOT8;AUH;ILVBL
prerank,regulation of multicellular organism growth (GO:0040014),-0.46214132918046025,-1.1668494735004036,0.2637571157495256,0.5568226394398302,1.0,5/15,17.74%,IGF1;GHR;PTCH1;STAT5A;STAT5B
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4978882460038516,-1.166828372240744,0.2735674676524954,0.5563046630790208,1.0,4/11,23.41%,IL34;ID2;PRKCA;HSF1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.45826484876950213,-1.1667447290949453,0.25925925925925924,0.5559584973652228,1.0,6/15,25.24%,PTN;LRRK2;VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,epithelial tube morphogenesis (GO:0060562),0.3899792973259381,1.1665471429409315,0.23076923076923078,0.6911649074583023,1.0,8/32,7.56%,CSF1R;PODXL;RYR2;FGF10;CSNK2B;PAK1;LHX1;ACVRL1
prerank,regulation of developmental growth (GO:0048638),-0.38432467506988954,-1.1661089346197433,0.2421875,0.5570775072341552,1.0,12/29,19.00%,IGF1;GHR;ABL1;GSK3B;NIPBL;CTTN;APOE;LATS1;SIX1;STAT5A;STAT5B;MUSK
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.38958103316362735,-1.1656263337038,0.24909090909090909,0.5576541913355514,1.0,9/26,18.91%,ST3GAL4;B4GALT1;FMOD;OGN;PRELP;ST3GAL3;LUM;B4GALT5;OMD
prerank,regulation of autophagosome maturation (GO:1901096),-0.4746591549924304,-1.1655637818041005,0.26045627376425856,0.5572561578459455,1.0,5/13,27.39%,UVRAG;RUBCN;IRGM;UBQLN4;ADRB2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.46072226336556593,1.165532148099194,0.23931623931623933,0.6927802825418347,1.0,2/13,3.31%,MIF;SIRT1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.29740029652073163,-1.1650117673210207,0.14549180327868852,0.5580231479109372,1.0,46/110,24.95%,TRABD2B;GSN;ABCA1;MPP7;EP300;GSK3B;SPIDR;STXBP1;CDC42;BRK1;IMPACT;TRAF2;HCFC1;ATF7IP;HJURP;FNIP1;RIOK3;RB1;SLF1;EIF2AK2;GFAP;APOE;VEGFA;DDX3X;LATS1;PRKCZ;FARP2;NOP53;IAPP;ICE1;VCP;NAPA;PARK7;RHOC;PTPN11;AJUBA;KIF9;FBLIM1;PIH1D1;BMF;HSF1;PREB;SAR1B;GNL3L;SYK;IRGM
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.3044259527994767,-1.1649654127693103,0.16470588235294117,0.5575752867720003,1.0,26/94,21.54%,ITPR1;FHIT;DDX5;PDK1;ABL1;BCL2;MAP3K5;AIFM1;CYP1B1;TRAF2;PRKCD;PRODH;CUL3;CASP2;PRKDC;ERN1;DDX3X;CUL2;TOPORS;IKBKE;RRP8;MSH6;PML;ATP2A3;CUL1;BNIP3
prerank,import into cell (GO:0098657),-0.35280141999398545,-1.164862349700287,0.22727272727272727,0.5573028454715535,1.0,12/41,14.17%,ATP1A2;SLC6A13;SLC1A3;SLC47A1;SLC5A3;SLC39A14;SLC12A7;LRRC8D;GLUL;SLC5A6;SLC22A4;SLC27A1
prerank,heterochromatin organization (GO:0070828),0.4620532213742888,1.1645637261619337,0.2680851063829787,0.6942365753062872,1.0,3/14,3.68%,MECOM;SIRT1;HMGA2
prerank,protein targeting to peroxisome (GO:0006625),-0.3919345754624285,-1.1644197940696226,0.2603550295857988,0.557880003321665,1.0,11/29,20.65%,ZFAND6;ABCD3;PXMP4;ABCD2;LONP2;PEX6;SLC25A17;PEX7;FIS1;PXMP2;PEX26
prerank,regulation of osteoblast proliferation (GO:0033688),-0.43859808608068407,-1.163867050544353,0.26356589147286824,0.558665971816403,1.0,10/17,20.74%,NPR3;FGFR2;MN1;RHOA;ATRAID;CCN1;EIF2AK2;PLXNB1;BMP2;TMEM119
prerank,amino sugar biosynthetic process (GO:0046349),-0.49214380179363215,-1.1637061751147282,0.2972972972972973,0.5585315048279657,1.0,5/12,26.43%,GFPT1;UAP1;RENBP;UAP1L1;PGM3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.38686049866908523,-1.1635101786494781,0.2577696526508227,0.5584651700187026,1.0,12/29,24.10%,UBE2N;ABL1;AXIN1;FBXW7;DTX3L;TOPORS;FEM1A;DCUN1D3;PARK7;ARRDC4;MAGEC2;BAG5
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.39824085233244144,-1.1634039035173698,0.2403846153846154,0.5581717897526154,1.0,6/26,16.48%,ATP1A2;UBQLN1;PKD2;SRI;YWHAE;ADRA2A
prerank,positive regulation of telomere maintenance (GO:0032206),-0.37222988916839483,-1.1631482605807737,0.2345924453280318,0.5582818026243217,1.0,13/31,27.54%,TNKS2;NBN;HNRNPD;DHX36;NABP2;MAP2K7;MRE11;PML;ERCC1;PPP1R10;NEK7;GNL3;ATRX
prerank,protein dephosphorylation (GO:0006470),-0.292373313816176,-1.16302399751274,0.15510204081632653,0.5580509143302975,1.0,34/135,15.20%,EYA2;PTPN13;EYA1;EYA4;PPP1R12A;PPM1D;PTPN14;PPM1E;TNS2;BTRC;PTPN9;PTPRS;PTPN21;DUSP16;PTPN3;SSU72;PTPRK;DAPP1;PTPN22;PPP4R2;PPP2CB;PPM1H;PTPN12;PTPN2;DUSP11;PPP2R5E;PPM1M;MTMR3;PPM1A;PPP2R5D;DUSP1;CDC14B;NCK1;PPP1CB
prerank,synaptic vesicle recycling (GO:0036465),0.3804459286175415,1.1629789078414827,0.22417582417582418,0.697687992601272,1.0,12/31,18.87%,SYT1;NLGN1;SYT7;SNCA;AMPH;SYT2;PLD2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.46269678791704805,-1.1628842349251,0.2702702702702703,0.5578596182494264,1.0,5/14,22.93%,ANXA1;NFKBIZ;PRKCZ;IL18;CD80
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.4133157475244573,-1.162615001827446,0.2665441176470588,0.5579743521623044,1.0,4/21,7.81%,ANK2;FLNA;SNTA1;CACNA1D
prerank,negative regulation of defense response to virus (GO:0050687),-0.5168521730806084,-1.1624778698058797,0.286231884057971,0.5577669418952929,1.0,8/10,41.27%,PCBP2;ILRUN;MUL1;C1QBP;TSPAN6;TRAF3IP1;TARBP2;RNF26
prerank,lipid phosphorylation (GO:0046834),0.5050245217609335,1.162267708398812,0.27765237020316025,0.6984118413758551,1.0,3/10,7.02%,DGKI;DGKH;DGKB
prerank,response to alcohol (GO:0097305),0.38367501459250786,1.1620877067831725,0.226890756302521,0.6975647572679644,1.0,6/27,10.09%,GRIN1;GLRA1;GRIN2A;GRIN2B;SLIT3;GRIN3A
prerank,membrane lipid biosynthetic process (GO:0046467),0.33520684438145393,1.1615593020935078,0.20342205323193915,0.6978276738318483,1.0,18/58,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ELOVL7;SGPP2;ELOVL4;HACD3;ST8SIA6;HACD1;PPM1L;SAMD8;PRKD3;KDSR;SGPP1;SPTLC2
prerank,plasma membrane organization (GO:0007009),-0.3289727688026047,-1.1612587784165804,0.1898989898989899,0.5602746080603461,1.0,16/61,11.74%,ANK2;COL5A1;ANXA6;A4GALT;PLSCR4;PLSCR2;PACSIN2;SNX9;MYOF;PLSCR1;CHMP4A;EHD2;ABCD2;TLCD2;STX4;UGCG
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38445308820669066,1.161136799201461,0.2280334728033473,0.697680894402567,1.0,4/29,12.49%,CADM1;IL12A;CYRIB;ITGAM
prerank,autophagy of peroxisome (GO:0030242),-0.47019798805958185,-1.1610302467607272,0.26601941747572816,0.5603121987010145,1.0,4/12,15.52%,NBR1;RB1CC1;PIK3C3;PIK3R4
prerank,amino acid import (GO:0043090),0.411766648456581,1.1604601872874016,0.2567849686847599,0.6982434695298149,1.0,6/21,9.58%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC7A8;SLC36A1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.38981672517120064,1.1603202479151515,0.23059360730593606,0.6972518789088501,1.0,10/27,17.13%,TIRAP;RPS27A;UBC;TLR2;UBB;HSPD1;CD36;TAB2;TNIP1;BTK
prerank,positive regulation of viral process (GO:0048524),-0.33351877138185365,-1.1596924441877554,0.21267893660531698,0.5630519357642625,1.0,27/60,31.73%,MDFIC;AXL;CCNT1;KPNA6;DHX9;LARP1;TBC1D20;NELFB;DDX3X;PPIH;POLR2H;PPID;GTF2F1;POLR2K;RAB7A;CTDP1;POLR2E;PPARA;PDE12;POLR2D;NELFA;CDK9;NELFE;KPNA2;ADARB1;NR5A2;TYRO3
prerank,membrane organization (GO:0061024),0.2727156714323208,1.159370104881853,0.12595419847328243,0.6987509446893481,1.0,48/227,15.25%,TFRC;DNM3;ACTB;SYT1;RIMS1;SGCZ;SH3GL2;AP2M1;ANK3;REEP1;BIN1;LPCAT2;SLC18A3;CERT1;HIP1;ATP10B;HSPA8;FNBP1L;AMPH;FCHO1;NAPG;RPS27A;UBC;DYSF;UBB;SCARB2;AP2B1;SAR1A;SUN1;SYT2;SPTBN1;CCDC88A;FZD4;PLEKHA3;SERP1;LEMD2;CNTN2;CPTP;SGIP1;TTPA;CLTB;SNAP29;NECAP1;SH3KBP1;PPT1;CHRM2;CORO1C;REEP3
prerank,regulation of chemotaxis (GO:0050920),-0.38232023400067705,-1.1590486938275302,0.23809523809523808,0.564121735691766,1.0,10/30,15.21%,PDGFRA;EFNB2;PDGFRB;THBS1;ADGRA2;ZSWIM8;PTPN2;STX4;P2RY12;P2RX4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3761138204780592,1.159037788805183,0.24746450304259635,0.6983992317819788,1.0,5/29,6.76%,RPS19;RPP40;RPS21;RPS8;RPS16
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.403521739619542,1.1587289034940076,0.2543103448275862,0.6979077139606413,1.0,6/23,16.28%,CHEK1;BUB1;WEE2;NABP1;CHFR;PLK2
prerank,positive regulation of translation (GO:0045727),-0.3049093059247807,-1.1586993798769782,0.1657142857142857,0.5644345316477851,1.0,18/94,14.85%,SAMD4A;PLD1;VIM;ZCCHC4;YTHDF3;KHDRBS1;THBS1;DHX9;MTOR;LARP1;HNRNPD;DHX36;PLXNB2;RCC1L;YBX3;CDC123;PRKDC;DDX3X
prerank,Golgi to lysosome transport (GO:0090160),-0.48961767537931267,-1.1584775642166354,0.2767676767676768,0.5644161087624506,1.0,4/11,17.98%,CCDC91;EHD3;LAMP1;ANKFY1
prerank,positive regulation of translational initiation (GO:0045948),-0.42747392136927836,-1.158297683891037,0.26499032882011603,0.5643577597890848,1.0,6/18,14.85%,YTHDF3;KHDRBS1;MTOR;LARP1;CDC123;DDX3X
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3610620447336908,-1.1580476387569623,0.23921568627450981,0.5644157721177033,1.0,14/39,17.67%,KMT5B;SPIDR;FUS;WDR48;SHLD2;PARP9;PARP1;KMT5C;SLF1;DTX3L;MMS19;PRKDC;SMCHD1;ARID2
prerank,positive regulation of vacuole organization (GO:0044090),-0.5013534268644184,-1.1580329099367204,0.2945590994371482,0.5638918356008729,1.0,3/10,8.27%,ANXA2;RAB3GAP1;PIP4K2C
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3132960556886102,-1.1578035849934503,0.1901840490797546,0.5639314408569488,1.0,23/76,17.56%,NTRK3;FCHSD2;ABL1;BAIAP2L1;NUMA1;BCAS3;SNX9;NRP1;CDC42;VASP;CDC42EP5;SYNPO2;FER;NES;NCKAP1;SYNPO;CTTN;NCK1;CARMIL1;NCK2;DYNC1H1;SORBS3;CDC42EP4
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.40264458588483465,-1.1576958559812982,0.25457875457875456,0.563632620528907,1.0,3/24,3.72%,EPHA7;FOXO3;NUPR1
prerank,endocrine system development (GO:0035270),-0.42252012125054805,-1.1573678824444669,0.25736738703339884,0.5639519382552918,1.0,4/21,2.97%,TGFBR1;WNT4;GLI2;DKK3
prerank,regulation of phospholipase activity (GO:0010517),-0.510318386420134,-1.1572393392165885,0.2774566473988439,0.5637378119803726,1.0,3/10,7.95%,LRP1;FGFR2;PDPK1
prerank,amino acid import across plasma membrane (GO:0089718),0.39771704285669457,1.1568914930992342,0.25510204081632654,0.7022569602576104,1.0,8/24,9.58%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8;SLC36A1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.31791647558909447,-1.1567520617089253,0.16796875,0.5643715792125952,1.0,24/72,26.64%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K;POLR2E;NCBP2;FGFRL1
prerank,snRNA transcription (GO:0009301),-0.31800520221782236,-1.1564493344721753,0.18473895582329317,0.5645796188019997,1.0,27/70,29.30%,CCNT2;CCNT1;INTS4;CDK7;PHAX;TBP;CCNK;RPRD2;NABP2;SNAPC3;TAF8;TAF13;GTF2B;ICE1;INTS6;POLR2H;INTS14;GTF2F1;POLR2K;SNAPC1;POLR2E;NCBP2;SNAPC5;GTF2E2;POLR2D;CDK9;INTS7
prerank,negative regulation of cell growth (GO:0030308),0.2938244673790466,1.1562806843430604,0.16631130063965885,0.7026883173450349,1.0,28/121,16.45%,DCC;MINAR1;MAG;MAP2;SIRT1;GNG4;FGF13;APBB1;SCGB3A1;PPP2R1A;TGFB2;SLIT3;WFDC1;PTPRJ;ACVRL1;RTN4R;APBB2;SOX17;DIP2B;NDUFA13;BMPR2;SMARCA2;CDKN1A;PPT1;RTN4;NPR1;CDKN1B;DNAJB2
prerank,positive regulation of phosphorylation (GO:0042327),-0.26751289327763283,-1.1553667252002917,0.13226452905811623,0.5667643305610419,1.0,38/240,8.57%,ZBTB20;ROCK2;IGF1;ROR1;EGFR;LMO4;EPHA7;LEPR;EPHA3;IL34;PDGFRA;ANGPT1;SLCO3A1;NTRK3;PELI2;FGF1;PDGFRB;AXL;DAB2;FAM20A;BMP4;ABL1;ARNT;LRRK2;PRKAA2;KIT;RYK;THBS1;AXIN1;NBN;NRP1;FGFR2;PFKFB4;LYN;MERTK;AR;EPHA4;IGF2
prerank,neutrophil degranulation (GO:0043312),0.2547468260530626,1.1550117824921187,0.06626506024096386,0.7050306033016599,1.0,90/425,17.91%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,negative regulation of cell projection organization (GO:0031345),0.34126401232078124,1.1550056697236963,0.2124248496993988,0.7036206270770642,1.0,20/48,19.43%,SPOCK1;DCC;MINAR1;MAG;SPRY3;GRIN2B;ITM2C;STMN2;RTN4R;CIB1;PRAG1;RTN4RL1;FKBP4;CRMP1;STX1B;RAB29;FYN;GAK;TRPV4;PTPRO
prerank,calcium ion import (GO:0070509),0.38067639924819935,1.1544299138693839,0.2488986784140969,0.7039306439297234,1.0,6/28,7.36%,CACNA1A;CACNA1B;SLC8A1;SLC25A23;CACNA1E;CACNB2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.30834418808063896,-1.1543130771714039,0.16666666666666666,0.5688668018163945,1.0,31/88,25.01%,TRABD2B;SMAD3;MPP7;BMP7;GSK3B;SPIDR;VPS4B;STX18;BRK1;SYNPO2;FNIP1;TPR;SLF1;SYNPO;VEGFA;EMILIN1;SDC4;ICE1;VCP;PARK7;RHOC;AJUBA;SNF8;PIH1D1;BMF;PRKCA;ERCC1;GNL3L;SYK;RAB7A;SDC1
prerank,cellular response to insulin stimulus (GO:0032869),-0.2875406458148605,-1.1541687962519807,0.15930902111324377,0.5686919550219852,1.0,41/124,21.34%,RHOQ;SORBS1;GRB10;KAT2B;ATP6V1B2;ENPP1;GSK3B;IRS1;ATP6V0D1;SLC39A14;INSIG2;RAB10;SHC1;FOXC2;ATP6V0A4;RAB12;PDPK1;VAMP2;IGF2;SELENOS;FER;PTPN2;DENND4C;PARP1;APPL1;PCK2;SLC27A1;PRKDC;CPEB1;TCIRG1;PHIP;LPIN2;SYAP1;LPIN3;INPP5K;GAB1;PKM;BAIAP2;PIK3R1;USF1;AKT2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.32658769659641634,-1.1539558709682822,0.21863117870722434,0.5686382592835354,1.0,14/55,15.15%,TGFBR1;WWOX;NUPR1;GSDME;DNM1L;PAK2;BCL2;TRAF2;BCLAF1;BECN1;LTBR;ING5;TPD52L1;TRIM39
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.45722988046125845,-1.1538368781154642,0.28066914498141265,0.568365330718568,1.0,6/14,15.89%,ADK;GMPS;PPAT;ATIC;RFK;PAICS
prerank,endoplasmic reticulum organization (GO:0007029),-0.31608981072945874,-1.1537657190565414,0.18237704918032788,0.5679885872345112,1.0,25/72,23.67%,TRAM2;LRRK2;ATL3;DNM1L;RAB10;EIF2AK3;STX18;VAMP2;VCPIP1;SEC31A;ATL2;STX5;DOP1B;ZBED3;EMD;MIA3;GET4;SEC16B;SMPD4;TMCC1;SEC16A;LPCAT3;VAPA;LMAN1;SPTSSB
prerank,positive chemotaxis (GO:0050918),0.4399062389447219,1.1537532337577963,0.26814516129032256,0.7045359197326094,1.0,6/17,10.68%,PLXNB3;FGF10;PTPRJ;GPNMB;SCG2;CORO1A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3590593039532217,1.1524664909729034,0.23376623376623376,0.7070550660578312,1.0,17/38,24.15%,MAGI2;SIRT1;PHLPP1;TRIB3;PTPRJ;AKT1;CIB1;PPP2R5B;PDCD6;ARRB2;HYAL2;RACK1;EPHA2;PHLDA3;DDIT3;FLCN;PIK3CB
prerank,glycerolipid catabolic process (GO:0046503),0.42113208433456806,1.1519445098285335,0.24740124740124741,0.707318434650216,1.0,2/19,2.01%,GPCPD1;ABHD2
prerank,Notch signaling involved in heart development (GO:0061314),-0.4959990915322944,-1.1518759063152877,0.286527514231499,0.5722143534816011,1.0,3/11,3.07%,NOTCH2;RBPJ;JAG1
prerank,cortical cytoskeleton organization (GO:0030865),-0.35200021412712834,-1.1515615243530832,0.23735408560311283,0.5724016093670165,1.0,12/41,18.97%,ROCK2;RHOQ;ROCK1;DLG1;RND3;FHOD1;RHOA;NCKAP1;RHOBTB2;RHOBTB1;RHOH;RHOC
prerank,cellular response to cAMP (GO:0071320),0.382920994479152,1.1515596294945936,0.2545454545454545,0.7070511859827632,1.0,5/30,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,protein tetramerization (GO:0051262),0.32351837152361823,1.1513730859338784,0.19958847736625515,0.7062706538357247,1.0,15/67,15.56%,HCN1;GRIN1;RYR3;GRIN2B;SNCA;TRPM2;KCNC3;HPRT1;HOMER1;KCNC1;FARSB;AQP4;GOLGA2;B2M;GLS
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.39971819945322784,-1.1512817721960307,0.2846153846153846,0.5725711623975728,1.0,7/23,18.63%,UACA;BMP7;CCN3;PPM1A;DDX3X;C1QTNF3;IFI35
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3971778759491652,-1.1511624157885003,0.2704761904761905,0.5723280872910208,1.0,8/23,16.11%,PIAS1;JAK1;PTPN2;NR1H3;PARP14;PARP9;STAT1;IFNGR1
prerank,protein autophosphorylation (GO:0046777),0.2815098505236943,1.1510773409911648,0.1423076923076923,0.7057287019006535,1.0,23/157,9.11%,FLT1;CAMK2A;IGF1R;TEK;ERBB4;CSF1R;EPHB1;HTATIP2;TNIK;MEX3B;KDR;CAMK4;NTRK2;WNK2;FLT3;AATK;SRMS;ALK;PAK1;MELK;AKT1;CDKL5;TAOK2
prerank,protein-containing complex disassembly (GO:0032984),-0.3356011689549468,-1.1510240734021546,0.23148148148148148,0.5721304795730582,1.0,12/54,10.05%,LRP6;CSNK1A1;UVRAG;GSK3B;AXIN1;UBQLN1;FZD2;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3
prerank,positive regulation of GTPase activity (GO:0043547),-0.27344402329555767,-1.150946279436216,0.14090019569471623,0.5717557417062885,1.0,32/188,9.98%,ARHGAP29;ARHGAP42;DOCK11;AFDN;ASAP3;SIPA1L1;NTRK3;LIMS1;TIAM2;ARAP1;TBC1D16;GSK3B;DOCK7;ARHGAP24;BCR;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;S100A10;RSU1;NDEL1;USP6NL;TBC1D2B;TBC1D20;TBC1D8B
prerank,methylguanosine-cap decapping (GO:0110156),-0.5057553583764473,-1.150669812029096,0.29853479853479853,0.5718999291960224,1.0,3/10,14.66%,DCP1A;DCP1B;EDC3
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.342759033069555,-1.1503359260766566,0.22332015810276679,0.5721772912973141,1.0,18/49,24.78%,KAT2B;EP300;TNRC6B;KMT2C;TNRC6A;KMT2D;MOV10;THBS1;RUNX1;MEF2C;PITHD1;HDAC1;TNRC6C;KMT2A;AGO1;CNOT4;KMT2E;RAB7B
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4200876637246095,-1.1501676226920812,0.2922465208747515,0.5720369073670073,1.0,3/21,1.01%,ATP1A2;CACNA1C;ANK2
prerank,muscle tissue morphogenesis (GO:0060415),-0.44130260497352797,-1.149844428036135,0.2824858757062147,0.5722814536618908,1.0,3/16,2.70%,TGFBR3;MYLK;BMP4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4713369822085478,1.1496414279607794,0.2841163310961969,0.7087155073749637,1.0,2/12,2.58%,GRIN1;ADGRB1
prerank,glycogen metabolic process (GO:0005977),-0.3750759589033691,-1.149518942524573,0.2366412213740458,0.5725725627259322,1.0,6/27,9.55%,PRKAG2;PHKB;GSK3B;PYGB;PHKA1;AGL
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3183681003087843,1.1495052081791886,0.19117647058823528,0.7077189822274434,1.0,11/70,9.41%,MBOAT1;MFSD2A;LPCAT2;PCYT1B;CHKA;ENPP2;CSNK2B;PLAAT1;TMEM86B;SLC44A5;PLA2G12A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4040995689809267,1.1494300605798309,0.25162689804772237,0.706545388275951,1.0,3/22,9.30%,SLC7A5;TRIM6;TRIL
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.49394201302007257,1.1492678443378368,0.26376146788990823,0.705642747404127,1.0,3/10,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.39531558174978587,-1.1490418904633315,0.27238805970149255,0.573235574627475,1.0,8/26,17.98%,APPL2;LGR4;FLOT2;IRAK3;APPL1;IRF1;OTUD4;LRRC14
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.503698203663155,-1.1485264039626197,0.3094812164579606,0.5734173793527879,1.0,3/10,12.14%,FTO;ASCC3;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.503698203663155,-1.1485264039626197,0.3094812164579606,0.5734173793527879,1.0,3/10,12.14%,FTO;ASCC3;ALKBH1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3854051718347168,-1.1482358268523,0.2682445759368836,0.5736320086494532,1.0,10/27,20.47%,AHNAK;ANK2;JPH1;CAMK2D;SELENON;YWHAE;CACNB1;ADRA2A;PRKACA;NOS1
prerank,cellular component assembly (GO:0022607),-0.2641713300330218,-1.1475132647293909,0.11411992263056092,0.5749433562039343,1.0,68/253,21.48%,CALD1;DPYSL3;PARVA;PAWR;RHOQ;TEAD1;GSN;LIMS1;MDM4;MYO1B;LIMA1;BAIAP2L1;SHROOM2;RHOJ;NLGN2;DLG4;MYO9A;YTHDF3;YAP1;FLNA;DNM1L;SNX9;CREBBP;CDC42;TUBGCP2;PPARGC1A;VAMP2;VASP;TLCD2;VCPIP1;GEMIN5;FLNC;MNAT1;WASL;TRAF2;RHOA;NCKAP1;RAD21;CAPZA1;WIPF1;HES1;TEAD2;TOGARAM1;PARD3;RANBP9;WASF1;REPS2;PPIH;ZFYVE27;PICALM;WNT5A;FAM107A;CFAP74;MICAL1;RHOH;FZD1;GPAA1;TUBGCP4;CDAN1;PML;BAIAP2;SPEF1;FBLIM1;PLS1;FANCC;KIFAP3;KMT2A;PPID
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.36206828467978897,-1.1473484355141566,0.24609375,0.5748150897868796,1.0,15/36,24.29%,FHIT;USP7;RPL11;GIPC1;PSMF1;OGT;TRIM39;NOP53;PSME3IP1;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,positive regulation of ruffle assembly (GO:1900029),0.4667202291399304,1.1468583134655692,0.2873051224944321,0.7115593700238072,1.0,4/13,13.65%,NLGN1;FAM98A;HRAS;PFN1
prerank,regulation of humoral immune response (GO:0002920),-0.34529748645424085,-1.1468270697053902,0.24621212121212122,0.5755416739402142,1.0,5/44,3.68%,CFH;SERPING1;VTN;PROS1;CD55
prerank,substrate-dependent cell migration (GO:0006929),-0.4657577942707265,-1.1465230553692098,0.2966417910447761,0.5757534597556839,1.0,4/14,13.96%,ITGA11;NRP1;P2RY12;EPHA8
prerank,histone mRNA catabolic process (GO:0071044),-0.446187773005508,-1.1464491193796573,0.2984189723320158,0.5753916409760426,1.0,5/15,15.99%,TENT2;TUT4;UPF1;XRN1;EXOSC10
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3963759342205049,-1.1462511615429294,0.26095617529880477,0.575333881950422,1.0,5/23,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,positive regulation of viral life cycle (GO:1903902),-0.40426320818208106,-1.1461164284731364,0.2766355140186916,0.5751286643013501,1.0,5/22,12.12%,AXL;KPNA6;CHMP3;LGALS1;TRIM11
prerank,T cell differentiation in thymus (GO:0033077),-0.45775374982598205,-1.1459136194100503,0.302536231884058,0.5750758009750069,1.0,1/14,0.85%,GLI3
prerank,lipid homeostasis (GO:0055088),-0.33547623288404194,-1.1458893572747078,0.23106796116504855,0.5745993005171064,1.0,15/57,17.82%,ZBTB20;RBP1;ABCA1;NR1D2;PRKAA2;ABHD5;TLCD2;NR1H3;RCN3;PNPLA8;FBXW7;APOE;DDX3X;ACOX1;PRKAA1
prerank,vasculogenesis (GO:0001570),0.3734813805665979,1.1456029555229525,0.2549800796812749,0.7140957668146245,1.0,7/32,7.29%,EGFL7;RAMP2;KDR;TGFBR3L;NOTCH1;WNT7B;APLNR
prerank,regulation of centrosome duplication (GO:0010824),-0.38099938394049415,-1.1454281975604848,0.25239005736137665,0.5752307151613764,1.0,19/29,36.32%,ALMS1;VPS4B;SPICE1;CHMP4B;CHMP5;CHMP3;CENATAC;CEP295;CEP76;FBXW5;NAT10;STIL;CEP295NL;CCNF;CHMP1B;CHMP1A;NPM1;GEN1;CEP131
prerank,regulation of cell cycle (GO:0051726),-0.26131644571281193,-1.1451580761119957,0.11156186612576065,0.5753226531520164,1.0,76/271,21.36%,NOTCH2;GRK5;TCF7L2;SMAD3;TGFBR1;SON;PKD1;LRP6;FBXL17;ANKRD17;KAT2B;BMP7;EP300;BMP4;GBF1;ABL1;CDC14A;NUPR1;CDK7;THBS1;UHRF2;NBN;STAT3;FGFR2;ASAH2;PUM1;FBXL12;MAEA;PTPRK;XIAP;MAP2K1;PRCC;MAP3K20;JUN;HCFC1;ID2;CDK11B;FAP;PKD2;SIK1;RB1;CDC123;IRF1;CDC26;CRLF3;DUSP1;CDC14B;ERN1;TMEM8B;WHAMM;CSNK2A1;NOP53;AFAP1L2;CITED2;PDCD4;TTC28;NR4A1;WDR12;RNF20;PRKACA;RASSF1;HNRNPU;RRP8;BMP2;DCUN1D3;CDK10;INHBA;NEK6;NF2;MAP2K6;PML;ZBTB49;CDK6;CDK5RAP3;AKT2;GATA6
prerank,protein destabilization (GO:0031648),-0.3676585223995672,-1.1450486783419422,0.22967479674796748,0.5750709664514851,1.0,11/32,19.87%,GSN;EP300;PRKN;BTRC;CTSH;CREBBP;GGA3;CUL3;DERL1;FBXW11;CDC73
prerank,regulation of cell population proliferation (GO:0042127),-0.24237654954524332,-1.1447938514937979,0.05063291139240506,0.5751403075514482,1.0,178/691,21.77%,BMP6;IGF1;GRK5;EGFR;ALDH1A2;TCF7L2;GAB2;TGFBR1;ZBTB7C;RBFOX2;PTN;BMPR1A;IL34;PDGFRA;KANK2;NTRK3;LIMS1;EFNB2;SMAD6;CELF1;COL4A3;BMP5;MDM4;ITGAV;DIS3L2;KSR1;FGF1;PDGFRB;KAT2B;PIAS1;IL6ST;IL31RA;BMP4;HDAC4;PDPN;PPM1D;ELN;BIRC6;JAG1;NPR3;PTPN14;TGFBR2;TNS2;PODN;BRD7;FRK;NUPR1;LMNA;GSDME;KIT;CLMN;NIBAN2;YAP1;IRS1;RARG;IGFBP3;TGFB1I1;KMT2D;CTSH;IL13RA1;IGFBP6;THBS1;DPP4;GAREM1;SKI;SPEG;STAT3;UFL1;TMEM127;FGFR2;SHC1;BCL2;NOX4;RUNX1;LYN;TES;REST;WNT9A;P3H3;AR;ACER3;IGF2;PTPRK;XIAP;MAP2K1;CDK13;JUP;CYP1B1;BTG3;COL18A1;NGF;FER;PTPN2;EGLN3;PDGFC;RHOA;JUN;ID2;STX4;ABI1;CNOT8;ROR2;PDS5B;HES1;AGTR1;PKD2;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;IRF1;GLI1;FKTN;COPS8;IGFBP7;EIF2AK2;ING5;STAT1;CD164;PRKDC;RBM5;VEGFA;HDAC1;CIAO1;CBFA2T3;CDC25B;RAPGEF2;VEGFD;NCK2;CSNK2A1;MNT;TGFB3;ADRA2A;ADAMTS1;SIX1;STAT5A;TBX2;TCIRG1;CACUL1;PHIP;ARID2;STAT5B;S100A11;PPP2R5C;SFRP4;PTGFR;SOD2;DHPS;SQLE;FGFBP1;GCNT2;IFI35;BMP2;HBEGF;CDK10;INHBA;CDK2;PBRM1;CDC73;NF2;IFIT3;PML;FRZB;FGFR4;NME1;ZBTB49;CDK6;FXN;TRAPPC14;XRCC6;AKT2;GID8;FGF2;EZH2;ECRG4;DLG5
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4136180911463815,1.144629167529463,0.25948103792415167,0.7155910863343905,1.0,3/21,4.74%,CSF1R;MIF;MTUS1
prerank,positive regulation of histone modification (GO:0031058),-0.37013444303466736,-1.1443679652159962,0.24266144814090018,0.5756447861499501,1.0,15/33,29.45%,UBE2N;BRD7;AKAP8L;PPARGC1A;NIPBL;ARRB1;SAP30BP;NOS1;PAXIP1;RPS6KA4;KDM1A;ZBTB7B;CDK9;RUVBL2;GLYR1
prerank,neutrophil mediated immunity (GO:0002446),0.2521011502778306,1.1442852213376788,0.08634538152610442,0.7152974051601065,1.0,90/432,17.91%,CD33;PTPRB;PTPRN2;CD93;TMEM30A;PGLYRP1;PRG2;LRRC7;ATP8A1;SLCO4C1;HRNR;MME;RAB4B;SLC2A3;ATP11A;MIF;S100A9;S100A8;FTH1;SLC2A5;TOLLIP;SNAP25;ENPP4;PGAM1;QPCT;SVIP;CSNK2B;HSPA8;NME2;DYNLL1;TRPM2;NFASC;NDUFC2;CPNE1;PECAM1;BRI3;TLR2;PTPRJ;EPX;FTL;HSP90AB1;PSMD12;GOLGA7;ARSA;HEBP2;LAIR1;ALDOC;SLPI;BIN2;GLA;GGH;ACTR10;CCT2;FABP5;PDAP1;TSPAN14;ITGAM;CTSB;VAT1;LCN2;HGSNAT;PSEN1;CD36;EEF1A1;ATP11B;SNAP29;PTGES2;COTL1;B2M;IDH1;RHOF;SCAMP1;LTA4H;RNASE3;PSMC3;PSMA2;RAP1A;STK11IP;XRCC5;RAP2B;HSP90AA1;RAB31;ATP6V0A1;GLB1;ARL8A;TMBIM1;C3AR1;PPIA;EEF2;HEXB
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3751478196033692,-1.1442505317086014,0.263671875,0.5753957610205606,1.0,7/29,9.78%,NOTCH2;IGF1;ITGAV;SHOC2;SHC1;LYN;NGF
prerank,blood vessel morphogenesis (GO:0048514),0.338162518015374,1.1440358238812376,0.23106060606060605,0.7146470933982424,1.0,10/54,7.29%,FLT1;EGFL7;PROX1;RAMP2;CDH2;KDR;SLC1A1;TGFBR3L;ID1;APLNR
prerank,regulation of programmed cell death (GO:0043067),0.27798585047159435,1.143955552796705,0.17341040462427745,0.7134713957796548,1.0,38/161,17.05%,PAX8;MECOM;LRP8;OMA1;HTATIP2;LCMT1;ACER2;SIRT1;PAX2;FLT3;HIP1;NME2;ALK;PHLPP1;CLU;AKT1;TPT1;NUP62;TRIM24;APEX1;RABGGTA;BCL3;CTSB;TNFRSF25;BCAR1;ACTN4;RPS3;MADD;ANP32A;NDRG1;ATM;USP42;RTN4;GLS2;FANK1;RAF1;MAGED1;HSP90AA1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.4480792258859172,-1.1437663598573997,0.2785977859778598,0.5761128953480451,1.0,7/15,15.37%,AEBP1;LRP1;RUNX1;FAP;RB1;EFEMP2;DDR1
prerank,myofibril assembly (GO:0030239),-0.34794898239147015,-1.1436002374455858,0.24431818181818182,0.5759561035629369,1.0,7/42,8.81%,PDGFRA;TPM1;CFLAR;PDGFRB;TMOD3;OBSL1;ACTN2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.44569553362137293,-1.1435927151918388,0.2846299810246679,0.5754266395527043,1.0,7/16,30.63%,VAMP7;CEBPG;VAMP2;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3880458752113406,-1.143380909747753,0.2783109404990403,0.5754312820047012,1.0,4/24,3.96%,ITPR1;ITPR2;ANXA6;IBTK
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4270777035983878,-1.143029065661759,0.3014705882352941,0.5757285712774425,1.0,2/18,5.19%,EGFR;LCOR
prerank,sphingolipid biosynthetic process (GO:0030148),0.32169190347302723,1.1427060919072498,0.20235756385068762,0.716016211639923,1.0,22/71,18.02%,SGMS1;ACER2;FA2H;DEGS2;CERT1;SPNS2;ST8SIA1;ELOVL7;SGPP2;ELOVL4;B4GALT6;SMPD1;HACD3;ST8SIA3;HACD1;PPM1L;SAMD8;PRKD3;TLCD3B;KDSR;SGPP1;SPTLC2
prerank,negative regulation of cell adhesion (GO:0007162),0.31535452687766286,1.1425204550961068,0.21627408993576017,0.715147522786185,1.0,12/72,8.51%,DSCAM;SPOCK1;PODXL;PLXNB3;SEMA6A;ACER2;ADAM22;SEMA4D;NOTCH1;ACVRL1;PLXNA4;NEXMIF
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4674112635881301,1.1424024574238556,0.3099787685774947,0.7140909353096889,1.0,3/12,10.49%,CXCL12;JAM2;AIF1
prerank,proton transmembrane transport (GO:1902600),0.35596196256758417,1.142033866382859,0.2719836400817996,0.7138295389047394,1.0,14/36,18.01%,UCP2;ATP1A3;SLC25A14;SLC25A27;ATP6V1F;ATP6V1A;SLC36A1;ATP1A4;ATP1A1;ATP5F1B;ATP5MF;DMAC2L;NNT;ATP6V0E2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5014947000022826,-1.1420295709007584,0.30518234165067176,0.577694451037792,1.0,4/10,14.47%,KAT2B;EP300;CREBBP;ESCO1
prerank,striated muscle tissue development (GO:0014706),-0.37874443070141456,-1.141531481861107,0.2628458498023715,0.5783684653296259,1.0,6/29,6.08%,SVIL;BMP5;CFLAR;BMP7;RBP4;IGSF8
prerank,regulation of glucose metabolic process (GO:0010906),-0.3634618383447446,-1.14146085843509,0.2424812030075188,0.5779890515298983,1.0,10/34,15.77%,PDK1;PRKN;IRS1;USP7;FOXK1;SELENOS;RORA;ZNF692;OGT;FOXK2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.39874710577376726,-1.1413371972193826,0.28982725527831094,0.5777544521814038,1.0,2/22,1.50%,ALDH1A2;RBP1
prerank,peptidyl-lysine methylation (GO:0018022),-0.3821401608594499,-1.1411904366109138,0.27153558052434457,0.5775459603929295,1.0,9/26,19.36%,SETD7;SMYD3;SETD3;SETD2;N6AMT1;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4097641319262055,1.1411649332406928,0.27682403433476394,0.7152199250376406,1.0,2/21,2.10%,SLC39A10;PRKCH
prerank,response to UV-A (GO:0070141),0.45157772473420704,1.1411485531357624,0.28602620087336245,0.7139046081513502,1.0,4/14,7.97%,MME;CCND1;TIMP1;AKT1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4819298320664089,-1.1410801240448143,0.3154121863799283,0.5772787627393338,1.0,5/12,16.89%,DPYSL3;CTPS2;ALDH6A1;DPYD;CTPS1
prerank,regulation of protein binding (GO:0043393),-0.2891365010154516,-1.1409950578380357,0.19393939393939394,0.5769374280167452,1.0,40/114,25.24%,TCF7L2;LRP1;PKD1;DAB2;STK3;ROCK1;BMP4;HDAC4;PRKN;LRRK2;VTN;GSK3B;STYX;MARK3;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;RPL11;DTX3L;RAPGEF2;PSME3IP1;DERL1;PRKACA;PRMT8;BMP2;PARK7;CARD16;SPPL3;TERT;PPP2CA;BTBD1;GTF2F1;HIP1R;TMBIM6;GNL3L;CFHR2;KDM1A
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4210172741281649,-1.1408997942649486,0.2948960302457467,0.5766501499472797,1.0,4/18,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,ERBB signaling pathway (GO:0038127),-0.3195433078145825,-1.1407221753453505,0.25760649087221094,0.5765457566983646,1.0,23/64,22.03%,EGFR;EFEMP1;PLCE1;SLC30A10;GAREM1;SHC1;BRAF;PDPK1;PLCG1;PTPN12;KIF16B;CPNE3;REPS2;NCK2;HBEGF;NRG4;GAB1;PTPN11;MVP;PIK3R1;AAMP;DGKD;PRKCA
prerank,positive regulation of vasculogenesis (GO:2001214),0.4881520128873652,1.1405883363015368,0.3250517598343685,0.7143192442601365,1.0,4/10,16.17%,KDR;CD34;RIN2;RAP1A
prerank,regulation of primary metabolic process (GO:0080090),-0.2866824339581215,-1.1403428154665507,0.1793372319688109,0.5769536618365602,1.0,48/126,29.31%,ROCK2;CHD9;NR1D2;NCOR1;TBL1X;TBL1XR1;CREBBP;NCOA6;NFYC;NCOA1;MED1;LDLR;PRKAB2;ID2;PSMF1;TGS1;LACTB;APOE;PSMB2;C1QTNF2;RXRA;NFYB;HMGCR;SQLE;CYP51A1;ABCA7;FGFR4;NFYA;PSMC1;PRKAB1;SC5D;FDFT1;PSMB6;PSMA3;SMARCD3;MVK;PSMA4;PPARA;EDF1;ZFP69;BBS4;HDAC3;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;PLPP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43479972928788446,-1.1400382229139876,0.27606177606177607,0.5772220809576256,1.0,4/17,5.36%,MCU;CAMK1D;RIPOR2;DNM1L
prerank,cellular response to alcohol (GO:0097306),-0.35199460330645643,-1.1390287741871865,0.2757936507936508,0.5792607426966025,1.0,12/42,9.18%,ADCY5;LRP6;KLF9;CTNNA1;SMO;SPIDR;GRAMD1C;CDH1;ADCY1;LARP1;ADCY6;JUP
prerank,regulation of response to external stimulus (GO:0032101),-0.29093806592580274,-1.1389244635137854,0.18962075848303392,0.5790080903122682,1.0,37/121,24.15%,FOXP1;APPL2;ADAMTS12;PDGFRA;EFNB2;CELF1;NR1D2;NMT2;CD55;SBNO2;ADGRA2;UFL1;ANXA1;GRK4;CASP12;XIAP;PTPN22;PTGES;TRIM5;AGTR1;APPL1;IRF1;PIK3AP1;P2RY12;P2RX4;TRAF3;WNT5A;AREL1;PARK7;MGLL;SHPK;GATA6;CAMKMT;DAGLB;USP18;FNTA;IL1RL2
prerank,nitrogen compound transport (GO:0071705),0.28290764703237214,1.1388941070795255,0.1803921568627451,0.7181496572270398,1.0,18/141,9.58%,SLC7A5;SLC6A6;LRP1B;TMEM30A;SLC7A1;AQP9;RAMP2;ABCG2;CERT1;SLC52A2;SLC15A3;SLC6A2;SLC6A8;SLC7A8;SLC52A3;SCARB2;SLC43A2;SLC36A1
prerank,regulation of cell morphogenesis (GO:0022604),-0.3754110977543447,-1.1387594314069307,0.2821011673151751,0.5788743270884211,1.0,9/30,13.57%,PDPN;SPARC;MYO9A;WTIP;MOV10;BCL9L;ZMYM4;ZMYM3;CAPZB
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.415119812637066,1.138475964348124,0.27608695652173915,0.7180417974854048,1.0,5/19,5.98%,HS6ST3;HS3ST5;HS6ST2;CSGALNACT1;NDST4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.36451992581474413,1.138450116777628,0.25918367346938775,0.7167522889783504,1.0,9/35,14.53%,FAR2;HPGD;GGT7;SCD;GGT1;HMGCLL1;BDH1;FAR1;PPT1
prerank,long-chain fatty acid transport (GO:0015909),-0.3767435144016295,-1.1382399862224284,0.2674199623352166,0.5796486012731501,1.0,10/30,14.17%,PRKAG2;ACSL1;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;APOE;SLC27A1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3400352544018737,-1.1377604210812684,0.25,0.5803651037879579,1.0,10/45,16.54%,EGFR;NFKB1;DDX5;BMP4;U2AF2;MAP2K1;WDR43;DIMT1;ERN1;BUD23
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.45923783712890487,-1.1375130450315185,0.2922201138519924,0.5804743679754447,1.0,5/13,29.37%,GAB2;STX4;LAMP1;SYK;SPHK2
prerank,metal ion export (GO:0070839),-0.3693528011107594,-1.1373284209556875,0.275,0.5803981853059413,1.0,4/31,6.27%,ATP1A2;KCNT2;SLC9A1;KCNK5
prerank,positive regulation of catabolic process (GO:0009896),-0.31803244773043926,-1.1371530209774572,0.24260355029585798,0.5802560452712575,1.0,17/65,18.42%,SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;DACT1;STX5;SMURF1;CSNK2A1;ASB5;WNT5A;AREL1;VCP
prerank,cellular amide metabolic process (GO:0043603),-0.2909847269070024,-1.136932346043215,0.21626984126984128,0.5802275307691576,1.0,29/102,23.25%,AEBP1;PCCA;PLPP3;HLCS;ASAH2;MCCC2;MTHFR;GPAT4;MTHFD2L;PANK2;ACSF2;SLC5A6;NAPEPLD;ACSL6;NLN;CPM;ACOT11;CPXM2;ACOT9;CPXM1;ALDH1L1;NIT1;ORMDL3;PPP2CA;SMPD2;ACOT8;ST6GAL1;DNPEP;ACOT6
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.31089890567584066,-1.1365976014313697,0.23931623931623933,0.5805861291316494,1.0,13/75,5.60%,ROCK2;SULF1;WNT4;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5
prerank,negative regulation of synaptic transmission (GO:0050805),0.3967725088386778,1.1365875210472263,0.2915811088295688,0.7210186568401676,1.0,4/23,9.16%,SLC24A2;SYT11;SLC30A1;SHANK2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.48872245679800064,-1.1361489165774026,0.3315018315018315,0.5812099268854571,1.0,7/11,32.97%,WIPI1;ATG9A;WDR45B;WIPI2;STX17;MFN2;WDR45
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3632453206604015,-1.136081646300643,0.25748502994011974,0.5808436566221861,1.0,16/33,26.61%,EGFR;ANKRD17;UBE2E2;RPTOR;STXBP4;ANXA1;GLI1;CCND3;DDX3X;ADAMTS1;EIF4G1;CDC73;EZH2;KMT2E;PHB2;LSM11
prerank,C-terminal protein amino acid modification (GO:0018410),0.4709900398046459,1.135863507037327,0.2894211576846307,0.7219270846071428,1.0,2/11,3.17%,AGBL4;LCMT1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3698194505650785,-1.135613808892939,0.27850467289719627,0.5815132249458665,1.0,13/33,22.89%,KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;PKD2;RB1;FAM107A;DCUN1D3;CDC73;CDK6;PLK5
prerank,plasma membrane invagination (GO:0099024),-0.37215291779662274,-1.1355947009827132,0.25239005736137665,0.5810323138398207,1.0,6/29,10.27%,GULP1;GSN;SNX9;VAMP7;CDC42;RHOA
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4554899251951884,1.1354693767568929,0.3114754098360656,0.7218008433051403,1.0,2/13,4.08%,RPP40;RPS21
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3980951519109682,1.1354667353838779,0.2826086956521739,0.7204330928882907,1.0,3/22,13.37%,SLC7A5;PRKCQ;RFTN1
prerank,ERBB2 signaling pathway (GO:0038128),0.3704154341935454,1.1344276207951258,0.2757201646090535,0.7221942872069249,1.0,5/31,6.85%,ERBB4;PTPRR;NRG2;NRG1;PTPN18
prerank,histone deubiquitination (GO:0016578),-0.41535123758273673,-1.1341191819384449,0.283203125,0.5842354916640065,1.0,4/18,7.43%,USP7;TRRAP;ENY2;BRCC3
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.42152150084275253,-1.1339786441652497,0.28875968992248063,0.5840318266106818,1.0,7/19,20.16%,VPS4B;CHMP4B;CHMP5;CHMP3;TPR;HNRNPU;EML3
prerank,regulation of neuron projection arborization (GO:0150011),0.43853059563255914,1.1338960418251183,0.29690721649484536,0.7224876503366117,1.0,7/15,11.92%,SPRY3;MFSD2A;GRIP1;NTNG1;NTNG2;FZD4;DVL1
prerank,amide transport (GO:0042886),0.38954521887050425,1.1337317158298936,0.3038229376257545,0.7216268911049287,1.0,4/26,4.27%,PLTP;ABCG2;AQP11;CERT1
prerank,fatty acid transmembrane transport (GO:1902001),-0.4206305173125787,-1.1335187663234776,0.30057803468208094,0.5846621582582104,1.0,8/19,14.17%,PRKAG2;PRKAA2;ABCD3;ABCD2;CPT2;PRKAB2;ABCD4;SLC27A1
prerank,peptide metabolic process (GO:0006518),-0.3152832819436833,-1.1330092650239074,0.2164750957854406,0.5853677469235017,1.0,26/75,23.52%,CPQ;AEBP1;PCSK5;HM13;ANPEP;SEC11C;MGAT3;NPEPPS;NLN;CPM;CPXM2;LNPEP;GSTT2;GLRX2;CTNS;CPXM1;SEC11A;GSTT1;ETHE1;CARNMT1;SPPL3;CLN5;DNPEP;PARL;GSTM2;APEH
prerank,fatty acid biosynthetic process (GO:0006633),0.3191626715821903,1.1329583566260952,0.22839506172839505,0.7225952569545637,1.0,16/63,17.68%,ABHD2;ELOVL7;CYP2E1;ELOVL4;TECR;HPGD;HACD3;SCD;ACOT7;FADS1;XBP1;HACD1;LTA4H;TECRL;NDUFAB1;LIAS
prerank,sulfate transport (GO:0008272),-0.4479542920127712,-1.132435109957499,0.30666666666666664,0.5863457787669976,1.0,3/14,7.01%,SLC13A4;SLC26A7;SLC26A2
prerank,regulation of macrophage cytokine production (GO:0010935),0.4535221461777501,1.13219426828775,0.28602620087336245,0.7234100843714513,1.0,3/13,5.82%,SIRT1;SEMA7A;TGFB2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.48177284414769295,-1.1321264734951793,0.3106212424849699,0.586065998528683,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.48177284414769295,-1.1321264734951793,0.3106212424849699,0.586065998528683,1.0,3/11,5.92%,INPP5B;SYNJ2;INPP5A
prerank,regulation of Golgi organization (GO:1903358),-0.42022946144711215,-1.13212475025258,0.3063583815028902,0.5855355035459244,1.0,7/17,15.44%,STX18;MAP2K1;USP6NL;STX5;ARMH3;EHD3;AKAP9
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.41286340179414643,-1.1320090523181014,0.2987012987012987,0.5852471983192951,1.0,9/21,23.49%,SMO;DCDC2;TTC23;EVC;ARMC9;GLI1;PDCL;DLG5;KIF7
prerank,mRNA export from nucleus (GO:0006406),-0.2921910990781036,-1.1318098837384019,0.2099009900990099,0.5851841382064611,1.0,36/102,26.63%,SMG6;SMG1;PABPN1;WDR33;CASC3;RANBP2;U2AF2;ENY2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,glycerophospholipid metabolic process (GO:0006650),0.3091434978011018,1.1313510867112564,0.22614107883817428,0.7246840081145833,1.0,23/75,20.45%,GPCPD1;CSF1R;PGP;PLCB1;DGKH;PLAAT1;CPNE1;PIGM;SERINC1;CRLS1;FAR1;PIP5K1A;GPLD1;PIGW;PNPLA3;PNPLA6;CPNE7;PLA2G4E;PIGG;SYNJ1;ACP6;PRDX6;ABCA3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.36567408286978187,-1.1310975830703907,0.2914285714285714,0.5864628704304031,1.0,11/33,19.36%,FOXO3;ARNT;HOXA5;STAT3;MED1;HIF1A;STAT1;PRKDC;PITHD1;STAT5B;INHBA
prerank,cellular response to glucose stimulus (GO:0071333),0.3698017431128937,1.130327064027641,0.28728070175438597,0.7262680724947038,1.0,5/30,3.78%,IGF1R;PTPRN2;ADCY8;PAX2;GAS6
prerank,regulation of blood circulation (GO:1903522),-0.36140615418545485,-1.13020247735779,0.2727272727272727,0.5881944098956475,1.0,11/34,20.94%,CELF2;TPM1;CAMK2D;ECE1;DMPK;AGTR1;SRI;BDKRB2;TBX2;DES;S100A1
prerank,cellular protein-containing complex assembly (GO:0034622),0.2735842983905475,1.1300283932614101,0.16205533596837945,0.7258023140378563,1.0,34/159,15.34%,NSG2;MAPK8IP2;OMA1;DNAAF3;RPL38;NRG1;ANLN;AP2M1;PDE4DIP;TMEM35A;COX7A1;SNCA;BIN1;HIP1;CSNK2B;CHCHD4;CLU;PFDN6;BBS10;FCHO1;HSP90AB1;DNAAF2;MID1IP1;CCT2;HOPX;CALY;HSPD1;SGIP1;NUP205;HIGD1A;CLTB;HIGD1B;RTN4;NDUFAF1
prerank,positive regulation of transferase activity (GO:0051347),0.2823011548380029,1.1299053546480375,0.2210953346855984,0.724802134022975,1.0,43/142,18.94%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;PRKCQ;KLF4;TRIB3;HSP90AB1;EPHA10;SERINC1;CCT2;DKC1;RET;EPHA1;CCT4;SORL1;RPS2;INSR;PARM1;DBI;RFC4;DCUN1D2;DDR2;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;FGFR3;RFC2;TCP1
prerank,positive regulation of vascular permeability (GO:0043117),-0.4699099633613348,-1.1298782762510404,0.3313840155945419,0.5884991175245834,1.0,2/12,1.37%,BMP6;ANGPT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3714058394938604,-1.1295927512270207,0.28274428274428276,0.5886626554024507,1.0,14/30,24.29%,FHIT;STYX;USP7;RPL11;GIPC1;OGT;TRIM39;NOP53;PARK7;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42313854732397266,-1.1295711915853353,0.3132075471698113,0.5881828831247191,1.0,2/19,0.80%,BMP6;AFDN
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.45659667581959995,-1.1294012424705415,0.30656934306569344,0.587547404550587,1.0,6/13,17.74%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),-0.45659667581959995,-1.1294012424705415,0.30656934306569344,0.587547404550587,1.0,6/13,17.74%,JAK1;IL15RA;STAT3;SHC1;STAT5A;STAT5B
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.4578966829498113,-1.129253031164931,0.32123411978221417,0.5873997354574928,1.0,4/13,6.88%,CBLB;KPNA4;RANBP2;KPNA6
prerank,cellular response to sterol (GO:0036315),-0.45199270944326275,-1.12924155887249,0.2900188323917137,0.5869109876598062,1.0,6/13,15.46%,LRP6;SMO;GRAMD1C;INSIG2;RORA;PTCH1
prerank,negative regulation of peptidase activity (GO:0010466),0.33581100846189815,1.128788360927989,0.256198347107438,0.7268666973763102,1.0,7/47,12.01%,SPOCK2;SPOCK1;SPOCK3;TIMP1;AKT1;SERPINB8;TIMP4
prerank,positive regulation of cellular component movement (GO:0051272),0.39376074029922864,1.128463952131057,0.2894168466522678,0.7264405808664309,1.0,6/24,13.02%,SPOCK2;CSF1R;RPS19;ETS1;NTN1;ACTN4
prerank,heart morphogenesis (GO:0003007),-0.329025046860658,-1.1283730708727588,0.2555970149253731,0.5885349709823147,1.0,14/50,19.53%,TGFBR3;TGFBR1;BMPR1A;FLRT2;MDM4;NIPBL;HES1;CHD7;VEGFA;ACVR1;HEYL;TBX2;BMP2;MEGF8
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4215130114301643,1.128156384127426,0.3152610441767068,0.7260350903240913,1.0,2/18,8.61%,CAMK2A;HEBP2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3419165238444574,-1.1280261288301625,0.2633587786259542,0.5889274661780863,1.0,14/43,21.31%,CTNNA1;BMP4;GSK3B;YAP1;EIF2AK3;GLUL;PARP9;TPR;ILRUN;DTX3L;LATS1;PARK7;ORMDL3;CDK5RAP3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.38709309552830407,-1.1275918480371891,0.28402366863905326,0.5894427531564403,1.0,9/24,18.00%,PKD1;CTSC;EPHA4;NUB1;RHBDF1;APOE;LATS1;PRKACA;ATP5IF1
prerank,regulation of calcium ion import (GO:0090279),0.4010866702408243,1.1274717728884138,0.31027253668763105,0.7267305609586471,1.0,5/21,10.22%,CXCL12;SLC30A1;PLPP4;CCL2;PDGFB
prerank,negative regulation of cellular component organization (GO:0051129),-0.30740606603146003,-1.1272613173593289,0.22153209109730848,0.5897607683207777,1.0,23/74,19.61%,BMP6;EPHA3;EP300;GSK3B;IRAK3;CDC42;RAPGEF3;AR;IMPACT;WASL;FAP;RIOK3;VEGFA;DDX3X;PRKCZ;CARMIL1;NOP53;IAPP;RUBCN;PRKD1;ABCA7;LRSAM1;TERF2
prerank,regulation of JNK cascade (GO:0046328),0.2913367446898008,1.1271319847762928,0.21199143468950749,0.7263552219495313,1.0,22/101,13.63%,IGF1R;MECOM;TIRAP;EPHB1;MAPK8IP2;MAP4K2;TRAF1;PLCB1;TNFRSF19;PHLPP1;WNT7B;ANKRD6;GPS2;MAPK8IP1;TAOK2;DAB2IP;MEN1;HIPK2;PJA2;DUSP15;MAP3K11;HRAS
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.39951985635537196,-1.1269015249627765,0.2720156555772994,0.5901092995309996,1.0,5/23,10.84%,TGFBR3;TPM1;FGFR2;ADAMTS9;ID2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.32201162438615594,-1.126553025037163,0.2421875,0.5904443535284329,1.0,14/57,14.36%,IGF1;IL6ST;IL31RA;GHR;KIT;PIBF1;STAT3;LYN;PTPN2;PARP14;PARP9;HES1;IL6R;VEGFA
prerank,histone H4-K16 acetylation (GO:0043984),-0.4051997754691566,-1.1262996505353604,0.29389312977099236,0.5905177163239067,1.0,9/19,23.98%,KANSL2;HCFC1;OGT;KAT8;MSL2;MSL3;KANSL3;KMT2A;JADE2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4160655551847516,-1.1262637727123435,0.2982791586998088,0.5900874082180648,1.0,6/18,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,neural tube development (GO:0021915),-0.44309135184870957,-1.1260764745675849,0.2824858757062147,0.5900712361395197,1.0,6/15,15.46%,ALDH1A2;PKD1;ARL13B;DACT1;PKD2;PTCH1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3997309202770271,-1.1253729702041733,0.27715355805243447,0.5912684712740192,1.0,8/23,20.39%,AGMO;PLCE1;GPAT4;PLA2G4A;MOGAT3;LPIN2;LPIN3;GPAT3
prerank,presynaptic endocytosis (GO:0140238),0.37838859931131863,1.1253488362606954,0.3020833333333333,0.7303774050560167,1.0,10/24,18.87%,SYT1;NLGN1;SNCA;AMPH;SYT2;SNCB;NLGN3;PACSIN1;SYNJ1;SYT5
prerank,regulation of cilium movement (GO:0003352),-0.49373808469072433,-1.1253284946174782,0.3180952380952381,0.5908578374665041,1.0,9/10,46.73%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,sensory organ development (GO:0007423),-0.33258831224293695,-1.1252759517171127,0.25903614457831325,0.5904745680625982,1.0,14/51,19.04%,PBX1;SMOC1;FOXC1;SH3PXD2B;SHROOM2;RBP4;PBX3;ECE1;HIPK1;ATF6;CHD7;SMCHD1;ZDHHC16;SIPA1L3
prerank,epithelium development (GO:0060429),-0.28860651808755455,-1.1252521428922468,0.21765913757700206,0.5900185436384018,1.0,30/107,18.84%,ALDH1A2;ERRFI1;DAG1;VCL;KANK2;PKD1;WNT4;SMO;OSR1;MEOX2;ANXA4;FGFR2;ANXA7;CNN3;VDAC1;DACT1;RCN3;PKD2;PGK1;STAT1;VEGFA;BDH2;PTCH1;SALL1;LOXL3;SIX1;TBX2;TAGLN;BMP2;CPT1A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3129818046047709,1.125219546355648,0.24217118997912318,0.7294224119909763,1.0,9/67,5.70%,FLT1;IGF1R;TEK;ERBB4;CSF1R;KDR;FLT3;AATK;SRMS
prerank,organic hydroxy compound transport (GO:0015850),0.3527908491649564,1.1250956055179124,0.2567287784679089,0.7284520698441931,1.0,6/36,13.58%,SLCO1C1;AQP9;NCOA2;SLCO2B1;ABCC4;SLC16A1
prerank,regulation of lipid storage (GO:0010883),-0.40325336656093397,-1.1250918161051413,0.3284403669724771,0.5898876604791994,1.0,7/22,19.37%,NFKB1;FTO;ITGAV;PTPN2;FBXW7;IKBKE;ITGB3
prerank,embryonic axis specification (GO:0000578),-0.4400787520658498,-1.1247767291572888,0.3074141048824593,0.5901437340264913,1.0,6/15,30.07%,SMAD6;SMAD2;PTCH1;CXXC4;COBL;STIL
prerank,ion homeostasis (GO:0050801),0.3618819894936832,1.1243777320464055,0.2851153039832285,0.7294090431269522,1.0,5/30,7.92%,SLC4A1;KLHL3;WNK2;UNC80;SLC30A3
prerank,cAMP-mediated signaling (GO:0019933),0.3865241703977886,1.1243639210031116,0.27682403433476394,0.7281097184907199,1.0,7/24,12.59%,RIMS2;EPHA5;AKAP6;PDE2A;ADCYAP1;CAP2;PDE4D
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.41071249347565497,-1.124044718888101,0.295668549905838,0.5914321759640173,1.0,4/20,7.62%,DICER1;PUM2;ZC3H7A;PUM1
prerank,receptor metabolic process (GO:0043112),0.3251214761506151,1.1239371118214516,0.2620967741935484,0.7281660813095431,1.0,6/53,4.64%,TFRC;DNM3;RAMP2;AP2M1;SNCA;GRK2
prerank,negative regulation of catalytic activity (GO:0043086),0.394851317454734,1.123889098363992,0.26997840172786175,0.7269717446490234,1.0,4/24,7.74%,CAMK2A;SIRT1;NOTCH1;TIMP1
prerank,protein targeting to mitochondrion (GO:0006626),0.32843037258664604,1.1237862274390635,0.25697211155378485,0.7259687109966895,1.0,14/52,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;PMPCA;PITRM1;TIMM22;NDUFA13;HSPD1;TSPO;HSP90AA1;TOMM70;TIMM10B;DNAJC19
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4618892527100031,1.123711340559655,0.2908704883227176,0.7248803358211581,1.0,3/13,7.90%,TMEM35A;STX3;HSP90AB1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4597948506641891,-1.1225212110126213,0.3127413127413127,0.5948478956776017,1.0,3/13,10.08%,ATP1A2;KCNJ2;SLC12A2
prerank,regulation of endopeptidase activity (GO:0052548),0.3184146164021728,1.1224953282811907,0.24066390041493776,0.7273148811903928,1.0,7/59,9.81%,SPOCK2;SPOCK1;SPOCK3;PSENEN;TIMP1;AKT1;SERPINB8
prerank,regulation of mitochondrion organization (GO:0010821),-0.33491491724871053,-1.1224439004205726,0.2591170825335892,0.5945171659232326,1.0,10/47,12.70%,PID1;EP300;PRKN;LRRK2;GSK3B;DNM1L;PPARGC1A;VDAC1;RHOT1;FBXW7
prerank,protein ADP-ribosylation (GO:0006471),-0.3757433862488861,-1.1224237925760543,0.26607142857142857,0.5940462207097563,1.0,12/28,24.53%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3;PARP12
prerank,ventricular septum morphogenesis (GO:0060412),-0.37267216087098715,-1.1219193627317845,0.29074074074074074,0.5948326845702239,1.0,6/27,3.24%,TGFBR3;TGFBR1;BMPR1A;BMP4;ROBO1;TGFBR2
prerank,thymus development (GO:0048538),-0.45575333439838317,-1.1219161529311847,0.3146067415730337,0.5943115678987159,1.0,6/13,25.77%,TGFBR1;ZBTB1;HES1;SIX1;FOXE1;EPHB3
prerank,regulation of hydrolase activity (GO:0051336),0.3138311464946113,1.1212655025847666,0.2545824847250509,0.7297277179155891,1.0,15/71,10.93%,CAMK2A;PLXNB3;EPHA5;CHN2;VAV3;NTRK2;PRKG1;RAP1GAP;SCARB2;PLXNA4;FGD5;CFAP100;DAB2IP;CHN1;FGD3
prerank,negative regulation of programmed cell death (GO:0043069),-0.25077090177009803,-1.1212361554783645,0.12903225806451613,0.5954849601177019,1.0,50/355,10.02%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;KANK2;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;FLNA;ANXA4;ANXA5;CTSH;THBS1;PAK2;SH3RF1;MAP4K4;TMBIM4;SHC1;BCL2;ANXA1;BRAF;VDAC1;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.430152153104514,1.1211449153866357,0.3118712273641851,0.7287569397517311,1.0,3/15,6.59%,PAX8;PAX2;LHX1
prerank,programmed necrotic cell death (GO:0097300),-0.4161164463619067,-1.121022280101474,0.31645569620253167,0.5954884830459807,1.0,9/18,32.33%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;PPIF;TLR3;LY96;ITPK1
prerank,inositol phosphate metabolic process (GO:0043647),-0.33626849288260985,-1.1207980148018832,0.2926356589147287,0.5955436451999014,1.0,10/46,10.26%,PLCE1;NUDT4;PLCD3;INPP5B;INPP5A;ISYNA1;INPPL1;PLCG1;PLCB3;PLCD1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45120691614733865,-1.1206872457166428,0.3448905109489051,0.5952901637151902,1.0,9/14,31.47%,UPP2;NT5M;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3102093274722902,-1.1204745906105646,0.25996204933586337,0.5952770148559497,1.0,27/69,28.48%,ECPAS;DNAJB14;UBQLN1;OS9;UBE4B;JKAMP;EDEM1;FAM8A1;SELENOS;RNF103-CHMP3;MAN1B1;RHBDD2;ERLIN1;TRIM25;FAF2;AUP1;DERL1;SYVN1;VCP;UBXN4;WFS1;BAG6;DNAJC18;TMUB2;SEL1L;USP19;DERL2
prerank,cell differentiation in spinal cord (GO:0021515),0.48715209761229317,1.120465180632177,0.3275488069414317,0.7295225084862346,1.0,2/10,6.59%,MDGA2;LHX1
prerank,hexose metabolic process (GO:0019318),0.347821453991475,1.120052797116879,0.29912663755458513,0.7294602881973188,1.0,7/39,10.71%,OMA1;KHK;KCNJ11;SLC37A4;PMM1;ALDOC;GDPGP1
prerank,apoptotic cell clearance (GO:0043277),-0.36967501424496607,-1.1196192178679607,0.26425855513307983,0.5968880012427327,1.0,11/30,19.37%,LRP1;ITGAV;HMGB1;THBS1;ANXA1;NR1H3;RHOBTB2;TXNDC5;RHOBTB1;RHOH;ITGB3
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2633005724075273,-1.119572390977155,0.1877637130801688,0.5964722629759734,1.0,69/203,25.40%,FBXL7;FBXL17;PCM1;PPP1R12B;PPP1R12A;BTRC;ALMS1;CCNH;ODF2;KHDRBS1;NINL;CDK7;CEP63;CEP135;PHF8;PHLDA1;PCNT;CHMP4B;FBXL12;ANAPC7;CSNK1E;BRSK1;EIF4E;MNAT1;NES;CUL3;RB1;MAPRE1;TPD52L1;HINFP;CRLF3;ACVR1;CCND3;RCC1;YWHAE;LATS1;CDC25B;PPP1CB;CUL2;AKAP9;CDC27;CCDC57;DYNC1H1;NASP;CEP76;CACUL1;UBE2S;PRKACA;FBXW11;CEP57;CSNK1D;AJUBA;INHBA;CDK2;CUL1;CDK6;TAF2;HAUS7;HAUS8;ACTR1A;BORA;DBF4;EIF4EBP1;CDC16;CCNE2;CCNJ;MASTL;CTDP1;ANAPC1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4577327366480222,-1.1195143420600628,0.32695984703632885,0.5960782425120248,1.0,8/13,28.66%,ABCA1;ITGB1;CD9;LDLR;SYK;FCER1G;LPL;CD81
prerank,necroptotic process (GO:0070266),-0.43080514156852756,-1.1191698303165045,0.3074074074074074,0.5964460788050421,1.0,8/16,32.33%,DNM1L;TLR4;TRPM7;MLKL;TICAM1;TLR3;LY96;ITPK1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4478102444904151,1.1190113854281558,0.3411513859275053,0.7313094698799506,1.0,2/13,3.17%,USP44;LCMT1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.41698001318278183,-1.1187885931141832,0.30828516377649323,0.5969305916529517,1.0,8/18,30.42%,PABPN1;ENY2;MCM3AP;DDX19B;NXF1;NUP93;THOC2;DDX25
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2916973085806261,-1.118592116479381,0.2263056092843327,0.5969056082395353,1.0,23/95,17.04%,INO80;UBE2N;RBBP8;SPIDR;SMC6;NBN;RAD51B;NSMCE2;WRN;SMC5;MCM9;NIPBL;RFWD3;PARP1;RAD21;RAD51D;NABP2;FANCM;MCM6;BRCA2;SFPQ;MRE11;ZSWIM7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4081383647581798,-1.1185729120845578,0.3123844731977819,0.596440436343904,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3958773370922877,-1.118392710067613,0.27419354838709675,0.596345926061606,1.0,9/21,28.60%,PRKN;COA8;SLC30A10;ABCD2;SIRT5;PARK7;AATF;PPARA;MT3
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41095200059096654,1.1183557339777335,0.2892561983471074,0.730599216818282,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41095200059096654,1.1183557339777335,0.2892561983471074,0.730599216818282,1.0,7/19,17.14%,TERF1;POLR2J;TERF2IP;POLR2B;POLR2I;TINF2;POLR2G
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.31945302951127497,-1.11737542020415,0.25882352941176473,0.5983612102541976,1.0,16/59,15.45%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3149984452546845,-1.1167858648213518,0.246,0.5992695411432793,1.0,19/65,17.27%,FOXP1;GAB2;IL31RA;EP300;BMP4;TGFBR2;KIT;SBNO2;RUNX1;CDC42;PARP1;SNX10;GLO1;VEGFA;CBFA2T3;FARP2;RXRA;PIR;PIK3CD
prerank,nucleosome organization (GO:0034728),-0.3192861259029279,-1.1167576147555585,0.2553191489361702,0.5988206026343239,1.0,28/55,37.35%,INO80;KAT6B;SMARCC2;RNF8;SETD2;MCM3AP;SPTY2D1;ANP32B;ANP32E;NASP;SMARCD2;ARID2;BPTF;H1-0;PRDM9;NAP1L4;SMARCD3;NAP1L1;ACTR6;ATRX;DMAP1;NAP1L2;CHAF1A;NAP1L3;SMARCA4;NPM1;ARID1A;SART3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.44383879123412545,1.1163189777136038,0.3170731707317073,0.7354346445706444,1.0,2/14,3.31%,PRKAR2B;SIRT1
prerank,macrophage chemotaxis (GO:0048246),0.4793149173493146,1.11622615935867,0.33406593406593404,0.7344051951054498,1.0,3/10,18.29%,CCL2;EDNRB;CKLF
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.36099015432875825,1.1158349318401706,0.3010752688172043,0.7342589326778795,1.0,4/33,7.97%,IGF1R;NYAP2;PIK3R5;AKT1
prerank,glycoprotein catabolic process (GO:0006516),-0.4203112905398355,-1.1155139685344375,0.321285140562249,0.6013396501443463,1.0,5/17,9.28%,ADAMTS12;NGLY1;OGA;EDEM1;ADAMTS9
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4702878282054911,1.1153954464629308,0.30493273542600896,0.7342803519708054,1.0,3/12,9.70%,ACTB;AHI1;VANGL2
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4994990238928443,-1.1153797753384243,0.3359073359073359,0.6011466241344051,1.0,5/10,24.99%,BMP5;HOXA7;EMILIN1;CD300A;SLIT2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3588905901161651,-1.115277954787149,0.2722117202268431,0.6008801429827231,1.0,17/34,31.73%,LGR4;IRAK3;PTPRS;LYN;OTUD4;TLR4;LRRC14;CD300A;TICAM1;RAB7B;CACTIN;GRAMD4;TNFAIP3;NLRP2B;TLR3;LY96;TYRO3
prerank,presynapse organization (GO:0099172),0.49817247608397813,1.1151693615956477,0.33640552995391704,0.7337057562971114,1.0,4/10,15.66%,LRRTM3;NLGN1;DVL1;NLGN3
prerank,RNA export from nucleus (GO:0006405),-0.2896171964222465,-1.1149593673285327,0.23658051689860835,0.6011696735347709,1.0,35/100,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;XPO5;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.30982138951328875,-1.114893945669848,0.25992063492063494,0.6007801722125127,1.0,13/68,16.48%,RHOQ;OPA1;ENPP1;LRRK2;TPST1;AMPD3;GPAT4;ACSF2;SULT1A1;ACSL6;ACOT11;ABHD14B;ACOT9
prerank,polyol biosynthetic process (GO:0046173),-0.4290850605697641,-1.1146289753791379,0.34146341463414637,0.6009459308725728,1.0,7/16,25.71%,CYP27A1;ISYNA1;ACER3;ITPKC;FGF2;CYP2R1;IP6K2
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2708635691454127,-1.1141622158351923,0.2020618556701031,0.6016230408287153,1.0,56/153,25.75%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;MKNK2;RICTOR;PRKDC;ERN1;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;CSNK1D;CDK2;NEK6;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN;DYRK1B;MAP3K13;CSNK1G2;MASTL;RPS6KA4;MAPK9;MAPK14
prerank,positive regulation of response to external stimulus (GO:0032103),-0.27929843387926717,-1.1139354297907778,0.22563176895306858,0.60161600359157,1.0,28/128,17.55%,BMP6;SASH1;PTN;ANKRD17;PDGFRB;PUM2;THBS1;PLSCR1;IL16;DHX9;PUM1;IL17RA;DDX60;NAPEPLD;STX4;NFKBIZ;RIOK3;AGTR1;P2RY12;CYBA;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A
prerank,proteasomal protein catabolic process (GO:0010498),-0.26489656519904103,-1.1135724371732827,0.2037735849056604,0.6020039331864714,1.0,77/201,29.56%,FBXL17;SMURF2;SPSB1;PRKN;RAD23B;BTRC;TBL1X;WWP2;TBL1XR1;UBXN2B;HUWE1;UBE4B;WWP1;ZSWIM8;DDI2;PCBP2;UBE2K;MAEA;TNFAIP1;RNF216;ERLEC1;SPOPL;RCN3;GID4;KCTD5;PSMF1;FBXL19;CUL3;FBXW7;KLHL22;NHLRC3;PSMB2;UBE2B;SMURF1;FBXO45;TOPORS;ERCC8;ARRB1;BFAR;DERL1;SYVN1;PPP2R5C;FBXW11;FBXW5;AREL1;VCP;SPSB4;UBE2D3;IFI27;COP1;PML;PSMC1;APPBP2;SHARPIN;KCTD17;GID8;PSMB6;RMND5A;PSMA3;SIAH2;ARMC8;PSMA4;BAG6;PCNP;SPSB2;PSME1;SEL1L;PSMD13;CDC34;PSMB10;PSMA5;SPSB3;CCDC47;PSMB9;KBTBD7;RBX1;NFE2L2
prerank,erythrocyte differentiation (GO:0030218),-0.33281438095349625,-1.1131145826675557,0.2837022132796781,0.6025874650996487,1.0,15/44,19.36%,TGFBR3;KIT;ACIN1;UFL1;LYN;CEBPG;UBA5;MED1;PTPN2;ID2;HSPA9;VEGFA;SLC25A38;ATP5IF1;INHBA
prerank,negative regulation of apoptotic process (GO:0043066),-0.24446324592099927,-1.1127766599290057,0.11715481171548117,0.6028438366703437,1.0,99/444,18.35%,FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;BMP4;ERC1;PDPN;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;NUPR1;GSK3B;NIBAN2;YAP1;FLNA;ANXA4;ANXA5;ITGB1;CTSH;THBS1;SLC30A10;SNX6;RNF213;PAK2;SH3RF1;MAP4K4;TMBIM4;ASAH2;SHC1;BCL2;ANXA1;MERTK;BRAF;PPARGC1A;VDAC1;MAEA;XIAP;MED1;HNRNPK;BAG3;NGF;ANKLE2;PRKCD;DNAJC3;USP47;TLE1;NFATC4;FNIP1;MEF2C;YME1L1;HSPA9;RB1;CASP2;CARD14;SH3RF2;APOE;GLO1;PRKDC;NAA15;VEGFA;HDAC1;DDX3X;YWHAE;ITGA5;TOPORS;CSNK2A1;RASA1;TXNDC5;TGFB3;SFPQ;MRE11;CITED2;SIX1;BFAR;WNT5A;PHIP;NR4A2;PRKAA1;CX3CR1;SOD2;AREL1;TRAF6
prerank,striated muscle cell development (GO:0055002),0.427146833746595,1.112241918372514,0.32489451476793246,0.7412515673843402,1.0,3/14,8.44%,MYH6;PGM5;TMOD1
prerank,muscle cell development (GO:0055001),0.35970964050315635,1.112040788146864,0.29324894514767935,0.7405870064963388,1.0,9/30,12.17%,SGCZ;RAMP2;BIN1;MYH6;SLC8A1;DYSF;NRAP;TCAP;MEGF10
prerank,cellular response to cytokine stimulus (GO:0071345),-0.24564528120010487,-1.1120320578630833,0.13627254509018036,0.6041701865121331,1.0,94/416,19.26%,PTPN13;COL1A2;DPYSL3;NFAT5;PID1;SMAD3;GAB2;ADAMTS12;LEPR;NFKB1;IL34;ZFAND6;ZEB1;FOXC1;GRB10;VIM;AXL;IL6ST;IL31RA;FOXO3;GHR;PTGIS;JAK1;PTPN14;GSK3B;GSDME;KIT;RIPOR2;SYNCRIP;TBK1;IRAK3;LBP;PTPN9;ITGB1;IL13RA1;SBNO2;RC3H1;STAT3;ASAH2;SHC1;BCL2;IL16;ANXA1;IRAK2;DHX9;F3;INPPL1;UBE2K;WNK1;PTPN12;UPF1;FER;PTPN2;SLC12A2;RHOA;HIF1A;ABL2;GREM2;STX4;CNTFR;RORA;NUMBL;MMP2;TPR;TEC;IL6R;YBX3;FN1;IRF1;TYK2;GBP3;STAT1;VEGFA;DUSP1;DAPK1;IFNGR1;IL18;STAT5A;PIK3CD;GBP7;GBP2;NPR2;TLR4;PRKACA;WNT5A;STAT5B;HNRNPU;NPNT;TRAF6;TANK;INPP5K;SMPD4;GBP6;PTPN11
prerank,peptide cross-linking (GO:0018149),-0.3882260438826858,-1.111773725892291,0.33524904214559387,0.6042846232515985,1.0,4/25,12.79%,COL3A1;THBS1;ANXA1;FN1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.482247568749052,1.1116121723912962,0.3367983367983368,0.7405887054369203,1.0,6/10,16.46%,ISG15;RPS27A;UBC;UBB;CHFR;NEDD8
prerank,membrane repolarization (GO:0086009),-0.43556744756860355,-1.1115930257874378,0.3233644859813084,0.6042063543831881,1.0,2/15,7.68%,ATP1A2;KCNJ2
prerank,positive regulation of neuron death (GO:1901216),-0.33163519435938293,-1.1114890496320542,0.269449715370019,0.6039554206741159,1.0,7/46,7.74%,EPHA7;EFNB2;FOXO3;NUPR1;GSK3B;REST;MAP3K5
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.27379952136518465,-1.111427103630759,0.2164750957854406,0.603586735170547,1.0,44/144,22.88%,ZIC1;TCF7L2;SMAD3;CEMIP;PCM1;XPO4;GSK3B;FLNA;SAE1;HUWE1;UBR5;BCAS3;CDH1;TFDP2;BCL2;ABLIM3;PCNT;RAPGEF3;VAMP2;JUP;BAG3;LEPROT;PRKCD;MAVS;TPR;NPEPPS;FBXW7;YWHAE;EMD;EFCAB7;ANP32B;ICE1;UBL5;SEC16B;UBE2D3;FIS1;SEC16A;TOMM7;PIK3R1;ARIH2;AKT2;KCNB1;CHP1;ZFAND1
prerank,lung epithelium development (GO:0060428),-0.4975503032616432,-1.1110929516462618,0.3399602385685885,0.6039343637433489,1.0,3/10,2.70%,ERRFI1;PKD1;BMP4
prerank,glycolipid metabolic process (GO:0006664),0.3274357679984798,1.1109583298854184,0.27944111776447106,0.7411960485263493,1.0,18/47,21.61%,ST6GALNAC3;ST3GAL6;B4GALNT1;NEU2;ARSA;GLA;SMPD1;ST8SIA6;CPTP;GALC;PIGW;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,cellular response to ketone (GO:1901655),-0.3535590999617687,-1.1108054102019087,0.3056092843326886,0.6041552070386638,1.0,8/35,7.97%,ROCK2;ADCY5;KLF9;NR3C1;ADCY1;LARP1;ADCY6;AR
prerank,positive regulation of viral transcription (GO:0050434),-0.38270278092666005,-1.1106680036651764,0.3160919540229885,0.6039810316124422,1.0,13/25,28.25%,MDFIC;CCNT1;DHX9;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3412147689661602,-1.1105621095299412,0.2891089108910891,0.6037364879866309,1.0,7/39,10.03%,EGFR;ERRFI1;RNF115;PTPN3;CDC42;PTPN12;PTPN2
prerank,negative regulation of protein polymerization (GO:0032272),0.37400816632702755,1.1105516290292463,0.3201754385964912,0.7411049376453415,1.0,7/27,9.44%,KANK3;MAP2;STMN1;SNCA;TUBB4A;STMN2;CYRIB
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29198017094521755,-1.1103434621759016,0.2434077079107505,0.6037706959434541,1.0,34/96,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.35707572824223227,1.1097947074110175,0.2842535787321063,0.7421962095984292,1.0,4/32,4.57%,GRM5;PGAM1;RPL10;NANOS3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.4226737474447998,-1.1097610729790022,0.2966417910447761,0.6046350382637375,1.0,6/16,27.42%,DICER1;HMGB1;H1-0;EXOG;DNASE2;CECR2
prerank,error-prone translesion synthesis (GO:0042276),0.4014752819185917,1.109424911809325,0.30417495029821073,0.7420288734589489,1.0,9/21,19.16%,RPA3;RPS27A;UBC;POLK;UBB;RFC4;RFC5;RFC2;POLI
prerank,establishment of endothelial barrier (GO:0061028),0.3691635975332198,1.109394245133627,0.3232758620689655,0.7408362881834882,1.0,11/29,16.88%,ROBO4;PDE2A;PPP1R16B;PECAM1;RAB1B;TJP1;MARVELD2;PDE4D;RAP1A;SOX18;RAP2B
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.37441304392666713,-1.1091972128481593,0.2978723404255319,0.6055203754828498,1.0,8/25,19.37%,PARVA;ITGAV;ITGB1;CXADR;JUP;ITGA5;ITGA4;ITGB3
prerank,cellular response to hormone stimulus (GO:0032870),-0.31268207895705796,-1.1090990977929371,0.2625482625482625,0.6052304432996797,1.0,15/69,11.68%,ATP1A2;THRB;KLF9;GHR;NR3C1;CTSH;BCAS3;TFPI;STAT3;RAMP1;AR;NCOA1;MED1;SLC5A5;MEF2C
prerank,neuromuscular process (GO:0050905),0.4325601521852737,1.108897285766492,0.3225806451612903,0.740953461726264,1.0,4/16,18.47%,NRXN1;DCTN1;GCH1;KCNA1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.38449606421844884,-1.108756316904999,0.31467181467181465,0.6056048868493268,1.0,8/24,12.58%,BOC;CDON;CTNNA1;ABL1;MEF2A;CDC42;MEF2C;TCF3
prerank,response to peptide (GO:1901652),0.3513549535105057,1.1086364776414281,0.27897838899803534,0.7404295975528906,1.0,3/33,1.58%,CACNA1A;CACNA1B;MMP12
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.325793209294488,1.107990623150489,0.27555555555555555,0.741134320831957,1.0,11/52,8.49%,KHDRBS2;RBFOX3;NOVA2;CELF5;RBFOX1;CELF4;RBM11;KHDRBS3;SRRM4;RBM15B;SRSF12
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.4012321279130985,-1.1078653374974738,0.32761904761904764,0.6073613599671094,1.0,8/20,30.48%,FKBP5;PPIH;PPWD1;NKTR;PPID;PPIC;PPIL1;PPIF
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2779848695909429,-1.107725297503861,0.24806201550387597,0.6071998918031442,1.0,24/121,12.73%,BMP6;IGF1;IL34;ANGPT1;IL6ST;IL31RA;GHR;ABL1;VTN;DLG4;KIT;PIBF1;PAK2;STAT3;NRP1;NOX4;LYN;EPHA4;IGF2;PARP14;PARP9;HES1;TEC;IL6R
prerank,response to interleukin-1 (GO:0070555),-0.3058948982463617,-1.107708490666624,0.2661596958174905,0.6067294760358922,1.0,15/73,19.78%,ADAMTS12;NFKB1;PTGIS;HDAC4;IRAK3;RC3H1;ANXA1;IRAK2;UPF1;HIF1A;GBP3;GBP2;TRAF6;TANK;IRAK1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.4144662087156519,1.107604989174824,0.3145833333333333,0.7409428344181133,1.0,6/17,14.32%,CD33;MAGI2;HSP90AB1;CALM1;CALM2;CALM3
prerank,monosaccharide transmembrane transport (GO:0015749),-0.42683214447129114,-1.1073462283996773,0.32136105860113423,0.607154217448547,1.0,2/16,6.74%,SLC5A3;SLC2A12
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.37135588010585624,1.1073071062561326,0.3067226890756303,0.740543697026912,1.0,6/27,10.86%,GRM1;HTR2C;GPR35;GPR17;F2RL2;F2R
prerank,T cell mediated immunity (GO:0002456),-0.4497126426171867,-1.1072807840225465,0.3475836431226766,0.6067932936925929,1.0,3/13,5.14%,JAG1;CD55;CTSH
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4322090486100976,1.1072010205737217,0.3275862068965517,0.739589117702345,1.0,6/16,20.08%,KCNC2;NOS3;NDNF;CD36;DDAH1;AGT
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.39971704584152534,-1.1071072557794215,0.3196078431372549,0.6066886592094763,1.0,4/21,3.09%,ROCK2;ROCK1;BCOR;ENPP1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.36051548149057894,1.1067365799857745,0.296218487394958,0.7397086000329403,1.0,11/34,14.32%,PDE4B;RYR2;SLC8A1;ADRA1A;RNF207;CALM1;SMAD7;PDE4D;ATP1B1;CALM2;CALM3
prerank,positive regulation of insulin secretion (GO:0032024),-0.35093206227175827,-1.1064906429702595,0.29902912621359223,0.6077368087638864,1.0,11/36,20.69%,TCF7L2;MCU;NLGN2;RBP4;GLUD1;NNAT;STX4;TRPM4;ANO1;C2CD2L;ACSL4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.45375474515213277,1.106452484356753,0.33853006681514475,0.7392768580226704,1.0,3/12,6.77%,TIRAP;MBP;KLF4
prerank,autophagosome organization (GO:1905037),-0.3213532231563805,-1.106431106266749,0.2490566037735849,0.6073712449181835,1.0,21/50,26.44%,UBXN2B;UBQLN1;RB1CC1;WIPI1;ATP2A2;ULK2;BECN1;ATG2A;PIK3C3;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;WIPI2;ATG14;MAP1LC3A;RAB7A;IRGM;STX12;ATG3
prerank,ncRNA transcription (GO:0098781),-0.4516308017130548,-1.106381754530722,0.36363636363636365,0.6069982046101633,1.0,9/13,38.98%,CAVIN1;BRF1;SNAPC3;SPIN1;GTF3C1;POLR1G;GTF3A;ANG;SNAPC2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.34413283962917907,-1.1063470555212505,0.2984189723320158,0.6065732161943085,1.0,13/39,15.01%,ROCK2;ROCK1;SNCAIP;RAP1B;PARP10;TRAF2;HCFC1;HJURP;SPTY2D1;GFAP;APOE;LATS1;RAPGEF2
prerank,positive regulation of cell projection organization (GO:0031346),0.28600138575721806,1.1061842733751441,0.2504930966469428,0.7388425242334339,1.0,27/115,12.14%,RIT2;PTPRD;LRRC7;IL1RAPL1;PLXNB3;S100A9;ITGA6;MAGI2;TOX;GRIP1;NTRK2;SCARF1;FUT9;NPTN;PLPPR5;TENM3;NDNF;SCARB2;PLXNA4;ROBO2;STMN2;CDKL5;RELN;DAB2IP;FZD4;DVL1;RET
prerank,protein oxidation (GO:0018158),-0.4714121275046555,-1.106013514354077,0.32941176470588235,0.6068490815855864,1.0,5/11,22.10%,LOXL1;LOX;LOXL3;TMX3;SUMF1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.33471005755427313,-1.105674825717887,0.2937625754527163,0.6072001886976678,1.0,17/45,23.39%,IGF1;PDGFRA;SKI;DHX9;PARP10;PDGFC;S100A6;FN1;EMD;WNT5A;MORC3;B4GALT7;CDC73;CDK6;SPHK1;CD300A;NLRC3
prerank,cholesterol transport (GO:0030301),-0.3329022996694893,-1.1055331665492603,0.28346456692913385,0.6070262365412429,1.0,8/45,14.09%,ABCA1;LIMA1;SOAT1;OSBPL5;LDLR;RELCH;NPC2;APOE
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4563419380554584,1.1053461119054526,0.33406593406593404,0.7388369137559144,1.0,2/10,8.96%,AP2M1;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4563419380554584,1.1053461119054526,0.33406593406593404,0.7388369137559144,1.0,2/10,8.96%,AP2M1;AP2B1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.36294606122362466,-1.1051677601847676,0.28544061302681994,0.6074370658305522,1.0,8/29,11.94%,GTF2H2;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;ERCC3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.470500994972563,1.105153910315131,0.3516949152542373,0.7381794528886965,1.0,5/10,19.19%,RUVBL1;PIH1D2;ZNHIT6;NAF1;NUFIP1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.33696262959758577,1.104773732131104,0.288135593220339,0.7381216990494294,1.0,9/44,7.97%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4464684584165439,-1.103609821136459,0.34750462107208874,0.6108960591480643,1.0,7/13,31.94%,LRRK2;TXN;PARK7;HGF;MET;NFE2L2;PDE8A
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24954054009090781,-1.1034701556157172,0.18220338983050846,0.6107465960844418,1.0,78/308,19.36%,LRP1;SMAD3;TGFBR1;SOX5;APPL2;PTN;BMPR1A;FOXD1;LEPR;COL1A1;ABCA1;SMURF2;FOXC1;GRB10;DAB2;ROCK1;BMP4;GHR;PDPN;ACSL1;SMO;TGFBR2;KMT5B;NUMA1;ALMS1;ADRA1B;PLA2R1;RREB1;NIBAN2;LBP;TGFB1I1;PPARGC1B;SMAD2;BCL9L;ZBTB16;VAMP7;MTOR;REST;PPARGC1A;GJA1;MED1;CPT2;PDGFC;SMAD4;SHLD2;PRKAB2;GNAS;EHMT1;OGT;KMT5C;TRPM4;SOX6;EIF2AK2;APOE;SLC27A1;VEGFA;ACVR1;ZBED3;KDM3A;GLIPR2;C1QTNF3;TGFB3;DYNC1H1;CMKLR1;ADRA2A;IL18;SERPINE1;SIX1;PIK3CD;WNT5A;TRPV2;B4GALT5;GCNT2;INPP5K;BMP2;ABCA7;PTPN11;INHBA
prerank,morphogenesis of an epithelium (GO:0002009),-0.37365246769526006,-1.1033946266866117,0.342911877394636,0.6104295174295189,1.0,6/25,11.59%,DAG1;VCL;LRP6;FGFR2;LAMA3;TBX18
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4844878878131518,1.1027984406811862,0.33266932270916333,0.74267229573949,1.0,3/10,9.89%,SEMA6A;IL12A;DAB2IP
prerank,cellular response to fatty acid (GO:0071398),-0.46442103812234714,-1.102701032846656,0.3475836431226766,0.6116807585437516,1.0,2/12,4.52%,PID1;IRS1
prerank,glial cell development (GO:0021782),0.3774826991975735,1.1026825316866953,0.2987551867219917,0.7417718701556512,1.0,8/25,16.78%,S100A9;TLR2;NSUN5;EIF2B3;TPPP;DLL1;SOX4;HES5
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4557275047425212,-1.102675754626288,0.3474903474903475,0.611229961819475,1.0,2/12,5.46%,LIMA1;PLEKHH2
prerank,regulation of vasoconstriction (GO:0019229),0.38014523392451516,1.1026252460238186,0.3081510934393638,0.7406956618959771,1.0,8/27,12.88%,CHRM3;KCNMB2;KCNMB4;ADRA1D;ADRA1A;F2R;PER2;BMPR2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.29415516631541794,-1.102177550043612,0.2782931354359926,0.6119690779492685,1.0,21/84,14.34%,CELF2;RBFOX2;SON;DDX5;CELF1;RBM39;MBNL2;SFSWAP;DDX17;KHDRBS1;WTAP;SRSF10;U2AF2;SRSF6;REST;HNRNPK;DAZAP1;YTHDC1;CWC22;NSRP1;RBM5
prerank,endothelial tube morphogenesis (GO:0061154),-0.4786827524149091,-1.1019315140682933,0.3645621181262729,0.6120788129621622,1.0,3/10,10.27%,RBPJ;BMP4;RHOA
prerank,positive regulation of phospholipid transport (GO:2001140),0.48097078090072487,1.1017898598847709,0.34511434511434513,0.741993956934545,1.0,3/10,14.68%,TMEM30A;ABCB4;DBI
prerank,regulation of translational initiation (GO:0006446),-0.3009367327723095,-1.1017704464739693,0.2821497120921305,0.6119591395876972,1.0,20/63,19.58%,EIF4G3;YTHDF3;KHDRBS1;EIF4A2;EIF2AK3;LARP1;IMPACT;CSDE1;DNAJC3;ALKBH1;TPR;EIF2AK4;CDC123;NCK1;DDX3X;NCK2;PAIP1;MIF4GD;EIF4G1;RBM4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.43036930322633293,-1.101494415414349,0.34345351043643263,0.6121267073302594,1.0,4/15,9.06%,FOXC1;BMP4;NUMA1;MED1
prerank,protein glycosylation (GO:0006486),0.2782578345813309,1.1010765272762275,0.26095617529880477,0.7428777328534044,1.0,30/125,16.10%,ST8SIA4;GAL3ST1;GALNT9;MGAT5B;AQP11;ST3GAL6;EOGT;GALNT6;ST8SIA1;FUT9;ALG3;PMM1;PLOD3;B3GALT5;ALG1;MGAT4C;MPI;SLC39A8;ST8SIA6;B3GNT2;TMEM258;ST8SIA3;SERP1;ALG8;GALNT2;POMGNT2;GOLGA2;POMGNT1;POGLUT1;MGAT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.42422119391691243,-1.1008069964872145,0.3576923076923077,0.6133182819737348,1.0,3/17,3.94%,AKAP13;ADCY9;ADRA1B
prerank,arachidonic acid metabolic process (GO:0019369),-0.34769080927332663,-1.100751459410634,0.2982456140350877,0.6129612352395647,1.0,10/35,15.83%,PTGDS;PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PTGES;PNPLA8;EPHX1;EPHX2
prerank,regulation of cell projection organization (GO:0031344),0.44545813378087334,1.1006338534086002,0.34237995824634654,0.7430427147608735,1.0,4/13,8.90%,MFSD2A;SEMA4D;NTNG1;NTNG2
prerank,regulation of protein kinase A signaling (GO:0010738),0.3960897219602476,1.100438988508146,0.3326226012793177,0.7423589912116841,1.0,3/20,3.16%,PRKAR2B;MIF;AKAP6
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.3745166676942159,-1.1003612922185986,0.321011673151751,0.6133599948065435,1.0,13/26,24.56%,EIF4E;HES1;CUL3;TTL;USP2;CDC25B;CCDC57;KLHL18;PRKCA;SPHK1;HSF1;EIF4EBP1;PPP1R10
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3469581388367509,1.1002467179070905,0.3118712273641851,0.7416349125423273,1.0,12/36,18.05%,NOSTRIN;NOS3;LYPLA1;AKT1;GLA;CALM1;SCARB1;ATP2B4;GCH1;HSP90AA1;NOSIP;DDAH1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.4216231755730021,-1.1001991025146545,0.3460837887067395,0.6132357642604715,1.0,10/16,30.28%,PRPF39;SFSWAP;DDX23;SRSF1;WBP11;NCBP2;RBM22;CACTIN;SNRNP200;PSIP1
prerank,regulation of mRNA processing (GO:0050684),-0.3554491375455744,-1.1001217651504198,0.30570902394106814,0.6129145386925061,1.0,11/32,13.34%,SON;RBM39;PABPN1;KHDRBS1;SRSF10;DHX9;SAFB2;HNRNPK;CDK11B;YTHDC1;CWC22
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4917027967423532,-1.1000591801730761,0.36432637571157495,0.612049972064425,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),-0.4917027967423532,-1.1000591801730761,0.36432637571157495,0.612049972064425,1.0,3/10,3.72%,HDAC4;NCOR1;NUPR1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40342756070610225,-1.0998462399844224,0.3102189781021898,0.6120722936325796,1.0,11/18,37.88%,RNFT1;TMEM259;ERN1;NCK1;USP13;PIK3R1;BAG6;BAK1;BCL2L11;FCGR2B;RNF185
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.46603010218833973,-1.0998077565590638,0.3363309352517986,0.6111616885762109,1.0,4/11,23.36%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.46603010218833973,-1.0998077565590638,0.3363309352517986,0.6111616885762109,1.0,4/11,23.36%,TNRC6A;TNRC6C;RBM4;AGO1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4722911479286983,-1.0995118486446334,0.36213235294117646,0.611434426696566,1.0,3/11,11.68%,EFNB2;DHX36;MEF2C
prerank,cellular response to UV-A (GO:0071492),0.4637659247871035,1.0994853097979538,0.35152838427947597,0.7426357893812537,1.0,2/11,7.74%,MME;TIMP1
prerank,negative regulation of complement activation (GO:0045916),-0.47932450507056445,-1.0992164329846967,0.3381818181818182,0.6116522520642933,1.0,3/10,14.01%,SERPING1;CD55;CR1L
prerank,linoleic acid metabolic process (GO:0043651),-0.41867766194450146,-1.0991845896124774,0.34235976789168276,0.6112167325340278,1.0,6/17,27.35%,ACSL1;PNPLA8;ELOVL1;GSTM2;ALOX12;ELOVL5
prerank,carnitine shuttle (GO:0006853),-0.4752333955321002,-1.0987418566351306,0.36,0.6117971755529703,1.0,4/11,10.83%,PRKAG2;PRKAA2;CPT2;PRKAB2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.37665953159848176,1.09871780871477,0.3202479338842975,0.7424344494424004,1.0,6/22,19.53%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.37665953159848176,1.09871780871477,0.3202479338842975,0.7424344494424004,1.0,6/22,19.53%,ZDHHC22;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;ZDHHC24
prerank,mRNA transport (GO:0051028),-0.28584952418095433,-1.0986107807098744,0.23260437375745527,0.611654625571863,1.0,34/101,26.63%,SMG6;SMG1;WDR33;CASC3;RANBP2;U2AF2;CPSF3;SRSF6;NUP42;SMG7;SLU7;EIF4E;UPF1;SLBP;NUP214;YTHDC1;MCM3AP;TPR;DDX19B;SRSF1;NXF1;SRSF7;SRSF11;NUP98;SRRM1;UPF3B;SRSF2;NUP43;CPSF4;NUP160;CPSF1;NCBP2;NUP93;FYTTD1
prerank,positive regulation of cellular component organization (GO:0051130),0.28499953613060885,1.0985881869554879,0.2654690618762475,0.7416091565690988,1.0,23/107,13.89%,IGF1R;TFRC;NRXN1;TIRAP;TMEM30A;NRG1;SHANK3;ATP10A;SNCA;GPX1;TAL1;TGFB2;CLU;RELN;TPPP;DAB2IP;SMPD1;ABCB4;DCTN1;CALY;RPS3;DLL1;INSR
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3291604981889099,-1.0983182642600657,0.2977941176470588,0.6118804311230888,1.0,13/46,21.07%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,multivesicular body organization (GO:0036257),-0.3598988885459584,-1.0981142799064632,0.3125,0.6119313237500973,1.0,7/31,12.11%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,protein modification by small protein removal (GO:0070646),-0.25436979723438463,-1.0977386340744328,0.21193415637860083,0.6123506301378812,1.0,93/252,29.34%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;SENP3;WDR48;SENP7;TRRAP;BRCC3;MYSM1;SENP6;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;SENP1;RHOT1;USP47;WDR20;SENP5;PSMF1;COPS2;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;COPS8;USP50;PSMB2;USP2;OTUD4;USP13;FOXK2;TNIP2;TRAF3;USP34;ATXN7;TRAF6;VCP;DESI1;DESI2;PSMC1;SMAD1;TAF9B;TOR1A;CLSPN;SENP2;PSMB6;PSMA3;USP18;SIAH2;OTUD1;USP9X;PSMA4;USP28;INO80D;INO80C;ACTR5;MBD6;ABRAXAS1;PSME1;ADRB2;PSMD13;USP19;ESR1;TNFAIP3;GPS1;RCE1;PSMB10;PSMA5;PSMB9;BIRC3;FOXO4
prerank,organonitrogen compound catabolic process (GO:1901565),-0.3153610014617257,-1.0976387405031953,0.28330206378986866,0.6120781431552167,1.0,16/57,24.03%,CPQ;MTOR;ANPEP;RENBP;PLA2G4A;PDXDC1;GGACT;PNPLA8;NPEPPS;LNPEP;LRSAM1;CLN5;BCKDK;SMPD2;TXN2;CLPX
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2589861354936352,1.0976196991026075,0.23265306122448978,0.7433834673737919,1.0,34/214,10.86%,TEK;ERBB4;TIRAP;PTPRR;CSF1R;EPHB1;NECAB2;SEMA6A;MIF;SPRY3;CNKSR3;DUSP6;HTR2C;CAMK2N1;GAS6;KDR;FGF10;NTRK2;WNK2;SEMA7A;NOTCH1;P2RY1;ZDHHC17;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;DAB2IP;PDGFB;LMO3;ATP6AP1;F2R
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.40123199077379784,-1.0975828119857194,0.3333333333333333,0.6117185589067586,1.0,5/20,12.97%,ITGAV;GSK3B;BCL2;CASP2;APPL1
prerank,autophagy of mitochondrion (GO:0000422),-0.34086790242621456,-1.0970519338878497,0.29672447013487474,0.6124790387192416,1.0,18/38,26.44%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;ATG14;MAP1LC3A;PHB2;ATG3
prerank,bicellular tight junction assembly (GO:0070830),0.3312576376381786,1.0968424108167056,0.2872340425531915,0.7444416728744266,1.0,9/46,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3561384484243303,-1.0967880421089777,0.3193916349809886,0.6126009192388947,1.0,7/33,10.52%,SMAD3;TEAD1;FOXO3;NR3C1;STAT3;JUN;HIF1A
prerank,protein homotrimerization (GO:0070207),-0.42911885376760844,-1.0966086254773053,0.32220039292730845,0.6119950236527257,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,protein trimerization (GO:0070206),-0.42911885376760844,-1.0966086254773053,0.32220039292730845,0.6119950236527257,1.0,4/14,3.98%,CLYBL;SLC1A5;DISP1;SCARA5
prerank,protein heterotetramerization (GO:0051290),0.4358488454677062,1.0961157023618842,0.32790224032586557,0.7453909156346015,1.0,3/13,11.08%,GRIN1;GRIN2B;FARSB
prerank,histone H2A monoubiquitination (GO:0035518),-0.4060979375838346,-1.0960964410721803,0.3351749539594843,0.6127802108912096,1.0,4/17,11.85%,BCOR;DDB2;PCGF2;PCGF6
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.32310605914878043,-1.0957411252515756,0.30210325047801145,0.6131559400056112,1.0,8/52,7.95%,EGFR;LRP1;SORBS1;EPHA3;PTPN9;DLG1;ITGB1;PDPK1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4303049953541245,-1.0957381422926011,0.3505747126436782,0.6126586549161441,1.0,7/15,10.56%,PDGFRA;NTRK3;PDGFRB;ABL1;KIT;PLCG1;ABL2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4846575508766618,-1.095738003912808,0.3768939393939394,0.6121572975880621,1.0,6/10,32.26%,LRRK2;TXN;PARK7;NFE2L2;PDE8A;STK26
prerank,glycosphingolipid metabolic process (GO:0006687),0.33532654355737607,1.095543631049515,0.3225152129817444,0.7459265233598577,1.0,18/42,21.61%,ST6GALNAC3;B4GALNT1;NEU2;ST8SIA1;B4GALT6;ARSA;GLA;SMPD1;ST8SIA3;CPTP;GALC;GLB1;HEXB;NEU1;NEU4;PSAP;ESYT2;SUMF2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4084592399087408,1.0954809304676016,0.3392070484581498,0.7448803228244469,1.0,5/17,13.90%,PODXL;TGFB2;SKAP1;RET;CIB1
prerank,cellular response to increased oxygen levels (GO:0036295),0.460674700822329,1.0952127544184813,0.346723044397463,0.7444486308896515,1.0,4/11,14.85%,ATP6V1A;ATP6AP1;FOXO1;TMEM199
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3977936282265899,1.0951745123924863,0.3310657596371882,0.7433324368249893,1.0,7/20,10.22%,PROX1;CCND1;MAPRE3;HSP90AB1;AKT1;CCNY;PDGFB
prerank,regulation of wound healing (GO:0061041),-0.3324077953810255,-1.0946841801446228,0.31226053639846746,0.6142208551504779,1.0,12/42,21.57%,MYLK;VTN;ITGB1;ARFGEF1;ANXA1;SRSF6;CD109;ADRA2A;SERPINE1;HBEGF;CLDN1;FGF2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.3555786120127769,-1.094572273481615,0.310546875,0.614019534271433,1.0,14/30,32.32%,PIGN;PIGK;DPM1;PIGS;GPAA1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,multivesicular body assembly (GO:0036258),-0.3607171886269166,-1.094393787334339,0.32706766917293234,0.6139511192263469,1.0,7/30,12.11%,VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;VPS37C;RAB11A
prerank,cell junction organization (GO:0034330),0.30329535078150455,1.0943883033113044,0.27010309278350514,0.7445474766374235,1.0,22/71,15.67%,GRM5;ACTB;CTNND2;SNCA;OCLN;PPFIA3;TGFB2;ELFN1;WNT7B;RAB39B;VMP1;APBB2;PPFIA2;TJP1;DVL1;MARVELD2;PPFIA4;SNCB;PSEN1;PAK3;NLGN3;CBLN2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.39708770205978855,-1.0941352707164518,0.36247723132969034,0.614100026001215,1.0,3/20,2.59%,PID1;RHOQ;DAB2
prerank,regulation of cell growth (GO:0001558),0.25866462457332173,1.0939495232003473,0.22587268993839835,0.7446990733145398,1.0,41/204,14.84%,NRG3;TFRC;SPOCK1;MINAR1;S100A9;S100A8;AKAP6;SIRT1;GNG4;APBB1;OGFR;MFSD2A;PAK5;SCGB3A1;PPP2R1A;TGFB2;SLIT3;PRKCQ;WFDC1;MELTF;PTPRJ;ACVRL1;RPS6KA1;AKT1;SGK3;H3-3A;TAOK2;NET1;APBB2;IL17RB;CEP43;SOX17;NDUFA13;BMPR2;BCAR1;CIB1;LGI1;SMARCA2;CDKN1A;PPT1;RTN4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.40401135631755536,-1.0937730202503984,0.3228200371057514,0.6145046529665916,1.0,7/20,22.55%,LBP;LYN;PTPN22;IL18;TLR4;IRAK1;TICAM1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34275946855951994,-1.0933529609696446,0.3246268656716418,0.6150583782997768,1.0,10/36,16.04%,NCOR1;PRKN;DLG1;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP1;DUSP10
prerank,insulin secretion (GO:0030073),0.398327805057931,1.0931713086112467,0.3291139240506329,0.7458062388439767,1.0,3/19,7.53%,PTPRN2;RIMS2;ADCYAP1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.45438710431872653,-1.0930828897253753,0.373046875,0.6152099072855604,1.0,7/12,32.24%,DHX9;MAVS;MUL1;CGAS;IFIH1;CAV1;ZCCHC3
prerank,histone mRNA metabolic process (GO:0008334),-0.3685588815849778,-1.0930492929494031,0.34462151394422313,0.6148097361599495,1.0,8/27,18.75%,TENT2;CPSF3;TUT4;UPF1;SLBP;XRN1;EXOSC10;SNRPF
prerank,regulation of microtubule nucleation (GO:0010968),0.48328677815440835,1.0930388535509257,0.3333333333333333,0.7449630541619437,1.0,5/10,19.29%,GIT1;PAK1;DCTN1;ARHGEF7;MECP2
prerank,acylglycerol homeostasis (GO:0055090),-0.38660652411815455,-1.0929987158701056,0.3333333333333333,0.6144228262376233,1.0,8/20,30.78%,NR1H3;RORA;PNPLA8;APOE;IL18;LPL;MLXIPL;ANGPTL3
prerank,membrane depolarization during action potential (GO:0086010),-0.3721898525390296,-1.0926436842234006,0.34689922480620156,0.614810040344627,1.0,5/26,7.81%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1D
prerank,positive regulation of immune effector process (GO:0002699),-0.36654268852268546,-1.0925767953584904,0.31690140845070425,0.6144760571456873,1.0,4/27,10.34%,APPL2;ANKRD17;LBP;DDX60
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.35127243980399514,-1.0924821570903636,0.324,0.6142258393548324,1.0,9/34,17.55%,SMAD3;ENPP1;YAP1;RUNX1T1;RORA;TRIB2;ANKRD26;TRIO;WNT5A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3268332371443378,-1.0922856637251668,0.312621359223301,0.6142274308072371,1.0,17/46,21.48%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,regulation of angiogenesis (GO:0045765),0.26216056464743087,1.0922481555489933,0.23976608187134502,0.7461648042556276,1.0,27/192,8.43%,FLT1;CLDN5;TEK;IL17F;MINAR1;ADAM12;TIE1;SEMA6A;RAMP2;ADGRB1;HTATIP2;SIRT1;NAXE;TSPAN12;HMGA2;PPARG;PPP1R16B;KDR;NOS3;TGFB2;ETS1;KLF4;APLNR;NINJ1;GPNMB;CD34;HSPB1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4148907132578409,1.0919365275724042,0.3240343347639485,0.7458772469737623,1.0,8/17,21.29%,NDUFA4;COX4I1;COX6A1;COX6B1;COX7C;COX10;COX8A;COX5B
prerank,secondary alcohol metabolic process (GO:1902652),-0.3332595950729321,-1.0918956808898748,0.3106212424849699,0.6146647561635326,1.0,17/42,34.61%,ABCA1;CYP27A1;SOAT1;OSBPL5;APOE;RXRA;SQLE;FDX1;GBA2;SCAP;CLN8;TSKU;ANGPTL3;CLN6;IDH2;CH25H;LCAT
prerank,phosphatidic acid metabolic process (GO:0046473),-0.32519836683269393,-1.0911539905795482,0.304029304029304,0.6160175155341507,1.0,13/48,21.07%,PLD1;GNPAT;DGKA;AGPAT4;DDHD1;ABHD5;GPAT4;PLA2G4A;SLC27A1;GPD1L;LPCAT1;GPAT3;DGKD
prerank,response to lipid (GO:0033993),0.2821327376029572,1.0910713074273923,0.2814498933901919,0.7472171824476839,1.0,25/105,15.14%,TIRAP;S100A9;S100A8;ACER2;PPARG;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;SLPI;GGT7;F2R;SCD;GGT1;FOXO1;CD36;TAB2;PAQR8;RXRG;PELI1;HSD17B2;GCH1;MAPKAPK2
prerank,steroid hormone biosynthetic process (GO:0120178),0.36833956831621867,1.0910157335726665,0.325626204238921,0.7461550120006798,1.0,10/29,19.40%,SRD5A2;HSD17B7;FDX2;TSPOAP1;TSPO;HSD17B2;DHCR7;STARD3NL;STARD3;SRD5A1
prerank,natural killer cell mediated immunity (GO:0002228),-0.43484098275770217,-1.0907203495134479,0.3314176245210728,0.6166301739992972,1.0,5/15,30.63%,CEBPG;PLEKHM2;KIF5B;ULBP1;RAET1E
prerank,cardiac muscle contraction (GO:0060048),-0.34757680211995495,-1.0905152311931643,0.3198458574181118,0.6166548790090307,1.0,3/34,1.44%,ATP1A2;GSN;TPM1
prerank,negative regulation of TOR signaling (GO:0032007),-0.34664719124381677,-1.0902892625104195,0.3068181818181818,0.6167585134224307,1.0,12/36,19.75%,RNF152;UBR2;PRKAA2;DEPTOR;TMEM127;SESN1;UBR1;FNIP1;CASTOR2;NPRL3;PRKAA1;TBC1D7
prerank,regulation of urine volume (GO:0035809),-0.47607457945713877,-1.0901871312662148,0.38415841584158417,0.6165463583506646,1.0,4/10,24.90%,NPR3;ADCY6;INPP5K;ADM
prerank,cellular response to glucagon stimulus (GO:0071377),0.4133864346368231,1.0889140186758066,0.33880903490759756,0.751155595385241,1.0,3/17,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,calcium-mediated signaling (GO:0019722),-0.2876152917246755,-1.0888264772015368,0.2958015267175573,0.6193766956388116,1.0,24/93,18.08%,CACNA1C;EGFR;ANK2;PLCE1;MCU;LRRK2;NUDT4;SLC9A1;CCR9;ADGRL1;EIF2AK3;TPCN2;PDPK1;PLCG1;DMPK;ATP2A2;AGTR1;TRPM4;P2RY12;P2RX4;PRKACA;PRKAA1;CX3CR1;PTGFR
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.37320894456991843,1.0886238172895693,0.34475374732334046,0.7507600383836885,1.0,7/25,11.90%,AKAP6;SNCA;THY1;APLNR;CACNB2;F2R;TRPC1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.42506890814709153,-1.0883883795469729,0.3618181818181818,0.6199592085927635,1.0,5/16,14.78%,DPYSL3;UPP2;NT5M;UPB1;DPYD
prerank,sensory perception of light stimulus (GO:0050953),-0.2883691901308767,-1.0881905613722547,0.2837022132796781,0.6199389007388434,1.0,20/87,18.22%,EFEMP1;COL1A1;OPA1;EYA4;ZIC2;SLC4A10;MYO9A;EML2;ADGRV1;DHRS3;PITPNA;COL18A1;RPGR;RP2;ATF6;IMPG2;OAT;ATXN7;RABGGTB;POU6F2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.41540607426878734,-1.0881076469799869,0.33397312859884837,0.6196251188727263,1.0,8/15,37.63%,IQGAP2;ARPC2;WHAMM;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,regulation of cell killing (GO:0031341),-0.423739673513445,-1.0880736448730077,0.3491773308957952,0.6192217508616071,1.0,6/16,17.55%,CFH;CD55;FZD7;CR1L;CYBA;WNT5A
prerank,RNA interference (GO:0016246),-0.4199793716376421,-1.087847145189348,0.34990439770554493,0.6192806092080552,1.0,3/17,7.10%,CELF1;DICER1;DHX9
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.3075651733544165,-1.087248707900034,0.32514177693761814,0.6201986391754338,1.0,23/65,21.54%,MDM4;BMP7;PTGIS;LMNA;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;RORA;ACAA2;NPEPPS;PGK1;VEGFA;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;GATA6;TBL2;BNIP3
prerank,small GTPase mediated signal transduction (GO:0007264),-0.28045229082812223,-1.0872480774067033,0.27435387673956263,0.6197039952195741,1.0,33/103,24.05%,PLD1;IGF1;PLCE1;KSR1;TIAM2;RREB1;SHOC2;ARL3;BCR;MRAS;SHC1;JUN;ARHGEF18;ARHGAP32;ARFIP2;RALA;SETDB1;RB1;USP50;RAPGEF2;GNB1;ARHGAP18;ADRA2A;PRKD1;RASSF1;PARK7;CDK2;FGF2;CRKL;RIT1;CHP1;SIAH2;USP28
prerank,blood circulation (GO:0008015),-0.31784181395827915,-1.0870718849052003,0.3045186640471513,0.6196314455713086,1.0,12/49,15.56%,ROCK2;COL4A3;ROCK1;ELN;SERPING1;MEOX2;MYOF;ADCY6;GUCY1A1;AGTR1;STAT1;BDKRB2
prerank,peptidyl-threonine modification (GO:0018210),-0.30670269691892177,-1.0864211246557842,0.2996031746031746,0.6207359987729616,1.0,23/66,23.09%,ROCK2;TGFBR1;ROCK1;LRRK2;TGFBR2;GSK3B;TBK1;CAMK2D;PDPK1;MAP2K1;WNK1;HIPK1;PRKCD;PRKDC;ACVR1;CSNK2A1;PRKD1;GALNT1;CDK10;GALNT11;MAP3K12;PRKCA;CDC42BPG
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3852742651196984,-1.0860933627608826,0.3333333333333333,0.6210251882412908,1.0,9/22,28.18%,MED17;MED12;DHX36;MED1;MED16;MED13;MED14;PAXIP1;ESR1
prerank,negative regulation of cell communication (GO:0010648),0.3930452350689816,1.0858325072931523,0.3463302752293578,0.7579119427579515,1.0,4/21,11.29%,GLRA1;SRMS;OPRM1;UBASH3B
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.36554935336760885,1.0857333583421382,0.3474576271186441,0.7570022725920559,1.0,6/27,7.54%,SLC7A5;SLC7A1;SLC1A1;SLC1A2;SLC6A5;SLC7A8
prerank,regulation of protein phosphorylation (GO:0001932),-0.24940658874253113,-1.0852048216521724,0.24050632911392406,0.6227768448056256,1.0,72/256,22.02%,PTPN13;ROCK2;EGFR;PID1;PLCE1;EPHA7;LEPR;IL34;ANGPT1;SLCO3A1;LRP6;NTRK3;PELI2;FBLN1;PLPP3;FGF1;BMP7;DAB2;FAM20A;BMP4;ABL1;PRKN;LRRK2;IBTK;IGFBP3;AXIN1;NSD1;EIF2AK3;LYN;AKAP8L;IGF2;IMPACT;PLXNB2;RB1CC1;FER;BMPER;MAVS;FNIP1;PPP2R5E;FN1;FKBP8;CARD14;MOB1B;CCN1;WDFY2;PRKDC;VEGFA;PPP2R5D;CCND3;ZBED3;VEGFD;PDCL3;ARRB1;NOP53;PHIP;MYADM;PPP2R5C;CSNK1D;INPP5K;BMP2;PARK7;MUSK;ITGB3;PML;TMEM119;PPP2CA;CDK5RAP3;AKT2;DVL3;FGF2;ATG14;CRKL
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.41431923808810983,-1.0851174111397879,0.35589941972920697,0.6224982865052168,1.0,2/17,0.36%,ATP1A2;CACNA1C
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3649393336646327,1.0850844147511187,0.32934131736526945,0.7577946547302485,1.0,4/25,3.87%,DSCAM;MIF;ITGA6;SNCA
prerank,potassium ion export across plasma membrane (GO:0097623),-0.44552510829983955,-1.0848737169698648,0.35564053537284895,0.6226045899215508,1.0,2/13,6.27%,KCNT2;KCNK5
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.27028665756504877,1.08472538843176,0.2670807453416149,0.7576531426067526,1.0,23/140,11.50%,GRIN1;CACNA1A;ADCY8;GRM1;RYR2;HTR2C;CACNA2D1;SLC8A1;CD24;TACR1;NPTN;GPR35;P2RY1;CIB2;ADCYAP1;ACKR4;GPR17;ADRA1D;ADRA1A;F2RL2;F2R;JPH3;P2RX7
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.36628265943922284,1.0846434744640276,0.3223684210526316,0.7566793453385685,1.0,10/25,18.05%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,peripheral nervous system development (GO:0007422),0.3792395121349621,1.0841684418227306,0.3292181069958848,0.7568639834349498,1.0,3/23,6.54%,ASIC2;ADGRB1;NFASC
prerank,protein localization to cell periphery (GO:1990778),0.2707896330603482,1.084079810660541,0.2887189292543021,0.7558984266800943,1.0,19/133,7.36%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;LIN7A;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2
prerank,response to cAMP (GO:0051591),0.34357153263827056,1.0839334947747366,0.34279918864097364,0.755145705305617,1.0,5/37,6.29%,HCN1;AQP9;AKAP6;PDE2A;HCN2
prerank,peroxisomal membrane transport (GO:0015919),-0.3726121539931301,-1.0838245114114837,0.3374485596707819,0.6247976677682519,1.0,14/27,32.19%,ABCD3;PXMP4;ABCD2;PEX6;ABCD4;SLC25A17;PEX7;FIS1;PXMP2;PEX26;PEX11B;PEX10;PEX16;RAB8B
prerank,mucosal immune response (GO:0002385),0.4153691612255147,1.083772196836184,0.34237995824634654,0.754399215117599,1.0,15/15,58.50%,DEFA6;RNASE3;OTUD7B;PLA2G1B;RPL39;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;IFNLR1
prerank,positive regulation of calcium ion import (GO:0090280),0.43893943894382365,1.083712306330885,0.34080717488789236,0.7533751298212138,1.0,3/12,10.22%,CXCL12;CCL2;PDGFB
prerank,heme biosynthetic process (GO:0006783),0.3888634060213005,1.0836389556134953,0.3277310924369748,0.7523808953095615,1.0,8/22,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,negative regulation of cell cycle (GO:0045786),-0.2959223924881558,-1.0828948065418458,0.2681992337164751,0.6265967999684317,1.0,23/73,23.94%,NR2F2;SMAD3;FOXC1;BMP7;BMP4;NUPR1;GAS1;PTPN3;PTPRK;BTG3;RB1;CDK5RAP1;DUSP1;LATS1;PDCD4;NR4A1;BMP2;INHBA;CDKN1C;CDK6;SCRIB;ANGEL2;TFAP4
prerank,superoxide metabolic process (GO:0006801),-0.3599100629527116,-1.082648517370158,0.3351449275362319,0.6266739618976035,1.0,12/29,28.60%,SH3PXD2B;CYB5R4;NOX4;SH3PXD2A;SOD3;CYBA;SOD2;NCF2;PRDX2;CCS;ALOX12;MT3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3672901749304667,-1.0826452605940546,0.3511450381679389,0.6261837946151003,1.0,6/27,12.89%,VPS13A;GBF1;VPS13D;OBSL1;COG7;VPS13C
prerank,SNARE complex assembly (GO:0035493),-0.46997236404485293,-1.081901504283486,0.375,0.6275150394579536,1.0,4/10,17.94%,UVRAG;STXBP1;VAMP2;VAMP4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.4689722544068272,1.0818443161743843,0.35698924731182796,0.7566674512785234,1.0,3/10,11.24%,KNSTRN;SPAG5;APC
prerank,regulation of cell differentiation (GO:0045595),-0.26441973898621307,-1.0817796141195755,0.2638888888888889,0.6273185531385833,1.0,33/148,17.47%,PHLDB2;SMOC1;TGFBR1;DAG1;EPHA3;DDX5;NREP;NR1D2;ZFHX3;CCN2;ROCK1;FLOT2;DDX17;CREBBP;TRIP4;FGFR2;RUNX1;REST;ST7;AR;IGF2;NGF;ID2;SIK1;CDK5RAP1;TRPS1;EIF2AK2;TAF8;ANP32B;RUNX2;NSUN2;SIX1;PRKACA
prerank,regulation of protein acetylation (GO:1901983),-0.45352259740759915,-1.081743731805955,0.37169811320754714,0.6269132566684774,1.0,7/12,19.80%,GSK3B;RAPGEF3;FAM161A;DDX3X;CEP295;PARK7;TAOK1
prerank,platelet aggregation (GO:0070527),-0.3496481663595068,-1.0815517646013653,0.32536764705882354,0.6268801843236016,1.0,9/33,15.57%,VCL;PDGFRA;TLN1;FLNA;STXBP1;GNAS;FN1;P2RY12;FIBP
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4717895371368927,-1.0814671176847608,0.3890909090909091,0.6265949149698438,1.0,4/10,12.63%,LRP1;PTPN12;PTPN2;APOD
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.41727854211532295,-1.0802935128637965,0.3685220729366603,0.6289655889890401,1.0,5/15,17.09%,TNRC6B;TNRC6A;EIF4ENIF1;TNRC6C;CNOT1
prerank,superoxide anion generation (GO:0042554),-0.4392603890739739,-1.0802425081603437,0.3629764065335753,0.6285885699475495,1.0,4/13,27.15%,NOX4;CYBA;NCF2;ALOX12
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4836152057246315,-1.0802133196388173,0.40350877192982454,0.6281603076027082,1.0,4/10,20.84%,SOX5;ZBTB16;SOX6;PKDCC
prerank,fatty acid oxidation (GO:0019395),-0.30992457013378644,-1.080187037850505,0.318,0.6277308372029642,1.0,15/57,18.00%,ABCD3;ACADM;ACAD10;ABCD2;PPARGC1A;ACAD11;CPT2;EHHADH;ACAA2;ABCD4;SLC25A17;BDH2;ECHDC2;ACOX1;ECI1
prerank,vasodilation (GO:0042311),0.4414785897379565,1.0797140291615261,0.34394904458598724,0.7617989401205363,1.0,4/13,17.02%,ADRB1;NOS3;KLF2;KCNMA1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.39368433222591137,-1.0797027606443206,0.36329588014981273,0.6284491612386855,1.0,5/20,13.71%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4388422167112883,-1.0796787173349092,0.3532710280373832,0.6280126174010969,1.0,6/13,19.26%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;PTPN11
prerank,negative regulation of telomere maintenance (GO:0032205),-0.41595594159675897,-1.0789335757378193,0.3644859813084112,0.6294286152540842,1.0,4/15,11.62%,SMG6;TNKS2;NBN;PARP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.34676563443297675,1.0788837705477552,0.3383947939262473,0.7631576200833263,1.0,11/35,18.89%,LIG3;RPA3;UNG;APEX1;POLG;POLD1;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3016401887297803,-1.0788372146006264,0.2958015267175573,0.6291675456816819,1.0,15/69,14.14%,IGF1;GAB2;PLCE1;PDGFRA;PI4KA;PDGFRB;PLCD3;IRS1;PLCB3;NGF;PLCD1;RHOA;PITPNM2;OGT;PIK3C3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4201328365245752,-1.0786753270200422,0.37265917602996257,0.629031650214956,1.0,7/15,24.80%,PRODH;GGACT;SARDH;CHAC2;ABHD12;ALDH4A1;GGT5
prerank,synaptic membrane adhesion (GO:0099560),0.42369901390745557,1.0784900932387176,0.3659043659043659,0.763096759508439,1.0,5/14,8.89%,PTPRD;LRRC4C;LRFN5;LRRC4B;NTNG1
prerank,actin filament polymerization (GO:0030041),-0.3594080069495126,-1.0784517713941106,0.3572744014732965,0.6290731250472072,1.0,9/29,17.57%,ARHGAP6;GAS7;GSN;DIAPH1;CORO7;WASL;TTC17;WASF1;FAM107A
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4232406287427537,1.0780526735478284,0.3706140350877193,0.7632393773084437,1.0,5/14,13.24%,ANK3;WNK2;GLRX;ACTN4;ATP1B1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3344939868465733,-1.0778401883776354,0.33266932270916333,0.6300361524262266,1.0,16/37,24.29%,FHIT;USP7;RPL11;GIPC1;OGT;TRIM39;PDCL3;CSNK2A1;NOP53;PARK7;PML;WAC;CCAR2;EIF3H;BAG5;BAG6
prerank,amino acid transport (GO:0006865),0.3189737959943708,1.0775938831089342,0.2903225806451613,0.7634304027029629,1.0,7/49,9.58%,SLC7A5;SLC6A6;SLC6A17;SLC7A1;SLC7A8;SLC43A2;SLC36A1
prerank,organic cation transport (GO:0015695),-0.384878758170589,-1.0770715028828868,0.34296028880866425,0.6314496952020008,1.0,8/20,28.93%,SLC47A1;SLC22A5;SLC22A4;SEC14L1;SLC5A7;SLC22A2;SLC44A2;SLC25A29
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.42469236059918114,-1.0764585901975827,0.36804308797127466,0.6324822938958518,1.0,5/15,14.53%,DICER1;ZC3H12C;NYNRIN;KHNYN;ZC3H12B
prerank,ventricular septum development (GO:0003281),-0.3420707156318844,-1.0764314157068908,0.324,0.6320574741717497,1.0,13/37,16.75%,TGFBR3;TGFBR1;BMPR1A;MDM4;ROBO1;TGFBR2;SMAD4;HES1;ACVR1;SALL1;HECTD1;HEYL;CITED2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4053694062073578,-1.0762305477612977,0.35260115606936415,0.6320562731074353,1.0,4/17,8.83%,FSTL1;SULF1;TWSG1;XIAP
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4141217170215399,-1.0759445373522323,0.36398467432950193,0.6322752488574134,1.0,8/16,32.69%,KAT2B;EP300;CREBBP;NAA15;NAA16;NAA80;NAA25;NAA40
prerank,detection of mechanical stimulus (GO:0050982),-0.3930210445556461,-1.0758067873598807,0.3675889328063241,0.6320958263404628,1.0,4/19,12.34%,PIEZO2;PKD1;JUP;PKD2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4771007436545308,-1.075740692077216,0.3996282527881041,0.6317434267428027,1.0,4/10,14.78%,UPP2;NT5M;UPB1;DPYD
prerank,regulation of cell division (GO:0051302),-0.2967311287373916,-1.0756830168957678,0.3173076923076923,0.6313878534293064,1.0,15/72,16.04%,MLLT3;KIF13A;FGF1;BIRC6;KLHL13;UVRAG;CSPP1;FGFR2;TXNIP;SETD2;RAB11A;BECN1;PIK3C3;PIK3R4;PRDM15
prerank,TOR signaling (GO:0031929),0.36967704682908786,1.075411280153718,0.32007952286282304,0.768903200413954,1.0,7/26,11.41%,PRR5L;RPS6;MEAK7;RPS6KB2;AKT1;EIF4EBP2;CCDC88A
prerank,regulation of innate immune response (GO:0045088),-0.3084140695616217,-1.0753134576422094,0.32061068702290074,0.6318503376176244,1.0,27/57,32.35%,APPL2;IRAK3;TRAFD1;PLSCR1;DHX9;XIAP;PTPN22;PARP9;RIOK3;APPL1;IRF1;PTPN1;IFI35;PTPN11;USP18;NLRC3;POLR3D;DHX58;CACTIN;ERAP1;MUL1;TNFAIP3;BIRC3;SAMHD1;TYRO3;PTPN6;TKFC
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4096247842782284,1.0750756201315192,0.35157894736842105,0.768701239172097,1.0,5/15,15.25%,REEP1;ARL6IP1;REEP2;RTN4;REEP3
prerank,regulation of apoptotic process (GO:0042981),-0.22695040037358272,-1.0749812301280028,0.18012422360248448,0.6321847858974826,1.0,153/676,19.06%,AKAP13;FSTL1;NOTCH2;IGF1;GRK5;FHL2;EGFR;PAWR;ARHGAP10;SON;NFKB1;ANGPT1;SMAD6;OPA1;ZFAND6;STEAP3;ARAF;CFLAR;AXL;IL6ST;DAB2;IL31RA;FOXO3;STK3;BMP4;TIAM2;ERC1;PDPN;ABL1;TAX1BP1;PRKN;BIRC6;OSR1;PRKAA2;ARHGEF17;NUPR1;GSK3B;STK17B;NIBAN2;FLNA;RARG;IGFBP3;ANXA4;ANXA5;HMGB1;ITGB1;CTSH;SLK;DNM1L;THBS1;HOXA5;PAK2;CREBBP;SH3RF1;MAP4K4;TMBIM4;PHLDA1;SHC1;BCL2;IFIT2;GAS1;ANXA1;BRAF;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;FBXO10;AIFM1;WRN;DDX42;VDAC1;ACTN2;XIAP;ADAMTSL4;MED1;UNC13B;HNRNPK;CYP1B1;MAP3K20;BAG3;NGF;NCSTN;PRMT2;ANKLE2;EGLN3;TRAF2;JUN;ARHGEF12;DNAJC3;ARHGEF18;USP47;BCLAF1;LGALS1;MEF2C;ERCC3;YME1L1;SOS2;HSPA9;RASSF2;CCAR1;CASP2;FGD1;CARD14;ATF6;SH3RF2;ING5;GLO1;STAT1;FGD4;PRKDC;NAA15;RBM5;VEGFA;HDAC1;DDX3X;LATS1;TOPORS;RASA1;ANP32B;ANP32E;TXNDC5;TGFB3;DAPK1;NGEF;PTPA;NOP53;MRE11;IAPP;ARHGEF11;TRIO;ARHGEF6;CITED2;BFAR;DAPK2;TMEM219;WNT5A;PHIP;ARHGEF1;PRKAA1;SFRP4;RABGGTB;AREL1;TRAF6;VCP;TMEM14A;BMP2;DCUN1D3;PARK7;CHM;APIP
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3884065901895023,-1.0745091407280167,0.3576923076923077,0.6328028631542716,1.0,4/20,10.08%,ATP1A2;SLC9A1;KCNJ2;SLC12A2
prerank,mitochondrion disassembly (GO:0061726),-0.3426950673047555,-1.0743452357086172,0.34375,0.6326943852965685,1.0,15/34,23.01%,PRKN;RB1CC1;WIPI1;ULK2;BECN1;ATG2A;ATG9A;WDR45B;ATG2B;AMBRA1;ATG5;FIS1;WIPI2;BNIP3;MAP1LC3A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.30971508828069294,-1.0741724548205747,0.31589147286821706,0.6326185261314734,1.0,16/56,13.89%,EGFR;EFEMP1;EPHA3;PDGFRA;PDGFRB;ABL1;TPST1;KIT;FGFR2;LYN;EPHA4;FER;ABL2;ABI1;TEC;TTL
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3954065433783943,-1.0738776878860292,0.32938856015779094,0.6328512860869063,1.0,3/20,3.72%,CFLAR;FLOT2;NUPR1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.47265663267764824,-1.0737311575436534,0.3927927927927928,0.6327208058656083,1.0,4/10,29.40%,ADGRV1;IFT88;PLS1;TSKU
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.28042660678277087,1.0737239715527958,0.31223628691983124,0.7715735276832161,1.0,18/100,10.86%,FLT1;IGF1R;TEK;PIP5K1B;SIRT1;PPP1R16B;KDR;NTRK2;SEMA4D;FLT3;TGFB2;PIK3R5;UNC5B;EPO;FBXL2;DAB2IP;PDGFB;F2R
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3155374066339083,1.0732301038391285,0.31896551724137934,0.7717949973692902,1.0,14/54,14.16%,TMSB4X;SIRT1;PPARG;KDR;NOS3;CSNK2B;ETS1;ACVRL1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;ATP2B4
prerank,regulation of interferon-gamma production (GO:0032649),0.29411744618507485,1.0723802413604606,0.3065217391304348,0.7732127460430552,1.0,8/71,12.68%,SLC7A5;PDE4B;GAS6;ISG15;IL12A;CYRIB;PDE4D;HSPD1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4581167008750597,-1.0721362032891422,0.39611650485436894,0.6362211350067666,1.0,2/11,7.02%,RC3H1;ANXA1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.37403820332860405,-1.0717902546236744,0.3525046382189239,0.6365411454949212,1.0,9/22,22.44%,PPM1D;PPM1E;DUSP16;PPP2CB;PPM1A;DUSP1;DUSP10;PPP2CA;DUSP7
prerank,response to glucagon (GO:0033762),0.39866304548369125,1.0712691232560396,0.3569937369519833,0.7754289628340407,1.0,3/19,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2819039933972234,-1.070155922324346,0.3288201160541586,0.6401116087274283,1.0,26/95,19.92%,NFKB1;VIM;AXL;PABPN1;LBP;HMGB1;SBNO2;CTR9;CHMP5;SELENOS;UPF1;NR1H3;RHOA;ADAM9;MEF2C;TNIP2;PDCD4;SERPINE1;TLR4;WNT5A;CX3CR1;TRAF6;IRAK1;SHPK;CDC73;CARD16
prerank,positive regulation of ATPase activity (GO:0032781),0.33591755070115026,1.069984315280917,0.35119047619047616,0.7780532950618261,1.0,11/41,17.70%,DNAJC9;RYR2;DNAL4;FGF10;DYNLL1;VMP1;ATP1B1;PFN1;DYNLL2;DNAJB2;AHSA1
prerank,regulation of blood coagulation (GO:0030193),-0.3644074950222881,-1.069936260140988,0.3731060606060606,0.6401429571112169,1.0,7/27,17.01%,ST3GAL4;VTN;THBS1;TFPI;FAP;APOE;SERPINE1
prerank,glycerol metabolic process (GO:0006071),0.44917602805029455,1.0698239692612135,0.3956692913385827,0.777311861384806,1.0,2/10,3.39%,COQ2;PGP
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3881223422423054,1.0695000139096902,0.3448275862068966,0.7770927604266246,1.0,6/21,14.11%,USP44;RPL23;UBE2C;RPL5;RPS7;GOLGA2
prerank,positive regulation of cell motility (GO:2000147),0.2536889326649561,1.0690272731967294,0.2618110236220472,0.7772702157664698,1.0,42/205,14.53%,SPOCK2;FLT1;IGF1R;LEF1;PTP4A1;SEMA3C;CSF1R;PODXL;SEMA6A;ITGA6;CXCL12;SEMA4A;SEMA4F;PPM1F;SEMA6D;KDR;SEMA4D;SEMA7A;FERMT3;HSPA5;NOTCH1;PAK1;PECAM1;GPNMB;NTN1;PDGFB;AIF1;F2R;CEP43;PIK3R3;APC;TJP1;RET;EPHA1;BCAR1;ACTN4;HRAS;XBP1;INSR;CIB1;ATM;PPP3CA
prerank,cholesterol efflux (GO:0033344),-0.3849291976094006,-1.0685219146588771,0.3614457831325301,0.6431592188944557,1.0,5/20,19.21%,ABCA1;SOAT1;NPC2;APOE;ABCA7
prerank,mesonephros development (GO:0001823),-0.45380464414475513,-1.0681500042991947,0.3968871595330739,0.6435945165758111,1.0,5/11,5.91%,FGF1;BMP7;BMP4;OSR1;ZBTB16
prerank,positive regulation of cellular protein localization (GO:1903829),0.2921807052384031,1.068099270388618,0.3247011952191235,0.7789136122533478,1.0,12/69,11.41%,TFRC;BICD1;NECAB2;SYT11;TMEM35A;MEAK7;STX3;HSP90AB1;AKT1;NUP62;APC;CCDC88A
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4774815649328951,-1.0680379344961886,0.3875685557586837,0.6433514957589773,1.0,5/10,34.02%,PTPRS;NLRC3;SIRPA;CACTIN;PYCARD
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.38005201312261916,-1.068000275722816,0.37545787545787546,0.6429478481623409,1.0,6/22,17.35%,ROCK2;LYN;EPHA4;RANBP9;IFNGR1;PICALM
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.39586446625946986,-1.0675500369071347,0.3950850661625709,0.6436277560373872,1.0,3/20,3.94%,AKAP13;ADCY9;ADRA1B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.34387180532828027,1.066858758889496,0.34968017057569295,0.781498514269932,1.0,7/33,10.32%,PTPRG;PTPRR;ADGRB1;ACVRL1;DNAJA4;DAB2IP;PTPRM
prerank,cGMP-mediated signaling (GO:0019934),0.43084507198529387,1.0667762609148517,0.37755102040816324,0.780535314962528,1.0,3/13,3.45%,KCNC2;PDE2A;HTR2C
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.44073755837610423,-1.0666892157666163,0.3996282527881041,0.6452931853392301,1.0,5/12,18.03%,JAG1;REST;HES1;NELFB;HNRNPU
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.37422906172737347,-1.0666089738842397,0.361003861003861,0.645009219074096,1.0,3/24,2.59%,PID1;RHOQ;DAB2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3577298244330383,1.0665375941394097,0.36764705882352944,0.780065339508287,1.0,4/26,4.98%,GRIN1;MBP;GRIN2B;PSENEN
prerank,positive regulation of cellular process (GO:0048522),0.2293597048607071,1.0661035786544661,0.2222222222222222,0.7801927492824676,1.0,92/565,14.28%,FLT1;CLDN5;IGF1R;LEF1;SLC6A6;CHEK1;GRIN1;KITLG;FRMD5;ERBB4;PROX1;CSF1R;RPS6;RPS19;S100A9;S100A8;IL7;NRG1;AQP11;CXCL12;CCND1;COPS9;RYR2;RPL23;AKAP6;ACER2;SIRT1;TRIM13;IL2RG;HMGA2;MFSD2A;GAS6;KDR;FGF10;NTRK2;FLT3;TENM4;IL12A;STX3;NOTCH1;TAL1;TGFB2;PAK1;SPAG5;ETS1;MLC1;RTKN2;FGF5;TLR2;PTPRJ;TIMP1;EPO;RPS6KA1;HSP90AB1;MVD;AKT1;ADRA1D;H3-3A;CNOT6L;THPO;NAMPT;SHANK2;TPPP;LIFR;PDGFB;AIF1;FAM98A;HMGN5;F2R;WDR77;CEP43;APC;RPS4X;P2RX7;TJP1;MAPK8;NOP2;DUSP26;EPHA1;ACTN4;AGPAT1;BMPR1B;HRAS;XBP1;DLL1;INSR;CD36;CIB1;ADGRG1;CCKBR;ATM;LGI1
prerank,plasma membrane repair (GO:0001778),0.43077532408855296,1.0655983860481455,0.3920704845814978,0.7804675981008182,1.0,4/13,10.84%,SYT7;SYT11;DYSF;SMPD1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26343749175642356,-1.06555704177181,0.31717171717171716,0.6471763955969818,1.0,29/141,12.34%,ATP1A2;ROCK2;EGFR;ADCY5;IGFBP5;DIAPH1;CTNNA1;LRRK2;SPIDR;NR3C1;LCOR;TFPI;RAP1B;CDH1;ADCY1;LARP1;ADCY6;RAPGEF3;AR;IMPACT;MED1;JUP;CYP1B1;SLC5A5;RORA;MEF2C;RIOK3;PDE3A;PKD2
prerank,peptidyl-methionine modification (GO:0018206),0.4454066900037538,1.0654036350162328,0.37763713080168776,0.7798742625605711,1.0,3/12,15.11%,METAP2;NAA30;NAA60
prerank,cellular protein catabolic process (GO:0044257),-0.30046885497327414,-1.065106808400268,0.3320079522862823,0.6478509710246493,1.0,21/59,27.56%,ADAMTS12;PRKN;CTSC;CTSH;AFG1L;RAB12;FAP;YME1L1;CLPP;TCIRG1;MYLIP;CTSF;BNIP3;CTSL;MAGEC2;SIAH2;AP2A1;CLPX;RAB7A;HTRA2;LONP1
prerank,response to exogenous dsRNA (GO:0043330),-0.39510742043715696,-1.0650720039184005,0.3761996161228407,0.6474283304804686,1.0,10/18,32.24%,IRAK3;DHX9;MAVS;TICAM1;MUL1;CGAS;TLR3;IFIH1;CAV1;ZCCHC3
prerank,protein targeting to lysosome (GO:0006622),0.37961221713552834,1.0649810265094355,0.3752535496957404,0.7799879789696874,1.0,10/20,20.67%,HSPA8;CLU;SCARB2;NCOA4;SORL1;M6PR;AP3M1;HGS;VPS4A;SNX16
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4675937828003592,-1.0648163611153205,0.3850574712643678,0.6475745974652177,1.0,8/10,33.56%,ZEB2;GIPC1;APPL1;RAPGEF2;CTNS;OPN3;CDH3;ATP7A
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.46046157691129963,-1.0641735994068844,0.3892100192678227,0.6486935317126651,1.0,8/11,31.89%,WNT4;BMP5;BMP2;FGFR4;EGR1;NR1H4;ASAH1;STAR
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.45307625262557294,-1.0640222958519716,0.3927272727272727,0.6485699873230794,1.0,2/12,7.55%,GMDS;GFPT1
prerank,establishment of protein localization to membrane (GO:0090150),-0.2938479312091361,-1.0636655567084343,0.3440453686200378,0.6489633747603408,1.0,16/66,18.95%,EGFR;AFDN;SYNE3;NACA;RAB10;RAB3GAP1;BRAF;RAB3IP;VPS37C;RAB11A;PARD3;SEC63;COX18;NECTIN3;ZDHHC1;CHM
prerank,negative regulation of catabolic process (GO:0009895),-0.32622083701391924,-1.0636355046201404,0.35661764705882354,0.6485478846997795,1.0,7/47,4.50%,EGFR;MDM4;HDAC4;NCOR1;NUPR1;FLNA;IRAK3
prerank,mitotic nuclear division (GO:0140014),-0.2880916592753187,-1.0635341353186718,0.3386454183266932,0.6483016711838528,1.0,19/71,17.46%,INO80;FLNA;PIBF1;SPICE1;KLHDC8B;SMC4;CHMP4B;NDEL1;STAG1;RHOA;LSM14A;RAB11A;KLHL22;ABRAXAS2;TOGARAM1;MAP9;ZWINT;STAG2;UBE2S
prerank,positive regulation of chromatin organization (GO:1905269),0.4388877987061734,1.0633553522978016,0.37924151696606784,0.7836001020512068,1.0,6/12,14.36%,TAL1;TERF1;H3-3A;TERF2IP;SIN3A;TINF2
prerank,acidic amino acid transport (GO:0015800),-0.4069962144927103,-1.0633321453520017,0.34592445328031807,0.6482671584082657,1.0,6/17,11.00%,SLC6A13;SLC1A3;LRRC8D;GJA1;GIPC1;SLC6A1
prerank,negative regulation of immune effector process (GO:0002698),-0.43794181888635203,-1.0632828322540855,0.38848920863309355,0.6479013891187835,1.0,5/13,12.97%,CD55;RC3H1;FER;ENPP3;APPL1
prerank,dendrite morphogenesis (GO:0048813),0.33657139041537804,1.0631600990205974,0.3818565400843882,0.7829160430661344,1.0,10/35,12.48%,CTNNA2;EPHB1;CTNND2;MAPK8IP2;SHANK3;MAP2;TAOK2;CELSR2;DVL1;DOCK10
prerank,striated muscle cell differentiation (GO:0051146),-0.4164494457919971,-1.063150438833062,0.3641509433962264,0.6477499087018006,1.0,4/16,12.53%,AKAP13;SKI;MEF2C;SIK1
prerank,long-term memory (GO:0007616),0.3869162327168888,1.062987298405086,0.3638297872340426,0.7822801589874808,1.0,4/19,12.90%,LRRN4;CAMK4;RASGRF1;PJA2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3602538873687543,-1.0627875772093414,0.349609375,0.6481721145074447,1.0,9/24,25.37%,PPM1D;DNMT3A;MPHOSPH8;PHF1;JARID2;EPC1;EZH2;PPHLN1;CREBZF
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.41932055806541724,1.0627653658776803,0.3675564681724846,0.7817273325715532,1.0,3/15,8.43%,TMSB4X;KDR;HSPB1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.41665307513799915,-1.0624599251737885,0.38953488372093026,0.6485028668325292,1.0,3/15,10.08%,ATP1A2;SLC9A1;SLC12A2
prerank,cellular response to chemical stress (GO:0062197),-0.2813571283661338,-1.0621509268507265,0.33070866141732286,0.6488567095020925,1.0,39/96,30.10%,FOXO3;ABL1;LRRK2;PRKAA2;NOX4;LRRC8D;PPARGC1A;SELENOS;STX4;PARP1;SOD3;MGAT3;PKD2;ADNP2;TXNRD2;DDX3X;GPX8;CYBA;PRKD1;PRKAA1;SOD2;PARK7;NCF2;PRDX2;FANCC;ZFAND1;GPX7;NUDT2;CCS;GSR;SLC25A24;HTRA2;LONP1;BRF2;MT3;NFE2L2;TXNRD1;CYCS;SRXN1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.41839434463994585,-1.0620668676741114,0.39365671641791045,0.6485934354597761,1.0,7/15,28.33%,DAB2;SMAP1;WASL;BMP2K;DGKD;HIP1R;NEU3
prerank,axon extension (GO:0048675),-0.3699853513191067,-1.061877762658217,0.36059479553903345,0.6486186836775631,1.0,5/23,11.05%,ALCAM;AUTS2;NRP1;SPG11;ULK2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.25836782763675703,-1.061812672584032,0.2965235173824131,0.648287181976613,1.0,48/148,24.24%,PRKAG2;MDM4;EP300;PRKAA2;BRD7;RBBP8;MAPKAP1;TAF3;USP7;NBN;MTOR;PDPK1;WRN;TAF4;TBP;CHD4;HIPK1;CHD3;RPL11;PRKAB2;EHMT1;RICTOR;ING5;USP2;HDAC1;CSNK2A1;TAF13;PRMT5;NOP53;MRE11;TTC5;PRKAA1;PPP2R5C;KMT5A;CDK2;MAP2K6;PML;TAF12;PRKAG3;CDK5RAP3;PRKAB1;TAF9B;TAF2;ATR;HDAC2;NUAK1;BOP1;MBD3
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.3197358771636255,-1.0616657577693576,0.3611111111111111,0.6481579247639778,1.0,10/45,11.06%,FOXO3;PUM2;ZC3H7A;RC3H1;LARP1;PUM1;GEMIN5;EIF4E;PARP9;YTHDC1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3808278973054554,-1.0612333531686857,0.36278195488721804,0.6487719420088696,1.0,4/21,8.85%,IGF1;ITGAV;CTSH;MAP2K1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4028672522168722,-1.061089587675037,0.39855072463768115,0.6486669028911894,1.0,5/17,12.95%,SLC9A1;SLC9A2;SLC12A2;SLC6A1;TRPM4
prerank,cellular response to hexose stimulus (GO:0071331),0.37349950625706557,1.0602058517594466,0.3841059602649007,0.7882746173308495,1.0,5/23,3.78%,IGF1R;ADCY8;SLC2A5;PAX2;GAS6
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.32560414294986784,-1.0601903734600922,0.34516765285996054,0.6504214242677806,1.0,27/42,37.37%,KLHL15;SPIDR;FUS;WDR48;PPP4C;PPP4R2;SETD2;SHLD2;PARP1;MMS19;HELB;SMCHD1;ARID2;KDM1A;UBQLN4;ACTR2;FANCB;TIMELESS;CGAS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;ERCC6;MRNIP;SIRT6
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4257679103866424,1.0600758251378806,0.37310195227765725,0.7874294990871986,1.0,4/13,18.22%,SYT1;SYT10;CACNA1I;SYT4
prerank,protein K48-linked deubiquitination (GO:0071108),0.36405683061185523,1.0599445282717808,0.36885245901639346,0.7866207040762926,1.0,9/23,18.82%,OTUD7A;YOD1;OTUB2;MINDY1;MINDY2;OTUB1;USP8;ATXN3;OTUD7B
prerank,protein kinase A signaling (GO:0010737),-0.4452808632259173,-1.059375162684041,0.4069097888675624,0.6520163576720018,1.0,10/12,53.21%,PRKACA;MYOM1;RDX;TTN;TCP11X2;TCP11;PRKACB;RAB13;LCP1;GAL
prerank,steroid biosynthetic process (GO:0006694),-0.3046044434824761,-1.05915441568549,0.34368932038834954,0.6520659269576082,1.0,15/56,23.09%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;CYP51A1;AMACR;DHRS11;SC5D;ACOT8;FDFT1;OSBPL3;LBR
prerank,protein localization to cell junction (GO:1902414),-0.38122004117151,-1.059141712708016,0.3714821763602251,0.6515993891064267,1.0,5/22,5.83%,CGNL1;JAK1;NLGN2;DLG4;PAK2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3234211022917217,1.0588959480507625,0.3663157894736842,0.7885093597650032,1.0,10/40,13.54%,PROX1;MMD2;BRINP1;HOXD3;NRCAM;CPNE1;BRINP3;ARHGEF2;SIN3A;BEND6
prerank,negative regulation of cell death (GO:0060548),-0.27786555439579,-1.0584442457219174,0.3538767395626243,0.6527749745493086,1.0,31/88,22.46%,KANK2;CCN2;BMP7;BMP4;PRKN;LRRK2;GSK3B;INPP5A;VPS4B;SRSF6;CHMP4B;CHMP4A;PPARGC1A;IMPACT;TRAF2;CCN3;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;SPEF1;BNIP3;FGF2;WNT16;WFS1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4464517376578899,1.0582241335124634,0.39300411522633744,0.7893459402631914,1.0,2/11,3.31%,MIF;SIRT1
prerank,cellular response to nutrient levels (GO:0031669),-0.301359514746565,-1.0582038401246547,0.3427495291902072,0.6528715194677371,1.0,24/62,27.05%,LRRK2;TFEB;PRKAA2;RPTOR;ZFYVE1;MTOR;WRN;LAMP2;USP33;WIPI1;FNIP1;WDR45B;FAM107A;PRKAA1;EIF4G1;WIPI2;ATG14;KCNB1;MAP1LC3A;PPARA;LPL;RRAGA;GAS2L1;VPS41
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.4345453226074253,-1.057782368586542,0.3850467289719626,0.6534513374596114,1.0,7/13,22.57%,MDFIC;SP100;TPR;SUFU;APOD;PARK7;CHP1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4319091478108798,1.0575016430595912,0.39148936170212767,0.7902675342429101,1.0,4/12,13.24%,ANK3;WNK2;GLRX;ATP1B1
prerank,activation of protein kinase A activity (GO:0034199),0.40364468426225014,1.0573098872543683,0.38253638253638256,0.7896114419615035,1.0,3/16,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4015202290848195,-1.057297364535332,0.38086642599277976,0.6541613727901248,1.0,5/17,17.43%,JAG1;CD55;STAT3;IL18;TLR4
prerank,mitotic metaphase plate congression (GO:0007080),-0.315683401518727,-1.0570213050154968,0.34345351043643263,0.6543768828727448,1.0,11/51,14.26%,EML4;PIBF1;VPS4B;CHMP4B;CHMP4A;CHMP5;CHMP3;RAB11A;CUL3;BECN1;NUDC
prerank,microtubule nucleation (GO:0007020),-0.38339286349304175,-1.056709467666482,0.3857677902621723,0.6546467572933398,1.0,8/19,19.56%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;TUBGCP4
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37558616398133976,1.0566516443558236,0.38193018480492813,0.790383946815208,1.0,4/23,3.16%,PROX1;ATP11A;NRG1;AKAP6
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4649557002589043,-1.0565177838414619,0.39325842696629215,0.6545937205031249,1.0,4/10,25.24%,VEGFA;CX3CR1;SMARCD3;KDM1A
prerank,regulation of protein ubiquitination (GO:0031396),-0.26850445934333483,-1.0564458717903737,0.32629558541266795,0.6542892178519796,1.0,36/108,24.61%,NXN;SASH1;TGFBR1;ANGPT1;HDAC8;UBE2N;PRKN;LRRK2;HUWE1;AXIN1;UBQLN1;UFL1;U2AF2;XIAP;SPOPL;CUL3;FBXW7;OGT;USP4;SH3RF2;FANCI;ARRB1;SPRTN;DERL1;FAM107A;TRAF6;PARK7;TBC1D7;CDK5RAP3;SPHK1;SENP2;WFS1;CHP1;BAG5;PAXIP1;GNL3L
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2353084729397196,-1.0562696999473478,0.302713987473904,0.6542266887414171,1.0,78/348,19.37%,BMP6;PRKAG2;ROCK2;IGF1;EGFR;TGFBR1;BMPR1A;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;RBPMS;CEMIP;ARAF;BMP5;FGF1;BMP7;DAB2;FAM20A;BMP4;GHR;ABL1;LRRK2;VTN;RPTOR;TBK1;DOCK7;CREBL2;SNX9;AXIN1;PAK2;NBN;TWSG1;NRP1;LYN;BRAF;RAPGEF3;UBE2K;IGF2;NGF;RB1CC1;PDGFC;SMAD4;MAVS;FNIP1;TEC;IL6R;RASSF2;CARD14;CCN1;WDFY2;TXN;VEGFA;ACVR1;CCND3;DDX3X;LATS1;RAPGEF2;VEGFD;ITGA5;AKAP9;TGFB3;ARRB1;MRE11;CACUL1;PRKD1;CX3CR1;CSNK1D;BMP2;PARK7;MUSK;MTCP1;PTPN11;EIF4G1;INHBA;ITGB3
prerank,muscle tissue development (GO:0060537),-0.426425869980252,-1.0559860363871674,0.41509433962264153,0.6544529632945669,1.0,4/13,15.46%,BMP4;SMO;CSRP2;PTCH1
prerank,homologous chromosome segregation (GO:0045143),0.3873931252649977,1.0556194430458237,0.3559322033898305,0.7922991587029595,1.0,2/20,4.07%,MEI4;FMN2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.34692720981929076,-1.05536126471447,0.3795066413662239,0.6555613519646205,1.0,5/28,10.12%,ITPR1;BCL2;MAP3K5;AIFM1;TRAF2
prerank,import into nucleus (GO:0051170),0.2855286568559023,1.055335162806836,0.348,0.7919445960936893,1.0,11/73,10.98%,IPO5;IPO4;MMP12;GEMIN8;HTATIP2;NXT1;AKT1;NUP62;FAM53B;SNRPD2;SNRPD1
prerank,renal filtration (GO:0097205),-0.45201018880428423,-1.0552785102136795,0.3913857677902622,0.65529005905773,1.0,3/10,9.98%,SULF1;SULF2;TBC1D8B
prerank,positive regulation of MAPK cascade (GO:0043410),-0.2461436154657647,-1.0546617284019018,0.30505050505050507,0.6563292792740144,1.0,52/245,16.48%,ROCK2;NOTCH2;IGF1;ROR1;EGFR;LPAR1;IL34;PDGFRA;ANGPT1;NTRK3;PELI2;CCN2;KSR1;FGF1;PDGFRB;ROCK1;ROBO1;LRRK2;ADRA1B;GSDME;KIT;RYK;HMGB1;SLC30A10;GAREM1;TAOK3;NRP1;FGFR2;SHC1;BRAF;MID1;IGF2;MAP2K1;PTPN22;PDGFC;BMPER;WWC1;ROR2;TRIM5;FBXW7;EIF2AK2;EPHA8;APOE;TPD52L1;VEGFA;RAPGEF2;PRKCZ;GLIPR2;MAP2K7;ARRB1;IAPP;ADRA2A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4190913978508769,-1.0541442920594646,0.3854748603351955,0.6571833671873131,1.0,3/14,5.41%,SULF1;SULF2;THBS1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.34182710952112516,-1.0538938521073282,0.36809815950920244,0.6573558343631724,1.0,10/33,18.24%,TPM1;IGFBP5;IGFBP3;OGN;MEF2C;APOD;EFEMP2;TGFB3;PDCD4;SOD2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4413156577002098,1.0538842403472113,0.40301724137931033,0.7951718121827066,1.0,4/12,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,positive regulation of cell death (GO:0010942),-0.30059537694933525,-1.0538085538909432,0.3443579766536965,0.6570742246370146,1.0,11/59,10.88%,SLC6A13;LRP1;EFNB2;CELF1;BMP4;LRRK2;GSK3B;RARG;MAP3K5;MARK4;PRODH
prerank,cellular amino acid catabolic process (GO:0009063),-0.28159400877607543,-1.0538000614426588,0.34398496240601506,0.6566054172400583,1.0,25/87,26.76%,DDO;ACADSB;ABAT;ASPA;IVD;HIBCH;GLUD1;MCCC2;GLUL;PRODH;ALDH6A1;DLST;SARDH;ALDH7A1;CARNMT1;NOS1;BCKDK;ALDH4A1;AMT;HIBADH;AUH;PIPOX;CBS;HNMT;PHYKPL
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4366704216145948,1.0535145913150972,0.39544513457556935,0.7951717547277547,1.0,2/12,3.31%,MIF;SIRT1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3561666622162022,-1.0533877985452358,0.3827392120075047,0.6571457762149229,1.0,8/26,20.94%,NPR3;POR;HIF1A;APOE;PARK7;TERF2;TERT;S100A1
prerank,xenobiotic transport (GO:0042908),0.3899858620468698,1.0533751365015926,0.38197424892703863,0.7944085790928586,1.0,2/17,2.21%,SLC7A5;ABCG2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.29141166230673604,-1.0530648047770321,0.350104821802935,0.6574420585608367,1.0,17/68,17.56%,PCCA;AOX1;ENPP1;HLCS;TCN2;MMUT;MCCC2;MTHFR;MTHFD2L;PANK2;SLC5A6;TPK1;ABCD4;RFK;PDXK;CUBN;ALDH1L1
prerank,apoptotic nuclear changes (GO:0030262),-0.36224362494503787,-1.0530285722339336,0.37755102040816324,0.6570547578364005,1.0,9/24,29.16%,DICER1;ACIN1;HMGB1;H1-0;CDK5RAP3;EXOG;DNASE2;CECR2;GPER1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4499384031672304,1.0528398606847147,0.38235294117647056,0.7947841372977342,1.0,3/10,23.10%,IL12A;NCKAP1L;DDIT3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3521970395242003,1.0527544110814673,0.3813559322033898,0.7938842125482795,1.0,10/29,17.73%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1;PPIA
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.24254049531942082,-1.05260417595398,0.27370689655172414,0.6576059913106154,1.0,71/291,20.08%,ROCK2;EGFR;PID1;NFKB1;EPHA3;PDGFRA;TPM1;IGFBP5;PTK7;VIM;AXL;PABPN1;WNT5B;WNT6;RPTOR;IRS1;LBP;HMGB1;LCOR;SBNO2;RAP1B;LYN;MTOR;WNT9A;ADCY6;RAPGEF3;DHX36;CTR9;PTPRK;IMPACT;CHMP5;SELENOS;UPF1;FER;NR1H3;RHOA;JUN;PRKCD;ADAM9;ABL2;SLC5A5;RORA;MEF2C;PDE3A;PKD2;FZD7;ADNP2;P2RY12;ERCC6L2;RAPGEF2;P2RX4;AKAP9;DAPK1;GNB1;TNIP2;CPEB1;PDCD4;SERPINE1;TLR4;WNT5A;PRKD1;CX3CR1;TRAF6;VCP;INPP5K;CDK2;IRAK1;SHPK;CDC73;CARD16;RAPGEF1
prerank,nucleic acid-templated transcription (GO:0097659),0.3209034439428654,1.0524836007790528,0.36472945891783565,0.7935399147854705,1.0,11/42,14.46%,PAX8;PTMA;HOXD3;XAB2;POLR2J;POLR2B;THAP1;POLR2I;BCL3;MED20;POLR3A
prerank,diacylglycerol metabolic process (GO:0046339),0.3714036993363985,1.052374234221371,0.37748344370860926,0.7927035321608396,1.0,6/23,10.44%,DGKI;LIPE;DGAT2;DGKH;DGKB;GPAM
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.3583951457347261,-1.0522410129438902,0.38285714285714284,0.6579898610847125,1.0,10/26,19.31%,EGFR;ANKRD17;UBE2E2;RPTOR;ANXA1;CCND3;DDX3X;ADAMTS1;CDK10;EIF4G1
prerank,bicarbonate transport (GO:0015701),0.35135201536131117,1.0521402954356283,0.3723849372384937,0.7922489463659834,1.0,4/25,10.66%,SLC4A1;CA4;CA2;SLC39A8
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3734867822367385,-1.0520453322592227,0.3614457831325301,0.6580296942605831,1.0,9/22,23.33%,MDFIC;LRRK2;SP100;SUFU;APOD;INPP5K;PARK7;CHP1;LMAN1
prerank,kinetochore organization (GO:0051383),-0.4314272370607888,-1.052044056265372,0.3977272727272727,0.6575440339969135,1.0,12/13,53.47%,CENPT;POGZ;CENPE;CENPH;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW;CENPC;CDT1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3742888518727885,-1.0517127681351413,0.37333333333333335,0.657874946234334,1.0,3/23,5.68%,ERRFI1;CBLB;SNX6
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36616765026955966,-1.0516410737506328,0.38803088803088803,0.6575650045807945,1.0,4/23,6.93%,IL34;BMP5;THBS1;LYN
prerank,regulation of filopodium assembly (GO:0051489),-0.32689570775157645,-1.0509760478494021,0.3789279112754159,0.6587153553609396,1.0,12/38,13.57%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;BCAS3;NRP1;CDC42;WASL;PRKCD;RALA;CAPZB
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4340523402002222,1.050669905825541,0.3956989247311828,0.7955089213254609,1.0,3/11,12.90%,STMN1;PAK1;BCAR1
prerank,nucleocytoplasmic transport (GO:0006913),0.321732951421573,1.0506373438567234,0.3724696356275304,0.7944043996140552,1.0,9/40,13.65%,GEMIN8;HTATIP2;NXT1;RBM15B;SNRPD2;SNRPD1;NUP205;ANP32A;DDX20
prerank,cell cycle checkpoint signaling (GO:0000075),0.43162846514593944,1.0502338972965795,0.4106382978723404,0.7944817091490523,1.0,5/12,16.28%,BUB1;WEE2;NABP1;CHFR;PLK2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.33011921162834185,1.049439035385912,0.36075949367088606,0.7957203595422565,1.0,8/39,13.15%,TEK;RAMP2;GAS6;KDR;NDNF;CCL2;SCG2;CD40
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41895207592068673,-1.0490055972229848,0.4194139194139194,0.6629790774466257,1.0,5/14,21.64%,MYO9A;CDC42;RHOA;MSN;SCRIB
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3375281436126701,1.0490052680776154,0.38329764453961457,0.7958820080694065,1.0,7/31,11.45%,DLG2;LRRC7;LIN7A;WDR1;MTCL1;CRB1;ANK1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.35655821232763607,-1.048953918858386,0.37937743190661477,0.6626070076458397,1.0,10/25,25.26%,IGF1;NIBAN2;NSD1;RB1;TRAF6;PARK7;H1-0;TWIST1;SOX11;ZBTB7A
prerank,anion transmembrane transport (GO:0098656),0.29128559581427044,1.0487787705838751,0.3613963039014374,0.795398734936065,1.0,12/67,7.96%,SLC7A5;SLC7A1;LRRC8B;SLC35A1;SLC1A1;SLC25A42;MFSD12;SLC1A2;SLC6A5;SLC6A8;SLC7A8;SLC25A14
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.38717236765461144,-1.048633922597678,0.3841698841698842,0.6629223980804027,1.0,3/19,5.41%,IL34;CAMK1D;THBS1
prerank,glycerophospholipid catabolic process (GO:0046475),0.35077276952789443,1.0486091875902988,0.386411889596603,0.7947000636601883,1.0,2/27,4.79%,GPCPD1;ENPP2
prerank,apoptotic mitochondrial changes (GO:0008637),0.34197467721562,1.0484750111502144,0.38266384778012685,0.7939114988482779,1.0,3/32,6.46%,CAMK2A;ERBB4;CLU
prerank,regulation of interleukin-8 production (GO:0032677),0.2882745788186593,1.0481808958105148,0.3481953290870488,0.7935378777059237,1.0,10/69,12.26%,CD33;TIRAP;IL17F;TMSB4X;KLF4;TLR2;NOD1;F2R;BCL10;BCL3
prerank,protein transport (GO:0015031),-0.235276939922255,-1.0479696503400668,0.28842105263157897,0.6641331705467522,1.0,110/332,27.96%,WLS;LRP1;TLK1;ABCA1;KIF13A;STEAP3;TANGO6;ATP6V1B2;TBC1D16;SGSM2;ATP6V0D1;SNX9;SNX6;SEC23IP;RAB10;STX16;RAB22A;STXBP1;VAMP5;VPS26C;ATP6V0A4;RAB12;RAMP1;SIL1;AP3B1;SLC10A7;LAMP2;VAMP2;COPZ2;USP6NL;SEC31A;TXNIP;SLU7;ARCN1;ARFGAP3;TBC1D2B;HERC2;TBC1D8B;CHMP3;GGA3;RPGR;COG7;RCN3;STX4;ARFIP2;SCAMP2;ARF1;MON1A;STX5;COPB2;TBCK;RAB21;CTTN;GRTP1;APOE;TBC1D22B;CTSA;DNAJC27;FAM91A1;TBC1D9;COPG2;SNX8;TCIRG1;TOM1;TMED3;MIA3;WDR11;VAMP4;NAPA;COPG1;TBC1D17;TMED5;TMED4;LRSAM1;RABGAP1;STX17;TBC1D10A;RAB24;GGA2;STX8;IFT27;ARRDC4;RABL3;VPS26B;ATP6V1G2;ARL5A;NSF;RAB3D;USO1;AP2A1;PREB;RAB8A;KIF3A;SAR1B;TVP23B;RAB7A;STX12;ARRDC2;RAB5A;STX1A;VPS45;TBC1D10B;AFM;STX7;TMED2;SEL1L;TBC1D9B;ARL4C;RIC1;RUFY1
prerank,regulation of intracellular protein transport (GO:0033157),-0.3408287199249275,-1.047865610726242,0.3752535496957404,0.6639290303664169,1.0,11/32,19.44%,PCM1;BMP4;PTPN14;BCAS3;PCNT;NDEL1;VAMP2;TPR;ICE1;PTPN1;IFI27
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.27677678782224574,1.0477064227925972,0.33867735470941884,0.7938152880758543,1.0,18/90,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;LCN2;ESRRG;EBF2;CD36
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3673983169388503,-1.0475718791526993,0.3780260707635009,0.6641645464458193,1.0,6/23,18.70%,INPP5B;SYNJ2;MTMR12;MTMR3;SACM1L;INPP5K
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4474282773945531,1.0475209364707145,0.40717299578059074,0.7932030182484127,1.0,2/10,4.32%,CHEK1;SMARCB1
prerank,DNA packaging (GO:0006323),-0.4032822625835347,-1.0469114406582072,0.4288537549407115,0.665321685009596,1.0,8/16,37.93%,AIFM1;HAT1;CDAN1;H1-0;BANF1;CHAF1A;NAA10;TP53
prerank,regulation of cell adhesion (GO:0030155),-0.2663407560471264,-1.0466933427849983,0.3539651837524178,0.665378592818787,1.0,31/129,17.89%,PLXNA2;ROCK2;EPHA7;ANGPT1;TPM1;FBLN1;ZFHX3;ITGAV;PPP1R12A;ROCK1;ABL1;RIPOR2;LYN;EPHA4;RSU1;PLXNB2;ABL2;STX4;ARHGDIB;EPHA8;CD164;VEGFA;DUSP1;PPP1CB;PLXND1;RASA1;PLXNB1;GPR4;IL18;MIA3;MYADM
prerank,positive regulation of T cell activation (GO:0050870),0.29504783408609014,1.0463954536203783,0.39014373716632444,0.7954415301199574,1.0,10/62,13.69%,TFRC;SLC7A1;IL7;THY1;PRKCQ;CCL2;CYRIB;AIF1;HSPD1;XBP1
prerank,response to prostaglandin E (GO:0034695),-0.4594521960218244,-1.046370968069094,0.4264705882352941,0.6656993266922281,1.0,3/10,16.03%,TGFBR3;ADCY6;GNB1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.38961890753398426,1.0461419846460756,0.39826839826839827,0.7949915947904591,1.0,6/17,10.22%,PROX1;CCND1;MAPRE3;AKT1;CCNY;PDGFB
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.26900590975559013,-1.0457316418787153,0.33267716535433073,0.6668922183124671,1.0,22/109,15.52%,PTPN13;PLEKHA2;PI4KA;PDGFRB;INPP5B;SYNJ2;MTMR12;INPPL1;PIP4K2C;PLA2G4A;PLCG1;PLCB3;PLCD1;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;SACM1L;PIK3R4
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.40809365620301896,1.0456204888024572,0.4008097165991903,0.7954521667119538,1.0,5/15,12.04%,USP44;RPL23;RPL5;RPS7;SMAD7
prerank,negative regulation of neuron differentiation (GO:0045665),-0.37013234671654494,-1.0455936270254067,0.3944223107569721,0.666768373971258,1.0,6/22,12.77%,BMP7;GSK3B;REST;MED1;HES1;EIF2AK4
prerank,signal transduction by p53 class mediator (GO:0072331),-0.34268886556219996,-1.0451949804125806,0.4,0.6672973485875606,1.0,4/30,5.93%,FHIT;DDX5;MDM4;NBN
prerank,cellular calcium ion homeostasis (GO:0006874),0.26195148133252516,1.044632922381433,0.33661417322834647,0.7972731826814173,1.0,23/133,14.16%,SLC24A4;SLC24A2;TRPC5;ADCY8;CXCL12;RYR2;CAV2;HTR2C;HCRTR1;SLC8A1;ATP2B3;TMEM178A;SLC30A1;NPTN;TPT1;HCRTR2;TRPC1;TMCO1;CD40;ATP1B1;PSEN1;ATP2B2;ATP2B4
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2722488796042044,1.0445382385007667,0.33727810650887574,0.7964106916600208,1.0,19/98,16.55%,SLCO1C1;PAX8;MAGI2;AHI1;PPARG;SNCA;KLF4;RAB1B;IFNAR1;AKT1;PDGFB;AGPAT1;NFKBIA;GHITM;INSR;CDKN1A;STARD4;TBC1D5;RAB29
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.26349040792532447,-1.0443407806584388,0.33752620545073375,0.6689410390825666,1.0,22/118,11.68%,PHLDB2;PID1;DAG1;SIPA1L1;PDLIM5;SDC2;KIF13B;LRRK2;SPARC;GSK3B;WTIP;BCL9L;PAK2;ADGRA2;RC3H1;FGFR2;EPHA4;SP100;BRSK1;BMPER;ZMYM4;MEF2C
prerank,macrophage activation involved in immune response (GO:0002281),-0.428957158158109,-1.0442307764164083,0.40535372848948376,0.6687268636942636,1.0,6/13,28.01%,LBP;SBNO2;CX3CR1;IFI35;SYK;GRN
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3859543165537554,1.0439187120361269,0.4192825112107623,0.7971199053946335,1.0,5/19,11.01%,DLG2;LRRC7;MTCL1;FOXJ1;CRB1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.32220947085537555,-1.043907951072943,0.37721021611001965,0.6690777875697955,1.0,9/40,21.34%,PID1;ABL1;LRRK2;BCL2;STOML2;ATP5IF1;VCP;PARK7;AKT2
prerank,zinc ion transport (GO:0006829),0.37497946352343636,1.043825613378631,0.4184549356223176,0.796210824098696,1.0,6/21,11.74%,SLC39A2;SLC30A1;TRPM2;SLC30A3;SLC39A8;SLC30A5
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.31903650786442694,-1.0435565859195688,0.3643410852713178,0.669491876164419,1.0,25/42,35.32%,INO80;ARID1B;SMARCC2;CHD8;RNF8;MBD2;CHD4;CHD3;SPTY2D1;HDAC1;ANP32E;NASP;SMARCD2;PBRM1;HDAC2;MBD3;ACTR5;ACTR6;CECR2;DMAP1;INO80B;ACTL6B;ACTR8;ERCC6;SMARCA4
prerank,regulation of postsynapse organization (GO:0099175),0.3432357760935245,1.0435527780348914,0.3947939262472885,0.7958839624021594,1.0,7/28,11.12%,IL1RAPL1;SHANK3;KIF1A;HOMER1;ZDHHC15;CDKL5;PPFIA2
prerank,histone monoubiquitination (GO:0010390),-0.3578642246149052,-1.043483652081898,0.3949416342412451,0.6691740406008215,1.0,8/24,22.39%,BCOR;CTR9;DDB2;DTX3L;UBE2E1;RNF20;CDC73;WAC
prerank,cellular response to interleukin-12 (GO:0071349),-0.30990456052847176,-1.0432849630138472,0.3941747572815534,0.6691745911875245,1.0,17/48,21.48%,JAK1;RAP1B;ANXA2;PAK2;CDC42;PITPNA;CAPZA1;ARF1;RALA;HSPA9;TYK2;PDCD4;AIP;SOD2;CNN2;P4HB;MSN
prerank,negative regulation of histone methylation (GO:0031061),-0.4603955761730746,-1.0431967614536928,0.43392857142857144,0.6688940063969159,1.0,7/10,35.44%,BCOR;PHF1;JARID2;KDM1A;WDR5;BRCA1;AASS
prerank,lipid transport (GO:0006869),0.27540260901291935,1.0430553117412518,0.3784860557768924,0.796181391355461,1.0,21/97,13.89%,SLCO1C1;PLTP;ATP8A1;MFSD2A;NCOA2;CERT1;CHKA;PITPNM1;SPNS2;PRELID3A;SLCO2B1;ABCC4;FABP5;PLEKHA3;PRELID2;CPTP;ABCG4;TTPA;SCARB1;SLC27A4;CD36
prerank,primary neural tube formation (GO:0014020),-0.339930003328014,-1.0426173398261733,0.3676190476190476,0.6698688820999084,1.0,6/30,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.36375896708991473,-1.0423813099242498,0.37115384615384617,0.6699514920580081,1.0,4/24,8.40%,PID1;LEPR;GFPT1;PPARGC1A
prerank,positive regulation of cholesterol transport (GO:0032376),0.35384651404916456,1.0423674528969078,0.3991769547325103,0.7971118175405206,1.0,7/27,14.94%,PLTP;SIRT1;PPARG;GPS2;ABCB4;NFKBIA;SCP2
prerank,cobalamin metabolic process (GO:0009235),-0.3974459785784187,-1.0423467942732905,0.39961759082217974,0.6695389444617325,1.0,4/17,16.51%,TCN2;MMUT;ABCD4;CUBN
prerank,macromolecule catabolic process (GO:0009057),-0.3602069083246126,-1.042193426366005,0.4,0.6694576494400057,1.0,15/26,38.10%,UVRAG;MTOR;KIF16B;BECN1;SMURF1;PIK3R4;LRSAM1;CLN5;CLPX;CLN8;CLN6;SNX25;IDE;NEDD4;LGMN
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3974302807840318,1.0420898382207413,0.41286307053941906,0.7967656836135087,1.0,3/17,6.77%,CD33;TMSB4X;KLF4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.34733078838040016,1.0420371321841422,0.38913043478260867,0.79579991057307,1.0,10/26,18.05%,CLU;KLF4;HSP90AB1;AKT1;KLF2;INSR;CD36;EDN1;HSP90AA1;DDAH1
prerank,negative regulation of angiogenesis (GO:0016525),-0.27965972616745227,-1.0418093863743676,0.3622881355932203,0.6699514428268811,1.0,16/84,10.08%,ROCK2;SULF1;DCN;COL4A3;FOXC1;ROCK1;SPARC;NIBAN2;HSPG2;THBS2;THBS1;HOXA5;ATF2;ADAMTS9;SEMA3E;SLC12A2
prerank,regulation of TOR signaling (GO:0032006),-0.29631533693822243,-1.0417351912534172,0.3704414587332054,0.6696507176860738,1.0,19/67,21.41%,ARAF;UBR2;PRKAA2;RPTOR;DEPTOR;TMEM127;TTI1;UBR1;FNIP1;TELO2;WDR59;RICTOR;TBCK;NPRL3;PRKAA1;TBC1D7;GPAT3;PIH1D1;LARS1
prerank,protein O-linked mannosylation (GO:0035269),-0.396446223706494,-1.0416866461125247,0.4064885496183206,0.6692750895242001,1.0,11/18,23.78%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.390997251667729,-1.0415950563612124,0.4148148148148148,0.6689986545071044,1.0,6/18,22.72%,FBN1;FBXW7;TLR4;GPR137B;TCTA;MAFB
prerank,response to X-ray (GO:0010165),-0.4088716418124545,-1.0410505227057796,0.41509433962264153,0.6699081418499896,1.0,4/14,11.47%,ANXA1;BRCC3;NIPBL;XRCC4
prerank,positive regulation of histone methylation (GO:0031062),-0.356772286000715,-1.040959277455296,0.3944223107569721,0.669644610128847,1.0,6/24,15.69%,AUTS2;CTR9;SMAD4;OGT;PHF1;JARID2
prerank,negative regulation of dephosphorylation (GO:0035305),0.3794178583782851,1.0406953952758564,0.3760504201680672,0.7986020111940999,1.0,3/18,4.95%,YWHAB;PPP1R16B;ZCCHC9
prerank,tight junction assembly (GO:0120192),0.30855608400524376,1.0402220399602753,0.3668763102725367,0.7989342590162037,1.0,9/49,12.08%,CLDN5;RAMP2;OCLN;CLDN14;ESAM;PECAM1;MICALL2;APC;MARVELD2
prerank,receptor-mediated endocytosis (GO:0006898),0.26332853786924376,1.0400388894155554,0.34297520661157027,0.7983187672401174,1.0,31/132,17.15%,TFRC;DNM3;LRP1B;TMEM108;RAMP2;AP2M1;CAV2;SNCA;GRK2;SNAP91;SCARF1;FNBP1L;FCHO1;SCARB2;AP2B1;CD163;ITGAM;SGIP1;SORL1;SCARB1;DLL1;INSR;CD36;CLTB;STAB2;PPT1;NLGN3;M6PR;CALCRL;HSP90AA1;RAB31
prerank,JNK cascade (GO:0007254),0.3155622425342648,1.0398811378281776,0.37100213219616207,0.7976823992522547,1.0,15/40,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;ADORA2B;NOD2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.4153146322588318,-1.0394308229943976,0.39776951672862454,0.673211780813517,1.0,3/15,6.09%,PIEZO2;KIT;ADGRV1
prerank,negative regulation of cell activation (GO:0050866),-0.4069365034741454,-1.0392767614126543,0.41544117647058826,0.673138655989522,1.0,4/14,14.42%,PDGFRA;LDLR;APOE;EMILIN1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2564596139537598,1.0391696065607448,0.3534136546184739,0.79860471945862,1.0,19/151,8.51%,ALAS2;SGMS1;GSTA4;PCSK1;ACER2;FA2H;DEGS2;MFSD2A;LPCAT2;CERT1;PCYT1B;CHKA;CSNK2B;SPNS2;ELOVL7;SGPP2;ELOVL4;GSTM5;SLC44A5
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3017604331144362,-1.038211257692856,0.3862745098039216,0.6752944651083339,1.0,13/54,13.89%,PCM1;FIGN;NUMA1;DLG1;SLK;VPS4B;TUBGCP6;TUBGCP2;FIGNL2;RHOA;CLIP4;RAB11A;KATNA1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.40056648529577066,-1.0380575084309063,0.42293233082706766,0.6751803098256839,1.0,2/15,3.68%,GLI3;CD55
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.40351325886588474,1.037548852505116,0.4083333333333333,0.8023423785801064,1.0,4/14,11.60%,SIRT1;CAMK4;SEMA7A;BCL10
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.37240222020352937,1.0374203270461666,0.39828693790149894,0.8015699542455023,1.0,6/21,9.89%,SPRY3;RASAL3;TGFB2;SPRY4;CYRIB;DAB2IP
prerank,metanephric mesenchyme development (GO:0072075),-0.45580338533717857,-1.0369680911940637,0.4101123595505618,0.6774503525934316,1.0,5/10,17.02%,WNT4;OSR1;PKD2;STAT1;SIX1
prerank,glycolipid biosynthetic process (GO:0009247),-0.3177656943726381,-1.0367386806157017,0.3822937625754527,0.6775619416043961,1.0,16/38,30.49%,LARGE1;ST3GAL4;A4GALT;PIGN;GBGT1;ST6GALNAC5;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;ST3GAL2;PIGZ;PIGP;PIGF
prerank,tube closure (GO:0060606),-0.33702888494976874,-1.0367155978463045,0.3791748526522593,0.677127439477612,1.0,6/31,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27090392221669984,1.0366235891006783,0.3654618473895582,0.8028576505276953,1.0,24/101,14.32%,FLT1;PROX1;CSF1R;TENM1;CCND1;SIRT1;HMGA2;SNCA;FLT3;CD24;DIRAS1;MAPRE3;PIK3R5;AKT1;CCNY;DAB2IP;PDGFB;CALM1;CD40;HRAS;CALM2;CIB1;ATP2B4;CALM3
prerank,negative regulation of macrophage activation (GO:0043031),0.40097840856102307,1.0365380813823357,0.4200426439232409,0.8019933890245969,1.0,2/16,2.79%,LRFN5;SYT11
prerank,microglial cell activation (GO:0001774),0.3756910720218029,1.0362923609118928,0.4008438818565401,0.8015424489690239,1.0,4/21,12.49%,SNCA;CLU;AIF1;ITGAM
prerank,oxoacid metabolic process (GO:0043436),-0.35037230236751293,-1.0361897174503985,0.4098671726755218,0.6779882480833418,1.0,7/27,18.99%,DDO;ENPP1;TPST1;SULT1A1;PPA1;ABHD14B;THAP4
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.41519522605033615,-1.0358769591454104,0.4030131826741996,0.6782820695652756,1.0,8/13,27.68%,UFL1;NCK1;BFAR;PTPN1;ABCA7;WFS1;ATF6B;PPP1R15B
prerank,cardiac myofibril assembly (GO:0055003),-0.4076244454985964,-1.0358188323809703,0.4107806691449814,0.6779492163885651,1.0,4/15,7.29%,PDGFRA;PDGFRB;MEF2A;OBSL1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.45916438397594644,-1.0357948782259474,0.4474708171206226,0.6775319719413463,1.0,7/10,46.26%,FBXW7;ADRA2A;HBEGF;EGF;ADAM17;BTC;NCF1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3034912802540144,-1.0356586453909638,0.39096267190569745,0.6773877406072025,1.0,10/48,9.75%,ADCY9;ADCY5;SLC35B3;AMPD3;ADCY1;SLC26A2;ADCY6;GMPS;GUCY1A1;PANK2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.3249694776541291,-1.0355073097708865,0.40150093808630394,0.6772805255714514,1.0,18/35,36.42%,NUMA1;VPS4B;CHMP4B;CHMP5;CHMP3;TPR;MAP9;DYNC1H1;HNRNPU;EML3;BORA;PARP3;CHMP1B;TACC3;HSPA1A;CHMP1A;TPX2;FSD1
prerank,regulation of synapse organization (GO:0050807),-0.3543620750426371,-1.0352466155292903,0.4126679462571977,0.6774702955831559,1.0,10/26,19.56%,PDLIM5;ABL1;SETD5;ABHD17B;EPHA4;GRIPAP1;MEF2C;WNT5A;SLITRK4;MDGA1
prerank,proteasome assembly (GO:0043248),-0.4453193317458999,-1.035131379501323,0.4165103189493433,0.6772836776439285,1.0,5/11,34.30%,PSMG1;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3455799155603565,-1.0350958383394928,0.4049079754601227,0.6768837771207006,1.0,9/28,21.31%,PRKN;NUPR1;CTSC;AXIN1;FBXW7;SMURF1;ATP5IF1;TMTC3;CDK5RAP3
prerank,autophagosome maturation (GO:0097352),-0.33596175281221663,-1.0350674298102591,0.404296875,0.6764673765388461,1.0,13/32,23.01%,UVRAG;UBQLN1;VTI1B;VAMP7;LIX1L;LAMP2;CHMP3;ATP2A2;VCP;WIPI2;STX17;ATG14;MAP1LC3A
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3727445942101908,-1.034987163217056,0.4,0.676167575818424,1.0,5/19,8.19%,RPTOR;CHD8;MTOR;AR;DHX36
prerank,regulation of stem cell differentiation (GO:2000736),-0.2756262598332875,-1.0347676284490328,0.37475728155339805,0.6762364265438567,1.0,30/89,29.12%,PTN;BMPR1A;PDGFRA;ABL1;JAG1;YAP1;RUNX1;HOXB4;PSMF1;HES1;TCF3;NELFB;EIF2AK2;PSMB2;PRKDC;NSUN2;HNRNPU;PSMC1;KMT2A;PSMB6;PSMA3;NUDT21;PSMA4;LDB1;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9
prerank,innate immune response in mucosa (GO:0002227),0.44436076068536995,1.03459920796906,0.4322033898305085,0.8054690555712744,1.0,10/10,55.59%,DEFA6;RNASE3;PLA2G1B;RPL39;LTF;DEFB1;BPIFB1;CAMP;IL4;NOS2
prerank,positive regulation of vasculature development (GO:1904018),0.27454151840159463,1.0340680469054435,0.35789473684210527,0.8058931704465131,1.0,14/94,8.43%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;APLNR;NINJ1;CD34;HSPB1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.27518679424882997,-1.0334158909937148,0.3891992551210428,0.6790802169267952,1.0,37/91,25.62%,PLD1;ITGAV;STXBP5;ABL1;LRRK2;PACSIN2;STON2;USP7;RAB10;NRP1;GAS1;RAB12;VAMP2;MAP2K1;ARFGAP1;CHMP3;ABL2;STX4;RAB11A;RALA;RINT1;RAB21;MBTPS1;ZFYVE16;PICALM;PTPN1;STON1;SPHK1;BET1L;NSF;RAB3D;HIP1R;RAB8A;SYK;SNX12;ATP9A;RAB5A
prerank,miRNA metabolic process (GO:0010586),-0.3689656205611585,-1.0329296723475576,0.43388429752066116,0.6797605755759134,1.0,4/20,8.00%,DIS3L2;DICER1;DDX17;TUT4
prerank,positive regulation of metabolic process (GO:0009893),0.26516283251722683,1.0329025867061281,0.4011627906976744,0.8082409150671582,1.0,20/103,13.89%,IGF1R;GATM;OMA1;KSR2;UCP2;ADRB1;HADH;EPAS1;ADCYAP1;ADIPOR2;APC;SCD;FABP5;PER2;AGPAT1;LCN2;ESRRG;EBF2;INSR;CD36
prerank,regulation of neuron differentiation (GO:0045664),-0.28103034617333955,-1.0328992008197557,0.3816046966731898,0.6793716769787534,1.0,19/76,13.75%,TCF4;NBL1;NREP;ZFHX3;ZEB1;BMP7;ROCK1;LRRK2;REST;IMPACT;MED1;NGF;RHOA;ID2;MEF2C;HES1;TCF3;EIF2AK4;CDK5RAP1
prerank,chromosome organization (GO:0051276),-0.26763959429065315,-1.0328950717606435,0.3927855711422846,0.6789017374979516,1.0,30/99,25.48%,TCF7L2;HDAC8;SETD7;BRWD1;ABL1;RAD23B;EZH1;MTHFR;DDB2;RFWD3;PARP1;TCF7L1;COPS2;EHMT1;COPS8;PHF1;HDAC1;LATS1;MSH3;TOP2B;HMG20A;MSH6;CDAN1;EZH2;HMGN3;HDAC2;CENPT;FAM50A;ZBTB7A;LDB1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2991320634489669,1.0328462931397049,0.38415841584158417,0.8072590639646888,1.0,12/54,12.13%,RPL35A;RPF2;RPL7;RPL10;RPL10A;RPLP0;RPL7A;RPL14;RPL5;RPL23A;NHP2;NOP2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3272401288349482,1.0327831194506853,0.3912133891213389,0.8063011682905165,1.0,7/36,11.62%,CAMK2A;LEF1;PLCB1;FZD6;GNG2;CALM1;FZD4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3657825595298213,1.0326583746366695,0.411522633744856,0.8055329713984278,1.0,8/22,14.32%,RYR2;AKAP6;VMP1;HAP1;CALM1;ATP1B1;CALM2;CALM3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3747077867545885,-1.032362437206048,0.4048507462686567,0.6797599817052606,1.0,7/22,11.96%,UGGT2;MAN1C1;OS9;EDEM3;EDEM1;MAN1B1;MAN1A2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.34709395185285086,-1.0321078789841602,0.4144486692015209,0.6799032204070302,1.0,8/28,13.02%,FOXP1;APPL2;CD55;XIAP;PTPN22;TRIM5;APPL1;IRF1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.31391543362199953,-1.0319732421968262,0.37549407114624506,0.6797299025949048,1.0,14/44,23.09%,PRKAG2;CYP7B1;CYP27A1;INSIG2;OSBPL9;HMGCR;SQLE;PARK7;AMACR;SC5D;ACOT8;PSAT1;OSBPL3;LBR
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3112407212180113,1.0308429112238224,0.41478439425051333,0.8098241885043053,1.0,9/47,11.80%,IGF1R;EPHB1;MAPK8IP2;TGFB2;PHLPP1;MAPK8IP1;TAOK2;DAB2IP;FOXO1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3078305195683762,1.0302503355987895,0.39263803680981596,0.810521614254767,1.0,12/46,19.77%,GDAP1;CHCHD4;TIMM21;DNAJC15;AKT1;PITRM1;TIMM22;HSPD1;TSPO;TOMM70;TIMM10B;DNAJC19
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.44665185653579015,-1.0302025148917524,0.4225865209471767,0.6837512546018257,1.0,2/10,8.69%,MTHFR;MTHFD2L
prerank,triglyceride biosynthetic process (GO:0019432),-0.38896353155996594,-1.0301639760702244,0.4413919413919414,0.6833891292632573,1.0,7/18,20.39%,AGMO;GPAT4;MOGAT3;PCK2;LPIN2;LPIN3;GPAT3
prerank,dephosphorylation (GO:0016311),0.2575929502475811,1.0301272809094648,0.3747534516765286,0.8097130386550829,1.0,31/147,15.17%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PLPPR1;PTPRT;DUSP6;PGP;PPM1F;PPP2R1A;PLPPR5;PTPN18;SGPP2;PTPRJ;PLPPR4;PLPP4;NT5C;MTMR6;PTPRM;DUSP28;DUSP26;DUSP15;CTTNBP2NL;PTPRZ1;PPM1L;PPP3CA;CTDSP2;PLPP6;PDP1;FRA10AC1
prerank,regulation of hippo signaling (GO:0035330),-0.39910737070263347,-1.0298499322932775,0.4419475655430712,0.6836597244123939,1.0,12/17,27.40%,WWC2;VGLL4;WTIP;MARK3;LIMD1;WWC1;AJUBA;NF2;DLG5;SOX11;MAPK14;NEK8
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4314745266486527,1.0296255323741612,0.410752688172043,0.8100899031559526,1.0,2/11,5.60%,ATF3;HSPA5
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.39204969599687334,-1.0295933819323373,0.40545454545454546,0.6838318317342822,1.0,4/16,11.62%,SMG6;TNKS2;DHX36;PARP1
prerank,protein localization to plasma membrane (GO:0072659),0.2573213202618218,1.0287078560110496,0.3816793893129771,0.811750007932704,1.0,24/129,11.89%,BSG;DPP10;EFR3B;MRAP2;KCNIP4;SPTBN4;RAMP2;ANK3;RAB3C;FGF13;TNIK;GAS6;MAP7;DPP6;ZDHHC22;P2RY1;EPB41L3;CACNB2;TSPAN17;RAB40B;SPTBN1;CCDC88A;ANK1;TSPAN14
prerank,tyrosine metabolic process (GO:0006570),-0.44117499495130097,-1.0278786581929877,0.42829076620825146,0.6876343753390425,1.0,5/11,43.22%,THAP4;TYR;HGD;IL4I1;FAH
prerank,neuron projection extension (GO:1990138),-0.3320700796867122,-1.0276712639374286,0.4051383399209486,0.6876995507858106,1.0,8/32,12.86%,ALCAM;AUTS2;NRP1;IMPACT;SPG11;ULK2;EIF2AK4;FLRT1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.42086285720306904,1.0273990402519282,0.4252136752136752,0.8145047471246929,1.0,1/12,0.11%,IGF1R
prerank,negative regulation of signaling (GO:0023057),0.3570339469321972,1.0273829872858176,0.40898876404494383,0.8134250960556526,1.0,7/25,20.01%,GLRA1;SRMS;OPRM1;UBASH3B;OPTN;BRAP;KIF26A
prerank,eosinophil migration (GO:0072677),0.40059011865151617,1.0269298007098653,0.4434782608695652,0.8125596547844498,1.0,14/14,59.98%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.40059011865151617,1.0269298007098653,0.4434782608695652,0.8125596547844498,1.0,14/14,59.98%,CCL2;SCG2;CCL13;CCL24;CCL26;LGALS3;CCL3;CCL1;CCL8;CCL7;CCL4;CCL11;CCL5;CX3CL1
prerank,regulation of striated muscle contraction (GO:0006942),-0.3465165541983121,-1.0268997103765862,0.40702479338842973,0.6892018567746874,1.0,8/27,20.47%,ATP1A2;ANK2;ASB3;SRI;P2RX4;PRKACA;SLC8A3;NOS1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.45735266428167953,-1.026622705396016,0.43079922027290446,0.6894083576131005,1.0,9/10,54.29%,TXN2;CBS;CTH;ADO;MPST;BLMH;MTRR;TST;GADL1
prerank,regulation of MAP kinase activity (GO:0043405),-0.26888266473735706,-1.0262074627104176,0.3835616438356164,0.68998537463059,1.0,29/92,22.48%,EGFR;IL34;KSR1;FGF1;PDGFRB;BMP7;BMP4;ROBO1;LRRK2;KIT;IRAK3;LYN;PDGFC;PRKCD;TRIB2;APOE;TPD52L1;VEGFA;DUSP1;ADRA2A;PTPN1;INPP5K;IRAK1;SNF8;CDK5RAP3;FGF2;EZH2;DUSP7;CD300A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3428038295938497,-1.026131935109782,0.4123314065510597,0.6896848993190503,1.0,5/27,7.01%,SLMAP;SNTA1;DLG1;PTPN3;CAMK2D
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3847498022025155,-1.0260066183668637,0.409009009009009,0.6895136057066434,1.0,5/17,12.13%,PTN;IL34;DICER1;ID2;HES1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2903510683493735,1.0242791641432225,0.399581589958159,0.819388490770624,1.0,12/56,15.14%,S100A9;S100A8;RPS27A;UBC;TLR2;UBB;NOD1;BCL10;CTSB;CD36;TAB2;MAPKAPK2
prerank,glycoprotein metabolic process (GO:0009100),-0.2950059923252352,-1.0242329174724114,0.40618955512572535,0.6934817791079682,1.0,18/53,19.51%,LARGE1;ST3GAL4;NGLY1;MAN1C1;OGA;GANC;ADAMTS9;MAN2A1;MAN1B1;HIF1A;MAN1A2;ERP44;MANBA;GANAB;MAN2A2;B4GALT5;PARK7;B4GALT7
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3364242750187018,1.0234894968394235,0.39307535641547864,0.8205954560474831,1.0,5/30,5.57%,SCN1A;FGF12;RYR2;CACNA2D1;SCN4B
prerank,hydrogen peroxide catabolic process (GO:0042744),0.42013857048707,1.023236095878004,0.41139240506329117,0.8202153244350717,1.0,5/11,23.23%,GPX1;PRDX5;PRDX1;PXDN;GPX3
prerank,protein polymerization (GO:0051258),-0.29492149101029685,-1.0230869254430977,0.4180790960451977,0.6959711946820994,1.0,11/55,10.05%,ARHGAP6;GAS7;GSN;DIAPH1;PRKN;CORO7;CHMP4B;CHMP4A;UBE2K;WASL;CHMP3
prerank,Golgi inheritance (GO:0048313),-0.43092226302458825,-1.022858561711615,0.4148148148148148,0.6960578535037903,1.0,3/11,13.00%,GBF1;VCPIP1;STX5
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.30205564330051976,-1.0228132349057895,0.39065420560747666,0.6956694082788328,1.0,20/52,24.44%,LMNA;TLN1;ATP6V0D1;SHC1;GFPT1;EDEM1;SEC31A;ARFGAP1;WIPI1;DNAJC3;KDELR3;ERN1;GOSR2;FKBP14;SYVN1;CUL7;WFS1;PREB;CXXC1;HYOU1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22261617548913976,-1.0227880000563137,0.3671399594320487,0.6952488031476067,1.0,84/423,18.37%,BMP6;TGFBR3;IGF1;FOXP1;GRK5;EGFR;PID1;TCF7L2;GAB2;TGFBR1;PTN;BMPR1A;IL34;PDGFRA;RBPJ;NTRK3;EFNB2;BMP5;ITGAV;FGF1;PDGFRB;IL6ST;IL31RA;BMP4;HDAC4;MAP3K3;OSR1;TGFBR2;YAP1;IRS1;KMT2D;CTSH;IL13RA1;THBS1;DPP4;GAREM1;UFL1;FGFR2;SHC1;BCL2;LYN;DHX9;AR;ACER3;IGF2;GJA1;CDK13;FER;PDGFC;NES;S100A6;ID2;STX4;CNOT8;MEF2C;HES1;CUL3;IL6R;FN1;CCAR1;TRPM4;CDC123;GLI1;CCN1;STAT1;VEGFA;HDAC1;CIAO1;CDC25B;VEGFD;CSNK2A1;TGFB3;ADRA2A;IL18;TBX2;TCIRG1;CACUL1;CCN4;WNT5A;PHIP;HNRNPU;PTGFR;DHPS;GCNT2
prerank,response to light stimulus (GO:0009416),-0.29322300585742006,-1.0225175996995215,0.4123314065510597,0.6954028275463706,1.0,16/55,24.91%,GTF2H2;UBE4B;DDB2;BRSK1;ERCC3;REV1;UBE2B;ERCC8;MAP2K7;SPRTN;ZRANB3;MSH6;USF1;CCAR2;PRIMPOL;CRY2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.31870204171650524,1.02248562025364,0.4073275862068966,0.8213478439276682,1.0,7/38,7.36%,KCNJ3;CTNNA3;CACNA2D1;BIN1;SCN4B;KCND3;CACNB2
prerank,establishment of protein localization to organelle (GO:0072594),0.27840498613812087,1.021793827456397,0.405189620758483,0.8221650658242147,1.0,11/72,10.00%,IPO5;IPO4;MMP12;RYR2;NXT1;AKT1;ZDHHC15;TSPAN17;NEURL1B;NUP62;FAM53B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3787125358001918,1.0217642778496974,0.44349680170575695,0.8211151048864134,1.0,5/17,13.42%,ALG3;MVD;ALG1;ALG8;DHDDS
prerank,lymphocyte mediated immunity (GO:0002449),-0.4185295241067612,-1.0210650422628738,0.43783783783783786,0.698507724348528,1.0,2/12,3.68%,JAG1;CD55
prerank,renal water homeostasis (GO:0003091),0.35566131702553055,1.0208757145678733,0.42083333333333334,0.8226683631487067,1.0,3/23,1.20%,PRKAR2B;ADCY8;ADCY3
prerank,phospholipid metabolic process (GO:0006644),0.2838416937346297,1.0208360943917474,0.39832285115303984,0.8216314739874921,1.0,17/71,19.22%,PLPPR1;MBOAT1;PGP;ENPP2;PLPPR5;PLPPR4;GPAM;SMPD1;FADS1;AGPAT1;PIP5K1A;PNPLA3;PLA2G4E;PIP4K2B;PLBD2;ACP6;PCYT2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.41686899582569065,-1.0207024849858441,0.4377431906614786,0.6989345691267026,1.0,2/13,4.04%,DDX5;PLA2R1
prerank,anion transport (GO:0006820),0.3252848474272714,1.019562552456808,0.4209445585215606,0.8242760530146221,1.0,6/33,10.28%,SLC4A1;ABCG2;LRRC8B;SLC17A6;SLCO2B1;VDAC2
prerank,receptor catabolic process (GO:0032801),-0.3506097417305387,-1.0188885811447184,0.4226415094339623,0.7029968437289353,1.0,7/24,17.47%,RNF43;UVRAG;KIF16B;BECN1;SMURF1;PIK3R4;MYLIP
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2527714406083714,1.0188398577734885,0.41139240506329117,0.8253210145762524,1.0,23/151,10.86%,TEK;ERBB4;TIRAP;CSF1R;NECAB2;MIF;HTR2C;GAS6;KDR;FGF10;NTRK2;SEMA7A;NOTCH1;P2RY1;ADCYAP1;GPNMB;ADRA1A;CCL2;THPO;OPRM1;PDGFB;ATP6AP1;F2R
prerank,protein insertion into ER membrane (GO:0045048),-0.31812619889096483,-1.0187186032477369,0.39738805970149255,0.7029252343799873,1.0,19/37,33.21%,EMC2;TRAM2;EMC7;VAMP2;STX5;EMD;EMC9;GET4;EMC4;VAPA;BAG6;EMC10;STX1A;EMC3;APP;CCDC47;GET3;EMC6;WDR83OS
prerank,regulation of mRNA stability (GO:0043488),-0.2504734797561265,-1.0184422892848586,0.42115768463073855,0.7031526850139483,1.0,57/145,31.71%,SAMD4A;ROCK2;CELF1;FTO;VIM;ROCK1;PUM2;YTHDF3;EIF4ENIF1;FUS;RC3H1;LARP1;PUM1;HNRNPD;DCP1A;DHX36;CSDC2;PRKCD;NUP214;XRN1;PSMF1;YBX1;SERBP1;PSMB2;EXOSC9;TENT5A;HNRNPU;PAIP1;EIF4G1;PSMC1;PRKCA;PSMB6;PSMA3;XPO1;EXOSC3;PSMA4;FXR1;PCBP4;PSME1;PDE12;PSMD13;DIS3;TENT5D;PARN;FASTKD1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;UBA52;THRAP3;TBRG4;YWHAZ;GDNF;GIGYF2;TNFSF13
prerank,acyl-CoA metabolic process (GO:0006637),-0.32531677479331705,-1.0180675703217121,0.42524271844660194,0.7035817666987954,1.0,11/35,23.25%,GPAT4;ACSF2;ACSL6;DLST;ACOT11;ACOT9;SUCLA2;MCEE;SUCLG2;ACOT8;ACOT6
prerank,oogenesis (GO:0048477),0.3887552148269252,1.0175803241823003,0.43451143451143454,0.8278309406213744,1.0,3/15,4.57%,MEI4;FMN2;NANOS3
prerank,regulation of neuron death (GO:1901214),0.2737180365355541,1.0173527388888148,0.40681362725450904,0.8274153090668646,1.0,16/82,13.01%,DCC;EPHB1;GRID2;TRIM2;GRIN2B;SNCA;CLU;AKT1;UBB;GPNMB;CD34;GPR75;CD200R1;SNCB;ITGAM;SORL1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.34073568714369695,-1.016887780487408,0.42084942084942084,0.7061275643869384,1.0,9/27,22.26%,IGF1;PDGFRA;DHX9;PDGFC;S100A6;FN1;WNT5A;CDK6;SPHK1
prerank,regulation of intracellular transport (GO:0032386),-0.3156866655374069,-1.0164229604477126,0.41141732283464566,0.7068348051519674,1.0,12/38,19.58%,LRRK2;NUMA1;GAS1;NDEL1;GRIPAP1;NUP214;WWC1;RINT1;DYNC1H1;LAMP1;PTPN1;RBM4
prerank,RNA 3'-end processing (GO:0031123),-0.279205785513293,-1.01638919034772,0.4020618556701031,0.7064359950467823,1.0,21/69,23.25%,TENT2;PABPN1;PCF11;WDR33;CASC3;U2AF2;CPSF3;SRSF6;TUT4;SLU7;RPRD2;SRSF1;CSTF3;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;CSTF1;CPSF4;NUDT21
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24499672325043897,-1.0160900648688624,0.4035433070866142,0.7066934935917492,1.0,49/172,22.99%,PTPN13;PLD1;PLEKHA2;PI4KA;SYNJ2;MTMR12;GNPAT;PLSCR1;DGKA;AGPAT4;DDHD1;INPPL1;ABHD5;PIP4K2C;GPAT4;STARD7;ETNK2;PLA2G4A;ABHD3;PTDSS1;PITPNM2;ARF1;PCYT1A;MBOAT7;MTMR3;CPNE3;PIK3C3;SLC27A1;PLEKHA8;HDHD5;SACM1L;CSNK2A1;PIK3R4;TAMM41;PIK3CD;LPIN2;LPIN3;GPD1L;INPP5K;LPCAT1;GPAT3;PIK3R1;CDS2;DGKD;FGF2;LPCAT3;PLEKHA4;PI4K2B;PTDSS2
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.33548005953282867,-1.0160899352846489,0.42052313883299797,0.706202198797572,1.0,14/29,36.26%,EIF4ENIF1;FUS;LARP1;YBX1;TENT5A;HNRNPU;PAIP1;TENT5D;E2F1;THRAP3;GDNF;SLC11A1;RBM24;ELAVL1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3415224049797145,1.0160705598995996,0.44398340248962653,0.8301724127751451,1.0,5/27,6.35%,B3GAT1;CHST9;B3GAT2;CSGALNACT1;CHSY3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3837673785892871,-1.015421259661859,0.4391634980988593,0.7074276346165054,1.0,9/16,21.57%,FOXD1;FGF1;BMP4;PKD2;SALL1;SIX1;NPNT;BMP2;FGF2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3629511042524261,-1.015243349463451,0.44626593806921677,0.7074015576070161,1.0,8/21,18.77%,AKAP13;CXADR;MEF2C;SIK1;VEGFA;ACVR1;MYH11;BMP2
prerank,positive regulation of apoptotic process (GO:0043065),-0.22913788174764,-1.0150084470720415,0.40618955512572535,0.7075141035319331,1.0,69/293,18.90%,AKAP13;PAWR;TGFBR1;EPHA7;FOXO3;STK3;BMP4;TIAM2;PTGIS;ABL1;ARHGEF17;NUPR1;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;FAP;ERCC3;SOS2;SIK1;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;TPD52L1;FGD4;RBM5;DDX3X;LATS1;TRIM39;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,axonal transport (GO:0098930),0.3241905604114983,1.0143819104925493,0.4228456913827655,0.8341175105283989,1.0,7/36,12.45%,SYBU;TMEM108;KIF1A;DST;AP3B2;HAP1;DCTN1
prerank,negative regulation of MAPK cascade (GO:0043409),0.27225465431111046,1.0143197556130343,0.42996108949416345,0.8331513317666593,1.0,18/87,13.01%,PTPRR;SEMA6A;SPRY3;CNKSR3;DUSP6;CAMK2N1;WNK2;PEBP1;PTPRJ;SPRY4;DAB2IP;UCHL1;LMO3;SMPD1;P2RX7;FOXO1;DUSP26;SORL1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.31821823172472447,-1.0141138526215392,0.43068391866913125,0.7093862340758341,1.0,13/36,18.05%,TGFBR1;DEPTOR;ASAH2;BCL2;RB1;ING5;TPD52L1;TRIM39;CSNK2A1;DAPK2;NR4A2;BCL2L12;CX3CR1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3383500598570121,1.0140990404539278,0.425531914893617,0.8326877063256226,1.0,7/27,12.68%,THY1;ETS1;PRKCQ;SKAP1;CCL2;CYRIB;HSPD1
prerank,regulation of establishment of protein localization (GO:0070201),-0.40817736115799363,-1.0140112182414607,0.43646408839779005,0.7091417304968922,1.0,3/13,16.90%,SPIDR;CEP135;CEP295
prerank,organic acid transport (GO:0015849),-0.2673161383898439,-1.0139954131177038,0.39,0.7086880481463737,1.0,13/94,9.00%,SLC7A11;SLC7A2;SLC6A13;SLC13A3;PDPN;ACSL1;SLC1A5;SLC26A7;SLC6A12;ATP8B1;LRRC8D;SLC22A6;NCOA1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.44423523504675827,-1.0139229897205582,0.4478178368121442,0.708364921528191,1.0,9/10,55.60%,PRKCZ;IL18;SPHK2;RARA;TSLP;GATA3;IL4;IRF4;LGALS9
prerank,positive regulation of protein kinase activity (GO:0045860),0.2495967104213696,1.0139175747007272,0.4151696606786427,0.8320814783100998,1.0,36/148,17.34%,GRM5;LRP8;CSF1R;MMD2;HMGA2;TNIK;GAS6;SNCA;PAK5;NAB2;TGFB2;PAK1;CLU;MAPRE3;ADCYAP1;HSP90AB1;RELN;TAOK2;DAB2IP;PDGFB;CALM1;CCDC88A;CALM2;PAK6;INSR;CIB1;TAB2;CALM3;CDKN1A;PAK3;STOX1;RAP1A;DDR2;XRCC5;HSP90AA1;RALB
prerank,ureteric bud morphogenesis (GO:0060675),0.3874070430661657,1.0134074209387502,0.4337606837606838,0.8325340546817744,1.0,2/16,3.56%,PAX8;PAX2
prerank,negative regulation of protein kinase activity (GO:0006469),0.2723311989227673,1.0133199313898171,0.4474789915966387,0.8316716420778631,1.0,29/88,20.40%,PTPRB;PTPRT;CAMK2N1;PPM1F;SNCA;THY1;SLC8A1;TRIB3;AKT1;YWHAG;HSPB1;DAB2IP;CEP43;UBASH3B;DVL1;DUSP26;EPHA1;SORL1;CDKN1A;CORO1C;CDKN1B;GNAQ;PPIA;ADAR;PTPRO;HYAL2;SH3BP5;DBNDD2;GSKIP
prerank,cell-cell junction maintenance (GO:0045217),0.42217794463957137,1.0130091742770018,0.4409090909090909,0.8314691619758148,1.0,3/11,11.65%,CSF1R;F2R;TJP1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.34721651045527474,-1.0129876206536197,0.41899441340782123,0.7102527785664222,1.0,8/25,30.41%,ITGAV;DLG4;PICALM;ITGB3;ANKRD13B;APP;NEU3;ARF6
prerank,protein localization to nucleus (GO:0034504),-0.26171979748256946,-1.0124967950993686,0.4248496993987976,0.7110025289398534,1.0,57/102,37.65%,APPL2;COL1A1;BMP7;BMP4;LMNA;TAF3;EIF4ENIF1;STAT3;WRN;NUP214;RPL11;IPO13;TPR;APPL1;YWHAE;TAF8;TOPORS;NOP53;FAM53C;SIX1;GBP2;MORC3;HNRNPU;ABCA7;PML;RPAIN;IPO9;TOR1A;TNPO3;PPP1R10;SYK;PHB2;ZBTB7A;NUP93;BBS4;RRS1;CHCHD10;RANBP17;TNPO2;CALR;SIX4;PINX1;E2F3;ARL2;RAN;IPO11;NUP133;SEC13;NUP88;FAM53A;MSX1;TOR1AIP1;SKP1;NUTF2;TSC2;IPO7;CSE1L
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.31676087330420866,1.012430476831006,0.4046610169491525,0.832084102728756,1.0,7/39,8.51%,MBP;PODXL;PPM1F;NOTCH1;KLF4;AKT1;NEXMIF
prerank,sphingolipid catabolic process (GO:0030149),0.3870979609161331,1.01237567702507,0.3978260869565217,0.8311159647269832,1.0,6/15,14.53%,ACER2;ENPP2;SMPDL3A;GLA;SMPD1;PPT1
prerank,retinol metabolic process (GO:0042572),-0.407405094909291,-1.0122497187459418,0.4675572519083969,0.7111533318944073,1.0,3/14,9.27%,RBP4;DHRS3;CYP1B1
prerank,telomere maintenance via telomerase (GO:0007004),0.34342050332932644,1.012204822757271,0.43923240938166314,0.8305061268414843,1.0,9/28,17.05%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,myelin assembly (GO:0032288),0.44086683665345083,1.0121984864915492,0.4668192219679634,0.8294076690026914,1.0,4/10,9.18%,TENM4;EPB41L3;CNTNAP1;TPPP
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.37755747118119504,-1.01213481649036,0.4533333333333333,0.7109548361912337,1.0,9/17,25.23%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3398715599767502,-1.012096594036788,0.4266666666666667,0.7105702318988149,1.0,9/27,15.44%,CACNA1C;ANK2;DLG1;CAMK2D;JUP;ATP2A2;TRPM4;SRI;AKAP9
prerank,DNA modification (GO:0006304),0.3637464567830691,1.0120861161200743,0.42116630669546434,0.828594677355397,1.0,6/22,16.97%,EXOSC5;TERF1;UNG;TERF2IP;TINF2;EXOSC4
prerank,regulation of GTPase activity (GO:0043087),-0.24228096149463726,-1.011841667194491,0.3951310861423221,0.710721020973574,1.0,30/177,9.97%,PLXNA2;DOCK11;AFDN;ASAP3;SIPA1L1;EPHA3;LIMS1;LRRK2;ARAP1;GSK3B;SGSM2;ITGB1;BCAS3;SNX9;MAP4K4;ARFGEF1;RAB3GAP1;MMUT;GMIP;RAPGEF3;ZC3H15;VAV2;S100A10;EPHA4;RSU1;NDEL1;USP6NL;PLXNB2;WNK1;TBC1D20
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.3042069486195161,-1.0110453731654845,0.4364326375711575,0.7122848394888985,1.0,9/42,9.18%,PLEKHA2;LIMS1;ROCK1;ABL1;GSK3B;MAP4K4;NRP1;S100A10;JUP
prerank,cellular senescence (GO:0090398),-0.34521138197555107,-1.0109543668525436,0.45930232558139533,0.7120145104010839,1.0,11/27,21.77%,OPA1;SMC6;NSMCE2;MAP2K1;SMC5;PRKCD;ID2;TBX2;TERF2;PML;ECRG4
prerank,histone acetylation (GO:0016573),-0.2781892941968512,-1.0107535661792717,0.42913385826771655,0.7120463856778813,1.0,18/69,18.15%,KAT2B;EP300;KAT6B;CREBBP;TRRAP;BRPF3;ZZZ3;HAT1;ATF2;TADA3;KAT14;KAT8;ING5;BRCA2;TAF5L;EPC1;TAF6L;MSL3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.447213228073006,-1.010743282343535,0.46415770609318996,0.7110940574871669,1.0,5/10,29.37%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.447213228073006,-1.010743282343535,0.46415770609318996,0.7110940574871669,1.0,5/10,29.37%,PRKCD;SMPD2;SIRT3;NSMAF;SPHK2
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.43505172369592304,-1.0107225844755805,0.4404332129963899,0.7106521149333853,1.0,6/10,47.71%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,inorganic ion transmembrane transport (GO:0098660),0.41626114429183836,1.0092489741455657,0.41914893617021276,0.8358573205935361,1.0,3/12,12.78%,ASIC2;KCNJ11;KCNJ8
prerank,sodium ion homeostasis (GO:0055078),-0.36336899877858564,-1.0091032737447792,0.46393762183235865,0.7142402801646327,1.0,3/21,10.08%,ATP1A2;SLC9A1;SLC12A2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.35656278642250044,1.0090534352685847,0.4276729559748428,0.8353598409103818,1.0,8/24,20.83%,ALAS2;ABCG2;CPOX;TSPO;FECH;COX10;HMBS;ABCB10
prerank,tetrapyrrole metabolic process (GO:0033013),-0.3776348608297404,-1.0089796841858416,0.43667296786389415,0.7140615183239113,1.0,4/18,16.51%,TCN2;MMUT;ABCD4;CUBN
prerank,glial cell differentiation (GO:0010001),0.3327433833428944,1.0089069290533086,0.4154488517745303,0.8346849330012571,1.0,10/28,18.85%,CDH2;PAX2;FGF10;RELN;TPPP;PTPRZ1;SOX4;HES5;METRN;SOX2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4124677018745661,-1.0088188955864865,0.45506692160611856,0.7139755539029414,1.0,5/13,15.99%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.28058830100858106,-1.0087405146027302,0.4095238095238095,0.7136834491819196,1.0,17/70,16.46%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2;NCK1;DOCK1
prerank,regulation of receptor recycling (GO:0001919),-0.3948808816918269,-1.008674565514863,0.458252427184466,0.7133762040468775,1.0,7/16,25.58%,TBC1D16;ANXA2;ECE1;KIF16B;SCRIB;NSF;AP1AR
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3002575100209769,1.0085502927679835,0.4422657952069717,0.8346710004495185,1.0,12/50,13.67%,PAX2;GAS6;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;RNF34;RFFL;CAAP1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3888010633257608,1.0084359060837702,0.4263565891472868,0.8339239208143054,1.0,2/16,4.90%,FGF10;IL12A
prerank,carboxylic acid metabolic process (GO:0019752),0.328027737878198,1.0084244411016439,0.46218487394957986,0.8328490834485137,1.0,4/33,5.63%,SLC2A1;SLC2A3;MIF;CSGALNACT1
prerank,regulation of cell junction assembly (GO:1901888),-0.3372009067471866,-1.008390932322758,0.4480651731160896,0.7135769626999502,1.0,6/27,6.91%,ROCK2;PDLIM5;ROCK1;SETD5;RAP1B;RUNX1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.36223722266842023,1.007917388727552,0.4397590361445783,0.8332606118699019,1.0,4/21,8.56%,PLTP;SIRT1;PPARG;GPS2
prerank,mesenchyme morphogenesis (GO:0072132),0.368371975576761,1.007638992038068,0.44420600858369097,0.8329723128874512,1.0,5/17,7.56%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1
prerank,negative regulation of defense response (GO:0031348),-0.2735185760598102,-1.0072431075085995,0.41495327102803736,0.7159795534459389,1.0,31/77,29.42%,PTGIS;IRAK3;TRAFD1;MAPKBP1;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;METRNL;SHARPIN;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,protein hydroxylation (GO:0018126),-0.3909048559105096,-1.0069181476679927,0.46942800788954636,0.716325182625928,1.0,4/15,10.09%,PLOD2;P3H3;ASPH;EGLN3
prerank,synaptic vesicle transport (GO:0048489),-0.42137007961169637,-1.006760204844647,0.45724907063197023,0.7161850044940723,1.0,4/11,26.29%,TMEM230;SPG11;TOR1A;KIF5B
prerank,myotube cell development (GO:0014904),-0.4444312406676134,-1.0062731295545504,0.4681274900398406,0.7169326970544676,1.0,4/10,17.02%,IGF1;SKI;SELENON;SIX1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2710999256451579,1.006073498593728,0.4372384937238494,0.8364696886561579,1.0,17/79,14.11%,ST8SIA4;ST3GAL6;CHST9;CSGALNACT1;ST8SIA1;FUT9;ALG3;B3GALT5;ALG1;MPI;ST8SIA6;B3GNT2;ST8SIA3;SERP1;BMPR2;BMPR1B;GOLGA2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.42343628397704913,-1.005847342533527,0.44669117647058826,0.7175335603764239,1.0,2/12,16.83%,NUPR1;IL18
prerank,response to retinoic acid (GO:0032526),-0.286151949489678,-1.0057657289070727,0.4419047619047619,0.7172626018029361,1.0,12/59,13.00%,EPHA3;PTK7;WNT5B;WNT6;RBP4;RARG;CTSH;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,mitotic spindle organization (GO:0007052),-0.24725872846442076,-1.0055902655991769,0.4316831683168317,0.717214088798919,1.0,81/153,39.55%,EML4;FLNA;MAP4;PIBF1;RANBP2;SPICE1;PCNT;NDEL1;STAG1;RHOA;LSM14A;DYNC1LI1;RAB11A;ABRAXAS2;MAPRE1;TOGARAM1;NUDC;MAP9;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;STAG2;PMF1;EFHC1;VCP;NEK6;TAOK1;WDR62;NUP98;SMC1A;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;KIF23;SUN2;INCENP;ABRAXAS1;KIF11;MZT1;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;CKAP5;RAN;PRC1;AHCTF1;NUP133;SEC13;SMC3;TTK;B9D2;MISP;TPX2;CENPI;DCTN6;RCC2;CENPH;KIFC1;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA
prerank,insulin receptor signaling pathway (GO:0008286),-0.2809878151538957,-1.00546597256624,0.4520547945205479,0.7170331370297752,1.0,14/69,10.03%,RHOQ;SORBS1;GRB10;ATP6V1B2;GSK3B;IRS1;ATP6V0D1;SLC39A14;SHC1;FOXC2;ATP6V0A4;IGF2;FER;PTPN2
prerank,regulation of mast cell activation (GO:0033003),-0.444747990407099,-1.004953275648058,0.45604395604395603,0.7179125612120082,1.0,4/10,20.55%,PLSCR1;LYN;NECTIN2;CD84
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.33833361161478226,1.0049237162581042,0.4520255863539446,0.838763125744546,1.0,3/26,3.87%,GRIN1;ADGRB1;SNCA
prerank,cardiac muscle cell action potential (GO:0086001),0.32327970470067724,1.0045257959065452,0.44285714285714284,0.8388673979924287,1.0,7/30,6.56%,SCN1A;FGF12;CACNA2D1;SLC8A1;SCN4B;HCN2;KCND3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4435325414059518,-1.0041053210935134,0.4805914972273567,0.7196277634694493,1.0,1/10,0.93%,APPL2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.30786687395070494,-1.0039054946397648,0.44664031620553357,0.7196783712978724,1.0,8/41,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,cellular response to light stimulus (GO:0071482),-0.2780905449022707,-1.0038910517775896,0.45229007633587787,0.7192287051390522,1.0,29/66,39.13%,INO80;EP300;CREBBP;DHX36;PTPRK;ZBTB1;PRKCD;USP47;PARP1;EIF2AK4;GNB1;SDE2;PCNA;BMF;ATR;USP28;KDM1A;SAG;RUVBL2;BAK1;OPN3;PDE6A;GPR88;NPM1;TRIAP1;NEDD4;TP53;CDC25A;CNGB1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3346412429252904,-1.0037088142656458,0.44834307992202727,0.7191968791744242,1.0,5/25,16.18%,ITPR1;LRRK2;TMBIM4;P2RX4;CMKLR1
prerank,regulation of platelet aggregation (GO:0090330),-0.3756834074983212,-1.003487086929116,0.4680451127819549,0.7192905853255128,1.0,8/17,27.15%,PDPN;CD9;LYN;PRKCD;PRKCA;F11R;SYK;ALOX12
prerank,negative regulation of viral process (GO:0048525),0.28902745107697625,1.003242239478932,0.4596774193548387,0.8416072560940306,1.0,9/57,10.91%,MBL2;PROX1;TRIM13;ISG15;TRIM62;TRIM6;IFITM3;SLPI;MID2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.41443126794172025,-1.0032081901784518,0.4676113360323887,0.719489342003444,1.0,5/12,18.87%,AKAP8L;NIPBL;VEGFA;PRKD1;SAP30BP
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3995487478033828,-1.003183023744679,0.4337121212121212,0.7190668939264341,1.0,6/13,29.28%,RNF152;SESN1;CASTOR2;SZT2;KPTN;CASTOR1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.2456485292480269,-1.0030219645818164,0.4583333333333333,0.7189997132069537,1.0,14/142,6.22%,ATP1A2;CACNA1C;LPAR1;SMAD3;PLCE1;PDGFRA;ADCY5;ABL1;CD55;DLG4;ADRA1B;CCR9;HMGB1;EDNRA
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.41385537364219777,-1.002814599590787,0.4485981308411215,0.7190456616577864,1.0,5/12,19.26%,SORBS1;IRS1;IGF2;PRKCZ;PTPN11
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.24694312944082478,-1.0028038437682592,0.44509803921568625,0.7185872536101869,1.0,40/150,21.57%,EGFR;TCF7L2;GAB2;TGFBR1;PDGFRA;ANGPT1;FGF1;PDGFRB;AXL;KIT;OSBPL8;IRS1;ITGB1;THBS1;FGFR2;F3;PDPK1;IGF2;FRS2;KL;RICTOR;PIK3AP1;P2RY12;TXN;P2RX4;IAPP;IL18;PIK3CD;CX3CR1;GCNT2;PARK7;MYOC;HBEGF;NRG4;GAB1;PTPN11;FGFR4;PIK3R1;AKT2;FGF2
prerank,metanephros development (GO:0001656),-0.34420309406362204,-1.0028007148900406,0.44621513944223107,0.7181141444161885,1.0,10/26,17.02%,FOXD1;PKD1;BMP7;BMP4;OSR1;CTSH;NIPBL;PKD2;PTCH1;SIX1
prerank,DNA catabolic process (GO:0006308),0.4146839498885674,1.002779301850092,0.4532520325203252,0.8418744872038239,1.0,1/11,1.05%,DNASE1
prerank,nucleotide catabolic process (GO:0009166),0.3796406667255827,1.0026740961560574,0.46236559139784944,0.8410944590873839,1.0,3/16,9.52%,NUDT3;GPX1;NT5C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.39487046786774543,1.0023045424831536,0.4465811965811966,0.8411232712622063,1.0,1/14,1.04%,IL17F
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3638506883021977,-1.0019679912136576,0.4533333333333333,0.7197794137525195,1.0,5/21,13.71%,ST3GAL4;B4GALT1;B3GALT1;ST3GAL3;ST6GALNAC5
prerank,protein homooligomerization (GO:0051260),0.25693915563742276,1.0019070143729567,0.43992248062015504,0.8411613641069194,1.0,13/114,7.43%,MPP2;HCN1;ADCY8;KCNC2;MIF;AQP11;RYR3;GLRA3;ASIC1;SLC1A2;TRPM2;NINJ1;HPRT1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4011314867069138,1.001620218690688,0.4753747323340471,0.8409418674393134,1.0,2/13,9.44%,IL12A;CYRIB
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3548362766001984,1.001567373155802,0.44849785407725323,0.840006452906268,1.0,4/22,8.89%,MBP;THY1;KLF4;SKAP1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3053596535116609,-1.0009929168331257,0.46322067594433397,0.7217919109201628,1.0,5/40,7.88%,IGF1;OPA1;PRKN;DNM1L;FAM162A
prerank,peptidyl-serine modification (GO:0018209),-0.24106040807835494,-1.000780835161579,0.44556451612903225,0.721885714187393,1.0,52/166,22.40%,ROCK2;TGFBR1;PKD1;TLK1;ROCK1;SMG1;CAMK1D;LRRK2;TGFBR2;CSNK1A1;TOP1;GSK3B;TBK1;MARK3;PAK2;EIF2AK3;CAMK2D;MTOR;PDPK1;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;ULK2;PARP1;MKNK2;POGLUT2;RICTOR;PRKDC;LATS1;PRKCZ;CSNK2A1;MARK1;IKBKE;PRKACA;PRKD1;MORC3;GALNT1;CSNK1D;CDK2;NEK6;NTMT1;CAB39;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;CLSPN
prerank,glucose homeostasis (GO:0042593),-0.26770295171139047,-1.000731176849687,0.4714828897338403,0.7215178065451975,1.0,25/83,22.46%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3;LRRC8D;FOXK1;PPARGC1A;PTPN2;HIF1A;FOXK2;ADRA2A;CRTC2;PRKAA1;INPP5K;PARK7;FGFR4;PIK3R1;USF1;KCNB1;WFS1
prerank,carboxylic acid catabolic process (GO:0046395),-0.41002490855631096,-1.0005248178324788,0.46588693957115007,0.721545771741953,1.0,8/12,46.18%,RENBP;BCKDK;ACOT8;PON3;NPL;IL4I1;NAGK;GNPDA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36978317056046306,1.0005229492336354,0.4329896907216495,0.8420392660316784,1.0,8/17,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.370295563823554,-1.0004339626351935,0.4671814671814672,0.7212853962148292,1.0,2/18,7.01%,ATP1A2;CAMK2D
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27393147190865413,-1.0003858919669206,0.46938775510204084,0.720927461624774,1.0,13/72,10.12%,CFLAR;TRIM44;PIAS1;AXL;TAX1BP1;JAK1;ELF1;IRAK3;RUNX1;IRAK2;HIPK1;PTPN2;TRAF2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3212587440691557,-0.9999876542327841,0.44861660079051385,0.7214345574016622,1.0,12/32,22.44%,MAP3K3;MEOX2;RHOJ;THBS1;FOXC2;ANXA1;RHOA;VEGFA;FGFBP1;FGF2;SRPX2;TBXA2R
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42106782260756337,-0.999884431134309,0.49193548387096775,0.7212308826675913,1.0,4/13,11.49%,BMP4;NFIB;REST;NFATC4
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.36666018338647166,-0.9998276492131963,0.47104247104247104,0.7208873204403279,1.0,9/19,23.47%,ELF1;RUNX1;IRAK2;DHX9;PARP9;MAVS;WNT5A;IRAK1;MAPK7
prerank,rRNA modification (GO:0000154),0.355409889659734,0.9996138403570668,0.45689655172413796,0.8436210142660259,1.0,5/21,12.06%,TSR3;TFB1M;FBL;DKC1;NHP2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.29698227855021536,0.9993436967763745,0.45085470085470086,0.8433705256964323,1.0,11/51,9.89%,NYAP2;CNTNAP2;GPM6A;TNIK;PAK1;EPB41L3;CNTNAP1;UBB;SHTN1;TAOK2;DAB2IP
prerank,cellular response to unfolded protein (GO:0034620),0.33580353754418835,0.998971584901258,0.4817813765182186,0.8433837171277967,1.0,6/26,12.68%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP;HSPD1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.37262284927484224,0.9988440624636323,0.45569620253164556,0.8426593085753475,1.0,5/18,15.39%,GINS2;LIG3;MCM3;RFC4;POLD3
prerank,endothelial cell proliferation (GO:0001935),0.38124773431732606,0.9988392626522054,0.4451345755693582,0.8415756915426887,1.0,5/17,12.88%,TEK;ACVRL1;CD34;THAP1;BMPR2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3468067936841229,0.9986617346227354,0.44676409185803756,0.8410425220618446,1.0,6/24,13.90%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1
prerank,DNA duplex unwinding (GO:0032508),-0.29486474885517694,-0.9983412721822951,0.45419103313840153,0.7241099182011094,1.0,25/50,33.12%,GTF2H2;RAD23B;NBN;ANXA1;DHX9;WRN;DDB2;MCM9;ASCC3;PARP1;ERCC3;MCM6;MRE11;SSBP1;GTF2H1;RECQL5;GTF2H4;MCM4;MCMDC2;SUPV3L1;RBX1;UBA52;TWNK;RAD51;DDB1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.3346665480895807,-0.9980492844616843,0.4577205882352941,0.7243551737394296,1.0,15/28,32.72%,PRKAG2;PRKAA2;MED1;PRKAB2;SIRT5;CTNS;CX3CR1;AVIL;FGFR4;SIRPA;NR1H4;FITM2;TNFRSF1B;C3;PDK4
prerank,T cell migration (GO:0072678),-0.40178624149930464,-0.9978413857966396,0.46466431095406363,0.7244106644849814,1.0,9/13,47.48%,CXCL16;SLC12A2;PIK3CD;MSN;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.42011605665859963,-0.9976166816053736,0.48237476808905383,0.7245164038426826,1.0,3/12,22.93%,IL17D;IL18;CD80
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3035220354565636,-0.9974758208139374,0.43520309477756286,0.7243873188623027,1.0,15/40,21.31%,ARAF;RAD23B;AXIN1;UFL1;NUB1;RPL11;FBXW7;SMURF1;LATS1;TRIM39;PDCL3;CSNK2A1;PML;DESI1;CDK5RAP3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3007550230118245,-0.9974714762846647,0.46558704453441296,0.723919380361436,1.0,15/44,22.48%,BMP7;BMP4;IRAK3;LYN;PTPN22;PRKCD;APOE;DUSP1;DUSP10;PDCD4;PTPN1;INPP5K;CDK5RAP3;DUSP7;CD300A
prerank,cation transmembrane transport (GO:0098655),-0.3024273125107088,-0.99709357404925,0.4549019607843137,0.7243608468750563,1.0,7/44,8.33%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC22A5;SLC6A9;SFXN2
prerank,mitochondrial fission (GO:0000266),0.37391415532969585,0.9962372717575585,0.46680080482897385,0.8470695435076774,1.0,4/16,12.49%,DNM3;GDAP1;MIEF1;SLC25A46
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4330650960418527,-0.995334507856717,0.47900763358778625,0.7283730788196119,1.0,8/10,43.56%,HMGB1;ATF7IP;THRA;ESR1;TP53;PSMC6;PSMC2;PSMC5
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.37058918226546744,-0.9951376033413722,0.46368715083798884,0.7283452616091429,1.0,8/19,18.77%,BMPR1A;SMAD6;MDM4;TGFBR2;SMAD4;ACVR1;HEYL;BMP2
prerank,C4-dicarboxylate transport (GO:0015740),0.394978892906492,0.9951002965327532,0.4791666666666667,0.8493743288071909,1.0,3/14,7.96%,SLC1A1;SLC1A2;SLC25A14
prerank,Rap protein signal transduction (GO:0032486),-0.43658427343179573,-0.9938308041995031,0.4952561669829222,0.7311465724089082,1.0,4/10,20.08%,RAP1B;RAPGEF3;RAPGEF2;RAPGEF1
prerank,positive regulation of neurogenesis (GO:0050769),0.28130258549815834,0.9938251395593637,0.4343629343629344,0.8520753357676626,1.0,11/68,9.60%,PTPRD;IL1RAPL1;MME;PLXNB3;SHANK3;NTRK2;NPTN;PLXNA4;ROBO2;CDKL5;OPRM1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2805360452696817,-0.9938183621364503,0.47928994082840237,0.7306907974585537,1.0,22/62,26.39%,PUM2;WTIP;TNRC6A;RANBP2;STAT3;DHX9;PUM1;NUP42;NUP214;LIMD1;TPR;POLR2H;AJUBA;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;FXR1;NUP93
prerank,myotube differentiation (GO:0014902),0.38155297384252296,0.9938171623666985,0.4613686534216336,0.8509947101601016,1.0,4/17,6.91%,ADGRB3;ADAM12;JAM2;KCNH1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2754285994932788,-0.9935837499447427,0.4619771863117871,0.7307695489359317,1.0,15/71,12.71%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.27771019844682165,-0.9931317410940889,0.4738878143133462,0.7314309883491655,1.0,12/66,10.24%,EGFR;SASH1;IL34;FGF1;PDGFRB;ROBO1;LRRK2;KIT;TAOK3;MAP3K5;TRAF2;PDGFC
prerank,regulation of platelet activation (GO:0010543),-0.35508892132388425,-0.9930613563690872,0.46078431372549017,0.7311155832857759,1.0,9/21,25.99%,PDGFRA;LYN;PLA2G4A;TEC;APOE;TLR4;PRKCA;SYK;FCER1G
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3198253582535663,-0.9922852718108353,0.4619883040935672,0.7320764054887536,1.0,14/31,27.98%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3198253582535663,-0.9922852718108353,0.4619883040935672,0.7320764054887536,1.0,14/31,27.98%,GTF2H2;CCNH;CDK7;MNAT1;ERCC3;RNGTT;POLR2H;GTF2F1;POLR2K;GTF2H1;POLR2E;NCBP2;GTF2H4;POLR2D
prerank,pyruvate metabolic process (GO:0006090),0.28603368999203527,0.9918669057499885,0.4573804573804574,0.8557291994274635,1.0,16/52,21.41%,BSG;PGAM4;PGAM1;ALDOC;PDHB;GCK;SLC16A1;PFKFB2;DLAT;GAPDHS;NR4A3;LDHB;LDHA;ENO2;SRR;GPI
prerank,regulation of protein kinase activity (GO:0045859),0.2539666610390173,0.991821764191248,0.4841897233201581,0.8547689778939597,1.0,26/106,16.88%,MMD2;SIRT1;CAMK2N1;GAS6;PPM1F;SNCA;THY1;MAPRE3;TRIB3;ADCYAP1;AKT1;YWHAG;HSPB1;RELN;SMG8;CEP43;UBASH3B;DVL1;EPHA1;TAB2;CDKN1A;RAP1A;GNAQ;DDR2;XRCC5;RAP2B
prerank,long-chain fatty acid import into cell (GO:0044539),0.42629153794316327,0.9917533045627017,0.4762979683972912,0.8538590901930084,1.0,4/10,15.73%,SLC2A1;SLC27A4;CD36;ACSL3
prerank,regulation of interleukin-12 production (GO:0032655),-0.30245556013611025,-0.9914012984746716,0.4666666666666667,0.7338137771118778,1.0,6/47,6.73%,FOXP1;IRAK3;PIBF1;HMGB1;THBS1;IL16
prerank,regulation of mitochondrial fusion (GO:0010635),0.4196017312411643,0.9913860065937805,0.44635193133047213,0.853857543932,1.0,2/11,2.11%,TFRC;OMA1
prerank,protein acetylation (GO:0006473),-0.3218453042383871,-0.9907166517541511,0.470703125,0.7350930200567279,1.0,8/30,16.29%,KAT2B;EP300;CREBBP;HAT1;ING5;NAA15;ESCO1;GTF2B
prerank,cardiac muscle cell contraction (GO:0086003),0.3593932285052374,0.9906311247696168,0.45625,0.8550065826441255,1.0,4/19,5.57%,SCN1A;FGF12;CACNA2D1;SCN4B
prerank,rRNA transcription (GO:0009303),-0.3763887822852583,-0.9904172879288233,0.4821763602251407,0.7353195416171057,1.0,9/17,34.60%,CAVIN1;BRF1;GTF3C4;SPIN1;GTF3C1;GTF3C6;POLR1G;GTF3A;ANG
prerank,sterol transport (GO:0015918),-0.3632506149875838,-0.9901764440737068,0.46897810218978103,0.7354588284653871,1.0,7/19,34.61%,OSBPL5;LDLR;NPC2;ARV1;CAV1;MSR1;LCAT
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.34422288765852677,-0.9898834998154882,0.47900763358778625,0.7357227185891423,1.0,6/24,17.01%,NBL1;HMGB1;LYN;CCN3;DUSP1;SERPINE1
prerank,response to glucose (GO:0009749),-0.2938120854081439,-0.9897249955825841,0.478515625,0.7356681831021867,1.0,17/46,23.18%,ZBTB20;TCF7L2;PRKAA2;SLC39A14;THBS1;VAMP2;UNC13B;SELENOS;PCK2;ERN1;ZBED3;PRKACA;PRKAA1;EIF2B4;PFKL;KCNB1;EIF2B5
prerank,megakaryocyte differentiation (GO:0030219),-0.4294696709791616,-0.9897148482920346,0.4835589941972921,0.7352090903466438,1.0,3/11,9.06%,KIT;UBA5;MED1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3537564604523607,-0.9894685241283253,0.5029821073558648,0.7353764586427102,1.0,10/24,24.21%,OPA1;PRKN;LRRK2;SELENOS;NR1H3;SYVN1;PARK7;LPCAT3;WFS1;TMBIM6
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.35784192099076395,0.9893358546324265,0.4791666666666667,0.8576729648599354,1.0,3/19,5.51%,CLDN5;PRKCH;OCLN
prerank,regulation of protein targeting to membrane (GO:0090313),0.33337354422738186,0.9892688881931968,0.4898373983739837,0.8567771903997995,1.0,7/28,14.98%,ANK3;MTCL1;MIEF1;ITGAM;HRAS;CIB1;GDI1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3238503826150016,-0.9891014198246287,0.5009560229445507,0.7358074891615636,1.0,9/30,19.07%,DSE;DCN;BGN;CHST15;HEXA;CHST11;CHPF2;CHSY1;CHST12
prerank,lytic vacuole organization (GO:0080171),-0.3163952963208952,-0.9883509954616654,0.48582995951417,0.7372164301592874,1.0,6/32,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.36368511214214233,-0.9883076704990594,0.4906716417910448,0.7368495679142154,1.0,5/20,18.35%,CD55;TRAF2;PRKCZ;IL18;TRAF6
prerank,nucleotide biosynthetic process (GO:0009165),-0.36736197867110254,-0.9883061047662205,0.47338403041825095,0.7363676239436419,1.0,10/18,27.62%,NMNAT2;RRM2B;ME1;PPAT;NMNAT3;NMNAT1;PRPSAP2;RRM1;PRPS1;PRPS1L1
prerank,gliogenesis (GO:0042063),0.38828798553557886,0.9882523581219851,0.4890829694323144,0.8586190993188055,1.0,4/15,9.08%,CDH2;PAX2;TGFB2;RELN
prerank,protein mannosylation (GO:0035268),-0.3588149654189251,-0.9881584899020652,0.4734848484848485,0.7362429935806437,1.0,11/22,23.78%,TMTC1;LARGE1;TMTC4;CRPPA;POMT2;FKTN;DPM1;TMTC3;POMT1;FKRP;DPM3
prerank,negative regulation of inflammatory response (GO:0050728),0.23948484730169917,0.9880249800664468,0.4838709677419355,0.8582336046709291,1.0,37/182,18.48%,TEK;PRKAR2B;ADCY8;ADCY3;LRFN5;GIT1;RPS19;RAMP2;ADRB1;PPARG;RHBDF2;KLF4;ADCYAP1;GNG2;GPS2;POMC;CD163;GPR176;CD200R1;ADCY4;PROC;GGT1;PTGER2;MFHAS1;OTULIN;PLK2;NPSR1;AOAH;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;TNFRSF1A;FYN;PRKAR1A;ADORA2B
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2909198910007404,-0.9876556986970778,0.48502994011976047,0.7370276973006068,1.0,19/54,19.51%,GPC6;SDC2;HS3ST3A1;GPC4;GNS;GPC3;EXT1;HSPG2;HS2ST1;NDST1;NDST2;GUSB;HEXA;PXYLP1;SDC4;HS6ST1;XYLT2;GCNT2;B4GALT7
prerank,positive regulation of chromosome organization (GO:2001252),-0.3854272766233012,-0.9869696044386275,0.46484375,0.7382742869555076,1.0,8/15,27.54%,NBN;DHX36;RAD21;MRE11;PML;PPP1R10;GNL3;ATRX
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.39115230092526315,-0.9867305052039278,0.4862204724409449,0.7384254339655708,1.0,8/14,30.55%,TNKS2;NABP2;BRCA2;TERF2;TERT;ATR;ATRX;PINX1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3820070188288609,-0.9866774298518373,0.47992351816443596,0.7380741106860998,1.0,6/15,18.60%,PCM1;PIBF1;CCDC14;SNX10;C2CD3;CSNK1D
prerank,respiratory chain complex IV assembly (GO:0008535),0.3532141330964636,0.986662390790873,0.46709129511677283,0.8611808674090784,1.0,11/21,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA6;COX10;COA3;OXA1L;SCO1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3729703840569363,0.9866096334193837,0.4799154334038055,0.8602206946740785,1.0,4/14,14.50%,GAS6;GPS2;RFFL;TRAIP
prerank,potassium ion homeostasis (GO:0055075),-0.3418944588851185,-0.9863151996200266,0.48722627737226276,0.7385016115278648,1.0,7/23,20.33%,ATP1A2;SLC12A7;KCNJ2;SLC12A2;SLC12A8;ATP1B3;SLC12A9
prerank,B cell mediated immunity (GO:0019724),0.43241679326204685,0.9863004894910137,0.4954954954954955,0.8600459836424822,1.0,1/10,3.14%,SLA2
prerank,RNA transport (GO:0050658),-0.27342870304292577,-0.9862144760672283,0.5060240963855421,0.738271993810484,1.0,21/71,23.72%,TGFBR2;CASC3;U2AF2;SRSF6;SIDT1;SLU7;EIF4E;SLBP;NUP214;TPR;YBX1;SRSF1;NXF1;SIDT2;SRSF7;SRSF11;SRRM1;UPF3B;SRSF2;XPO5;RTRAF
prerank,lipoprotein localization (GO:0044872),0.41309952078395346,0.9858572825245555,0.48106904231625836,0.860349166822734,1.0,4/11,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,positive regulation of protein deacetylation (GO:0090312),-0.39193622815168483,-0.9858353934984933,0.47591522157996147,0.7387253943682951,1.0,8/14,30.73%,AKAP8L;NIPBL;SAP30BP;FNTA;ZBTB7B;DYRK1A;NNMT;BRMS1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.39715981552777824,0.9850019342163161,0.49269311064718163,0.8617618625684498,1.0,2/12,1.57%,EPHB1;SPTBN4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4150797946372266,-0.9848191599310733,0.4832347140039448,0.7407537544888202,1.0,3/12,10.23%,ABCA1;ITGAV;NR1H3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3689267203485274,0.984804531495583,0.4617067833698031,0.8612560031423219,1.0,4/17,8.43%,SIRT1;NME5;AKT1;HSPB1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3475280815501929,-0.9845865356168125,0.47036328871892924,0.7408284904987843,1.0,8/22,28.12%,SASH1;RELL1;VEGFA;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24844370458910725,0.9845192372641766,0.47474747474747475,0.8609777282948089,1.0,34/132,17.89%,RPS19;GEMIN8;RPL38;RPF2;RPS27;RPL10;CELF5;SNRPC;CELF4;XAB2;RPLP0;HSP90AB1;PRMT7;MRPS7;RPS15;LSM4;RPL5;WDR77;SNRPD2;SNRPD1;RPL23A;NOP2;RPS14;DDX20;DDX1;RPS5;RPS28;MDN1;PTGES3;XRCC5;HSP90AA1;NAF1;PPAN;CELF6
prerank,endocardial cushion development (GO:0003197),0.34682095992708684,0.9841019788617912,0.465979381443299,0.8611001807171742,1.0,7/21,12.88%,HEY1;NOS3;NOTCH1;TGFB2;ACVRL1;FOXF1;BMPR2
prerank,membrane lipid metabolic process (GO:0006643),0.3423780571204246,0.9836477408757138,0.489749430523918,0.861297231613826,1.0,4/22,8.58%,GAL3ST1;ST3GAL6;TECR;SERINC1
prerank,positive regulation of intracellular transport (GO:0032388),-0.30528472607949003,-0.9833383915567363,0.49382716049382713,0.7435217154218975,1.0,13/38,18.26%,PCM1;NUMA1;BCAS3;STX18;PCNT;EHD2;VAMP2;ACTN2;TBC1D20;TPR;DYNC1H1;ICE1;EIPR1
prerank,regulation of axon regeneration (GO:0048679),-0.4129965443918081,-0.9831782547999681,0.48867924528301887,0.7434323073320391,1.0,3/12,8.09%,PTN;PTPRS;EPHA4
prerank,apical junction assembly (GO:0043297),-0.28397541769069473,-0.9831763937141981,0.45778611632270166,0.7429493766532713,1.0,9/53,10.27%,AFDN;VCL;MPP7;PARD6G;CTNNA1;DLG1;PAK2;CLDN11;RHOA
prerank,prostaglandin metabolic process (GO:0006693),-0.32499791267768807,-0.9831626689966613,0.46534653465346537,0.7425029088854016,1.0,6/26,12.46%,PTGDS;PTGIS;PTGS1;PLA2G4A;PTGES;PNPLA8
prerank,clathrin-dependent endocytosis (GO:0072583),0.33337534401610297,0.9829606540463628,0.5,0.8622918002018004,1.0,8/26,14.08%,AP2M1;SNAP91;FNBP1L;FCHO1;AP2B1;SGIP1;DLL1;CLTB
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3470072622816886,0.9828655723838738,0.47401247401247404,0.8614866017506768,1.0,3/21,6.99%,GRIN1;GRIN2B;BEX3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3538839686982109,-0.9828075070620584,0.45348837209302323,0.7428751925618583,1.0,9/20,25.25%,MCU;YME1L1;LETM1;MICU1;STOML2;SLC8A3;PARL;SLC8B1;PHB2
prerank,skeletal muscle tissue development (GO:0007519),-0.3260328336273266,-0.9826763084282654,0.483402489626556,0.7427397610231561,1.0,6/32,11.68%,SVIL;CFLAR;SKI;IGSF8;SELENON;MEF2C
prerank,negative regulation of JNK cascade (GO:0046329),-0.3158525946728865,-0.9825950434234718,0.4619771863117871,0.7424560121373234,1.0,9/31,16.90%,NCOR1;PRKN;TAOK3;DACT1;PTPN22;FKTN;SH3RF2;DUSP10;PDCD4
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2615844516834719,0.9825406997509941,0.5032119914346895,0.861393867843697,1.0,14/88,10.54%,EGFL7;TEK;PROX1;PLXNB3;TIE1;SIRT1;CAV2;PPP1R16B;KDR;ACVRL1;AKT1;PDGFB;PTPRM;SCG2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2695608410331166,-0.982189853499247,0.4894433781190019,0.7430350448115908,1.0,21/76,23.39%,BMP7;PTGIS;TAX1BP1;IRAK3;ANXA4;USP7;UFL1;IRAK2;PARP10;CYP1B1;PRMT2;CMKLR1;ARRB1;DAP;TRAF3;LRRC14;IRAK1;CDK5RAP3;CHP1;COMMD7;NLRC3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.373308564477223,0.9821608464934735,0.4671201814058957,0.86146533606804,1.0,6/16,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3999022748613359,-0.9820936344092241,0.4851301115241636,0.7428034945910706,1.0,6/14,27.14%,LIMS1;FLNA;LOXL3;PRKD1;CD63;SLC2A10
prerank,nuclear membrane organization (GO:0071763),-0.36141090782630486,-0.9819998052512626,0.49809885931558934,0.7425714693421475,1.0,7/19,29.16%,UBXN2B;AKAP8L;CHMP4B;EMD;TOR1A;NEMP1;GPER1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.36128388497199,0.9817311213606633,0.4707070707070707,0.8616864910770328,1.0,7/19,16.63%,TMEM109;SIRT1;HIPK2;BCL3;AEN;DDIT4;CDIP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3834421499789001,0.9816597164500505,0.47558386411889597,0.8608018493408756,1.0,7/15,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3620974183985352,-0.9815982118777653,0.48905109489051096,0.7430632258272994,1.0,4/18,12.34%,FLNA;PHF8;EIF2AK3;WDR43
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.38453823226696604,0.9815798250985137,0.4713656387665198,0.8599491303734305,1.0,4/14,16.18%,RPF2;RPL7;ZNHIT6;DDX18
prerank,regulation of protein neddylation (GO:2000434),0.4206803573967543,0.9814607728381771,0.4853273137697517,0.8592330225241592,1.0,4/10,15.74%,COPS9;EPAS1;RPL5;DCUN1D2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3092764092197498,-0.9814025732128135,0.4766355140186916,0.7431211574781655,1.0,10/36,14.09%,NR2F2;DCN;HMGB1;THBS1;SP100;JUP;ADAMTS9;MEF2C;ANGPT2;APOE
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3956749583626489,-0.9812762678353399,0.48811700182815354,0.7429381666452698,1.0,5/12,26.52%,AR;SELENOS;HDAC2;AP2A1;TAF7
prerank,macrophage differentiation (GO:0030225),-0.39708653863872445,-0.9808789256910339,0.4917431192660551,0.7434372425691302,1.0,5/13,14.36%,IL31RA;BMP4;CDC42;PARP1;VEGFA
prerank,protein deubiquitination (GO:0016579),-0.22619244956296203,-0.9807820058142066,0.5070707070707071,0.7431939568545126,1.0,46/242,14.79%,SMAD3;TGFBR1;INO80;SMURF2;MDM4;USP24;KAT2B;EP300;PRKN;RAD23B;USP7;SMAD2;WDR48;TRRAP;ENY2;BRCC3;MYSM1;AR;FOXK1;DDB2;VCPIP1;USP33;TRAF2;RHOA;TADA3;HIF1A;HCFC1;SMAD4;RHOT1;USP47;WDR20;PSMF1;OGT;USP12;KDM1B;USP11;USP4;ABRAXAS2;BECN1;USP46;USP35;USP50;PSMB2;USP2;OTUD4;USP13
prerank,icosanoid secretion (GO:0032309),-0.40236942927866093,-0.9806205528017852,0.490272373540856,0.7431480819525209,1.0,3/12,15.56%,ANXA1;PNPLA8;BDKRB2
prerank,RNA splicing (GO:0008380),-0.2553785667063245,-0.9802716052594183,0.48565965583174,0.7435657214371728,1.0,34/95,26.80%,SYNCRIP;SRSF10;FUS;SF3B1;PRPF6;RNPC3;PPARGC1A;SLU7;PRPF3;USP39;SCAF11;SF3A3;RSRC1;ZCRB1;DDX23;TCERG1;SFPQ;ZMAT5;SNRPF;SRSF7;SRSF11;GEMIN2;SRRM1;PPP2CA;SRSF2;USB1;LUC7L3;CCAR2;SMU1;DHX15;NONO;NCBP2;PRPF8;LSM6
prerank,response to hydroxyurea (GO:0072710),-0.41703591386495775,-0.9802329739084975,0.498989898989899,0.7431753866404647,1.0,2/11,7.42%,SPIDR;DDI2
prerank,positive regulation of blood coagulation (GO:0030194),-0.37281602836917466,-0.9800494920630447,0.4955116696588869,0.7431758982656788,1.0,3/17,7.34%,ST3GAL4;THBS1;F3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2694763868414245,-0.9796731704704194,0.49433962264150944,0.7436582399086644,1.0,15/73,12.71%,CYFIP2;ABL1;WASF2;LYN;CDC42;VAV2;BRK1;PLCG1;WASL;PRKCD;YES1;ABI1;NCKAP1;WIPF1;ARPC2
prerank,artery development (GO:0060840),-0.3399207336116318,-0.9790772756856165,0.5164609053497943,0.744656148422223,1.0,8/23,16.74%,TGFBR1;ROBO1;NRP1;HES1;PKD2;EFEMP2;VEGFA;HECTD1
prerank,protein localization to chromosome (GO:0034502),-0.31332197507859344,-0.9790619163280944,0.4569789674952199,0.7442199211451842,1.0,19/34,37.28%,TNKS2;MCM9;XRCC4;RAD21;RB1;SLF1;TERF2;ATR;IFFO1;BOD1;ATRX;ESR1;PARP3;WAPL;PINX1;RPA2;SLF2;MSH2;MRNIP
prerank,cardiac cell development (GO:0055006),0.41383074656947166,0.9790514869606952,0.49333333333333335,0.8653701265597472,1.0,4/11,9.53%,MYH6;SLC8A1;NOTCH1;TCAP
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2576738384715733,-0.978763826077719,0.5289421157684631,0.7445129146430666,1.0,13/98,7.95%,EGFR;LRP1;SORBS1;EPHA3;CEMIP;SLC5A3;PRKN;PTPN9;DLG1;ITGB1;TFDP2;BCL2;PDPK1
prerank,defense response to tumor cell (GO:0002357),-0.4267097533053378,-0.9784497454409049,0.5121951219512195,0.7448024550413938,1.0,4/10,22.89%,RBMS3;DAPK1;PRDX2;PLK5
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3211494757482639,-0.9781651292961057,0.4816326530612245,0.745012472593144,1.0,5/28,8.60%,NUMA1;UBXN2B;ITGB1;NDEL1;GJA1
prerank,proteolysis (GO:0006508),-0.22599016720817997,-0.9779836824444886,0.5019762845849802,0.7449995132384346,1.0,48/252,17.11%,CPQ;TRABD2B;AEBP1;ADAMTS12;PCSK5;TBL1X;XPNPEP1;HTRA3;PLAT;HM13;CTSC;CTSH;DPP4;ADGRV1;DPP8;F3;DDI2;ECE1;SENP6;ANPEP;FBXO3;ADAMTS9;NCSTN;LONP2;MMP14;SENP1;LAP3;ADAM19;FAP;YME1L1;MMP2;SUFU;NPEPPS;ADAM33;NLN;CPM;OGT;CASP2;LACTB;CTSA;CPXM2;MBTPS1;PTCH1;LNPEP;ATG4D;SPRTN;CLPP;CPXM1
prerank,response to muramyl dipeptide (GO:0032495),-0.41381987527588393,-0.9775951594037471,0.4971857410881801,0.7455414447683689,1.0,3/12,9.46%,VIM;PTPN22;CHMP5
prerank,toll-like receptor signaling pathway (GO:0002224),0.25670289981963507,0.9774584741687614,0.4946236559139785,0.8690784303635273,1.0,18/84,17.13%,TIRAP;S100A9;S100A8;RPS27A;UBC;TLR2;UBB;TRIL;BCL10;ITGAM;CTSB;HSPD1;RFTN1;CD36;TAB2;MAPKAPK2;TNIP1;BTK
prerank,"wound healing, spreading of cells (GO:0044319)",-0.33800079893848795,-0.9772961808941715,0.49521988527724664,0.7457751260134535,1.0,11/24,23.14%,COL5A1;PDPN;FLNA;ARHGAP24;RHOA;CCN1;ITGA5;DDR1;RHOC;TOR1A;ARHGAP35
prerank,protein alkylation (GO:0008213),0.3437090761254498,0.977224997102339,0.49079754601226994,0.8687062447966747,1.0,6/22,15.05%,LCMT1;EEF1AKMT1;ETF1;FAM98A;VCPKMT;METTL22
prerank,response to laminar fluid shear stress (GO:0034616),-0.4324070485206313,-0.9770030911193487,0.49171270718232046,0.7459939442441595,1.0,2/10,1.66%,ABCA1;SMAD6
prerank,purine nucleotide metabolic process (GO:0006163),0.33173832590354974,0.976970896538318,0.48625792811839325,0.8683517135045288,1.0,6/24,12.98%,GPX1;GART;HPRT1;MTHFD1;NT5C;GUK1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3915987213555555,-0.9768051021485187,0.5017857142857143,0.7460102619662585,1.0,4/14,16.83%,TGFBR2;CD55;PTPN22;IL18
prerank,regulation of inflammatory response (GO:0050727),-0.23438123032730576,-0.9763677931765684,0.52465483234714,0.7466381877127157,1.0,55/190,24.15%,FOXP1;ADAMTS12;CELF1;NR1D2;PTGIS;SBNO2;SNX6;DAGLA;UFL1;IL16;ANXA1;DHX9;VAMP2;CASP12;XIAP;IL17RA;SELENOS;PTPN2;CCN3;NR1H3;PTGES;ENPP3;PRKCD;NAPEPLD;NFKBIZ;RORA;AGTR1;RB1;PIK3AP1;APOE;C1QTNF3;GPR4;FEM1A;IL18;PDCD4;SERPINE1;TLR4;CCN4;WNT5A;AREL1;IFI35;METRNL;PARK7;MGLL;SHPK;SHARPIN;LPCAT3;SPHK1;DAGLB;USP18;NLRC3;MAPK7;MVK;SIRPA;IL1RL2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4046712504856666,-0.97619366136426,0.4971209213051823,0.746130953985142,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4046712504856666,-0.97619366136426,0.4971209213051823,0.746130953985142,1.0,2/12,4.33%,IGF1;SLC9A1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.41032739246484046,0.975817298739101,0.49896907216494846,0.8706520559554914,1.0,3/11,14.55%,TIRAP;PJA2;MFHAS1
prerank,regulation of lipid catabolic process (GO:0050994),0.3522854952018444,0.9755906801162912,0.501039501039501,0.8702282698668988,1.0,2/19,5.87%,HCAR2;ALK
prerank,focal adhesion assembly (GO:0048041),-0.3531944624087023,-0.9753819449623824,0.5096525096525096,0.7476919983529433,1.0,6/21,15.29%,SORBS1;BCR;PTPRK;ACTN2;CTTN;WHAMM
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3526764703411285,0.9753735524359857,0.4553191489361702,0.8697800540483859,1.0,5/19,7.55%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.38955345139997416,0.975284054695598,0.5251046025104602,0.8689648728696321,1.0,3/13,13.01%,TMEM30A;SAR1A;SORL1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.33164662713035276,0.9751501561689575,0.4698275862068966,0.8682954391355788,1.0,3/27,4.46%,FLT1;TEK;FLT3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4197333845997151,-0.9748592674752893,0.4932821497120921,0.7484997278003297,1.0,4/11,6.65%,IGF1;GHR;IRS1;EIF2AK3
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2744950787685939,-0.9743612966392546,0.486,0.7492728509207913,1.0,24/64,29.42%,ACSL1;DAGLA;ASAH2;CPT2;CYP1B1;PLA2G4A;ACSL6;PNPLA8;EPHX1;EPHX2;ACOX1;ACAD9;CPT1A;MGLL;ACSL4;ELOVL1;ACOT8;DAGLB;GSTM2;ACSBG1;ALOX12;ELOVL5;PLA2G4C;AIG1
prerank,endothelial cell differentiation (GO:0045446),0.4017576709859377,0.9743363577504506,0.4897959183673469,0.8697066483954925,1.0,4/12,7.56%,PROX1;TIE1;KDR;ACVRL1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3181570718846683,0.9738800509554454,0.4968553459119497,0.8700161782300125,1.0,5/31,13.15%,TIRAP;PLCB1;TLR2;HSPD1;CD40
prerank,positive regulation of macrophage migration (GO:1905523),-0.3549000649621666,-0.9730827342861486,0.4981549815498155,0.751923934799462,1.0,5/19,16.18%,IL34;THBS1;P2RY12;P2RX4;CMKLR1
prerank,lipoprotein transport (GO:0042953),0.41838168204534926,0.9729325221456243,0.5,0.8716672431907129,1.0,4/10,13.89%,PPARG;ZDHHC17;VMP1;CD36
prerank,myeloid cell development (GO:0061515),-0.367332848796589,-0.97245050913031,0.5096525096525096,0.7530238637847065,1.0,4/18,9.06%,FOXP1;KIT;ANXA2;MED1
prerank,microtubule anchoring (GO:0034453),-0.3934218846003087,-0.972002416450326,0.4970873786407767,0.7536090798444041,1.0,2/12,1.98%,DAG1;PCM1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2579080525204966,-0.9719250092333157,0.5248508946322068,0.7533106715255904,1.0,22/87,23.02%,RBFOX2;FLRT2;HNRNPH1;FGF1;SHOC2;HNRNPM;FGFR2;FRS2;KIF16B;KL;FLRT1;FIBP;NR4A1;FGFBP1;CEP57;POLR2H;PTPN11;SPRED2;FGFR4;FGF2;GTF2F1;POLR2K
prerank,positive regulation of behavior (GO:0048520),0.43266440779015386,0.9718641788491361,0.49023861171366595,0.8737559237585839,1.0,4/10,18.27%,NLGN1;NPAS2;SGIP1;NR4A3
prerank,plasma membrane tubulation (GO:0097320),-0.3967239112554886,-0.97151699023408,0.4962121212121212,0.7538044459489206,1.0,5/13,15.29%,PACSIN2;SNX9;CHMP4A;EHD2;WHAMM
prerank,negative regulation of binding (GO:0051100),-0.2602156076903159,-0.9712396303499575,0.5059288537549407,0.7539897378414355,1.0,16/81,10.43%,ARHGAP28;DAB2;ROCK1;SMO;LRRK2;GSK3B;STYX;IFIT2;SP100;DACT1;CSNK1E;BTAF1;USP33;NES;JUN;PRKCD
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3594009037390324,-0.9712166224602579,0.4897579143389199,0.7535670743227664,1.0,8/18,18.77%,BMPR1A;MDM4;BMP4;TGFBR2;ACVR1;HEYL;TBX2;BMP2
prerank,smoothened signaling pathway (GO:0007224),-0.3092034269028641,-0.9711884580446063,0.49709864603481624,0.753154058201984,1.0,9/32,15.46%,GLI3;GLI2;SMO;ARL13B;EVC2;HIPK1;CC2D2A;GLI1;PTCH1
prerank,activation of adenylate cyclase activity (GO:0007190),0.30761121865256963,0.970649933231002,0.4796573875802998,0.8761834320402059,1.0,7/35,11.11%,ADCY8;ADCY3;ADRB1;LGR5;ADCYAP1;CAP2;ADCY4
prerank,positive regulation of nuclear division (GO:0051785),-0.3281995469516143,-0.9706390537990939,0.5074349442379182,0.7540343649969399,1.0,3/25,8.57%,IGF1;PDGFRB;IGF2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24876474084646355,-0.9700940049092499,0.5193798449612403,0.7549522222764835,1.0,32/110,23.47%,ROCK2;SMURF2;PRKN;WWP2;GSK3B;GPC3;HUWE1;AXIN1;WWP1;SEC22B;SLC6A9;DACT1;NR1H3;AGTR1;STX5;APOE;SMURF1;RANBP9;IL17D;CSNK2A1;IL18;ASB5;WNT5A;AREL1;VCP;EIF4G1;INHBA;SNF8;WFS1;CD80;NSF;MAPK7
prerank,negative regulation of transport (GO:0051051),0.2910682007374543,0.9700241864620437,0.5149700598802395,0.8769327996097925,1.0,8/51,7.93%,NRG1;SYT11;MCTP1;PPM1F;SNCA;TLR2;DYSF;YRDC
prerank,glycolytic process (GO:0006096),0.32520672858934624,0.970016916668599,0.5061728395061729,0.8758667623870456,1.0,9/28,21.41%,PGAM4;PGAM1;ALDOC;GCK;PFKFB2;GAPDHS;LDHA;ENO2;GPI
prerank,spliceosomal snRNP assembly (GO:0000387),0.3047923010079929,0.9699316385388935,0.4889380530973451,0.8750318183245409,1.0,11/38,14.81%,GEMIN8;SNRPC;SRSF12;PRMT7;LSM4;WDR77;SNRPD2;SNRPD1;DDX20;LSM2;CD2BP2
prerank,protein maturation (GO:0051604),0.25751003330727446,0.9696806399773044,0.5215686274509804,0.8746881856852522,1.0,19/95,13.72%,MME;LMF2;PCSK1;PCSK2;METAP2;PHEX;PCSK6;PSENEN;MMP16;PITRM1;PCSK7;TSPAN17;TMPRSS4;TSPAN14;HSPD1;SORL1;TASP1;GALNT2;PSEN1
prerank,negative regulation of secretion (GO:0051048),0.42881806030856173,0.9692076501264821,0.5135135135135135,0.8750165824598573,1.0,1/10,2.45%,NRG1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4064891944957256,-0.9687351918946092,0.50390625,0.7578321712828671,1.0,3/12,4.74%,PCM1;NIN;NINL
prerank,T cell activation involved in immune response (GO:0002286),-0.3958753885080336,-0.9685283167266535,0.50682261208577,0.757861998700752,1.0,11/12,58.53%,EIF2AK4;FCER1G;ICAM1;MDK;SLC11A1;LILRB1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,positive regulation of cell adhesion (GO:0045785),0.26581394669144365,0.9683001007575883,0.5,0.8766588636444846,1.0,18/74,14.53%,FRMD5;MAGI1;CXCL12;PPM1F;IL12A;STX3;TGFB2;PTPRJ;NDNF;PDGFB;SMAD7;RET;MEGF10;DUSP26;CIB1;ADGRG1;ATM;PPP3CA
prerank,negative regulation of hemostasis (GO:1900047),-0.4058836225373982,-0.9679850266202491,0.4906716417910448,0.7587090903966277,1.0,4/12,17.01%,VTN;TFPI;APOE;SERPINE1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.34762095887277905,-0.9678629583315915,0.4945054945054945,0.7585530356001396,1.0,3/20,1.77%,BMPR1A;GLI2;NBL1
prerank,regulation of epithelial cell migration (GO:0010632),-0.2860644453749848,-0.9675689476895525,0.5178571428571429,0.7588491486917746,1.0,14/51,16.46%,DOCK5;SASH1;PTN;RHOJ;RREB1;CTSH;GLUL;PLCG1;HIF1A;BMPER;RAB11A;GLIPR2;DUSP10;DOCK1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3496990621049817,-0.967475637457567,0.5180505415162455,0.7585821699141171,1.0,10/20,29.45%,PRKAA2;BRD7;PPARGC1A;ARRB1;PRKAA1;NOS1;PAXIP1;RPS6KA4;RUVBL2;GLYR1
prerank,carbohydrate homeostasis (GO:0033500),-0.2697313334606247,-0.9671661143108916,0.5424063116370809,0.7588710966069676,1.0,9/67,6.07%,TCF7L2;APPL2;LEPR;MCU;PRKAA2;CYB5R4;RBP4;IRS1;STAT3
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3365273203460022,0.9671635835229592,0.5217391304347826,0.8789117631876527,1.0,4/22,10.79%,PDE4B;GPR35;CACNB2;CACNB4
prerank,regulation of endocytosis (GO:0030100),-0.27326205612141236,-0.9670067406420694,0.5019455252918288,0.7587922796289299,1.0,24/61,25.90%,LRP1;EPHA3;DAB2;ROCK1;ABL1;PACSIN2;GPC3;STON2;ARFGAP1;ABL2;APOE;ZFYVE16;RUBCN;PICALM;PRKD1;PTPN1;ABCA7;LRSAM1;STON1;SPHK1;HIP1R;SNX12;RAB5A;CLIP3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3704531829353401,-0.9668905878266802,0.48349514563106794,0.758597462388491,1.0,4/16,12.87%,AUTS2;ARHGAP24;ARHGAP17;OGT
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3991087917461741,0.9668806648497821,0.4988962472406181,0.8786420473902294,1.0,3/12,8.89%,FUT9;AKT1;SKAP1
prerank,negative regulation of cellular component movement (GO:0051271),-0.3814636796198697,-0.9668436449278686,0.5093283582089553,0.7582386456269625,1.0,4/15,8.67%,TGFBR3;FBLN1;CD9;SP100
prerank,neural tube closure (GO:0001843),-0.30703263181959234,-0.9667841436397389,0.5039525691699605,0.7578968461131609,1.0,6/34,9.33%,LMO4;LRP6;SKI;MTHFR;VASP;PLXNB2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.29894716059892185,0.9667347388386035,0.5020661157024794,0.8779876179968042,1.0,6/39,5.95%,PAX8;TIE1;PAX2;KDR;FGF10;PAK1
prerank,epiboly involved in wound healing (GO:0090505),-0.36994980595016796,-0.9663346523196878,0.5121042830540037,0.7585397075013582,1.0,8/16,23.14%,PDPN;FLNA;RHOA;CCN1;DDR1;RHOC;TOR1A;ARHGAP35
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3887139480822939,-0.9661713003169522,0.4852941176470588,0.7584741312976284,1.0,5/13,19.19%,PLA2G4A;MOGAT3;ABHD12;ABHD6;MGLL
prerank,regulation of multicellular organismal development (GO:2000026),-0.33108226795870443,-0.9655099510434074,0.5168539325842697,0.7595892793809698,1.0,7/25,16.92%,PTN;TRIP12;MYSM1;DHX36;NIPBL;EHMT1;OAS2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3465086618768607,-0.9651229328168064,0.5243445692883895,0.760041349904452,1.0,3/20,5.41%,SULF1;SULF2;THBS1
prerank,tRNA 5'-leader removal (GO:0001682),0.3846546916577785,0.9650611779651649,0.49557522123893805,0.881807709355848,1.0,3/13,12.32%,RPP40;RPP30;POP5
prerank,negative regulation of myotube differentiation (GO:0010832),-0.39138650490051485,-0.9649669127176234,0.5,0.7599832098709889,1.0,5/12,20.74%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119
prerank,fibrinolysis (GO:0042730),-0.40650498496378284,-0.9649069388769257,0.4962121212121212,0.7596573549457907,1.0,9/13,54.56%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,acetyl-CoA metabolic process (GO:0006084),0.3790610296131201,0.9648596488905575,0.5154185022026432,0.8813379651930414,1.0,7/15,24.94%,MVD;ACSS1;HMGCS1;PPCS;PMVK;ACAT1;DIP2A
prerank,positive regulation of angiogenesis (GO:0045766),0.2517450938716913,0.9641156551581219,0.5273109243697479,0.882485661228018,1.0,22/108,13.94%,FLT1;TEK;ADAM12;TIE1;RAMP2;SIRT1;HMGA2;KDR;NOS3;ETS1;KLF4;APLNR;NINJ1;CD34;HSPB1;HIPK2;TJP1;EPHA1;CD40;XBP1;DLL1;ANGPTL4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4300359461869109,-0.9639980747001035,0.5380333951762524,0.7613566742784496,1.0,5/10,27.54%,INO80;STOML2;SSBP1;DBF4;ATRX
prerank,monocarboxylic acid transport (GO:0015718),-0.2845522316214469,-0.9638042936401288,0.5369261477045908,0.7613839724810901,1.0,10/51,10.92%,SLC6A13;SLC16A12;SLCO3A1;SLC6A12;SLCO2A1;SLC16A6;ATP8B1;NCOA1;SLC16A9;SLC5A6
prerank,iron ion transport (GO:0006826),-0.28978431146858763,-0.9634656575953876,0.5095785440613027,0.7617676154614983,1.0,7/47,7.13%,CP;STEAP3;ATP6V1B2;SCARA5;ATP6V0D1;SLC39A14;ATP6V0A4
prerank,icosanoid metabolic process (GO:0006690),-0.2987152972747092,-0.963109925650982,0.5370018975332068,0.7621911819057626,1.0,16/40,29.81%,PTGIS;DAGLA;PTGS1;CYP1B1;PLA2G4A;PON2;PNPLA8;EPHX1;MGLL;DAGLB;ABCC10;PON3;GGT5;ALOX12;PLA2G4C;TBXAS1
prerank,cellular response to hydroxyurea (GO:0072711),-0.4178676789207345,-0.9628238977606318,0.5079051383399209,0.762398863660595,1.0,2/10,7.42%,SPIDR;DDI2
prerank,regulation of TORC1 signaling (GO:1903432),-0.31210567705064707,-0.9622070878657144,0.5089820359281437,0.7633931816825472,1.0,12/33,26.24%,RNF152;SESN1;TELO2;CASTOR2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;SZT2;KPTN;RRAGA
prerank,cardiac muscle cell development (GO:0055013),-0.35349100806620837,-0.9619360590621981,0.5314183123877917,0.7635281569946039,1.0,5/20,7.29%,PDGFRA;PDLIM5;PDGFRB;CXADR;OBSL1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.40290996719182093,0.9618181131445458,0.4810924369747899,0.8879829698601438,1.0,2/11,3.31%,HCAR2;SIRT1
prerank,photoreceptor cell development (GO:0042461),0.38593784662043074,0.9615058350702329,0.4968814968814969,0.8878522764832812,1.0,4/14,14.28%,AHI1;MFSD2A;RORB;DCX
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.343283839374328,-0.9614897940656032,0.4885057471264368,0.7641548120075135,1.0,5/21,9.09%,ADCY9;ADCY5;ADCY1;ADCY6;GUCY1A1
prerank,negative regulation of cilium assembly (GO:1902018),-0.40121004878228594,-0.9610253303611518,0.5129151291512916,0.7648709368252432,1.0,7/12,27.43%,YAP1;MAP4;ODF2L;CDK10;TBC1D7;TCHP;TESK1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.334761050697711,0.9609510072054471,0.5096774193548387,0.8883544315326839,1.0,4/22,8.74%,PSMA1;ENC1;PSMA6;PSMB3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.22372739661908136,-0.9603526572742463,0.5619834710743802,0.7660781474054612,1.0,55/234,18.53%,ROR1;SMAD3;NFKB1;SLCO3A1;LRP6;PLPP3;UBE2N;CFLAR;ZIC2;STK3;EP300;HDAC4;ERC1;CAMK1D;SMO;EDA;FLOT2;KIT;IRAK3;PPARGC1B;FZD2;STAT3;ADCY1;IRAK2;DHX9;TRIM8;CEBPG;CRTC3;AR;PPARGC1A;JUP;ATF2;FER;TRAF2;CRTC1;MAVS;MBTPS2;TRIM5;ARID5B;TCF3;TRIM25;ANXA3;CARD14;EIF2AK2;VEGFA;PRKCZ;IL18;IKBKE;TLR4;CRTC2;WNT5A;PRKD1;CX3CR1;TRAF6;FZD1
prerank,body fluid secretion (GO:0007589),0.37058886550110004,0.9602583277851712,0.49072164948453606,0.8893232419526862,1.0,2/15,7.13%,ERBB4;GUCA1B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.42248740800088824,-0.9601523159491654,0.5419847328244275,0.766071803629166,1.0,3/10,8.59%,IVD;ACADM;ACAD11
prerank,DNA metabolic process (GO:0006259),-0.2218914763446853,-0.9593344815694083,0.5828343313373253,0.7676073158403548,1.0,111/270,33.61%,TCF7L2;INO80;UBE2N;KMT5B;RBBP8;UVRAG;TOP1;HMGB1;USP7;UHRF2;NBN;RAD51B;TRRAP;PDS5A;WRN;SP100;DDB2;ZBTB1;CSNK1E;UPF1;MNAT1;PARP1;RAD21;RAD51D;PDS5B;ERCC3;ALKBH1;NABP2;KMT5C;DDX23;PARP4;MMS19;PRKDC;HINFP;UBE2B;MCM6;CTC1;MSH3;DMC1;NOP53;MRE11;GLRX2;HELB;ZRANB3;PRIM2;TOP2B;VCP;PARK7;MSH6;CDK2;TERF2;POLE4;POLA2;TERT;PCNA;SMC1A;FANCC;RPAIN;STN1;XRCC6;ATR;UBE2V2;SMARCAL1;DNASE2;NSMCE4A;RAD51C;ERCC1;GTF2H1;PRIMPOL;DBF4;POLE2;CBS;RECQL5;OGG1;ENDOV;ORC1;RAD54L;LONP1;GTF2H4;DNASE1L1;MCM4;MPG;CDC34;POLH;TIMELESS;IGHMBP2;SUPV3L1;NUDT1;KPNA2;PARP3;MGMT;TOP1MT;SAMHD1;UBA52;FANCG;PARG;PARP2;POLD2;NEIL3;RPA2;RAD9A;PNKP;RMI2;RAD51;PSME4;CDC45;POLA1;DDB1;LIG4;BRCA1;RAN
prerank,positive regulation of protein modification process (GO:0031401),-0.2262129700279348,-0.9592292731283926,0.5915492957746479,0.7673887225186364,1.0,37/203,15.02%,TRABD2B;ROCK2;EGFR;LEPR;IL34;ANGPT1;SLCO3A1;NTRK3;PELI2;UBE2N;FGF1;DAB2;FAM20A;BMP4;ABL1;LRRK2;AXIN1;RAB3GAP1;LYN;RAMP1;RAPGEF3;PPP1R7;IGF2;RB1CC1;ANKLE2;FAM161A;PRKCD;MAVS;FNIP1;CARD14;CCN1;WDFY2;TXN;VEGFA;CCND3;DDX3X;VEGFD
prerank,negative regulation of cellular senescence (GO:2000773),-0.3989413709336427,-0.9590550226724447,0.5134649910233393,0.7673406783393446,1.0,8/13,24.88%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;TERF2;TERT;CDK6;TWIST1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4101792102721032,0.9588995318999523,0.5257510729613734,0.8921008749129122,1.0,2/11,8.26%,MECOM;CD34
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.29434634138196875,-0.9588780218018483,0.52734375,0.7672993818954217,1.0,21/40,35.65%,WRN;MCM9;RFWD3;FANCM;MSH3;BOD1L1;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;DONSON;TIPIN;ATRX;CDK9;TIMELESS;EME2;RAD51;POLE;CENPX;GEN1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3919466749090633,0.9588496250662374,0.49318181818181817,0.8911740011090916,1.0,3/12,9.38%,GART;HPRT1;MTHFD1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.39542613777173546,-0.9587575735258833,0.5047984644913628,0.7671356008013757,1.0,3/13,8.60%,CACNA1C;ANK2;GJA1
prerank,positive regulation of JNK cascade (GO:0046330),0.26517137526739293,0.958648882106054,0.5135135135135135,0.8907364272556748,1.0,16/70,14.55%,TIRAP;MAP4K2;TRAF1;PLCB1;TNFRSF19;WNT7B;ANKRD6;MAPK8IP1;TAOK2;DAB2IP;HIPK2;PJA2;DUSP15;MAP3K11;HRAS;MFHAS1
prerank,regulation of cell death (GO:0010941),-0.2520750378477428,-0.9583040165883924,0.562015503875969,0.7677438914795878,1.0,31/94,22.57%,LRP1;CELF1;CCN2;BMP7;BMP4;PRKN;LRRK2;TBK1;VPS4B;SRSF6;CHMP4B;ACER3;IMPACT;CCN3;PRODH;ADNP2;BECN1;CCN5;CCN1;NCK1;CCN4;PRKD1;ATG5;PARK7;EIF4G1;RILPL1;SPEF1;BNIP3;FGF2;WNT16;CHP1
prerank,positive regulation of axonogenesis (GO:0050772),0.29223480944987706,0.9582907365011358,0.5325443786982249,0.8907095742323345,1.0,9/43,9.96%,PLXNB3;NTRK2;SEMA4D;SEMA7A;SHTN1;PLXNA4;ROBO2;CDKL5;NTN1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3111006578579771,-0.9580024459346954,0.5158878504672897,0.7680154273703613,1.0,10/32,22.99%,OSBPL8;PLSCR1;OSBPL5;PLA2G4A;PTDSS1;SLC27A1;PLA1A;ABHD12;LPCAT3;PTDSS2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3663205297451795,-0.9578954417923563,0.5092936802973977,0.7678092550013755,1.0,10/16,38.61%,WRN;MCM6;SSBP1;RECQL5;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2632880374489802,-0.9574672102766032,0.5214007782101168,0.7683522869491822,1.0,19/73,18.42%,SMAD3;COL4A3;CFLAR;ROBO1;EIF2AK3;F3;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;ANP32B;DAP;HSPE1;BCL2L13;VCP
prerank,negative regulation of protein catabolic process (GO:0042177),-0.3008005507537856,-0.9572580010357518,0.49101796407185627,0.7683993578136553,1.0,14/40,21.31%,TIMP3;EGFR;MDM4;ROCK1;FLNA;IRAK3;PTPN3;SNRNP70;ATRAID;CTSA;HMGCR;CYP51A1;TIMP2;CDK5RAP3
prerank,atrial septum morphogenesis (GO:0060413),-0.42305465497646266,-0.9559284676048395,0.5343228200371057,0.7712446031489126,1.0,1/10,0.31%,NOTCH2
prerank,amino acid transmembrane transport (GO:0003333),0.28265252818090303,0.9558156515100644,0.5112474437627812,0.8969814335484273,1.0,6/45,9.58%,SLC7A5;SLC6A6;SLC7A1;MFSD12;SLC7A8;SLC36A1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2572937829005299,-0.9554802505097206,0.5499058380414312,0.7718717512057546,1.0,37/87,35.11%,FBXL7;KANK2;FHL1;BRD7;DLG1;DACT1;PRMT2;USP47;PSMF1;PKD2;RB1;PSMB2;FAM107A;DCUN1D3;CDC73;CUL1;CDK6;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;ZFP36L2;PSMB10;PSMA5;PSMB9;RBX1;CDK2AP2;PINX1;PSME4;MYO16;PSMB8;PSMD10;CDKN2C;RBL2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29574441366303716,-0.9553082564511385,0.5329218106995884,0.7717983222302714,1.0,8/41,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4200282081006093,-0.9552308285255507,0.5419847328244275,0.7715086009208679,1.0,3/10,9.06%,FOXC1;NUMA1;MED1
prerank,positive regulation of catalytic activity (GO:0043085),-0.3027823248139974,-0.9551076402530145,0.5248618784530387,0.7713402783653274,1.0,14/37,22.11%,SLC5A3;ABL1;BCAS3;WRN;IGF2;NCSTN;ABL2;STX4;XRCC4;MSH3;MSH6;FGFR4;FXN;SSBP1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41905786773392506,-0.9550475144575045,0.5483870967741935,0.7705354347072525,1.0,4/10,22.49%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41905786773392506,-0.9550475144575045,0.5483870967741935,0.7705354347072525,1.0,4/10,22.49%,CDC42;CDC42EP5;CDC42EP4;CDC42EP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.30020417239046726,-0.9550423484335505,0.552,0.7700762960808886,1.0,5/37,4.00%,PHLDB2;EPHA3;ROCK1;PRKAA2;GSK3B
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.424051131053792,-0.9545642863289578,0.4972375690607735,0.7707456318195214,1.0,1/10,0.08%,BMP6
prerank,regulation of calcium ion transport (GO:0051924),0.2755718810185454,0.9543476575176012,0.5402542372881356,0.9002790587068122,1.0,9/54,10.86%,CAMK2A;CD33;CACNA2D1;EPB41;CACNB2;HOMER1;PLPP4;HOMER2;F2R
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26138308628034523,0.9542218288998321,0.5178197064989518,0.8995454185083108,1.0,11/75,10.54%,EGFL7;TEK;PROX1;PLXNB3;SIRT1;PPP1R16B;KDR;APLNR;AKT1;PDGFB;SCG2
prerank,protein lipidation (GO:0006497),-0.2738936478351265,-0.9541508563880896,0.5387673956262425,0.7713118694781923,1.0,26/59,34.10%,PIGN;GLUL;WIPI1;ZDHHC13;UGCG;PIK3C3;DPM1;WDR45B;ZDHHC1;ATG5;ZDHHC16;HHAT;PIGH;WIPI2;MPPE1;PIGC;DPM3;PIGA;ZDHHC8;PIGZ;PIGP;ATG10;PIGF;PIGO;WDR45;ATG12
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.25612608383795415,0.9541394657032336,0.573170731707317,0.8987097217016425,1.0,13/93,8.20%,TFRC;SPTBN4;MIF;TENM1;CNKSR3;GAS6;PPM1F;SNCA;SH2D3C;PAK1;HSP90AB1;AKT1;TRIM6
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4035061816759278,-0.9533033543828373,0.5269461077844312,0.7729399556289334,1.0,4/11,15.61%,EP300;CLK2;SIK1;C1QTNF3
prerank,cellular glucose homeostasis (GO:0001678),-0.2944517090122397,-0.9529485032127558,0.5110294117647058,0.7732770701691553,1.0,13/41,17.82%,ZBTB20;PRKAA2;SLC39A14;LRRC8D;FOXK1;PPARGC1A;UNC13B;HIF1A;PCK2;ERN1;FOXK2;PRKACA;PRKAA1
prerank,acylglycerol metabolic process (GO:0006639),0.2993484336044411,0.9527072180044097,0.5175983436853002,0.9017229102208661,1.0,5/37,7.02%,DGKI;ABHD2;DGAT2;DGKH;DGKB
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2920463921656963,0.9524778312773798,0.4940944881889764,0.9012867492260922,1.0,8/41,12.17%,PODXL;MAGI1;ANK3;THY1;SKAP1;TJP1;SMAD7;MEGF10
prerank,positive regulation of telomere capping (GO:1904355),-0.3577432847303086,-0.9522202816074697,0.5211538461538462,0.7745854095314332,1.0,4/17,15.75%,TNKS2;HNRNPD;NABP2;MAP2K7
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3240387547078251,0.9515072213407231,0.5185185185185185,0.9030953841465211,1.0,8/26,15.33%,TIRAP;NINJ1;TLR2;PJA2;WDFY1;MFHAS1;RTN4;RSAD2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3136173182817651,0.9514976807866107,0.5379876796714579,0.9020546811513551,1.0,10/30,21.36%,HSPA13;HSPA8;CHCHD4;HSPA5;CCT2;PTGES3;ST13;GAK;BAG1;ENTPD5
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.353827254382005,-0.9513484066838044,0.5251396648044693,0.7762327026788258,1.0,8/19,27.00%,GFPT1;UAP1;PMM2;RENBP;SLC35D1;UAP1L1;PGM3;NANS
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.29586515080318554,-0.950797853840878,0.5428015564202334,0.7770505625392675,1.0,10/35,18.00%,SULF1;NR2F2;COL4A3;SPARC;THBS1;MEF2C;APOE;STAT1;ATOH8;ATP5IF1
prerank,protein catabolic process (GO:0030163),-0.2732622796413477,-0.9506865180426962,0.546875,0.7768638470218617,1.0,19/59,26.35%,NGLY1;PRKN;RAB12;MTOR;DDI2;OGA;LAMP2;ADAMTS9;APOE;MANBA;VCP;LRSAM1;CLN5;MAGEC2;SIAH2;CLPX;BAG6;HTRA2;CLN8
prerank,regulation of dephosphorylation (GO:0035303),-0.3726468285189174,-0.9506357060601045,0.5189393939393939,0.7765110560647308,1.0,5/15,21.31%,SMG6;SMG7;MTMR3;INPP5K;CDK5RAP3
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3164640301180426,-0.9505293331907367,0.546692607003891,0.7763095247197906,1.0,8/27,20.64%,NFKB1;BTRC;MAP3K5;MAP3K20;MAP2K7;TNIP2;FBXW11;CUL1
prerank,regulation of protein kinase B signaling (GO:0051896),0.22743600944613152,0.9503936913603356,0.5811088295687885,0.9040945079977178,1.0,23/193,9.14%,IGF1R;KITLG;TEK;ERBB4;NRG2;NRG1;MAGI2;SIRT1;GAS6;FGF10;NTRK2;FLT3;HIP1;PHLPP1;CPNE1;FGF5;PIK3R5;TRIB3;PTPRJ;HSP90AB1;AKT1;THPO;MYORG
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3289956402301277,-0.9502556673633104,0.5380333951762524,0.7765070284552475,1.0,4/23,10.12%,SASH1;TAOK3;MAP3K5;TRAF2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.24549417412443247,-0.9499985826534675,0.5485714285714286,0.7766779644644416,1.0,25/108,17.29%,UACA;SMAD3;GSN;COL4A3;CFLAR;ROBO1;HMGB1;EIF2AK3;F3;REST;MAP3K5;FAM162A;AIFM1;CASP12;NGF;EGLN3;TRAF2;SENP1;CASP2;DDX3X;ANP32B;DAPK1;DAP;HSPE1;BCL2L13
prerank,engulfment of apoptotic cell (GO:0043652),0.35625296989850946,0.9496479206581558,0.4957446808510638,0.905148414577203,1.0,4/15,16.21%,ADGRB1;XKR6;MEGF10;XKR4
prerank,monocyte differentiation (GO:0030224),0.4199505029516421,0.9496221680981851,0.5454545454545454,0.9041445460829356,1.0,3/10,5.22%,CSF1R;PPARG;MT1G
prerank,amyloid-beta metabolic process (GO:0050435),0.35641622267532613,0.9493634732777919,0.5221238938053098,0.9038479028709285,1.0,4/16,13.72%,MME;PSENEN;NAT8;PSEN1
prerank,negative regulation of heart contraction (GO:0045822),-0.40229314422890944,-0.9492868505140438,0.5205724508050089,0.7779946259083176,1.0,1/11,0.03%,ATP1A2
prerank,protein-containing complex subunit organization (GO:0043933),-0.2430294413890263,-0.9489978997542036,0.5656192236598891,0.7782360200872648,1.0,35/109,22.67%,TEAD1;MDM4;DLG4;YAP1;DNM1L;SNX9;CREBBP;TUBGCP2;PPARGC1A;VAMP2;GEMIN5;MNAT1;WASL;TRAF2;CAPZA1;WIPF1;HES1;TEAD2;TPR;PARD3;RANBP9;WASF1;REPS2;PPIH;PICALM;GPAA1;TUBGCP4;PML;NUP98;FANCC;KIFAP3;KMT2A;PPID;DET1;LAMC1
prerank,B cell differentiation (GO:0030183),-0.28416134028440865,-0.9488617091815585,0.5393258426966292,0.778076386360656,1.0,12/46,18.28%,HDAC4;KIT;ITGB1;DCAF1;CEBPG;PTPN2;FNIP1;TCF3;ITGA4;KLF6;SYVN1;BLNK
prerank,axoneme assembly (GO:0035082),0.31319534186390824,0.9488368106649017,0.5433884297520661,0.9042886505470027,1.0,6/30,16.18%,SPAG16;DNAAF3;FOXJ1;DNAAF2;DCX;SPAG1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24310613072369222,0.9487725648549187,0.5894941634241245,0.9034152636520432,1.0,25/117,19.10%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3024886998774786,-0.9485271534798437,0.5390781563126252,0.7784108099243345,1.0,16/32,27.99%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;CLSPN;DONSON;ABRAXAS1;FZR1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.28874857606238347,-0.9484562716373097,0.5465346534653466,0.7781244112679035,1.0,9/45,9.77%,SMAD3;FOXC1;BMP7;BMP4;GAS1;PTPN3;PRCC;BTG3;TOM1L2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3007289637571893,0.9483624505841108,0.5343347639484979,0.9035164180579102,1.0,9/35,13.89%,RIMS2;EPHA5;AKAP6;PDE2A;HTR2C;ADCYAP1;CAP2;PDE4D;CD36
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3649058074451431,-0.9482437935036618,0.5168539325842697,0.778168416164696,1.0,6/16,20.94%,NPR3;HIF1A;APOE;TERF2;TERT;S100A1
prerank,vesicle transport along microtubule (GO:0047496),-0.33370121317930446,-0.9481307534716941,0.5357798165137615,0.7779895529086308,1.0,9/23,26.29%,TRAK1;KIF13A;NDEL1;KIF1C;DYNC1H1;FBXW11;KIFAP3;KIF3A;KIF5B
prerank,extracellular matrix assembly (GO:0085029),0.3250456550560688,0.9480655797063675,0.525879917184265,0.9032628545627385,1.0,5/23,8.90%,RAMP2;GPM6B;GAS6;NTNG1;NTNG2
prerank,regulation of JUN kinase activity (GO:0043506),-0.30866245967101164,-0.9480164243095968,0.53125,0.777789076399619,1.0,11/33,26.77%,SASH1;TAOK3;MAP3K5;PTPN22;TRAF2;DUSP10;PDCD4;TRAF6;DVL3;DVL2;AIDA
prerank,response to unfolded protein (GO:0006986),0.2830997226761537,0.9479797726936764,0.5664621676891616,0.9024671813742833,1.0,8/48,9.89%,HSPA13;PACRG;HSPA8;HSPA5;HSPA4L;HSP90AB1;HSPB1;DAB2IP
prerank,cellular response to retinoic acid (GO:0071300),-0.29061603599687247,-0.9479468637503864,0.5454545454545454,0.7774848451793429,1.0,9/42,13.00%,EPHA3;PTK7;WNT5B;WNT6;LYN;WNT9A;ABL2;FZD7;ADNP2
prerank,cellular response to interleukin-7 (GO:0098761),-0.36033353228558607,-0.9476088620559945,0.530188679245283,0.7773634414680137,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.36033353228558607,-0.9476088620559945,0.530188679245283,0.7773634414680137,1.0,4/17,6.07%,BRWD1;JAK1;IRS1;STAT3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.31560842096341674,-0.9475520082786321,0.5255198487712666,0.7770273565800757,1.0,14/25,42.82%,DNM1L;FAM162A;BMF;BNIP3;PDCD5;PLAUR;GPER1;PPIF;BCL2L11;PYCARD;BIK;TP53;HRK;PMAIP1
prerank,tRNA modification (GO:0006400),-0.26570971891123246,-0.9472864512751842,0.5658914728682171,0.7771705085152958,1.0,29/62,33.29%,TRMT9B;PUS10;NSUN6;ALKBH1;QTRT2;METTL2A;METTL2B;TYW5;METTL1;NSUN2;TYW1;THUMPD3;ELP5;FTSJ1;PUS3;CDKAL1;LCMT2;WDR6;DTWD1;GTPBP3;TRMT1;MTO1;DTWD2;TRMT44;TRMT61B;TYW3;PUS1;ALKBH8;TRMT12
prerank,regulation of cholesterol transport (GO:0032374),-0.34397990295847153,-0.9472346244984452,0.5229357798165137,0.776837124058559,1.0,2/20,1.19%,LRP1;NFKB1
prerank,positive regulation of chemotaxis (GO:0050921),0.28961310760455633,0.9472248662890771,0.5480572597137015,0.9035752632709236,1.0,8/43,10.49%,DSCAM;TMSB4X;PPM1F;KDR;STX3;HSPB1;PDGFB;AIF1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.31454189662865395,0.946983679170795,0.5022026431718062,0.9031695527439255,1.0,3/29,4.46%,FLT1;TEK;FLT3
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2715943688937508,-0.9467018885280835,0.5475285171102662,0.7776794733005342,1.0,23/61,24.47%,CCNH;KHDRBS1;CDK7;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;CUL1;CDK6;DBF4;EIF4EBP1;CCNE2
prerank,negative regulation of cell aging (GO:0090344),0.3621568207343001,0.9462587943142421,0.5331858407079646,0.9042658709422232,1.0,3/16,3.68%,MIF;SIRT1;HMGA2
prerank,positive regulation of hydrolase activity (GO:0051345),-0.23612213239183166,-0.9459756510077906,0.6074950690335306,0.7789864472041549,1.0,24/137,11.11%,DOCK11;AFDN;ASAP3;LIMS1;ARAP1;GSK3B;SGSM2;ITGB1;CTSH;BCAS3;SNX9;MAP4K4;RAB3GAP1;MMUT;RAPGEF3;ZC3H15;S100A10;RSU1;WRN;NDEL1;USP6NL;TBC1D20;RHOA;RCN3
prerank,ganglion development (GO:0061548),0.39779481621554913,0.9457374516836217,0.5475206611570248,0.904734362160175,1.0,4/11,21.62%,UNC5C;TUBB3;CTNNB1;SEMA3A
prerank,synaptic vesicle membrane organization (GO:0048499),0.3624077095639101,0.9454695107203047,0.5419354838709678,0.9044700682320606,1.0,4/17,16.46%,SNAP25;STX3;SNAP29;STX1B
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.3683167042737492,-0.9453765403301481,0.5532710280373832,0.7799799054393778,1.0,6/16,20.81%,PDK1;PRKN;FOXK1;RORA;FOXK2;BCKDK
prerank,entry into host (GO:0044409),-0.3843353613241336,-0.9447115602889893,0.5397412199630314,0.7811891503672133,1.0,2/13,6.03%,ITGAV;CDH1
prerank,positive regulation of hormone secretion (GO:0046887),0.3464478485003089,0.9445084758895704,0.5271629778672032,0.9061709600375752,1.0,3/17,9.76%,HCAR2;NMB;GRP
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4017477737537314,0.9438469225194965,0.5387840670859538,0.9070743016866665,1.0,3/11,12.26%,PTPRT;SOCS1;BCL3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2953519358241533,-0.9437660951175417,0.5555555555555556,0.7829918473067105,1.0,8/36,10.96%,TRIM44;AXL;PRKN;UBE2K;PARP14;HIF1A;PARP9;MAVS
prerank,interstrand cross-link repair (GO:0036297),-0.27405045258814503,-0.9431273029182288,0.5719626168224299,0.7841017244613429,1.0,25/53,32.53%,WDR48;RNF8;MCM9;RFWD3;FANCE;ERCC6L2;FANCM;FANCI;VCP;DCLRE1A;MSH6;POLN;FANCC;FAAP100;ATR;ERCC1;FANCB;UBA52;FANCD2;FANCG;FAAP20;NEIL3;RPA2;EXO5;RAD51
prerank,protein depolymerization (GO:0051261),-0.31504418194717143,-0.9430580853788343,0.5332068311195446,0.7837872200226522,1.0,4/27,5.95%,MICAL3;GSN;MICAL2;VPS4B
prerank,neuron apoptotic process (GO:0051402),0.34390602758930594,0.9429749816310352,0.5253164556962026,0.9085196126734079,1.0,4/19,13.42%,TRPC5;TNFRSF21;SCN2A;CIT
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.33007414489225073,0.9427791209975969,0.5382932166301969,0.9080286884976568,1.0,4/21,10.30%,SLC39A10;PRKCH;GPS2;LPXN
prerank,female gamete generation (GO:0007292),-0.31330862987332764,-0.9426138462389061,0.5636007827788649,0.7843952395638559,1.0,3/29,4.94%,DIAPH2;PTN;KMT2D
prerank,regulation of rRNA processing (GO:2000232),-0.36075437512152897,-0.9422393536300926,0.5390199637023594,0.7848164766892266,1.0,4/16,16.54%,KAT2B;WDR43;DIMT1;BUD23
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3019467583068991,-0.941929218838635,0.5676691729323309,0.7850937897737121,1.0,12/35,28.12%,SASH1;DLG1;PTPN22;RELL1;VEGFA;DUSP1;DUSP10;BMP2;SPHK1;EMC10;GADD45G;MINK1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.31453192838211813,-0.9415656629087217,0.556390977443609,0.785502573502875,1.0,13/29,43.90%,DDO;ACADSB;PRODH;SARDH;ALDH4A1;CBS;KMO;GOT2;BLMH;HGD;IL4I1;FAH;HAAO
prerank,modulation by symbiont of entry into host (GO:0052372),0.35848100083535067,0.9414190967863133,0.5701754385964912,0.9108720112894451,1.0,3/16,8.20%,HS3ST5;TRIM62;TRIM6
prerank,protein targeting (GO:0006605),0.23675622174071742,0.9413631801421029,0.5955284552845529,0.9099795078613765,1.0,31/118,19.77%,NLGN1;GDAP1;AQP11;AKAP6;RASSF9;GABARAP;ZDHHC22;AP4B1;GOLGA7;PITRM1;CACNG3;ZDHHC15;TAOK2;HAP1;TIMM22;HACL1;SORL1;TSPO;SRPRA;ZDHHC4;SEC61G;ZDHHC14;HOMER3;VPS37A;RTP4;ARL6;TOMM70;TIMM10B;ZDHHC24;VPS37D;DNAJC19
prerank,positive regulation of embryonic development (GO:0040019),-0.3448950134869787,-0.941264352611633,0.5628517823639775,0.7857517858334088,1.0,3/19,4.22%,WNT4;OSR1;NIBAN2
prerank,NAD biosynthetic process (GO:0009435),-0.33614425154090055,-0.9411443140403016,0.544256120527307,0.7855956875266303,1.0,6/20,14.93%,PTGIS;NMNAT2;PARP10;PARP9;NMNAT3;NMNAT1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.42288230663959364,-0.9411297822398627,0.5464285714285714,0.7851557935432002,1.0,5/10,18.94%,PRKAA2;SETD5;KLF15;PRKAA1;PARK7
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.33502809834016944,-0.9408091746982913,0.5671641791044776,0.7850064451761265,1.0,10/21,33.12%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.33502809834016944,-0.9408091746982913,0.5671641791044776,0.7850064451761265,1.0,10/21,33.12%,GTF2H2;DDB2;PARP1;ERCC3;ERCC1;GTF2H1;GTF2H4;RBX1;RPA2;DDB1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2590369522223217,-0.9405337619701324,0.5577299412915852,0.7852049713443686,1.0,28/73,29.73%,KAT2B;EP300;HDAC4;PPM1D;DNMT3A;SF3B1;IGF2;TAF1D;TBP;PHF2;MPHOSPH8;CGGBP1;KDM1B;PHF1;JARID2;EPC1;BAZ1B;POLR2H;EZH2;POLR2K;PPHLN1;POLR2E;CREBZF;TAF1C;POLR1G;TAF1A;SPHK2;POLR1C
prerank,cellular response to acid chemical (GO:0071229),0.3210775210883336,0.9404424101159602,0.5418502202643172,0.9115191796196116,1.0,9/27,20.81%,IPO5;GLRA1;GLRA2;KLF2;XBP1;LAMTOR2;CAPN2;SPAAR;RRAGD
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24214683990720295,0.9404369440713913,0.6035502958579881,0.9104733182946921,1.0,25/116,19.10%,PRKAR2B;ADCY8;ADCY3;RAMP2;ADRB1;RHBDF2;ADCYAP1;GNG2;POMC;CD163;GPR176;ADCY4;GGT1;PTGER2;PLK2;NPSR1;CALCRL;ADCYAP1R1;GPR45;PTGER4;CYSLTR1;FYN;PRKAR1A;ADORA2B;ADORA2A
prerank,transepithelial transport (GO:0070633),0.362907891924665,0.9401923371693754,0.5752577319587628,0.9101091349788037,1.0,3/15,5.81%,ABCG2;SLC1A1;SLC1A2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25531242737516013,0.9398194249034426,0.5840163934426229,0.9101667540126186,1.0,17/80,12.56%,SIRT1;PAX2;GAS6;PPM1F;SNCA;GPX1;ARL6IP1;KLF4;BEX3;RPS6KA1;AKT1;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,phagosome-lysosome fusion (GO:0090385),0.40963760942951716,0.9396431507882482,0.5460385438972163,0.9096195273850805,1.0,1/10,1.84%,SYT7
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.34866579441216206,-0.9396249749967099,0.5318725099601593,0.7869868779558717,1.0,6/18,19.93%,NGLY1;DERA;OGA;ADAMTS9;MANBA;NAGA
prerank,retinal metabolic process (GO:0042574),0.3724640488190283,0.939491137928885,0.5626373626373626,0.9090061497674219,1.0,2/12,5.75%,BCO1;DHRS13
prerank,Fc receptor signaling pathway (GO:0038093),-0.24449185784285513,-0.9392947498811531,0.5988142292490118,0.7872965128107547,1.0,36/110,29.12%,GAB2;NFKB1;BTRC;KIT;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35670969037855943,-0.9386746396757657,0.551789077212806,0.7883343124881577,1.0,6/17,22.30%,TAOK3;LYN;MID1;EIF2AK2;TAOK1;KLHDC10
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.35539438904282633,0.9386237288139763,0.54,0.910447100134776,1.0,4/18,8.04%,TRIM13;RPS27A;UBC;UBB
prerank,regulation of lymphocyte activation (GO:0051249),-0.38636938898571205,-0.9385281219535819,0.5617977528089888,0.7882153588006366,1.0,1/12,3.42%,PAG1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3958384723470759,0.9384189517586125,0.546236559139785,0.909972340126453,1.0,2/12,4.90%,CSF1R;IL12A
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.35855804098847976,-0.9382696155017322,0.5481335952848723,0.7883383865877545,1.0,8/18,23.39%,SKI;PARP10;EMD;MORC3;B4GALT7;CDC73;CD300A;NLRC3
prerank,negative regulation of actin filament polymerization (GO:0030837),0.32794338612209434,0.9381692400202888,0.5195071868583162,0.9096039883166525,1.0,3/22,2.63%,KANK3;TMSB4X;TMSB10
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3210501553875494,-0.9378420599115254,0.5349716446124764,0.7889510909104404,1.0,8/28,17.57%,PTN;ABL1;GSK3B;ADCY1;EPHA4;EIF2AK4;APOE;FAM107A
prerank,C21-steroid hormone metabolic process (GO:0008207),0.348713547139746,0.9376109668660462,0.5612903225806452,0.9101487622826023,1.0,6/20,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;HSD17B10;STARD3
prerank,nuclear transport (GO:0051169),0.35315889278542406,0.9372039915434403,0.5377969762419006,0.9102529734882854,1.0,4/16,13.45%,NXT1;RBM15B;NUP205;ANP32A
prerank,protein modification process (GO:0036211),-0.2515138397212287,-0.9368801028312097,0.5777777777777777,0.790848705405504,1.0,25/76,21.34%,ARAF;ABL1;WWP2;PLOD2;PLAT;UBE2I;PPP4R2;ABL2;GGCX;YES1;PARP1;PARP4;LOX;PRKDC;MANBA;UBL5;FBXO22;UBE2S;UBA7;RPN1;RABGGTB;UBE2D3;B4GALT7;PIGH;AKT2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3525546283427964,0.936670379977483,0.5466970387243736,0.9107097997376925,1.0,6/17,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;ATP5MG
prerank,chemical homeostasis (GO:0048878),-0.2670003404200476,-0.9362534615454409,0.5784313725490197,0.7919212731939117,1.0,12/61,12.70%,ZBTB20;RBP1;NR1D2;SLC4A10;ABHD5;TLCD2;WNK4;WNK1;NR1H3;PNPLA8;SLC4A3;FBXW7
prerank,negative regulation of response to stimulus (GO:0048585),0.2693463800521628,0.9359640283626323,0.5816554809843401,0.911688830445424,1.0,12/60,11.29%,AQP11;MCTP1;SIRT1;HMGA2;THY1;SRMS;CLU;KLF4;CD34;GGT7;TLE5;UBASH3B
prerank,T cell proliferation (GO:0042098),0.37715820788597154,0.9358798237669994,0.5460385438972163,0.9108882374710354,1.0,1/13,0.98%,CADM1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2343088986539267,-0.9357605053711789,0.6247582205029013,0.792673495048621,1.0,34/117,26.45%,IGF1;ALDH1A2;PCCA;ME2;HLCS;CYP26B1;ACADSB;ABAT;GNPAT;CPT1C;MCCC2;VDAC1;PANK2;ACSF2;ME1;SLC5A6;PNPLA8;ACOT11;GLO1;PDHA1;ECHDC3;CPT1A;AMACR;MECR;ACSL4;ALDH4A1;ACOT6;SCPEP1;GBA2;GGT5;PPARA;LPL;AASDH;ME3
prerank,inositol phosphate catabolic process (GO:0071545),-0.38472104712992955,-0.9356613220450123,0.5614035087719298,0.7924432311216245,1.0,3/12,5.92%,INPP5B;SYNJ2;INPP5A
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.39070462173992543,-0.9355413655682489,0.539622641509434,0.792272415891687,1.0,5/11,26.22%,DHX36;ZC3H3;CDC73;AHCYL1;NCBP2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.34215937667931795,-0.9355190878845652,0.5504424778761062,0.7918545630330402,1.0,7/20,18.35%,NFKB1;HM13;NCSTN;ADAM9;MBTPS2;MBTPS1;TRAF6
prerank,regulation of vasculature development (GO:1901342),0.31925948658697645,0.9354778184066527,0.5700197238658777,0.9110217817268343,1.0,4/26,8.17%,HTATIP2;TSPAN12;ETS1;GPNMB
prerank,positive regulation of response to stimulus (GO:0048584),0.2847069128393248,0.9350786113033245,0.5622406639004149,0.9110721638198055,1.0,11/40,19.57%,SIRT1;HMGA2;YPEL3;TGFB2;HOMER1;B2M;RSAD2;IER5;CDKN2AIP;ILK;EEF1E1
prerank,negative regulation of hydrolase activity (GO:0051346),0.27446031235252144,0.934930019960919,0.5571142284569138,0.9104468383601502,1.0,5/49,6.34%,CAMK2A;PLXNB3;MAP2;ZCCHC9;FICD
prerank,cAMP biosynthetic process (GO:0006171),-0.40764426572743917,-0.9347759280574485,0.5586592178770949,0.7932188490695261,1.0,4/10,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,transferrin transport (GO:0033572),0.3022732545515143,0.9347554491742027,0.5644820295983086,0.9098975198363622,1.0,13/33,22.74%,TFRC;ATP6V1F;ATP6V1A;ATP6AP1;ATP6V1C1;ATP6V0B;ATP6V0A1;ATP6V0E2;ATP6V1D;REP15;HFE;ATP6V0C;ATP6V1G1
prerank,regulation of macrophage activation (GO:0043030),-0.3091665933211087,-0.9347141339743762,0.5540540540540541,0.7929012745917775,1.0,11/30,22.26%,IL31RA;LBP;THBS1;NR1H3;TNIP2;TLR4;WNT5A;GPR137B;SHPK;KARS1;SPHK1
prerank,protein localization to chromatin (GO:0071168),-0.34497132092577043,-0.9346603912041593,0.5411334552102377,0.7925435378193422,1.0,10/18,37.28%,MCM9;NIPBL;RAD21;PIH1D1;PPHLN1;ESR1;RUVBL2;WAPL;MSH2;MRNIP
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3740098779898896,0.9345259274697262,0.5532359081419624,0.9095020346452727,1.0,3/13,13.30%,CSTF2T;CSTF2;CPSF2
prerank,organic substance transport (GO:0071702),0.23715837794832856,0.9341144106728172,0.6425855513307985,0.9096408788877428,1.0,11/121,6.79%,PLTP;LRP1B;ATP8A1;AQP9;RAMP2;ABCG2;MFSD2A;CHKA;SPNS2;MFSD12;SLC6A2
prerank,positive regulation of cell killing (GO:0031343),-0.3802804509403628,-0.9337945408584156,0.5481481481481482,0.7941146679435135,1.0,5/13,25.22%,FZD7;CYBA;WNT5A;SYK;DVL2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.38664648619071185,-0.9336064289401665,0.5479204339963833,0.7940855465179821,1.0,7/12,33.09%,BDH2;CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.33984451559145223,0.9334539616684232,0.5661914460285132,0.9104367056989894,1.0,2/21,3.53%,PROX1;TOX
prerank,"base-excision repair, AP site formation (GO:0006285)",0.35553433278903473,0.9332427819637549,0.5379310344827586,0.9099891805875966,1.0,4/17,14.36%,TERF1;UNG;TERF2IP;TINF2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4195342541205299,-0.9327643517172228,0.5566218809980806,0.7957348282560197,1.0,3/10,13.02%,DNMT3A;IGF2;KDM1B
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24551427924509495,-0.9326185869855067,0.582089552238806,0.7956075707095993,1.0,40/91,34.19%,BTRC;ANAPC5;ANAPC7;ANAPC4;ANAPC16;MN1;PSMF1;ERCC3;FBXW7;PSMB2;CDC26;TRIM39;CDC27;UBE2E1;UBE2S;ANAPC11;CUL1;PSMC1;PSMB6;PSMA3;TFAP4;PSMA4;DBF4;CDC16;ANAPC1;TCIM;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;NEK10;NEK11;MAD2L1;PSME4;BUB1B;DDB1;PSMB8;PSMD10
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2964398181723635,0.9321808134397934,0.5342741935483871,0.9118808836580953,1.0,6/34,11.13%,FLT1;TEK;FLT3;DAB2IP;PDGFB;PIK3R3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2370364022667458,-0.9320676059175738,0.6510204081632653,0.7964477129494733,1.0,45/119,31.08%,PTPN13;PLEKHA2;PI4KA;SMG1;PIGN;SYNJ2;MTMR12;INPPL1;PIP4K2C;TTC7B;EFR3A;PITPNM2;ARF1;MBOAT7;MTMR3;PIK3C3;SLC27A1;PLEKHA8;DPM1;SACM1L;PIK3R4;SOCS7;PIK3CD;INPP5K;ITPKC;PIGH;MPPE1;PIK3R1;FGF2;PIGC;PLEKHA4;PI4K2B;DPM3;PIGA;RAB5A;IP6K2;PLEKHA1;PIGZ;RUFY1;PIGP;PI4KB;PIGF;CISH;SOCS3;PIP5K1C
prerank,negative regulation of nuclear division (GO:0051784),-0.3939518196011368,-0.9319814360376732,0.5418994413407822,0.7962202558658374,1.0,3/11,9.77%,BMP7;BMP4;TOM1L2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.33102477244984674,-0.9319731121675229,0.5411764705882353,0.795765000707956,1.0,6/22,12.97%,APPL2;LBP;LYN;PTPN22;NR1H3;APPL1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.34200866956806286,0.9317946404928149,0.5615866388308977,0.9119289438937362,1.0,4/18,8.61%,SLC2A1;OCLN;TRIB3;RTN2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.22225520446467648,-0.9316325293920051,0.6588693957115009,0.7961257463650446,1.0,79/184,33.80%,APPL2;PKD1;INO80;PCM1;CDC14A;BTRC;ALMS1;ODF2;NINL;CEP63;CEP135;PCNT;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CSNK1E;ID2;PSMF1;ERCC3;CUL3;APPL1;MAPRE1;PSMB2;CDC26;CDC14B;YWHAE;AKAP9;CDC27;UBE2E1;DYNC1H1;CEP76;KLHL18;UBE2S;PRKACA;CEP57;CSNK1D;CDK2;NEK6;ANAPC11;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;PLK5;ACTR1A;PSMA3;TFAP4;PSMA4;CDC16;ANAPC1;HAUS3;PSME1;PSMD13;CEP41;FZR1;ZFP36L2;PSMB10;E2F1;PSMA5;PSMB9;HAUS5;UBA52;HAUS4;PLK4;NEK11;MAD2L1;CEP72;CENPE;PTPN6;SSNA1;CEP164;PSME4;BUB1B;DDB1;RIOK2;CKAP5;PSMB8
prerank,response to organic cyclic compound (GO:0014070),-0.2763165628711771,-0.9315704840732401,0.5823529411764706,0.7958005492491422,1.0,7/52,9.27%,IGFBP5;LRRK2;HLCS;STRN3;STAT3;ANXA1;CYP1B1
prerank,phosphate ion transport (GO:0006817),0.357642644962409,0.9313405579896616,0.5553235908141962,0.9121337905057063,1.0,3/16,7.96%,SLC37A4;SLC37A1;SLC25A14
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.41464054128208466,-0.9310854797712189,0.5457943925233645,0.7965094111600467,1.0,7/10,46.18%,RENBP;ST6GAL1;GNE;NANP;NPL;NAGK;GNPDA1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.383058990666503,-0.9309338712916203,0.5447619047619048,0.7964161396131982,1.0,4/13,14.36%,TGFBR2;NRP1;SEMA3E;VEGFA
prerank,response to growth factor (GO:0070848),-0.2916619374654655,-0.9305707536877122,0.5621414913957935,0.7967862397444236,1.0,16/41,26.32%,TGFBR1;BMPR1A;TGFBR2;SHC1;CPNE3;ACVR1;EMD;STAT5B;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;TWF2;HTRA2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.3708185620330805,-0.93054621282253,0.5625,0.7963739051108392,1.0,8/14,33.31%,NMNAT2;ME1;NMNAT3;NMNAT1;CMPK2;AK1;PNP;AK7
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3161940159963291,-0.930288278707243,0.5733855185909981,0.7965058877167226,1.0,10/27,26.17%,NFKB1;ABCA1;ITGAV;NR1H3;AGTR1;IL18;ITGB3;MAPK9;PPARA;LPL
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.35040163612427433,-0.9301874479320259,0.5647058823529412,0.7962979331932813,1.0,7/17,24.75%,BMP4;VEZF1;ATOH8;SFRP4;FGF2;TMEM100;NKX6-1
prerank,phosphate ion transmembrane transport (GO:0035435),0.3766776546537702,0.9294633657758172,0.5522388059701493,0.9164546884802887,1.0,3/12,7.96%,SLC37A4;SLC37A1;SLC25A14
prerank,cellular metal ion homeostasis (GO:0006875),-0.240891143582357,-0.9290751003670599,0.586,0.798440518023394,1.0,16/102,13.64%,ATP1A2;SLC24A3;STIM1;ANK2;ATP13A5;SLC41A1;SLC9A1;TPCN2;KCNJ2;SLC10A7;SLC12A2;DMPK;ATP2A2;ATP2B1;ATP13A3;LETM1
prerank,glycogen catabolic process (GO:0005980),-0.35859392327905903,-0.9290555401202736,0.5458015267175572,0.7980084654204488,1.0,6/15,14.95%,PHKB;PYGB;PHKA1;AGL;RB1CC1;PYGM
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.32946193152884323,-0.9289456023286745,0.5343228200371057,0.7977992893983119,1.0,7/21,23.68%,MCU;ANXA6;LETM1;MICU1;SLC8A3;FIS1;SLC8B1
prerank,T-helper cell differentiation (GO:0042093),0.3632566135782789,0.9288686678963908,0.564755838641189,0.9170986832140431,1.0,2/14,5.85%,LEF1;TMEM98
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3436320804308931,-0.9287237512351261,0.5700389105058365,0.7978808143257243,1.0,3/18,7.60%,FCHSD2;ERC1;TBC1D24
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.31175798875844757,-0.9286503452589456,0.5651302605210421,0.7976065931428382,1.0,3/26,3.96%,ITPR1;ITPR2;IBTK
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.30615072282485806,-0.9283296616811743,0.550561797752809,0.7979339938643896,1.0,9/29,29.39%,LDLRAD4;BMP5;IL17RD;VASN;SPRED2;PPP2CA;USF3;SDHAF2;MAD2L2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.3948318022220404,0.9279458562271227,0.5383064516129032,0.9186607555183898,1.0,3/10,13.05%,HECW1;HECW2;STK39
prerank,positive regulation of dendrite development (GO:1900006),-0.4085956729521122,-0.9278385507594105,0.5708955223880597,0.7986794251643603,1.0,3/10,2.52%,PTN;BMP5;BMP7
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3763402388667326,-0.9277123428798217,0.546112115732369,0.7985048491474384,1.0,4/14,34.36%,IL6ST;PARK7;OSMR;ADAM8
prerank,positive regulation of immune system process (GO:0002684),0.35580420064150553,0.9262129363041091,0.5343680709534369,0.9224086091960282,1.0,2/16,5.82%,HCAR2;TGFB2
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.19937263871176664,-0.9261176498532642,0.787321063394683,0.8018477726165484,1.0,86/532,14.36%,COL1A2;GAB2;APPL2;LEPR;NFKB1;IL34;LIMS1;PELI2;ZEB1;UBE2N;BRWD1;FOXC1;GRB10;VIM;IL6ST;IL31RA;FOXO3;GHR;MAP3K3;EDA;JAK1;BTRC;KIT;YAP1;IRAK3;IRS1;LBP;IL15RA;ITGB1;IL13RA1;RAP1B;ANXA2;PAK2;STAT3;SHC1;BCL2;IL16;IFIT2;CAMK2D;ANXA1;IRAK2;TRIM8;TRAF3IP2;F3;MID1;INPPL1;CDC42;CAMK2G;CTR9;TNFRSF11B;SP100;IL17RA;PITPNA;FER;TRAF2;PRKCD;HIF1A;ABL2;SMAD4;GREM2;STX4;CNTFR;RORA;CAPZA1;TRIM5;UGCG;PSMF1;NUMBL;ARF1;RALA;IRF9;HSPA9;MMP2;TEC;TRIM25;IL6R;FN1;APPL1;IRF1;CARD14;LTBR;TYK2;SLC27A1;STAT1;PSMB2;VEGFA
prerank,axonal transport of mitochondrion (GO:0019896),-0.3947702864785381,-0.9259859316466,0.5623836126629422,0.8017030782994372,1.0,3/11,10.52%,TRAK1;OPA1;HIF1A
prerank,translational elongation (GO:0006414),0.23953690710155937,0.9254237155831685,0.6072874493927125,0.9235800270009569,1.0,32/101,23.08%,MRPS25;MRPL14;MRPS12;EEF1B2;MRPL49;TUFM;MRPL13;MRPS18A;EEF1D;MRPS7;MRPS14;MRPL45;EEF1A2;MRPL36;MRPL23;EEF1A1;MRPL54;MRPS5;EEF2;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;RACK1;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,fatty acid transport (GO:0015908),0.34987190095826953,0.9252515695892278,0.5696465696465697,0.9230354865554664,1.0,5/17,13.89%,PPARG;MFSD2A;FABP5;SLC27A4;CD36
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.38435579964335964,-0.9242281377581287,0.5609284332688588,0.8054205177651,1.0,4/11,17.35%,ACTN2;LEPROTL1;LEPROT;PICALM
prerank,cell junction maintenance (GO:0034331),0.3598020776283874,0.9241878377228706,0.5762004175365344,0.9250172616293735,1.0,5/14,19.82%,CSF1R;F2R;DCTN1;CBLN2;CBLN1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.22079116724806425,-0.9241194518508539,0.6789883268482491,0.8052067005902949,1.0,47/190,19.75%,UACA;ITPR1;CGNL1;DAG1;UBR2;BMP7;WWC2;PRKAA2;VGLL4;DEPTOR;WTIP;MARK3;THBS1;TMEM127;BCL2;LYN;MAPKBP1;UBR1;CCN3;LIMD1;TLE1;WWC1;FNIP1;RORA;RIOK3;PDE3A;PPM1A;STAT1;DUSP1;UBE2B;DDX3X;TRIM39;C1QTNF3;PRDM15;NOP53;NPRL3;PRKAA1;MYADM;PPP2R5C;RHOH;TANK;GPD1L;IFI35;INPP5K;ABCA7;AJUBA;TBC1D7
prerank,positive regulation of programmed cell death (GO:0043068),-0.21105858931447555,-0.9241028252658988,0.7029702970297029,0.8047685713687164,1.0,63/272,18.90%,AKAP13;PAWR;FOXO3;STK3;BMP4;TIAM2;ABL1;LRRK2;ARHGEF17;STK17B;RARG;IGFBP3;HMGB1;ITGB1;DNM1L;HOXA5;PHLDA1;IFIT2;REST;PLEKHG2;MAP3K5;FAM162A;VAV2;CALHM2;AIFM1;MARK4;ADAMTSL4;UNC13B;CYP1B1;MAP3K20;NGF;NCSTN;PRMT2;JUN;ARHGEF12;ARHGEF18;BCLAF1;ERCC3;SOS2;RASSF2;CCAR1;CASP2;FGD1;ATF6;ING5;FGD4;RBM5;DDX3X;LATS1;TGFB3;DAPK1;NGEF;PTPA;IAPP;ARHGEF11;TRIO;ARHGEF6;DAPK2;ARHGEF1;SFRP4;TRAF6;BMP2;DCUN1D3
prerank,in utero embryonic development (GO:0001701),-0.3119229777564055,-0.923950940186424,0.5577299412915852,0.8046637564184423,1.0,9/25,18.77%,TGFBR1;PKD1;FGFR2;IGF2;CHD7;HINFP;VEGFA;TGFB3;BMP2
prerank,homeostasis of number of cells (GO:0048872),0.377465463977895,0.9239354926507711,0.5484581497797357,0.9246631570328807,1.0,4/12,10.86%,NOS3;NOTCH1;OCIAD1;F2R
prerank,membrane fusion (GO:0061025),-0.3017573247783152,-0.9234555646988744,0.5838150289017341,0.8053605340068886,1.0,14/33,23.62%,OPA1;UBXN2B;HUWE1;DNM1L;MYOF;VTI1B;VAMP2;GCA;SNAP23;NAPA;CHP1;VAPA;NSF;USO1
prerank,second-messenger-mediated signaling (GO:0019932),0.25053193867444845,0.9228895188162307,0.6288659793814433,0.9265848405694774,1.0,11/82,8.25%,CHRM3;KSR2;RYR2;MCTP1;NOS3;RCAN2;PPP2R1A;PPP1R9A;ACKR4;NDNF;RCAN3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3068766353436896,0.9227577570330829,0.5773420479302832,0.9259318351394544,1.0,4/26,6.26%,USP44;LCMT1;UBE2C;HECW2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2652896423604903,0.9226173267142402,0.5857740585774058,0.9253067037332111,1.0,11/57,12.56%,GRIN1;GRIN2A;SIRT1;GRIN2B;PPM1F;ACVR1C;NOD1;F2R;BCL10;NDUFA13;TNFSF10
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.39853696885810197,0.9225658076016782,0.5482546201232033,0.9244340662572039,1.0,2/10,3.78%,CXCL12;GAS6
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2746774153647052,-0.9218964774235583,0.5912698412698413,0.8086187227462591,1.0,9/47,17.43%,PID1;PDGFRB;SLC5A3;TGFBR2;THBS1;PRKCD;AGTR1;CYBA;TLR4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3894867474354704,-0.9216664659608794,0.5719360568383659,0.808686325435836,1.0,6/11,27.39%,GTF2H2;GRK3;ARRB1;ADM;SAG;ADRB2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.25506651357369675,-0.9215902813000681,0.6015325670498084,0.808412060081914,1.0,10/71,7.80%,ADAMTS12;NGLY1;FBXL17;PRKN;HM13;CTSC;CTSH;VPS4B;DDI2;CHMP4B
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3805393798582357,-0.92156643840659,0.5774378585086042,0.8080091474643364,1.0,3/12,12.12%,GSN;TRIM5;TRIM11
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3139183719752889,0.9215544633059193,0.5657620041753654,0.9262288342695278,1.0,5/24,7.55%,TEK;PPM1F;KDR;THY1;PTPRJ
prerank,blood vessel diameter maintenance (GO:0097746),-0.29216346682314287,-0.9214916853433656,0.5562248995983936,0.8077516216665428,1.0,5/34,7.77%,ROCK2;ROCK1;EDNRA;ADCY6;ECE1
prerank,regulation of organelle organization (GO:0033043),-0.24187395452078903,-0.9208800701524861,0.6424242424242425,0.8087512331125999,1.0,28/80,25.16%,DIAPH1;EP300;PRKN;DNM1L;PAK2;STX18;ZEB2;CLIC4;USP6NL;RHOT1;MAVS;STX5;ARMH3;SURF4;EHD3;AKAP9;PLXNB1;TAOK1;FIS1;SPEF1;MSN;PARL;F11R;LMAN1;RHOT2;PREB;SAR1B;NEXN
prerank,regulation of interleukin-6 production (GO:0032675),0.2400279982364165,0.9206786491229867,0.6516393442622951,0.9276045231133042,1.0,17/96,15.81%,TIRAP;MBP;IL17F;SYT11;GAS6;TLR2;FOXJ1;CD200R1;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1;MAPKAPK2;POU2F2
prerank,positive regulation of transport (GO:0051050),-0.24537341755430297,-0.9205813475427147,0.6465863453815262,0.8089869700744791,1.0,26/85,25.99%,LRP1;DAB2;CAMK1D;NUMA1;GSK3B;GPC3;IL15RA;ANXA2;ANXA1;MERTK;NR1H3;APOE;CYBA;RXRA;DYNC1H1;INPP5K;ABCA7;AKT2;KMT2A;ZNF205;CHP1;HIP1R;SIRPA;KCTD7;CLIP3;FCER1G
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22028038856978058,-0.9203285653325195,0.7111984282907662,0.8091083708598551,1.0,29/198,10.72%,PLCE1;EPHA7;PI4KA;PLPP3;ENPP1;LRRK2;NUDT4;GK5;TOP1;PLCD3;INPP5B;PAK2;NUDT5;INPP5A;STAT3;ISYNA1;NADK;DUSP16;PFKFB4;MTOR;GFPT1;INPPL1;PLA2G4A;PLCG1;PLCB3;PANK2;PLCD1;ENPP3;LIMD1
prerank,regulation of centrosome cycle (GO:0046605),-0.3267777819526963,-0.9189897853402346,0.5745454545454546,0.8118494344723624,1.0,5/21,10.05%,VPS4B;CHMP4B;MARK4;CHMP5;CHMP3
prerank,regulation of endocytic recycling (GO:2001135),-0.3913288074811079,-0.9188893550627474,0.5757575757575758,0.8116175165506349,1.0,5/11,28.68%,EHD2;ACTN2;EIPR1;ATP9A;EHD1
prerank,protein-DNA complex disassembly (GO:0032986),0.34688184565620367,0.9188565350945307,0.5634408602150538,0.9315463941724407,1.0,4/16,14.93%,RPL23;SMARCB1;SET;SMARCD1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.29635217899928257,-0.918739326485468,0.5763358778625954,0.8115143109133224,1.0,9/34,19.21%,ROCK2;IGF1;ROCK1;EPHA4;GGA3;APOE;IFNGR1;PICALM;ABCA7
prerank,calcineurin-mediated signaling (GO:0097720),-0.4072675246114481,-0.9186607676928873,0.5758157389635317,0.8107583311690695,1.0,3/10,18.69%,NFAT5;NFATC4;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4072675246114481,-0.9186607676928873,0.5758157389635317,0.8107583311690695,1.0,3/10,18.69%,NFAT5;NFATC4;NFATC3
prerank,sterol biosynthetic process (GO:0016126),-0.2951215095101099,-0.9184518081819364,0.5852272727272727,0.8107909536148542,1.0,11/33,23.77%,PRKAG2;INSIG2;ACAA2;HMGCR;SQLE;CYP51A1;SC5D;FDFT1;ARV1;LBR;MVK
prerank,negative regulation of receptor internalization (GO:0002091),0.373318021226095,0.9179860446060526,0.5560253699788583,0.9329901704617534,1.0,1/12,1.67%,NECAB2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3720341816817582,-0.9179234838889684,0.569811320754717,0.8115660842319775,1.0,6/14,21.07%,ADGRV1;VEGFA;WNT5A;MYADM;GPD1L;DGKD
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2567165994808664,-0.9167501989893002,0.6195028680688337,0.8138480845039032,1.0,13/70,14.85%,SMAD3;ITGAV;GSK3B;BCL2;PDPK1;HIPK1;BAG3;NGF;TRAF2;IL6R;CASP2;APPL1;DDX3X
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3045671914876126,-0.9167010073962809,0.6242774566473989,0.8134831099761487,1.0,19/30,35.07%,RNF169;TRIP12;KLHL15;UBR5;SHLD2;HELB;SMCHD1;HSF1;TWIST1;UBQLN4;OGG1;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP;ERCC6
prerank,positive regulation of lipid transport (GO:0032370),-0.3870470962273641,-0.915976680523664,0.5627450980392157,0.8146757491612862,1.0,3/12,20.22%,LRP1;APOE;SPP1
prerank,purine-containing compound catabolic process (GO:0072523),0.3636474110581882,0.9157661643964565,0.5610278372591007,0.9381321747529693,1.0,2/13,9.52%,GPX1;NT5C
prerank,positive regulation by host of viral transcription (GO:0043923),0.3598042245101547,0.915711897828586,0.5676767676767677,0.9372467547349435,1.0,2/15,4.32%,LEF1;SMARCB1
prerank,cell chemotaxis (GO:0060326),0.2602452086177033,0.9156610799317931,0.6210526315789474,0.9363414784670293,1.0,9/60,10.23%,LEF1;EPHB1;PLXNB3;CXCL12;DOCK4;PRKCQ;ACKR4;PDGFB;BIN2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3541521728228784,-0.9155852740288791,0.555765595463138,0.8151745557249408,1.0,10/16,33.94%,KLHL15;SHLD2;HELB;SMCHD1;UBQLN4;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.381443954236747,-0.9155381505995636,0.5877551020408164,0.814816353981394,1.0,2/12,1.57%,ADAMTS12;DCN
prerank,positive regulation of cell cycle (GO:0045787),-0.2572707592126964,-0.9149718319221405,0.6231060606060606,0.8157176209887179,1.0,16/62,16.75%,EGFR;PKD1;LRP6;ANKRD17;NUPR1;FGFR2;EIF4E;CCNYL1;HCFC1;PKD2;TTL;USP2;CCND3;CDC25B;CCDC57;CITED2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.37164145469895216,-0.914619177045942,0.5636704119850188,0.8160624993753733,1.0,4/13,19.78%,NFAT5;RHOA;TRAF6;IRAK1
prerank,negative regulation of phagocytosis (GO:0050765),0.3403386599524071,0.914237015350288,0.5639412997903563,0.9392790348642482,1.0,4/17,9.10%,SYT11;TLR2;DYSF;CD300LF
prerank,hexose biosynthetic process (GO:0019319),-0.2758304789557796,-0.9140912926081215,0.5961904761904762,0.8168337639912931,1.0,10/42,17.45%,RBP4;SLC39A14;AKR1B1;PPARGC1A;CHST15;MDH1;PGK1;PCK2;SLC25A11;CRTC2
prerank,motile cilium assembly (GO:0044458),0.37729913754107824,0.9139902653263446,0.5667351129363449,0.93889945500103,1.0,2/12,10.41%,DNAAF3;BBS5
prerank,regulation of myelination (GO:0031641),0.3165051257041819,0.9136935074373607,0.5822510822510822,0.9387233771175864,1.0,7/25,13.74%,JAM2;TENM4;TMEM98;NSUN5;TPPP;TNFRSF21;PTPRZ1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.24395796449031726,0.9134349960615649,0.621900826446281,0.9383773941091946,1.0,18/86,16.15%,CHEK1;ATF3;EPAS1;PSMA1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3;KLF2;HIGD1A;PSME3;ATF4;STOX1;PSMC3;PSMA2
prerank,protein localization to lysosome (GO:0061462),0.3013954455161647,0.9133408221697017,0.5852156057494866,0.9376251342000048,1.0,13/28,23.56%,SCARB2;NCOA4;GLMP;SORL1;RTN4;M6PR;AP3M1;HGS;VPS4A;SNX16;LMBRD1;SH3BP4;GCC2
prerank,estrogen metabolic process (GO:0008210),-0.3617035844144146,-0.9133357445174436,0.598825831702544,0.8181209457080217,1.0,3/15,10.63%,CYP1B1;SULT1A1;HSD17B11
prerank,negative regulation of blood pressure (GO:0045776),0.3662698242476276,0.913136745218512,0.5685071574642127,0.9371424114703225,1.0,2/13,12.88%,NOS3;BMPR2
prerank,regulation of membrane repolarization (GO:0060306),0.3674337588991696,0.9127105448745264,0.5733041575492341,0.937256543567548,1.0,2/13,3.72%,AKAP6;CACNA2D1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.38907386317348114,-0.9126878894277911,0.6163636363636363,0.8191428787805025,1.0,5/10,21.04%,PIBF1;PTPN2;PARP14;NF2;PPP2CA
prerank,regulation of cellular component organization (GO:0051128),0.22753682948385429,0.9125643343646681,0.694331983805668,0.9365918990710579,1.0,20/135,10.63%,NRG3;TFRC;SPOCK1;RIT2;RAB4B;OGFR;SEMA4D;PAK5;HIP1;HSPA8;PRKCQ;WFDC1;BBS10;MELTF;RAB4A;SGK3;TAOK2;DAB2IP;NET1;IL17RB
prerank,positive regulation of exosomal secretion (GO:1903543),-0.36324714984609363,-0.9125275762477273,0.6033519553072626,0.8190410459999061,1.0,5/15,25.01%,VPS4B;SDC4;SNF8;RAB7A;SDC1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.38073097141282397,0.9124651758259822,0.5769230769230769,0.9358431681662323,1.0,3/12,6.71%,PFDN5;CLU;PFDN6
prerank,phagolysosome assembly (GO:0001845),0.3786579994784361,0.9123177841060992,0.591304347826087,0.9352333157236737,1.0,2/12,10.68%,SYT7;CORO1A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.32871113632537036,-0.9122873285759278,0.5891783567134269,0.8191450082898062,1.0,3/19,2.75%,DCN;CCBE1;ROBO1
prerank,positive regulation of coagulation (GO:0050820),-0.40244306909623223,-0.9122295769204765,0.5881294964028777,0.8183446072530642,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.40244306909623223,-0.9122295769204765,0.5881294964028777,0.8183446072530642,1.0,2/10,5.41%,ST3GAL4;THBS1
prerank,transcription by RNA polymerase III (GO:0006383),-0.3097932465189554,-0.9121223205981916,0.6019607843137255,0.8181205486669583,1.0,16/27,39.92%,TBP;BRF1;SNAPC3;ICE1;GTF3C4;POLR2K;GTF3C1;SNAPC1;POLR3H;GTF3C6;SNAPC5;GTF3A;SNAPC4;POLR2L;SNAPC2;POLR3K
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.25201629550755233,-0.9118984510194373,0.6351606805293005,0.8181911720831022,1.0,26/70,25.77%,PARVA;ITGAV;LAMC3;RADIL;ARL13B;NRP1;ATRNL1;FER;RHOA;MEF2C;RB1;FN1;RILPL2;ITGA4;TBCD;SIPA1L3;ITGB3;RILPL1;PIK3R1;ANTXR1;LAMB2;LAMC1;ITGA8;DACT2;UNK;EPHB3
prerank,regulation of response to oxidative stress (GO:1902882),0.3913776983042021,0.9117238546191608,0.5741525423728814,0.9358241035646495,1.0,4/11,16.06%,MCTP1;HEBP2;GGT7;STOX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.28428930790810975,0.9116148903180272,0.6075949367088608,0.9351363702100952,1.0,13/42,19.16%,SIRT1;ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3244863734725468,-0.9116058419468668,0.5927342256214149,0.8183755754145859,1.0,6/22,14.09%,AKAP13;AEBP1;ABL1;PRUNE1;EFEMP2;APOE
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3377523746973445,0.9113301179771729,0.5958333333333333,0.9349052409379597,1.0,5/17,16.89%,MIF;SIRT1;RNF34;RFFL;MDM2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.38762794034005565,-0.9109941605558046,0.594392523364486,0.8193309727131982,1.0,9/12,37.05%,UPP2;DHODH;TK2;UMPS;CDA;CAD;UCK1;DCK;TK1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.2769769493182783,0.9107934898211143,0.6345733041575492,0.935320001862617,1.0,8/42,13.91%,AARS2;VARS1;VARS2;GARS1;RARS1;FARSB;AIMP2;IARS1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29003904452014945,0.9107544392242144,0.5942622950819673,0.9344058635647118,1.0,7/35,9.89%,SPRY3;RASAL3;STMN1;TGFB2;KCTD13;SPRY4;DAB2IP
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2529297004008637,0.9106438232040377,0.6369565217391304,0.9336797919142349,1.0,11/68,13.69%,TIRAP;MBP;IL17F;TLR2;ARHGEF2;AIF1;F2R;BCL10;POU2AF1;HSPD1;XBP1
prerank,positive regulation of growth (GO:0045927),-0.25583996931848685,-0.9106039698582761,0.6566037735849056,0.8197707464726913,1.0,16/64,15.45%,EGFR;TGFBR1;INO80;RPTOR;BCL2;HDGFL2;CDC42;CXCL16;MMP14;USP47;N6AMT1;ADNP2;KLHL22;EXOSC9;DDX3X;CSNK2A1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.35484187634516373,-0.9103377434913551,0.6134122287968442,0.8199251682165488,1.0,5/15,15.02%,NTRK3;IL16;F3;VEGFA;VEGFD
prerank,regulation of phosphorylation (GO:0042325),-0.23184113241335802,-0.9099660158134264,0.6692913385826772,0.8203148251152649,1.0,23/120,12.91%,PRKAG2;EGFR;BMP7;EP300;ROCK1;BMP4;THBS1;RANBP2;NRP1;LYN;NUP42;AR;PLXNB2;FER;ANKLE2;NUP214;HIF1A;FNIP1;TPR;KCTD20;FN1;OGT;FZD7
prerank,cellular component disassembly (GO:0022411),0.26124149973488453,0.9099447516878835,0.6037735849056604,0.9345802056761077,1.0,5/53,8.12%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.32431598191155303,-0.9094640111834564,0.5928705440900562,0.8210193346290147,1.0,11/22,30.60%,BMP7;ROCK1;BMP4;ANKLE2;INPP5K;INHBA;CDKN1C;PRKRIP1;TESK1;CDA;INHA
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.33082002694031526,-0.9093630709819153,0.5670498084291188,0.8207961381377111,1.0,5/21,7.03%,SULF1;EXT1;SULF2;GLCE;HS2ST1
prerank,extracellular matrix disassembly (GO:0022617),0.2608947563032414,0.9093246478021744,0.6301652892561983,0.9352870015342387,1.0,5/53,8.12%,BSG;TMPRSS6;MMP12;TIMP1;MMP16
prerank,regulation of acute inflammatory response (GO:0002673),0.335691267829674,0.9087733711339719,0.6079295154185022,0.935734142209465,1.0,1/18,1.05%,DNASE1
prerank,inner ear morphogenesis (GO:0042472),0.32341926699464146,0.9085378353007003,0.6067653276955602,0.9353717818691336,1.0,2/22,3.56%,PAX8;PAX2
prerank,iron ion transmembrane transport (GO:0034755),0.38667582196192896,0.908376570636291,0.5990990990990991,0.9348080783700808,1.0,3/10,10.66%,SLC40A1;SLC25A37;SLC39A8
prerank,pentose-phosphate shunt (GO:0006098),-0.3907863138896952,-0.9083725155593712,0.5996309963099631,0.82261722110836,1.0,6/11,26.16%,DERA;H6PD;PGLS;SHPK;RBKS;RPE
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3177729144947212,0.907847098504139,0.5961945031712473,0.9352449153115958,1.0,6/22,16.15%,IPO5;CAMK2N1;MEN1;APC;CDKN1A;CDKN1B
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.34636239011482645,0.9078037340293728,0.6180698151950719,0.9343438617232139,1.0,8/15,26.13%,NME2;ENTPD3;AK5;ENTPD1;ENTPD5;ENTPD7;AK4;ENTPD2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2581171006143135,-0.9077228587139491,0.6479166666666667,0.8236100668912625,1.0,30/57,32.29%,FOXN3;NBN;TAOK3;BRCC3;ATF2;BRSK1;RFWD3;RINT1;STK33;PRKDC;CDC14B;TRIM39;NOP53;MRE11;SDE2;CDK2;TAOK1;CDK5RAP3;WAC;CLSPN;DONSON;TIPIN;ABRAXAS1;FZR1;FANCD2;MDC1;NEK11;RPA2;EME2;RAD9A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2988454294983,-0.9075875570176591,0.6204379562043796,0.8234287626935968,1.0,17/31,36.86%,UBE2N;BTRC;AXIN1;FBXW7;CDC14B;TOPORS;UBE2S;DCUN1D3;ARRDC4;MAGEC2;FZR1;DCUN1D5;UBE2L3;DCUN1D4;PIN1;GORASP1;SKP1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.28283905625945793,-0.9071940306843925,0.6323809523809524,0.8238655509352432,1.0,16/40,32.01%,UBE2N;SMG1;ABL1;PRKCD;BCLAF1;RFWD3;WDR76;NEK4;KMT5A;UBE2V2;NSMCE4A;FXR1;CDK9;POLH;PARG;RPA2
prerank,cellular response to interleukin-2 (GO:0071352),-0.38959752960771105,-0.9069640039383646,0.5923694779116466,0.8234630799483863,1.0,5/11,24.64%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.38959752960771105,-0.9069640039383646,0.5923694779116466,0.8234630799483863,1.0,5/11,24.64%,JAK1;SHC1;STAT5A;STAT5B;SYK
prerank,regulation of cell development (GO:0060284),0.28691709123064907,0.9065901477894636,0.6396761133603239,0.9365297597604786,1.0,11/36,17.00%,HDAC9;RPS19;HEY1;AKT1;FOXO1;PER2;HES6;BHLHE40;DLL1;HES5;CTNNB1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3311496552505028,0.9063029838128295,0.5960698689956332,0.9363026652790302,1.0,7/18,16.78%,TENM4;NOTCH1;TMEM98;OPALIN;TNFRSF21;PTPRZ1;HES5
prerank,amide biosynthetic process (GO:0043604),0.27520242122583594,0.9061662330805245,0.6239130434782608,0.935673132206556,1.0,4/47,3.33%,SGMS1;PCSK1;FA2H;DEGS2
prerank,negative regulation of transferase activity (GO:0051348),-0.30202077429648344,-0.9058870281957242,0.5946969696969697,0.8254881499013754,1.0,8/28,20.48%,ABL1;GSK3B;EIF4A2;DTX3L;HNRNPU;INPP5K;PARK7;CDKN1C
prerank,response to nitric oxide (GO:0071731),0.36118925413147007,0.9057880493656799,0.5755102040816327,0.9356296288070568,1.0,4/13,20.52%,KCNC2;FOXO1;EGLN1;CCL19
prerank,cytosolic calcium ion transport (GO:0060401),0.30018291279998216,0.9057292608537162,0.612691466083151,0.9347710912391697,1.0,7/28,11.22%,RYR2;CACNA2D1;SLC8A1;ATP2B3;SLC25A23;ADRA1A;JPH3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.28575800179938277,0.9057256116259121,0.6325678496868476,0.9337765733445722,1.0,9/39,13.02%,SPOCK1;ACER2;AJAP1;NOTCH1;MELTF;NEXMIF;SPRY4;FZD4;ACTN4
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39404256470475163,-0.9047724288245061,0.5735849056603773,0.8275993690566528,1.0,4/10,17.48%,RIPOR2;WASL;APOD;MIA3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.29297719578397113,-0.9046911999104115,0.5872420262664165,0.827313724870878,1.0,6/33,7.95%,TCF7L2;ANGPT1;CAST;NUPR1;YAP1;PDPK1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.258419499796786,0.9045764676669116,0.634765625,0.93583584154218,1.0,20/60,18.94%,PRKCQ;KLF4;HSP90AB1;PDGFB;CCT2;DKC1;CCT4;ATM;PARM1;RFC4;PTGES3;XRCC5;RFC5;CTNNB1;HSP90AA1;NAF1;MAPK3;NVL;RFC2;TCP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.3436762919774377,-0.9043978819582965,0.5974955277280859,0.8275028111104513,1.0,5/17,23.08%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,replication fork processing (GO:0031297),-0.28222742147772806,-0.9042755559056194,0.6231060606060606,0.8272983807901793,1.0,18/38,35.65%,WRN;RFWD3;FANCM;BRCA2;BOD1L1;MRE11;ZRANB3;PCNA;ATR;SMARCAL1;PRIMPOL;ATRX;CDK9;SAMHD1;EME2;RAD51;CENPX;GEN1
prerank,innate immune response (GO:0045087),0.2122356996520989,0.9039592051707158,0.733739837398374,0.9365044561314251,1.0,33/217,16.08%,MASP2;PGLYRP1;MBL2;TRIM13;PPARG;SNCA;ISG15;CAPZA2;TRIM43;SRMS;TRIM62;TLR2;TRIM6;IFITM3;TRIM59;SLPI;CYBC1;CORO1A;SMPD1;MID2;BCL10;IRF7;PJA2;CD40;DEFA6;LCN2;TRIM35;POLR3A;MFHAS1;B2M;GCH1;OTULIN;RNASE3
prerank,negative regulation of anoikis (GO:2000811),-0.3607606949350065,-0.903261368509069,0.608286252354049,0.8291580113491036,1.0,4/14,15.36%,ITGB1;BCL2;TLE1;ITGA5
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2882793382658645,-0.9032063849322538,0.622093023255814,0.8288246353983991,1.0,13/36,24.77%,AFDN;KIF13A;RAB10;VAMP5;VAMP2;GGA3;RILPL2;NECTIN3;VAMP4;RILPL1;GGA2;NSF;RAB7A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3585624985767721,-0.9031214929113355,0.5756385068762279,0.8285621625390281,1.0,10/15,35.85%,TSEN2;ERN1;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,regulation of mitochondrial translation (GO:0070129),-0.32792426558524124,-0.9030540238111825,0.603515625,0.8282484797421273,1.0,10/21,31.68%,RCC1L;NSUN3;ALKBH1;MTG2;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,regulation of transposition (GO:0010528),-0.36979378501465043,-0.9030511252834091,0.6064030131826742,0.8277847809574632,1.0,2/13,16.94%,UBR2;MYBL1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.31138366639825893,0.9029841525003872,0.608,0.9380903197468868,1.0,7/24,16.70%,DACH1;ACVRL1;TERF2IP;BMPR2;RPS3;CDKN1A;XRCC5
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.29515266571392,-0.9025319055479183,0.6066790352504638,0.828017946533867,1.0,7/29,23.25%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.29515266571392,-0.9025319055479183,0.6066790352504638,0.828017946533867,1.0,7/29,23.25%,GPAT4;ACSF2;ACSL6;ACOT11;ACOT9;ACOT8;ACOT6
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3989668600218083,-0.9024910697023839,0.5891891891891892,0.8276437481957698,1.0,2/10,3.68%,TGFBR2;CD55
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.2697479230026056,0.9023873357046155,0.6506276150627615,0.9386608014960734,1.0,5/41,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,protein complex oligomerization (GO:0051259),0.24561352363109326,0.9017773653629672,0.7002053388090349,0.9392838912311053,1.0,21/85,19.16%,MPP2;ADCY8;KCNC2;AQP11;SNCA;GLRA3;KCNC3;NINJ1;HOMER1;KCNC1;RNF112;BCL10;HGSNAT;MAT2A;ZNHIT6;PNPT1;VSTM5;G3BP2;PDCD6IP;OXA1L;LRRC8A
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3287029339650731,0.9013225621082136,0.5858369098712446,0.939458703592684,1.0,9/18,20.69%,TIMM21;COA5;FASTKD3;COX16;COX17;BCS1L;COA3;OXA1L;SCO1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3532497398804855,-0.901307759821052,0.5973282442748091,0.8299360726116228,1.0,5/15,14.17%,LDLR;NR1H3;SIK1;FBXW7;SLC27A1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.26088619669352275,0.9012016316210859,0.6141078838174274,0.9387653749766713,1.0,11/54,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;COPS9;ISG15;AKT1;RPL5;PER2;SMAD7;RPS3
prerank,positive regulation of heart contraction (GO:0045823),-0.3343703772111086,-0.900720728292823,0.621414913957935,0.8308283287995929,1.0,1/19,0.03%,ATP1A2
prerank,regulation of biomineral tissue development (GO:0070167),-0.30554957230797014,-0.9002750050703048,0.630648330058939,0.8313827246597815,1.0,4/26,8.44%,ROCK2;ROCK1;ENPP1;NBR1
prerank,sulfur compound transport (GO:0072348),-0.30062048812184433,-0.9000445239055538,0.6317829457364341,0.8314689465002415,1.0,8/27,18.64%,SLC6A13;SLC13A4;SLC26A7;LRRC8D;SLC5A6;SLC27A1;SLC25A11;MGST1
prerank,positive regulation of heart rate (GO:0010460),0.3405480500235004,0.9000119429810921,0.5971370143149284,0.9407880724672405,1.0,6/17,16.31%,ADRB1;RYR2;ADRA1D;ADRA1A;PDE4D;EDN1
prerank,peptide hormone secretion (GO:0030072),-0.30691327282823366,-0.8997943815614984,0.6180422264875239,0.831572602532855,1.0,4/26,8.15%,CYB5R4;CDK16;ANXA1;CAMK2G
prerank,histone H4-K5 acetylation (GO:0043981),-0.3418859805416974,-0.898827381224945,0.637065637065637,0.8327972680410363,1.0,6/15,23.98%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),-0.3418859805416974,-0.898827381224945,0.637065637065637,0.8327972680410363,1.0,6/15,23.98%,KANSL2;HCFC1;OGT;KAT8;KANSL3;JADE2
prerank,negative regulation of nervous system development (GO:0051961),-0.3407019501645132,-0.898452566775691,0.5988805970149254,0.8331975325720127,1.0,3/17,7.45%,APPL2;PCM1;REST
prerank,regulation of isotype switching (GO:0045191),0.3594173285352166,0.8980058060771623,0.5948275862068966,0.9451362594727397,1.0,1/14,0.13%,TFRC
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2716167044856884,-0.8978054726541715,0.6600397614314115,0.834196112605708,1.0,9/47,10.91%,KIF13A;CCDC93;ARL3;RAB10;OSBPL5;VAMP5;VAMP2;GGA3;EXOC2
prerank,neurotrophin signaling pathway (GO:0038179),0.32634755366708007,0.8975025746109393,0.5975609756097561,0.9454630635947455,1.0,7/21,19.56%,MAGI2;NTRK2;HAP1;BCAR1;RAP1A;DDIT4;SORT1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2958222256143418,-0.8973498666408491,0.6179159049360147,0.8347625644934027,1.0,8/29,20.28%,WWOX;THBS1;PAK2;TRAF2;LTBR;INHBA;PPP2R1B;PML
prerank,negative regulation of cytokine production (GO:0001818),0.22089897537324643,0.896255071433875,0.7307692307692307,0.9477663812053604,1.0,19/163,11.20%,CD33;LEF1;NAV3;HDAC9;TMSB4X;SYT11;GAS6;ISG15;IL12A;RPS6KA5;NPTN;KLF4;GPNMB;CD34;FOXJ1;CD200R1;HOMER2;PPP1R11;TNFRSF21
prerank,organophosphate ester transport (GO:0015748),0.31152447438524267,0.8956967274967003,0.6061269146608315,0.9482491516063717,1.0,8/24,18.20%,PLTP;PITPNM1;PRELID3A;PRELID2;SCARB1;SCP2;MTTP;PITPNB
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28619606665916275,0.8956279317253242,0.612,0.9474116606820656,1.0,5/33,7.97%,TFRC;OMA1;GPX1;CLU;AKT1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.37819371162925175,-0.89541694180564,0.6288288288288288,0.8387220503260122,1.0,6/12,24.66%,GLUD1;ACO2;ACO1;ASS1;SIRT4;IREB2
prerank,cochlea morphogenesis (GO:0090103),0.3794710219364986,0.8950811684082786,0.5919661733615222,0.9478463029889099,1.0,1/10,3.56%,PAX2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.27481640156365983,-0.8950742115321804,0.651031894934334,0.839007933765008,1.0,7/40,14.17%,SLC7A11;SLC13A3;ABCC5;SLC38A11;SLC5A6;SLC38A6;SLC27A1
prerank,organelle transport along microtubule (GO:0072384),-0.2967889771046494,-0.8946901018199536,0.6559546313799622,0.8393686767758342,1.0,9/31,18.62%,TRAK1;ARHGAP21;CDC42;NDEL1;RHOT1;COPG2;FBXW11;TMEM201;COPG1
prerank,regulation of protein dephosphorylation (GO:0035304),0.2821506757320043,0.8946477459180054,0.6419753086419753,0.947906394240204,1.0,12/37,22.84%,YWHAB;PPP1R16B;SMPD1;CALM1;CALM2;CALM3;MFHAS1;PPIA;CAMTA1;PPP2R5A;PPP1R16A;PPP6R1
prerank,apoptotic process (GO:0006915),-0.21064952221815061,-0.8941269670841341,0.7753036437246964,0.8401858847907827,1.0,41/203,17.29%,NOTCH2;PAWR;RNF152;CFLAR;STK3;EP300;CYFIP2;TGFBR2;PLSCR1;ZBTB16;BCL2;IFIT2;MTOR;FAM162A;AIFM1;VDAC1;CASP12;TNFAIP1;EGLN3;MAGI3;PRKCD;DMPK;CDK11B;AKAP1;BCLAF1;NCKAP1;PARP1;FAP;ERCC3;OGT;CASP2;IRF1;RFK;DAPK1;IAPP;DAP;GLRX2;ARHGEF6;PDCD4;DAPK2;BCL2L13
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2821262506654491,-0.8938069032028407,0.6308851224105462,0.8404637597085467,1.0,10/36,20.76%,GULP1;GSN;THBS1;VAMP7;CDC42;RHOBTB2;DOCK1;RHOBTB1;RHOH;ARHGAP12
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33293797432092725,-0.8937674604027818,0.606,0.8400886175078501,1.0,8/18,22.22%,MAP3K3;RHOJ;FOXC2;ANXA1;VEGFA;FGFBP1;FGF2;SRPX2
prerank,protein import into peroxisome membrane (GO:0045046),-0.3210002249974937,-0.8937376590284662,0.635814889336016,0.8396837572322828,1.0,7/22,20.65%,ABCD3;PXMP4;ABCD2;SLC25A17;FIS1;PXMP2;PEX26
prerank,mitotic DNA replication (GO:1902969),-0.39855872645035223,-0.8933086279032263,0.6109022556390977,0.8402050996806446,1.0,7/10,38.61%,MCM6;MCM4;MCMDC2;CDC45;POLA1;GINS1;MCM2
prerank,pre-replicative complex assembly (GO:0036388),0.25088126200446625,0.8922688211619391,0.643956043956044,0.9531243719664508,1.0,14/64,19.98%,PSMA1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;MCM3;PSME3;PSMC3;PSMA2;PSMB7;ORC6;MCM8
prerank,regulation of phagocytosis (GO:0050764),0.2596720011452628,0.8921457947469301,0.6576402321083172,0.9524496912951763,1.0,6/53,7.68%,SYT7;SYT11;IL2RG;GAS6;TLR2;DYSF
prerank,positive regulation of organelle assembly (GO:1902117),-0.2716919009166057,-0.892110684017104,0.6494845360824743,0.8425020591693257,1.0,16/44,26.41%,ASAP1;NUMA1;RAB3GAP1;STX18;PIP4K2C;MARK4;CNOT2;SDC4;DYNC1H1;CNOT1;LRSAM1;KCTD17;TAPT1;ARHGAP35;SDC1;BBS4
prerank,protein O-linked glycosylation (GO:0006493),0.2375853448759138,0.8917919506888106,0.695049504950495,0.9523927622896676,1.0,16/96,13.35%,TMTC2;GALNT9;GALNT15;GALNT13;MGAT5B;EOGT;GALNT14;GALNT6;SLC35C1;PLOD3;GALNT3;ST8SIA6;GALNTL6;B3GNT2;GALNT2;POMGNT2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3195054998297936,0.8914891447785,0.6044444444444445,0.9521859682727265,1.0,5/21,12.86%,PDE2A;NUDT3;HPRT1;PDE4D;HINT1
prerank,quinone biosynthetic process (GO:1901663),0.34989299623081715,0.8914559120211393,0.6153846153846154,0.9512751725765592,1.0,2/14,5.43%,COQ2;COQ7
prerank,base-excision repair (GO:0006284),0.2663645540831928,0.8912386515844479,0.650103519668737,0.9508492013696759,1.0,13/48,18.89%,HMGA2;LIG3;RPA3;UNG;APEX1;POLG;POLD1;PRMT6;RFC4;POLD3;RFC5;ADPRS;RFC2
prerank,positive regulation of transporter activity (GO:0032411),-0.3603410666143294,-0.8908932924580312,0.5769944341372912,0.8446941464298859,1.0,10/13,47.42%,NR1H3;RXRA;KMT2A;KCTD7;TRPC6;SGK1;SYNGR3;SGK2;PDZK1;WNK3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3546072221597919,-0.8906597235771899,0.6183953033268101,0.8447132926807861,1.0,3/14,10.27%,MEOX2;THBS1;RHOA
prerank,positive regulation of protein transport (GO:0051222),0.24758616196742206,0.8904007541232059,0.68389662027833,0.9519952496441464,1.0,6/67,5.82%,CD33;PRR5L;TENM1;APBB1;APBB3;TGFB2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28608222300952924,-0.8903928152041486,0.6573556797020484,0.8448245849331663,1.0,12/34,19.26%,PTPN13;TNS2;PTPN9;PTPRS;DUSP16;PTPN22;PTPN12;PTPN2;DUSP1;DUSP10;PTPN1;PTPN11
prerank,positive regulation of isotype switching (GO:0045830),0.34956576030704234,0.8903676847450072,0.5873015873015873,0.9510825637465474,1.0,3/15,13.15%,TFRC;SHLD3;CD40
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2674710174908869,0.8902162207268725,0.635593220338983,0.9504644176503401,1.0,12/48,13.90%,HDAC9;TMSB4X;SIRT1;KDR;NOS3;ETS1;AKT1;HSPB1;PDGFB;ATP5F1B;CD40;CIB1
prerank,regulation of centriole replication (GO:0046599),-0.3393006850037823,-0.8898335060745246,0.6111111111111112,0.8456199469438315,1.0,5/17,17.08%,KAT2B;ALMS1;SPICE1;CEP295;CEP76
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.24105614293350378,-0.8896407357153369,0.7047619047619048,0.8455731648057458,1.0,23/83,20.87%,CCNH;KHDRBS1;CDK16;CDK7;TFDP2;PHF8;EIF4E;MNAT1;CUL3;RB1;HINFP;CRLF3;ACVR1;RCC1;LATS1;CUL2;NASP;CACUL1;INHBA;CDK2;PCNA;CUL1;CDK6
prerank,peptidyl-arginine modification (GO:0018195),0.3447673687558635,0.889635552597267,0.625,0.9510036867515977,1.0,3/15,12.85%,NDUFAF5;PRMT7;ART3
prerank,protein acylation (GO:0043543),-0.2770049463881089,-0.8894824028712647,0.638,0.8454944303756,1.0,14/38,28.21%,KAT2B;EP300;CREBBP;GLUL;ZDHHC13;ING5;GTF2B;ZDHHC1;ZDHHC16;HHAT;SPHK1;ZDHHC8;NAT10;NAA80
prerank,regulation of T cell cytokine production (GO:0002724),-0.34544678661831607,-0.8888983555033786,0.6245353159851301,0.8463187409630367,1.0,4/15,18.35%,CD55;TRAF2;TRPM4;TRAF6
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.31565703139985496,0.8886683988075427,0.6332665330661322,0.9515126774014727,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.31565703139985496,0.8886683988075427,0.6332665330661322,0.9515126774014727,1.0,10/23,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,histone H4 acetylation (GO:0043967),-0.2639115569903167,-0.8881744776144215,0.6727642276422764,0.8474285195452984,1.0,17/47,21.38%,EP300;TRRAP;ZZZ3;HAT1;ATF2;KANSL2;TADA3;HCFC1;OGT;KAT8;ING5;BRCA2;MSL2;EPC1;MSL3;KANSL3;KMT2A
prerank,negative regulation of platelet activation (GO:0010544),-0.33305910189986243,-0.8880057453729403,0.6266173752310537,0.847324253671385,1.0,4/16,14.09%,PDGFRA;CD9;PRKCD;APOE
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.311515598922874,0.8878810713514483,0.6252545824847251,0.95254005343888,1.0,6/23,15.96%,CYP2E1;HPGD;ACOT7;FADS1;LTA4H;GSTM1
prerank,atrioventricular valve development (GO:0003171),-0.35725668013974626,-0.8877630133116241,0.6206261510128913,0.8473930755476619,1.0,3/14,3.24%,BMPR1A;MDM4;TGFBR2
prerank,rRNA 3'-end processing (GO:0031125),-0.3878334076718642,-0.8877274043070859,0.6358490566037736,0.8470010417073736,1.0,4/10,15.99%,ERI3;ERI2;EXOSC9;EXOSC10
prerank,carbohydrate catabolic process (GO:0016052),0.2776304181926692,0.8876995327619692,0.6618852459016393,0.9519892086419262,1.0,12/38,21.41%,PGAM4;PGAM1;NEU2;ALDOC;GCK;PFKFB2;GAPDHS;NEU1;LDHA;ENO2;NEU4;GPI
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2570925363676531,-0.8876603978785167,0.6673469387755102,0.8466665941858715,1.0,6/55,8.57%,IGF1;IGFBP2;IL6ST;HMGB1;ANXA1;IGF2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3624633852538873,-0.8872739778699366,0.6190476190476191,0.8470850179355989,1.0,3/13,10.62%,RBPJ;TGFBR2;SMAD4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2640637042722459,0.8871798400276231,0.6828752642706131,0.9523094673798543,1.0,5/43,8.91%,CD33;SYT11;GAS6;CD34;POMC
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.32698770726259335,-0.8869285228935567,0.6431226765799256,0.8473775190519395,1.0,9/19,24.64%,ZMIZ1;AXL;ZBTB1;MMP14;PRKDC;RHOH;PPP2R3C;XRCC6;SYK
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.28188197898687595,-0.8868448949874324,0.6629001883239172,0.8470759277269537,1.0,9/38,17.01%,BMP5;CFLAR;GSK3B;THBS1;SP100;TRAF2;STX4;DDX3X;SERPINE1
prerank,positive regulation of innate immune response (GO:0045089),-0.2879708826962539,-0.8862385439319332,0.6853932584269663,0.847986743062036,1.0,8/30,18.63%,LBP;PLSCR1;DHX9;UBE2K;MAVS;RIOK3;WNT5A;IFI35
prerank,sarcomere organization (GO:0045214),0.2989786858315614,0.8862366618195099,0.6341991341991342,0.9537558864686918,1.0,4/27,9.53%,MYH6;FHOD3;WDR1;TCAP
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3815263375217831,-0.8860338369264287,0.6308851224105462,0.847959502451858,1.0,6/11,30.06%,UQCRC1;UQCR10;UQCR11;CYC1;UQCRFS1;CYCS
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.32350057441923663,-0.8857555231532397,0.6173076923076923,0.8480826394784005,1.0,11/18,34.80%,RIPOR2;TNFAIP1;ABL2;CUL3;MYOC;ARHGAP35;KANK1;SCAI;MET;CCDC125;KCTD10
prerank,positive regulation of endocytosis (GO:0045807),-0.2693742636876818,-0.8851317144915528,0.6640316205533597,0.8490622114330174,1.0,8/45,9.23%,LRP1;APPL2;AXL;DAB2;VTN;GPC3;CDC42;HNRNPK
prerank,regulation of actin filament-based movement (GO:1903115),-0.39231358804667327,-0.8850774423965846,0.6257197696737045,0.8487109029765915,1.0,2/10,2.84%,ANK2;PDPN
prerank,ubiquinone metabolic process (GO:0006743),0.33915985413678007,0.8849794167005135,0.6323529411764706,0.9560445689548915,1.0,2/15,5.43%,COQ2;COQ7
prerank,response to tumor necrosis factor (GO:0034612),-0.2360420074287856,-0.8848462491366533,0.7047619047619048,0.8487289461283736,1.0,17/91,18.79%,PID1;ADAMTS12;ZFAND6;AFF3;GSDME;DHX9;NUB1;CXCL16;ADAM9;YBX3;GBP3;MAP2K7;GBP2;NPNT;TANK;INPP5K;SMPD4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3144221439096646,0.8846512728544307,0.6247288503253796,0.9558476069038451,1.0,4/20,10.08%,AMPD1;GART;HPRT1;GMPR2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2725290812641485,0.8845017076608762,0.6666666666666666,0.9552423479677501,1.0,16/38,20.39%,CLU;KLF4;HSP90AB1;AKT1;CD34;KHSRP;GLA;KLF2;INSR;CD36;ATP2B4;EDN1;HSP90AA1;DDAH1;CD47;RAC1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.35077564081158447,-0.8842313950381401,0.6189555125725339,0.8495988143782353,1.0,2/14,9.12%,IGF1;LDLR
prerank,regulation of anoikis (GO:2000209),-0.3267542486623133,-0.8841102309214619,0.6408317580340265,0.8494353717193458,1.0,5/19,15.36%,ITGB1;BCL2;TLE1;SIK1;ITGA5
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3411933067240497,-0.8841064160781578,0.626746506986028,0.8489790135166623,1.0,2/17,4.65%,ANK2;SNTA1
prerank,nuclear membrane reassembly (GO:0031468),-0.2586869799682098,-0.8837897175801753,0.6730401529636711,0.8492475782126908,1.0,23/54,35.08%,LMNA;UBXN2B;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2871659505533921,-0.8835906419763063,0.6556420233463035,0.8492560436399338,1.0,8/28,16.33%,ARHGAP28;FCHSD2;PLEKHG2;BRK1;CTTN;LATS1;RASA1;ARHGAP18
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.33184631797787645,-0.8829875448034209,0.6459854014598541,0.8501021316184574,1.0,4/18,17.35%,ROCK2;EPHA4;IFNGR1;PICALM
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3725253583653918,-0.8828418060250225,0.6358695652173914,0.8499513768304812,1.0,3/11,11.02%,DHX9;SAFB2;CDK11B
prerank,cholesterol metabolic process (GO:0008203),-0.24628885281843466,-0.8826772030045826,0.728,0.8498422616049252,1.0,23/68,31.10%,ABCA1;CYP27A1;SOAT1;INSIG2;OSBPL5;ACAA2;APOE;RXRA;HMGCR;SQLE;CYP51A1;FDX1;FDFT1;ARV1;LBR;MVK;GBA2;SCAP;CLN8;MT3;TSKU;ANGPTL3;CLN6
prerank,axonemal dynein complex assembly (GO:0070286),0.2978384647365732,0.8824905914899492,0.6356107660455487,0.9593494753267156,1.0,4/27,10.04%,DNAAF3;LRRC49;CFAP100;DNAAF2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.35213096574866265,0.8823787122296949,0.6442953020134228,0.9586457864014196,1.0,1/14,0.13%,TFRC
prerank,defense response to Gram-negative bacterium (GO:0050829),0.26620597949348224,0.8820462333820357,0.6617336152219874,0.9584786698027026,1.0,8/42,19.26%,RPS19;ADGRB1;RPL30;DROSHA;DEFA6;RNASE3;OPTN;CHGA
prerank,protein insertion into membrane (GO:0051205),-0.28685862561139003,-0.8819366531157427,0.6564299424184261,0.8509925722690458,1.0,11/32,29.11%,EGFR;TRAM2;VAMP2;STX5;COX18;EMD;GET4;VAPA;STX1A;APP;CCDC47
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.25346597668526877,-0.8818804463610732,0.6541501976284585,0.8506594259437701,1.0,8/55,13.51%,PID1;PDGFRB;PRKN;TGFBR2;THBS1;CYP1B1;AGTR1;SIRT5
prerank,autonomic nervous system development (GO:0048483),0.332068095850911,0.8818232096810895,0.6405228758169934,0.9580576122673399,1.0,1/17,0.21%,PHOX2A
prerank,ubiquinone biosynthetic process (GO:0006744),0.3422727191765485,0.8817095602077556,0.603448275862069,0.9573338921687794,1.0,2/15,5.43%,COQ2;COQ7
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3082717088690606,-0.881452590170843,0.6536203522504892,0.8511672309886934,1.0,6/23,10.14%,ABL1;PRKN;LRRK2;SLC9A1;ADCY6;GABPA
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2295169005244096,-0.881071957011259,0.7238658777120316,0.8515109195708841,1.0,35/109,29.12%,GAB2;NFKB1;BTRC;MAP2K4;PAK2;SHC1;LYN;VAV2;PDPK1;PLCG1;FER;JUN;PSMF1;TEC;PSMB2;MAP2K7;FBXW11;TRAF6;MAP3K1;NFATC3;CUL1;PIK3R1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;MAPK9;FCER1G;SOS1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,endocytic recycling (GO:0032456),-0.2578789266175033,-0.8809079345484823,0.6878612716763006,0.8513927124456004,1.0,21/50,36.05%,CCDC93;ANKRD50;VPS26C;EHD2;VPS39;ANKRD27;ACAP2;EHD3;EIPR1;EHD4;SNF8;PTPN23;SNX12;RAB7A;ARL4C;EHD1;ARF6;DENND1B;STX6;MICALL1;CCDC22
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22672566649731635,-0.8807832476911722,0.7224489795918367,0.8511755585467511,1.0,38/104,27.81%,LRP6;KSR1;ABL1;CCNT2;UVRAG;CCNH;RPTOR;CCNT1;CDK7;MAP2K1;CCNK;MNAT1;RHOA;TELO2;RB1;TRIB2;SLC27A1;CCND3;DDX3X;CNPPD1;SYAP1;SLC8A3;MTCP1;SNF8;CAB39;PPP2CA;PIH1D1;CDK5RAP3;EZH2;GTF2H1;BCCIP;CCNE2;CCNJ;IRGM;INCENP;ADRB2;TESK1;CAMK1
prerank,cellular response to osmotic stress (GO:0071470),-0.31888415125424674,-0.880698217114201,0.6421845574387948,0.8508950328191992,1.0,7/21,22.88%,MYLK;LRRC8D;PKD2;YBX3;DDX3X;CAB39;ZFAND1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.32954350126230514,-0.8798691508009324,0.6437847866419295,0.8522566337548391,1.0,2/17,4.65%,ANK2;SNTA1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.24118846648788836,-0.8798565479820905,0.7248576850094877,0.8518172989439967,1.0,21/73,20.47%,EGFR;NTRK3;ARAF;RPTOR;TBK1;DOCK7;CREBL2;AXIN1;BRAF;RAPGEF3;NGF;FNIP1;TXN;VEGFA;LATS1;AKAP9;PRKD1;PARK7;MTCP1;EIF4G1;NOS1
prerank,glutathione derivative metabolic process (GO:1901685),0.31424672477110666,0.8794831755852738,0.6365591397849463,0.9611569423740574,1.0,5/20,19.27%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.31424672477110666,0.8794831755852738,0.6365591397849463,0.9611569423740574,1.0,5/20,19.27%,GSTA4;GSTM5;ESD;GSTM1;MGST3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3881587928543654,0.8792250363423022,0.6382978723404256,0.9608036358367451,1.0,2/10,7.01%,PPM1F;TERF1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2894600784130951,-0.8789268526531996,0.6435643564356436,0.8533811670440095,1.0,3/29,6.61%,TGFBR3;TPM1;FGFR2
prerank,regulation of cytokine production (GO:0001817),0.22270811864601525,0.878860424528764,0.7434343434343434,0.9607452561338296,1.0,12/126,9.30%,CADM1;IL17F;HDAC9;MIF;BTNL9;SYT11;ISG15;MOG;RPS6KA5;NPTN;GPNMB;TRIL
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3345523505564453,0.8785060418663682,0.6150627615062761,0.960622402508385,1.0,4/17,13.73%,AJAP1;CD24;APOLD1;DLL1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3766909316756449,0.8783971642689002,0.6261261261261262,0.9599037281577673,1.0,4/10,16.69%,DGKH;F2R;PRKD3;GAP43
prerank,O-glycan processing (GO:0016266),0.2604309426465562,0.8782827020981631,0.6836734693877551,0.9592227830600483,1.0,5/54,5.33%,GALNT9;GALNT15;GALNT13;GALNT14;GALNT6
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.23219869073730784,0.8781715191502172,0.7329192546583851,0.9585166658742094,1.0,19/94,16.24%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;NOD1;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP
prerank,regulation of immune response (GO:0050776),0.21820839355183022,0.8780534909309752,0.7475728155339806,0.9578135979914995,1.0,12/135,9.54%,CD33;LRP8;TIRAP;KLRC1;SPPL2B;SLA2;TGFB2;CD34;LAIR1;ICAM2;CD300LF;CD200R1
prerank,error-free translesion synthesis (GO:0070987),0.31669378677657445,0.8780154147447558,0.6056034482758621,0.9569135473595054,1.0,8/22,18.89%,RPA3;RPS27A;UBC;UBB;POLD1;RFC4;RFC5;RFC2
prerank,cardiocyte differentiation (GO:0035051),-0.3950399725885131,-0.8772318266608845,0.639344262295082,0.8566105777556768,1.0,5/10,21.36%,AKAP13;SIK1;EEF1AKMT4-ECE2;BMP2;GATA6
prerank,manganese ion transport (GO:0006828),0.3529634902647115,0.8771792954362821,0.6179540709812108,0.9580480271086576,1.0,3/14,11.90%,TRPC5;SLC39A8;TRPC1
prerank,histone exchange (GO:0043486),-0.27925494269598244,-0.876950368255271,0.6527777777777778,0.8567869383123566,1.0,21/37,40.11%,RNF8;HJURP;SPTY2D1;CENPP;ANP32E;NASP;ITGB3BP;CENPT;ACTR6;DMAP1;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3711886484906784,-0.87692348033448,0.6297709923664122,0.8563826886176982,1.0,2/11,6.93%,RC3H1;LYN
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.36589337451070236,-0.8767562310060529,0.6446124763705104,0.8562748104360647,1.0,3/13,12.86%,ADHFE1;D2HGDH;DLST
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3731414424222861,0.8766942881948663,0.6207627118644068,0.958297560283028,1.0,2/10,7.90%,CD24;HSP90AB1
prerank,response to lipopolysaccharide (GO:0032496),0.22165422871369053,0.8766070975784052,0.7702127659574468,0.957530301245784,1.0,26/138,15.14%,PDE4B;TIRAP;GIT1;S100A9;S100A8;SNCA;NOS3;IL12A;HNRNPA0;IFNAR1;TRIM6;CCL2;DAB2IP;SLPI;GGT7;F2R;BCL10;GGT1;MAPK8;SCARB1;DEFA6;XBP1;TAB2;PELI1;GCH1;MAPKAPK2
prerank,negative regulation of calcium ion transport (GO:0051926),0.33787728873363604,0.8764571165960763,0.6287425149700598,0.956914207944624,1.0,3/15,7.75%,CD33;SLC30A1;EPO
prerank,regulation of viral entry into host cell (GO:0046596),0.28736109686660344,0.8762814023551512,0.6475583864118896,0.9563601058493528,1.0,7/30,14.35%,HS3ST5;TRIM62;TRIM6;IFITM3;TMPRSS4;MID2;LY6E
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.29098547405766795,-0.876024370204014,0.6266666666666667,0.8573801537104689,1.0,8/28,16.43%,EGFR;WWP2;NIBAN2;MMP14;NOTCH3;FBXW7;ARRB1;TSPAN15
prerank,B cell homeostasis (GO:0001782),-0.38928180823917624,-0.8759928144349386,0.6166982922201139,0.856986030830556,1.0,3/10,11.68%,DOCK11;LYN;MEF2C
prerank,cellular response to type I interferon (GO:0071357),-0.27061923202029153,-0.8751631394037719,0.6737451737451737,0.8578886427030948,1.0,22/41,34.85%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,type I interferon signaling pathway (GO:0060337),-0.27061923202029153,-0.8751631394037719,0.6737451737451737,0.8578886427030948,1.0,22/41,34.85%,JAK1;IFIT2;SP100;IRF9;IRF1;TYK2;STAT1;OAS2;GBP2;IFI35;IFI27;IRAK1;IFIT3;IRF2;IP6K2;EGR1;SAMHD1;IFITM1;IRF5;PSMB8;MYD88;IRF8
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.332328576657939,0.8749078361443636,0.6265560165975104,0.9588012046223959,1.0,4/18,8.43%,SIRT1;NME5;AKT1;HSPB1
prerank,negative regulation of cation channel activity (GO:2001258),0.29289542762050347,0.8745679969681396,0.6602972399150743,0.9587113224796148,1.0,6/26,14.32%,GPR35;EPO;KCNAB1;CALM1;CALM2;CALM3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23261736780513495,0.8745181517199029,0.7505154639175258,0.9578527041022764,1.0,9/86,6.46%,NAV3;PROX1;TENM1;BIN1;GPX1;OCLN;PAK1;WDR1;CLU
prerank,regulation of T cell proliferation (GO:0042129),0.24986811980938867,0.8743387772803398,0.697495183044316,0.957329344877791,1.0,5/61,11.20%,TFRC;SLC7A1;GPNMB;AIF1;TNFRSF21
prerank,maturation of SSU-rRNA (GO:0030490),0.27667747575686974,0.8742148926492191,0.6639676113360324,0.9566519782423084,1.0,4/34,6.76%,TSR3;RPS19;RPS8;RPS16
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3774287969279887,0.8739328483341001,0.6336206896551724,0.9563596707843218,1.0,3/10,13.43%,TIRAP;NINJ1;WDFY1
prerank,maturation of LSU-rRNA (GO:0000470),0.29322258233423953,0.8738378674610495,0.6572008113590264,0.9556187764303381,1.0,8/26,16.18%,RPF2;RPL7;RPL10A;RPL7A;NHP2;NOP2;ZNHIT6;DDX18
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.26789721821731005,0.8735274268038229,0.6637554585152838,0.9554581154489162,1.0,11/39,18.49%,MYO1E;KIF1A;FNBP1L;BICDL1;MYO6;HAP1;PPFIA2;ACTN4;SYT4;MYO5A;MYO19
prerank,glutathione metabolic process (GO:0006749),0.2673440434524784,0.8732289878997959,0.6702819956616052,0.9552106572551792,1.0,6/38,11.62%,GSTA4;GPX1;GSTM5;GGT7;NAT8;GGT1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3362004018081364,0.8731192531110087,0.6328600405679513,0.9545364446325054,1.0,15/15,66.41%,KYAT1;KYNU;GSTZ1;TAT;QDPR;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;FAH;IL4I1;HGD;KMO
prerank,glucan catabolic process (GO:0009251),0.34130016200714763,0.8724390851662323,0.6183673469387755,0.9552357407403947,1.0,2/15,1.96%,PHKG1;PGM2L1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2375860214858091,0.872367064481014,0.7351694915254238,0.9544475695055331,1.0,9/73,11.60%,TIRAP;IL17F;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2;BCL10
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.32209697148535554,0.8722986932741579,0.6442105263157895,0.9536672868324825,1.0,3/18,9.00%,FLT1;PPARG;CCL2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.30397776852128366,-0.8718719321671716,0.667296786389414,0.8645823758503527,1.0,6/23,14.43%,GHR;KIT;PIBF1;CYP1B1;HES1;CRLF3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3315641535651949,-0.8717642101748442,0.6471734892787524,0.8643408051498321,1.0,6/17,18.24%,TPM1;MEF2C;EFEMP2;TGFB3;PDCD4;SOD2
prerank,acute inflammatory response (GO:0002526),-0.3052930273561488,-0.8715043447176465,0.6553571428571429,0.8644333444858326,1.0,4/23,12.73%,LBP;PLSCR1;F3;IL6R
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.32299564685569615,-0.8714806722165875,0.6700404858299596,0.8640126024816464,1.0,10/20,31.31%,BCL2;CAMK2D;ATP2A2;FIS1;PML;KCTD17;WFS1;CCDC47;BAK1;HERPUD1
prerank,cAMP metabolic process (GO:0046058),-0.35401054278712585,-0.871175810549472,0.6512059369202227,0.8641916783562301,1.0,4/13,7.73%,ADCY9;ADCY5;ADCY1;ADCY6
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2787143515103443,0.8710309532482043,0.650319829424307,0.9557783123457771,1.0,5/32,8.51%,MFSD2A;PCYT1B;CHKA;CSNK2B;SLC44A5
prerank,basement membrane organization (GO:0071711),-0.3461213134958792,-0.870657312013321,0.6299810246679317,0.8648519953574766,1.0,3/14,5.97%,NID1;FLRT2;NID2
prerank,regulation of necroptotic process (GO:0060544),-0.30829621684417785,-0.8705802473952401,0.6502835538752363,0.8645459990553633,1.0,4/23,12.87%,CFLAR;FLOT2;YBX3;OGT
prerank,regulation of intracellular pH (GO:0051453),-0.2762601774588661,-0.8704678191312906,0.6641509433962264,0.8643130239150801,1.0,5/34,6.17%,LRRK2;SLC4A10;SLC9A1;SLC9A8;SLC9A2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.25289252138851065,-0.8702561087509565,0.6985018726591761,0.8643144654041302,1.0,15/45,17.36%,JAK1;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;STAT1;IFNGR1;OAS2;GBP2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.3111824091608438,-0.8699755951658609,0.6546762589928058,0.8644228748776034,1.0,6/23,20.33%,SLC9A1;SLC12A7;ATP6V0A4;SLC12A2;SLC12A8;SLC12A9
prerank,response to hexose (GO:0009746),-0.2961569981646755,-0.8699565324429553,0.6504065040650406,0.8640043845461197,1.0,9/25,26.17%,TCF7L2;THBS1;VAMP2;SELENOS;ZBED3;EIF2B4;PFKL;EIF2B5;LPL
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.28137042336880447,0.8697610214861905,0.6838842975206612,0.957890630804532,1.0,9/33,17.05%,TERF1;HSP90AB1;PIF1;TERF2IP;DKC1;NHP2;TINF2;PTGES3;HSP90AA1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3609476368288804,0.8695793551271853,0.6123348017621145,0.9573876579355807,1.0,3/12,3.94%,RYR2;CTNNA3;BIN1
prerank,protein processing (GO:0016485),-0.22733440231746777,-0.8691189599644207,0.7651821862348178,0.8653309748434354,1.0,30/102,22.50%,AEBP1;PCSK5;HM13;CTSH;F3;DDI2;ECE1;SEC11C;NCSTN;LONP2;MMP14;ADAM19;YME1L1;CPM;OGT;CASP2;CPXM2;STOML2;PTCH1;SPRTN;CPXM1;SEC11A;SDE2;EEF1AKMT4-ECE2;SPPL3;CLN5;FXN;CTSL;MYRF;PARL
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23262169705230884,-0.8691138854333912,0.736346516007533,0.8648723167033858,1.0,40/88,37.06%,FBXL7;FBXL17;BTRC;FBXL4;FBXL12;PSMF1;FBXL18;AMN1;FBXW7;PSMB2;FBXO38;CUL2;FBXW11;FBXW5;CUL1;PSMC1;FBXW4;PSMB6;PSMA3;PSMA4;FBXL14;FBXO4;PSME1;PSMD13;PSMB10;PSMA5;FBXL3;PSMB9;RBX1;FBXL8;FBXO9;CCNF;PSME4;FBXL13;PSMB8;PSMD10;CUL5;FBXL6;SKP1;PSMD3
prerank,regulation of myotube differentiation (GO:0010830),-0.3039009362030521,-0.8689200738327327,0.6932515337423313,0.864824287252089,1.0,13/24,28.18%,HDAC4;CCN3;MMP14;DMPK;SIK1;BHLHE41;MAML1;HDAC1;FBXO22;TMEM119;MAPK14;HDAC3;SMYD1
prerank,regulation of cellular component size (GO:0032535),-0.2844450097852567,-0.8688568057209013,0.6719858156028369,0.8644918298806377,1.0,5/30,7.90%,RPTOR;RARG;RAB22A;MTOR;VAV2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.24278387887910424,0.8686039551584627,0.7045009784735812,0.9588098288408833,1.0,13/75,11.24%,PRKAR2B;IPO5;SPRY3;SIRT1;SLC8A1;PTPRJ;AKT1;SPRY4;DAB2IP;UCHL1;MEN1;SMPD1;APC
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.37555320970468586,-0.8683792533351115,0.6436781609195402,0.8650805607982112,1.0,2/10,11.43%,RC3H1;NFKBIZ
prerank,isotype switching (GO:0045190),-0.386887327807254,-0.8679114224530433,0.647495361781076,0.8656040703111552,1.0,6/10,37.27%,RNF8;MSH6;EXOSC3;BATF;LIG4;MSH2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3413057000939287,0.8678213776242966,0.640495867768595,0.9597056372755266,1.0,3/16,7.29%,PPP1R16B;IL12A;APLNR
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3115979326613628,-0.8677915647186292,0.638671875,0.8653950204517715,1.0,3/21,9.11%,PAG1;PIBF1;PTPN22
prerank,chromosome condensation (GO:0030261),-0.27128657693237523,-0.867722761930107,0.7134387351778656,0.8650700698101808,1.0,11/36,21.83%,ACIN1;PHF8;SMC4;AKAP8L;AIFM1;RB1;MCPH1;CSNK2A1;KMT5A;H1-0;NCAPD3
prerank,response to ionizing radiation (GO:0010212),-0.24229324741026634,-0.8673044929793361,0.7189922480620154,0.8654366954286128,1.0,23/70,26.93%,EYA1;INO80;SPIDR;ANXA1;BRCC3;RNF8;CLK2;BRSK1;RFWD3;XRCC4;NABP2;PRKAA1;TANK;DCUN1D3;COP1;BRAT1;USP28;PAXIP1;EYA3;MAPK14;TNKS1BP1;IKBIP;ABRAXAS1
prerank,membrane protein proteolysis (GO:0033619),-0.2730874132240603,-0.8669353434730387,0.6781818181818182,0.8657442802244965,1.0,12/37,20.20%,DAG1;NFKB1;HM13;CTSH;NCSTN;ADAM9;MBTPS2;ADAM19;MBTPS1;CLPP;TRAF6;SPPL3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.28258887800688526,0.8668108511381479,0.6775431861804223,0.9611618775800537,1.0,5/31,9.89%,HSPA13;PACRG;HSPA8;HSPA5;DAB2IP
prerank,cardiac ventricle development (GO:0003231),0.3172364364170591,0.8666158057911126,0.6921397379912664,0.9606372859930778,1.0,3/20,5.70%,HEY1;PDE2A;NOTCH1
prerank,piRNA metabolic process (GO:0034587),0.33022723196969805,0.8663186730101551,0.6419213973799127,0.9603899811775166,1.0,3/19,19.07%,TDRD12;PIWIL2;TDRKH
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3791819663725539,-0.8662931194463667,0.644927536231884,0.8666383121234085,1.0,6/10,51.98%,FCER1G;CD81;CD27;FCGR2B;TLR8;CARD9
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3572154170236803,0.8662462681708446,0.6447368421052632,0.9596256240183414,1.0,1/12,1.66%,HUS1B
prerank,anterograde axonal transport (GO:0008089),0.2758596731110901,0.8660649629439036,0.6821052631578948,0.9591158299026582,1.0,5/37,10.81%,DLG2;KIF1A;AP3B2;HSPB1;HAP1
prerank,positive regulation of protein depolymerization (GO:1901881),0.366507118415637,0.865598854066033,0.6017130620985011,0.9592616657659045,1.0,2/11,8.72%,WDR1;STMN2
prerank,regulation of protein transport (GO:0051223),-0.29211508947348047,-0.8655341040917945,0.6609195402298851,0.8677914579167214,1.0,5/27,8.46%,DNAJC1;STXBP5;WWP2;DISP1;NDEL1
prerank,response to progesterone (GO:0032570),0.31739230193071466,0.8651385868739697,0.6845493562231759,0.9594266998111086,1.0,4/18,12.35%,ABHD2;TGFB2;UBE3A;WBP2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.26282675817350826,-0.8651062193881424,0.6685934489402697,0.8682748579978528,1.0,11/45,20.77%,ASPA;MMUT;NOX4;GLUD1;MTHFR;GLUL;ASPG;OAT;ALDH18A1;THAP4;ASS1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3214125752492265,0.8648535700491609,0.6369426751592356,0.9591794769977384,1.0,6/17,22.83%,NLGN1;SYT10;CACNA1I;SYT4;SLC4A8;RAB3A
prerank,regulation of cellular response to heat (GO:1900034),0.23921951680088716,0.8645503520442701,0.7450592885375494,0.9589895310491151,1.0,27/77,22.09%,CAMK2A;SIRT1;NUP210;HSPA8;RPA3;HSP90AB1;CD34;NUP62;NUP205;ATM;MAPKAPK2;NUP54;FKBP4;PTGES3;CHORDC1;HSP90AA1;MLST8;IER5;MAPK3;NUP85;BAG2;CRYAB;BAG1;RAE1;AKT1S1;NUP107;DNAJC2
prerank,lysosome localization (GO:0032418),-0.27716256245132426,-0.8638489491593025,0.6963636363636364,0.8705171595346208,1.0,18/37,41.59%,TFEB;KIT;NDEL1;SYTL4;PIK3CD;PLEKHM2;SPAG9;KIF5B;S100A13;KLC2;MYH9;RAB34;SNAPIN;MILR1;BORCS6;PIK3CG;HPS6;ARL8B
prerank,organelle fission (GO:0048285),0.29561774485782627,0.862621448284766,0.6832298136645962,0.9625318873117557,1.0,2/24,1.86%,DNM3;GDAP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.23424377417330233,-0.8625999077890107,0.7495069033530573,0.8726638533586366,1.0,15/78,15.72%,NR2F2;EGFR;PKD1;CCNT2;CCNH;CCNT1;CDK7;CCNK;MNAT1;CCNYL1;PKD2;CDK5RAP1;CCND3;LATS1;CNPPD1
prerank,vesicle organization (GO:0016050),0.2636190099782504,0.8625361464156203,0.699009900990099,0.9617885484234877,1.0,14/46,21.05%,CAV2;HOOK1;FNBP1L;CD34;AKTIP;SAR1A;CORO1A;CHMP2B;USP8;DNM1;SORT1;PI4K2A;DNAJC13;SNX11
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.27865940934147904,0.8618581378329944,0.6772823779193206,0.9624319502087171,1.0,10/32,18.25%,MAGI2;PPP1R16B;HSP90AB1;SMPD1;CALM1;DUSP26;CALM2;CALM3;PPIA;CAMTA1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.22250697501579955,-0.861742935737683,0.7806841046277666,0.8739962797284563,1.0,28/94,22.93%,PCM1;ALMS1;ODF2;NINL;CEP63;CEP135;CEP162;PCNT;MARK4;CSNK1E;RAB3IP;RAB11A;CC2D2A;C2CD3;MAPRE1;YWHAE;AKAP9;DYNC1H1;CEP76;TCTN1;PRKACA;CEP57;CSNK1D;CEP89;NPHP1;HAUS7;HAUS8;ACTR1A
prerank,gastrulation (GO:0007369),-0.34296862121233845,-0.8616820044744018,0.6560747663551402,0.873643880091529,1.0,2/15,5.30%,GPC3;SMAD2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2694621144379901,0.8614992385326437,0.683982683982684,0.9623216893076951,1.0,10/37,16.85%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3693907195751778,-0.8607490914380208,0.6626506024096386,0.8751399017123239,1.0,2/11,4.07%,PDPN;RREB1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.37404852884427275,0.8600189621814283,0.6493212669683258,0.9649488888450707,1.0,5/10,22.94%,MFSD2A;DNAJC19;ABCA3;MTMR9;MTMR2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.32329628808459765,-0.8596946274263141,0.6772277227722773,0.8768292828279335,1.0,6/18,25.95%,PAG1;PTPN22;WNK1;MIA3;ASS1;PPARA
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.23871208993250284,-0.8594522965960073,0.740234375,0.8768586025577797,1.0,28/70,35.75%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;MFSD6;CYBA;LNPEP;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,tRNA processing (GO:0008033),-0.24566353249424028,-0.8593409840776228,0.7120315581854043,0.8766194590286831,1.0,23/61,26.39%,FARS2;TRMT9B;TSEN2;NSUN6;QTRT2;TSEN15;TYW5;METTL1;NSUN2;ELP5;KARS1;FTSJ1;PUS3;CDKAL1;LCMT2;CPSF4;TRNT1;DTWD1;RTRAF;TRMT1;CPSF1;ELAC2;DTWD2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.33376574993208624,-0.8591390999925904,0.6735074626865671,0.8765861099152701,1.0,4/15,11.01%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,modulation by host of symbiont process (GO:0051851),0.2805762622149784,0.8589511259930578,0.6857707509881423,0.9664851517280241,1.0,3/31,4.32%,LEF1;HMGA2;SMARCB1
prerank,mitochondrion transport along microtubule (GO:0047497),0.3497555014856686,0.8589326989364744,0.6496815286624203,0.9655832000493672,1.0,2/13,8.04%,SYBU;UBB
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3528771253947177,-0.8583877407965401,0.6722222222222223,0.8776388121155141,1.0,4/12,15.89%,GMPS;PPAT;ATIC;PAICS
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.30976530406771446,0.8581861363230145,0.6632016632016632,0.9663918531175776,1.0,8/19,14.84%,BIN1;NTRK2;CLU;RTN2;HAP1;RTN1;SORL1;RTN4
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3325610645932756,0.8579161724802967,0.6617021276595745,0.9660515601670973,1.0,3/15,5.82%,STOX2;CELF4;TGFB2
prerank,protein palmitoylation (GO:0018345),0.2748053530813136,0.8578103630829952,0.7022132796780685,0.9653452583256376,1.0,8/30,19.53%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14;PORCN;ZDHHC24
prerank,regulation of histone acetylation (GO:0035065),0.26987042934908756,0.8575236374969172,0.6943866943866944,0.9651143921030206,1.0,5/33,10.18%,CHEK1;SNCA;RPS6KA5;IWS1;SET
prerank,actin filament-based transport (GO:0099515),-0.306119430407473,-0.8574995199539761,0.6968576709796673,0.8789858907187571,1.0,4/21,12.66%,SYNE2;MYO1B;WASL;MYO1F
prerank,establishment of melanosome localization (GO:0032401),-0.3056376269691392,-0.8573289784646235,0.659217877094972,0.8788477654880126,1.0,6/19,28.24%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,regulation of axon guidance (GO:1902667),-0.3764016902475902,-0.8572182383138215,0.6441605839416058,0.8786088363644099,1.0,3/10,14.36%,NRP1;ZSWIM8;VEGFA
prerank,myeloid cell differentiation (GO:0030099),0.2570958708482352,0.8570992860099929,0.7119341563786008,0.9651453754321785,1.0,9/47,14.55%,ALAS2;TIRAP;RPS19;TAL1;EPO;HIPK2;RPS14;SNRK;MFHAS1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.3497026915338579,-0.8569811794456766,0.6473880597014925,0.8786358175220894,1.0,6/13,33.56%,ABL1;ABL2;SIRT4;SZT2;MT3;ATP7A
prerank,telomere capping (GO:0016233),-0.3262471812703228,-0.8568979394965719,0.6685823754789272,0.8783327936479445,1.0,7/16,21.10%,NBN;PRKDC;CTC1;MRE11;DCLRE1A;TERF2;STN1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.36514700063804095,0.8568875799975474,0.6537634408602151,0.9646770518973178,1.0,3/10,15.24%,HSPA5;CCL2;ATF4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2985366814001973,0.8567922421623584,0.6856492027334852,0.9639594928880753,1.0,4/22,10.86%,ERBB4;NOTCH1;OCIAD1;F2R
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3155331721659233,0.8561552935943206,0.6789366053169734,0.9645058825337196,1.0,7/18,18.94%,RUVBL1;CCT2;DKC1;NHP2;CCT4;NAF1;TCP1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.35744881609013635,-0.8558819050525983,0.6697416974169742,0.8799189476106095,1.0,10/12,61.39%,IL18;SLC11A1;CCR2;IL12RB1;IL23A;IL23R;IL12B;XCL1;IL1B;IL18R1
prerank,neuromuscular junction development (GO:0007528),-0.29530867653738874,-0.8556146412877109,0.6912878787878788,0.8800325332099735,1.0,4/24,9.26%,PDZRN3;LRRK2;UNC13B;UNC13C
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2507162733972339,-0.8554412020384282,0.7534246575342466,0.8799267904422539,1.0,14/53,20.68%,PKD1;ARAF;PRKN;RAD23B;NUPR1;UFL1;PSMF1;FBXW7;RHBDF1;APOE;PSME3IP1;PRKACA;TMTC3;DESI1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3258923866343604,0.8553335223754491,0.6458752515090543,0.9654234046531797,1.0,2/16,1.96%,PHKG1;PGM2L1
prerank,mammary gland development (GO:0030879),0.314664669893007,0.8550041834705945,0.6638655462184874,0.9652328269351518,1.0,3/21,6.62%,ERBB4;NRG1;WNT7B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2958600616512181,-0.8549920100085606,0.6679764243614931,0.880400093672313,1.0,6/25,9.41%,ANK2;COA8;SLC6A9;ACTN2;WNK4;WNK1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.2801472534048844,-0.8549242524447536,0.6872509960159362,0.8800740211594174,1.0,16/29,30.32%,LIMA1;PRKN;PLEKHH2;ARFGEF1;PRKCD;SMAD4;MYADM;HIP1R;SLIT2;KANK1;TWF1;TWF2;SSH3;SSH2;PFN2;KANK4
prerank,t-circle formation (GO:0090656),-0.37113715536352965,-0.8546351463645782,0.6484375,0.8792650315917037,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.37113715536352965,-0.8546351463645782,0.6484375,0.8792650315917037,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.37113715536352965,-0.8546351463645782,0.6484375,0.8792650315917037,1.0,4/10,23.40%,NBN;WRN;SMARCAL1;ERCC1
prerank,negative regulation of viral life cycle (GO:1903901),-0.33063173807325474,-0.8545795610858924,0.6653620352250489,0.8789008744323352,1.0,3/15,12.12%,GSN;TRIM5;TRIM11
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.28622460693411994,-0.8544833368815263,0.6866537717601547,0.8786266195403386,1.0,8/27,21.57%,SMG6;PDGFRB;NIBAN2;NABP2;PARP4;TERF2;FGFR4;FGF2
prerank,regulation of chromatin binding (GO:0035561),-0.3755208467748117,-0.8539059794998323,0.6860254083484574,0.8793139559219609,1.0,3/10,13.47%,BTAF1;PARP9;DTX3L
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3424858543739723,-0.8537527882917223,0.6642728904847397,0.8791640730864327,1.0,4/13,13.05%,SRSF10;PRPF6;PRPF3;USP4
prerank,mitotic cytokinesis (GO:0000281),-0.25631717299253765,-0.8535338770807878,0.7349896480331263,0.8791518943230521,1.0,7/47,7.80%,ROCK2;SON;ROCK1;ARL3;SNX9;KLHDC8B;CHMP4B
prerank,glutamate metabolic process (GO:0006536),-0.3183304033736084,-0.8534419292964159,0.7039848197343453,0.8788793552602245,1.0,8/19,28.86%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;DGLUCY;GCLC;GOT1
prerank,tRNA 5'-end processing (GO:0099116),0.32773213994807837,0.8529059674260648,0.6806167400881057,0.9691349306230772,1.0,3/15,12.32%,RPP40;RPP30;POP5
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.27420784266524545,-0.8528153728819511,0.6679462571976967,0.8796246183752289,1.0,8/33,14.09%,MEOX2;HMGB1;THBS1;JUP;RHOA;MEF2C;ANGPT2;APOE
prerank,regulation of myoblast fusion (GO:1901739),-0.36083087273889003,-0.8523109610580999,0.6629422718808193,0.880174809706303,1.0,3/11,7.98%,CFLAR;RIPOR2;EHD2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25900890247229436,-0.8522696722272173,0.7366412213740458,0.8797914735566043,1.0,13/46,22.74%,PIEZO2;NFKB1;SLC9A1;MAP2K4;CASP2;IRF1;LTBR;MAP3K14;TLR4;MAP3K1;CNN2;BNIP3;F11R
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2986715655204821,0.8519856955060856,0.6810344827586207,0.9702736181964439,1.0,2/24,2.52%,TTLL7;AGBL4
prerank,cellular response to hypoxia (GO:0071456),-0.21348018899446816,-0.8519785898163723,0.8286252354048964,0.8799231296583832,1.0,45/126,29.47%,MDM4;BMP7;EP300;PTGIS;ARNT;LMNA;CREBBP;UBQLN1;MTOR;FAM162A;EGLN3;HIF1A;LIMD1;RORA;PSMF1;ACAA2;NPEPPS;PGK1;PSMB2;VEGFA;CUL2;CPEB1;NOP53;SLC8A3;CARD16;TERT;P4HB;PSMC1;HIF3A;GATA6;TBL2;BNIP3;PSMB6;PSMA3;PSMA4;HYOU1;TWIST1;PSME1;PSMD13;PSMB10;MT3;EGLN2;PSMA5;PSMB9;RBX1
prerank,protein polyglutamylation (GO:0018095),0.35277674732966485,0.8515983502392265,0.642706131078224,0.9702757182976282,1.0,1/11,2.40%,TTLL7
prerank,negative regulation of insulin secretion (GO:0046676),-0.3339882139758526,-0.8513557960574046,0.6866267465069861,0.8807275512818568,1.0,7/17,22.37%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,lymphocyte migration (GO:0072676),0.2690388983757229,0.8511427100180767,0.6940928270042194,0.9703951821969754,1.0,7/32,20.52%,CCL2;RET;CCL25;CKLF;S1PR1;CCL13;CCL19
prerank,negative regulation of protein secretion (GO:0050709),-0.2647668437688772,-0.8509038537252611,0.690978886756238,0.8811730608201176,1.0,14/38,22.37%,PRKN;IRS1;REST;CCN3;NR1H3;SERGEF;RHBDF1;APOE;ADRA2A;HMGCR;CYP51A1;DPH3;SIRT4;KCNB1
prerank,vesicle transport along actin filament (GO:0030050),0.30776971697213384,0.8504089642831715,0.6754385964912281,0.9710892666658936,1.0,6/19,18.49%,MYO1E;FNBP1L;MYO6;ACTN4;MYO5A;MYO19
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.33697941254995123,0.8504020029105753,0.6537634408602151,0.9701694169403382,1.0,4/13,14.61%,NAXE;NUDT12;NAMPT;NAXD
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2808840317731977,-0.8503310880341525,0.6796875,0.881820073059204,1.0,9/30,26.49%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,ketone body metabolic process (GO:1902224),-0.3791459267631673,-0.8502328307631148,0.6691449814126395,0.8815352904252484,1.0,3/10,20.34%,ACSS3;BDH2;OXCT1
prerank,histone H3 acetylation (GO:0043966),-0.26230409890008477,-0.849912657456725,0.7326732673267327,0.8817192708568312,1.0,13/40,25.48%,KAT2B;KAT6B;BRPF3;TADA3;KAT14;ING5;BRCA2;TAF5L;TAF6L;TAF12;YEATS2;JADE2;LDB1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.33505213195364647,0.8499073375343343,0.6428571428571429,0.9703638702351091,1.0,3/13,12.41%,ALG3;ALG1;ALG8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.35521049255044257,0.8496889813121916,0.6637362637362637,0.9699058028901634,1.0,1/11,0.45%,ST18
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2401039305104384,0.8485890064053707,0.7677419354838709,0.9715290767874417,1.0,10/62,9.77%,CXCL12;SIRT1;NME5;CLU;RTKN2;EPO;AKT1;TPT1;HSPB1;ARHGEF2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.254476487686062,-0.848478650765843,0.7293666026871402,0.8840840700105875,1.0,8/48,9.20%,ZMIZ1;KAT2B;EP300;ARID1B;SF3B1;TAF1D;TBP;PHF2
prerank,lysosome organization (GO:0007040),-0.2663214525722732,-0.8484694706629474,0.680161943319838,0.8836385655338188,1.0,6/36,7.41%,ABCA1;LRRK2;TFEB;ZKSCAN3;MTOR;TPCN2
prerank,stabilization of membrane potential (GO:0030322),0.32139608068100584,0.8484548057363517,0.6784140969162996,0.9709017956998635,1.0,4/16,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,granulocyte differentiation (GO:0030851),0.3141475062470671,0.8483578161068085,0.6641074856046065,0.9701750382078359,1.0,2/18,5.80%,LEF1;TAL1
prerank,positive regulation of ion transport (GO:0043270),0.2530552552317157,0.8483178474012181,0.7588357588357588,0.9693264023812151,1.0,7/48,11.50%,CAMK2A;CNKSR3;ANK3;SCN4B;CACNB2;F2R;P2RX7
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.37061113935839696,-0.848228940782314,0.678373382624769,0.883657475224101,1.0,4/10,25.56%,COMT;SARDH;ALDH7A1;HNMT
prerank,regulation of tumor necrosis factor production (GO:0032680),0.21323388051952566,0.8481251356130479,0.7979166666666667,0.968817881411065,1.0,12/112,9.77%,CD33;TIRAP;MIF;SYT11;GAS6;CLU;TLR2;PTPRJ;CD34;HSPB1;POMC;ARHGEF2
prerank,response to interferon-beta (GO:0035456),-0.30394332807268226,-0.84795891142644,0.7009345794392523,0.8837531240172889,1.0,9/22,28.23%,PLSCR1;UBE2K;IRF1;STAT1;IKBKE;SHFL;IRGM;HTRA2;CDC34
prerank,positive regulation of T cell differentiation (GO:0045582),-0.26549049228156685,-0.8476895959869074,0.7281947261663286,0.8838354664124756,1.0,3/36,1.70%,GLI3;ZMIZ1;GLI2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.28971696442472006,0.8473828651011622,0.7041036717062635,0.9695459894904084,1.0,12/30,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.28878349377620915,0.84716607480684,0.6787878787878788,0.9690887567739503,1.0,3/25,5.60%,HSPA13;HSPA8;HSPA5
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.21702295472276548,0.8463986442055518,0.8243801652892562,0.9698935658175484,1.0,22/114,18.96%,ST18;TMSB4X;PSMA1;TRAF1;TNFRSF9;TNFSF13B;PSMD12;PSMA6;PSMB3;TNFRSF12A;TNFRSF25;ACTN4;CD40;NFKBIA;PSME3;PSMC3;PSMA2;CDIP1;TNFRSF1A;ILK;PSMB7;RIPK1
prerank,myelin maintenance (GO:0043217),0.363416964712468,0.8462484165999501,0.636986301369863,0.9693066633169468,1.0,2/10,7.03%,CLU;EPB41L3
prerank,regulation of glycogen metabolic process (GO:0070873),0.35115850526441383,0.846045594136631,0.6875,0.9688329210890239,1.0,2/12,7.97%,KHK;AKT1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3576988397694293,-0.8457307525554112,0.6915887850467289,0.8873154476274804,1.0,3/11,22.55%,SCARA3;TNIP2;TICAM1
prerank,regulation of phosphatase activity (GO:0010921),-0.29268867823460304,-0.8456664728973018,0.6857142857142857,0.8869730646946635,1.0,12/24,37.51%,SH3RF2;PTPA;GPATCH2;BMP2;CDK5RAP3;CHP1;PPP1R2;PPP6R2;HTT;SH2D4A;URI1;PPP1R26
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2503887293184486,-0.8453748046597056,0.7346534653465346,0.8871144856597775,1.0,8/48,12.87%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2221550179316518,-0.8450525237368142,0.8134615384615385,0.8872507378413098,1.0,26/93,22.30%,SASH1;CCN2;HMGB1;AXIN1;SH3RF1;TAOK3;MID1;MAP3K5;RELL1;TRAF2;RASSF2;FZD7;LTBR;EIF2AK2;SH3RF2;TPD52L1;VEGFA;SH3RF3;TRAF3;TRAF6;BMP2;TAOK1;WNT16;TRAF5;SPHK1;KLHDC10
prerank,regulation of T cell differentiation (GO:0045580),0.27061263059402235,0.8450044047063437,0.7182795698924731,0.9701720513248184,1.0,7/33,14.37%,IL7;CAMK4;PRDM1;FANCA;TCF7;XBP1;NFATC2
prerank,cellular response to virus (GO:0098586),-0.27702958597441246,-0.8446326080918927,0.7126865671641791,0.8876339596352453,1.0,6/30,14.85%,GBF1;GSDME;HIF1A;RIOK3;ARF1;DDX3X
prerank,negative regulation of GTPase activity (GO:0034260),-0.3011604424180277,-0.8442361745971619,0.6712328767123288,0.8879816749115061,1.0,5/22,9.41%,LRRK2;BCAS3;ARFGEF1;GMIP;WNK1
prerank,positive regulation of lipid storage (GO:0010884),-0.30723591928409627,-0.8441795132695937,0.673469387755102,0.8876222977242764,1.0,9/21,32.18%,NFKB1;OSBPL11;PLIN3;IKBKE;LPL;EHD1;FITM2;MSR1;C3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.34401818322730504,-0.8434571070576632,0.7080979284369114,0.8886252890020092,1.0,9/13,37.04%,MMS19;CIAO1;NFU1;YAE1;GLRX5;BOLA2;LTO1;CIAO2B;GLRX3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.23403744941056445,0.8429038292897868,0.7874493927125507,0.9737939507438803,1.0,20/72,18.89%,COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;RFC2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.270425842418539,-0.8428601361902808,0.699047619047619,0.8893261831386169,1.0,7/31,14.71%,DIS3L2;DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2827158563459321,-0.8426451667975791,0.6964980544747081,0.8892894486472537,1.0,14/28,32.55%,KMT5B;SHLD2;PARP9;KMT5C;DTX3L;PRKDC;SMCHD1;HSF1;ACTR2;PARP3;MAD2L2;NUDT16L1;PNKP;TFIP11
prerank,regulation of cellular senescence (GO:2000772),-0.28155064633485016,-0.8425934683527535,0.7208872458410351,0.8889326402619226,1.0,14/28,28.56%,MAP3K3;ZKSCAN3;SLC30A10;YBX1;NEK4;NEK6;TERF2;TERT;CDK6;NUAK1;TWIST1;RSL1D1;VASH1;CGAS
prerank,regulation of protein polymerization (GO:0032271),-0.26544723594964226,-0.8424867341177656,0.7115009746588694,0.8886611906529451,1.0,9/35,16.33%,ARHGAP28;FCHSD2;ABL1;PLEKHG2;PRUNE1;CTTN;LATS1;RASA1;ARHGAP18
prerank,Rac protein signal transduction (GO:0016601),-0.31598901603061014,-0.8424055384377055,0.6962025316455697,0.8883500527978433,1.0,5/18,18.46%,BRK1;NCKAP1;WASF1;FARP2;RHOH
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3518691883718779,-0.8422915115806809,0.7040441176470589,0.8881116519513599,1.0,5/12,27.35%,ACSL1;ACOX1;ELOVL1;ACOT8;ELOVL5
prerank,response to interferon-alpha (GO:0035455),0.31448977184144605,0.8422244211056239,0.707983193277311,0.9743317726285358,1.0,7/16,21.38%,GAS6;IFNAR1;IFITM3;ADAR;KLHL20;BST2;RO60
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.31331947239792635,-0.8420350431100733,0.6879699248120301,0.888127432738661,1.0,7/18,27.02%,CEP135;CCT6A;CCT8;CCT5;CEP295;CHP1;CCT3
prerank,telomere maintenance (GO:0000723),-0.24489678472627918,-0.8413341436549175,0.7868525896414342,0.8890523869274541,1.0,17/50,21.95%,SMC6;NBN;NSMCE2;WRN;SP100;SMC5;PARP1;RAD51D;PRKDC;CTC1;MRE11;TERF2;TERT;PCNA;STN1;XRCC6;ATR
prerank,negative regulation of protein binding (GO:0032091),-0.2282736895664762,-0.8411412511767402,0.7817836812144212,0.888962329049072,1.0,12/71,10.95%,DAB2;ROCK1;LRRK2;GSK3B;STYX;IFIT2;DACT1;CSNK1E;USP33;NES;PRKCD;ATP2A2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3445444342598163,-0.8408255742057481,0.656188605108055,0.8891327525592205,1.0,6/12,22.89%,RFWD3;PRKDC;SDE2;CDK2;WAC;PLK5
prerank,negative regulation of protein transport (GO:0051224),0.2843280085988016,0.8406615514810222,0.7044534412955465,0.976776501041819,1.0,3/25,4.90%,RHBDF2;PPM1F;IL12A
prerank,cristae formation (GO:0042407),0.2860345745785644,0.8406236237951967,0.697986577181208,0.9759379449347929,1.0,8/27,19.24%,ATP5F1D;ATP5F1B;ATP5ME;ATP5MF;DMAC2L;UQCC3;CHCHD6;ATP5MG
prerank,N-glycan processing (GO:0006491),0.3134757994711366,0.840505435507354,0.6815286624203821,0.9752759341669612,1.0,4/18,11.97%,ST8SIA4;ST8SIA1;ST8SIA6;ST8SIA3
prerank,ruffle organization (GO:0031529),-0.31827143572107663,-0.8401230436212145,0.7025948103792415,0.8901005638891225,1.0,9/16,31.46%,TPM1;LIMA1;ARFIP2;CARMIL1;INPP5K;AIF1L;PLEKHA1;ARF6;CORO1B
prerank,GPI anchor metabolic process (GO:0006505),-0.2804425592323149,-0.8396090260787168,0.722007722007722,0.8906579015736387,1.0,11/26,32.32%,PIGN;DPM1;PIGH;MPPE1;PIGC;DPM3;PIGA;PIGZ;PIGP;PIGF;PIGO
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3249438528076262,-0.8395709174658329,0.6847389558232931,0.8902736285267855,1.0,7/18,22.37%,PRKN;IRS1;REST;CCN3;ADRA2A;SIRT4;KCNB1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.293572579808992,-0.839567396646277,0.7113594040968343,0.889817023754354,1.0,7/23,31.00%,AXL;HMGB1;TLR4;INHBA;NR1H4;INHA;C1QBP
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.34375639500658123,-0.8395106047038208,0.6739130434782609,0.8894540915014497,1.0,4/13,10.96%,TRIM44;AXL;DHX9;MAVS
prerank,response to ketone (GO:1901654),0.2855299109264116,0.8394650605347524,0.7244897959183674,0.976568475195382,1.0,6/24,12.35%,ABHD2;TGFB2;SLIT3;UBE3A;ABCB4;WBP2
prerank,proteoglycan biosynthetic process (GO:0030166),0.266506335601096,0.8394231967682241,0.7293388429752066,0.9757220508263328,1.0,4/31,5.63%,B3GAT1;CHST9;B3GAT2;CSGALNACT1
prerank,positive regulation of peptidase activity (GO:0010952),-0.30132967370611463,-0.8393638390734558,0.7177570093457943,0.8893051582361807,1.0,7/20,28.01%,CTSH;NCSTN;RCN3;VCP;TANK;PSME1;GRN
prerank,inorganic anion transport (GO:0015698),0.24291446529325772,0.8393224881868507,0.7524366471734892,0.9750136628010078,1.0,7/53,11.00%,SLC4A1;GLRA1;CLIC5;ANO5;SLC25A14;ANO4;CLCN1
prerank,negative regulation of viral genome replication (GO:0045071),0.2595335380847044,0.8392081415401438,0.7261904761904762,0.9743386420289812,1.0,6/40,10.05%,PROX1;HMGA2;ISG15;TRIM6;IFITM3;SLPI
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.27523070777155156,0.8385670202394463,0.7288503253796096,0.9748101233109941,1.0,6/33,16.55%,SLA2;THY1;PTPRJ;BCL10;RPS3;RAB29
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3316827538553219,-0.838248384906462,0.6996336996336996,0.891031423972203,1.0,6/14,23.77%,EHHADH;ACOX1;DECR2;AMACR;ACOT8;ACOX3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.32956164892312034,0.8373757584518412,0.7049180327868853,0.9764449345812145,1.0,3/13,13.73%,NOTCH1;EID2B;DLL1
prerank,B cell activation (GO:0042113),-0.23295016519033263,-0.8371500580276434,0.8068833652007649,0.8926696678673044,1.0,14/68,18.28%,HDAC4;KIT;ITGB1;DCAF1;BCL2;CEBPG;PTPN2;MEF2C;TCF3;ITGA4;KLF6;CTPS1;PIK3CD;BLNK
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.34749401278773684,0.8369312082105046,0.6743697478991597,0.9764352208746728,1.0,4/12,14.32%,CALM1;PDE4D;CALM2;CALM3
prerank,RNA methylation (GO:0001510),-0.2403944453003919,-0.8364840121360059,0.7859848484848485,0.8934697961468718,1.0,25/60,33.29%,ZCCHC4;WTAP;NSUN6;NSUN3;TGS1;DIMT1;METTL2A;METTL2B;BUD23;METTL1;NSUN2;THUMPD3;FTSJ1;ZC3H13;LCMT2;WDR6;GTPBP3;MTO1;TRMT44;TRMT61B;TRMT10C;TYW3;MRM2;ALKBH8;TRMT12
prerank,cognition (GO:0050890),0.25413737645309614,0.8364428115646667,0.7420634920634921,0.9765457351584281,1.0,7/42,13.21%,GRM5;PTCHD1;MFSD2A;NSUN5;TTC8;DGCR2;GPR155
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35187237686560063,-0.8347269497548073,0.6794171220400729,0.8963091587782425,1.0,2/11,2.72%,ZMIZ1;ARID1B
prerank,cardiolipin metabolic process (GO:0032048),0.33569071070827755,0.8346980483498686,0.6862745098039216,0.9793878687617372,1.0,3/13,11.47%,HADHA;CRLS1;PTPMT1
prerank,dopaminergic neuron differentiation (GO:0071542),0.3067203098338402,0.8342311382556588,0.728952772073922,0.9794450367221096,1.0,1/19,0.21%,PHOX2A
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.34563032984685327,0.8338266893476284,0.698237885462555,0.979412563988624,1.0,5/11,23.69%,TIMM22;NDUFA13;TOMM70;TIMM10B;ROMO1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.294184441508036,0.8334989721416488,0.7148936170212766,0.9792019927380071,1.0,4/23,12.27%,METAP2;GUCA1B;CALM1;NMT1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3493751278393914,0.8332959685765009,0.698237885462555,0.9787170726225918,1.0,2/11,10.46%,NOVA2;ZNF445
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.24859557111449562,-0.8332131277869257,0.7574626865671642,0.8987578426672923,1.0,16/46,24.09%,PARVA;ITGAV;LAMC3;RADIL;NRP1;ATRNL1;FER;RHOA;FN1;ITGA4;ITGB3;PIK3R1;ANTXR1;LAMB2;LAMC1;ITGA8
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2336213095390937,-0.8330057304970058,0.7935222672064778,0.8986930753104421,1.0,9/65,10.03%,EGFR;ERRFI1;ARAP1;RNF115;PTPN3;CDC42;PTPN12;FER;PTPN2
prerank,ear morphogenesis (GO:0042471),-0.2996556673529822,-0.8329382556925559,0.7283236994219653,0.8983499418477644,1.0,6/20,17.02%,ZIC1;OSR1;FGFR2;NIPBL;CHD7;SIX1
prerank,regulation of transport (GO:0051049),-0.26331710912805917,-0.8327182568409227,0.7298850574712644,0.8983108080335429,1.0,8/36,15.13%,LEPR;PRKN;LRRK2;NRP1;VAMP2;WWC1;RAB11A;MBTPS1
prerank,negative regulation of response to wounding (GO:1903035),0.30193029558522466,0.8326734888848407,0.7125256673511293,0.9790904613891388,1.0,3/19,8.96%,GIT1;AJAP1;RTN4R
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3097779765162185,0.8325312278329958,0.6974789915966386,0.9784701752515593,1.0,2/17,4.81%,HDAC9;PCSK6
prerank,positive regulation of histone acetylation (GO:0035066),-0.2868473850797866,-0.8322575643201096,0.7298311444652908,0.8986858417143022,1.0,11/23,29.45%,BRD7;PPARGC1A;SMAD4;ARRB1;NOS1;PIH1D1;PAXIP1;RPS6KA4;RUVBL2;SPHK2;GLYR1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2117352035465974,-0.8318909634576693,0.8703703703703703,0.8989665847697875,1.0,32/113,24.64%,TRABD2B;ABCA1;MPP7;ASAP1;GTF2H2;GSK3B;SPIDR;RAP1B;BRK1;DDB2;UNC13B;FNIP1;PARP1;ERCC3;SLF1;USP50;VEGFA;DDX3X;ICE1;TLR4;VCP;PARK7;RHOC;AJUBA;EIF4G1;PIH1D1;BMF;ATR;ERCC1;GTF2H1;GNL3L;SYK
prerank,regulation of cell-substrate adhesion (GO:0010810),0.2512014699404291,0.831883385152796,0.7573839662447257,0.978943259105104,1.0,7/42,11.62%,SPOCK1;PPM1F;THY1;NOTCH1;NDNF;PDGFB;FZD4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3267208362952266,-0.8318023379865424,0.7047970479704797,0.898672181513079,1.0,8/15,34.32%,EIF2AK2;USP50;DDX3X;TLR4;NLRC3;NLRP2B;DHX33;MYD88
prerank,exit from mitosis (GO:0010458),0.34369818974676836,0.8315056841006625,0.6646216768916156,0.9787804644800936,1.0,7/12,22.76%,UBE2C;CLASP2;CLASP1;CHMP2A;CHMP7;SIRT7;EPS8
prerank,cholesterol homeostasis (GO:0042632),-0.23274559152869406,-0.8309912411221468,0.8247011952191236,0.8997419656647353,1.0,11/64,16.83%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.300140204691746,-0.8309599376023112,0.7184466019417476,0.8993432229652171,1.0,7/21,19.07%,DCN;BGN;CHST15;CHST11;CHPF2;CHSY1;CHST12
prerank,endodermal cell fate commitment (GO:0001711),-0.36632588079273326,-0.830955972056936,0.6810176125244618,0.8988863240529165,1.0,3/10,19.87%,CTR9;RTF1;CDC73
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2720302374069963,-0.8309546816702921,0.759493670886076,0.8984274319111069,1.0,3/32,2.67%,FHIT;DDX5;EP300
prerank,cell-substrate junction assembly (GO:0007044),-0.2679479912600561,-0.8302536105756825,0.7391304347826086,0.8992777338048467,1.0,8/33,15.29%,SORBS1;BCR;PTPRK;ACTN2;LAMA3;FN1;CTTN;WHAMM
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2906033790939014,-0.8299416281850928,0.722117202268431,0.8994106576067488,1.0,5/22,11.94%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.33077046588069164,0.8297675429003144,0.6818181818181818,0.9814702127816224,1.0,2/14,4.67%,CHKA;PISD
prerank,positive regulation of integrin activation (GO:0033625),-0.3455240852841101,-0.8296802320453879,0.6811881188118812,0.8994382394339939,1.0,2/11,13.84%,RAP1B;P2RY12
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.24799741418032573,-0.8296474581425821,0.7607843137254902,0.8990427298394642,1.0,9/48,13.52%,ANK2;CEMIP;DIAPH1;JPH1;CAMK2D;PDPK1;PLCG1;SELENON;SRI
prerank,regulation of B cell differentiation (GO:0045577),-0.3178149582264693,-0.8295268580534655,0.7230215827338129,0.898784068711846,1.0,8/17,32.49%,MMP14;ID2;INHBA;PPP2R3C;SYK;ZFP36L2;INHA;CD27
prerank,vitamin D metabolic process (GO:0042359),-0.33232634278568157,-0.8294570813566106,0.6994328922495274,0.8984716166566402,1.0,10/13,55.87%,PIAS4;CUBN;CYP2R1;LGMN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,peptidyl-asparagine modification (GO:0018196),-0.2726534051357056,-0.8292457455761021,0.7252964426877471,0.8983964778133949,1.0,9/31,26.49%,UGGT2;STT3A;DPM1;RPN1;ST6GAL1;LMAN1;DPM3;MCFD2;ASGR1
prerank,positive regulation of protein polymerization (GO:0032273),-0.23271987147247977,-0.8291043858027002,0.811787072243346,0.8982060493899218,1.0,15/65,15.44%,FCHSD2;BAIAP2L1;NUMA1;SNX9;VASP;CDC42EP5;FER;NCKAP1;MAPRE1;TOGARAM1;CTTN;NCK1;CARMIL1;NCK2;AKAP9
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3348352744487689,-0.8291015896677052,0.6758241758241759,0.8977514678857079,1.0,2/13,2.72%,ZMIZ1;ARID1B
prerank,fatty acid metabolic process (GO:0006631),-0.20917809875369514,-0.8287032190079486,0.8557312252964426,0.8980464674227028,1.0,31/115,26.25%,ACSL1;ACADSB;ABCD3;GNPAT;ACADM;CPT1C;ABCD2;PPARGC1A;CPT2;ACSF2;PON2;ACSL6;PNPLA8;ACOT11;ACOX1;ECHDC3;LPIN2;ACAD9;LPIN3;CPT1A;CBR4;MECR;ACSL4;ACOT8;ACOT6;PON3;GGT5;ACSBG1;PPARA;LPL;AASDH
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.29128504799813115,0.8284405825477419,0.7145748987854251,0.9833742505063449,1.0,3/22,5.91%,PROX1;TOX;TAFA1
prerank,telomere organization (GO:0032200),0.25637970434964424,0.8283825261494432,0.7795918367346939,0.9825826348054212,1.0,12/43,16.70%,HUS1B;RPA3;TERF1;H3-3A;TERF2IP;APEX1;POLD1;ATM;TINF2;POLD3;PTGES3;XRCC5
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3454269714234558,0.8280923571081976,0.6736842105263158,0.982301969772275,1.0,2/11,13.69%,SIRT1;XBP1
prerank,sterol homeostasis (GO:0055092),-0.23104709318747652,-0.8278660641382162,0.82,0.8991346219388556,1.0,11/65,16.83%,ABCA1;CYP7B1;LIMA1;SOAT1;LDLR;NR1H3;NPC2;RORA;APOE;EPHX2;IL18
prerank,establishment of vesicle localization (GO:0051650),-0.3063918182715628,-0.8271585076997532,0.7277992277992278,0.8999791522018199,1.0,7/18,27.43%,TMEM230;SPG11;RAB11A;CCDC186;TOR1A;KIF5B;TESK1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.23981642043172574,-0.8269689394613879,0.791015625,0.8998673589851625,1.0,13/55,18.55%,IGF1;PDGFRB;BMP7;BMP4;OBSL1;IGF2;CDK13;TOM1L2;DUSP1;RCC1;PRMT5;PHIP;NME6
prerank,regulation of double-strand break repair (GO:2000779),-0.2525282829127094,-0.8268257834366186,0.7586206896551724,0.8996865506415156,1.0,9/39,13.24%,RNF169;TRIP12;SPIDR;UBR5;PPP4C;PPP4R2;SETD2;SHLD2;SLF1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3180614051794277,-0.8266850336195396,0.746641074856046,0.8994973671051097,1.0,8/17,36.76%,DNM1L;BCL2;SOD2;FIS1;GGCT;BAK1;SFN;TIMM50
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.28702732026703964,0.8263151688175109,0.7379454926624738,0.9851139366154162,1.0,3/23,6.59%,PAX8;PAX2;LHX1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2551457840930556,0.8260435066727173,0.7278617710583153,0.9847546139098253,1.0,10/39,16.85%,RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;RFC4;POLD3;RFC5
prerank,regulation of protein localization to centrosome (GO:1904779),0.35305028257134097,0.8255728437956215,0.7022222222222222,0.9848535774091487,1.0,3/10,11.24%,BICD1;NUP62;APC
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3551385905086152,-0.8252509801127736,0.7074074074074074,0.9017284948347861,1.0,6/11,28.54%,MSH3;ZRANB3;SMARCAL1;DONSON;TIPIN;TIMELESS
prerank,cellular copper ion homeostasis (GO:0006878),0.3259856087075658,0.8252509278202628,0.6894273127753304,0.9846237026013928,1.0,1/14,0.93%,MT2A
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.34102119373322126,-0.8250458042821729,0.7150442477876107,0.9016514635828969,1.0,3/12,12.63%,CBLB;F3;APOD
prerank,positive regulation of DNA recombination (GO:0045911),-0.28467884747587385,-0.8248647510662315,0.7258382642998028,0.9015079648590242,1.0,14/27,29.39%,KMT5B;FUS;WDR48;SHLD2;PARP1;KMT5C;MMS19;ARID2;PRDM9;PAXIP1;ACTR2;FANCB;TIMELESS;MAD2L2
prerank,mitochondrial translational elongation (GO:0070125),0.21993783749604023,0.8247729745043887,0.820040899795501,0.9846635009480945,1.0,26/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,response to estrogen (GO:0043627),-0.2721768426048269,-0.8247102711316865,0.7538461538461538,0.901317016877867,1.0,6/31,16.75%,EP300;KMT2D;BCAS3;AR;TRIM25;CITED2
prerank,positive regulation of cytokine production (GO:0001819),-0.18863087256617783,-0.8245376333833506,0.9627450980392157,0.9012006708030724,1.0,49/292,17.55%,ROCK2;SULF1;FOXP1;NFKB1;CCBE1;IL6ST;EP300;ARNT;PLA2R1;TBK1;LBP;SULF2;PIBF1;HMGB1;CREBBP;STAT3;EIF2AK3;IL16;RUNX1;ANXA1;DHX9;F3;CEBPG;DHX36;IL17RA;PTPN22;CYP1B1;TRAF2;HIF1A;MAVS;RORA;IL6R;APPL1;IRF1;EIF2AK2;PRKDC;PRKCZ;IL17D;STOML2;CYBA;C1QTNF3;MRE11;ADRA2A;AFAP1L2;IL18;SERPINE1;PIK3CD;TLR4;WNT5A
prerank,regulation of cellular pH (GO:0030641),0.27318893744224515,0.824289561256997,0.739406779661017,0.9847476942305036,1.0,5/29,11.42%,SLC4A1;CA2;ATP6AP1;ATP1A4;ATP5F1B
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.279987450736415,-0.8242530440957346,0.7540394973070018,0.9012648794814738,1.0,8/26,20.15%,ADCY5;CDK16;STXBP4;STX4;TRPM4;ADRA2A;ANO1;C2CD2L
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.29427234322151846,-0.82412303343392,0.7288135593220338,0.9010359637822893,1.0,5/21,22.19%,CYP26B1;ACOX1;LPIN2;LPIN3;ACOT8
prerank,striated muscle contraction (GO:0006941),-0.2390367147014576,-0.823968748872457,0.8015122873345936,0.9008426011898294,1.0,2/53,1.44%,ATP1A2;TPM1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.33568101664828776,-0.8237030857626872,0.7013232514177694,0.9008703752578245,1.0,6/14,29.16%,THBS1;PLCG1;ITGA4;PDCD4;PRKCI;GPER1
prerank,regulation of neurogenesis (GO:0050767),-0.24100279116455045,-0.8236450589743939,0.7995951417004049,0.900513042539197,1.0,12/55,18.05%,APPL2;PCM1;YAP1;DOCK7;REST;PRUNE1;NUMBL;HES1;BHLHE41;NUMB;HEYL;CX3CR1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.33145909591371747,-0.8234736648148503,0.7277992277992278,0.9003518590735137,1.0,2/14,5.41%,IL34;THBS1
prerank,positive regulation of protein maturation (GO:1903319),-0.3514213530303136,-0.8231513315706844,0.6856127886323268,0.900467352112491,1.0,1/11,2.47%,CCBE1
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.24444112304734983,-0.8230250091521857,0.7881188118811882,0.8997867261633707,1.0,22/51,35.08%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,mitotic nuclear membrane organization (GO:0101024),-0.24444112304734983,-0.8230250091521857,0.7881188118811882,0.8997867261633707,1.0,22/51,35.08%,LMNA;CHMP4B;CHMP4A;UBE2I;ANKLE2;CHMP3;CC2D1B;RCC1;EMD;NUP98;PPP2CA;NUP43;LBR;NUP160;NUP93;PPP2R2A;BANF1;RAN;REEP4;AHCTF1;NUP133;SEC13
prerank,myeloid dendritic cell activation (GO:0001773),-0.34480328710088803,-0.8228772417580861,0.7281368821292775,0.8996025744320686,1.0,2/12,5.03%,TGFBR2;HMGB1
prerank,secretion (GO:0046903),0.32516508296372704,0.8224871889785881,0.6878850102669405,0.9874201782358104,1.0,2/14,7.13%,RIMS1;GUCA1B
prerank,tRNA aminoacylation (GO:0043039),0.2562148106287152,0.8215869277578751,0.7521739130434782,0.9884054077967481,1.0,8/37,14.31%,VARS1;GARS1;RARS1;FARSB;AIMP2;GATB;IARS1;GATC
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2989800217672608,0.8215705516118337,0.6995884773662552,0.9875226737064344,1.0,5/21,16.57%,CNKSR3;PPM1F;SMAD7;PDE4D;DDIT4
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3334251546655219,0.8212417281916862,0.7121212121212122,0.9872763576860087,1.0,3/13,9.50%,TOX;CAMK4;FOXJ1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.3503520605699465,-0.8210877174803527,0.7193308550185874,0.9023600624654706,1.0,1/11,0.80%,AFDN
prerank,regulation of lymphocyte migration (GO:2000401),0.3568646823481698,0.8210728891934134,0.6997840172786177,0.9867083126359192,1.0,2/10,7.97%,JAM2;AKT1
prerank,regulation of mRNA catabolic process (GO:0061013),0.2073553512196319,0.8209765085902135,0.8797595190380761,0.98599486900066,1.0,17/121,10.81%,PRR5L;EXOSC5;YWHAB;PSMA1;HSPA8;RPS27A;UBC;AKT1;UBB;PSMD12;HSPB1;PSMA6;PSMB3;PABPC1;KHSRP;SET;APEX1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3325093137055054,-0.820499333396715,0.6955719557195572,0.9029888874549649,1.0,4/13,12.12%,TRIM8;CHMP3;TRIM5;TRIM11
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2977579449755201,-0.8201714981038976,0.7237569060773481,0.903131166878309,1.0,11/20,28.02%,TAF3;SP100;TAF8;TOPORS;MORC3;HNRNPU;PARK7;PML;SUN2;BBS4;CHCHD10
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.23999636567145077,-0.819406786674319,0.7858508604206501,0.9040338884404104,1.0,21/55,34.19%,FBXL7;FHL1;USP47;PSMF1;PSMB2;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;PSME4;PSMB8;PSMD10
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2422538309369956,-0.8193713971432126,0.7627450980392156,0.9036434743789421,1.0,13/52,21.13%,SAE1;HUWE1;TFDP2;BCL2;ABLIM3;LEPROT;NPEPPS;FBXW7;YWHAE;UBL5;UBE2D3;TOMM7;ARIH2
prerank,cellular response to interferon-beta (GO:0035458),-0.32803726260709515,-0.8193658704946705,0.7243243243243244,0.903193565931431,1.0,6/14,28.23%,UBE2K;IRF1;STAT1;IRGM;HTRA2;CDC34
prerank,cellular lipid catabolic process (GO:0044242),-0.2747844353641584,-0.8190718725682169,0.738404452690167,0.9032574546626545,1.0,12/27,36.45%,CYP1B1;ACOX1;LPIN2;ABHD12;LPIN3;ACOT8;MT3;ANGPTL3;SMPDL3B;NUDT19;FAAH;ACADL
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3357280225591195,-0.8188239855341939,0.7401574803149606,0.9032475496620163,1.0,5/13,22.55%,AXL;ZBTB1;IL18;LAMP1;TICAM1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3505178035643178,-0.818589608622083,0.7035647279549718,0.9032122853824529,1.0,7/11,48.74%,P2RX4;PLCG2;TREM2;P2RX5;TRAT1;CCL4;NEUROD2
prerank,regulation of nervous system development (GO:0051960),-0.25554222590049747,-0.8184954365841117,0.764,0.9029162473184392,1.0,9/37,18.12%,PTN;YAP1;DOCK7;PRUNE1;HES1;BHLHE41;HEYL;CX3CR1;LGI4
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.22964310864957319,-0.818346842520797,0.8234086242299795,0.9027267104404281,1.0,20/63,28.75%,MDM4;EP300;TFDP2;RFWD3;CNOT8;CASP2;PRKDC;CNOT2;CNOT1;SDE2;CNOT10;CDK2;PML;PCNA;WAC;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.32297902954124236,0.8181075071534135,0.737603305785124,0.9909750318329251,1.0,6/15,22.19%,NTRK2;HAP1;BCAR1;DDIT4;SORT1;BDNF
prerank,negative regulation of neuron death (GO:1901215),0.22001465031870693,0.8176158498996202,0.8333333333333334,0.9911186619247659,1.0,19/93,15.24%,MAG;FOXQ1;SNCA;NTRK2;VSTM2L;UNC5B;NDNF;AKT1;GPNMB;CD34;CCL2;CD200R1;RETREG1;SET;F2R;SORL1;PTPRZ1;PPT1;ATF4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3144437727908852,0.8163804194497275,0.7432150313152401,0.9926971312959192,1.0,3/16,18.05%,SLC2A5;BMPR2;DDAH1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.24940805595088306,0.8157803774207244,0.7670103092783506,0.9930028842348896,1.0,10/40,15.77%,BICD1;MAGI2;AHI1;HIP1;CLU;SGIP1;INSR;PPT1;B2M;TBC1D5
prerank,response to organophosphorus (GO:0046683),0.31323567206531794,0.8153935649234909,0.7094017094017094,0.9928469431016245,1.0,3/16,13.33%,KCNJ11;P2RX7;VGF
prerank,response to organonitrogen compound (GO:0010243),0.2555269455589666,0.8151704422112321,0.7928286852589641,0.9923956816845745,1.0,6/38,11.20%,GLRA1;GLRA3;MEAK7;TRPM2;GLRA2;BRSK2
prerank,positive regulation of inflammatory response (GO:0050729),0.21641410286697924,0.8151169731840194,0.8604651162790697,0.9916066900020267,1.0,8/86,7.51%,RPS19;S100A9;S100A8;PDE2A;SNCA;ETS1;NINJ1;TLR2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3550268662682333,-0.8150340172159071,0.7237076648841355,0.908206049797321,1.0,3/10,14.42%,DPP4;FAP;EMILIN1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.24339781302326058,-0.8147617603921551,0.8047808764940239,0.9082412938592647,1.0,19/43,27.99%,FOXN3;NBN;TAOK3;BRCC3;BRSK1;NABP2;RINT1;CDC14B;TRIM39;NOP53;MRE11;TAOK1;CDK5RAP3;NAE1;CLSPN;DONSON;ORC1;ABRAXAS1;FZR1
prerank,negative regulation of histone modification (GO:0031057),0.32362890100368114,0.8146927376955636,0.7333333333333333,0.9915373725186508,1.0,3/14,13.55%,SNCA;SET;PRMT6
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3093155271992196,-0.8143392650886349,0.7335834896810507,0.9085560656704427,1.0,6/16,21.04%,PIBF1;LEPROT;PTPN2;PARP14;NF2;PPP2CA
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2763375580459215,0.8142945901156092,0.7478632478632479,0.9914681815270328,1.0,7/25,14.84%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A;RTN4
prerank,cytoplasmic translational initiation (GO:0002183),-0.3069229829982771,-0.8138074868723991,0.7250996015936255,0.909006015754872,1.0,5/17,19.58%,EIF4A2;DENR;EIF3A;EIF4G1;RBM4
prerank,endothelial cell development (GO:0001885),0.2788247018255053,0.8135141654430029,0.7274678111587983,0.9921059833046465,1.0,8/25,16.52%,ROBO4;PDE2A;PPP1R16B;PECAM1;MARVELD2;PDE4D;RAP1A;SOX18
prerank,regulation of ATP metabolic process (GO:1903578),-0.23695782955139083,-0.8135049641893315,0.8302658486707567,0.9091154388878134,1.0,22/54,35.09%,PRKAG2;EP300;RANBP2;NUP42;NUP214;HIF1A;TPR;OGT;ATP5IF1;FIS1;NUP98;NUP43;NUP160;ZBTB7A;NUP93;JMJD8;SPHK2;COX7A2L;ATP7A;NUP133;SEC13;NUP88
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.33489126917318673,0.8125117333479678,0.7310924369747899,0.9931754001359403,1.0,5/12,19.22%,FDX2;TSPOAP1;TSPO;STARD3NL;STARD3
prerank,cellular response to UV (GO:0034644),-0.2206601984812873,-0.8122435805782476,0.8443579766536965,0.9109098237094069,1.0,24/76,25.45%,INO80;EP300;CREBBP;DHX36;PTPRK;IMPACT;DDB2;ZBTB1;PRKCD;USP47;PARP1;MMP2;EIF2AK4;SDE2;MFAP4;CARD16;PCNA;BMF;PPID;ATR;ERCC1;USP28;KDM1A;ACTR5
prerank,regulation of amyloid fibril formation (GO:1905906),0.3173482150921419,0.811976343232302,0.7334754797441365,0.9933608955013628,1.0,6/15,20.46%,PFDN5;CLU;PFDN6;PSEN1;PFDN1;CRYAB
prerank,positive regulation of rRNA processing (GO:2000234),-0.34814419078381775,-0.8118769689467468,0.7063063063063063,0.9110933397375826,1.0,3/10,16.54%,WDR43;DIMT1;BUD23
prerank,peptidyl-amino acid modification (GO:0018193),-0.3644856106825061,-0.8117089904612927,0.7334630350194552,0.910909465536926,1.0,3/10,15.93%,TTLL4;FKBP10;FKBP7
prerank,positive regulation of secretion by cell (GO:1903532),0.2249363747950269,0.8116154388101249,0.832258064516129,0.993152032928773,1.0,7/70,5.82%,CD33;CADPS;APBB1;SNCA;GRK2;APBB3;TGFB2
prerank,regulation of cellular response to stress (GO:0080135),-0.20490238093390403,-0.8115492911992049,0.8825995807127882,0.9107359880284258,1.0,17/115,11.11%,ROCK2;EP300;SMG1;ABL1;PRKN;NUPR1;GSK3B;RPTOR;RANBP2;CREBBP;CAMK2D;MTOR;NUP42;CAMK2G;BAG3;NUP214;MBTPS2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2887667471010168,0.8113808713752385,0.7490118577075099,0.9927080678328801,1.0,4/22,11.09%,NDOR1;IBA57;ISCU;ISCA2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.33174940860638463,0.8112686400925531,0.7315010570824524,0.9920375063501553,1.0,3/14,9.89%,HSPA5;FICD;DAB2IP
prerank,neuron projection fasciculation (GO:0106030),0.3517541183672548,0.8110371865508469,0.7114967462039046,0.9916146469416157,1.0,5/10,21.74%,NRCAM;CNTN4;RTN4;CDK5R1;AMIGO1
prerank,mitochondrion organization (GO:0007005),-0.19602523502935656,-0.8109406399707074,0.9299610894941635,0.911338984964452,1.0,64/165,33.56%,PID1;TRAK1;OPA1;PRKN;LRRK2;MEF2A;DNM1L;CXADR;VPS13D;AFG1L;MIGA2;IFIT2;AIFM1;PPARGC1A;MTX3;GABPA;HCFC1;RHOT1;PARP1;NRF1;YME1L1;VPS13C;SIRT5;WASF1;STOML2;AIP;PARK7;MGME1;FIS1;TERT;TOMM7;PYROXD2;WDR81;FMC1;BNIP3;SIRT4;SSBP1;RHOT2;SIRT3;CLUH;PHB2;TIMM13;MFN2;SAMM50;TIMM44;LONP1;HIGD2A;MYH14;CHCHD10;MUL1;SUPV3L1;TOMM5;POLRMT;MIGA1;CYCS;FANCG;TWNK;HK2;TIMM9;PTCD2;AFG3L2;MTFR2;COX7A2L;ATP7A
prerank,neural crest cell differentiation (GO:0014033),0.30570653513161533,0.8104183067004453,0.7351694915254238,0.9918692412614946,1.0,3/18,6.01%,NRG1;CDH2;CYP26C1
prerank,regulation of keratinocyte migration (GO:0051547),-0.33930136467086774,-0.8103623895846921,0.7231638418079096,0.9118933690732763,1.0,3/12,10.53%,MAP4K4;MTOR;ADAM9
prerank,acute-phase response (GO:0006953),0.33071696704954623,0.8101271144491347,0.7226890756302521,0.9915350181150715,1.0,1/12,0.95%,MBL2
prerank,positive regulation of vasoconstriction (GO:0045907),0.3234178173403295,0.8100020872404754,0.7131147540983607,0.9908957305095601,1.0,3/13,10.86%,ADRA1D;ADRA1A;F2R
prerank,negative regulation of interleukin-6 production (GO:0032715),0.2745611655819509,0.8098162231267473,0.7484143763213531,0.9903565479830939,1.0,4/27,9.54%,SYT11;GAS6;FOXJ1;CD200R1
prerank,regulation of receptor binding (GO:1900120),-0.3575201420431867,-0.8096700711807473,0.7282809611829945,0.9125749501993904,1.0,4/10,30.08%,ATP2A2;GREM2;ATP2A3;PTPRF
prerank,cGMP biosynthetic process (GO:0006182),-0.3480942699846381,-0.80933821489061,0.7047619047619048,0.9126893360383211,1.0,2/10,17.37%,GUCY1A1;NPR2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.28846308023713785,0.8092671122003287,0.7478260869565218,0.9905089417322598,1.0,7/21,21.90%,PGM2L1;TALDO1;GCK;TKT;RPIA;GPI;G6PC3
prerank,aerobic respiration (GO:0009060),0.29209114815520926,0.8088298025241991,0.7409766454352441,0.9904635173731464,1.0,3/20,7.96%,SDHC;ATP5F1D;SLC25A14
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.31902743196947314,-0.8085978319527624,0.7255639097744361,0.9135160341459578,1.0,8/15,28.68%,RIPOR2;RAPGEF3;EHD2;ADAM9;MAPK14;CD53;CAMK1;EHD1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.29551288336305404,0.8081922015786712,0.7235421166306696,0.990817875110715,1.0,5/19,14.36%,HNRNPC;TERF1;TEN1;PIF1;TINF2
prerank,regulation of protein localization (GO:0032880),-0.23118430634285786,-0.8081384241124564,0.8268876611418048,0.9138322551494685,1.0,23/58,27.94%,AFDN;WDPCP;DLG1;UFL1;CSNK1E;PARP1;TRIM5;TPR;FBXW7;TRIM25;DZIP1L;PICALM;ITGB3;DVL3;PLEKHM2;BORA;RAB9A;TRIM68;KDM1A;RSL1D1;TESK1;CAMK1;TRIM46
prerank,macrophage activation (GO:0042116),0.2602741936579359,0.8081279734648988,0.7484143763213531,0.9900324460621127,1.0,6/34,12.49%,CD93;SNCA;CLU;DYSF;AIF1;ITGAM
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.20388846756135012,0.8078759494615907,0.9017094017094017,0.9896162295291663,1.0,25/124,18.41%,CAMK2A;LEF1;AP2M1;PSMA1;PLCB1;FZD6;GNG2;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;CALM1;FZD4;DVL1;PFN1;PSME3;PPP3CA;PSMC3;PSMA2;CTNNB1;AGO4;PRICKLE2;PSMB7
prerank,negative regulation of response to external stimulus (GO:0032102),-0.20880903192935008,-0.8078503838248688,0.8595194085027726,0.9138865792296834,1.0,37/105,29.42%,PTGIS;IRAK3;TRAFD1;PTPRS;MAPKBP1;EPHA4;PCBP2;SELENOS;PTPN2;CCN3;NR1H3;ENPP3;PRKCD;CD109;RORA;RB1;ILRUN;APOE;C1QTNF3;FEM1A;SERPINE1;METRNL;CARD16;SHARPIN;FGF2;LPCAT3;NLRC3;MAPK7;MVK;SIRPA;PPARA;DHX58;CACTIN;MUL1;TNFAIP3;GPER1;NR1H4
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24023182735325532,0.8069637532783297,0.8070539419087137,0.9904405276704368,1.0,5/47,7.97%,GRM5;RPL10;NANOS3;KLF4;AKT1
prerank,negative regulation of endocytosis (GO:0045806),-0.28450912392135463,-0.8067912528186783,0.7739307535641547,0.9152618536316445,1.0,8/24,22.48%,EPHA3;NR1H3;RUBCN;PICALM;PRKD1;ABCA7;LRSAM1;CD300A
prerank,organophosphate catabolic process (GO:0046434),0.3320176275877747,0.8056029506640046,0.7101123595505618,0.9921504229870982,1.0,1/11,4.79%,ENPP2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3272808215302707,-0.805545631752672,0.73828125,0.9168791291836139,1.0,9/14,35.85%,TSEN2;TSEN15;CPSF4;RTRAF;CPSF1;TRPT1;TSEN54;RTCB;FAM98B
prerank,tryptophan catabolic process (GO:0006569),0.33611599297012296,0.8054253482935947,0.720682302771855,0.991577938809525,1.0,11/11,66.41%,KYAT1;KYNU;AFMID;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.31379294638769173,0.8052852062733704,0.7331975560081466,0.9909563453422455,1.0,2/15,3.31%,MIF;SIRT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23476990508011378,-0.80506720055258,0.832046332046332,0.9172420438265214,1.0,22/48,34.02%,EP300;ABL1;BCL2;HIPK1;CASP2;PRKDC;TOPORS;IKBKE;MSH6;PML;USP28;BAG6;BCL2L2;HTRA2;E2F1;BAK1;HIC1;SNW1;BCL2L11;TNFRSF1B;BRCA1;PYCARD
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.33813890408454306,-0.8047817344176331,0.7518248175182481,0.9172897743908662,1.0,2/12,6.07%,NCOR1;STAT3
prerank,cholesterol biosynthetic process (GO:0006695),0.271480013120031,0.8046691964839455,0.7658227848101266,0.9912043329722019,1.0,12/31,19.88%,MVD;HSD17B7;IDI1;DHCR7;PLPP6;HMGCS1;ACAT2;TM7SF2;EBP;MSMO1;FDPS;NSDHL
prerank,regulation of interferon-beta production (GO:0032648),-0.2434700394662454,-0.8042412836971056,0.8317399617590823,0.9177291447069114,1.0,17/46,27.37%,TBK1;PTPRS;DHX9;RNF216;MAVS;RIOK3;IRF1;DDX3X;TRAF3;OAS2;TLR4;PTPN11;NLRC3;POLR3D;SIRPA;DHX58;CACTIN
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.29150582025955035,-0.8039372036482131,0.7428571428571429,0.9177974716522432,1.0,12/20,33.85%,PLOD2;PLSCR1;PTDSS1;SLC27A1;CHAC2;GSS;PTDSS2;GGCT;GCLC;HAGH;CNDP2;GAMT
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.32857946446008257,-0.8038128560017559,0.7338129496402878,0.9175358724259289,1.0,6/13,22.46%,NUPR1;EIF2AK3;NR1H3;MBTPS2;LPCAT3;WFS1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.31505472532148715,0.8030375892308326,0.7387755102040816,0.9933430352353202,1.0,3/14,13.30%,CSTF2T;CSTF2;CPSF2
prerank,transition metal ion homeostasis (GO:0055076),-0.269162512109528,-0.8030021658585696,0.7685009487666035,0.9184388940457159,1.0,4/28,8.83%,CP;PRKN;SLC39A14;XIAP
prerank,regulation of tissue remodeling (GO:0034103),-0.2976004372479353,-0.802746991429489,0.759469696969697,0.9184322779399846,1.0,4/18,16.83%,LEPR;RUNX1;SUCO;IL18
prerank,DNA replication (GO:0006260),-0.2060249943740882,-0.8011282670232738,0.8939096267190569,0.9207020347698718,1.0,42/105,34.63%,RBMS1;RBBP8;TOP1;BAZ1A;NBN;NT5M;WRN;UPF1;MCM9;REV1;ING5;MCM6;MRE11;HELB;CDK2;POLA2;RPAIN;ATR;CLSPN;DBF4;NAP1L1;DONSON;POLE2;RECQL5;KIN;ORC1;TIPIN;MCM4;TIMELESS;IGHMBP2;TOP1MT;POLD2;RPA2;RAD9A;PNKP;RMI2;CDC45;POLA1;BRCA1;PCLAF;RFC1;POLE
prerank,ether lipid metabolic process (GO:0046485),-0.32421536788004,-0.800381794596523,0.7350096711798839,0.9215253340327436,1.0,2/14,5.34%,AGMO;GNPAT
prerank,inflammatory response (GO:0006954),-0.18928399661328346,-0.7999162283153166,0.9614643545279383,0.9218307560695584,1.0,34/195,19.19%,NFKB1;HDAC4;TPST1;KIT;TBK1;HSPG2;HMGB1;THBS1;STAT3;ADCY1;NOX4;ANXA1;TRAF3IP2;ABCF1;NFATC4;AGTR1;SCUBE1;PARP4;IL17D;CYBA;BDKRB2;LOXL3;CMKLR1;AFAP1L2;IL18;PTGDR;PIK3CD;TLR4;PXK;PTGFR;BLNK;NFATC3;BMP2;MGLL
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.26428025679988876,0.7998579634563184,0.7739872068230277,0.9984314854935816,1.0,6/29,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,regulation of T cell activation (GO:0050863),0.24755469596685098,0.799682904179862,0.8170731707317073,0.9978524309156906,1.0,6/42,12.68%,THY1;PRKCQ;GPNMB;CCL2;CYRIB;HSPD1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2917618612628231,-0.7991563198133609,0.7545787545787546,0.9226621884931009,1.0,11/19,32.95%,TAF3;TAF8;TOPORS;MORC3;HNRNPU;PML;TAPT1;BBS4;CHCHD10;HK2;ARL2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.27891356383507326,-0.799082528429929,0.7576923076923077,0.9223158619379109,1.0,9/22,25.23%,EFNB2;ROBO1;NRP1;VEGFA;NR4A1;MIA3;FGF2;SLIT2;EPHB4
prerank,glutathione biosynthetic process (GO:0006750),-0.33857634252694346,-0.798909120110189,0.7224199288256228,0.9221457377322092,1.0,6/11,33.09%,CHAC2;GSS;GGCT;GCLC;HAGH;CNDP2
prerank,regulation of exit from mitosis (GO:0007096),-0.25432322984294686,-0.7987066152361841,0.7790055248618785,0.922033383121871,1.0,14/38,25.40%,CDC14A;ANAPC5;ANAPC7;ANAPC4;ANAPC16;CDC26;CDC14B;CDC27;UBE2E1;UBE2S;ANAPC11;CDC16;PHB2;ANAPC1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3339819231734873,0.7986329763607988,0.7331932773109243,0.9988132341599802,1.0,11/11,66.62%,LPO;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;PKD1L3;PKD2L1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.33571487985423176,0.7984763327183466,0.7267080745341615,0.9982053726515167,1.0,3/11,11.90%,CXCL12;GAS6;IRF7
prerank,regulation of fibroblast migration (GO:0010762),0.2889994652914989,0.7982965411965224,0.7510917030567685,0.9976778890551421,1.0,8/20,20.39%,PRR5L;RFFL;ARHGEF7;CORO1C;DDR2;GNA12;HYAL2;RAC1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.1946568955189005,0.7980180329148154,0.9643564356435643,0.9973006792792244,1.0,32/163,18.41%,PDE4B;BTNL9;SLA2;VAV3;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;NFATC2;PAK3;CD38;PSMC3;PSMA2;BTK;SH2B2;NCKAP1L;FYN;PSMB7
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.33771575978154383,-0.7976269693554523,0.736328125,0.9233509381533762,1.0,3/11,9.70%,STX18;VCPIP1;ATL2
prerank,RNA modification (GO:0009451),0.23267470963168846,0.7976111525942341,0.8281573498964804,0.9971812166980234,1.0,6/54,8.12%,TSR3;AARS2;QTRT1;NSUN5;TFB1M;RBM15B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3037720659760802,-0.7974766552700688,0.7644859813084112,0.923142586660339,1.0,6/16,25.46%,ABHD5;LDLR;NR1H3;SLC27A1;DAGLB;PNPLA2
prerank,integrated stress response signaling (GO:0140467),0.3166355567294245,0.7974595880544842,0.7478813559322034,0.9965762640902244,1.0,3/14,9.00%,OMA1;HSPA5;CCL2
prerank,chromatin assembly or disassembly (GO:0006333),-0.34233402155812337,-0.7973876612737545,0.7288135593220338,0.9228283068776073,1.0,1/11,1.47%,HDAC8
prerank,regulation of histone deacetylation (GO:0031063),-0.31890353023101536,-0.7972788783609701,0.7452471482889734,0.9225433783842425,1.0,6/13,29.37%,CAMK2D;AKAP8L;NIPBL;SAP30BP;ZBTB7B;SPHK2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.28867620030595154,0.7971855292890859,0.7477876106194691,0.9961639762866932,1.0,3/19,12.49%,TIRAP;TRIL;ITGAM
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32090463288591703,0.7967793254773096,0.7127192982456141,0.9959550187724877,1.0,1/12,1.19%,ADCY8
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.3254859082076534,-0.7964782188010048,0.7348066298342542,0.923405514046468,1.0,5/13,30.89%,RHOT1;BMF;BNIP3;RHOT2;BCL2L11
prerank,negative regulation of cell cycle process (GO:0010948),-0.22792786095336853,-0.7962013065095328,0.8647540983606558,0.9234095033501295,1.0,24/61,33.55%,BMP7;BMP4;RBBP8;CBX5;TFDP2;TOM1L2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1;NME6;TERF2;EZH2;PPP1R10;APAF1;E2F1;GPER1;FOXO4;WAPL;ZFYVE19;RAD51;E2F6;BRCA1
prerank,negative regulation of B cell activation (GO:0050869),-0.2862375706454201,-0.7960832506161345,0.7658349328214972,0.9231389126410489,1.0,11/21,39.23%,RC3H1;LYN;ID2;INHBA;CD300A;TNFAIP3;PARP3;INHA;FCGR2B;BANK1;SFRP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2346199037459255,-0.7959982241021157,0.8208955223880597,0.9228307361744698,1.0,9/51,17.01%,PTN;IL34;HMGB1;THBS1;IL6R;VEGFA;VEGFD;CMKLR1;SERPINE1
prerank,cellular response to oxygen levels (GO:0071453),0.341012742146117,0.7958834015002767,0.7114967462039046,0.9966894286412732,1.0,3/10,14.85%,ATP6V1A;ATP6AP1;TMEM199
prerank,tryptophan metabolic process (GO:0006568),0.335676625659051,0.7955492103331705,0.7245119305856833,0.9964224932782515,1.0,11/11,66.46%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO;ATP7A
prerank,lipoxygenase pathway (GO:0019372),0.316854195090076,0.7954466123206361,0.7361419068736141,0.9957275194024635,1.0,2/14,9.46%,GPX1;HPGD
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.25179236234436847,0.7953914506309814,0.7991967871485943,0.994932135554085,1.0,12/35,21.90%,ERBB4;NOTCH1;SOCS1;OCIAD1;F2R;BCL3;HES5;HGS;DOT1L;NLK;PIGU;IL10RB
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3126505318586046,0.7949673474302376,0.7358490566037735,0.9948392551884065,1.0,3/15,8.43%,TMSB4X;NOTCH1;HSPB1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.31928686398319817,-0.7948122030834572,0.7596899224806202,0.9243253508470878,1.0,3/13,18.04%,NIBAN2;EMILIN1;PTPN1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.2653064582739833,-0.7937732935476087,0.8047882136279927,0.9256093147974923,1.0,5/26,11.94%,GTF2H2;RAD23B;DDB2;PARP1;ERCC3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27972282566120404,-0.7937407552769419,0.7741312741312741,0.9252100138238887,1.0,9/22,27.79%,ERI3;ERI2;URB1;EXOSC9;EXOSC10;WDR12;EXOSC3;PES1;RRS1
prerank,protein methylation (GO:0006479),-0.2442775251490627,-0.7934436941134565,0.8247011952191236,0.9252532394433293,1.0,14/40,22.32%,NSD3;NSD1;SETD3;PRMT2;N6AMT1;EHMT1;PCMT1;METTL21A;PRMT5;PRMT8;EEF2KMT;NTMT1;EZH2;CAMKMT
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2649717889846665,-0.7926708493373545,0.7855626326963907,0.9260504481292762,1.0,12/28,29.30%,CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;DONSON;E2F1;INTS7
prerank,mitochondrial translational termination (GO:0070126),0.21034680963898628,0.7926376550854849,0.8672032193158954,0.9981419266606814,1.0,25/88,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,microvillus organization (GO:0032528),-0.32210084296655506,-0.7924495761314937,0.7480769230769231,0.925944608310612,1.0,4/13,17.00%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3251677103478745,0.7922413495426592,0.7237687366167024,0.9979144631351918,1.0,4/12,16.98%,MFSD2A;ACSL3;SOAT2;MTTP
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.322300163295878,-0.7922361867255675,0.7401574803149606,0.9258459460385796,1.0,5/13,11.38%,MOV10;RC3H1;ZC3HAV1;UPF1;CNOT8
prerank,lipid catabolic process (GO:0016042),0.292784343063643,0.7920520184974308,0.7760869565217391,0.9973766232042494,1.0,3/18,14.53%,LIPE;HSD11B1;PPT1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2336612169823573,-0.7920069995335681,0.83399209486166,0.9253062080460158,1.0,17/50,27.98%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2336612169823573,-0.7920069995335681,0.83399209486166,0.9253062080460158,1.0,17/50,27.98%,PUM2;TNRC6A;RANBP2;PUM1;NUP42;NUP214;TPR;POLR2H;EIF4G1;NUP98;NUP43;POLR2K;AGO1;NUP160;POLR2E;NUP93;POLR2D
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34935644562724605,-0.7918951253809122,0.7191650853889943,0.9250320296627268,1.0,4/10,26.77%,PTPN22;DUSP10;PDCD4;AIDA
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3522829489159936,-0.7918013530779131,0.7407407407407407,0.9247381205432589,1.0,3/10,10.53%,MAP4K4;MTOR;ADAM9
prerank,DNA replication checkpoint signaling (GO:0000076),0.3024446859701946,0.791088770336171,0.7321428571428571,0.9981905583533325,1.0,1/16,1.66%,HUS1B
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3112870124627243,-0.7907898142586222,0.7616487455197133,0.9259138404401369,1.0,8/16,29.89%,PID1;PPARGC1A;PARP1;VCP;PPARA;SPHK2;ANTKMT;ENO1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.31466728039577324,-0.7904924368232316,0.7262569832402235,0.9259265564709915,1.0,7/14,31.68%,RCC1L;RMND1;RPUSD4;MPV17L2;TRMT10C;C1QBP;MRPS27
prerank,positive regulation of dephosphorylation (GO:0035306),0.26685816043297234,0.7904694991037328,0.803347280334728,0.9983909114097792,1.0,9/27,20.82%,PPP1R16B;SMPD1;CALM1;CALM2;CALM3;PPIA;CAMTA1;PPP2R5A;MTMR9
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3453115949691411,-0.7904258933901428,0.7567049808429118,0.9255621539438306,1.0,2/10,4.82%,RARB;RARG
prerank,renal absorption (GO:0070293),-0.34741321135133185,-0.7900213402590213,0.7621832358674464,0.9257171094975565,1.0,2/10,9.04%,GSN;WNK4
prerank,protein localization to mitochondrion (GO:0070585),0.3291487762549516,0.7897676680373297,0.7341772151898734,0.9988130033305017,1.0,3/11,11.38%,ISG15;AKT1;MTCH2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3341491398143239,-0.7893659271966864,0.752851711026616,0.9262891384453117,1.0,6/12,30.89%,ATF6;ERN1;PTPN1;PIK3R1;BAK1;BCL2L11
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3264832973513697,-0.7893384788549869,0.7486338797814208,0.9258740669148477,1.0,5/12,23.94%,REST;JUN;HDAC1;INPP5K;TFAP4
prerank,placenta development (GO:0001890),0.3194783354030283,0.789080556468373,0.7384937238493724,0.9991928788786918,1.0,2/12,12.29%,PPARG;E2F7
prerank,microtubule-based transport (GO:0099111),0.31812190069675483,0.7890354681702821,0.7120879120879121,0.9983813933102709,1.0,12/12,68.21%,DNAAF2;SPEF2;DYNC1I2;DYNC1I1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;HTT
prerank,negative regulation of kinase activity (GO:0033673),0.22346742380087933,0.7889237838345171,0.8714285714285714,0.9976941584695013,1.0,12/62,12.85%,CAMK2N1;PPM1F;SNCA;THY1;TRIB3;AKT1;YWHAG;HSPB1;CEP43;UBASH3B;DVL1;EPHA1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.265931050330372,0.7885224798106429,0.798728813559322,0.9975052195877637,1.0,3/27,6.39%,CHKA;PISD;PLAAT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.34536786239818185,0.7884895360655703,0.7155555555555555,0.9966876934049478,1.0,3/10,14.24%,ACER2;NEXMIF;JAM3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.25254605793076035,-0.7883735103923466,0.8086303939962477,0.9269959357347605,1.0,9/33,19.26%,TBK1;DHX9;MAVS;RIOK3;IRF1;DDX3X;OAS2;TLR4;PTPN11
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.260183658788413,0.7881784021867334,0.8021978021978022,0.9963464847610729,1.0,6/30,13.15%,RPS27A;UBC;UBB;CD300LF;IRF7;CD40
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3384934483835739,-0.7873023461003708,0.7592233009708738,0.9282280343885676,1.0,3/11,14.51%,NBL1;CCN3;DUSP1
prerank,"phototransduction, visible light (GO:0007603)",-0.3186079730714232,-0.7872365160357917,0.7817836812144212,0.9278764600412088,1.0,8/14,47.71%,ABCA4;GNB1;SAG;PDE6A;CNGB1;PDE6G;GNA11;PDE6B
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.33729421028501416,0.7872142033042485,0.735357917570499,0.9970992273909239,1.0,2/10,7.97%,SNCA;AKT1
prerank,cellular response to pH (GO:0071467),-0.29788738949681914,-0.7870807490000121,0.7752380952380953,0.9276639647320926,1.0,11/17,42.56%,SLC9A1;IMPACT;CHP1;MCOLN1;GPR68;PKD2L1;PKD1L3;HVCN1;KCNK4;RAB11FIP5;HYAL1
prerank,regulation of DNA recombination (GO:0000018),-0.2525439590340597,-0.7869422400876762,0.7985212569316081,0.9274347100330564,1.0,10/32,20.12%,SPIDR;PPP4C;PPP4R2;SETD2;SHLD2;MSH3;MRE11;ZRANB3;MSH6;H1-0
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23297641889106357,-0.7867774172907102,0.8408163265306122,0.9272290720213503,1.0,19/51,28.16%,SMG6;TNKS2;CCT6A;XRN1;CCT8;CTC1;CCT5;MAP2K7;EXOSC10;HNRNPU;TERF2;STN1;ATR;GNL3L;FBXO4;NEK7;NAT10;CCT3;PARN
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34764921428865514,0.786424129464514,0.7477876106194691,0.9975785874062684,1.0,2/10,9.89%,NELL1;DAB2IP
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.31210304273009065,-0.7859423563748943,0.7490636704119851,0.9280845344938166,1.0,6/14,25.95%,IRS1;ABCD2;LONP2;AKT2;TWIST1;PPARA
prerank,intermediate filament organization (GO:0045109),-0.3006190201883285,-0.7858893754630155,0.7587476979742173,0.9277070157191498,1.0,6/17,36.24%,VIM;GFAP;DES;BFSP1;TCHH;KLHL24
prerank,cellular response to interferon-gamma (GO:0071346),-0.20612250880303076,-0.7857944364641424,0.916030534351145,0.9274022754347285,1.0,21/88,17.55%,JAK1;SYNCRIP;CAMK2D;TRIM8;MID1;CAMK2G;SP100;PRKCD;TRIM5;IRF9;TRIM25;IRF1;GBP3;STAT1;DAPK1;IFNGR1;OAS2;GBP7;GBP2;TLR4;WNT5A
prerank,protein K63-linked deubiquitination (GO:0070536),-0.25472007012315245,-0.7854789142511142,0.7864077669902912,0.9274322704413036,1.0,7/31,14.79%,USP7;BRCC3;USP33;ABRAXAS2;USP50;OTUD4;USP13
prerank,regulation of microtubule-based movement (GO:0060632),0.3371949068957324,0.78532196652043,0.7456896551724138,0.9985273286088547,1.0,2/11,10.81%,MAP2;HAP1
prerank,reverse cholesterol transport (GO:0043691),-0.3137232615650909,-0.7839314922095295,0.7732342007434945,0.929289950825067,1.0,2/13,14.09%,ABCA1;APOE
prerank,indolalkylamine catabolic process (GO:0046218),0.3360948973827903,0.7835074268863218,0.7584033613445378,1.0,1.0,10/10,66.41%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,neuron fate commitment (GO:0048663),0.3176986192505726,0.7832404045690742,0.7556008146639511,1.0,1.0,1/14,0.68%,MYT1L
prerank,L-glutamate transmembrane transport (GO:0015813),0.3455305935200679,0.7827006640957707,0.7214912280701754,1.0,1.0,2/10,5.81%,SLC1A1;SLC1A2
prerank,protein import into mitochondrial matrix (GO:0030150),0.289571159226666,0.782558571709217,0.7692307692307693,0.9996790177263576,1.0,6/18,23.69%,TIMM21;DNAJC15;TOMM70;DNAJC19;TIMM17B;ROMO1
prerank,microtubule polymerization (GO:0046785),-0.2611930438859321,-0.782317027357002,0.812992125984252,0.9312466917082173,1.0,9/28,19.56%,TUBGCP6;TUBGCP2;NDEL1;RANBP9;AKAP9;CCDC57;CSNK1D;MAP7D3;TUBGCP4
prerank,regulation of microglial cell activation (GO:1903978),0.30269204227690105,0.7821959755019012,0.7916666666666666,0.9994626572276761,1.0,1/15,2.79%,SYT11
prerank,nucleotide-excision repair (GO:0006289),0.2047636057596389,0.78112521533951,0.9251968503937008,1.0,1.0,24/101,18.89%,HUS1B;SIRT1;COPS6;LIG3;RPA3;RPS27A;UBC;XAB2;POLK;UBB;ERCC2;POLR2J;POLR2B;POLR2I;BRIP1;POLD1;RFC4;POLD3;RFC5;POLR2G;AQR;TCEA1;ATXN3;RFC2
prerank,regulation of neuron apoptotic process (GO:0043523),0.20688137545447655,0.7807952405941438,0.9148514851485149,1.0,1.0,13/96,10.86%,MAG;GRID2;TRIM2;FOXQ1;NTRK2;TGFB2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,negative regulation of lipid metabolic process (GO:0045833),0.26744925056763363,0.7806689326933419,0.7714285714285715,0.9994232134189478,1.0,2/22,5.87%,HCAR2;ALK
prerank,protein-DNA complex assembly (GO:0065004),-0.19835176687284883,-0.7806300796046706,0.9406130268199234,0.9333582974134546,1.0,43/116,34.77%,TCF4;GTF2H2;KAT6B;RAD23B;CCNH;CDK7;DDB2;MNAT1;PARP1;PSMF1;ERCC3;SPTY2D1;PSMB2;MCM6;ANP32B;DMC1;PSMC1;NAP1L4;PSMB6;PSMA3;GTF2H1;PSMA4;NAP1L1;ORC1;PSME1;ATRX;GTF2H4;PSMD13;MCM4;PSMB10;PSMA5;PSMB9;RBX1;UBA52;NAP1L2;RPA2;RAD51;PSME4;DDB1;CHAF1A;PSMB8;PSMD10;NAP1L3
prerank,development of primary male sexual characteristics (GO:0046546),0.24874935026493725,0.7801245291618981,0.8347457627118644,0.999410110937973,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,regulation of spindle organization (GO:0090224),-0.2951185177431107,-0.7801053639106889,0.8011363636363636,0.933708045448758,1.0,10/18,39.21%,NUMA1;SENP6;MAP9;DYNC1H1;BORA;PARP3;TACC3;TPX2;FSD1;RNF4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.33588611108738187,0.779549268276214,0.7110655737704918,0.9994889011917685,1.0,5/10,24.41%,TERF2IP;APEX1;RTEL1;ACD;DCLRE1B
prerank,amyloid fibril formation (GO:1990000),0.23191555806339878,0.7788374596636315,0.8250497017892644,0.9997864936313815,1.0,12/51,14.60%,SNCA;PSENEN;RPS27A;UBC;UBB;H3-3A;NAT8;TSPAN14;SORL1;CD36;SERF1A;B2M
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2958298666393401,-0.7788021825022808,0.8212290502793296,0.9352027136344089,1.0,10/17,32.83%,EMC2;EMC7;EMC9;GET4;EMC4;BAG6;EMC10;EMC3;GET3;EMC6
prerank,lysine metabolic process (GO:0006553),-0.329470353540409,-0.7787363447036716,0.7486437613019892,0.9343905379543226,1.0,8/12,40.49%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,lysine catabolic process (GO:0006554),-0.329470353540409,-0.7787363447036716,0.7486437613019892,0.9343905379543226,1.0,8/12,40.49%,DLST;ALDH7A1;PIPOX;PHYKPL;GCDH;HYKK;AASS;DLD
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2934183860622853,0.7786409292143428,0.79,0.9992439013379827,1.0,5/18,18.01%,SLA2;BCAR1;GPLD1;C3AR1;SH2B2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3360058436342209,0.7786101379261913,0.7565217391304347,0.9984368482502208,1.0,2/10,13.62%,SIRT1;DNMT1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.30839873938523205,0.7784512514661215,0.7604395604395604,0.9978264991333996,1.0,1/13,2.83%,PTPRT
prerank,copper ion transport (GO:0006825),0.32782145818950476,0.7784126805616536,0.7532751091703057,0.9970274734223872,1.0,3/11,15.26%,STEAP2;ATOX1;COX17
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.27151938132602005,-0.7784104035456018,0.7830188679245284,0.9344303857690536,1.0,13/25,29.47%,YAP1;ARHGAP24;PRKCD;ODF2L;CAPZB;CDK10;TBC1D7;TCHP;SLIT2;KANK1;ARHGAP44;TESK1;PFN2
prerank,negative regulation of DNA replication (GO:0008156),-0.31866138885695905,-0.778076368715199,0.7640449438202247,0.934488209032992,1.0,9/13,44.85%,PDS5A;S100A11;CDAN1;ATR;WAPL;GMNC;TSPYL2;GMNN;CDC6
prerank,synaptonemal complex organization (GO:0070193),-0.30186414947152485,-0.7770372543046312,0.7757352941176471,0.9352045449794518,1.0,8/15,46.99%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.30186414947152485,-0.7770372543046312,0.7757352941176471,0.9352045449794518,1.0,8/15,46.99%,RAD21;BAG6;P3H4;TEX11;REC8;SYCE2;TEX12;STAG3
prerank,regulation of hormone secretion (GO:0046883),-0.3081298111338744,-0.7769573432223663,0.7824427480916031,0.934873135511769,1.0,3/15,8.49%,SNX6;ANXA1;VAMP2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.27087346129176937,-0.776742126122148,0.7909604519774012,0.9347409794867759,1.0,10/24,26.73%,TNKS2;XRN1;PARP1;CTC1;EXOSC10;HNRNPU;TERF2;STN1;GNL3L;NAT10
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2390794888893112,0.7767342805630323,0.8329764453961456,0.9989040159018747,1.0,5/38,9.89%,OTUD7A;SIRT1;CARD19;TRIM59;DAB2IP
prerank,regulation of astrocyte differentiation (GO:0048710),0.31277600804815353,0.7762843633880472,0.7571115973741794,0.9987277529155681,1.0,2/12,5.70%,BIN1;NOTCH1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.248348397390942,0.7759880552267121,0.8208661417322834,0.998317948093725,1.0,2/36,1.66%,CHEK1;HUS1B
prerank,cellular response to arsenic-containing substance (GO:0071243),0.2966842796178362,0.775944948059651,0.8131212723658051,0.9975232658085273,1.0,1/15,0.80%,ATF3
prerank,regulation of protein localization to cell surface (GO:2000008),0.25018514108538253,0.7754117831073156,0.8541266794625719,0.9975382264161232,1.0,4/33,7.90%,GPM6B;TMEM35A;STX3;HSP90AB1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2902896100363497,-0.7753827748566547,0.7853309481216458,0.9363347001031722,1.0,5/18,23.08%,ROCK1;ITGB1;ITGA4;CX3CR1;VCAM1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.260438905984046,0.7752169052883164,0.8024691358024691,0.9970199358457665,1.0,5/25,11.76%,RPL23;HSP90AB1;RPL5;HIPK2;RPS7
prerank,regulation of nuclear division (GO:0051783),-0.28124303445779747,-0.7749206014918548,0.789279112754159,0.936561778329331,1.0,7/20,26.58%,OBSL1;CDK13;RCC1;PRMT5;CUL7;BORA;CCDC8
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.34600527949395143,-0.7743785153036654,0.7824427480916031,0.9369177826295545,1.0,2/10,10.23%,ABCD2;NR1H3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3026492747575871,-0.7743422413453978,0.771484375,0.9360608307498194,1.0,4/15,17.09%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3026492747575871,-0.7743422413453978,0.771484375,0.9360608307498194,1.0,4/15,17.09%,TNRC6B;DHX36;TNRC6C;CNOT1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.23012984592654634,-0.7742210335705921,0.8700787401574803,0.935776971539723,1.0,18/51,37.53%,HMGB1;STAT3;IL16;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;S100A13;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.3205383572578302,-0.7741190944116586,0.7625231910946196,0.9354841389569105,1.0,1/12,5.93%,NBN
prerank,epithelial cell development (GO:0002064),-0.2800538807907427,-0.7740680578418871,0.8198198198198198,0.935098575087931,1.0,15/20,51.43%,WNT5B;RILPL2;SIPA1L3;RILPL1;DACT2;BFSP1;EXPH5;ACTA2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;RAB25;ROS1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3250170107264331,-0.7738293369248517,0.7879377431906615,0.9349813214775802,1.0,3/12,12.66%,HDAC8;RAD21;RB1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3238028467536258,-0.7732891290847749,0.7909270216962525,0.93527455060052,1.0,4/13,13.96%,OS9;EDEM1;ERLEC1;UBAC2
prerank,ATP transport (GO:0015867),0.3383465359971662,0.7732818801635539,0.7402597402597403,0.9992829027654114,1.0,5/10,25.69%,SLC25A42;CD47;ABCC6;SLC25A5;SLC25A4
prerank,translational termination (GO:0006415),0.2029655788662962,0.7728323873803679,0.9054325955734407,0.9991260623655971,1.0,26/95,23.08%,MRPS25;MRPL14;MRPS12;MRPL49;ETF1;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;MRPL54;MRPS5;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2;PTCD3;MRPL16;MRPL40;MRPS9;MRPS23
prerank,regulation of viral life cycle (GO:1903900),-0.27984326843220747,-0.772482142013383,0.7914230019493177,0.9360036277532219,1.0,5/21,14.33%,AXL;KPNA6;TRIM5;TRIM25;NECTIN2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.335950361565781,0.7718709363895815,0.7572614107883817,0.9997413935934624,1.0,4/11,12.96%,TERF1;CCT2;DKC1;CCT4
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2983885964000652,-0.7714059028348321,0.793168880455408,0.9371016108802959,1.0,7/16,26.24%,TELO2;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26156870839504653,0.7711949938421636,0.8195652173913044,0.9999451954728787,1.0,5/25,10.08%,AMPD1;GART;HPRT1;MTHFD1;GMPR2
prerank,nucleoside salvage (GO:0043174),0.32853187418313107,0.7710791048295689,0.7571743929359823,0.9992887856233277,1.0,2/10,7.43%,UCKL1;HPRT1
prerank,protein import into nucleus (GO:0006606),0.2154962934823118,0.770978703339424,0.9014675052410901,0.9985972766988305,1.0,8/66,10.00%,IPO5;IPO4;MMP12;RPL23;NXT1;AKT1;NUP62;FAM53B
prerank,non-motile cilium assembly (GO:1905515),-0.2547466168251168,-0.7707732298239616,0.817658349328215,0.9376273847423505,1.0,9/30,19.91%,PCM1;PIBF1;ARL13B;IFT88;C2CD3;TOGARAM1;CSNK1D;GORAB;CEP89
prerank,zymogen activation (GO:0031638),-0.24010366754040235,-0.7706483056095271,0.8661417322834646,0.9373634512779844,1.0,6/39,13.42%,CYFIP2;PLAT;CTSH;ASPH;MMP14;PGK1
prerank,androgen metabolic process (GO:0008209),0.2864603209465686,0.7704386136606478,0.7960396039603961,0.9985971500921008,1.0,5/18,20.65%,SRD5A2;HSD17B7;HSD17B10;SRD5A1;HSD17B4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3348555246879169,-0.7690357058894073,0.7651515151515151,0.9392255546413476,1.0,2/10,6.93%,KIT;LYN
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20666810660349835,0.7685862122802616,0.9181818181818182,1.0,1.0,16/85,16.15%,MAGI2;AP2M1;PSMA1;FZD6;PSMD12;PSMA6;PSMB3;AP2B1;VANGL2;CELSR2;FZD4;DVL1;PFN1;PSME3;PSMC3;PSMA2
prerank,skeletal muscle contraction (GO:0003009),0.2790128108515446,0.768237728129744,0.7876106194690266,1.0,1.0,19/19,72.13%,TCAP;STAC2;STAC;TNNI3;STAC3;MYH8;MYH3;MYH7;CHRNA1;TNNT1;JSRP1;TNNC2;TNNI2;RCSD1;CCDC78;TNNC1;TNNI1;TNNT3;MYH14
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2617104242075564,0.7681817650250173,0.8259911894273128,0.9995225029143725,1.0,6/24,14.07%,RPS27A;UBC;UBB;RNF34;NOD1;TAB2
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22552900309848783,-0.7679987035721932,0.8947368421052632,0.940288215762241,1.0,10/49,18.94%,LBP;HMGB1;STAT3;F3;MAVS;IL17D;AFAP1L2;SERPINE1;TLR4;PARK7
prerank,positive regulation of defense response (GO:0031349),0.2060070405620927,0.767795851171,0.9122807017543859,0.9992878515691794,1.0,8/89,7.51%,S100A9;S100A8;PDE2A;SNCA;NPAS2;ETS1;NINJ1;TLR2
prerank,regulation of viral transcription (GO:0046782),-0.23885153642049134,-0.7676122727715119,0.8425047438330171,0.9404116595367061,1.0,15/39,28.25%,MDFIC;CCNT1;DHX9;UBP1;TRIM11;NELFB;POLR2H;GTF2F1;POLR2K;CTDP1;POLR2E;POLR2D;NELFA;CDK9;NELFE
prerank,B cell proliferation (GO:0042100),-0.29240188594656347,-0.7676104420722144,0.7726432532347505,0.9399623352013102,1.0,3/17,16.89%,BCL2;MEF2C;CTPS1
prerank,neurogenesis (GO:0022008),-0.23230125570966842,-0.7675500078905394,0.8425925925925926,0.9396094136076193,1.0,5/43,7.02%,LPAR1;TRAK1;RYK;DAGLA;ANXA1
prerank,regulation of receptor internalization (GO:0002090),-0.2444621835027504,-0.7664870403356017,0.8287937743190662,0.9406600807991934,1.0,10/35,26.06%,ANGPT1;DLG4;MKLN1;ARF1;VEGFA;ARRB1;SFRP4;ANKRD13B;CD63;EGF
prerank,cellular response to fluid shear stress (GO:0071498),-0.3186444769187666,-0.7664495151003812,0.7775735294117647,0.9402623817553275,1.0,7/12,29.56%,MEF2C;PKD2;ASS1;MAPK7;MTSS1;HDAC3;NFE2L2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2464629414569382,-0.7661908431962694,0.8512241054613936,0.940196746704092,1.0,4/33,10.84%,IL34;ACIN1;RUNX1;ID2
prerank,regulation of pH (GO:0006885),-0.3326779250065654,-0.7661535486295143,0.789279112754159,0.9397973579654951,1.0,2/11,7.13%,SLC9A1;ATP6V0A4
prerank,male gonad development (GO:0008584),0.24164635877297208,0.7661244916053332,0.85625,1.0,1.0,3/34,5.82%,KITLG;SRD5A2;TGFB2
prerank,iron-sulfur cluster assembly (GO:0016226),0.2677461664412252,0.7651150097937754,0.8269617706237424,1.0,1.0,4/24,11.09%,NDOR1;IBA57;ISCU;ISCA2
prerank,regulation of protein modification process (GO:0031399),-0.22618322291096632,-0.7649647596954895,0.8826923076923077,0.9409645889600444,1.0,16/50,22.96%,KAT2B;LYN;IGF2;PLXNB2;FER;FNIP1;FN1;FKTN;NOP53;PHIP;SPRED2;PML;PPP2CA;ATG14;RABL3;CCAR2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.30905148488496564,0.7640772786722395,0.7651006711409396,1.0,1.0,2/13,4.58%,TMSB4X;NOS3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.24013695612070785,-0.7639544977253218,0.8373015873015873,0.9419330086206884,1.0,10/37,21.43%,NUPR1;GSDME;DNM1L;BCL2;BCLAF1;BECN1;NCK1;SFPQ;FIS1;BMF
prerank,heterochromatin assembly (GO:0031507),-0.2858269280847401,-0.7639046092416074,0.7855822550831792,0.9415408074616077,1.0,6/20,18.55%,EZH1;BAZ2A;MBD2;HDAC1;SMCHD1;RRP8
prerank,gonad development (GO:0008406),-0.23509095986702486,-0.763807950135609,0.8754789272030651,0.9412342801309797,1.0,5/41,10.07%,NR2F2;WNT4;KIT;AR;CSDE1
prerank,protein import (GO:0017038),0.2044988507312507,0.7637495637944245,0.9322709163346613,1.0,1.0,9/84,10.00%,IPO5;IPO4;MMP12;GDAP1;NXT1;CLU;AKT1;NUP62;FAM53B
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2786319436833411,-0.7636405164915073,0.8014981273408239,0.9410070093397903,1.0,5/21,11.32%,DAG1;HM13;NCSTN;ADAM9;ADAM19
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2368976248332002,0.763422931079475,0.8762278978388998,1.0,1.0,8/43,13.73%,RYR2;AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2860337258302771,0.7632757423573108,0.7966457023060797,1.0,1.0,5/17,16.57%,CALM1;SMAD7;CALM2;CALM3;DDIT4
prerank,positive regulation of cell development (GO:0010720),-0.2519788513107356,-0.7632506767987459,0.8565737051792829,0.9410767827689634,1.0,11/31,30.13%,BMP4;NIBAN2;NUMBL;PDE3A;NUMB;CX3CR1;NKX6-1;SOX11;NAP1L1;GPER1;SNW1
prerank,microvillus assembly (GO:0030033),-0.3041858511809658,-0.7631746391873535,0.8220502901353965,0.9407314741722321,1.0,4/14,17.00%,RAP1B;MAP4K4;RAPGEF2;FXYD5
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2253987098535895,0.7630466689113419,0.8794178794178794,1.0,1.0,9/50,13.23%,MINAR1;CAMLG;ADGRB1;IVNS1ABP;ISG15;AKT1;PER2;SMAD7;RPS3
prerank,coenzyme A biosynthetic process (GO:0015937),0.32921050554976705,0.7629215622358679,0.7724550898203593,0.9981768771406091,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.32921050554976705,0.7629215622358679,0.7724550898203593,0.9981768771406091,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.32921050554976705,0.7629215622358679,0.7724550898203593,0.9981768771406091,1.0,6/11,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.24381060436964078,0.7619288041211182,0.8640973630831643,0.9988215654549953,1.0,6/33,11.41%,HIP1;AKT1;NUP62;HAP1;PDE6H;CCDC88A
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24727360278801017,-0.7615033331330776,0.8504672897196262,0.942637704848697,1.0,8/33,16.18%,UBR2;RPTOR;MTOR;SESN1;UBR1;CASTOR2;KLHL22;CPEB1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3129088724793842,0.7613513068561439,0.7689161554192229,0.998869513307421,1.0,2/11,11.57%,SEMA6A;KLF2
prerank,cranial nerve development (GO:0021545),0.32811195560026546,0.7609883758456251,0.7695560253699789,0.9985811586103557,1.0,2/11,13.09%,PAX2;TMEM126A
prerank,ESCRT III complex disassembly (GO:1904903),-0.33256476595981216,-0.7606748131276935,0.7967032967032966,0.942862191541098,1.0,2/10,9.46%,VPS4B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),-0.33256476595981216,-0.7606748131276935,0.7967032967032966,0.942862191541098,1.0,2/10,9.46%,VPS4B;CHMP5
prerank,regulation of lipase activity (GO:0060191),0.3064100807936737,0.7604915129573137,0.7911392405063291,0.9984787472365899,1.0,2/13,4.81%,SNCA;PCSK6
prerank,prostanoid metabolic process (GO:0006692),-0.3037976987624016,-0.7604858153318025,0.7954110898661568,0.9426650338308734,1.0,6/13,34.21%,PTGS1;PTGES;ACOX1;CYP2S1;PTGR2;PTGR1
prerank,muscle filament sliding (GO:0030049),0.2330862645815518,0.7602081183554256,0.838,0.9972373336758471,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,actin-myosin filament sliding (GO:0033275),0.2330862645815518,0.7602081183554256,0.838,0.9972373336758471,1.0,5/38,9.53%,MYH6;MYL1;TMOD1;MYL6;TCAP
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2656987129054754,0.7595795418325973,0.8523206751054853,0.9973054968094696,1.0,4/23,8.04%,COPS6;RPS27A;UBC;UBB
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3316613765945656,-0.7589212617808725,0.7855787476280834,0.9443420089539749,1.0,2/10,21.64%,RC3H1;SCRIB
prerank,mitochondrial translation (GO:0032543),0.19592534566930978,0.758719553487332,0.9306122448979591,0.997696524697113,1.0,24/104,20.09%,MRPS25;MRPL14;MRPS12;MRPL49;TUFM;MRPL13;MRPS18A;MRPS7;MRPS14;MRPL45;MRPL36;MRPL23;GATB;GATC;MRPL54;MRPS5;NDUFA7;MRPS22;MRPS28;MRPS35;MRPL18;OXA1L;MRPL37;MRPL2
prerank,protein localization to kinetochore (GO:0034501),-0.3032354713460342,-0.7587078200457198,0.8041825095057035,0.9442047540734647,1.0,8/14,44.99%,IK;CENPT;KNL1;TTK;RCC2;SPDL1;CDK1;MTBP
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3090666668808599,0.7586266290752341,0.7840909090909091,0.9970050687535362,1.0,3/12,11.31%,SIRT1;TRIB3;ERLIN2
prerank,bile acid biosynthetic process (GO:0006699),-0.2618705451180405,-0.7583846916974333,0.8515037593984962,0.9441616367979384,1.0,6/24,22.49%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3
prerank,stress-activated MAPK cascade (GO:0051403),0.21232922084496894,0.7581411424012907,0.9094736842105263,0.9968631106741136,1.0,17/61,18.99%,MAP4K2;SH2D3C;TNFRSF19;RPS27A;UBC;UBB;GPS2;TAOK2;NOD1;MAPK8;MAP3K11;TAB2;MAPK10;PTGER4;MAPK3;ADORA2B;NOD2
prerank,positive regulation of TOR signaling (GO:0032008),-0.23242729857438213,-0.7580590524020204,0.8747628083491461,0.9441384919377267,1.0,21/40,41.44%,RPTOR;FNIP1;TELO2;WDR59;RICTOR;KLHL22;SIK3;GPR137B;PIH1D1;LARS1;RRAGA;HDAC3;RRAGC;SEC13;MIOS;LAMTOR4;LAMTOR5;SEH1L;WDR24;TREM2;HTR6
prerank,acylglycerol catabolic process (GO:0046464),0.24806944062601394,0.7578100170006333,0.8468085106382979,0.9964864857452169,1.0,3/30,11.77%,ABHD2;LIPE;FABP5
prerank,spermatid development (GO:0007286),0.24474601705675497,0.756017336735248,0.8406708595387841,0.9982864518994766,1.0,5/32,15.13%,JAM2;NME5;IQCG;CIB1;ING2
prerank,copper ion homeostasis (GO:0055070),0.28268837083635473,0.7550076465776999,0.7883369330453563,0.9989193778154332,1.0,1/17,0.93%,MT2A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3120594129639337,-0.75484273500954,0.7767175572519084,0.9480906205074419,1.0,6/12,30.13%,CYP26B1;DHRS3;CNOT1;EZH2;CALR;SNW1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1904162344890195,-0.7541953117331343,0.9636363636363636,0.9485088167984399,1.0,64/125,40.47%,EML4;MAP4;RANBP2;PCNT;NDEL1;SETD2;DYNC1LI1;MAPRE1;NUDC;ZWINT;RCC1;CENPP;SKA2;DYNC1H1;PTPA;PMF1;EFHC1;NEK6;TAOK1;WDR62;NUP98;NUP43;XPO1;TBCE;BCCIP;ITGB3BP;NUP160;CENPT;SUN2;INCENP;KIF11;STIL;DSN1;KNL1;MAD2L1;CENPE;KIF2A;CENPU;BUB1B;TACC3;CKAP5;RAN;AHCTF1;NUP133;SEC13;TTK;B9D2;CENPI;DCTN6;RCC2;CENPH;SEH1L;NSL1;NDC80;CENPN;CENPF;PAFAH1B1;KIF4A;KNTC1;SPDL1;TUBG2;CENPA;CENPQ;SGO1
prerank,negative regulation of DNA recombination (GO:0045910),-0.22923718948189037,-0.7539989609437465,0.8906560636182903,0.9483045095436128,1.0,19/43,29.39%,KLHL15;SHLD2;MSH3;HELB;ZRANB3;SMCHD1;POLR2H;MSH6;TERF2;H1-0;POLR2K;POLR2E;UBQLN4;ATRX;FANCB;POLR2D;CGAS;PARP3;MAD2L2
prerank,positive regulation of receptor internalization (GO:0002092),0.26189865969076387,0.7539103028456025,0.8187250996015937,0.9995748150575318,1.0,2/22,3.00%,MAGI2;AHI1
prerank,membrane repolarization during action potential (GO:0086011),0.3058521229952183,0.7531722983787001,0.7836134453781513,0.9997857685585212,1.0,3/13,13.24%,KCND3;ATP1A1;ATP1B1
prerank,mitotic chromosome condensation (GO:0007076),0.2524562939276352,0.7523430331519968,0.8097251585623678,1.0,1.0,5/26,10.27%,CSNK2B;TENT4A;NUSAP1;SET;NCAPH2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.25148482958619867,-0.7521080300063825,0.8545780969479354,0.9503574389960906,1.0,14/29,35.50%,YTHDF3;UBE2K;PTPN2;MAVS;WNT5A;PTPN1;PTPN11;USP18;CACTIN;MUL1;SAMHD1;PTPN6;ZBP1;TTLL12
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.24375373859856186,-0.7520745731624299,0.8468634686346863,0.9499405413027059,1.0,15/33,35.63%,GLUD1;GLUL;PRODH;OAT;ALDH18A1;NIT2;ALDH4A1;SIRT4;DGLUCY;GCLC;GOT1;CAD;PYCR2;GOT2;PYCR3
prerank,transcription preinitiation complex assembly (GO:0070897),-0.30524143528027226,-0.7520428709652718,0.8088495575221238,0.9495359647446538,1.0,4/12,26.52%,TBP;GTF2B;TAF12;TAF7
prerank,tRNA wobble base modification (GO:0002097),-0.2974314446393072,-0.7520273214149733,0.806949806949807,0.9491119077839176,1.0,10/14,44.32%,TRMT9B;ALKBH1;DPH3;GTPBP3;MTO1;ALKBH8;MOCS3;ADAT2;CTU2;CTU1
prerank,triglyceride metabolic process (GO:0006641),-0.22880252183025845,-0.7518636683761497,0.9041353383458647,0.9488805688549496,1.0,12/48,27.49%,AGMO;GK5;GPAT4;MOGAT3;APOE;LPIN2;LPIN3;GPAT3;LMF1;PNPLA2;LPL;SEL1L
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2510572275597687,-0.7514316415933829,0.8544061302681992,0.948985699529843,1.0,10/30,22.48%,PIBF1;PTPN2;PRKCD;PARP14;PRKCZ;SH3BP5L;NF2;MVP;PPP2CA;CD300A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.28824386829577364,-0.7507622776618311,0.8145315487571702,0.9494024499356025,1.0,7/16,30.49%,PIGN;PIGH;PIGC;PIGA;PIGZ;PIGP;PIGF
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.24284912677529671,0.7504056186855846,0.9027484143763214,1.0,1.0,1/34,0.20%,SLC7A5
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27015428740706027,-0.7503022603117893,0.8099630996309963,0.9495247946054297,1.0,5/22,18.35%,CD55;ZBTB1;TRAF2;FBXO38;TRAF6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.20613201816030613,0.7501542749023835,0.93125,1.0,1.0,10/74,8.74%,EPAS1;PSMA1;NOTCH1;RPS27A;UBC;EPO;UBB;PSMD12;PSMA6;PSMB3
prerank,regulation of macrophage migration (GO:1905521),0.32827815192717524,0.7499747554282112,0.7991452991452992,1.0,1.0,2/10,9.54%,MTUS1;CD200R1
prerank,actin filament network formation (GO:0051639),0.31894584339026205,0.749803663451657,0.813953488372093,1.0,1.0,2/11,7.34%,FHOD3;SPIRE2
prerank,regulation of T cell chemotaxis (GO:0010819),-0.31627811662831895,-0.7489181966382916,0.8040665434380776,0.9508627089683238,1.0,6/11,39.93%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CXCL10
prerank,protein autoprocessing (GO:0016540),0.2790176601201574,0.7485954119012166,0.8301486199575372,1.0,1.0,1/17,2.11%,OMA1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.25164929771150346,-0.7483775094988151,0.8574108818011257,0.9510963050807909,1.0,11/27,29.87%,RRM2B;CTPS2;AK6;DTYMK;CTPS1;NUDT13;NME1;RRM1;GSR;AK1;TXNRD1
prerank,bile acid metabolic process (GO:0008206),-0.25128854039087883,-0.7480253825092273,0.8638941398865785,0.9510966160756065,1.0,7/27,24.71%,CYP7B1;CYP27A1;OSBPL9;AMACR;ACOT8;OSBPL3;GBA2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.27672227470085875,-0.7480109660581544,0.8083941605839416,0.9506677722364718,1.0,12/20,38.26%,TXNIP;TXN;P2RX4;IL18;SUGT1;PSTPIP1;APP;C3;PYCARD;CASP1;NT5E;ANO6
prerank,sister chromatid segregation (GO:0000819),-0.24271640469517528,-0.7476548723356807,0.8568627450980392,0.9506925873412941,1.0,8/31,20.40%,INO80;SMC4;RB1;KLHL22;ZWINT;LATS1;TOP2B;SMC1A
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3089550846883006,0.7473481781611386,0.8091106290672451,1.0,1.0,2/12,8.89%,THY1;SKAP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24430736962420732,0.7464743775202722,0.8615071283095723,1.0,1.0,1/31,0.13%,TFRC
prerank,ceramide catabolic process (GO:0046514),0.2921022049085749,0.7463963377014086,0.8098290598290598,1.0,1.0,6/14,20.72%,ACER2;NEU2;GLA;HEXB;NEU1;NEU4
prerank,negative regulation of ATPase activity (GO:0032780),0.28519754308626893,0.7461220249149101,0.8362068965517241,1.0,1.0,4/16,22.80%,SIRT1;VCPKMT;OXA1L;TNNI3
prerank,sphingosine metabolic process (GO:0006670),-0.2827638675800226,-0.7461120732484549,0.8116504854368932,0.9522414415876712,1.0,3/17,8.43%,PLPP3;ASAH2;ACER3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3183144322509383,0.7459345496480456,0.8,0.9998502848980484,1.0,4/12,15.15%,MELTF;SPRY4;ACTN4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3183144322509383,0.7459345496480456,0.8,0.9998502848980484,1.0,4/12,15.15%,MELTF;SPRY4;ACTN4;CORO1C
prerank,sulfur amino acid metabolic process (GO:0000096),-0.2595645244237521,-0.7456839665173062,0.8584905660377359,0.9523179987405745,1.0,12/24,39.18%,MMUT;NOX4;MTHFR;TXN2;CBS;GCLC;CDO1;MTR;CTH;ADO;MPST;AHCY
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.21271818859731886,-0.7452242392331037,0.9209486166007905,0.952471235425867,1.0,4/59,4.06%,ALDH1A2;CYP7B1;CYP27A1;ABCD3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.18306049028975038,-0.7450504536623609,0.9757085020242915,0.9522396209841476,1.0,67/145,38.71%,FBXL7;PCM1;FHL1;ALMS1;ODF2;NINL;CEP63;CEP135;VPS4B;RAD51B;PCNT;CSNK1E;USP47;PSMF1;RAB11A;MAPRE1;PSMB2;YWHAE;CDC25B;AKAP9;DYNC1H1;CEP76;PRKACA;CEP57;CSNK1D;CDK2;CUL1;PSMC1;HAUS7;PSMB6;HAUS8;ACTR1A;PSMA3;RAD51C;PSMA4;AVEN;HAUS3;PSME1;PSMD13;CEP41;PSMB10;PSMA5;PSMB9;RBX1;HAUS5;HAUS4;PINX1;PLK4;CEP72;SSNA1;CEP164;PSME4;CKAP5;PSMB8;PSMD10;TUBA1A;TPX2;CEP131;RCC2;SKP1;PSMD3;NEDD1;CENPF;PAFAH1B1;CDC25A;DTL;HMMR
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.31676023289106836,-0.7450313660333283,0.8037735849056604,0.9518159628916382,1.0,6/12,27.03%,CCT6A;CCT8;CCT5;GNL3L;CCT3;GNL3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2581268573492259,-0.7449558124566699,0.8551859099804305,0.9514592039384719,1.0,9/24,23.63%,JPH1;CAMK2D;SELENON;PKD2;SRI;PRKACA;NOS1;GSTM2;JPH2
prerank,magnesium ion transport (GO:0015693),0.3051806411232556,0.7448576046002767,0.7978723404255319,1.0,1.0,5/12,18.64%,NIPA1;NIPAL3;NIPAL4;MMGT1;MAGT1
prerank,glucose metabolic process (GO:0006006),0.21230493706899325,0.7447651282405973,0.9037656903765691,0.9998201868066899,1.0,9/58,15.24%,OMA1;PGAM1;KCNJ11;SLC37A4;ALDOC;GDPGP1;PER2;ADPGK;ATF4
prerank,rRNA catabolic process (GO:0016075),0.28444248509487036,0.7447597769977621,0.8445378151260504,0.9990090592253045,1.0,1/16,0.97%,EXOSC5
prerank,regulation of viral release from host cell (GO:1902186),0.26415080737634467,0.744705362643707,0.8537117903930131,0.998259928484067,1.0,8/21,21.06%,TRIM13;TRIM62;MID2;TRIM35;CHMP2B;VPS4A;CHMP2A;TRIM21
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.3083439681732336,-0.7446706530876459,0.8054545454545454,0.951383298643901,1.0,3/13,16.41%,ENPP1;ENPP3;ENTPD6
prerank,nucleus organization (GO:0006997),0.22072278429175066,0.7445613063186917,0.8950617283950617,0.9976158492308962,1.0,14/47,21.20%,SYNE1;RPS19;BIN1;SUN1;LEMD2;NUP205;REEP3;NUP54;CHMP2B;PITPNB;PDCD6IP;VPS4A;CHMP2A;CHMP7
prerank,mitochondrial transport (GO:0006839),0.21752716380923892,0.7445067983777673,0.8908382066276803,0.9968845471599898,1.0,19/53,25.69%,GDAP1;PITRM1;TIMM22;TMEM14C;TSPO;BCS1L;HSP90AA1;TOMM70;OXA1L;STARD3;TIMM10B;DNAJC19;ABCB10;TIMM17B;BCAP31;SLC25A5;MFF;TOMM22;SLC25A4
prerank,nucleosome assembly (GO:0006334),-0.24458139470743784,-0.7443943583677592,0.8505747126436781,0.9512950784456141,1.0,7/31,16.45%,KAT6B;UBN1;HAT1;CABIN1;SPTY2D1;ANP32B;NASP
prerank,pore complex assembly (GO:0046931),-0.27272786357813295,-0.744219311800297,0.8414414414414414,0.9510780701720695,1.0,3/19,12.60%,AFDN;TPR;GSDMD
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.20921466958727294,-0.7439746607095352,0.9239766081871345,0.9509287652969876,1.0,25/67,35.75%,ITGAV;ITGB5;SEC22B;PSMF1;PSMB2;CYBA;TAP2;SNAP23;NCF2;PSMC1;PSMB6;PSMA3;PSMA4;TAP1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;CALR;PSME4;PSMB8;PSMD10;TAPBP;FCGR1A
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2917547778856775,-0.743892776458611,0.8240740740740741,0.950581697271156,1.0,4/15,13.19%,NLGN2;STXBP1;SYN3;USP46
prerank,mesoderm formation (GO:0001707),-0.27957551977387884,-0.7438257811543898,0.8363636363636363,0.9502209068487225,1.0,5/17,24.76%,ITGB1;SMAD2;ITGB3;ITGA8;SNAI1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.23709400126450073,0.7433950575485866,0.875,0.9975541147732655,1.0,7/35,14.60%,BICD1;HIP1;SNAP91;CLU;SGIP1;PPT1;B2M
prerank,response to gamma radiation (GO:0010332),0.25319244288678194,0.7427178000716805,0.8540305010893247,0.997653269547606,1.0,9/24,20.96%,TMEM109;TRIM13;MEN1;HRAS;ATM;XRCC5;MDM2;CRYAB;TSPYL5
prerank,regulation of osteoclast differentiation (GO:0045670),-0.24033013327611968,-0.7426433371669232,0.8617424242424242,0.9512456021801686,1.0,7/33,22.72%,FBN1;MTOR;TLR4;TRAF6;GPR137B;TCTA;MAFB
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2841446613774584,-0.7425254670794988,0.8123861566484517,0.9509370521936482,1.0,7/16,24.38%,AMPD3;GMPS;PPAT;ATIC;PAICS;AMPD2;NUDT2
prerank,folic acid metabolic process (GO:0046655),-0.27430427036180627,-0.742206503265181,0.8244897959183674,0.9508611164596735,1.0,3/18,17.56%,MTHFR;MTHFD2L;ALDH1L1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2952932858145154,-0.74217234227373,0.8486590038314177,0.9504531956306995,1.0,3/15,8.56%,RAB10;RAB3GAP1;EDEM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.21390635072256356,-0.7419443552538207,0.9030303030303031,0.9503035535116554,1.0,22/54,38.04%,MDM4;EP300;TFDP2;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;CNOT4;TNKS1BP1;CRADD;PCBP4;E2F1;PLAGL1;RBL2;GADD45A;SFN;TRIAP1;TP53;PLK3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.20830737511158598,0.741576802542834,0.9268774703557312,0.9982864080496461,1.0,10/69,10.86%,MAG;FOXQ1;NTRK2;VSTM2L;UNC5B;NDNF;CCL2;RETREG1;SET;F2R
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24288899840711486,-0.7407352234687862,0.884990253411306,0.9513448587107177,1.0,13/32,37.01%,CDK16;TFDP2;ID2;RB1;HINFP;PCNA;NPAT;ORC1;E2F1;CDC45;POLA1;CDK15;CDK18
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.21232338648150445,0.7403175730802276,0.9032258064516129,0.9990816461647598,1.0,9/50,16.15%,ACTB;CCND1;CAMK2N1;HSP90AB1;CDK5R2;CCNB2;CDKN1A;STOX1;CDKN1B
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24487765075681583,-0.7398874232085163,0.8706563706563707,0.9519253311305995,1.0,5/30,17.43%,PIBF1;HMGB1;STAT3;PRKCZ;TLR4
prerank,UV protection (GO:0009650),0.31775940875934944,0.7397430686755081,0.7899343544857768,0.9990175994608713,1.0,2/10,9.45%,GPX1;ERCC2
prerank,mesoderm development (GO:0007498),0.2769998271943182,0.7394592844921148,0.8344226579520697,0.9985208433866798,1.0,1/18,1.78%,TIE1
prerank,positive regulation of RNA splicing (GO:0033120),-0.24554922585490865,-0.739177554647818,0.8807692307692307,0.9523378628464682,1.0,12/29,33.43%,U2AF2;DAZAP1;ERN1;NUP98;PIK3R1;RBM22;DYRK1A;SNW1;THRAP3;SF3B4;RBMX;HSPA1A
prerank,membrane raft organization (GO:0031579),0.28786095905866416,0.7390877006231482,0.8202479338842975,0.998178659211293,1.0,4/15,14.53%,FA2H;NAXE;RFTN1;PPT1
prerank,translesion synthesis (GO:0019985),0.22808751526376042,0.7386671686906106,0.90020366598778,0.9979061686458758,1.0,12/42,19.16%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.22866212665325308,-0.7379735500665348,0.8912621359223301,0.9533498904708876,1.0,5/39,7.81%,ANK2;FHL1;WWP2;PTPN3;CACNA1D
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.25130496679798653,-0.7377249437811619,0.8370786516853933,0.9531740721944005,1.0,5/25,12.61%,B3GALT1;EXT1;HS2ST1;NDST1;NDST2
prerank,lipid biosynthetic process (GO:0008610),-0.19991685620078994,-0.7377175607178085,0.9396887159533074,0.9527367747385285,1.0,25/77,32.52%,ACSL1;PRKAA2;ABCD3;GNPAT;AGPAT4;PDSS2;GPAT4;ACSL6;HMGCR;PRKAA1;CYP51A1;CBR4;LPCAT1;DHRS11;FDFT1;MVK;LPL;CLN8;OXSM;DOLPP1;PDSS1;FITM2;STAR;MCAT;SREBF1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.23789112000547197,0.7371245603108297,0.8704883227176221,0.9990899500673618,1.0,10/30,19.17%,GPX1;NOS3;ARHGEF2;RNF34;TNFSF10;RFFL;FAIM2;TMBIM1;RIPK1;FAIM
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2509442333257276,0.7364633952840409,0.8688524590163934,0.9991162729981883,1.0,6/24,15.63%,ATF3;HSPA5;NOTCH1;KLF2;ATF4;CHD6
prerank,regulation of cell cycle process (GO:0010564),-0.19187655210369084,-0.7361970185598828,0.9645669291338582,0.954131094928935,1.0,20/104,16.15%,KIF13A;BIRC6;KLHL13;NUMA1;UVRAG;OBSL1;CDC42;MARK4;CDK13;SETD2;RAB11A;BECN1;TTL;PIK3C3;MAP9;RCC1;CSNK2A1;PIK3R4;DYNC1H1;PRMT5
prerank,defense response to protozoan (GO:0042832),0.2995873921079128,0.7360501773324244,0.8145833333333333,0.9988175021756114,1.0,3/12,13.15%,BATF2;GBP4;CD40
prerank,axonal fasciculation (GO:0007413),-0.3077847571789975,-0.7358025155665718,0.8297101449275363,0.9541299825436252,1.0,5/12,25.77%,EPHA3;EPHA4;MEGF8;ARHGAP35;EPHB3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.21106396806562355,0.7353692550039383,0.9315068493150684,0.9988554887066677,1.0,14/56,16.71%,ANLN;ANK3;STMN1;TRIM36;SPIRE2;RAB35;NUSAP1;APC;SPTBN1;CIT;EFHC2;BIN3;MYH10;USP8
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21306539837117824,-0.7353363052737993,0.9130434782608695,0.9542745832830316,1.0,16/49,28.80%,NGLY1;PRKN;RAB12;OGA;HNRNPD;ADAMTS9;XRN2;MTREX;MANBA;SIDT2;MAGEC2;SIAH2;PABPC4;HTRA2;DNASE1L1;SUPV3L1
prerank,T cell receptor signaling pathway (GO:0050852),0.18343605621273854,0.7352917983032663,0.9618473895582329,0.9981557407619712,1.0,23/138,16.15%,PDE4B;BTNL9;PSMA1;THY1;MOG;PAK1;PRKCQ;PTPRJ;PSMD12;EIF2B3;PSMA6;PSMB3;SKAP1;TNFRSF21;BCL10;PDE4D;BCAR1;RFTN1;TAB2;PSME3;PAK3;PSMC3;PSMA2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.29031185554634786,-0.7346725722651168,0.8265107212475633,0.9546059865761098,1.0,2/15,11.25%,MOXD1;SAT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.28972462878495286,0.7343742990385106,0.8351177730192719,0.9984560318865136,1.0,1/14,0.89%,TIRAP
prerank,regulation of phosphate metabolic process (GO:0019220),0.2823500738913537,0.7332988245688689,0.8214285714285714,0.9989926322186424,1.0,5/16,19.83%,PGAM1;CD24;PSEN1;BARD1;SMG5
prerank,regulation of smooth muscle contraction (GO:0006940),-0.2671416690227685,-0.7332298285315972,0.8365384615384616,0.9558166714890305,1.0,6/20,23.07%,PLCE1;SETD3;ATP2B1;CTTN;SPHK1;NMU
prerank,positive regulation of phosphatase activity (GO:0010922),0.26066758967119635,0.7331671569531655,0.8261802575107297,0.9983504385426266,1.0,6/21,16.58%,MAGI2;HSP90AB1;CALM1;CALM2;CALM3;GPLD1
prerank,phospholipid dephosphorylation (GO:0046839),0.22975564668882806,0.7330935406510758,0.8672032193158954,0.9976381027347082,1.0,6/37,10.20%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP4;MTMR6
prerank,cellular response to chemokine (GO:1990869),-0.21724177962335064,-0.7322865444033599,0.9029850746268657,0.9564815465828349,1.0,5/46,10.27%,FOXC1;RIPOR2;WNK1;SLC12A2;RHOA
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2148122198577556,-0.7319952127647376,0.9221556886227545,0.9563812654337833,1.0,19/49,30.25%,MDM4;ABL1;CEP63;NBN;CDC5L;MAP3K20;STK33;HINFP;ATR;CLSPN;USP28;PAXIP1;DONSON;MAPK14;ATRX;E2F1;INTS7;MAD2L2;BATF
prerank,negative regulation of innate immune response (GO:0045824),-0.24027342467871343,-0.7319130294209821,0.8960302457466919,0.9560159544551392,1.0,13/34,29.59%,SERPING1;YTHDF3;IRAK3;TRAFD1;PTPN2;USP18;NLRC3;DHX58;CACTIN;GRN;MUL1;TNFAIP3;SAMHD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.30380762310869325,0.7317967013153492,0.7926829268292683,0.9984013968061867,1.0,2/11,6.51%,ANK3;PRKCQ
prerank,cellular response to inorganic substance (GO:0071241),0.26468035176187543,0.730450851258999,0.8553459119496856,0.999252925371903,1.0,3/21,11.80%,KCNC2;DDX11;FOXO1
prerank,B cell receptor signaling pathway (GO:0050853),0.2360884917501856,0.7301817779157338,0.892933618843683,0.9987609409934317,1.0,8/32,18.23%,VAV3;BCAR1;RFTN1;NFATC2;CD38;BTK;SH2B2;NCKAP1L
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.22993955419021828,-0.7301749116156848,0.903921568627451,0.9576067492374779,1.0,8/36,16.89%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,regulation of T cell migration (GO:2000404),0.2700308989300983,0.730071832346134,0.8376623376623377,0.9980860401985651,1.0,5/18,19.30%,CXCL12;CD200R1;AIF1;DOCK8;LRCH1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3098438617227055,0.7297320953073281,0.7976470588235294,0.997685664434764,1.0,2/10,10.98%,KLF4;TLE5
prerank,aspartate family amino acid metabolic process (GO:0009066),0.26633505112755773,0.7293091637848222,0.8412371134020619,0.9973656209031481,1.0,3/18,9.38%,SMS;ASNS;MTHFD1
prerank,defense response to virus (GO:0051607),-0.19078334136245298,-0.7291953084279789,0.9753787878787878,0.9583062774468417,1.0,30/100,30.85%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;AKAP1;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;ZDHHC1;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;PHB2;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.2770907141011533,-0.7290873946234749,0.858508604206501,0.9579683904917584,1.0,7/18,25.99%,LBP;SBNO2;ENPP3;IFI35;KARS1;SYK;FCER1G
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.30734952614071426,0.7290510995399996,0.7857142857142857,0.9960735286048257,1.0,10/10,69.28%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.30734952614071426,0.7290510995399996,0.7857142857142857,0.9960735286048257,1.0,10/10,69.28%,CEP250;GRM6;RPE65;CACNA2D4;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2676319146103967,0.7285889660059051,0.8524590163934426,0.9958154836275973,1.0,2/17,10.49%,CXCL12;AIF1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.31423939111054483,-0.7285518474897653,0.8077634011090573,0.9581017032790908,1.0,3/11,11.52%,ENPP3;TPK1;CTPS2
prerank,triglyceride homeostasis (GO:0070328),0.24384944670109193,0.728184835608661,0.8822355289421158,0.9954885038837591,1.0,5/26,13.94%,SIRT1;DGAT2;SCARB1;XBP1;ANGPTL4
prerank,protein N-linked glycosylation (GO:0006487),0.20318497329632965,0.7276806240214736,0.9585062240663901,0.9953037809446036,1.0,12/66,16.10%,GAL3ST1;MGAT5B;ALG3;PMM1;ALG1;MGAT4C;SLC39A8;TMEM258;ALG8;OSTC;OST4;MGAT1
prerank,intracellular protein transmembrane transport (GO:0065002),0.2231027004085326,0.7275470806571147,0.9100418410041841,0.9946919728384976,1.0,11/42,21.64%,CHCHD4;HSPA5;TIMM21;DNAJC15;RTN2;HSPD1;SEC61G;TOMM70;DNAJC19;SEC61A2;TIMM17B
prerank,mRNA stabilization (GO:0048255),-0.22418957997888395,-0.7256603120450327,0.9235294117647059,0.9608705105607315,1.0,10/40,18.07%,SYNCRIP;EIF4ENIF1;FUS;DHX9;LARP1;YBX3;YBX1;TENT5A;HNRNPU;PAIP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3081639477262793,0.7251117667421757,0.8248945147679325,0.9967314255897357,1.0,2/11,9.63%,SMARCB1;DDX11
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.22706808118352795,-0.725093609159536,0.9168316831683169,0.9610384523012345,1.0,11/39,22.47%,PI4KA;SMG1;PIP4K2C;TTC7B;EFR3A;PIK3C3;SOCS7;PIK3CD;ITPKC;PIK3R1;PI4K2B
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3165836851878856,-0.7250466219918333,0.8282442748091603,0.9606543996104004,1.0,6/10,37.57%,RFWD3;WDR76;CCAR2;RPA2;FEM1B;ETAA1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3003788825695204,0.7242547495926551,0.822680412371134,0.9969162940387327,1.0,5/11,19.79%,IPO4;H3-3A;HIRA;RBBP4;ASF1A
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2156201536873146,-0.7240961609476518,0.9048507462686567,0.961311162564416,1.0,13/49,21.43%,NUPR1;GSDME;DNM1L;UBQLN1;EIF2AK3;BCL2;BCLAF1;BECN1;DDX3X;DAPK2;FIS1;P4HB;BMF
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19975768586165168,-0.7234745210527979,0.9576107899807321,0.9615474426689588,1.0,20/70,29.12%,FOXC1;ABL1;YAP1;RUNX1;PSMF1;TCF3;EIF2AK2;PSMB2;PRKDC;PSMC1;KMT2A;PSMB6;PSMA3;PSMA4;LDB1;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,purine-containing compound salvage (GO:0043101),0.29412364998150087,0.7230921613852092,0.8361344537815126,0.9975134122314421,1.0,3/12,10.08%,AMPD1;HPRT1;GMPR2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.28127957582208335,0.7230136374681765,0.851931330472103,0.996812072030158,1.0,5/15,20.80%,ORMDL1;ORMDL2;SAMD8;TNFRSF1A;RACK1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.1990328477478458,0.7221614746513231,0.9463519313304721,0.9969375044103841,1.0,7/69,9.77%,TIRAP;MIF;CLU;TLR2;PTPRJ;HSPB1;ARHGEF2
prerank,gluconeogenesis (GO:0006094),-0.22265763606750769,-0.7213555140145711,0.9115913555992141,0.96341010148075,1.0,13/39,29.89%,RBP4;SLC39A14;PPARGC1A;MDH1;PGK1;PCK2;SLC25A11;CRTC2;PGM1;ALDOA;ENO3;GOT1;ENO1
prerank,DNA-dependent DNA replication (GO:0006261),0.1807943021842351,0.7210876952282258,0.9859154929577465,0.9973552773665132,1.0,26/128,20.10%,GINS2;NOC3L;PSMA1;RPA3;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;RECQL;MCM3;POLG;POLD1;PSME3;RFC4;POLD3;PSMC3;PSMA2;RFC5;PSMB7;RFC2;ORC6;WDHD1;MCM8;CDK2AP1
prerank,organelle fusion (GO:0048284),-0.2589828998474771,-0.7210251638951323,0.8486590038314177,0.9633188005503104,1.0,4/22,11.22%,OPA1;EEA1;MIGA2;STX4
prerank,synaptic vesicle localization (GO:0097479),0.29086925324080937,0.7206207759255071,0.8308977035490606,0.9970907528061566,1.0,1/13,1.68%,NLGN1
prerank,vacuolar acidification (GO:0007035),-0.25629369622209697,-0.7206133646161178,0.885036496350365,0.9633355912649282,1.0,11/21,40.41%,ATP6V0D1;ATP6V0A4;TCIRG1;CLN5;DMXL1;GRN;ATP6V0D2;CLN6;SLC11A1;TMEM9;ATP6V1H
prerank,regulation of cholesterol esterification (GO:0010872),-0.319830971811351,-0.7206025485199977,0.8314393939393939,0.9629033765253453,1.0,2/10,14.09%,AGTR1;APOE
prerank,acyl-CoA biosynthetic process (GO:0071616),0.27866338446675726,0.7200725608668459,0.8643006263048016,0.9969461051874494,1.0,7/16,25.35%,SCD;PPT1;ACSS1;PPCS;ACAT1;DIP2A;HSD17B8
prerank,histone H3 deacetylation (GO:0070932),0.27917253010843524,0.719119851532023,0.8510204081632653,0.9972235172077175,1.0,2/15,3.31%,HDAC9;SIRT1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.25987562910584416,0.7186944904189363,0.888663967611336,0.9969347483366975,1.0,6/22,14.32%,GPNMB;TAOK2;PDGFB;CALM1;CALM2;CALM3
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.23633184312941036,-0.7186335763702495,0.8992094861660079,0.9645621884263742,1.0,7/30,17.46%,ACSL1;ABCD3;ABCD2;ACSL6;ABCD4;HACD4;ACOX1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.26101547671884123,-0.7185758969072458,0.8646034816247582,0.9641784798089789,1.0,14/19,56.86%,APOE;SLC5A7;NQO1;CHRNA4;CHRFAM7A;CHRNA7;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,protein prenylation (GO:0018342),-0.30881821697390194,-0.7183783030442032,0.831758034026465,0.9639593247359116,1.0,5/10,28.41%,RABGGTB;CHM;CHML;FNTA;RCE1
prerank,canonical glycolysis (GO:0061621),-0.24491927546181647,-0.7181680696288862,0.9001956947162426,0.9633006849270299,1.0,11/24,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.24491927546181647,-0.7181680696288862,0.9001956947162426,0.9633006849270299,1.0,11/24,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.2555213046623605,0.7180278150114527,0.8605577689243028,0.9968972622522223,1.0,4/20,13.05%,HECW1;HECW2;EPO;STK39
prerank,serine family amino acid metabolic process (GO:0009069),0.2743522453612413,0.7176054529427712,0.8580786026200873,0.9965294067516354,1.0,5/16,21.19%,SEPHS2;MTHFD1;SRR;SEPSECS;THNSL2
prerank,endoderm development (GO:0007492),0.2902239348992931,0.7173301760288968,0.8436213991769548,0.9960331806202855,1.0,3/13,15.20%,LHX1;SOX17;SOX7
prerank,heart looping (GO:0001947),0.22364410653614125,0.7170226246052018,0.9011406844106464,0.9955956277097672,1.0,7/39,13.73%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,regulation of adaptive immune response (GO:0002819),0.2690784457334875,0.7167343150642317,0.8685344827586207,0.9951083855780016,1.0,3/18,11.90%,SIRT1;SKAP1;IRF7
prerank,mitochondrial transcription (GO:0006390),-0.31342726801751664,-0.7166281821468251,0.8461538461538461,0.9645165676349303,1.0,1/10,2.62%,FOXO3
prerank,respiratory electron transport chain (GO:0022904),0.28009617181800717,0.7160948007627667,0.8583509513742071,0.99501841857551,1.0,4/14,15.97%,ETFA;ETFB;ETFDH;GPD2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2787079225796648,-0.7155043077185209,0.8880597014925373,0.9648467557966003,1.0,3/15,14.83%,DTNBP1;AP3B1;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2787079225796648,-0.7155043077185209,0.8880597014925373,0.9648467557966003,1.0,3/15,14.83%,DTNBP1;AP3B1;BLOC1S5
prerank,cellular respiration (GO:0045333),0.22154239932167075,0.7149089758476549,0.9301848049281314,0.9955141906783178,1.0,11/41,20.64%,SDHC;ATP5F1D;SLC25A14;ETFA;ETFB;ETFDH;UQCRH;NR4A3;COX10;OXA1L;UQCRC2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.22945942417894946,0.7148840451502364,0.9171974522292994,0.9947576234567495,1.0,7/33,14.24%,ACER2;FERMT3;TGFB2;NEXMIF;RET;CIB1;JAM3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24319026269822216,0.7140423042405645,0.8974358974358975,0.9948721303066819,1.0,1/25,0.20%,SLC7A5
prerank,negative regulation of coagulation (GO:0050819),0.28188079104656877,0.7125338887067506,0.8509719222462203,0.9956982963503948,1.0,5/14,19.96%,HS3ST5;CD34;PROC;EDN1;PROCR
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2251295521135886,-0.7124865032576815,0.9050505050505051,0.9674677724515193,1.0,11/35,28.16%,TNKS2;CCT6A;DHX36;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2092056878553324,0.7124115879726717,0.9376299376299376,0.9950479856753364,1.0,12/50,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.26921502430839384,-0.7115387139298518,0.8714555765595463,0.9680363888833728,1.0,9/16,39.80%,NUPR1;VCP;PDE12;MLXIPL;PPIF;COX7A2L;ATP7A;SHMT2;UQCC2
prerank,mitochondrial gene expression (GO:0140053),0.21403421181024987,0.7114376549766648,0.9175475687103594,0.9952925104542623,1.0,14/42,22.12%,MRPS12;MRPS18A;MRPS7;MRPS14;MRPL23;FASTKD5;GATB;GATC;NDUFA7;MRPS28;MRPL2;PTCD3;TFB2M;MRPL16
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.25629710593655497,0.7113239714451475,0.8975501113585747,0.9946385935646682,1.0,3/21,9.53%,MBOAT1;PLA2G12A;OSBPL10
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2646915647392234,-0.7102572392543012,0.875,0.9688947608091824,1.0,9/17,44.99%,IK;RB1;BOD1;KNL1;TTK;SPDL1;CENPA;CDK1;MTBP
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.25317914231697264,0.7102432597723858,0.8688172043010752,0.9949565488004092,1.0,4/21,14.55%,YWHAB;PPP1R16B;PPP1R11;MFHAS1
prerank,pre-miRNA processing (GO:0031054),-0.28213352580861145,-0.7090008860910073,0.8494208494208494,0.9696625996248809,1.0,2/14,8.00%,DICER1;TUT4
prerank,regulation of G0 to G1 transition (GO:0070316),-0.22006645949148343,-0.7082017752933012,0.9168278529980658,0.9700285559565485,1.0,8/38,16.89%,RBBP8;CBX5;TFDP2;PCGF2;PCGF6;EHMT1;L3MBTL2;EPC1
prerank,embryonic heart tube development (GO:0035050),-0.2779474635625352,-0.7079011770158921,0.8500948766603416,0.9698974755963486,1.0,5/14,19.53%,HES1;ACVR1;CITED2;TBX2;MEGF8
prerank,cGMP metabolic process (GO:0046068),0.2820454608314662,0.7072046140180076,0.8369351669941061,0.9973301953902155,1.0,1/12,3.36%,PDE2A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2721995928415375,0.7071950717501011,0.8653846153846154,0.9965596777581095,1.0,2/15,7.97%,PPARG;AKT1
prerank,UV-damage excision repair (GO:0070914),-0.2917830292874251,-0.705211189488993,0.8644688644688645,0.972042694709057,1.0,2/12,8.91%,INO80;DDB2
prerank,negative regulation of leukocyte activation (GO:0002695),0.27149354345107907,0.7043016472553305,0.8714285714285714,0.9987207204728424,1.0,2/15,9.10%,LRFN5;CD300LF
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3070417223096111,-0.7034911480658392,0.8703007518796992,0.9732456617005374,1.0,5/10,38.74%,WNK1;WNT5A;ADAM10;CCR2;ADAM17
prerank,regulation of immunoglobulin production (GO:0002637),-0.24984200575989096,-0.7034734822112058,0.8893280632411067,0.9728122682949643,1.0,2/23,11.22%,RBP4;STX4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.20087043614783925,-0.7016646633664677,0.9611650485436893,0.9740884451702481,1.0,21/59,31.38%,ROCK2;ROCK1;ERC1;TBK1;IRAK2;TRAF2;MAP3K14;TLR4;TRAF6;TANK;SHARPIN;TICAM1;NKIRAS1;NLRC3;IRAK1BP1;TRADD;BIRC3;UBA52;TLR3;LY96;RNF31
prerank,regulation of ruffle assembly (GO:1900027),0.2452263789385259,0.7006347134906497,0.8983050847457628,1.0,1.0,5/23,16.73%,NLGN1;FAM98A;HRAS;PFN1;EVL
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.21979126948976996,-0.7002203677771921,0.9289940828402367,0.9749814905729174,1.0,11/36,27.39%,ITGB1;NRP1;HIF1A;FBXW7;HDAC1;ADRA2A;PARK7;HBEGF;HDAC2;EGF;ADRB2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.1924909897126939,0.6996814039807342,0.96900826446281,1.0,1.0,7/73,8.74%,KITLG;PSMA1;TAL1;LMO2;PSMD12;PSMA6;PSMB3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.2781346460305619,-0.6992836026887574,0.8664259927797834,0.9754173311862869,1.0,3/14,10.03%,IRS1;PPARGC1A;PTPN2
prerank,regulation of chemokine production (GO:0032642),0.2229919987785837,0.6992713890448862,0.9370932754880694,1.0,1.0,4/36,10.49%,CSF1R;IL7;TLR2;AIF1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18758479106978163,-0.6983050758234393,0.9809160305343512,0.9759130831521038,1.0,33/84,34.19%,ANAPC5;ANAPC7;ANAPC4;ANAPC16;PSMF1;CUL3;RB1;PSMB2;CDC26;CDC27;UBE2E1;UBE2S;CDK2;ANAPC11;PSMC1;ECRG4;PSMB6;PSMA3;PSMA4;CDC16;ANAPC1;PSME1;PSMD13;FZR1;PSMB10;PSMA5;PSMB9;UBA52;MAD2L1;PSME4;BUB1B;PSMB8;PSMD10
prerank,protein deneddylation (GO:0000338),-0.3033198277339668,-0.6979636581838246,0.8504854368932039,0.9757814275845363,1.0,5/10,31.22%,COPS2;COPS8;TOR1A;GPS1;COPS5
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.22480939313371417,-0.6979475725967059,0.9278557114228457,0.9753497071615361,1.0,13/35,27.68%,PDGFRB;PPP1R12A;GSK3B;MTOR;BOD1L1;PTPA;CD300A;PPP1R2;NUAK1;CRY2;MASTL;BOD1;PPP1R15B
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2600414346774548,0.6974797554674624,0.8715203426124197,1.0,1.0,1/18,0.29%,NELL1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.23705533384365912,0.6971557547657056,0.8991935483870968,1.0,1.0,4/25,13.23%,PDE4B;SPTBN1;PDE4D;RPS3
prerank,AMP metabolic process (GO:0046033),0.2755194986768972,0.6970757177770598,0.8864628820960698,1.0,1.0,1/13,2.25%,AMPD1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.24532188906661606,0.6962909336890076,0.9028077753779697,1.0,1.0,3/24,7.13%,SEMA4D;FERMT3;PECAM1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2764726370243814,-0.6962853210547192,0.8785211267605634,0.9764449042259702,1.0,9/15,40.13%,YTHDF3;PTPN2;USP18;CACTIN;MUL1;SAMHD1;TTLL12;NLRC5;YTHDF2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.16735940771807556,0.695854599857235,0.9957537154989384,1.0,1.0,23/175,14.27%,ST18;TMSB4X;SIRT1;PSMA1;TRAF1;TNFRSF9;TNFSF13B;AKT1;PSMD12;PSMA6;PSMB3;CCL2;ARHGEF2;DAB2IP;TNFRSF12A;TNFRSF21;TNFRSF25;ACTN4;CD40;RPS3;NFKBIA;CIB1;PSME3
prerank,T cell homeostasis (GO:0043029),0.30356503146444913,0.6956923969149408,0.8651685393258427,1.0,1.0,2/10,18.23%,AKT1;NCKAP1L
prerank,adipose tissue development (GO:0060612),-0.3002565092120303,-0.6955279888187823,0.8359375,0.9766754865709039,1.0,3/11,11.76%,SH3PXD2B;PGRMC2;ARID5B
prerank,phagosome acidification (GO:0090383),-0.2363505312769203,-0.6953804085809857,0.9168278529980658,0.9763642967553232,1.0,3/26,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,microtubule bundle formation (GO:0001578),0.21470177269856697,0.6952098771161295,0.9287169042769857,0.9997768696113275,1.0,7/42,15.28%,SPAG16;MTCL1;TPPP;FOXJ1;DCX;CAPN6;TPPP3
prerank,lipid oxidation (GO:0034440),-0.2907537812202034,-0.695005877950342,0.8528864059590316,0.9762704638689866,1.0,3/12,27.15%,PPARGC1A;ACOX1;ALOX12
prerank,regulation of protein localization to cell periphery (GO:1904375),0.25273948571551264,0.6945981533431476,0.864476386036961,0.9995522559558365,1.0,1/18,0.74%,ACTB
prerank,actin nucleation (GO:0045010),-0.24699730190737007,-0.6943435892619594,0.8957528957528957,0.9764314000861674,1.0,9/21,37.63%,IQGAP2;ARPC2;WHAMM;LMOD1;ACTR2;ARPC5;JMY;ARPC3;ARPC4
prerank,intestinal absorption (GO:0050892),0.2836460983397733,0.693972003329641,0.854,0.9993463026161734,1.0,1/13,2.66%,SLC2A5
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2990924811455812,-0.6933676762118989,0.8491620111731844,0.9768691532696158,1.0,5/10,32.92%,CD9;PRKCD;ALOX12;RDX;ADAMTS18
prerank,genitalia development (GO:0048806),-0.29289939531701736,-0.6929500669010534,0.8713450292397661,0.9768074340651204,1.0,4/12,19.26%,PKD1;CHD7;WNT5A;PTPN11
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.19098145219548085,0.6926013609466306,0.988,0.9998329489947796,1.0,12/72,15.39%,DNASE1;MEI4;RPA3;RPS27A;UBC;POLK;UBB;ERCC2;POLD1;DDX1;RFC4;POLD3
prerank,negative regulation of phosphatase activity (GO:0010923),0.23518049235726698,0.6921721063907671,0.930379746835443,0.9994284107629127,1.0,4/25,11.19%,SEMA4D;ZCCHC9;TGFB2;PPP1R11
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.24084115275388163,0.692126117906769,0.8920704845814978,0.998710255638614,1.0,2/23,9.41%,MBOAT1;PLA2G12A
prerank,triglyceride catabolic process (GO:0019433),0.254772670183371,0.6921100693523609,0.8881578947368421,0.9979530469091563,1.0,19/19,74.55%,FABP5;PNPLA3;FABP6;APOC3;PNPLA5;FABP2;PNPLA1;LIPI;PNLIPRP2;CPS1;LIPG;FABP3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL;PNPLA2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2913910292625381,0.69208624510197,0.8587443946188341,0.9972091678435929,1.0,1/11,6.51%,PRKCQ
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3016984780905233,-0.6917039923914187,0.8487084870848709,0.9774623819248937,1.0,2/11,12.74%,NUPR1;YBX3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2676122359752005,0.6910652375037052,0.8791208791208791,0.9973869313373795,1.0,1/15,1.66%,HUS1B
prerank,membrane lipid catabolic process (GO:0046466),-0.30508874464359503,-0.6904526900561974,0.8799249530956847,0.9781505543583452,1.0,4/10,21.82%,CYP1B1;PDXDC1;NAGA;SMPD2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3131572833289683,-0.6894291746974718,0.8597449908925319,0.9785981739277354,1.0,2/10,12.46%,PLA2G4A;PNPLA8
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2966882770143118,-0.6883056572462195,0.8717948717948718,0.9791402207876438,1.0,5/11,28.71%,EGLN3;P4HA2;P4HB;P4HA1;EGLN2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.29018573136688686,-0.6876790096839782,0.871304347826087,0.9792426762099448,1.0,6/12,33.55%,YTHDC1;SMCHD1;HNRNPU;PCGF3;CDYL;BRCA1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.25747964479490376,-0.6870601737720936,0.8794063079777366,0.9793537507820895,1.0,4/18,14.98%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.29836392415540713,-0.6870429988836185,0.8720472440944882,0.9789182583628929,1.0,4/11,21.63%,LMNA;SMAD4;P2RX4;MLIP
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.29185921885514615,0.6868508251310733,0.8550420168067226,0.9996507720581141,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.29185921885514615,0.6868508251310733,0.8550420168067226,0.9996507720581141,1.0,5/11,19.06%,CCT2;DKC1;CCT4;TCP1;MEPCE
prerank,phagosome maturation (GO:0090382),0.22214676747081488,0.6866316496753895,0.9464668094218416,0.9990824573765286,1.0,15/35,24.49%,ATP6V1F;ATP6V1A;CORO1A;ATP6V1C1;ATP6V0B;RAB31;ATP6V0A1;ATP6V0E2;ATP6V1D;RAB32;RAB14;ATP6V0C;ATP6V1G1;ATP6V1E1;MREG
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3078511939919273,-0.6866104220898913,0.8789571694599627,0.9788444057170875,1.0,3/10,13.96%,OS9;ERLEC1;UBAC2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2860444528684295,-0.6856902075590546,0.8848920863309353,0.9792219684184976,1.0,2/13,6.82%,UPP2;NT5M
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.29150180559067496,0.6855855187769534,0.8728448275862069,0.9992443028883791,1.0,2/11,12.49%,CAMK4;ITGAM
prerank,regulation of neutrophil migration (GO:1902622),0.29578359759981854,0.6849397268962312,0.8814317673378076,0.9990403260769829,1.0,3/10,20.39%,JAM3;NCKAP1L;RAC1
prerank,serine family amino acid catabolic process (GO:0009071),-0.3037637674280017,-0.6847265212207111,0.875,0.9796388662235872,1.0,7/10,47.83%,AMT;CBS;SHMT2;DLD;GLDC;SHMT1;DAO
prerank,regulation of lipid kinase activity (GO:0043550),-0.29403003745322437,-0.684127788569161,0.8842676311030742,0.9797158233933773,1.0,4/11,21.16%,WDR91;RB1;PIK3R1;WDR81
prerank,ncRNA metabolic process (GO:0034660),0.21808166808377147,0.6840341902209952,0.9311023622047244,0.9990967220461046,1.0,8/37,19.07%,TDRD12;KHSRP;DTD1;DROSHA;BCDIN3D;PIWIL2;MEPCE;TDRKH
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23947528713626415,-0.6838700140716251,0.9130434782608695,0.9794929464172232,1.0,4/22,12.34%,PHF8;EIF2AK3;MTOR;WDR43
prerank,positive regulation of transmembrane transport (GO:0034764),-0.27381355681442143,-0.6837939205551934,0.8740740740740741,0.9791134016540984,1.0,2/13,7.41%,ACSL1;BRAF
prerank,regulation of viral genome replication (GO:0045069),0.20015244887214567,0.6834442106211935,0.9495798319327731,0.9988121915490569,1.0,11/56,18.08%,PROX1;ISG15;TRIM6;IFITM3;PABPC1;SLPI;HACD3;RSAD2;TNIP1;PPIA;ADAR
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2541285712532182,0.6832735013069655,0.8839662447257384,0.9981718178842044,1.0,2/17,11.13%,PLA2G12A;CRLS1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24710580138513932,0.6831565949725302,0.8954248366013072,0.9974950140384862,1.0,5/19,15.39%,AMPD1;HPRT1;GMPR2;POLD1;POLD3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.22313130818762011,0.6830513108427276,0.940552016985138,0.9968240693652782,1.0,9/30,18.37%,PREPL;ANK3;GOLGA7;SPTBN1;MACF1;RAB31;BBS1;BLZF1;OPTN
prerank,negative regulation of T cell activation (GO:0050868),-0.21517525480485628,-0.6822202917644777,0.931640625,0.980042850569826,1.0,6/35,22.93%,PAG1;RIPOR2;PTPN22;SDC4;DLG5;CD80
prerank,neuron projection organization (GO:0106027),-0.2622036555696153,-0.6820009171961431,0.9,0.9797778284573408,1.0,3/15,12.16%,GSK3B;ABCD2;ARF1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2364505259336978,0.6813790326557655,0.930672268907563,0.9974446586794755,1.0,4/26,8.43%,SIRT1;NME5;AKT1;HSPB1
prerank,response to hydrogen peroxide (GO:0042542),-0.2069265287348293,-0.6812654054102547,0.9431372549019608,0.9799326052412866,1.0,17/45,30.48%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD;ADAM9;APTX;GLRX2;PARK7;FXN;MAPK7;SIRPA;PLEKHA1;TNFAIP3;NFE2L2;PPIF
prerank,regulation of inclusion body assembly (GO:0090083),0.2879899648110022,0.6810748216369482,0.8655097613882863,0.9969349143447855,1.0,3/11,16.45%,SACS;DNAJA4;DNAJB2
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2972347821908592,-0.6809566581138702,0.8520599250936329,0.9797361428397189,1.0,1/10,0.81%,STIM1
prerank,snRNA 3'-end processing (GO:0034472),0.25271150699892564,0.680438753346259,0.881104033970276,0.9966942432388128,1.0,5/19,20.60%,EXOSC5;INTS2;EXOSC4;TOE1;INTS5
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2685626075360262,-0.6800927152597852,0.8835125448028673,0.9800191510165756,1.0,9/15,33.41%,ANAPC7;TPR;CDC27;NEK6;CDC16;ANAPC1;CENPE;RIOK2;TACC3
prerank,nerve growth factor signaling pathway (GO:0038180),0.29401893863333217,0.6800443482887537,0.8851774530271399,0.9962700028650299,1.0,1/10,2.80%,MAGI2
prerank,defense response to symbiont (GO:0140546),-0.18069599946665418,-0.6799409202592417,0.9844357976653697,0.9796966981192337,1.0,27/92,30.85%,FLNA;MOV10;PLSCR1;BCL2;IFIT2;SETD2;MAVS;TRIM5;IRF1;EIF2AK2;STAT1;MAP3K14;OAS2;SHFL;MLKL;IFI27;IFIT3;BNIP3;IRF2;NCBP3;ABCC9;PDE12;CGAS;ZMYND11;SAMHD1;TLR3;IFIH1
prerank,DNA biosynthetic process (GO:0071897),0.265478472895812,0.6788703466040644,0.9144736842105263,0.9964572613716406,1.0,7/16,25.05%,SIRT1;POLD1;POLD3;PPIA;CDKN2D;RFC3;TYMS
prerank,nuclear body organization (GO:0030575),0.2787662239512446,0.6783420878501614,0.8768267223382046,0.9961190738036069,1.0,2/12,11.52%,ETS1;HIPK2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23921309083242445,-0.6780684838112155,0.9011857707509882,0.9807429351604292,1.0,5/24,21.01%,PLA2G4A;PNPLA8;SLC27A1;LPCAT1;CDS2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.257584915153408,0.6779452110404567,0.9089026915113871,0.9956944405580692,1.0,3/17,15.42%,HMGA2;THPO;PDCD2
prerank,coenzyme A metabolic process (GO:0015936),0.27314358534458516,0.6777442061219615,0.8618556701030928,0.9950864769496663,1.0,6/14,24.09%,ACOT7;PANK4;PANK3;PPCS;PANK1;ACAT1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2972864406117788,-0.6766217245098974,0.8752362948960303,0.9814739979479482,1.0,1/10,2.74%,DICER1
prerank,cilium-dependent cell motility (GO:0060285),-0.23698720553123492,-0.6759815650355548,0.9323017408123792,0.9815405510723796,1.0,7/22,28.28%,CFAP44;CCDC39;EFHC1;DNAH8;GAS8;RSPH9;DNAH2
prerank,melanosome localization (GO:0032400),-0.23721962429632756,-0.6752586654952009,0.9124767225325885,0.9816691839915506,1.0,6/21,28.24%,SHROOM2;RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,protein targeting to membrane (GO:0006612),0.17944489672159505,0.674062699266084,0.9919517102615694,0.9972220128081427,1.0,18/83,19.71%,GDAP1;AQP11;ARL6IP1;ZDHHC22;SGTB;GOLGA7;ZDHHC15;TAOK2;SRPRA;ZDHHC4;ZDHHC14;VPS37A;RTP4;ARL6;PEX3;SGTA;ZDHHC24;VPS37D
prerank,determination of heart left/right asymmetry (GO:0061371),0.2081512338726079,0.6736736315644396,0.9429133858267716,0.996744255250389,1.0,7/42,13.73%,AHI1;NOTCH1;APLNR;VANGL2;BBS5;SOX17;DLL1
prerank,lymphocyte proliferation (GO:0046651),-0.2385458112437377,-0.67221062737844,0.9225225225225225,0.9836264914865019,1.0,6/22,25.82%,BCL2;ELF4;MEF2C;CTPS1;MSN;LMBR1L
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2685330487728329,0.6719439702613378,0.8722943722943723,0.9973506300421388,1.0,12/12,73.17%,RMDN1;MAD1L1;MIS12;CHAMP1;CDT1;CENPC;KIF2C;NUF2;NDC80;SEH1L;CENPE;BOD1
prerank,regulation of superoxide anion generation (GO:0032928),-0.2677390683167117,-0.6716526257268414,0.8884540117416829,0.983600205140335,1.0,3/14,24.64%,PRKCD;AATF;SYK
prerank,regulation of establishment of planar polarity (GO:0090175),-0.17900707201299068,-0.6713135636577576,0.990990990990991,0.9833985675053689,1.0,27/88,29.12%,SMURF2;FZD2;VANGL1;CDC42;DACT1;RHOA;ROR2;PSMF1;FZD7;PSMB2;DAAM1;SMURF1;WNT5A;FZD1;SPEF1;PSMC1;DVL3;PSMB6;PSMA3;AP2A1;PSMA4;DVL2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,negative regulation of hormone secretion (GO:0046888),-0.2944545447413032,-0.6698066070597226,0.8821292775665399,0.9840881542229013,1.0,1/10,8.60%,GJA1
prerank,mismatch repair (GO:0006298),-0.2249750804208444,-0.6685653218557936,0.9387755102040817,0.9846164580595747,1.0,8/27,23.40%,ABL1;MLH1;SETD2;MCM9;MSH3;MSH6;PCNA;ERCC1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.21955450927413797,-0.6685458019098436,0.9364161849710982,0.9841893808731327,1.0,6/29,14.71%,DDX6;DCP1A;CNOT8;DCP1B;EDC3;EXOSC9
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.23566546521321052,-0.6685221717694578,0.9152854511970534,0.9837659208131192,1.0,3/22,10.31%,RNF115;VPS4B;VPS37C
prerank,nitric oxide metabolic process (GO:0046209),0.26283357475590385,0.6682450964463783,0.9135254988913526,0.9994389653151015,1.0,3/14,15.09%,NOS3;AKT1;GCH1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.19291553119801047,0.6680323652602407,0.9615384615384616,0.9988298708369542,1.0,5/48,8.56%,PPARG;GAS6;ISG15;SLIT3;GPS2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.23992290822981532,0.6668023917379646,0.8934782608695652,0.9989775262271954,1.0,3/18,12.22%,DNAAF2;SPEF2;AQP4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.28187078595013004,0.6667988659244517,0.8849372384937239,0.9982242543960022,1.0,2/11,13.05%,BIN1;STK39
prerank,glutamine family amino acid catabolic process (GO:0009065),0.2706276209724752,0.6660338321391002,0.8673684210526316,0.9980540686873293,1.0,5/13,18.05%,NOS3;GAD1;GLS2;GLS;DDAH1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.22684799011477286,-0.6658549789325415,0.9238095238095239,0.9852600817065895,1.0,4/26,9.27%,CYB5B;ASAH2;ACER3;CYP1B1
prerank,regulation of cholesterol storage (GO:0010885),-0.25849675672454053,-0.6657773778655638,0.9092664092664092,0.9848747299066783,1.0,6/15,31.68%,ABCA1;NR1H3;PPARA;LPL;EHD1;MSR1
prerank,cellular response to lectin (GO:1990858),-0.17289782758486183,-0.6655552413298683,0.9960079840319361,0.984143779701648,1.0,25/104,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.17289782758486183,-0.6655552413298683,0.9960079840319361,0.984143779701648,1.0,25/104,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.2886524083410669,0.6654409314106678,0.8586278586278586,0.9977264127478032,1.0,2/10,11.52%,ING4;HIPK2
prerank,negative regulation of immune response (GO:0050777),-0.16360974203390277,-0.6646034232383274,0.9961685823754789,0.9843995295304139,1.0,16/154,11.19%,COL3A1;ADCY9;ADCY5;IRAK3;TRAFD1;RC3H1;ADCY1;LYN;MAPKBP1;RAMP1;ADCY6;PCBP2;PLCG1;FER;ENPP3;YES1
prerank,steroid metabolic process (GO:0008202),-0.18204356128172633,-0.6641021282946171,0.9813278008298755,0.9843289760862702,1.0,15/72,24.71%,CYP7B1;CYP26B1;CYP27A1;CYP1B1;SULT1A1;PIAS4;CUBN;CYP51A1;AMACR;DHRS11;FDX1;FDFT1;ARV1;CYP2R1;GBA2
prerank,N-terminal protein amino acid modification (GO:0031365),0.26105391680968454,0.6639660543186625,0.9158110882956879,0.9980362266912725,1.0,1/14,3.27%,METAP2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.21679525863706525,-0.6633814713572884,0.9582504970178927,0.9844190331114199,1.0,6/33,10.43%,ABL1;ANXA1;MAP3K5;IMPACT;CYP1B1;PRKCD
prerank,detection of visible light (GO:0009584),-0.25704023578702906,-0.66291690631991,0.9013539651837524,0.9843034510805053,1.0,1/16,5.81%,ABCA4
prerank,steroid catabolic process (GO:0006706),-0.2910056983527214,-0.6623720369751928,0.8757396449704142,0.9842550309131207,1.0,2/10,20.22%,HSD17B11;SPP1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.21776363992400172,-0.6622464317897043,0.90715667311412,0.9839047605468395,1.0,14/27,36.57%,DDX5;PLA2R1;KMT5A;SPRED2;ATR;SNAI1;TWIST1;KDM1A;DYRK1A;HIC1;PSMD10;CD44;MSX1;SPRED1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.2148289189428187,-0.6617117188557673,0.9349593495934959,0.983832979557249,1.0,10/32,28.16%,TNKS2;CCT6A;CCT8;CCT5;MAP2K7;ATR;FBXO4;NEK7;CCT3;PARN
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.17183367828310536,-0.6613370821006068,0.992,0.9836578647477408,1.0,25/105,29.12%,NFKB1;EP300;BTRC;PAK2;CREBBP;LYN;PDPK1;PRKCD;PSMF1;PSMB2;PRKACA;FBXW11;TRAF6;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;SYK;FCER1G;PSME1;PSMD13;PSMB10;PSMA5;PSMB9
prerank,nitric oxide biosynthetic process (GO:0006809),0.26729774047347976,0.6607359639385751,0.9082774049217002,0.9996274777075198,1.0,3/13,15.09%,NOS3;AKT1;GCH1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2371936515242826,0.660266118073059,0.9125,0.997710154319712,1.0,6/20,18.53%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2371936515242826,0.660266118073059,0.9125,0.997710154319712,1.0,6/20,18.53%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2371936515242826,0.660266118073059,0.9125,0.997710154319712,1.0,6/20,18.53%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,inner mitochondrial membrane organization (GO:0007007),0.19627569919004384,0.65948655228601,0.9703389830508474,0.9975270305717149,1.0,13/47,19.39%,ATP5F1D;TIMM22;ATP5F1B;ATP5ME;NDUFA13;GHITM;ATP5MF;DMAC2L;UQCC3;TOMM70;CHCHD6;ATP5MG;TIMM10B
prerank,pancreas development (GO:0031016),0.2701647975231743,0.6594636325986251,0.8902691511387164,0.9967888230247798,1.0,2/12,10.19%,PROX1;FOXF1
prerank,response to interferon-gamma (GO:0034341),-0.18317714611580893,-0.6594021465968839,0.9847619047619047,0.9845598012372437,1.0,13/67,19.07%,SYNCRIP;SP100;NUB1;CXCL16;GBP3;STAT1;DAPK1;GBP7;GBP2;TLR4;SHFL;WNT5A;GBP6
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.2846173292564299,-0.6592850522759477,0.8947368421052632,0.9842030638660987,1.0,6/11,50.75%,AGTR1;ABCG1;LIPC;PLA2G5;PLA2G7;PLA2G3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.28219841401395235,-0.6591180451546677,0.9032258064516129,0.9838792824954422,1.0,3/11,14.17%,LDLR;NR1H3;SLC27A1
prerank,calcium import into the mitochondrion (GO:0036444),-0.2908167989165842,-0.6589774994655783,0.8754646840148699,0.9835440259082026,1.0,2/10,14.65%,MCU;MICU1
prerank,tRNA wobble uridine modification (GO:0002098),-0.26033397022255184,-0.6584741102062383,0.9064327485380117,0.9834544247168958,1.0,7/14,35.21%,TRMT9B;DPH3;GTPBP3;MTO1;TRMU;ALKBH8;MOCS3
prerank,rRNA methylation (GO:0031167),-0.23362810227982184,-0.6582285530068792,0.9364161849710982,0.9831677455769695,1.0,5/22,16.54%,ZCCHC4;NSUN3;DIMT1;METTL15;BUD23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.1768430569519297,0.6577625972756268,0.9917525773195877,0.9965069559881776,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.1768430569519297,0.6577625972756268,0.9917525773195877,0.9965069559881776,1.0,12/78,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,positive regulation of cellular respiration (GO:1901857),-0.2802254635426098,-0.6577246649635777,0.8897058823529411,0.9830613027353095,1.0,3/11,18.94%,NUPR1;VCP;PARK7
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2049124372828406,0.6575921644539977,0.9475806451612904,0.9958869574377337,1.0,8/37,18.58%,DNASE1;ENTPD3;SND1;RNASEH2A;DFFB;RNASE3;PNPT1;ENTPD1
prerank,polyamine metabolic process (GO:0006595),0.26393544334296304,0.6574343443640035,0.9030172413793104,0.9952407342394392,1.0,5/13,21.31%,SMS;SMOX;SAT2;ODC1;HDAC6
prerank,regulation of cell aging (GO:0090342),-0.2778814878755778,-0.6573078264657625,0.9056974459724951,0.9829175872271122,1.0,6/11,27.16%,LMNA;NEK4;NEK6;NUAK1;RSL1D1;VASH1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2603119392162081,-0.6558828385252403,0.8920454545454546,0.9834527236375674,1.0,6/14,30.77%,FOXO3;EARS2;FASTKD1;MRPL12;POLRMT;TWNK
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.29310184676205314,-0.6558610795043367,0.8783269961977186,0.9830214863948972,1.0,3/10,15.34%,CCT6A;CCT8;CCT5
prerank,intracellular pH reduction (GO:0051452),-0.21051852524162137,-0.6557391316098841,0.9629629629629629,0.9826578062003493,1.0,11/33,29.79%,ATP6V1B2;ATP6V0D1;ATP6V0A4;TCIRG1;ATP6V1G2;GPR89B;GPR89A;DMXL1;RAB7A;RAB39A;ATP6V0D2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.18156613793073464,-0.6553719489180132,0.9924098671726755,0.9824617728038861,1.0,23/72,29.20%,DICER1;BTRC;TRAF2;PSMF1;CARD14;COPS8;PSMB2;MAP3K14;FBXW11;TRAF6;IRAK1;CUL1;PSMC1;PSMB6;PSMA3;PSMA4;NFKB2;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;BIRC3
prerank,positive regulation of T cell migration (GO:2000406),0.23922189630701787,0.6552949816473989,0.9182389937106918,0.9960028636619135,1.0,4/20,17.21%,CXCL12;AIF1;STK39;DOCK8
prerank,positive regulation of myelination (GO:0031643),0.2761030069238379,0.6551878923429261,0.8837209302325582,0.9953374805042772,1.0,2/11,9.18%,TENM4;TPPP
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.23362851666149445,-0.6535999320667196,0.9334637964774951,0.9831927003322403,1.0,3/19,17.56%,MTHFR;MTHFD2L;ALDH1L1
prerank,alcohol catabolic process (GO:0046164),-0.2942237298914707,-0.6533862705225442,0.8801498127340824,0.9828922532124714,1.0,2/10,14.09%,CYP27A1;APOE
prerank,protein localization to condensed chromosome (GO:1903083),-0.27073766989157205,-0.6530495012123771,0.8893129770992366,0.9826809447481533,1.0,1/12,5.15%,IK
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.18614706008547866,-0.6522816959768913,0.9752380952380952,0.9827134456776503,1.0,23/61,34.19%,PRKAG2;PANK2;PSMF1;SIRT5;PSMB2;FGFR4;PSMC1;PSMB6;PSMA3;PSMA4;PPARA;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;NR1H4;CAV1;PSME4;PDK4;NQO1;PSMB8;PSMD10
prerank,protein homotetramerization (GO:0051289),0.19330622108600118,0.6517584714035095,0.9698924731182795,0.9968799610948533,1.0,8/49,15.56%,HCN1;RYR3;TRPM2;HPRT1;AQP4;GOLGA2;B2M;GLS
prerank,negative regulation of transmembrane transport (GO:0034763),-0.29081269932650455,-0.6513641072346499,0.8994307400379506,0.9828814978681528,1.0,3/10,21.34%,THBS1;INPP5K;AKT2
prerank,positive regulation of mRNA processing (GO:0050685),-0.22754508210408858,-0.6510058054365199,0.940952380952381,0.9826720706624893,1.0,9/21,32.44%,DHX36;DAZAP1;CDC73;NUP98;NCBP2;SNW1;THRAP3;SF3B4;RBMX
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2655161217779504,0.6497258145267414,0.911340206185567,0.9974531833620564,1.0,5/12,20.61%,HSPA5;SGTB;SEC61G;SGTA;SEC61A2
prerank,regulation of aerobic respiration (GO:1903715),0.24865187234461275,0.6489288783451129,0.9305263157894736,0.9972357444545406,1.0,1/15,3.24%,COX7A1
prerank,oligodendrocyte differentiation (GO:0048709),0.23998667931063036,0.6486832135329356,0.908,0.9966448831613828,1.0,5/19,16.78%,NSUN5;EIF2B3;TPPP;PTPRZ1;HES5
prerank,cellular response to gamma radiation (GO:0071480),-0.24435171392691094,-0.6485509677175211,0.9124513618677043,0.983826456210737,1.0,7/17,25.24%,YAP1;WRN;MAP3K20;XRCC6;ATR;HSF1;KDM1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.25802734246979997,0.6484812629704046,0.8991416309012875,0.9960331755140757,1.0,1/12,6.51%,PRKCQ
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2576235770709374,0.6480671228119999,0.9211087420042644,0.9955544036213961,1.0,4/14,21.73%,BCL10;RPS3;RAB29;CARD11
prerank,cellular response to interleukin-1 (GO:0071347),0.1617924990428711,0.6470461175477761,1.0,0.9954422205267649,1.0,30/143,20.52%,ST18;TOLLIP;PSMA1;RPS6KA5;PLCB1;RPS27A;UBC;UBB;PSMD12;PSMA6;PSMB3;CCL2;DAB2IP;NOD1;CD40;NFKBIA;TAB2;PSME3;PELI1;PSMC3;PSMA2;IL1RAP;CCL25;MAPK3;PSMB7;NOD2;CD47;HYAL2;CCL13;CCL19
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2517273847054291,0.6465786648090678,0.9201680672268907,0.9949892079168843,1.0,2/15,10.32%,PPARG;MID1IP1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2119819398886044,0.6457046831540714,0.9426229508196722,0.9947745688673849,1.0,6/29,15.73%,ELOVL7;TECR;SCD;HACD1;PPT1;ACSL3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.18931972055458418,0.6456320599077416,0.9847494553376906,0.9940740849169136,1.0,12/53,21.87%,PSMA1;PSMD12;PSMA6;PSMB3;PSME3;PSMC3;PSMA2;PSMB7;ODC1;OAZ1;AZIN1;PSMD7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.21521862556975496,-0.6454781848495669,0.9510357815442562,0.9848764137384021,1.0,16/29,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.21521862556975496,-0.6454781848495669,0.9510357815442562,0.9848764137384021,1.0,16/29,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.2554989130505376,-0.6445100400533181,0.9284403669724771,0.9850558638989912,1.0,7/14,31.26%,PPP2CB;DUSP1;NCK1;PPP2CA;PPP2R2C;PPP1R15B;PPP2R2A
prerank,positive regulation of phagocytosis (GO:0050766),-0.19330991064727407,-0.644032226985439,0.967741935483871,0.9849143410409148,1.0,4/47,7.33%,APPL2;CAMK1D;IL15RA;MERTK
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.22857789148008828,0.6437903855728988,0.9287211740041929,0.9944742736240114,1.0,6/21,18.53%,BUB1;APC;ATM;BUB3;TEX14;MAD1L1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.21655715160082709,-0.6423182236592532,0.9454191033138402,0.9854922014880626,1.0,11/25,32.20%,FOXK1;PGK1;FOXK2;PFKP;PKM;PFKM;PFKL;ALDOA;ENO3;ENO1;HK2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.25757799514882046,-0.6420345213205206,0.9275929549902152,0.985209683826687,1.0,2/13,8.13%,CYFIP2;ASPH
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2505482863200636,-0.6418802731528641,0.9260628465804066,0.9848612211059623,1.0,5/15,26.17%,NFKB1;AGTR1;IL18;MAPK9;LPL
prerank,centromere complex assembly (GO:0034508),-0.20390306791235543,-0.6398929905915182,0.9578544061302682,0.9855891958027858,1.0,19/36,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;POGZ;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPF;CENPA;CENPQ
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2152973785384983,-0.639342455105601,0.943359375,0.9854652103237274,1.0,4/27,17.48%,PTN;IL6R;VEGFA;MIA3
prerank,organophosphate biosynthetic process (GO:0090407),0.19847764134016296,0.6382139159915154,0.9489194499017681,0.9970516437734948,1.0,13/37,22.40%,MBOAT1;GPAM;FADS1;GK;PIP5K1A;IPMK;TKT;IP6K1;PCYT2;PPIP5K1;IPPK;GPHN;PNPO
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2642004401113638,-0.6379531612205621,0.9092592592592592,0.985846926209355,1.0,1/12,2.20%,B3GALT1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.18415278134509397,-0.637834088516831,0.9867924528301887,0.9854792392078997,1.0,18/54,29.20%,CFLAR;TAX1BP1;PRKN;UBE2K;HIPK1;PTPN2;TRAF2;CCDC3;CARD16;SHARPIN;SPHK1;SYK;CLIP3;SPPL2A;TRADD;TNFAIP3;NLRP2B;BIRC3
prerank,chromatin disassembly (GO:0031498),0.24583645334627685,0.637433355697091,0.9207708779443254,0.9960329325439111,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.24583645334627685,0.637433355697091,0.9207708779443254,0.9960329325439111,1.0,3/14,14.93%,SMARCB1;SET;SMARCD1
prerank,establishment of spindle localization (GO:0051293),-0.2516470695826606,-0.6360953105036784,0.8980769230769231,0.985989010688033,1.0,3/14,16.14%,MAP4;ZBED3;DYNC1H1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2183636872794761,-0.6356043919486809,0.9566854990583804,0.9858434131752498,1.0,7/26,20.91%,UBE2N;ALPK1;IRAK2;TRAF6;IRAK1;MAP2K6;AAMP
prerank,positive regulation of exocytosis (GO:0045921),-0.2036593770088379,-0.6343404389303252,0.9632495164410058,0.9861234529447571,1.0,11/35,25.62%,STXBP5;VPS4B;RAB2B;SDC4;SYTL4;SNF8;RAB3D;RAB9A;RAB7A;SDC1;RAB5A
prerank,vasoconstriction (GO:0042310),0.266129887091485,0.6334924738707681,0.9350348027842227,0.997571166601934,1.0,3/11,17.97%,SLC8A1;EDN1;EDNRB
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.22584428236710832,0.6323963874187385,0.9351464435146444,0.9974524147500207,1.0,3/20,11.24%,IPO5;MEN1;APC
prerank,regulation of protein metabolic process (GO:0051246),-0.19059541810316113,-0.6321772094277915,0.9728155339805825,0.9869034981396897,1.0,11/44,23.47%,ROCK2;LDLR;SPOPL;APOE;CENATAC;TRAF3;ABCA7;SNF8;WFS1;PARL;MAPK7
prerank,vitamin transport (GO:0051180),0.2103554524445288,0.6310130284708679,0.9608247422680413,0.9975247375403955,1.0,3/29,7.80%,ABCG2;SLC52A2;SLC52A3
prerank,ether lipid biosynthetic process (GO:0008611),-0.27537561673871724,-0.6306950693910885,0.8990654205607477,0.9873241815348889,1.0,6/10,32.57%,GNPAT;PLA2G4A;PEX7;CHPT1;PLA2G4C;PEDS1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.17006933894498774,0.6304817793660829,0.9979123173277662,0.9970735312840833,1.0,12/79,16.04%,SH3GL2;AP2M1;CAPZA2;DYNLL1;AP1S2;AP2B1;ACTR10;DCTN1;AP1B1;DCTN2;DYNLL2;DYNC1LI2
prerank,endosome organization (GO:0007032),-0.19293300142012854,-0.6302148139697888,0.9807692307692307,0.9871366007356146,1.0,11/41,25.64%,EEA1;RAB22A;SNX10;USP50;TMCC1;PLEKHF1;ALS2;PI4K2B;WASHC4;ARFGEF2;PHETA1
prerank,protein import into peroxisome matrix (GO:0016558),-0.26152887685721526,-0.6300080533238774,0.9334600760456274,0.9868306117731092,1.0,8/12,44.81%,PEX6;PEX7;PEX26;PEX10;PEX16;PEX12;PEX1;PEX14
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.25021569554241624,-0.6296551247819644,0.9342359767891683,0.9865844168521749,1.0,3/14,12.44%,PKD1;PKD2;SUFU
prerank,leukotriene biosynthetic process (GO:0019370),0.2436455449125564,0.6272767016206743,0.9532293986636972,0.9980090366989478,1.0,4/14,19.27%,GGT7;GGT1;LTA4H;MGST3
prerank,positive regulation of viral genome replication (GO:0045070),-0.21121003347264056,-0.6270165353631671,0.9744597249508841,0.9875605142568689,1.0,10/29,33.12%,LARP1;DDX3X;PPIH;TOP2B;PPID;PPARA;PDE12;ADARB1;NR5A2;DDB1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.24722474444855502,-0.6265406231246909,0.9340866290018832,0.9873605288435783,1.0,8/14,49.49%,WNK1;WNT5A;ADAM10;CCR2;ADAM17;CCL5;CCL4;CCL7
prerank,postreplication repair (GO:0006301),0.19093216420633888,0.6261488830848769,0.9870689655172413,0.9978653411177576,1.0,12/45,19.16%,ISG15;RPA3;RPS27A;UBC;POLK;UBB;POLD1;RFC4;POLD3;RFC5;RFC2;POLI
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20734432700262373,0.6259350720549398,0.9762931034482759,0.9972489162972543,1.0,11/28,24.19%,RPS27A;UBC;UBB;NOD1;TAB2;OTULIN;NOD2;CASP8;ITCH;UBE2V1;CYLD
prerank,negative regulation of centrosome duplication (GO:0010826),-0.26403629470107937,-0.6253257788623356,0.9027522935779817,0.987585254653854,1.0,1/11,2.52%,KAT2B
prerank,sphingoid metabolic process (GO:0046519),-0.2616368255683608,-0.6245581045771241,0.9299242424242424,0.9875379263453063,1.0,2/12,6.66%,PLPP3;ASAH2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2527024384525727,-0.6241216690261221,0.9343065693430657,0.9873135116159721,1.0,1/13,2.20%,B3GALT1
prerank,DNA replication initiation (GO:0006270),-0.19658228060045063,-0.6235224998983666,0.9735349716446124,0.9871954193672426,1.0,20/37,39.60%,MCM6;PRIM2;CDK2;POLE4;POLA2;DBF4;POLE2;ORC1;MCM4;CDC34;RPA2;CDC45;POLA1;POLE;MCM2;MCM7;PRIM1;POLE3;MCM5;MCM10
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.16962494160518443,0.6230767357899485,0.9979591836734694,0.9980274026238043,1.0,11/82,12.45%,PRKAR2B;KCNH5;PPP2R1A;DYNLL1;CCP110;HAUS2;TUBB4A;YWHAG;CEP43;TUBA4A;DCTN1
prerank,mitochondrial fusion (GO:0008053),0.2345571161560421,0.6226060038428058,0.9611231101511879,0.9975438779616446,1.0,4/18,15.78%,GDAP1;MIEF1;USP30;MFN1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.1730823536123201,0.6202028915762787,0.9873150105708245,0.9980332324116431,1.0,7/66,13.89%,CD33;GIT1;HSPB1;F2R;P2RX7;CPTP;CD36
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2056403836414068,0.6197218748583081,0.9670103092783505,0.9975359487082579,1.0,5/29,17.41%,LPCAT2;TMEM86B;PLA2G12A;DBI;PLA2G4E
prerank,double-strand break repair via break-induced replication (GO:0000727),0.25340129303099573,0.6191906812231499,0.9255079006772009,0.9970740847027834,1.0,2/12,11.96%,GINS2;MCM3
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2608667055049888,-0.6171932499043826,0.9420289855072463,0.9899378704616201,1.0,9/12,51.67%,NEK6;PRKCA;LPIN1;PLK1;CDK1;VRK1;NEK9;CCNB1;PRKCB
prerank,cellular response to estrogen stimulus (GO:0071391),-0.24670305746430005,-0.6141296320008874,0.9267399267399268,0.9909688052196653,1.0,2/14,7.97%,BCAS3;AR
prerank,DNA strand elongation (GO:0022616),0.22620060563372657,0.6130419649115378,0.9267241379310345,0.9992387395037953,1.0,4/18,15.39%,GINS2;MCM3;RFC4;POLD3
prerank,I-kappaB phosphorylation (GO:0007252),0.26296248799247035,0.6127565403420716,0.9157894736842105,0.9986446758719494,1.0,2/10,9.89%,TLR2;DAB2IP
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.21836919227616927,-0.6122498903936433,0.9539594843462247,0.9914348042530818,1.0,4/21,14.98%,VPS4B;RAD51B;RAB11A;CDC25B
prerank,protein deacylation (GO:0035601),0.20795909866499043,0.6102180437534961,0.9658314350797267,0.9990506676873946,1.0,9/23,22.17%,SIRT1;LYPLA1;SIN3A;PPT1;HDAC7;ABHD17C;NOTUM;HDAC6;SIRT7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.25387099883347364,0.6098553530708498,0.9173387096774194,0.9984893169108437,1.0,2/11,11.52%,ING4;HIPK2
prerank,icosanoid biosynthetic process (GO:0046456),0.25989539404512657,0.6087803953274717,0.9295454545454546,0.9982646260810037,1.0,3/10,19.27%,FADS1;LTA4H;MGST3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.26347655164484257,-0.6085202264975037,0.9136276391554703,0.9926938845033597,1.0,1/10,2.99%,PRKN
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.19900578391530002,-0.607944219761922,0.9666011787819253,0.9925233646205849,1.0,14/31,42.81%,RC3H1;LYN;SDC4;DLG5;CD300A;CD80;SOX11;CEBPB;FCGR2B;CD274;LST1;CD86;LILRB1;IL4I1
prerank,mRNA methylation (GO:0080009),-0.23982063806587928,-0.6073321309665527,0.9426386233269598,0.9923598062291473,1.0,5/15,30.77%,WTAP;NSUN2;ZC3H13;TRMT61B;TRMT10C
prerank,positive regulation of immune response (GO:0050778),-0.16910439222283213,-0.6042008817558199,0.9961538461538462,0.9932800474407131,1.0,9/64,20.00%,IL6ST;PLSCR1;DHX9;STX4;RIOK3;EIF2AK4;CYBA;IFI35;KARS1
prerank,regulation of catabolic process (GO:0009894),-0.22432332303362923,-0.6041736924877836,0.9538461538461539,0.9928519186904741,1.0,4/18,20.14%,ITGB1;FAP;CENATAC;SNF8
prerank,positive regulation of cilium assembly (GO:0045724),0.22640152060837376,0.6031921975612041,0.9639278557114228,0.9999847512140959,1.0,6/18,20.37%,CCP110;HAP1;CCDC88A;ENTR1;FUZ;CROCC
prerank,ncRNA catabolic process (GO:0034661),0.20047528008509152,0.602109005909679,0.9738955823293173,0.9997265097204262,1.0,2/28,4.72%,EXOSC5;LIN28B
prerank,RNA catabolic process (GO:0006401),-0.17659754446249704,-0.6017801417444679,0.9886148007590133,0.9934032582764413,1.0,15/46,34.07%,DIS3L2;HNRNPD;XRN2;ERN1;MTREX;CNOT10;SIDT2;PABPC4;LSM6;ZFP36L2;SUPV3L1;NUDT16;NUDT16L1;HSPA1A;RNASEH2C
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2103096272198084,0.6015243156322126,0.9668737060041408,0.9992370033252073,1.0,1/23,1.05%,DNASE1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.17251095387816717,-0.6001315793957555,0.9939516129032258,0.993654918740714,1.0,24/65,34.19%,FBXL7;FHL1;USP47;PSMF1;NABP2;PSMB2;CUL1;PSMC1;CDK5RAP3;PSMB6;PSMA3;PSMA4;AVEN;PSME1;PSMD13;PSMB10;PSMA5;PSMB9;RBX1;PINX1;ZFYVE19;PSME4;PSMB8;PSMD10
prerank,regulation of interleukin-10 production (GO:0032653),-0.18099150290266292,-0.599544492477112,0.992,0.9934290048801876,1.0,6/44,17.43%,PIBF1;HMGB1;STAT3;TRIB2;PRKCZ;TLR4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2502981233917027,0.5990375363192224,0.9316628701594533,0.999535677469425,1.0,10/10,74.99%,ATP5F1D;ATP5MG;ATP5MC3;ATP5PD;ATP5PO;VPS9D1;ATP5F1C;ATP5F1A;ATP5MC2;ATP5MC1
prerank,amino sugar metabolic process (GO:0006040),0.25364950409286413,0.5989048675090143,0.9401330376940134,0.9988587655993968,1.0,1/10,5.63%,CSGALNACT1
prerank,regulation of ERAD pathway (GO:1904292),-0.25358314915770563,-0.5981770779679347,0.9546313799621928,0.9935513485617978,1.0,6/11,31.31%,RNFT1;TMEM259;USP13;BAG6;USP19;HERPUD1
prerank,sphingosine biosynthetic process (GO:0046512),-0.2511456444620215,-0.5980431215431969,0.9406307977736549,0.9927237301385283,1.0,5/11,30.40%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,sphingoid biosynthetic process (GO:0046520),-0.2511456444620215,-0.5980431215431969,0.9406307977736549,0.9927237301385283,1.0,5/11,30.40%,ASAH2;ACER3;SPHK1;SPHK2;ASAH1
prerank,phasic smooth muscle contraction (GO:0014821),0.24973325801795007,0.5980126810878068,0.9253112033195021,0.9984787847039028,1.0,10/10,75.04%,EDN1;EDNRB;PTGER3;EDN2;DRD2;HTR1D;TIFAB;HTR2B;GDNF;EDN3
prerank,ncRNA export from nucleus (GO:0097064),-0.18869444702036053,-0.5976038657023762,0.9805068226120858,0.9924594736895189,1.0,16/36,37.29%,RANBP2;NUP42;PHAX;NUP214;TPR;NUP98;NUP43;NUP160;NCBP2;NUP93;RAN;NUP133;SEC13;NUP88;NPM1;SEH1L
prerank,negative regulation of receptor binding (GO:1900121),-0.2619640182968802,-0.5972650021670718,0.9497098646034816,0.9921745801705086,1.0,3/10,30.08%,ATP2A2;ATP2A3;PTPRF
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2469054155966228,0.5969377968075981,0.9424307036247335,0.998174435356266,1.0,1/12,3.76%,PPARG
prerank,cellular response to ionizing radiation (GO:0071479),0.17740493011893582,0.5963419142286961,0.9901574803149606,0.9977067348991323,1.0,10/47,16.89%,TMEM109;SIRT1;EEF1D;NET1;HRAS;KDM4D;ATM;CDKN1A;XRCC5;MDM2
prerank,lymphocyte chemotaxis (GO:0048247),-0.18880016054508764,-0.5955702129553898,0.9835766423357665,0.992417664367709,1.0,3/34,10.08%,CYP7B1;CXCL16;SLC12A2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2603907035138392,-0.5950707719683814,0.93812375249501,0.992179949731349,1.0,2/10,15.32%,ACTN2;CARMIL1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.22135887915735675,0.5942590064060949,0.9381663113006397,0.9978217312112384,1.0,4/18,15.73%,ELOVL7;TECR;HACD1;ACSL3
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.22154372297490887,-0.5926157825796454,0.9559386973180076,0.9927343871640142,1.0,3/18,21.30%,ABL1;PRKDC;XRCC6
prerank,regulation of sensory perception of pain (GO:0051930),-0.24978273294669584,-0.5925424605860522,0.9562043795620438,0.9923269645304968,1.0,4/11,21.85%,CCN3;MGLL;ZFHX2;TMEM100
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.23312968190766375,-0.5905319946497732,0.9695817490494296,0.9926767942047766,1.0,8/14,41.87%,ECE1;AGTR1;EDN3;ACE2;CORIN;ENPEP;ACE;RASL10B
prerank,regulation of vacuole organization (GO:0044088),-0.2121203773940868,-0.5886788480087668,0.9585687382297552,0.9929404637179956,1.0,8/20,32.00%,ANXA2;IFT88;MTMR3;NPRL3;RAB5A;ENO3;ENO1;NPRL2
prerank,determination of left/right symmetry (GO:0007368),-0.18293971131067693,-0.5885993899200763,0.9921414538310412,0.9925433657383363,1.0,7/36,20.94%,SMO;PKD2;CCDC39;CITED2;MEGF8;GALNT11;ZIC3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.24551245982677344,-0.5881464274995909,0.9726775956284153,0.9922937401427991,1.0,3/12,17.46%,BTRC;CDC14B;UBE2S
prerank,cilium movement (GO:0003341),-0.17287085666550364,-0.5875747346614818,0.9962335216572504,0.9920755111531738,1.0,31/47,48.31%,ODAD1;CFAP251;CCDC39;SPEF1;DNAAF5;DNAH11;GAS8;RSPH9;CFAP61;DNAI4;DNHD1;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;ADCY10;CFAP54;SPAG17;ODAD3;SPA17;ODAD4;TEKT2;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.19168640871665354,0.5867504300777958,0.9895397489539749,0.9999421201305922,1.0,3/31,7.26%,CHCHD4;TIMM21;DNAJC15
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23320778405524167,0.5844802666788729,0.9520833333333333,1.0,1.0,13/13,76.70%,RPS15;NMD3;EIF6;NOP9;LSG1;LTV1;ABCE1;NPM1;NUP88;RAN;RRS1;XPO1;SDAD1
prerank,tRNA metabolic process (GO:0006399),-0.22222715243991437,-0.5842936525677305,0.9551401869158879,0.9928189366048867,1.0,1/17,1.83%,FARS2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.19258272231581397,0.5805979907524808,0.9839679358717435,1.0,1.0,8/31,23.25%,SRD5A2;SCP2;GCH1;NOXRED1;LIAS;SRD5A1;GPHN;LSS
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2183854765378483,-0.5804646639909642,0.9739776951672863,0.9937013814702169,1.0,3/18,14.09%,NCSTN;ADAM19;APOE
prerank,negative regulation of potassium ion transport (GO:0043267),0.2326447965679474,0.5788629603088318,0.9702127659574468,1.0,1.0,2/13,13.05%,BIN1;STK39
prerank,regulation of cellular respiration (GO:0043457),-0.21735226198485041,-0.5785900303654972,0.9669117647058824,0.9939016407692968,1.0,10/17,44.42%,CBFA2T3;NOP53;VCP;NOA1;IDE;PRDM16;SHMT2;TRAP1;IFNLR1;NOS2
prerank,dendritic cell chemotaxis (GO:0002407),-0.23577727103784135,-0.5775918993889845,0.9508506616257089,0.9938008494048316,1.0,7/14,38.77%,HMGB1;TRPM4;GPR183;CCR5;CCR2;CXCR4;PIK3CG
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.21777143490212383,-0.5775883151602641,0.9586466165413534,0.993371399047562,1.0,8/17,46.56%,PLA2G4A;MBOAT7;PLA2G4C;LCLAT1;PLAAT3;PLA2G4F;PLA2G5;PLBD1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15920144944725154,-0.5750875427548281,1.0,0.9937488002975686,1.0,20/72,28.75%,MDM4;EP300;NBN;TFDP2;SP100;CNOT8;CASP2;CNOT2;CNOT1;CNOT10;PML;PCNA;TFAP4;CNOT4;PAXIP1;TNKS1BP1;CRADD;PCBP4;ATRX;E2F1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.23192368543691827,-0.5748002115338703,0.9536679536679536,0.9933964206494107,1.0,6/14,37.94%,NUDT5;ENTPD6;NUDT1;NUDT16;NUDT18;ADPRM
prerank,purine ribonucleotide transport (GO:0015868),-0.22470341398685534,-0.5724046104622634,0.9776951672862454,0.9936870022668527,1.0,7/16,34.59%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,pigment granule transport (GO:0051904),-0.20803824276285282,-0.5720077297865844,0.968978102189781,0.9929557901580707,1.0,5/18,28.24%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,melanosome transport (GO:0032402),-0.20803824276285282,-0.5720077297865844,0.968978102189781,0.9929557901580707,1.0,5/18,28.24%,RAB11A;BLOC1S5;BBS4;MLPH;BBS2
prerank,histone H2A acetylation (GO:0043968),0.2185422019373884,0.5719379078018951,0.9488272921108742,1.0,1.0,2/16,6.81%,RUVBL1;YEATS4
prerank,aromatic amino acid family metabolic process (GO:0009072),0.24855440661712433,0.5715473962832094,0.9492600422832981,1.0,1.0,3/10,22.89%,ASRGL1;KYAT1;KYNU
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.22049664649745923,0.5706906529989065,0.9719827586206896,1.0,1.0,2/15,12.04%,TGFB2;SMAD7
prerank,pseudouridine synthesis (GO:0001522),-0.23310382026482093,-0.5705325683176776,0.9624765478424016,0.992961218757843,1.0,7/13,41.10%,PUS10;PUS3;GAR1;PUS1;PUS7L;PUSL1;RPUSD2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.1869148235076833,0.5701233341623732,0.9832635983263598,1.0,1.0,11/28,25.75%,GABARAP;DAB2IP;DELE1;TNFRSF1A;SORT1;DDX47;CASP8;TNFRSF10B;BAX;CASP8AP2;BID
prerank,nuclear envelope organization (GO:0006998),-0.20677254481287421,-0.5665802434527356,0.9829222011385199,0.9936872798002235,1.0,6/20,26.39%,DMPK;EMD;TOR1A;NEMP1;SUN2;NUP93
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.18352325001796052,0.5654800345688622,0.9900398406374502,1.0,1.0,10/31,22.02%,YWHAB;YWHAG;MAPK8;NMT1;PPP3R1;PPP1R13B;BBC3;CASP8;YWHAQ;PPP3CC
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.23590297876593208,-0.5644236502108029,0.9545454545454546,0.9939181993446635,1.0,1/12,3.12%,LRRK2
prerank,negative regulation of chemokine production (GO:0032682),-0.22210810775467532,-0.5624451679772474,0.9747747747747748,0.9940373531554573,1.0,4/14,28.27%,APOD;C1QTNF3;SIRPA;MUL1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.2205815583600973,-0.5607340416220646,0.9654510556621881,0.9940944496355069,1.0,7/14,45.32%,PRKCZ;IL18;CD81;DENND1B;CD86;RARA;NLRP3
prerank,determination of bilateral symmetry (GO:0009855),0.19279080852000405,0.5605218724061933,0.9785575048732943,1.0,1.0,7/24,23.20%,NOTCH1;FOXJ1;DLL1;ARL6;DNAH5;NPHP3;TBX1
prerank,protein localization to vacuole (GO:0072665),0.22617702448210925,0.5595465076681704,0.9678111587982833,1.0,1.0,13/13,77.40%,GLMP;RTN4;LMBRD1;SH3BP4;MFSD1;SH3GLB1;ATP13A2;RNF128;LAMTOR5;LAMTOR4;CD81;KPTN;SZT2
prerank,chromatin remodeling at centromere (GO:0031055),-0.18416332771686278,-0.5589269096864357,0.9809885931558935,0.9941545931431969,1.0,16/31,40.11%,HJURP;CENPP;NASP;ITGB3BP;CENPT;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;CENPH;MIS18A;CENPN;CENPA;CENPQ
prerank,lipoprotein catabolic process (GO:0042159),-0.24173429177566483,-0.5582730969534758,0.9714285714285714,0.9939154976029828,1.0,4/11,24.56%,ABHD17B;APOE;ABHD10;LYPLA2
prerank,diol biosynthetic process (GO:0034312),-0.21746972115041174,-0.5577427782176753,0.9718045112781954,0.9936193750399146,1.0,2/15,8.43%,ASAH2;ACER3
prerank,glycine metabolic process (GO:0006544),0.22992906911053912,0.5561927910291206,0.9744680851063829,1.0,1.0,12/12,77.02%,RIDA;GCSH;SDSL;SDS;BAAT;GLYAT;SHMT1;GLDC;DLD;GCAT;SHMT2;AMT
prerank,cellular response to superoxide (GO:0071451),-0.24765262781224334,-0.5528387111138795,0.9611111111111111,0.9944738687026429,1.0,6/10,33.56%,SOD3;SOD2;PRDX2;CCS;MT3;ATP7A
prerank,meiosis I (GO:0007127),0.1960707948791367,0.5518975970686063,0.9822834645669292,1.0,1.0,22/23,69.13%,ZCWPW1;ING2;FOXJ3;PTTG1;FOXJ2;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;MEIKIN;MOV10L1;BRDT;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZSCAN21;HSF2BP;BCL2L11
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.20041737623861533,-0.5516165582963427,0.9817850637522769,0.9943611620552701,1.0,4/19,19.89%,CYBA;ACOX1;PARK7;PRDX2
prerank,adenine nucleotide transport (GO:0051503),-0.21033839568901902,-0.5514201383070829,0.9760147601476015,0.9939776888872797,1.0,7/17,34.59%,LRRC8D;ABCC5;SLC25A17;SLC25A24;SLC35B2;SLC17A9;SLC19A1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.23425630592638721,0.5504292383429077,0.9704016913319239,1.0,1.0,3/11,14.32%,CALM1;CALM2;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.23425630592638721,0.5504292383429077,0.9704016913319239,1.0,1.0,3/11,14.32%,CALM1;CALM2;CALM3
prerank,mRNA modification (GO:0016556),-0.19373490864760956,-0.5503874700590535,0.9710669077757685,0.993793746067842,1.0,11/22,43.89%,WTAP;NSUN2;PUS3;ZC3H13;TRMT61B;TRMT10C;PUS1;CBLL1;RPUSD2;TRMT61A;VIRMA
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.22389194476102092,-0.5495390047923642,0.9729241877256317,0.99356519970222,1.0,1/13,6.09%,ADGRV1
prerank,negative regulation of cyclase activity (GO:0031280),-0.2184422830262887,-0.545416882079719,0.9776951672862454,0.9941103344301433,1.0,1/14,6.09%,ADGRV1
prerank,macrophage migration (GO:1905517),0.21745886543610526,0.545199061258278,0.9696969696969697,1.0,1.0,3/13,18.29%,CCL2;EDNRB;CKLF
prerank,extracellular transport (GO:0006858),-0.2280721203366339,-0.5433789800795062,0.9764492753623188,0.9941414505383733,1.0,1/12,3.63%,WWP2
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.21591713071844065,-0.5425378883497112,0.9695885509838998,0.99390945268848,1.0,2/14,10.37%,ENPP1;ENPP3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.16879325061144235,0.5398092609618996,1.0,1.0,1.0,9/38,20.15%,IPO4;RUVBL1;H3-3A;HIRA;CENPL;SMARCA5;RBBP4;ASF1A;CENPO
prerank,chromatin assembly (GO:0031497),0.16520677440474837,0.5363126351987484,0.9938650306748467,1.0,1.0,9/38,21.35%,SIRT1;HMGA2;H3-3A;NAA60;SMARCA5;RBBP4;CTCF;ASF1A;NOC2L
prerank,receptor recycling (GO:0001881),-0.23243724693366147,-0.5345367616871242,0.9653179190751445,0.9951784553811601,1.0,3/10,25.64%,EHD3;ARFGEF2;PHETA1
prerank,outer dynein arm assembly (GO:0036158),-0.21072836198685163,-0.5307771986165656,0.9809160305343512,0.9954970897291556,1.0,10/14,47.12%,DNAL1;ODAD1;DNAH8;DNAAF5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,nuclear membrane disassembly (GO:0051081),-0.21527103607760942,-0.5294362440198312,0.9848484848484849,0.9953438380777837,1.0,3/14,22.03%,AKAP8L;NEK6;PRKCA
prerank,snRNA metabolic process (GO:0016073),-0.20128373764811416,-0.527896606516519,0.9851301115241635,0.9951999513525546,1.0,3/17,18.53%,INTS4;MTREX;INTS6
prerank,regulation of integrin activation (GO:0033623),-0.20476331872964115,-0.527370883392578,0.982,0.9948608346256356,1.0,4/15,27.70%,RAP1B;FARP2;FBLIM1;FERMT2
prerank,sympathetic nervous system development (GO:0048485),-0.2095588721616112,-0.5270909957019242,0.9848771266540642,0.9944881827353431,1.0,5/15,35.31%,NRP1;SOX11;NRP2;GDNF;SEMA3F
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.156407522595177,-0.5130716677592638,1.0,0.9964949675037602,1.0,15/45,37.53%,STAT3;GSDMD;USP50;TLR4;WNT5A;TMEM106A;LPL;APP;EGR1;PYCARD;MYD88;RIPK2;CASP1;FZD5;AGER
prerank,eye photoreceptor cell development (GO:0042462),0.20214290380989502,0.5115178006928464,0.979296066252588,1.0,1.0,2/15,13.34%,THY1;RORB
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.19454051975387765,0.5104587955216799,0.982532751091703,1.0,1.0,5/16,21.57%,CELF4;CIRBP;PRDX6;RBMXL1;RBM3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.21183731686081053,0.5083355239345974,0.9825708061002179,1.0,1.0,4/11,19.58%,IPMK;IP6K1;PPIP5K1;IPPK
prerank,positive regulation of bone resorption (GO:0045780),-0.2163974090986321,-0.5032765537951301,0.9793621013133208,0.9975168387456903,1.0,3/11,24.64%,SPP1;PRKCA;SYK
prerank,negative regulation of lyase activity (GO:0051350),-0.19316467430858952,-0.5023845280263168,0.9868173258003766,0.9972049507859336,1.0,1/16,6.09%,ADGRV1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1679665903016086,0.5021286192896319,0.997867803837953,1.0,1.0,3/29,14.95%,MEI4;ZCWPW1;SYCP2
prerank,protein neddylation (GO:0045116),-0.20299540998587917,-0.49918778368897154,0.9964850615114236,0.9972033842840974,1.0,5/13,33.49%,DCUN1D3;NAE1;DCUN1D5;RBX1;DCUN1D4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.15982369159110674,0.4987461541937725,0.9959183673469387,1.0,1.0,9/32,22.07%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,tRNA export from nucleus (GO:0006409),0.15982369159110674,0.4987461541937725,0.9959183673469387,1.0,1.0,9/32,22.07%,NUP210;NOL6;NUP62;NUP205;NUP54;NUP85;XPOT;RAE1;NUP107
prerank,L-serine metabolic process (GO:0006563),0.21223033122258914,0.49718455995472516,0.9807280513918629,1.0,1.0,3/10,20.32%,PHGDH;SERINC3;SRR
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.21239576901822113,0.495478927172901,0.991304347826087,1.0,1.0,2/10,13.89%,AKT1;CD36
prerank,inner dynein arm assembly (GO:0036159),0.20731583907274365,0.49444651788349925,0.9759519038076152,1.0,1.0,1/10,8.93%,CFAP100
prerank,tRNA transport (GO:0051031),-0.15710091173822333,-0.4930625667850544,0.9961389961389961,0.9975117405402356,1.0,5/35,13.28%,RANBP2;NUP42;NUP214;TPR;YBX1
prerank,dendritic cell migration (GO:0036336),-0.19264777446250528,-0.4895909690553857,0.9869402985074627,0.9974410317043075,1.0,2/16,12.95%,HMGB1;TRPM4
prerank,regulation of B cell activation (GO:0050864),0.16562193366544675,0.48885983538009187,0.9941291585127201,1.0,1.0,24/25,71.71%,FOXJ1;SH3KBP1;NOD2;ZFP36L1;LAPTM5;AHR;SAMSN1;TLR9;IGLL1;TNFSF4;MZB1;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;BANK1;FCGR2B;ZFP36L2;TNFAIP3
prerank,cellular response to radiation (GO:0071478),0.15062466959684112,0.48879161924010994,1.0,1.0,1.0,5/40,14.52%,SIRT1;EEF1D;NET1;KDM4D;CDKN1A
prerank,negative regulation of cell division (GO:0051782),0.20804646463155796,0.4883797843137468,0.9875518672199171,1.0,1.0,5/11,25.92%,E2F7;ORC6;VPS4A;SUSD2;CHMP4C
prerank,heterocycle biosynthetic process (GO:0018130),-0.1930315197371478,-0.48758796968001916,0.9884169884169884,0.9972426374295092,1.0,8/14,43.91%,MOCS1;NFS1;PYCR2;MOCS3;PYCR3;MOCS2;PYCR1;ALOX5
prerank,pinocytosis (GO:0006907),-0.2159972041863942,-0.4867081411095995,0.983177570093458,0.9969197861466518,1.0,8/10,47.49%,CARMIL1;PYCARD;RAB34;MAPKAPK3;DOCK2;AHSG;SNX33;SNX5
prerank,toxin transport (GO:1901998),-0.21259147931195843,-0.4862458506850696,0.9912739965095986,0.9965481984225177,1.0,4/10,32.85%,ANTXR2;ANTXR1;SLC22A2;ADAM10
prerank,snRNA processing (GO:0016180),0.1846721651860999,0.4804631232288496,0.9914346895074947,1.0,1.0,5/16,20.60%,INTS2;INTS11;INTS10;TOE1;INTS5
prerank,negative regulation of bone remodeling (GO:0046851),0.20633809131772624,0.4777456362751115,0.9844789356984479,1.0,1.0,2/11,11.50%,UBASH3B;P2RX7
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.183564567769477,0.4753809654407362,0.9938524590163934,1.0,1.0,14/14,81.66%,ATP6AP1;POU4F2;IFNG;TYROBP;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TRAF6
prerank,ncRNA 3'-end processing (GO:0043628),0.18538514658798402,0.47368265965328193,0.9936170212765958,0.9997508056270534,1.0,14/14,81.48%,INTS2;ERI1;TOE1;INTS5;INTS8;INTS12;PTCD1;SSB;INTS6L;INTS7;ELAC2;TRNT1;INTS14;INTS6
prerank,negative regulation of interleukin-10 production (GO:0032693),0.18252712243643096,0.4700392073678515,0.9878048780487805,0.9993726056487954,1.0,2/16,13.73%,TNFRSF21;DLL1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.1551936912652518,-0.46628799233141643,0.996116504854369,0.9979268454000619,1.0,5/28,22.93%,RC3H1;SDC4;SCRIB;DLG5;CD80
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.18892177599308094,-0.46464835074062616,0.9884615384615385,0.9976280907836208,1.0,2/13,24.64%,PRKCD;SYK
prerank,nuclear pore organization (GO:0006999),0.1776855224111067,0.4550475830758064,0.9956427015250545,0.9998376377129383,1.0,3/14,15.35%,NUP205;RTN4;NUP54
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.18059224686528347,-0.4548676180491326,0.9926739926739927,0.9979078098345636,1.0,7/14,38.74%,NCSTN;ADAM19;ABCA7;DYRK1A;ADAM10;ABCG1;ADAM17
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.15316060035191462,0.43878382547883565,1.0,1.0,1.0,7/23,23.69%,TIMM22;NDUFA13;HSP90AA1;TOMM70;TIMM10B;BAX;ROMO1
prerank,leukotriene metabolic process (GO:0006691),0.1611677473654392,0.43876001895572175,1.0,0.9994168705084729,1.0,4/19,19.27%,GGT1;MAPKAPK2;LTA4H;MGST3
prerank,male meiosis I (GO:0007141),0.1693978778175426,0.4345278088720059,0.9959349593495935,0.9989342347103148,1.0,16/16,83.08%,ING2;FOXJ3;FOXJ2;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;BRDT;SLC25A31;DDX4;TDRD9;SYCP3;ZSCAN21;HSF2BP;MYBL1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.15056348245955023,-0.42805562944382136,1.0,0.9988967580887569,1.0,3/22,16.04%,RUNX1;IRF1;DUSP10
prerank,nuclear pore complex assembly (GO:0051292),-0.18326830384239817,-0.4210554383992153,0.9982608695652174,0.9987156568108653,1.0,4/10,34.39%,TPR;NUP98;NUP93;AHCTF1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.15773811620539502,0.41861362811338265,0.9957894736842106,0.9988710487401071,1.0,1/16,6.67%,HFM1
